Clustering O 0 0.00012085562775610015
of O 0 4.076176992384717e-06
missense O 0 0.0011780679924413562
mutations O 0 0.00018155826546717435
in O 0 2.3944598069647327e-05
the O 0 0.00087800930486992
ataxia B-Disease 1 0.9999585151672363
- I-Disease 1 0.9965998530387878
telangiectasia I-Disease 1 0.9983471632003784
gene O 0 7.455303421011195e-05
in O 0 1.1759012522816192e-05
a O 0 0.00026497174985706806
sporadic B-Disease 0 0.3037433624267578
T I-Disease 1 0.9996912479400635
- I-Disease 1 0.9914366602897644
cell I-Disease 1 0.991555392742157
leukaemia I-Disease 1 0.9997782111167908
. O 0 0.00026108024758286774

Ataxia B-Disease 1 0.9998911619186401
- I-Disease 1 0.9986086487770081
telangiectasia I-Disease 1 0.9989608526229858
( O 0 0.0009034992544911802
A B-Disease 1 0.9986839890480042
- I-Disease 1 0.9967719912528992
T I-Disease 1 0.999398946762085
) O 0 3.879375981341582e-06
is O 0 4.90670436192886e-06
a O 0 5.394405889092013e-05
recessive B-Disease 1 0.8959615230560303
multi I-Disease 1 0.986151397228241
- I-Disease 1 0.9989572763442993
system I-Disease 1 0.9916478395462036
disorder I-Disease 1 0.9999908208847046
caused O 1 0.8900887966156006
by O 0 1.8614839063957334e-05
mutations O 0 6.359098915709183e-05
in O 0 2.8261176794330822e-06
the O 0 9.39394703891594e-06
ATM O 0 0.0005634891567751765
gene O 0 2.6742669433588162e-05
at O 0 5.183577013667673e-05
11q22 O 0 0.0010247885948047042
- O 0 0.00038908017450012267
q23 O 0 0.000494945386890322
( O 0 3.348206155351363e-05
ref O 0 0.006016791332513094
. O 0 4.0148688640329055e-06
3 O 0 1.6796042473288253e-05
) O 0 8.804207027424127e-06
. O 0 1.8516540876589715e-05

The O 0 0.0003895126865245402
risk O 0 0.025257905945181847
of O 0 0.000142202916322276
cancer B-Disease 1 0.9999768733978271
, O 0 9.229818533640355e-05
especially O 0 0.0002553531085141003
lymphoid B-Disease 1 0.9606631994247437
neoplasias I-Disease 0 0.36417561769485474
, O 0 2.5944187655113637e-05
is O 0 2.8723054128931835e-05
substantially O 0 0.010007994249463081
elevated O 1 0.9973536729812622
in O 0 0.00010821277101058513
A B-Disease 1 0.9997110962867737
- I-Disease 1 0.9998295307159424
T I-Disease 1 0.9999849796295166
patients O 1 0.9990084767341614
and O 0 1.4486625332210679e-05
has O 0 3.5982808185508475e-05
long O 0 0.00043617840856313705
been O 0 7.313513197004795e-05
associated O 0 0.00012582045746967196
with O 0 0.00015985354548320174
chromosomal O 1 0.9994370341300964
instability O 1 0.9980466365814209
. O 0 0.0006128725945018232

By O 0 0.00019349507056176662
analysing O 0 0.00888484064489603
tumour B-Disease 1 0.9999415874481201
DNA O 0 0.002604836132377386
from O 0 0.00030110968509688973
patients O 1 0.9795302748680115
with O 0 4.9460926675237715e-05
sporadic B-Disease 0 0.24348336458206177
T I-Disease 1 0.9991645812988281
- I-Disease 0 0.1022052988409996
cell I-Disease 0 0.20613078773021698
prolymphocytic I-Disease 1 0.9773392081260681
leukaemia I-Disease 1 0.9998944997787476
( O 0 0.0015065480256453156
T B-Disease 1 0.9982448816299438
- I-Disease 0 0.011903003789484501
PLL I-Disease 0 0.2294616997241974
) O 0 9.966256584448274e-06
, O 0 3.610867224779213e-06
a O 0 3.7209767469903454e-05
rare O 0 0.0023441913072019815
clonal B-Disease 0 0.3306733965873718
malignancy I-Disease 1 0.999175488948822
with O 0 4.615427769749658e-06
similarities O 0 1.2209105989313684e-05
to O 0 1.4968735513321008e-06
a O 0 0.0001406224473612383
mature B-Disease 0 0.016951220110058784
T I-Disease 1 0.9986541271209717
- I-Disease 0 0.04595503956079483
cell I-Disease 0 0.08298368752002716
leukaemia I-Disease 1 0.9997259974479675
seen O 0 0.00015956084826029837
in O 0 1.8115993952960707e-05
A B-Disease 1 0.9956504702568054
- I-Disease 1 0.9714330434799194
T I-Disease 1 0.9995569586753845
, O 0 1.0767729463623255e-06
we O 0 1.5091590910287778e-07
demonstrate O 0 4.5594720177177805e-07
a O 0 5.533227067644475e-07
high O 0 3.5946329717262415e-06
frequency O 0 2.6223258942081884e-07
of O 0 4.452548694189318e-07
ATM O 0 0.0012751718750223517
mutations O 0 0.0001580993994139135
in O 0 6.432260852307081e-05
T B-Disease 1 0.9970034956932068
- I-Disease 0 0.01283801905810833
PLL I-Disease 0 0.48513272404670715
. O 0 0.00014837893832009286

In O 0 2.44393122557085e-05
marked O 0 6.282691902015358e-05
contrast O 0 1.5334206182160415e-05
to O 0 5.61922604447318e-07
the O 0 3.0932681056583533e-06
ATM O 0 0.00048009835882112384
mutation O 0 4.126725980313495e-05
pattern O 0 7.435791485477239e-05
in O 0 1.7216363630723208e-05
A B-Disease 1 0.9904834032058716
- I-Disease 1 0.8669393062591553
T I-Disease 1 0.9987370371818542
, O 0 8.262853725682362e-07
the O 0 5.082933967059944e-07
most O 0 5.092346668789105e-07
frequent O 0 8.84504788700724e-06
nucleotide O 0 1.2640003660635557e-05
changes O 0 6.156444214866497e-06
in O 0 7.133834060368827e-06
this O 0 5.569493805523962e-05
leukaemia B-Disease 1 0.9997815489768982
were O 0 9.89651307463646e-05
missense O 0 0.005767591763287783
mutations O 0 0.0012144725769758224
. O 0 0.00011397785419831052

These O 0 6.221581315912772e-06
clustered O 0 0.00010535861656535417
in O 0 3.1604797641193727e-06
the O 0 2.389202336416929e-06
region O 0 1.716609176583006e-06
corresponding O 0 1.204229761242459e-06
to O 0 2.9129162726349023e-07
the O 0 2.000505674004671e-06
kinase O 0 2.1817158994963393e-05
domain O 0 2.655902790138498e-06
, O 0 5.11263294811215e-07
which O 0 2.5246120571864594e-07
is O 0 5.696057883142203e-07
highly O 0 8.336851351486985e-06
conserved O 0 7.66226185078267e-06
in O 0 8.42561166791711e-06
ATM O 0 0.0025571025907993317
- O 0 0.00015252220327965915
related O 0 1.399303164362209e-05
proteins O 0 5.972895905870246e-06
in O 0 6.982722879911307e-06
mouse O 0 0.000327962712617591
, O 0 3.2205409752350533e-06
yeast O 0 0.00013061401841696352
and O 0 7.886193088779692e-06
Drosophila O 0 0.00011078344687120989
. O 0 6.718059012200683e-05

The O 0 4.889721822110005e-05
resulting O 0 0.0003483990440145135
amino O 0 0.0002859671658370644
- O 0 0.0009200290660373867
acid O 0 0.000944268424063921
substitutions O 0 1.3915183444623835e-05
are O 0 7.689350809414464e-07
predicted O 0 4.052746226079762e-05
to O 0 4.073154968864401e-07
interfere O 0 8.132570656016469e-06
with O 0 4.091451955900993e-06
ATP O 0 0.027598435059189796
binding O 0 3.723379268194549e-05
or O 0 2.7066074835602194e-05
substrate O 0 0.0007907644030638039
recognition O 0 9.354746725875884e-05
. O 0 0.00013468354882206768

Two O 0 7.130528501875233e-06
of O 0 6.330051746772369e-06
seventeen O 0 0.0014701440231874585
mutated O 0 0.3890143632888794
T B-Disease 1 0.995011568069458
- I-Disease 0 0.0028163492679595947
PLL I-Disease 0 0.011926373466849327
samples O 0 1.3457924069371074e-05
had O 0 2.6215553589281626e-05
a O 0 3.1896041036816314e-05
previously O 0 0.0002080286358250305
reported O 0 0.0019907657988369465
A B-Disease 1 0.979555070400238
- I-Disease 1 0.939287543296814
T I-Disease 1 0.998855710029602
allele O 0 0.0002624013868626207
. O 0 7.634779467480257e-05

In O 0 6.411818321794271e-05
contrast O 0 9.791436605155468e-05
, O 0 1.192510171676986e-05
no O 0 2.1088535504532047e-05
mutations O 0 2.948623114207294e-05
were O 0 5.19676450494444e-06
detected O 0 0.0001885839010355994
in O 0 1.023432787405909e-06
the O 0 5.063743628852535e-06
p53 O 0 9.439507994102314e-05
gene O 0 3.389240009710193e-05
, O 0 5.043665169068845e-06
suggesting O 0 0.00010128472786163911
that O 0 5.80007190364995e-06
this O 0 9.197599138133228e-05
tumour B-Disease 1 0.999957799911499
suppressor O 0 0.006717660930007696
is O 0 7.699984962528106e-06
not O 0 1.6623087049083551e-06
frequently O 0 2.0208612113492563e-05
altered O 0 0.00026702976902015507
in O 0 1.075790078175487e-05
this O 0 8.92710595508106e-05
leukaemia B-Disease 1 0.9999294281005859
. O 0 0.00028703518910333514

Occasional O 0 0.0027831168845295906
missense O 0 0.0025096626486629248
mutations O 0 0.00020960169786121696
in O 0 1.3571276213042438e-05
ATM O 0 0.0014037457294762135
were O 0 1.2566962141136173e-05
also O 0 8.247098776337225e-06
found O 0 5.3900410421192646e-05
in O 0 5.266467633191496e-05
tumour B-Disease 1 0.9999302625656128
DNA O 0 0.0003337022790219635
from O 0 8.186607010429725e-05
patients O 1 0.9798579216003418
with O 0 8.348927076440305e-05
B B-Disease 1 0.8191956877708435
- I-Disease 0 0.012646698392927647
cell I-Disease 0 0.008932365104556084
non I-Disease 0 0.003261303761973977
- I-Disease 1 0.9804725050926208
Hodgkins I-Disease 1 0.9999326467514038
lymphomas I-Disease 1 0.9968512654304504
( O 0 7.981307135196403e-05
B B-Disease 0 0.0024052991066128016
- I-Disease 0 9.595589654054493e-05
NHL I-Disease 0 6.071581447031349e-05
) O 0 5.077400828668033e-07
and O 0 2.1489478285730002e-07
a O 0 1.207957848237129e-05
B B-Disease 0 0.0014638471184298396
- I-Disease 0 0.00032144514261744916
NHL I-Disease 0 0.0006225309916771948
cell O 0 0.0013578609796240926
line O 0 0.0001795437274267897
. O 0 6.869537173770368e-05

The O 0 1.3206087714934256e-05
evidence O 0 8.239127055276185e-06
of O 0 2.8691863462881884e-07
a O 0 1.3087582374282647e-05
significant O 0 7.139523859223118e-06
proportion O 0 7.967427336552646e-06
of O 0 2.3649304239370394e-06
loss O 0 0.013832839205861092
- O 0 0.00013367735664360225
of O 0 9.610486131350626e-07
- O 0 0.00015263931709341705
function O 0 3.6485630516835954e-06
mutations O 0 7.542836101492867e-06
and O 0 2.535842327233695e-07
a O 0 3.3419444207538618e-06
complete O 0 8.025185707083438e-06
absence O 0 1.744674773362931e-05
of O 0 1.963098839041777e-07
the O 0 3.8455882531707175e-06
normal O 0 3.0023449653526768e-05
copy O 0 1.2580761904246174e-05
of O 0 4.683386123360833e-07
ATM O 0 0.00040059597813524306
in O 0 1.0177078593187616e-06
the O 0 1.688094812379859e-06
majority O 0 3.883555109496228e-06
of O 0 1.218788656842662e-05
mutated O 1 0.8401260375976562
tumours B-Disease 1 0.9997206330299377
establishes O 0 0.002949815010651946
somatic O 0 0.0006903143948875368
inactivation O 0 0.0015845175366848707
of O 0 3.1982423820409167e-07
this O 0 1.6361608459192212e-06
gene O 0 1.3907196262152866e-05
in O 0 2.005977194130537e-06
the O 0 1.633289321034681e-05
pathogenesis O 0 0.09852849692106247
of O 0 1.3708782717003487e-05
sporadic B-Disease 1 0.6972261071205139
T I-Disease 1 0.999541163444519
- I-Disease 0 0.04845377057790756
PLL I-Disease 0 0.10927854478359222
and O 0 5.321402113622753e-06
suggests O 0 3.70369634765666e-05
that O 0 4.44519309894531e-06
ATM O 0 0.00043822158477269113
acts O 0 1.889022132672835e-05
as O 0 5.032523404224776e-05
a O 0 0.0029619638808071613
tumour B-Disease 1 0.9999672174453735
suppressor O 0 0.16347549855709076
. O 0 0.00018593459390103817

As O 0 1.5283358152373694e-05
constitutional O 0 1.5693649402237497e-05
DNA O 0 0.0002311114512849599
was O 0 6.18184931227006e-05
not O 0 1.0233693501504604e-06
available O 0 9.919604053720832e-07
, O 0 1.0825698382177507e-06
a O 0 2.315932397323195e-05
putative O 0 0.003428482683375478
hereditary O 1 0.9944936633110046
predisposition O 1 0.9886173605918884
to O 0 0.00017196936823893338
T B-Disease 1 0.9984392523765564
- I-Disease 0 0.003449337789788842
PLL I-Disease 0 0.021008571609854698
will O 0 7.466362035302154e-07
require O 0 2.8490603654063307e-06
further O 0 5.184404926694697e-06
investigation O 0 0.00023815696476958692
. O 0 2.2514719603350386e-05
. O 0 8.013461047085002e-05

Myotonic B-Disease 1 0.9997532963752747
dystrophy I-Disease 1 0.9999362230300903
protein O 0 0.001884741592220962
kinase O 0 0.0006438791751861572
is O 0 5.474176759889815e-06
involved O 0 2.938758825621335e-06
in O 0 4.4105021856921667e-07
the O 0 4.204121921702608e-07
modulation O 0 2.378619228693424e-06
of O 0 1.2542859906261583e-07
the O 0 1.534529474156443e-05
Ca2 O 0 0.001451727352105081
+ O 0 0.0020314501598477364
homeostasis O 0 0.2016306221485138
in O 0 0.0002607175847515464
skeletal O 1 0.9996041655540466
muscle O 1 0.9985829591751099
cells O 0 0.2262316197156906
. O 0 0.00040917861042544246

Myotonic B-Disease 1 0.9999809265136719
dystrophy I-Disease 1 0.9999971389770508
( O 1 0.7309833765029907
DM B-Disease 1 0.9999816417694092
) O 0 7.051468855934218e-05
, O 0 6.7610435507958755e-06
the O 0 1.1678024748107418e-05
most O 0 0.00011524998990353197
prevalent O 1 0.9928574562072754
muscular B-Disease 1 0.9999897480010986
disorder I-Disease 1 0.9999964237213135
in O 0 0.0008426462300121784
adults O 0 0.4806060791015625
, O 0 3.450472650001757e-05
is O 0 7.474201993318275e-05
caused O 0 0.015340271405875683
by O 0 3.3845532016130164e-05
( O 0 6.134728027973324e-05
CTG O 0 0.009143246337771416
) O 0 9.541732651996426e-06
n O 0 7.192176417447627e-05
- O 0 6.669762660749257e-05
repeat O 0 3.1782055884832516e-05
expansion O 0 3.3561957479832927e-06
in O 0 1.686828596803025e-07
a O 0 1.716953079267114e-06
gene O 0 1.4743922065463266e-06
encoding O 0 7.554834837719682e-07
a O 0 7.504020686610602e-06
protein O 0 6.782921991543844e-05
kinase O 0 0.0002394420007476583
( O 0 4.027449176646769e-05
DM B-Disease 1 0.9950828552246094
protein O 0 0.00022990313300397247
kinase O 0 0.0002962241414934397
; O 0 1.714796781016048e-05
DMPK O 0 0.004931604955345392
) O 0 3.2794907838251675e-06
and O 0 8.963231152847584e-07
involves O 0 2.5547164113959298e-05
changes O 0 1.7488360754214227e-05
in O 0 1.4242885299609043e-05
cytoarchitecture O 0 0.0022759668063372374
and O 0 1.2755939678754658e-05
ion O 0 0.0096100103110075
homeostasis O 1 0.9702481031417847
. O 0 0.00044215796515345573

To O 0 6.297717391134938e-06
obtain O 0 5.2587447498808615e-06
clues O 0 1.650958802201785e-05
to O 0 3.53878817804798e-07
the O 0 1.1798684909081203e-06
normal O 0 1.8973143596667796e-05
biological O 0 9.386522833665367e-06
role O 0 2.1197406567807775e-06
of O 0 1.8133666799258208e-06
DMPK O 0 0.013752885162830353
in O 0 1.2864741620433051e-05
cellular O 0 0.00034099421463906765
ion O 0 0.0015093934489414096
homeostasis O 0 0.4737035632133484
, O 0 7.45281295166933e-06
we O 0 5.685648147846223e-07
have O 0 4.639075541490456e-07
compared O 0 1.691131546976976e-05
the O 0 8.74087527336087e-06
resting O 0 0.0401066392660141
[ O 0 0.00032118751551024616
Ca2 O 0 0.001904698321595788
+ O 0 0.0010436897864565253
] O 0 0.00013814771955367178
i O 0 7.437860404024832e-06
, O 0 1.6946714254117978e-07
the O 0 2.8070846269656613e-07
amplitude O 0 1.099171186069725e-06
and O 0 3.669163675112941e-07
shape O 0 2.8579848731169477e-05
of O 0 1.5959076336002909e-06
depolarization O 0 0.07774100452661514
- O 0 0.008980080485343933
induced O 0 0.12142327427864075
Ca2 O 0 0.0033469952177256346
+ O 0 0.0012902090093120933
transients O 0 0.0008670840761624277
, O 0 8.44571957259177e-07
and O 0 1.4274496606958564e-07
the O 0 3.6709732853523747e-07
content O 0 6.492514330602717e-07
of O 0 7.049580403872824e-07
ATP O 0 0.09615831822156906
- O 0 0.00019031511328648776
driven O 0 2.723894067457877e-05
ion O 0 0.00025052428827621043
pumps O 0 0.0005399546935223043
in O 0 2.457200207572896e-05
cultured O 0 0.009441434405744076
skeletal O 1 0.9985697269439697
muscle O 1 0.9902616143226624
cells O 0 0.00045841385144740343
of O 0 2.822449232553481e-06
wild O 0 0.0002899302344303578
- O 0 0.0008129721973091364
type O 0 0.00016671299817971885
and O 0 1.0516546353755984e-05
DMPK O 0 0.04181498661637306
[ O 0 0.000979933305643499
- O 0 0.00327250175178051
/ O 0 0.0012591778067871928
- O 0 0.0004556463100016117
] O 0 0.0001809240347938612
knockout O 0 0.006336582358926535
mice O 0 0.01071217656135559
. O 0 7.989456207724288e-05

In O 0 8.79525687196292e-05
vitro O 0 0.0009859049459919333
- O 0 0.0012924986658617854
differentiated O 0 0.0009073529508896172
DMPK O 0 0.14647676050662994
[ O 0 0.0025362016167491674
- O 0 0.005434576887637377
/ O 0 0.0011422166135162115
- O 0 0.0002353035961277783
] O 0 7.151660247473046e-05
myotubes O 0 0.00038257791311480105
exhibit O 0 2.559280619607307e-05
a O 0 9.054463589563966e-06
higher O 0 7.438004831783473e-05
resting O 0 0.0282338447868824
[ O 0 0.0004184122080914676
Ca2 O 0 0.0020818025805056095
+ O 0 0.0010619597742334008
] O 0 8.274651918327436e-05
i O 0 7.713788363616914e-06
than O 0 2.72724037131411e-07
do O 0 9.85065412351105e-07
wild O 0 4.312029341235757e-05
- O 0 0.00027962919557467103
type O 0 0.0002098188706440851
myotubes O 0 0.0007359479204751551
because O 0 1.9618314581748564e-06
of O 0 1.1775096453447986e-07
an O 0 9.977354238799307e-06
altered O 0 6.306088471319526e-05
open O 0 6.0415964071580674e-06
probability O 0 1.6119102497214044e-07
of O 0 4.154992438998306e-07
voltage O 0 0.0003045029297936708
- O 0 0.0002126439067069441
dependent O 0 5.6919248891063035e-05
l O 0 0.0014291409170255065
- O 0 0.00011915825598407537
type O 0 9.746199793880805e-05
Ca2 O 0 0.00023109736503101885
+ O 0 0.00010134357580682263
and O 0 6.5066174101957586e-06
Na O 0 0.002264550421386957
+ O 0 0.00015610198897775263
channels O 0 2.131724431819748e-05
. O 0 1.6600937669863924e-05

The O 0 0.00011029793677153066
mutant O 0 0.0011406660778447986
myotubes O 0 0.003290302585810423
exhibit O 0 0.0001006028542178683
smaller O 0 7.441904472216265e-06
and O 0 4.01341412725742e-06
slower O 0 0.00017741529154591262
Ca2 O 0 0.0006426150212064385
+ O 0 0.00014563770673703402
responses O 0 9.026873158290982e-06
upon O 0 8.402022103837226e-06
triggering O 0 0.0006140047335065901
by O 0 2.600413245090749e-05
acetylcholine O 1 0.7227504849433899
or O 0 4.5949451305205e-05
high O 0 0.00036831951001659036
external O 0 0.0002987079496961087
K O 0 0.004006580915302038
+ O 0 0.003058931790292263
. O 0 7.687944889767095e-05

In O 0 4.407795495353639e-05
addition O 0 1.9267583411419764e-05
, O 0 3.1477743505092803e-06
we O 0 4.176532115707232e-07
observed O 0 2.4718633540032897e-06
that O 0 5.437134404928656e-07
these O 0 1.038182290358236e-06
Ca2 O 0 0.0015805846778675914
+ O 0 0.002005846006795764
transients O 0 0.005149934906512499
partially O 0 0.0020670422818511724
result O 0 3.0179613531799987e-05
from O 0 2.636559429447516e-06
an O 0 1.8621744857227895e-06
influx O 0 1.149967465607915e-05
of O 0 2.493044348739204e-07
extracellular O 0 0.00016418015002273023
Ca2 O 0 0.0003453528042882681
+ O 0 5.4745934903621674e-05
through O 0 1.2085233720426913e-06
the O 0 4.591531705955276e-06
l O 0 0.0018223692895844579
- O 0 0.00012448611960280687
type O 0 0.00010698402184061706
Ca2 O 0 0.0003931735991500318
+ O 0 0.0002782678056973964
channel O 0 5.5352305935230106e-05
. O 0 1.7883792679640464e-05

Neither O 0 0.00013757249689660966
the O 0 5.362075171433389e-06
content O 0 7.15950091034756e-06
nor O 0 1.5413790606544353e-05
the O 0 7.547345148850582e-07
activity O 0 2.1156326965865446e-06
of O 0 1.1878959185196436e-06
Na O 0 0.009522511623799801
+ O 0 0.0004739270661957562
/ O 0 0.00020475489145610482
K O 0 0.0001802858168957755
+ O 0 0.00023487523139920086
ATPase O 0 0.00036777916830033064
and O 0 1.8672801161301322e-05
sarcoplasmic O 0 0.04286424070596695
reticulum O 0 0.021893272176384926
Ca2 O 0 0.0024687377735972404
+ O 0 0.0018270123982802033
- O 0 0.0004911994910798967
ATPase O 0 0.0003683656977955252
are O 0 1.1058457403123612e-06
affected O 0 5.23239687026944e-05
by O 0 2.3314307327382267e-05
DMPK O 1 0.5978202819824219
absence O 0 0.004342301283031702
. O 0 0.00023290056560654193

In O 0 3.5847584513248876e-05
conclusion O 0 6.43729290459305e-05
, O 0 6.15519411439891e-06
our O 0 1.2132879874116043e-06
data O 0 9.019034223456401e-06
suggest O 0 2.8600408768397756e-05
that O 0 5.7678043958730996e-06
DMPK O 0 0.0039007561281323433
is O 0 3.002688345077331e-06
involved O 0 5.718466582038673e-06
in O 0 2.096067873935681e-06
modulating O 0 0.00020034346380271018
the O 0 2.7401215447753202e-06
initial O 0 8.211343811126426e-06
events O 0 7.098166179275722e-07
of O 0 5.995153742333059e-07
excitation O 0 0.0008918907842598855
- O 0 0.004460110794752836
contraction O 0 0.0027646254748106003
coupling O 0 0.0012059175642207265
in O 0 0.0004915716126561165
skeletal O 1 0.9998095631599426
muscle O 1 0.9991099238395691
. O 0 0.00024085289624053985
. O 0 0.0001811928377719596

Constitutional O 0 0.003870464162901044
RB1 O 1 0.9940363168716431
- O 0 0.005288057029247284
gene O 0 0.00020827393746003509
mutations O 0 0.00019473845895845443
in O 0 8.373324817512184e-05
patients O 1 0.9967323541641235
with O 0 0.00012054292164975777
isolated O 0 0.2502467632293701
unilateral B-Disease 0 0.05191794037818909
retinoblastoma I-Disease 1 0.9979152083396912
. O 0 0.0008300647605210543

In O 0 0.00010383559128968045
most O 0 0.00015730090672150254
patients O 1 0.9973980188369751
with O 0 0.00011279297177679837
isolated O 0 0.1303408294916153
unilateral B-Disease 0 0.014831648208200932
retinoblastoma I-Disease 1 0.9994321465492249
, O 0 0.00040597570477984846
tumor B-Disease 1 0.999539852142334
development O 0 1.683629488979932e-05
is O 0 5.295235496305395e-06
initiated O 0 8.613459067419171e-05
by O 0 5.614059318759246e-06
somatic O 0 0.0002941343409474939
inactivation O 0 0.0007010764675214887
of O 0 1.490280112648179e-07
both O 0 6.07361982929433e-07
alleles O 0 4.827069005841622e-06
of O 0 1.049985371537332e-06
the O 0 0.00019534585590008646
RB1 O 1 0.9985116124153137
gene O 0 0.0009199432679452002
. O 0 0.0001398946187691763

However O 0 6.409336492652074e-05
, O 0 3.5345083233551122e-06
some O 0 3.303071309801453e-07
of O 0 8.747761626182182e-07
these O 0 1.576739850861486e-05
patients O 1 0.9986525177955627
can O 0 4.053221709909849e-05
transmit O 0 0.0030641246121376753
retinoblastoma B-Disease 1 0.9936708211898804
predisposition O 0 0.03125183284282684
to O 0 2.605986765047419e-06
their O 0 3.856363491649972e-06
offspring O 0 0.0008499228279106319
. O 0 7.45756333344616e-05

To O 0 2.0207119177939603e-06
determine O 0 4.32048500442761e-06
the O 0 9.724625442686374e-07
frequency O 0 3.1660908916819608e-06
and O 0 5.987725444356329e-07
nature O 0 5.315092494129203e-06
of O 0 7.300808988475183e-07
constitutional O 0 0.00044605910079553723
RB1 O 1 0.9982008934020996
- O 0 0.003045197343453765
gene O 0 0.00017586593457963318
mutations O 0 0.00019962403166573495
in O 0 4.7209017793647945e-05
patients O 1 0.9982777833938599
with O 0 7.725823525106534e-05
isolated O 0 0.07933299988508224
unilateral B-Disease 0 0.010695947334170341
retinoblastoma I-Disease 1 0.9965040683746338
, O 0 1.163489378086524e-05
we O 0 1.1925701528525678e-06
analyzed O 0 3.514064883347601e-05
DNA O 0 0.0002092221548082307
from O 0 6.376270903274417e-05
peripheral O 1 0.9900156855583191
blood O 1 0.9931793212890625
and O 0 5.8875732065644115e-05
from O 0 0.006605544593185186
tumor B-Disease 1 0.9999682903289795
tissue O 1 0.9988871216773987
. O 0 0.000552749668713659

The O 0 1.1577548320929054e-05
analysis O 0 9.90974331216421e-06
of O 0 3.650178405223414e-05
tumors B-Disease 1 0.9999632835388184
from O 0 5.286962914397009e-05
54 O 0 0.00026567649911157787
( O 0 1.5061013982631266e-05
71 O 0 7.587733125546947e-05
% O 0 1.940194351846003e-06
) O 0 7.755462547720526e-07
of O 0 5.53670020053687e-07
76 O 0 0.0011258444283157587
informative O 0 0.0005944626173004508
patients O 1 0.9974330067634583
showed O 0 0.0012301068054512143
loss O 0 0.000478494941489771
of O 0 2.218445388280088e-06
constitutional O 0 0.00031161747756414115
heterozygosity O 1 0.9611124992370605
( O 0 0.0030438140965998173
LOH O 1 0.9995737671852112
) O 0 5.0405971705913544e-05
at O 0 0.00028725803713314235
intragenic O 0 0.007069860585033894
loci O 0 0.0012037254637107253
. O 0 0.0001916272594826296

Three O 0 7.733882739557885e-06
of O 0 8.437325959675945e-06
13 O 0 0.001984544564038515
uninformative O 1 0.9960135221481323
patients O 1 0.9989911913871765
had O 0 0.0003073413681704551
constitutional O 0 0.00012426977627910674
deletions O 0 0.0010015650186687708
. O 0 0.0001968200522242114

For O 0 1.4965600712457672e-05
39 O 0 0.00010500455391593277
randomly O 0 3.33038333337754e-05
selected O 0 0.00016827366198413074
tumors B-Disease 1 0.9998842477798462
, O 0 6.271414895309135e-05
SSCP O 0 0.0403909869492054
, O 0 4.9492260586703196e-05
hetero O 0 0.015610435977578163
- O 0 0.0003889785730279982
duplex O 0 0.0010616886429488659
analysis O 0 2.2730564523953944e-06
, O 0 1.8684255564949126e-06
sequencing O 0 6.410888545360649e-06
, O 0 1.431818304808985e-06
and O 0 8.902991908144031e-07
Southern O 0 1.1421221643104218e-05
blot O 0 0.00028823630418628454
analysis O 0 1.8987523162650177e-06
were O 0 2.0389820747368503e-06
used O 0 1.5899738627922488e-06
to O 0 1.0802648375829449e-06
identify O 0 4.178518429398537e-05
mutations O 0 0.00028722628485411406
. O 0 6.282691902015358e-05

Mutations O 0 0.0011606921907514334
were O 0 3.9872360503068194e-05
detected O 0 0.0009287218563258648
in O 0 1.2254716239112895e-05
21 O 0 3.649746940936893e-05
( O 0 7.65762979426654e-06
91 O 0 9.159840556094423e-05
% O 0 2.1266043859213823e-06
) O 0 1.5561370219074888e-06
of O 0 2.396740228505223e-06
23 O 0 0.05807811766862869
tumors B-Disease 1 0.9999808073043823
with O 0 0.008392262272536755
LOH O 1 0.9997232556343079
. O 0 0.00035658746492117643

In O 0 6.188231782289222e-05
6 O 0 9.72015768638812e-05
( O 0 7.129671303118812e-06
38 O 0 1.6634912753943354e-05
% O 0 2.1728001229348592e-06
) O 0 1.3212536487117177e-06
of O 0 2.320786279597087e-06
16 O 0 0.010489625856280327
tumors B-Disease 1 0.9999905824661255
without O 0 0.0010492816800251603
LOH O 1 0.9992355108261108
, O 0 4.413747774378862e-06
one O 0 1.714966288091091e-06
mutation O 0 6.903659232193604e-05
was O 0 0.00016611731552984565
detected O 0 0.0004923691158182919
, O 0 1.1663506711556693e-06
and O 0 5.896901598134718e-07
in O 0 1.9971412257291377e-06
9 O 0 1.700642860669177e-05
( O 0 1.83002566700452e-06
56 O 0 4.923203960061073e-06
% O 0 7.89513990184787e-07
) O 0 6.526826723529666e-07
of O 0 7.02757006365573e-07
the O 0 0.0022903569042682648
tumors B-Disease 1 0.9999953508377075
without O 0 0.003669832134619355
LOH O 1 0.9997246861457825
, O 0 6.865543127787532e-06
both O 0 2.3670875179959694e-06
mutations O 0 9.696124470792711e-05
were O 0 1.666610114625655e-05
found O 0 0.00017101148841902614
. O 0 8.59617066453211e-05

Thus O 0 4.430045373737812e-05
, O 0 2.401444362476468e-06
a O 0 2.069340098387329e-06
total O 0 3.5581041402110714e-07
of O 0 2.900840456732112e-07
45 O 0 1.4923515664122533e-05
mutations O 0 4.73608924949076e-05
were O 0 5.151870482222876e-06
identified O 0 0.0001517478667665273
in O 0 0.0001440869236830622
tumors B-Disease 1 0.9999527931213379
of O 0 2.059254802588839e-05
36 O 0 0.10719943791627884
patients O 1 0.9994420409202576
. O 0 0.00023783926735632122

Thirty O 0 0.0003800220147240907
- O 0 9.126421355176717e-05
nine O 0 1.2412741625666968e-06
of O 0 2.813272885759943e-07
the O 0 1.2587207493197639e-05
mutations O 0 5.201819658395834e-05
- O 0 2.4408796889474615e-05
including O 0 6.408379817912646e-07
34 O 0 5.3621979532181285e-06
small O 0 7.528980404458707e-06
mutations O 0 3.424134411034174e-05
, O 0 2.718976475080126e-06
2 O 0 1.8107219148078002e-05
large O 0 4.539700239547528e-05
structural O 0 0.04165005311369896
alterations O 0 0.011730611324310303
, O 0 1.9232320482842624e-05
and O 0 1.080062247638125e-05
hypermethylation O 0 0.08927171677350998
in O 0 0.00010068019037134945
3 O 0 0.04751129448413849
tumors O 1 0.9999902248382568
- O 0 0.0033428622409701347
were O 0 8.826855264487676e-06
not O 0 2.260052497149445e-06
detected O 0 7.250143244164065e-05
in O 0 6.827594347669219e-07
the O 0 2.2289086700766347e-06
corresponding O 0 6.399650010280311e-05
peripheral O 1 0.995579183101654
blood O 1 0.9960632920265198
DNA O 0 0.005622651427984238
. O 0 0.00021551128884311765

In O 0 5.6451775890309364e-05
6 O 0 0.00010022050992120057
( O 0 7.049256964819506e-06
17 O 0 1.687519579718355e-05
% O 0 1.2255896990609472e-06
) O 0 3.2375842806686705e-07
of O 0 1.497354702451048e-07
the O 0 1.3545505680667702e-05
36 O 0 0.0002750238636508584
patients O 1 0.9575707316398621
, O 0 5.914726898481604e-06
a O 0 2.704744656512048e-05
mutation O 0 0.00016571786545682698
was O 0 0.00022086648095864803
detected O 0 0.0002355850738240406
in O 0 1.2426362445694394e-06
constitutional O 0 8.028338015719783e-06
DNA O 0 7.00787641108036e-05
, O 0 2.472603682690533e-06
and O 0 4.0216949059868057e-07
1 O 0 1.590753413438506e-06
of O 0 9.054534899632927e-08
these O 0 8.247627647506306e-07
mutations O 0 3.351314444444142e-05
is O 0 2.8299314180912916e-06
known O 0 9.689949365565553e-06
to O 0 8.962247761701292e-07
be O 0 2.189779024774907e-06
associated O 0 2.2224767235456966e-05
with O 0 1.4770838788535912e-05
reduced O 0 0.006084940396249294
expressivity O 1 0.5792980790138245
. O 0 0.00039353841566480696

The O 0 8.520337360096164e-06
presence O 0 2.99085058941273e-06
of O 0 2.072809053288438e-07
a O 0 1.596397123648785e-05
constitutional O 0 2.350496106373612e-05
mutation O 0 0.00011733169230865315
was O 0 0.00012536501162685454
not O 0 1.4550681726177572e-06
associated O 0 5.722853529732674e-06
with O 0 1.1382926459191367e-06
an O 0 5.987702024867758e-06
early O 0 7.601550896652043e-05
age O 0 0.0010920703643932939
at O 0 0.002387220738455653
treatment O 1 0.9971091151237488
. O 0 0.0003055489796679467

In O 0 0.00016787269851192832
1 O 0 0.0008938534301705658
patient O 1 0.9033591151237488
, O 0 5.460396278067492e-05
somatic O 0 0.001994743011891842
mosaicism O 1 0.5507084727287292
was O 0 0.0001841690973378718
demonstrated O 0 2.1675226889783517e-05
by O 0 7.626587148479302e-07
molecular O 0 8.702473678567912e-06
analysis O 0 4.887351678917184e-07
of O 0 3.0845731657791475e-07
DNA O 0 0.00012256269110366702
and O 0 4.442574208951555e-06
RNA O 0 0.0002990222128573805
from O 0 8.807392441667616e-05
peripheral O 1 0.9957024455070496
blood O 1 0.9971473813056946
. O 0 0.00014848167484160513

In O 0 0.00019765768956858665
2 O 0 0.0010256568202748895
patients O 1 0.9776239395141602
without O 0 2.0095416402909905e-05
a O 0 6.275333726080135e-05
detectable O 0 0.008189373649656773
mutation O 0 0.0001853322610259056
in O 0 5.5199496273417026e-05
peripheral O 1 0.997912585735321
blood O 1 0.9991005659103394
, O 0 0.00011302295024506748
mosaicism O 1 0.9892955422401428
was O 0 0.0008981836144812405
suggested O 0 7.173496851464733e-05
because O 0 4.785140390595188e-06
1 O 0 3.554082468326669e-06
of O 0 5.097321604807803e-07
the O 0 0.000430991523899138
patients O 1 0.9997931122779846
showed O 1 0.9968230724334717
multifocal O 1 0.9999724626541138
tumors B-Disease 1 0.9999960660934448
and O 0 2.0491912437137216e-05
the O 0 8.733275535632856e-06
other O 0 2.503367795725353e-06
later O 0 0.00017100463446695358
developed O 0 0.001000619842670858
bilateral B-Disease 0 0.01013054046779871
retinoblastoma I-Disease 1 0.9976927042007446
. O 0 0.0006870073266327381

In O 0 3.0006760425749235e-05
conclusion O 0 3.338064925628714e-05
, O 0 3.567288331396412e-06
our O 0 1.026110567181604e-06
results O 0 5.8152313613391016e-06
emphasize O 0 5.133572358317906e-06
that O 0 1.0632105613694876e-06
the O 0 6.240395123313647e-06
manifestation O 0 0.0007658376707695425
and O 0 1.1302811799396295e-05
transmissibility O 0 0.0024212028365582228
of O 0 7.327641014853725e-06
retinoblastoma B-Disease 0 0.35328078269958496
depend O 0 8.528238140570465e-06
on O 0 1.965408273463254e-06
the O 0 7.677348889956193e-07
nature O 0 1.1797671959357103e-06
of O 0 7.807820168181934e-08
the O 0 2.125452965628938e-06
first O 0 3.1648833100916818e-06
mutation O 0 8.699526915734168e-06
, O 0 2.375789449615695e-07
its O 0 1.1260386401090727e-07
time O 0 3.924222653495235e-07
in O 0 5.584032010119699e-07
development O 0 1.5664915054003359e-06
, O 0 4.930524255541968e-07
and O 0 2.406432315638085e-07
the O 0 4.2284969481443113e-07
number O 0 1.8558316128292063e-07
and O 0 4.6647400608890166e-07
types O 0 3.7486536257347325e-06
of O 0 9.438417691853829e-07
cells O 0 0.0020703664049506187
that O 0 3.855076101899613e-06
are O 0 1.7528482203488238e-06
affected O 0 9.205067181028426e-05
. O 0 1.5084155165823177e-05
. O 0 4.7073343012016267e-05

Hereditary B-Disease 1 0.9995937943458557
deficiency I-Disease 1 0.9999672174453735
of I-Disease 0 2.829909590218449e-06
the I-Disease 0 1.288084877160145e-05
fifth I-Disease 0 5.254127609077841e-05
component I-Disease 0 8.036497092689388e-06
of I-Disease 0 3.29165629864292e-07
complement I-Disease 0 1.7128908439190127e-05
in O 0 2.0897585272905417e-05
man O 0 0.0015633495058864355
. O 0 6.741174729540944e-05

I O 0 0.009634854272007942
. O 0 0.000292729411739856

Clinical O 0 0.0628955140709877
, O 0 0.00012200181663502008
immunochemical O 0 0.016562020406126976
, O 0 2.64815262198681e-05
and O 0 1.0417892553959973e-05
family O 0 0.0002046832669293508
studies O 0 0.00012112167314626276
. O 0 0.00013936591858509928

The O 0 2.7374848286854103e-05
first O 0 2.175798363168724e-05
recognized O 0 6.522665353259072e-05
human O 0 0.0003449940704740584
kindred O 0 0.482594758272171
with O 0 0.0012102591572329402
hereditary B-Disease 1 0.9999308586120605
deficiency I-Disease 1 0.999992847442627
of I-Disease 0 2.6084981072926894e-06
the I-Disease 0 1.7142179785878398e-05
fifth I-Disease 0 0.00012888602213934064
component I-Disease 0 1.4361672583618201e-05
of I-Disease 0 6.865183195259306e-07
complement I-Disease 0 6.524968193843961e-05
( O 0 5.6785076594678685e-05
C5 O 0 0.13231782615184784
) O 0 7.511080184485763e-06
is O 0 9.740898349264171e-06
described O 0 0.00032046655542217195
. O 0 7.730767538305372e-05

The O 0 5.2719147788593546e-05
proband O 0 0.0013479486806318164
, O 0 6.063924047339242e-06
a O 0 1.955018160515465e-05
20 O 0 3.172288779751398e-05
- O 0 0.00026163397706113756
year O 0 4.076977711520158e-05
- O 0 0.0005687176599167287
old O 0 0.0007663723663426936
black O 0 0.0006138684111647308
female O 0 0.0029959166422486305
with O 1 0.901507556438446
systemic B-Disease 1 0.9999998807907104
lupus I-Disease 1 0.9999998807907104
erythematosus I-Disease 1 0.9999994039535522
since O 0 0.4073871970176697
age O 0 0.16025477647781372
11 O 0 0.0009725054842419922
, O 0 6.866786134196445e-05
lacked O 0 0.12930630147457123
serum O 1 0.9960854053497314
hemolytic O 1 0.9997044205665588
complement O 0 8.217807044275105e-05
activity O 0 5.824492109240964e-05
, O 0 9.35184652917087e-06
even O 0 2.7092364689451642e-05
during O 0 0.001053756452165544
remission O 1 0.99689120054245
. O 0 0.0001814568677218631

C5 O 1 0.953071653842926
was O 0 0.0035183909349143505
undetectable O 0 0.41305360198020935
in O 0 1.2252834494574927e-05
her O 0 0.00010663457214832306
serum O 0 0.030790671706199646
by O 0 4.434159109223401e-06
both O 0 1.0249779734294862e-05
immunodiffusion O 0 0.04012812674045563
and O 0 0.0002688709064386785
hemolytic O 1 0.9998468160629272
assays O 0 0.0037829838693141937
. O 0 0.0005983886658214033

Other O 0 4.174631158093689e-06
complement O 0 1.164506102213636e-05
components O 0 1.994409649341833e-05
were O 0 8.167264240910299e-06
normal O 0 0.00015125582285691053
during O 0 0.0008800207288004458
remission O 1 0.9949775338172913
of O 0 0.00012931331002619117
lupus O 1 0.9999932050704956
, O 0 0.00012084525951649994
but O 0 9.439769200980663e-05
C1 O 1 0.9944844841957092
, O 0 4.1855062590911984e-05
C4 O 0 0.04998893290758133
, O 0 3.160916458000429e-05
C2 O 1 0.8035386800765991
, O 0 1.1825691217381973e-05
and O 0 9.838177902565803e-06
C3 O 1 0.9797701835632324
levels O 0 0.002797149820253253
fell O 0 0.03672495856881142
during O 0 0.002513208193704486
exacerbations O 1 0.9940496683120728
. O 0 0.0002457171503920108

A O 0 0.000704580161254853
younger O 0 0.000370860769180581
half O 0 7.505864778067917e-05
- O 0 0.0008293971768580377
sister O 0 0.00031837113783694804
, O 0 9.841837709245738e-06
who O 0 4.3453088437672704e-05
had O 0 0.0003949924430344254
no O 0 0.00034550853888504207
underlying O 1 0.9988123178482056
disease O 1 0.9999971389770508
, O 0 5.23762937518768e-05
was O 0 0.0021777404472231865
also O 0 9.836414392339066e-06
found O 0 1.729040377540514e-05
to O 0 5.265805611998076e-06
lack O 0 0.000699763186275959
immunochemically O 0 0.08340650796890259
detectable O 1 0.6778135895729065
C5 O 1 0.927158772945404
. O 0 0.00012673993478529155

By O 0 0.0023408883716911077
hemolytic O 1 0.9996862411499023
assay O 0 0.004053525626659393
, O 0 6.337667582556605e-05
she O 0 0.00022550900757778436
exhibited O 0 0.00030565037741325796
1 O 0 1.9566557966754772e-05
- O 0 2.4456703613395803e-05
2 O 0 6.815597544118646e-07
% O 0 1.155049531575969e-07
of O 0 6.060312074396279e-08
the O 0 6.869053777336376e-06
normal O 0 0.00044274632818996906
serum O 0 0.44716233015060425
C5 O 0 0.006211897358298302
level O 0 1.8430670024827123e-05
and O 0 5.037369419369497e-07
normal O 0 1.089421220967779e-05
concentrations O 0 1.4019851732882671e-05
of O 0 7.06832281593961e-08
other O 0 7.67362962506013e-07
complement O 0 1.7282425687881187e-05
components O 0 8.337805047631264e-05
. O 0 0.00010217954695690423

C5 O 0 0.2236056923866272
levels O 0 0.00024127720098476857
of O 0 6.235275122890016e-07
other O 0 1.6260745496765594e-06
family O 0 3.410336285014637e-05
members O 0 1.7168744079754106e-06
were O 0 2.6448194603290176e-06
either O 0 4.73352929475368e-06
normal O 0 2.0101895643165335e-05
or O 0 3.5067455428361427e-06
approximately O 0 2.666193495315383e-06
half O 0 1.604698809387628e-05
- O 0 0.0001408449315931648
normal O 0 2.326273897779174e-05
, O 0 1.4163184687276953e-06
consistent O 0 1.9792367311310954e-05
with O 0 1.1989117410848849e-05
autosomal O 1 0.9837839603424072
codominant O 0 0.01668683812022209
inheritance O 0 0.000108455860754475
of O 0 1.698474989098031e-06
the O 0 6.598163599846885e-05
gene O 0 0.0018645409727469087
determining O 0 0.004142457619309425
C5 B-Disease 1 0.9999486207962036
deficiency I-Disease 1 0.9999991655349731
. O 0 0.0010749303037300706

Normal O 0 0.3401966691017151
hemolytic O 1 0.9998960494995117
titers O 1 0.9448218941688538
were O 0 4.409981920616701e-05
restored O 0 0.0002648457302711904
to O 0 1.7810630197345745e-06
both O 0 1.2641835382964928e-05
homozygous O 0 0.016334887593984604
C5 B-Disease 1 0.9996895790100098
- I-Disease 1 0.9983452558517456
deficient I-Disease 1 0.9999499320983887
( O 0 0.000303514301776886
C5D B-Disease 1 0.9980118274688721
) O 0 2.8410338927642442e-05
sera O 0 0.0010710643837228417
by O 0 1.4275179864853271e-06
addition O 0 2.5042083962034667e-06
of O 0 9.812362122829654e-07
highly O 0 0.0006644598906859756
purified O 0 0.018452288582921028
human O 0 0.0011789195705205202
C5 O 1 0.9671866297721863
. O 0 0.00024655094603076577

In O 0 5.8897974668070674e-05
specific O 0 8.953569340519607e-05
C5 O 1 0.9809277653694153
titrations O 0 0.054719120264053345
, O 0 1.679533852438908e-05
however O 0 1.901215910038445e-05
, O 0 6.214821496541845e-06
it O 0 3.530856247380143e-06
was O 0 7.211459887912497e-05
noted O 0 1.2273311767785344e-05
that O 0 4.154623809426994e-07
when O 0 3.1262700304068858e-06
limited O 0 1.623073558221222e-06
amounts O 0 4.256505235389341e-06
of O 0 1.4199118822944001e-06
C5 O 0 0.01532671321183443
were O 0 2.3143720682128333e-06
assayed O 0 3.570579065126367e-05
in O 0 5.561158786804299e-07
the O 0 9.977002264349721e-07
presence O 0 2.0422708075784612e-06
of O 0 5.20250978297554e-07
low O 0 0.00037846993654966354
dilutions O 0 0.0013299158308655024
of O 0 5.804897227790207e-06
either O 0 0.0008910405449569225
C5D B-Disease 1 0.9985525012016296
serum O 1 0.9514458775520325
, O 0 1.0204475074715447e-05
curving O 0 0.00022532565344590694
rather O 0 3.470580850262195e-06
than O 0 1.547277520330681e-06
linear O 0 0.00016133199096657336
dose O 0 0.04851952940225601
- O 0 0.0008582775481045246
response O 0 1.700973734841682e-05
plots O 0 7.37548998586135e-06
were O 0 2.6376862933830125e-06
consistently O 0 4.5272059651324525e-05
obtained O 0 1.45623534990591e-05
, O 0 3.858113814203534e-06
suggesting O 0 4.292828089091927e-05
some O 0 2.3082486677594716e-06
inhibitory O 0 0.00033453904325142503
effect O 0 0.00020497484365478158
. O 0 0.0001114191982196644

Further O 0 4.290233482606709e-05
studies O 0 3.256974741816521e-05
suggested O 0 5.546527972910553e-05
that O 0 3.519647862049169e-06
low O 0 0.0002045431756414473
dilutions O 0 0.0016038906760513783
of O 0 1.837770287238527e-05
C5D B-Disease 1 0.9991993308067322
serum O 1 0.5594971776008606
contain O 0 6.167424726299942e-05
a O 0 5.9213001804891974e-05
factor O 0 3.0027229513507336e-05
( O 0 6.790082807128783e-06
or O 0 5.951710136287147e-06
factors O 0 5.520347258425318e-06
) O 0 3.1106744700082345e-06
interfering O 0 1.50428713823203e-05
at O 0 8.076272024482023e-06
some O 0 7.151927547965897e-07
step O 0 1.5368786989711225e-05
in O 0 4.279595941625303e-06
the O 0 4.531426020548679e-05
hemolytic O 1 0.9996070265769958
assay O 0 0.0004956847405992448
of O 0 9.411504834133666e-06
C5 O 1 0.9132577180862427
, O 0 2.581931767053902e-06
rather O 0 1.5614709809597116e-06
than O 0 1.1247501561229e-06
a O 0 1.9351502487552352e-05
true O 0 4.920753781334497e-05
C5 O 1 0.6543787717819214
inhibitor O 0 0.017834626138210297
or O 0 0.00017528634634800255
inactivator O 0 0.016567153856158257
. O 0 0.00013460703485179693

Of O 0 1.896666617540177e-05
clinical O 0 0.00421884236857295
interest O 0 8.77953880262794e-06
are O 0 1.6226138086494757e-06
( O 0 4.4861189962830395e-06
a O 0 8.025537681533024e-06
) O 0 1.4680546200906974e-06
the O 0 2.8270449092815397e-06
documentation O 0 2.900743311329279e-05
of O 0 2.491029408702161e-05
membranous O 1 0.9998323917388916
glomerulonephritis B-Disease 1 0.9999914169311523
, O 1 0.9273571968078613
vasculitis B-Disease 1 0.9999973773956299
, O 0 0.025530420243740082
and O 0 0.1612289696931839
arthritis B-Disease 1 0.9999998807907104
in O 0 6.47909109829925e-05
an O 0 5.681773109245114e-05
individual O 0 2.4358103473787196e-05
lacking O 0 0.02655436098575592
C5 O 1 0.8887385129928589
( O 0 6.640925221290672e-06
and O 0 9.87380076367117e-07
its O 0 1.6496635453222552e-06
biologic O 0 0.000542186782695353
functions O 0 2.019530938923708e-06
) O 0 4.296824954508338e-06
, O 0 9.635851938583073e-07
and O 0 9.771628128874e-07
( O 0 3.911320163751952e-06
b O 0 2.2274161892710254e-05
) O 0 1.012062625704857e-06
a O 0 3.961662969231838e-06
remarkable O 0 4.3186719267396256e-05
propensity O 0 0.0017447700956836343
to O 0 8.196331327781081e-05
bacterial B-Disease 1 0.9999529123306274
infections I-Disease 1 0.9999814033508301
in O 0 3.8618469261564314e-05
the O 0 8.018459629965946e-05
proband O 0 0.025430236011743546
, O 0 7.840209946152754e-06
even O 0 5.2261775635997765e-06
during O 0 1.6866701116668992e-05
periods O 0 2.8912594643770717e-05
of O 0 2.0994407350372057e-06
low O 0 0.003589322790503502
- O 0 0.0004729166394099593
dose O 0 0.000632347771897912
or O 0 1.1244670531596057e-05
alternate O 0 4.4171956687932834e-05
- O 0 0.0022976300679147243
day O 0 0.00028988768463023007
corticosteroid O 1 0.9910691976547241
therapy O 1 0.9312604665756226
. O 0 0.00020239075820427388

Other O 0 6.895905244164169e-06
observations O 0 1.1396980880817864e-05
indicate O 0 5.172742748982273e-05
that O 0 1.9968003925896483e-06
the O 0 2.0208612113492563e-05
C5D B-Disease 1 0.9795506000518799
state O 0 3.300714070064714e-06
is O 0 2.3548657281935448e-06
compatible O 0 8.017666004889179e-06
with O 0 2.9442569484672276e-06
normal O 0 0.000156905734911561
coagulation O 0 0.0020524959545582533
function O 0 5.903051260247594e-06
and O 0 1.2300814660193282e-06
the O 0 2.497916284482926e-06
capacity O 0 8.746996172703803e-06
to O 0 7.348098165493866e-07
mount O 0 0.00031237449729815125
a O 0 0.0005776084144599736
neutrophilic O 1 0.994590163230896
leukocytosis O 1 0.9955624341964722
during O 1 0.8327423334121704
pyogenic B-Disease 1 0.9996696710586548
infection I-Disease 1 0.9999480247497559
. O 0 0.00020837364718317986
. O 0 0.00043062359327450395

Susceptibility O 1 0.8930355310440063
to O 0 0.006624310277402401
ankylosing B-Disease 1 0.9999966621398926
spondylitis I-Disease 1 0.9999995231628418
in O 0 0.0011233718832954764
twins O 0 0.027415841817855835
: O 0 9.702775059849955e-06
the O 0 1.7628160549065797e-06
role O 0 4.578318112180568e-06
of O 0 6.38659912510775e-07
genes O 0 3.0059720302233472e-05
, O 0 1.7565635062055662e-05
HLA O 1 0.9847840070724487
, O 0 3.671677177408128e-06
and O 0 1.2253442491783062e-06
the O 0 9.582659913576208e-06
environment O 0 0.00022225035354495049
. O 0 0.00011283190542599186

OBJECTIVE O 0 7.87101816968061e-05
To O 0 1.7531056073494256e-06
determine O 0 3.707072892211727e-06
the O 0 3.83536553272279e-06
relative O 0 3.820512574748136e-05
effects O 0 0.00021282583475112915
of O 0 2.1318924154911656e-06
genetic O 0 0.0004815142892766744
and O 0 1.130667169491062e-05
environmental O 0 0.00017272861441597342
factors O 0 3.78559525415767e-05
in O 0 8.201945456676185e-05
susceptibility O 1 0.9600297808647156
to O 0 0.006710391491651535
ankylosing B-Disease 1 0.9999996423721313
spondylitis I-Disease 1 0.9999998807907104
( O 0 0.04629960656166077
AS B-Disease 1 0.9947758913040161
) O 0 0.00016092744772322476
. O 0 0.0001582834083819762

METHODS O 0 0.00021197908790782094
Twins O 0 0.00190906529314816
with O 0 2.398443393758498e-05
AS B-Disease 0 0.0023460055235773325
were O 0 6.543213203258347e-06
identified O 0 1.8614377040648833e-05
from O 0 1.762204192345962e-06
the O 0 1.739635808917228e-05
Royal O 0 0.06339508295059204
National O 0 0.1072390004992485
Hospital O 1 0.9998093247413635
for O 0 0.04722242429852486
Rheumatic B-Disease 1 0.9999994039535522
Diseases I-Disease 1 0.9999933242797852
database O 0 0.07224734872579575
. O 0 0.0009249375434592366

Clinical O 0 0.031376734375953674
and O 0 7.504246605094522e-05
radiographic O 0 0.028304146602749825
examinations O 0 0.001017242670059204
were O 0 1.867460014182143e-05
performed O 0 6.564448267454281e-05
to O 0 4.939391146763228e-06
establish O 0 0.00013372249668464065
diagnoses O 1 0.9969269633293152
, O 0 0.0001595398352947086
and O 0 0.0016694829100742936
disease O 1 0.9999963045120239
severity O 1 0.9986395239830017
was O 0 0.00232982961460948
assessed O 0 0.00015271939628291875
using O 0 2.9890600217186147e-06
a O 0 1.3845714420313016e-05
combination O 0 3.0479490305879153e-05
of O 0 8.080656357378757e-07
validated O 0 0.0001717281702440232
scoring O 0 4.141956378589384e-05
systems O 0 0.0007911153370514512
. O 0 9.075322304852307e-05

HLA O 0 0.35716351866722107
typing O 0 0.0010852421401068568
for O 0 5.3819516324438155e-05
HLA O 1 0.9857447743415833
- O 0 0.0012646880932152271
B27 O 0 0.0007876483723521233
, O 0 2.290029988216702e-05
HLA O 1 0.5519415736198425
- O 0 0.00031068213866092265
B60 O 0 0.00019306880130898207
, O 0 3.5063376344623975e-06
and O 0 1.8198172256234102e-05
HLA O 1 0.9980210065841675
- O 0 0.0071176402270793915
DR1 O 1 0.6777850389480591
was O 0 7.544011896243319e-05
performed O 0 2.7199384931009263e-05
by O 0 2.777351255645044e-06
polymerase O 0 0.0002401924430159852
chain O 0 0.00015860384155530483
reaction O 0 3.0113777029328048e-05
with O 0 8.765222787587845e-07
sequence O 0 7.361968982877443e-06
- O 0 3.8745809433748946e-05
specific O 0 1.18126115467021e-06
primers O 0 6.344948633341119e-05
, O 0 3.1974418561731e-06
and O 0 3.284323383923038e-06
zygosity O 0 0.0020648441277444363
was O 0 0.00016102477093227208
assessed O 0 0.00015449766942765564
using O 0 2.099142329825554e-05
microsatellite O 0 0.008628297597169876
markers O 0 0.006367367226630449
. O 0 0.00019696573144756258

Genetic O 0 0.0011053354246541858
and O 0 9.753838639880996e-06
environmental O 0 4.635683217202313e-05
variance O 0 3.0531862194038695e-06
components O 0 3.17093072226271e-05
were O 0 7.199294941528933e-06
assessed O 0 6.079460581531748e-05
with O 0 1.6482954379171133e-06
the O 0 8.188946594600566e-06
program O 0 7.538236968684942e-05
Mx O 0 0.002147581661120057
, O 0 4.391660866076563e-07
using O 0 3.730201854068582e-07
data O 0 9.074907438844093e-07
from O 0 1.107764774133102e-06
this O 0 2.0385957100188534e-07
and O 0 3.752240615995106e-07
previous O 0 3.6602868931367993e-06
studies O 0 2.373819370404817e-06
of O 0 1.1179871535205166e-06
twins O 0 0.0058927107602357864
with O 0 4.9113212298834696e-05
AS B-Disease 0 0.3522350788116455
. O 0 0.00017695793940220028

RESULTS O 0 0.00021856835519429296
Six O 0 1.3123803000780754e-05
of O 0 2.276931354572298e-06
8 O 0 0.00024312596360687166
monozygotic O 0 0.010325095616281033
( O 0 0.00019680560217238963
MZ O 1 0.9872584939002991
) O 0 2.7572164981393144e-05
twin O 0 0.002489984268322587
pairs O 0 0.0007116798660717905
were O 0 0.0009686023695394397
disease O 1 0.9999699592590332
concordant O 0 0.17445522546768188
, O 0 1.4864753211440984e-05
compared O 0 4.052286749356426e-05
with O 0 2.401879328317591e-06
4 O 0 6.393438980012434e-06
of O 0 7.761566962471989e-07
15 O 0 4.481494033825584e-05
B27 O 0 0.000837332452647388
- O 0 0.0001723301684251055
positive O 0 1.9177394278813154e-05
dizygotic O 0 0.0016980931395664811
( O 0 5.075243461760692e-05
DZ O 0 0.06326363235712051
) O 0 1.3256712918519042e-05
twin O 0 0.000285063695628196
pairs O 0 7.394864223897457e-05
( O 0 1.2133240488765296e-05
27 O 0 2.996784314746037e-05
% O 0 3.465573172434233e-06
) O 0 9.315317583968863e-07
and O 0 2.832113636941358e-07
4 O 0 1.6365478359148256e-06
of O 0 5.057118528384308e-07
32 O 0 3.742635453818366e-05
DZ O 0 0.015699168667197227
twin O 0 0.00026285561034455895
pairs O 0 3.425280738156289e-05
overall O 0 3.092924089287408e-05
( O 0 4.8058755055535585e-06
12 O 0 6.526218385261018e-06
. O 0 1.6543048104722402e-06
5 O 0 5.735332706535701e-06
% O 0 5.310158030624734e-06
) O 0 6.521838258777279e-06
. O 0 1.8316881323698908e-05

Nonsignificant O 0 0.028828274458646774
increases O 0 0.00036737180198542774
in O 0 4.2417304939590394e-06
similarity O 0 3.1221916287904605e-05
with O 0 5.829585006722482e-06
regard O 0 1.4605077922169585e-05
to O 0 7.231469680846203e-06
age O 0 0.006190953776240349
at O 1 0.5839493870735168
disease O 1 0.9999934434890747
onset O 1 0.9997178912162781
and O 0 2.977934855152853e-06
all O 0 3.6571464079315774e-07
of O 0 2.3607253751833923e-06
the O 0 0.009062308818101883
disease O 1 0.9999955892562866
severity O 1 0.9951079487800598
scores O 0 0.0003155572048854083
assessed O 0 0.0008504258585162461
were O 0 3.687530988827348e-05
noted O 0 0.0008080185507424176
in O 0 0.0008948206668719649
disease O 1 0.9999879598617554
- O 1 0.7477424740791321
concordant O 1 0.9607494473457336
MZ O 1 0.9977883100509644
twins O 0 0.030794782564044
compared O 0 0.000946655694860965
with O 0 0.00017808712436817586
concordant O 1 0.9749438762664795
DZ O 1 0.9978258013725281
twins O 0 0.3156813383102417
. O 0 0.0004519445647019893

HLA O 1 0.9908662438392639
- O 0 0.004880984779447317
B27 O 0 0.001334704109467566
and O 0 8.653289114590734e-06
B60 O 0 0.00046311249025166035
were O 0 3.9720284803479444e-06
associated O 0 3.2303782063536346e-05
with O 0 2.718035102589056e-05
the O 0 0.0015861932188272476
disease O 1 0.9999874830245972
in O 0 4.3486586946528405e-05
probands O 0 0.025766033679246902
, O 0 2.966664624182158e-06
and O 0 5.815247732243733e-07
the O 0 3.7364684430940542e-06
rate O 0 6.0772810684284195e-05
of O 0 1.169405095424736e-05
disease O 1 0.9999710321426392
concordance O 0 0.0025660402607172728
was O 0 0.0020007246639579535
significantly O 0 0.0004576165520120412
increased O 0 4.13963025494013e-05
among O 0 1.049301317834761e-05
DZ O 0 0.2404424250125885
twin O 0 0.0004229526093695313
pairs O 0 3.093483974225819e-05
in O 0 3.2805573937366717e-06
which O 0 2.5881663532345556e-06
the O 0 2.0361785573186353e-05
co O 0 0.001617647591046989
- O 0 0.00048711089766584337
twin O 0 0.00041641504503786564
was O 0 6.328016752377152e-05
positive O 0 4.323873326939065e-06
for O 0 1.1415899052735767e-06
both O 0 8.517071364622097e-06
B27 O 0 0.0024263965897262096
and O 0 6.734120688633993e-05
DR1 O 1 0.988532543182373
. O 0 0.00019720569252967834

Additive O 0 0.002935942495241761
genetic O 0 0.0013423808850347996
effects O 0 0.0012798509560525417
were O 0 6.267268872761633e-06
estimated O 0 1.0136523087567184e-05
to O 0 4.817866283701733e-07
contribute O 0 3.1894107905827696e-06
97 O 0 1.61101470439462e-05
% O 0 2.8635307103286323e-07
of O 0 7.502351451194045e-08
the O 0 3.717452727869386e-06
population O 0 2.769456159512629e-06
variance O 0 2.627051253512036e-05
. O 0 7.509330316679552e-05

CONCLUSION O 0 0.0012878149282187223
Susceptibility O 0 0.0032967892475426197
to O 0 9.594107723387424e-06
AS B-Disease 0 0.001867658575065434
is O 0 1.3305601896718144e-05
largely O 0 2.4455443053739145e-05
genetically O 0 6.378381658578292e-05
determined O 0 1.989922020584345e-05
, O 0 2.0814627532672603e-06
and O 0 1.015776433632709e-06
the O 0 9.105206117965281e-06
environmental O 0 0.00016414928541053087
trigger O 0 0.0007170533062890172
for O 0 1.1261088729952462e-05
the O 0 0.00198314618319273
disease O 1 0.9999920129776001
is O 0 0.0001515920739620924
probably O 0 0.000996527960523963
ubiquitous O 0 0.002817278727889061
. O 0 0.00011553454532986507

HLA O 1 0.987815260887146
- O 0 0.0015850993804633617
B27 O 0 0.0002537203545216471
accounts O 0 1.925347305586911e-06
for O 0 3.4052840192089207e-07
a O 0 3.3193921353813494e-06
minority O 0 8.712785302122938e-07
of O 0 1.2683064198881766e-07
the O 0 8.687141416885424e-06
overall O 0 0.0001537150383228436
genetic O 0 0.0006970485555939376
susceptibility O 0 0.0032762072514742613
to O 0 1.0773404028441291e-05
AS B-Disease 0 0.04745827987790108
. O 0 0.00012803517165593803

Cell O 0 0.010843265801668167
cycle O 0 0.0037731132470071316
- O 0 0.0013440579641610384
dependent O 0 0.00011944950529141352
colocalization O 0 0.0006442557205446064
of O 0 2.5100471248151734e-06
BARD1 O 0 0.03070603497326374
and O 0 1.0793578439916018e-05
BRCA1 O 0 0.0006332485354505479
proteins O 0 4.111764155823039e-06
in O 0 1.705805857454834e-06
discrete O 0 1.65989749802975e-05
nuclear O 0 0.000609399052336812
domains O 0 0.00025152802118100226
. O 0 6.156219751574099e-05

Germ O 1 0.9920544624328613
- O 0 0.0017768217949196696
line O 0 7.370574894594029e-05
mutations O 0 7.115881999197882e-06
of O 0 2.668747640655056e-07
the O 0 4.933119998895563e-05
BRCA1 O 0 0.008237429894506931
gene O 0 0.0001258455158676952
predispose O 0 0.00030222852365113795
women O 0 6.852592377981637e-06
to O 0 3.945111075154273e-06
early O 0 0.0010544382967054844
- O 1 0.9958224296569824
onset O 1 0.9999467134475708
breast B-Disease 1 0.9999923706054688
and I-Disease 1 0.9927549958229065
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999991655349731
by O 0 5.052845517639071e-05
compromising O 0 0.0019340593134984374
the O 0 1.8961296518682502e-05
genes O 0 4.85328164359089e-05
presumptive O 0 0.16962550580501556
function O 0 7.153147453209385e-05
as O 0 7.29280145606026e-05
a O 0 0.003946439363062382
tumor B-Disease 1 0.9996684789657593
suppressor O 0 0.06271210312843323
. O 0 0.0001310101943090558

Although O 0 5.688143937732093e-05
the O 0 1.0396672223578207e-05
biochemical O 0 0.0003599628689698875
properties O 0 4.159340460319072e-05
of O 0 1.6048257748479955e-05
BRCA1 O 0 0.0988316535949707
polypeptides O 0 0.00025515598827041686
are O 0 1.533917725282663e-06
not O 0 3.7213937957858434e-06
understood O 0 3.389631092431955e-05
, O 0 1.2704797427431913e-06
their O 0 5.873183681615046e-07
expression O 0 7.782893590047024e-06
pattern O 0 3.230794391129166e-05
and O 0 2.159302766813198e-06
subcellular O 0 9.939109440892935e-05
localization O 0 0.00014831572480034083
suggest O 0 1.5149636055866722e-05
a O 0 8.492827873851638e-06
role O 0 1.6942292859312147e-05
in O 0 1.8553444533608854e-05
cell O 0 0.0077110943384468555
- O 0 0.0008116230019368231
cycle O 0 0.00023124637664295733
regulation O 0 0.00038513142499141395
. O 0 5.931246778345667e-05

When O 0 0.0011918123345822096
resting O 1 0.8986765146255493
cells O 0 0.0014714101562276483
are O 0 2.278321517223958e-06
induced O 0 0.0035019703209400177
to O 0 1.6946486312008346e-06
proliferate O 0 0.00018838582036551088
, O 0 8.220520726354152e-07
the O 0 1.4597939070881694e-06
steady O 0 0.0001035976383718662
- O 0 2.1975714844302274e-05
state O 0 5.879819013898668e-07
levels O 0 8.895702194422483e-06
of O 0 3.8196702689674566e-07
BRCA1 O 0 0.0006256111082620919
increase O 0 4.85471309730201e-06
in O 0 3.778659674935625e-06
late O 0 0.00017919723177328706
G1 O 0 0.010550503619015217
and O 0 4.766112056131533e-07
reach O 0 1.1091008218500065e-06
a O 0 2.7708615562005434e-06
maximum O 0 4.168766736256657e-06
during O 0 0.00018024251039605588
S O 0 0.007363176438957453
phase O 0 0.0007660628180019557
. O 0 9.73772766883485e-05

Moreover O 0 0.0006751935579814017
, O 0 1.620086550246924e-05
in O 0 1.562164834467694e-05
S O 0 0.00990605354309082
phase O 0 0.0006926446803845465
cells O 0 0.0017218776047229767
, O 0 2.0891027816105634e-05
BRCA1 O 0 0.002095951931551099
polypeptides O 0 9.431823855265975e-05
are O 0 1.598725816620572e-06
hyperphosphorylated O 0 0.0008578569395467639
and O 0 3.733191761057242e-06
accumulate O 0 0.00012746217544190586
into O 0 2.7478463380248286e-06
discrete O 0 3.632711013779044e-05
subnuclear O 0 0.005961368791759014
foci O 0 0.0025851507671177387
termed O 0 0.01847287267446518
" O 0 0.0003855011018458754
BRCA1 O 0 0.03155501186847687
nuclear O 0 0.001538387150503695
dots O 0 0.0021430370397865772
. O 0 0.00013967789709568024

" O 0 0.0008293101564049721
BRCA1 O 0 0.02578897401690483
associates O 0 0.002281276509165764
in O 0 9.212173608830199e-06
vivo O 0 0.00013332691742107272
with O 0 5.259853423922323e-06
a O 0 0.00019976873591076583
structurally O 0 0.4803626537322998
related O 0 0.0005113397492095828
protein O 0 0.0012866024626418948
termed O 0 0.17809827625751495
BARD1 O 1 0.9834040999412537
. O 0 0.0002686863881535828

Here O 0 3.120512337773107e-05
we O 0 9.019636308948975e-07
show O 0 9.964983291865792e-07
that O 0 2.1473991296261374e-07
the O 0 1.7196043700096197e-06
steady O 0 0.00011558533878996968
- O 0 2.9491631721612066e-05
state O 0 1.8423605752104777e-06
levels O 0 2.6321797122363932e-05
of O 0 1.2163490055172588e-06
BARD1 O 0 0.03257540613412857
, O 0 5.951255843683612e-06
unlike O 0 9.627451618143823e-06
those O 0 8.072122454905184e-07
of O 0 3.7863067063881317e-06
BRCA1 O 0 0.2548656761646271
, O 0 1.2029868230456486e-05
remain O 0 1.7024098269757815e-05
relatively O 0 2.143341589544434e-05
constant O 0 2.365093314438127e-05
during O 0 0.000590641750022769
cell O 0 0.012310139834880829
cycle O 0 0.004708383232355118
progression O 1 0.9592345952987671
. O 0 0.0002914209326263517

However O 0 0.00048744643572717905
, O 0 0.0001008279577945359
immunostaining O 0 0.01520549226552248
revealed O 0 0.002290444215759635
that O 0 3.0486815376207232e-05
BARD1 O 0 0.035817645490169525
resides O 0 0.00030899664852768183
within O 0 1.2243115634191781e-05
BRCA1 O 0 0.008227573707699776
nuclear O 0 0.0003529887180775404
dots O 0 0.00020761031191796064
during O 0 8.020218228921294e-05
S O 0 0.000474473723443225
phase O 0 1.5165276636253111e-05
of O 0 4.099627801679162e-07
the O 0 1.259035252587637e-05
cell O 0 0.000595674617215991
cycle O 0 6.276051135500893e-05
, O 0 1.4126964060778846e-06
but O 0 5.334982802196464e-07
not O 0 2.8534415719150275e-07
during O 0 1.5534591511823237e-05
the O 0 1.1781429748225491e-05
G1 O 0 0.22980552911758423
phase O 0 0.0007334361434914172
. O 0 0.00015641249774489552

Nevertheless O 0 0.0037514730356633663
, O 0 0.00010487907275091857
BARD1 O 0 0.011456525884568691
polypeptides O 0 0.00010112154996022582
are O 0 8.715917942936358e-07
found O 0 9.350526852358598e-06
exclusively O 0 1.771250254023471e-06
in O 0 7.721684482930868e-07
the O 0 1.1504305348353228e-06
nuclear O 0 7.361014013440581e-06
fractions O 0 2.9591777206405823e-07
of O 0 1.7600363833025767e-07
both O 0 7.230531991808675e-06
G1 O 1 0.7779346704483032
- O 0 0.00023830277496017516
and O 0 3.422634790695156e-06
S O 0 0.0032053906470537186
- O 0 0.0002581565349828452
phase O 0 0.00024664148804731667
cells O 0 0.0014321280177682638
. O 0 4.362873005447909e-05

Therefore O 0 9.493454126641154e-05
, O 0 2.55705581366783e-05
progression O 0 0.0028294604271650314
to O 0 5.398036591941491e-06
S O 0 0.0015836904058232903
phase O 0 6.046931230230257e-05
is O 0 2.076775444947998e-06
accompanied O 0 1.3475492778525222e-05
by O 0 7.914030675237882e-07
the O 0 2.0745467281813035e-06
aggregation O 0 4.985558916814625e-05
of O 0 1.393953539263748e-06
nuclear O 0 0.000763595337048173
BARD1 O 0 0.0053725047037005424
polypeptides O 0 0.00011193014506716281
into O 0 5.108987170387991e-05
BRCA1 O 0 0.03626757115125656
nuclear O 0 0.0024728511925786734
dots O 0 0.00261636427603662
. O 0 0.00017483500414527953

This O 0 3.1445062631974e-05
cell O 0 0.0022531922440975904
cycle O 0 0.0013519740896299481
- O 0 0.0004413145361468196
dependent O 0 6.774641951778904e-05
colocalization O 0 0.00042157387360930443
of O 0 3.088669473072514e-06
BARD1 O 0 0.04340030252933502
and O 0 1.4584938980988227e-05
BRCA1 O 0 0.0029361462220549583
indicates O 0 3.882481178152375e-05
a O 0 6.136357569630491e-06
role O 0 5.771435553469928e-06
for O 0 4.932127922074869e-06
BARD1 O 0 0.022121291607618332
in O 0 7.537798228440806e-05
BRCA1 O 1 0.9334439635276794
- O 0 0.034664079546928406
mediated O 1 0.7420439720153809
tumor B-Disease 1 0.9996802806854248
suppression O 0 0.10146324336528778
. O 0 0.00028953852597624063

Ethnic O 0 8.717142009118106e-06
differences O 0 3.068744626943953e-05
in O 0 1.776743374648504e-05
the O 0 6.807130557717755e-05
HFE O 1 0.8545496463775635
codon O 0 0.00033249775879085064
282 O 0 0.0015368771273642778
( O 0 0.000168877886608243
Cys O 1 0.9709195494651794
/ O 0 0.0038364906795322895
Tyr O 0 0.013857755810022354
) O 0 1.7663061953498982e-05
polymorphism O 0 0.00012374477228149772
. O 0 7.83438517828472e-05

Recent O 0 0.0003040283627342433
studies O 0 5.8108005760004744e-05
have O 0 1.3723288248002063e-05
shown O 0 0.0003382342110853642
that O 0 0.0003200196078978479
hereditary B-Disease 1 0.9999896287918091
hemochromatosis I-Disease 1 0.9999997615814209
( O 1 0.5440421104431152
HH B-Disease 1 0.9999109506607056
) O 0 4.281817746232264e-05
is O 0 1.1898156117240433e-05
likely O 0 2.157341623387765e-05
to O 0 1.0547747706368682e-06
be O 0 5.180110292712925e-06
caused O 0 0.0005096413660794497
by O 0 4.065489065396832e-06
homozygosity O 0 0.0005157192936167121
for O 0 1.2927348507218994e-06
a O 0 3.807267057709396e-05
Cys282Tyr O 0 0.001275105751119554
mutation O 0 4.608188828569837e-05
in O 0 2.584863523225067e-06
the O 0 2.612538264656905e-05
HFE O 1 0.7849125266075134
gene O 0 0.00013942905934527516
located O 0 5.781880463473499e-05
4 O 0 0.00010521122749196365
. O 0 4.1751212847884744e-05

5 O 0 0.00032774079591035843
Mb O 0 0.007544216234236956
telomeric O 0 0.0041406163945794106
to O 0 3.493622352834791e-05
HLA O 1 0.9949710369110107
- O 0 0.0015327914152294397
A O 0 0.0003259301302023232
. O 0 6.623133958783001e-05

Population O 0 6.981044407439185e-06
studies O 0 2.4697708340681856e-06
of O 0 2.2958964507324708e-07
this O 0 1.892365503408655e-06
polymorphism O 0 2.7709129426511936e-05
are O 0 3.142795890198613e-07
facilitated O 0 2.4451712306472473e-05
by O 0 1.059106921275088e-06
the O 0 2.5461292807449354e-06
fact O 0 3.3854714729386615e-06
that O 0 8.362805488104641e-07
the O 0 5.6296935326827224e-06
Cys282Tyr O 0 0.0028335656970739365
mutation O 0 0.00010262599244015291
creates O 0 8.418464130954817e-05
a O 0 5.7798843045020476e-05
Rsal O 0 0.004245167598128319
restriction O 0 0.0003398398112040013
site O 0 0.00044755791896022856
. O 0 0.00011528791219461709

We O 0 3.4751744806271745e-06
have O 0 9.830832823354285e-07
studied O 0 4.683886800194159e-06
the O 0 2.6650650397641584e-06
codon O 0 5.5503685871372e-05
282 O 0 0.0004347120993770659
( O 0 0.00012638983025681227
Cys O 1 0.9600193500518799
/ O 0 0.004006463102996349
Tyr O 0 0.007105020806193352
) O 0 3.9606693462701514e-06
polymorphism O 0 6.4071173255797476e-06
in O 0 5.384737278291141e-07
different O 0 1.4120188041033543e-07
ethnic O 0 2.453155730108847e-06
groups O 0 1.21176990433014e-05
. O 0 0.0001035276145557873

In O 0 2.018992745433934e-05
agreement O 0 2.320875682926271e-05
with O 0 3.4703657547652256e-06
previous O 0 1.4563741387974005e-05
observations O 0 9.192191100737546e-06
the O 0 2.8296317395870574e-05
Tyr O 0 0.028081929311156273
allele O 0 7.554636977147311e-05
appeared O 0 7.934576569823548e-05
to O 0 7.864913982302824e-07
be O 0 3.377158236617106e-06
rare O 0 0.00020100933033972979
or O 0 2.8883549020974897e-05
absent O 0 0.0015970028471201658
in O 0 3.497032230370678e-05
Asiatic O 0 0.023684034124016762
( O 0 2.5121637008851394e-05
Indian O 0 3.5341960028745234e-05
, O 0 7.702114999119658e-06
Chinese O 0 2.2968493794905953e-05
) O 0 2.375957956246566e-05
populations O 0 0.00010836302681127563
. O 0 8.259814785560593e-05

The O 0 1.7024975022650324e-05
highest O 0 5.4105010349303484e-05
allele O 0 9.207545190292876e-06
frequency O 0 3.4655106446734862e-06
( O 0 2.4738158117543207e-06
7 O 0 4.742996225104434e-06
. O 0 6.595567469958041e-07
5 O 0 3.0236537895689253e-06
% O 0 1.354690539301373e-06
) O 0 1.8034965023616678e-06
was O 0 4.5345601392909884e-05
found O 0 2.975420829898212e-05
in O 0 8.911384611565154e-06
Swedes O 0 0.0007435337756760418
. O 0 8.285271906061098e-05

Saamis O 0 0.010371269658207893
( O 0 4.462209835764952e-05
2 O 0 3.2277363061439246e-05
% O 0 7.5105785981577355e-06
) O 0 4.800635451829294e-06
and O 0 2.168905893995543e-06
Mordvinians O 0 0.0008330405107699335
( O 0 3.6145604553894373e-06
1 O 0 5.182788754609646e-06
. O 0 5.960907287771988e-07
8 O 0 4.096644261153415e-06
% O 0 1.4889376416249434e-06
) O 0 2.583210061857244e-06
had O 0 1.4430549526878167e-05
significantly O 0 2.2652166080661118e-05
lower O 0 2.3274011255125515e-05
frequencies O 0 2.376799983494493e-07
of O 0 2.3344279043158167e-07
the O 0 4.720910874311812e-05
Tyr O 0 0.07279207557439804
allele O 0 0.0003704395203385502
. O 0 0.00011314426228636876

Comparisons O 0 1.3147704521543346e-05
with O 0 1.9778628939093323e-06
allele O 0 6.893360932735959e-06
frequencies O 0 8.410682426074345e-07
based O 0 2.74591570814664e-06
on O 0 2.1371775801526383e-05
prevalence O 0 0.03732205554842949
estimates O 0 5.245326246949844e-05
of O 0 1.579301169840619e-05
HH B-Disease 1 0.9997522234916687
showed O 0 0.0006625000387430191
some O 0 1.428296855010558e-06
disagreements O 0 9.334386413684115e-05
with O 0 3.92079891753383e-06
the O 0 1.3726075849262998e-05
RFLP O 0 0.0017260914901271462
data O 0 1.4113973520579748e-05
, O 0 8.983763109426945e-06
particularly O 0 2.3995942683541216e-05
in O 0 2.8511414711829275e-05
Finns O 0 0.0020630990620702505
. O 0 0.00014960199769120663

The O 0 0.0002257088344777003
newly O 0 0.0018292756285518408
described O 0 0.003476469311863184
HFE O 1 0.9793096780776978
marker O 0 0.00034160848008468747
provides O 0 9.621815479476936e-06
a O 0 5.265941581455991e-06
new O 0 1.016717419588531e-06
approach O 0 9.522083814772486e-07
to O 0 2.3631847057004052e-07
the O 0 2.0990405573684257e-06
screening O 0 7.197074592113495e-05
of O 0 4.913166321784956e-06
HH B-Disease 1 0.9995855689048767
as O 0 9.259444595954847e-06
well O 0 1.640779714762175e-06
as O 0 7.102107133505342e-07
studies O 0 4.2694844637480855e-07
of O 0 1.3895866857183137e-07
the O 0 2.981597617690568e-06
relationship O 0 2.4609222236904316e-05
between O 0 1.3366750863497145e-05
the O 0 0.00030072356457822025
HFE O 1 0.9978271126747131
Tyr O 1 0.6505596041679382
allele O 0 0.00012197613250464201
and O 0 1.0656871381797828e-05
different O 0 0.00011104234727099538
disorders O 1 0.9999849796295166
including O 0 0.268729567527771
cancer B-Disease 1 0.9999943971633911

Autosomal B-Disease 1 0.9989584684371948
dominant I-Disease 1 0.9931557774543762
neurohypophyseal I-Disease 1 0.9995396137237549
diabetes I-Disease 1 0.9999990463256836
insipidus I-Disease 1 0.9997101426124573
associated O 0 0.000532081350684166
with O 0 7.8706025306019e-06
a O 0 6.223901436896995e-05
missense O 0 0.0003081435279455036
mutation O 0 4.3439340515760705e-05
encoding O 0 2.086656058963854e-05
Gly23 O 0 0.012398693710565567
- O 0 0.0034634890034794807
- O 0 0.0008926882292144
> O 0 0.0005182205350138247
Val O 0 0.0012457137927412987
in O 0 4.038105544168502e-05
neurophysin O 0 0.023962222039699554
II O 1 0.9964737296104431
. O 0 0.00031732296338304877

Autosomal B-Disease 1 0.9983420372009277
dominant I-Disease 1 0.9955564141273499
neurohypophyseal I-Disease 1 0.9997095465660095
diabetes I-Disease 1 0.9999992847442627
insipidus I-Disease 1 0.9998793601989746
( O 0 0.003539219032973051
ADNDI B-Disease 1 0.9976357221603394
) O 0 6.967641093069687e-05
is O 0 0.0001346653007203713
an O 0 0.016316555440425873
inherited B-Disease 1 0.9999972581863403
disease I-Disease 1 0.9999998807907104
caused O 1 0.9995625615119934
by O 0 0.0019108178094029427
progressive O 1 0.9991330504417419
degeneration O 1 0.9999402761459351
of O 0 8.124903615680523e-06
the O 0 0.0002674866409506649
magnocellular O 0 0.22259068489074707
neurons O 0 0.00033281807554885745
of O 0 1.091911030925985e-06
the O 0 3.543821003404446e-05
hypothalamus O 0 0.0024080718867480755
leading O 0 6.586771633010358e-05
to O 0 2.923072770499857e-06
decreased O 0 0.00025196754722855985
ability O 0 1.5525024537055288e-06
to O 0 2.1255937099340372e-07
produce O 0 2.087072061840445e-06
the O 0 1.210388472827617e-05
hormone O 0 0.014719598926603794
arginine O 0 0.0011290810070931911
vasopressin O 0 0.004159045405685902
( O 0 0.00012032243830617517
AVP O 0 0.2597007751464844
) O 0 7.042619108688086e-05
. O 0 8.055076614255086e-05

Affected O 0 0.0013835277641192079
individuals O 0 9.520153980702162e-06
are O 0 2.680154011613922e-06
not O 0 1.5525556591455825e-05
symptomatic O 1 0.995830237865448
at O 0 0.00019903143402189016
birth O 0 0.003222090657800436
, O 0 8.324505870405119e-06
but O 0 1.790526403055992e-05
usually O 0 0.0004452788853086531
develop O 0 0.06581391394138336
diabetes B-Disease 1 0.9999914169311523
insipidus I-Disease 1 0.9984138011932373
at O 0 0.0006454911199398339
1 O 0 0.0002879943058360368
- O 0 0.000767568068113178
6 O 0 5.24164606758859e-05
yr O 0 0.002120547229424119
of O 0 1.3171850241633365e-06
age O 0 0.0008871200261637568
. O 0 0.00013164570555090904

The O 0 2.7218793547945097e-05
genetic O 0 0.00012145093933213502
locus O 0 4.445547529030591e-05
of O 0 3.926344106730539e-06
the O 0 0.002756940433755517
disease O 1 0.9999884366989136
is O 0 4.383019040687941e-05
the O 0 0.00010626639414113015
AVP O 1 0.9884280562400818
- O 0 0.014025026932358742
neurophysin O 0 0.035454925149679184
II O 1 0.9869864583015442
( O 0 7.979512156452984e-05
NPII O 0 0.018939515575766563
) O 0 1.7925236534210853e-05
gene O 0 5.601777957053855e-05
, O 0 2.968254875668208e-06
and O 0 3.1286383546103025e-06
mutations O 0 9.134798165177926e-05
that O 0 7.666076271561906e-06
cause O 0 0.0245804600417614
ADNDI B-Disease 1 0.6279151439666748
have O 0 7.757535058772191e-06
been O 0 8.676476682012435e-06
found O 0 4.4334487938613165e-06
in O 0 2.839415458311123e-07
both O 0 2.188679673054139e-07
the O 0 9.758143733051838e-07
signal O 0 1.1646793609543238e-05
peptide O 0 2.0785984816029668e-05
of O 0 3.587276182770438e-07
the O 0 2.74313788395375e-05
prepro O 0 0.014185097068548203
- O 0 0.003863339312374592
AVP O 0 0.19313742220401764
- O 0 0.0007639388786628842
NPII O 0 0.00377310230396688
precursor O 0 0.00042573356768116355
and O 0 4.236402219248703e-06
within O 0 1.0568011930445209e-05
NPII O 0 0.27176183462142944
itself O 0 0.0006510469829663634
. O 0 0.00015930757217574865

An O 0 0.00025972272851504385
affected O 0 0.0006869863718748093
girl O 0 0.0031472386326640844
who O 0 2.3537260858574882e-05
presented O 0 2.593345197965391e-05
at O 0 4.571431054500863e-05
9 O 0 3.650178405223414e-05
months O 0 1.853590401879046e-05
of O 0 5.79923664645321e-07
age O 0 0.00019226984295528382
and O 0 6.623467925237492e-06
her O 0 0.0002174129622289911
similarly O 0 0.0017151932697743177
affected O 0 0.0008902741828933358
younger O 0 0.0008557832334190607
brother O 0 0.0006962574552744627
and O 0 7.292734153452329e-06
father O 0 0.0002502927090972662
were O 0 3.556388264769339e-06
all O 0 1.9084926350387832e-07
found O 0 1.2585443073476199e-05
to O 0 3.360079006142769e-07
have O 0 6.874899440845184e-07
a O 0 4.320147127145901e-06
novel O 0 3.1845676858210936e-05
missense O 0 0.0006419940036721528
mutation O 0 0.00018221729260403663
( O 0 2.845105882443022e-05
G1758 O 0 0.0016925183590501547
- O 0 0.0027734609320759773
- O 0 0.0007679090485908091
> O 0 0.0003100971516687423
T O 0 0.0010387300280854106
) O 0 6.799121621270388e-08
encoding O 0 6.991012213575232e-08
the O 0 1.815538581695364e-07
amino O 0 4.563110451272223e-06
acid O 0 0.00046486841165460646
substitution O 0 7.383504998870194e-05
Gly23 O 0 0.008131613954901695
- O 0 0.002295374870300293
- O 0 0.0005872426554560661
> O 0 0.0004839860484935343
Val O 0 0.0008759416523389518
within O 0 2.625093111419119e-05
NPII O 0 0.05636296793818474
. O 0 0.00016441420302726328

The O 0 4.3697102228179574e-05
mutation O 0 0.000341991864843294
was O 0 0.00036599452141672373
confirmed O 0 9.499467705609277e-05
by O 0 6.906692306074547e-06
restriction O 0 7.169591845013201e-05
endonuclease O 0 0.001448355265893042
analysis O 0 1.945666372193955e-05
. O 0 5.7430956076132134e-05

A O 0 0.0035832668654620647
T1 O 1 0.9763031005859375
- O 0 0.0001869646366685629
weighted O 0 7.862598067731597e-06
magnetic O 0 4.861199158767704e-06
resonance O 0 2.124541970260907e-05
imaging O 0 6.758992094546556e-05
of O 0 8.259135597654677e-07
the O 0 7.325092883547768e-05
fathers O 0 0.0010950007708743215
pituitary O 1 0.9974390268325806
gland O 1 0.9905607104301453
demonstrates O 0 0.000515572726726532
an O 0 0.0001219443729496561
attenuated O 1 0.7685973644256592
posterior O 1 0.9536871314048767
pituitary O 1 0.9963751435279846
bright O 0 0.13064146041870117
spot O 0 0.0039014918729662895
. O 0 0.00021711608860641718

This O 0 2.8475735234678723e-05
mutation O 0 0.00019752996740862727
may O 0 4.958981662639417e-05
be O 0 7.055674018374702e-07
valuable O 0 3.516521246638149e-06
for O 0 5.98733720380551e-07
developing O 0 1.9658016753965057e-05
models O 0 1.0341119377699215e-05
of O 0 1.047801379172597e-05
dominantly B-Disease 1 0.9983276724815369
inherited I-Disease 1 0.9999347925186157
neurodegeneration I-Disease 1 0.9999879598617554
, O 0 2.463187774992548e-05
as O 0 5.75332296648412e-06
the O 0 6.157971256470773e-06
early O 0 3.053115869988687e-05
age O 0 8.277279994217679e-05
of O 0 8.15888779470697e-06
onset O 1 0.9998409748077393
of O 0 0.0003678649081848562
symptoms O 1 0.9999759197235107
suggests O 0 0.0006762071279808879
that O 0 4.972711849404732e-06
this O 0 5.2169452828820795e-06
mutation O 0 0.00015226297546178102
may O 0 2.7308806238579564e-05
be O 0 9.721619562697015e-07
particularly O 0 5.9179319578106515e-06
deleterious O 0 4.8741207137936726e-05
to O 0 8.02161139290547e-07
the O 0 3.5788256354862824e-05
magnocellular O 0 0.42145684361457825
neuron O 1 0.9643094539642334
. O 0 5.229538874118589e-05
. O 0 0.0001038579794112593

Frequent O 0 0.002477169269695878
inactivation O 0 0.018809987232089043
of O 0 4.907355469185859e-05
PTEN O 1 0.9943296313285828
/ O 0 0.2291620969772339
MMAC1 O 1 0.825797438621521
in O 0 0.0009418349363841116
primary O 1 0.9976757168769836
prostate B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999982118606567
. O 0 0.0018735621124505997

Sporadic B-Disease 1 0.9953805208206177
prostate I-Disease 1 0.9999991655349731
carcinoma I-Disease 1 0.9999996423721313
is O 0 0.00010520219802856445
the O 0 1.774244083208032e-05
most O 0 2.0580710042850114e-05
common O 0 0.0008781406213529408
male B-Disease 0 0.13152816891670227
cancer I-Disease 1 0.9999756813049316
in O 0 5.1552274271671195e-06
the O 0 1.1726817319868132e-05
Western O 0 1.884730409074109e-05
world O 0 2.0499848687904887e-05
, O 0 1.877595991572889e-06
yet O 0 1.3977728485770058e-06
many O 0 5.3208573547181004e-08
of O 0 1.295253326816237e-07
the O 0 6.460516942752292e-06
major O 0 0.00010118057980434969
genetic O 0 7.674474181840196e-05
events O 0 2.805141321005067e-06
involved O 0 7.158040261856513e-06
in O 0 1.7403955325789866e-06
the O 0 4.93399556944496e-06
progression O 0 0.0036395417992025614
of O 0 1.0117643114426755e-06
this O 0 4.4663222070084885e-05
often O 0 0.08795090019702911
fatal O 1 0.999984860420227
cancer B-Disease 1 0.9999886751174927
remain O 0 0.00012731274182442576
to O 0 7.59324939281214e-06
be O 0 2.6709511075750925e-05
elucidated O 0 0.02528979815542698
. O 0 0.00012854015221819282

Numerous O 0 0.000975412258412689
cytogenetic O 0 0.0400628037750721
and O 0 6.245930126169696e-05
allelotype O 0 0.012073169462382793
studies O 0 5.9027352108387277e-05
have O 0 1.381500896968646e-05
reported O 0 0.0005067951278761029
frequent O 0 0.0002991964283864945
loss O 0 0.0010824553901329637
of O 0 6.227672201930545e-06
heterozygosity O 0 0.05995221808552742
on O 0 0.00028884701896458864
chromosomal O 1 0.9225022196769714
arm O 1 0.9829319715499878
10q O 0 0.04174989089369774
in O 0 0.0017784169176593423
sporadic B-Disease 1 0.999054491519928
prostate I-Disease 1 1.0
cancer I-Disease 1 0.9999990463256836
. O 0 0.0026188341435045004

Deletion O 0 0.002022229367867112
mapping O 0 0.00016197552031371742
studies O 0 3.0440682166954502e-05
have O 0 6.485629455710296e-06
unambiguously O 0 0.00023492272885050625
identified O 0 3.0410941690206528e-05
a O 0 7.255288437590934e-06
region O 0 3.2296143217536155e-06
of O 0 5.49003061678377e-07
chromosome O 0 0.00022245495347306132
10q23 O 0 0.00023514791973866522
to O 0 5.715227757718822e-07
be O 0 7.944664730530349e-07
the O 0 2.3555126063001808e-06
minimal O 0 0.00010177656076848507
area O 0 1.8465399989509024e-05
of O 0 4.907247330265818e-06
loss O 0 0.3386595845222473
. O 0 0.00022649159654974937

A O 0 0.0010629576863721013
new O 0 0.0006449116044677794
tumor B-Disease 1 0.9986874461174011
suppressor O 0 0.0071631004102528095
gene O 0 0.0003739369276445359
, O 0 8.423892722930759e-05
PTEN O 1 0.9251511096954346
/ O 0 0.0075835115276277065
MMAC1 O 0 0.05426929518580437
, O 0 1.8607099264045246e-05
was O 0 0.00042913827928714454
isolated O 0 0.0012856017565354705
recently O 0 0.0001978069922188297
at O 0 1.411093217029702e-05
this O 0 7.613506909365242e-07
region O 0 1.5416229643960833e-06
of O 0 6.774577059331932e-07
chromosome O 0 0.0004342455940786749
10q23 O 0 0.0006075375131331384
and O 0 2.6718037133832695e-06
found O 0 6.678263162029907e-06
to O 0 6.193836270540487e-07
be O 0 2.475227120157797e-06
inactivated O 0 0.00013017213495913893
by O 0 2.3699335542914923e-06
mutation O 0 6.380662671290338e-05
in O 0 2.450972533551976e-05
three O 0 0.0754932314157486
prostate B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999996423721313
cell O 1 0.9917730689048767
lines O 0 0.004183880984783173
. O 0 0.0003236813936382532

We O 0 0.00021903670858591795
screened O 0 0.02160640060901642
80 O 0 0.09639516472816467
prostate B-Disease 1 0.9999954700469971
tumors I-Disease 1 0.9999642372131348
by O 0 3.6229961551725864e-05
microsatellite O 0 0.0024792489130049944
analysis O 0 1.0838283742486965e-05
and O 0 6.305145234364318e-06
found O 0 5.4540774726774544e-05
chromosome O 0 0.00012287325807847083
10q23 O 0 0.00018526037456467748
to O 0 1.145674445979239e-06
be O 0 2.8366052902129013e-06
deleted O 0 6.658806523773819e-05
in O 0 8.109862392302603e-06
23 O 0 0.00019992442685179412
cases O 0 0.00037118507316336036
. O 0 9.963116463040933e-05

We O 0 4.330327101342846e-06
then O 0 4.081856332049938e-06
proceeded O 0 6.111460606916808e-06
with O 0 2.1987214893215423e-07
sequence O 0 4.243358944222564e-07
analysis O 0 2.7081929943051364e-07
of O 0 1.9026825270884729e-07
the O 0 4.153787449467927e-05
entire O 0 0.0014832830056548119
PTEN O 1 0.9879034161567688
/ O 0 0.009321555495262146
MMAC1 O 0 0.027496714144945145
coding O 0 0.0004035413439851254
region O 0 1.2803984645870514e-05
and O 0 4.349423761595972e-06
tested O 0 9.478058200329542e-05
for O 0 1.3757927490587463e-06
homozygous O 0 0.00011369875574018806
deletion O 0 0.00022877700394019485
with O 0 6.245265467441641e-06
new O 0 3.697601641761139e-05
intragenic O 0 0.003635955508798361
markers O 0 0.00026171081117354333
in O 0 2.9962777716718847e-06
these O 0 1.2047121344949119e-06
23 O 0 6.573069549631327e-05
cases O 0 7.154000195441768e-05
with O 0 1.6046851669671014e-05
10q23 O 0 0.0057084448635578156
loss O 0 0.0018694442696869373
of O 0 1.660103225731291e-05
heterozygosity O 1 0.8484755754470825
. O 0 0.0005074246437288821

The O 0 8.015325875021517e-06
identification O 0 1.6640772173559526e-06
of O 0 1.0127956073802125e-07
the O 0 3.1850672712607775e-06
second O 0 1.3191285688662902e-05
mutational O 0 0.0004273031954653561
event O 0 2.6100131435669027e-05
in O 0 3.3801773042796412e-06
10 O 0 7.00413147569634e-06
( O 0 7.226988145703217e-06
43 O 0 3.128289245069027e-05
% O 0 4.462767537916079e-05
) O 0 0.0002900264225900173
tumors B-Disease 1 0.9998607635498047
establishes O 0 0.06908008456230164
PTEN O 1 0.9940172433853149
/ O 0 0.007366163656115532
MMAC1 O 0 0.0036111478693783283
as O 0 4.841660484089516e-06
a O 0 1.1758686923712958e-05
main O 0 3.112096601398662e-05
inactivation O 0 0.0012178556062281132
target O 0 2.947875827885582e-06
of O 0 1.325597850154736e-06
10q O 0 0.004078720696270466
loss O 0 0.013416673988103867
in O 0 0.0006038474384695292
sporadic B-Disease 1 0.9993100166320801
prostate I-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
. O 0 0.00026751571567729115
. O 0 0.0003599494812078774

Risk O 0 0.03582681342959404
reversals O 0 0.0012556870933622122
in O 0 1.4411762094823644e-05
predictive O 0 0.0002845453564077616
testing O 0 0.0029105280991643667
for O 0 0.004005916882306337
Huntington B-Disease 1 0.9999920129776001
disease I-Disease 1 0.999998927116394
. O 0 0.00471227802336216

The O 0 1.06961524579674e-05
first O 0 7.6130950219521765e-06
predictive O 0 7.544831896666437e-05
testing O 0 0.0004719414282590151
for O 0 0.0004208449099678546
Huntington B-Disease 1 0.9999847412109375
disease I-Disease 1 0.9999984502792358
( O 0 0.00046830333303660154
HD B-Disease 0 0.022586390376091003
) O 0 7.2989896580111235e-06
was O 0 2.516040694899857e-05
based O 0 4.0174975879381236e-07
on O 0 8.884417184162885e-07
analysis O 0 4.4322212033875985e-07
of O 0 8.960641366684285e-07
linked O 0 0.0011358963092789054
polymorphic O 0 0.0005784464301541448
DNA O 0 0.0002598332066554576
markers O 0 9.31194590521045e-05
to O 0 8.044694368436467e-07
estimate O 0 7.019591521384427e-06
the O 0 1.1571404456844903e-06
likelihood O 0 1.3288585250847973e-05
of O 0 2.7452821882434364e-07
inheriting O 0 0.0011116564273834229
the O 0 8.33998365123989e-06
mutation O 0 8.398129284614697e-05
for O 0 9.383667929796502e-06
HD B-Disease 0 0.01622823253273964
. O 0 5.4909425671212375e-05

Limits O 0 9.643017619964667e-06
to O 0 6.284034839154629e-07
accuracy O 0 2.1959187961329008e-06
included O 0 1.050029482030368e-06
recombination O 0 1.2991631592740305e-05
between O 0 1.9556428014766425e-06
the O 0 6.497880349343177e-06
DNA O 0 0.0001537110802019015
markers O 0 6.984285573707893e-05
and O 0 1.1779234228015412e-06
the O 0 6.926375590410316e-06
mutation O 0 0.00013402161130215973
, O 0 7.569996796519263e-06
pedigree O 0 0.0013907558750361204
structure O 0 0.0002335957542527467
, O 0 4.768921826325823e-06
and O 0 1.7042416402546223e-06
whether O 0 5.628834514936898e-06
DNA O 0 5.727666575694457e-05
samples O 0 1.1558341611817013e-05
were O 0 2.746769723671605e-06
available O 0 4.063934738951502e-06
from O 0 9.114206477534026e-06
family O 0 8.085722947726026e-05
members O 0 3.617176116677001e-05
. O 0 0.00017668768123257905

With O 0 5.593462446995545e-06
direct O 0 5.80260575588909e-06
tests O 0 1.4913287486706395e-05
for O 0 6.583401841453451e-07
the O 0 2.0725512513308786e-05
HD B-Disease 0 0.005465851631015539
mutation O 0 7.558218931080773e-05
, O 0 9.6980534181057e-07
we O 0 1.945649756862622e-07
have O 0 2.2821262746219872e-07
assessed O 0 7.510320756409783e-06
the O 0 2.371008918089501e-07
accuracy O 0 4.186445607956557e-07
of O 0 1.283555377540324e-07
results O 0 1.2363084351818543e-05
obtained O 0 1.2246888218214735e-05
by O 0 3.0796220471529523e-06
linkage O 0 0.00010441117046866566
approaches O 0 1.1008530236722436e-05
when O 0 1.184383927466115e-05
requested O 0 1.0395463505119551e-05
to O 0 4.0887263708100363e-07
do O 0 3.843010745185893e-07
so O 0 4.271981026704452e-07
by O 0 4.3423017359600635e-07
the O 0 3.85561315852101e-06
test O 0 6.44355095573701e-05
individuals O 0 1.3792418940283824e-05
. O 0 0.00011865801207022741

For O 0 1.2616927961062174e-05
six O 0 1.7683993064565584e-05
such O 0 2.0305758425820386e-06
individuals O 0 5.598991720034974e-06
, O 0 5.739589596487349e-06
there O 0 5.032537956140004e-06
was O 0 0.00013481704809237272
significant O 0 1.9419107047724538e-05
disparity O 0 0.0004967835848219693
between O 0 5.2768650675716344e-06
the O 0 4.7968791477615014e-05
tests O 0 0.0005978328990750015
. O 0 8.841438830131665e-05

Three O 0 1.5068226275616325e-05
went O 0 8.263739437097684e-05
from O 0 1.1148484190925956e-05
a O 0 8.510398038197309e-05
decreased O 0 0.015893319621682167
risk O 0 0.00046172685688361526
to O 0 4.6735166847611254e-07
an O 0 9.251553819922265e-06
increased O 0 9.051865345099941e-05
risk O 0 0.0006398956757038832
, O 0 7.066273042255489e-07
while O 0 4.963417268299963e-07
in O 0 6.576706255145837e-07
another O 0 1.4288036709331209e-06
three O 0 1.7581368183527957e-06
the O 0 3.472675962257199e-05
risk O 0 0.22827230393886566
was O 0 0.0038639651611447334
decreased O 0 0.029224766418337822
. O 0 0.0001267207262571901

Knowledge O 0 5.172636065253755e-06
of O 0 8.911248983167752e-07
the O 0 8.359485036635306e-06
potential O 0 2.0789215341210365e-05
reasons O 0 3.921270035789348e-06
for O 0 3.901251659499394e-07
these O 0 3.319305221793911e-07
changes O 0 2.7819212391477777e-06
in O 0 2.79208484244009e-06
results O 0 1.0258091606374364e-05
and O 0 1.0583386256257654e-06
impact O 0 1.0769972504931502e-05
of O 0 1.0129151633009315e-06
these O 0 9.698611393105239e-06
risk O 0 0.014090834185481071
reversals O 0 0.0012778595555573702
on O 0 4.184041608823463e-05
both O 0 5.448640513350256e-05
patients O 1 0.9958386421203613
and O 0 9.941340067598503e-06
the O 0 2.2897569579072297e-05
counseling O 0 0.0003834875242318958
team O 0 7.262251983775059e-06
can O 0 6.653017976532283e-07
assist O 0 1.1014725487257238e-06
in O 0 5.110156848786573e-07
the O 0 6.481261607405031e-07
development O 0 7.996779913810315e-07
of O 0 1.9872851453328622e-07
strategies O 0 1.4844382349110674e-05
for O 0 2.113704567818786e-06
the O 0 3.465820918790996e-05
prevention O 0 0.25305595993995667
and O 0 4.486846592044458e-06
, O 0 3.6074598028790206e-06
where O 0 3.2865352750377497e-06
necessary O 0 5.833260729559697e-06
, O 0 2.751871988948551e-06
management O 0 3.0375200367416255e-05
of O 0 7.290859116437787e-07
a O 0 0.0002743696386460215
risk O 0 0.009862327948212624
reversal O 0 0.0004183711134828627
in O 0 2.5155495677608997e-06
any O 0 2.541158664826071e-06
predictive O 0 2.7663025321089663e-05
testing O 0 0.00011761856876546517
program O 0 4.369176531326957e-05
. O 0 8.35111040942138e-06
. O 0 3.135989754809998e-05

A O 0 0.00034402357414364815
novel O 0 0.0002363594830967486
common O 0 9.809125913307071e-05
missense O 0 0.0005217021098360419
mutation O 0 9.6562085673213e-05
G301C O 0 0.0002829964505508542
in O 0 2.1196899524511537e-06
the O 0 6.274170118558686e-06
N O 0 0.0007810586248524487
- O 0 0.0005808602436445653
acetylgalactosamine O 0 0.002227950841188431
- O 0 0.00031836386187933385
6 O 0 0.0001226176245836541
- O 0 0.0007737093255855143
sulfate O 0 0.09286738187074661
sulfatase O 0 0.06862122565507889
gene O 0 0.00023980274272616953
in O 0 8.071024785749614e-05
mucopolysaccharidosis B-Disease 1 0.6141254901885986
IVA I-Disease 1 0.9937506318092346
. O 0 0.00036364863626658916

Mucopolysaccharidosis B-Disease 1 0.9171554446220398
IVA I-Disease 1 0.995505690574646
( O 0 0.0014313256833702326
MPS B-Disease 1 0.9911673665046692
IVA I-Disease 1 0.9994568228721619
) O 0 6.421584112104028e-05
is O 0 2.2904254365130328e-05
an O 0 0.00012308104487601668
autosomal B-Disease 1 0.9993064403533936
recessive I-Disease 1 0.9998704195022583
lysosomal I-Disease 1 0.9999901056289673
storage I-Disease 1 0.9999659061431885
disorder I-Disease 1 0.9999980926513672
caused O 1 0.9987331032752991
by O 0 0.00011177163833053783
a O 0 0.006030598189681768
genetic B-Disease 1 0.9985687732696533
defect I-Disease 1 0.9998133778572083
in O 0 4.7356061259051785e-05
N O 0 0.0054128109477460384
- O 0 0.00156493263784796
acetylgalactosamine O 0 0.0027958545833826065
- O 0 0.0003064699994865805
6 O 0 0.0001649133046157658
- O 0 0.0018638240871950984
sulfate O 0 0.25362569093704224
sulfatase O 1 0.7447479963302612
( O 0 0.00021187422680668533
GALNS O 0 0.13698774576187134
) O 0 5.939284528722055e-05
. O 0 6.422246224246919e-05

In O 0 5.208252332522534e-05
previous O 0 8.12066500657238e-05
studies O 0 2.0739746105391532e-05
, O 0 4.283353064238327e-06
we O 0 9.886755378829548e-07
have O 0 9.701503813630552e-07
found O 0 4.7784546950424556e-06
two O 0 9.730301826493815e-07
common O 0 6.554527499247342e-05
mutations O 0 0.00021375584765337408
in O 0 2.820950248860754e-05
Caucasians O 0 0.0034514986909925938
and O 0 1.1074647773057222e-05
Japanese O 0 0.0015436182729899883
, O 0 4.7818070015637204e-05
respectively O 0 0.000261600041994825
. O 0 0.00011872569302795455

To O 0 2.006975410040468e-05
characterize O 0 0.0003760224499274045
the O 0 3.1201227102428675e-05
mutational O 0 0.0016656573861837387
spectrum O 0 5.085392331238836e-05
in O 0 7.791216489749786e-07
various O 0 2.4425358446933387e-07
ethnic O 0 1.5949460703268414e-06
groups O 0 2.146669203284546e-06
, O 0 4.618479124474106e-06
mutations O 0 2.7740587029256858e-05
in O 0 3.5397604278841754e-06
the O 0 1.9354436517460272e-05
GALNS O 0 0.02082196995615959
gene O 0 0.00014001899398863316
in O 0 3.9312206354225054e-05
Colombian O 0 0.0020616455003619194
MPS B-Disease 1 0.9968894124031067
IVA I-Disease 1 0.9999563694000244
patients O 1 0.9996448755264282
were O 0 0.00017072766786441207
investigated O 0 0.005763584282249212
, O 0 1.103256636270089e-05
and O 0 6.0430543271650095e-06
genetic O 0 0.00017291761469095945
backgrounds O 0 1.4867815480101854e-05
were O 0 1.164161858469015e-05
extensively O 0 0.00012758241791743785
analyzed O 0 3.1269264582078904e-05
to O 0 8.515296485711588e-07
identify O 0 3.3017909117916133e-06
racial O 0 5.17090484208893e-06
origin O 0 8.8732991798679e-07
, O 0 1.1183710739715025e-06
based O 0 4.1454140387031657e-07
on O 0 4.3387190089561045e-06
mitochondrial O 0 0.00010038167965831235
DNA O 0 0.00012880883878096938
( O 0 1.0176691830565687e-05
mtDNA O 0 2.988405140058603e-05
) O 0 1.0139017831534147e-05
lineages O 0 0.00012673751916736364
. O 0 8.623774192528799e-05

Three O 0 5.670811879099347e-05
novel O 0 0.00041648076148703694
missense O 0 0.003010822692885995
mutations O 0 0.0005978171830065548
never O 0 0.00017180171562358737
identified O 0 8.205434278352186e-05
previously O 0 5.8007844927487895e-05
in O 0 2.846208872142597e-06
other O 0 1.1788854408223415e-06
populations O 0 1.1289690519333817e-05
and O 0 1.4110456731941667e-06
found O 0 1.2445120773918461e-05
in O 0 1.826449533837149e-06
16 O 0 4.42716645920882e-06
out O 0 4.4078151972826163e-07
of O 0 4.2023901869470137e-07
19 O 0 0.00012620807683560997
Colombian O 0 0.0005160850705578923
MPS B-Disease 0 0.09948872774839401
IVA I-Disease 1 0.9956480860710144
unrelated O 0 0.000718932191375643
alleles O 0 3.238441058783792e-05
account O 0 1.1909781278518494e-05
for O 0 1.1175149666087236e-05
84 O 0 0.002377401804551482
. O 0 0.00013673548528458923

2 O 0 1.7650096197030507e-05
% O 0 1.3302634442879935e-06
of O 0 7.557011372227862e-08
the O 0 3.459556864982005e-06
alleles O 0 7.006102350715082e-06
in O 0 2.5883118723868392e-06
this O 0 4.180906671535922e-06
study O 0 6.76158451824449e-05
. O 0 6.903264147695154e-05

The O 0 0.00011119916598545387
G301C O 0 0.0012033615494146943
and O 0 9.776729712029919e-06
S162F O 0 0.000720554031431675
mutations O 0 2.837895226548426e-05
account O 0 2.502446477592457e-06
for O 0 6.0936695263080765e-06
68 O 0 0.0007749928627163172
. O 0 8.899856038624421e-05

4 O 0 0.00011663371697068214
% O 0 1.1935364454984665e-05
and O 0 9.402999239682686e-06
10 O 0 4.996758434572257e-05
. O 0 8.620403241366148e-05

5 O 0 4.1561961552361026e-05
% O 0 3.0251937914727023e-06
of O 0 8.621245228823682e-07
mutations O 0 0.00013525586109608412
, O 0 2.3226150460686767e-06
respectively O 0 1.324872482655337e-05
, O 0 1.645494876356679e-06
whereas O 0 6.493093223980395e-06
the O 0 2.6071948013850488e-06
remaining O 0 1.2909120414406061e-05
F69V O 0 0.004348610527813435
is O 0 2.3915069959912216e-06
limited O 0 1.0357416613260284e-06
to O 0 1.7985843214773922e-07
a O 0 3.1851584481046302e-06
single O 0 1.478524245612789e-05
allele O 0 7.544774416601285e-05
. O 0 5.37343330506701e-05

The O 0 9.154451981885359e-05
skewed O 0 0.0006116620497778058
prevalence O 0 0.003833748633041978
of O 0 2.755642981355777e-06
G301C O 0 0.0010407175868749619
in O 0 7.266783541126642e-06
only O 0 9.603269973013084e-06
Colombian O 0 0.0005658701993525028
patients O 1 0.7064151763916016
and O 0 3.304896836198168e-06
haplotype O 0 0.0002004139678319916
analysis O 0 1.2802489663954475e-06
by O 0 2.7332755507814e-06
restriction O 0 4.632673517335206e-05
fragment O 0 0.00017185135220643133
length O 0 5.647568468702957e-05
polymorphisms O 0 0.00012782937847077847
in O 0 3.317100890853908e-06
the O 0 2.0528452296275645e-05
GALNS O 0 0.05486751347780228
gene O 0 0.00011008598085027188
suggest O 0 3.822039798251353e-05
that O 0 2.228602625109488e-06
G301C O 0 0.00028061680495738983
originated O 0 1.3744991520070471e-05
from O 0 5.475910256791394e-06
a O 0 3.9830854802858084e-05
common O 0 0.00010813665721798316
ancestor O 0 0.00035525497514754534
. O 0 0.00014306984667200595

Investigation O 0 9.799122926779091e-05
of O 0 1.38160169171897e-06
the O 0 2.4145607312675565e-05
genetic O 0 0.00014766742242500186
background O 0 1.7308520909864455e-05
by O 0 1.648329885028943e-06
means O 0 1.2106770554964896e-06
of O 0 2.6720815071712423e-07
mtDNA O 0 3.1165276595856994e-05
lineages O 0 2.749087434494868e-05
indicate O 0 2.6248979338561185e-05
that O 0 1.8929755469798693e-06
all O 0 8.446597234978981e-07
our O 0 2.3048803996061906e-05
patients O 1 0.7709144353866577
are O 0 9.381871564073663e-07
probably O 0 1.9668555978569202e-05
of O 0 3.462632491846307e-07
native O 0 3.2297466532327235e-05
American O 0 0.0001450837153242901
descent O 0 0.004344217013567686

Low O 0 0.00013577482604887336
frequency O 0 3.2210539302468533e-06
of O 0 3.152000772388419e-06
BRCA1 O 0 0.00678050983697176
germline O 0 0.0012283194810152054
mutations O 0 3.149281474179588e-05
in O 0 1.1281425940978806e-05
45 O 0 0.0004112168389838189
German O 1 0.9988418221473694
breast B-Disease 1 0.9999969005584717
/ I-Disease 1 0.9999492168426514
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999992847442627
families O 0 0.0018999279709532857
. O 0 0.0008570701465941966

In O 0 1.69832055689767e-05
this O 0 3.765787823795108e-06
study O 0 2.3209333448903635e-05
we O 0 4.632131094695069e-06
investigated O 0 0.0005466124275699258
45 O 0 0.00039709784323349595
German O 1 0.99806147813797
breast B-Disease 1 0.9999967813491821
/ I-Disease 1 0.999962568283081
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999982118606567
families O 0 6.815352389821783e-05
for O 0 2.480532566551119e-05
germline O 0 0.010107227601110935
mutations O 0 6.0496186051750556e-05
in O 0 3.6194139738654485e-06
the O 0 6.737409421475604e-05
BRCA1 O 0 0.06408893316984177
gene O 0 0.00040482249460183084
. O 0 0.00010749706416390836

We O 0 1.3207498341216706e-05
identified O 0 3.6928551708115265e-05
four O 0 8.505788173351903e-06
germline O 0 0.0021219542250037193
mutations O 0 8.876758511178195e-05
in O 0 2.3912580218166113e-05
three O 0 0.0018593849381431937
breast B-Disease 1 0.9999951124191284
cancer I-Disease 1 0.9999852180480957
families O 0 3.185536843375303e-05
and O 0 5.5841405810497236e-06
in O 0 9.421721188118681e-05
one O 0 0.08737634122371674
breast B-Disease 1 0.9999994039535522
- I-Disease 1 0.9999916553497314
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
family O 0 0.002662493847310543
. O 0 1.156334656116087e-05
among O 0 1.3651540484715952e-06
these O 0 6.737157605130051e-07
were O 0 4.223904852551641e-06
one O 0 1.2030327525280882e-05
frameshift O 0 0.007066219579428434
mutation O 0 0.00011344598897267133
, O 0 2.673353264981415e-06
one O 0 2.559958829806419e-06
nonsense O 0 0.00021500434377230704
mutation O 0 9.281688835471869e-05
, O 0 1.1820793588412926e-06
one O 0 1.6714315052013262e-06
novel O 0 5.2334948122734204e-05
splice O 0 0.00040434158290736377
site O 0 0.00011953894863836467
mutation O 0 7.263921725098044e-05
, O 0 2.5645133518992225e-06
and O 0 1.2083079354852089e-06
one O 0 8.88343492988497e-06
missense O 0 0.0011526374146342278
mutation O 0 0.0006215127068571746
. O 0 0.00010712918447097763

The O 0 0.00012842449359595776
missense O 0 0.001411493169143796
mutation O 0 0.0002636633289512247
was O 0 0.00022133511083666235
also O 0 8.97944573807763e-06
found O 0 2.9460963560268283e-05
in O 0 1.0530286090215668e-05
2 O 0 0.00010360870510339737
. O 0 8.590138895669952e-05

8 O 0 4.915847603115253e-05
% O 0 2.0444338133529527e-06
of O 0 1.6889340770376293e-07
the O 0 5.684461484634085e-06
general O 0 2.9981732950545847e-05
population O 0 1.8100287206834764e-06
, O 0 4.252707185514737e-06
suggesting O 0 6.482483877334744e-05
that O 0 1.7600845012566424e-06
it O 0 3.0241151307563996e-06
is O 0 2.005222995649092e-05
not O 0 8.03214279585518e-05
disease O 1 0.9999619722366333
associated O 0 0.002708480693399906
. O 0 0.00036635127617046237

The O 0 4.611811164068058e-05
average O 0 0.0002007655130000785
age O 0 0.00043343580910004675
of O 0 8.677219739183784e-05
disease O 1 0.9999954700469971
onset O 1 0.9998979568481445
in O 0 7.703459414187819e-05
those O 0 2.3637583581148647e-05
families O 0 0.00012628115655388683
harbouring O 1 0.9937812685966492
causative O 0 0.09501566737890244
mutations O 0 0.0004739541036542505
was O 0 0.0003901275049429387
between O 0 2.151036824216135e-05
32 O 0 0.00012879213318228722
. O 0 9.558730380376801e-05

3 O 0 0.00020420488726813346
and O 0 1.641153903619852e-05
37 O 0 0.00032566642039455473
. O 0 0.00011214402184123173

4 O 0 0.0003054916160181165
years O 0 9.603425132809207e-05
, O 0 5.380844413593877e-06
whereas O 0 2.1050420400570147e-05
the O 0 8.17165073385695e-06
family O 0 0.00014134004595689476
harbouring O 0 0.017729971557855606
the O 0 1.3835629943059757e-05
missense O 0 0.00048553728265687823
mutation O 0 6.888153438922018e-05
had O 0 8.898086889530532e-06
an O 0 1.9880749277945142e-06
average O 0 1.0860922884603497e-05
age O 0 1.7015268895193003e-05
of O 0 9.299855037170346e-07
onset O 1 0.9991150498390198
of O 0 1.1335608178342227e-05
51 O 0 0.0026599192060530186
. O 0 0.00018985204224009067

2 O 0 0.0007838662713766098
years O 0 0.0006477413699030876
. O 0 0.000271097756922245

These O 0 5.296210019878345e-06
findings O 0 9.871960355667397e-05
show O 0 1.2189048902655486e-05
that O 0 4.471775355341379e-06
BRCA1 O 0 0.0026402862276881933
is O 0 1.195434288092656e-05
implicated O 0 0.0005654902197420597
in O 0 1.5462375131392037e-06
a O 0 6.9146276473475154e-06
small O 0 5.075443368696142e-06
fraction O 0 3.749515599338338e-05
of O 0 0.0002694385766517371
breast B-Disease 1 0.9999979734420776
/ I-Disease 1 0.9999678134918213
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
families O 0 0.00014795440074522048
suggesting O 0 0.0005292630521580577
the O 0 5.662980584020261e-06
involvement O 0 3.6376542993821204e-05
of O 0 1.0238437653242727e-06
another O 0 0.0001333523541688919
susceptibility O 0 0.01112748496234417
gene O 0 0.00047111421008594334
( O 0 0.00010575278429314494
s O 0 0.005384240299463272
) O 0 0.00015003985026851296

Paternal O 0 0.05916528031229973
transmission O 1 0.5296782851219177
of O 0 0.016705447807908058
congenital B-Disease 1 0.9999998807907104
myotonic I-Disease 1 0.9999996423721313
dystrophy I-Disease 1 0.9999994039535522
. O 0 0.07237820327281952

We O 0 2.1393188944784924e-05
report O 0 5.06916840095073e-05
a O 0 7.35749927116558e-05
rare O 0 0.0009696419583633542
case O 0 0.00021504492906387895
of O 0 4.367635483504273e-05
paternally O 1 0.9981682300567627
transmitted O 1 0.9998795986175537
congenital B-Disease 1 0.9999998807907104
myotonic I-Disease 1 0.9999990463256836
dystrophy I-Disease 1 0.9999995231628418
( O 1 0.9956364035606384
DM B-Disease 1 0.9999884366989136
) O 0 0.0018954218830913305
. O 0 0.00036544117028824985

The O 0 6.711246533086523e-05
proband O 0 0.002026487374678254
is O 0 7.956060471769888e-06
a O 0 2.568822310422547e-05
23 O 0 7.377564907073975e-05
year O 0 0.00012133471318520606
old O 0 0.018554601818323135
, O 0 0.00032369003747589886
mentally B-Disease 1 0.999931812286377
retarded I-Disease 1 0.9997833371162415
male O 1 0.8143003582954407
who O 1 0.995667576789856
suffers O 1 0.999996542930603
severe O 1 0.9999963045120239
muscular B-Disease 1 0.9999971389770508
weakness I-Disease 1 0.9999488592147827
. O 0 0.005328385159373283

He O 0 0.0010735548567026854
presented O 0 0.0009892955422401428
with O 0 0.0106480298563838
respiratory O 1 0.9999954700469971
and O 0 0.00025363979511894286
feeding O 0 0.1296105682849884
difficulties O 0 0.02532503567636013
at O 0 0.0022020807955414057
birth O 0 0.0566927008330822
. O 0 0.000197250657947734

His O 0 0.00046629569260403514
two O 0 0.00034770078491419554
sibs O 1 0.9968306422233582
suffer O 1 0.9983381032943726
from O 0 0.0015744937118142843
childhood O 1 0.9991430044174194
onset O 1 0.9999816417694092
DM B-Disease 1 0.9999842643737793
. O 0 0.0038470840081572533

Their O 0 2.8247810405446216e-05
late O 0 0.0006916545098647475
father O 0 0.0002783908857963979
had O 0 3.830852438113652e-05
the O 0 3.220325879738084e-06
adult O 0 4.5094795495970175e-05
type O 0 0.0005286845262162387
of O 0 2.3217038688017055e-05
DM B-Disease 1 0.999968409538269
, O 0 2.9857106710551307e-05
with O 0 4.66031015093904e-05
onset O 1 0.9996091723442078
around O 0 3.448328061494976e-05
30 O 0 0.00012725374836008996
years O 0 0.0002114742383128032
. O 0 7.951520819915459e-05

Only O 0 5.140798293723492e-06
six O 0 7.432698112097569e-06
other O 0 9.654543191572884e-07
cases O 0 3.116925654467195e-05
of O 0 2.384711024205899e-06
paternal O 0 0.054158639162778854
transmission O 1 0.5146865248680115
of O 0 0.0023550651967525482
congenital B-Disease 1 0.9999998807907104
DM I-Disease 1 0.9999947547912598
have O 0 0.0007733440725132823
been O 0 0.0019055630546063185
reported O 0 0.006752027198672295
recently O 0 0.005551127716898918
. O 0 0.0001872115390142426

We O 0 8.130832611641381e-06
review O 0 1.8821152480086312e-05
the O 0 6.969404694245895e-06
sex O 0 7.59552203817293e-05
related O 0 8.570452337153256e-05
effects O 0 0.0015844120644032955
on O 0 9.099656017497182e-05
transmission O 0 0.21653752028942108
of O 0 0.0007376678404398263
congenital B-Disease 1 0.9999998807907104
DM I-Disease 1 0.999994158744812
. O 0 0.006384317763149738

Decreased O 0 0.027272025123238564
fertility O 0 0.005604527425020933
of O 0 1.5914483810774982e-06
males O 0 4.354684642748907e-05
with O 0 5.4118943808134645e-05
adult O 0 0.10267160832881927
onset O 1 0.9999479055404663
DM B-Disease 1 0.9999725818634033
and O 0 2.0472827600315213e-05
contraction O 0 0.000820162589661777
of O 0 5.814210908283712e-07
the O 0 9.890237379295286e-06
repeat O 0 0.00042833047336898744
upon O 0 1.532441092422232e-05
male O 0 9.51326364884153e-05
transmission O 0 0.0002253901184303686
contribute O 0 3.7691902434744406e-06
to O 0 2.2269702526500623e-07
the O 0 2.5054457637452288e-06
almost O 0 1.1879380508617032e-05
absent O 0 0.00033257188624702394
occurrence O 0 5.5588552640983835e-05
of O 0 2.2925341909285635e-06
paternal O 0 0.03616509959101677
transmission O 0 0.47121766209602356
of O 0 0.002961434656754136
congenital B-Disease 1 0.9999998807907104
DM I-Disease 1 0.9999943971633911
. O 0 0.006649813149124384

Also O 0 3.121429108432494e-05
the O 0 3.883651515934616e-06
fathers O 0 8.123144652927294e-06
of O 0 8.117901870718924e-07
the O 0 0.00013548447168432176
reported O 0 0.030276572331786156
congenitally O 1 0.9923638105392456
affected O 0 0.0009017568663693964
children O 0 0.0001330086961388588
showed O 0 0.00023116034572012722
, O 0 2.2538752091350034e-06
on O 0 5.827739187225234e-06
average O 0 3.2763826311565936e-05
, O 0 7.174018719524611e-06
shorter O 0 0.0005304096848703921
CTG O 0 0.027953777462244034
repeat O 0 0.0007452991558238864
lengths O 0 0.0003017293056473136
and O 0 1.149360014096601e-05
hence O 0 0.0001948547433130443
less O 0 0.0021073531825095415
severe O 1 0.9999598264694214
clinical O 1 0.9996511936187744
symptoms O 1 0.9999585151672363
than O 0 1.6412055629189126e-05
the O 0 5.589814099948853e-05
mothers O 0 0.0023759573232382536
of O 0 7.415761956508504e-06
children O 0 0.011027066968381405
with O 1 0.8959991335868835
congenital B-Disease 1 1.0
DM I-Disease 1 0.9999967813491821
. O 0 0.009592358022928238

We O 0 1.033788521453971e-05
conclude O 0 9.284760744776577e-05
that O 0 5.482891083374852e-06
paternal O 0 0.000750803155824542
transmission O 0 0.009310985915362835
of O 0 0.0006064004264771938
congenital B-Disease 1 0.9999998807907104
DM I-Disease 1 0.9999960660934448
is O 0 0.0007891313289292157
rare O 0 0.006149117834866047
and O 0 9.621971912565641e-06
preferentially O 0 0.00022156781051307917
occurs O 0 9.749695163918659e-05
with O 0 1.7219203073182143e-05
onset O 1 0.9993748068809509
of O 0 7.300727884285152e-05
DM B-Disease 1 0.999937891960144
past O 0 7.173955236794427e-05
30 O 0 3.2079773518489674e-05
years O 0 1.8941562302643433e-05
in O 0 2.859204869309906e-06
the O 0 1.0435880540171638e-05
father O 0 0.0005766281974501908
. O 0 2.6304131097276695e-05
. O 0 5.25221366842743e-05

The O 0 0.00035664168535731733
RB1 O 1 0.9710956811904907
gene O 0 0.0002097132382914424
mutation O 0 5.036230504629202e-05
in O 0 7.029264907032484e-06
a O 0 4.389452806208283e-05
child O 0 0.002985352650284767
with O 0 0.0012939489679411054
ectopic B-Disease 1 0.9997521042823792
intracranial I-Disease 1 0.9999834299087524
retinoblastoma I-Disease 1 0.9996445178985596
. O 0 0.0016286767786368728

The O 0 0.0004622861451935023
RB1 O 1 0.9843706488609314
gene O 0 0.00036808010190725327
mutation O 0 0.00035470115835778415
was O 0 0.00019767276535276324
investigated O 0 0.0001492455048719421
in O 0 4.684700343204895e-06
a O 0 8.344239176949486e-05
child O 0 0.0015835026279091835
with O 0 0.0002429720916552469
ectopic B-Disease 1 0.9992392063140869
intracranial I-Disease 1 0.9999310970306396
retinoblastoma I-Disease 1 0.9892895817756653
using O 0 2.1543684852076694e-05
DNA O 0 7.867896056268364e-05
obtained O 0 6.798674348829081e-06
from O 0 3.7848051306355046e-06
both O 0 3.923016720364103e-06
the O 0 4.9222555389860645e-05
pineal B-Disease 0 0.4651908278465271
and I-Disease 0 0.00018392516358289868
retinal I-Disease 1 0.999437153339386
tumours I-Disease 1 0.9999229907989502
of O 0 1.4944095710234251e-05
the O 0 0.0026027641724795103
patient O 1 0.9992778897285461
. O 0 0.0005575555260293186

A O 0 0.0009350383188575506
nonsense O 0 0.0007815064745955169
mutation O 0 8.442147372988984e-05
in O 0 5.6973190112330485e-06
exon O 0 0.00043180122156627476
17 O 0 5.6723045418038964e-05
( O 0 5.404222520155599e-06
codon O 0 1.9651157344924286e-05
556 O 0 8.649072697153315e-05
) O 0 6.857154062345217e-07
of O 0 2.5312877482974727e-07
the O 0 4.661795173888095e-05
RB1 O 1 0.9952151775360107
gene O 0 0.00016054397565312684
was O 0 8.676250581629574e-05
found O 0 7.778738108754624e-06
to O 0 1.474077180319e-07
be O 0 5.73503086798155e-07
present O 0 2.904997927544173e-06
homozygously O 0 0.0003274734190199524
in O 0 2.1173464119783603e-06
both O 0 2.1211581042734906e-06
the O 0 5.763658555224538e-05
retinal B-Disease 1 0.9973523616790771
and I-Disease 0 5.049877654528245e-05
the I-Disease 0 0.001199522172100842
pineal I-Disease 1 0.9976791739463806
tumours I-Disease 1 0.9999237060546875
. O 0 0.0010749875800684094

The O 0 2.7967353162239306e-05
same O 0 1.5011341929493938e-05
mutation O 0 0.00010984094114974141
was O 0 5.1756644097622484e-05
present O 0 9.816192687139846e-06
heterozygously O 0 0.0004420146287884563
in O 0 2.1071093669888796e-06
the O 0 2.4793569082248723e-06
DNA O 0 1.9547609554138035e-05
from O 0 1.0761631301647867e-06
the O 0 1.4035406366019743e-06
constitutional O 0 6.0990005295025185e-06
cells O 0 7.087366975611076e-05
of O 0 6.123211733211065e-07
the O 0 8.188182982848957e-05
patient O 1 0.9944242835044861
, O 0 1.559445445309393e-05
proving O 0 0.00021688333072233945
it O 0 7.058197866172122e-07
to O 0 1.8982530036737444e-07
be O 0 4.598744567374524e-07
of O 0 6.979088311709347e-07
germline O 0 0.0018411761848255992
origin O 0 1.6194439012906514e-05
. O 0 8.67702838149853e-05

The O 0 3.916256900993176e-05
initial O 0 0.0002467244921717793
mutation O 0 0.0002573485253378749
was O 0 0.00019932884606532753
shown O 0 9.688332283985801e-06
to O 0 6.208769036675221e-07
have O 0 1.395910544488288e-06
occurred O 0 2.7470199711387977e-05
in O 0 2.4799126094876556e-06
the O 0 1.4224288861441892e-05
paternally O 0 0.006810197606682777
derived O 0 0.00047361632459796965
RB1 O 1 0.990947425365448
allele O 0 0.000777870649471879
. O 0 0.00013000429316889495

The O 0 6.475688132923096e-05
mutation O 0 6.542862684000283e-05
is O 0 1.7977646393774194e-06
in O 0 1.165351022791583e-06
an O 0 1.8406061599307577e-06
area O 0 2.0408690488693537e-06
of O 0 8.246292537705813e-08
the O 0 2.3818518002372002e-06
gene O 0 5.310886990628205e-06
that O 0 1.596431360439965e-07
encodes O 0 1.8774135241983458e-06
the O 0 2.9126683784852503e-06
protein O 0 4.916204125038348e-05
- O 0 6.124487117631361e-05
binding O 0 4.086452463525347e-06
region O 0 5.200780833547469e-06
known O 0 1.1488745258247945e-05
as O 0 4.142468242207542e-06
the O 0 1.8350172467762604e-05
pocket O 0 0.003158604959025979
region O 0 1.1314265066175722e-05
and O 0 5.786646397609729e-06
has O 0 3.14772296405863e-05
been O 0 7.106045813998207e-05
detected O 0 0.00042895361548289657
in O 0 2.0371353457449004e-06
other O 0 1.863880129349127e-06
cases O 0 9.505248453933746e-05
of O 0 1.6372052414226346e-05
retinoblastoma B-Disease 1 0.9983135461807251
. O 0 0.00010771901725092903
. O 0 0.00013240661064628512

Low O 0 0.0009748802985996008
levels O 0 8.63883615238592e-05
of O 0 1.8502150851418264e-06
beta O 0 0.0011453075567260385
hexosaminidase O 0 0.0014401341322809458
A O 0 0.00011602506128838286
in O 0 1.5037277080409694e-05
healthy O 0 0.0009255135664716363
individuals O 0 8.512012755090836e-06
with O 0 0.00011867972352774814
apparent O 1 0.9984254837036133
deficiency O 1 0.9999868869781494
of O 0 3.1298141038860194e-06
this O 0 3.910782470484264e-05
enzyme O 0 0.015932193025946617
. O 0 0.00012332764163147658

Appreciable O 0 0.004140262957662344
beta O 0 0.0019156583584845066
hexosaminidase O 0 0.0045747896656394005
A O 0 0.00016320710710715503
( O 0 9.113745363720227e-06
hex O 0 9.689007129054517e-05
A O 0 2.009097079280764e-05
) O 0 9.701152521301992e-07
activity O 0 3.63007461601228e-06
has O 0 6.287215455813566e-06
been O 0 1.987877294595819e-05
detected O 0 0.000591510150115937
in O 0 3.0315184631035663e-05
cultured O 0 0.30764350295066833
skin O 1 0.9996639490127563
fibroblasts O 1 0.6444153785705566
and O 0 0.00903125386685133
melanoma B-Disease 1 0.9999978542327881
tissue O 1 0.9991496801376343
from O 0 0.0004920779610984027
healthy O 0 0.03773749619722366
individuals O 0 2.690574365260545e-05
previously O 0 0.001994507620111108
reported O 0 0.013258032500743866
as O 0 0.00019864334899466485
having O 0 0.012509834952652454
deficiency B-Disease 1 0.999966025352478
of I-Disease 0 2.2548642846231814e-06
hex I-Disease 0 0.0009187168907374144
A I-Disease 0 6.954545096959919e-05
activity O 0 8.585794603277463e-06
indistinguishable O 0 3.880371150444262e-05
from O 0 2.0659781512222253e-06
that O 0 1.3729800230066758e-06
of O 0 5.842686732648872e-06
patients O 1 0.9995216131210327
with O 1 0.5376986861228943
Tay B-Disease 1 0.9999977350234985
- I-Disease 1 0.999932050704956
Sachs I-Disease 1 0.9999895095825195
disease I-Disease 1 0.9999947547912598
( O 0 0.005941565148532391
TSD B-Disease 1 0.9985760450363159
) O 0 0.00026334449648857117
. O 0 0.0002936753735411912

Identification O 0 5.0708025810308754e-05
and O 0 9.363464414491318e-06
quantitation O 0 0.0009529672097414732
of O 0 5.038785729993833e-06
hex O 0 0.0011291804257780313
A O 0 0.00024275256146211177
, O 0 7.565284704469377e-06
amounting O 0 3.991305857198313e-05
to O 0 2.513669187464984e-06
3 O 0 6.538321758853272e-05
. O 0 5.0945960538228974e-05

5 O 0 0.00024601182667538524
% O 0 6.868659693282098e-05
- O 0 0.0014696234138682485
6 O 0 0.00014882384857628495
. O 0 7.052565342746675e-05

9 O 0 6.435807881643996e-05
% O 0 1.6136681324496749e-06
of O 0 2.540850800869521e-07
total O 0 5.532078830583487e-06
beta O 0 0.00083844707114622
hexosaminidase O 0 0.001411600038409233
activity O 0 1.1103518772870302e-05
, O 0 1.5324994819820859e-06
has O 0 3.8544958442798816e-06
been O 0 3.1197057523968397e-06
obtained O 0 6.494777608168079e-06
by O 0 1.7279526218771935e-05
cellulose O 0 0.3620721995830536
acetate O 0 0.052040647715330124
gel O 0 0.014568113721907139
electrophoresis O 0 0.001132047502323985
, O 0 3.2196880056289956e-05
DEAE O 0 0.00793573446571827
- O 0 0.00036481066490523517
cellulose O 0 0.0021367997396737337
ion O 0 0.0006350562325678766
- O 0 0.0002701080811675638
exchange O 0 8.906258153729141e-05
chromatography O 0 0.0033704466186463833
, O 0 3.208494308637455e-05
radial O 0 0.007022040896117687
immunodiffusion O 0 0.010247411206364632
, O 0 2.2500724298879504e-05
and O 0 1.7808079064707272e-05
radioimmunoassay O 0 0.017294704914093018
. O 0 0.00015572881966363639

Previous O 0 0.0004955174517817795
family O 0 0.000303508248180151
studies O 0 6.604723603231832e-05
suggested O 0 9.200177737511694e-05
that O 0 2.027959226325038e-06
these O 0 1.244648956344463e-06
individuals O 0 1.0206987099081744e-05
may O 0 0.00011365182581357658
be O 0 6.9285097197280265e-06
compound O 0 0.00045967756886966527
heterozygotes O 0 0.00032532040495425463
for O 0 6.396717822099163e-07
the O 0 5.914005214435747e-06
common O 0 9.503371984465048e-05
mutant O 0 0.0021137534640729427
TSD B-Disease 1 0.9709134697914124
gene O 0 0.00011575916869333014
and O 0 4.661765615310287e-06
a O 0 6.366063462337479e-05
rare O 0 0.0014269201783463359
( O 0 3.229676076443866e-05
allelic O 0 0.0009317664662376046
) O 0 2.3643897293368354e-05
mutant O 0 0.00045788887655362487
gene O 0 0.0005099851987324655
. O 0 8.000975503819063e-05

Thus O 0 5.563877130043693e-05
, O 0 5.691627848136704e-06
the O 0 6.110446520324331e-06
postulated O 0 0.00026242691092193127
rate O 0 0.00010362076136516407
mutant O 0 0.00017754710279405117
gene O 0 4.7167886805254966e-05
appears O 0 2.103872066072654e-05
to O 0 1.2069898502886645e-07
code O 0 2.75958029760659e-07
for O 0 6.623921677828548e-08
the O 0 2.185467593562862e-07
expression O 0 4.980211656402389e-07
of O 0 1.2633087465019344e-07
low O 0 4.721820369013585e-05
amounts O 0 9.528183909424115e-06
of O 0 1.1607346550590592e-06
hex O 0 0.0010950196301564574
A O 0 0.000449727667728439
. O 0 7.633834320586175e-05

Heterozygotes O 0 0.0033008356112986803
for O 0 8.710187103133649e-06
the O 0 3.7340862036217004e-05
rare O 0 0.0061441343277692795
mutant O 0 0.001543834456242621
may O 0 9.504251647740602e-05
be O 0 2.540482682888978e-06
indistinguishable O 0 8.723655628273264e-05
from O 0 7.767048373352736e-06
heterozygotes O 0 0.00027196345035918057
for O 0 2.2671072201774223e-06
the O 0 1.8000609998125583e-05
common O 0 0.0007543293759226799
TSD B-Disease 1 0.993166983127594
mutant O 0 0.004513204097747803
. O 0 0.0002557590778451413

However O 0 0.00014050556637812406
, O 0 4.56547377325478e-06
direct O 0 2.4804896838759305e-06
visualization O 0 0.00014605658361688256
and O 0 2.4751375349296723e-06
quantitation O 0 0.0004337902646511793
of O 0 1.27639771108079e-06
hex O 0 0.00034216896165162325
A O 0 4.83140283904504e-05
by O 0 2.2130275283416267e-06
the O 0 4.444197202246869e-06
methods O 0 1.1387789527361747e-05
described O 0 0.0018472631927579641
may O 0 0.0003966317162849009
prevent O 0 0.0004722379962913692
false O 0 0.00044799025636166334
- O 0 0.0012062564492225647
positive O 0 0.00019601997337304056
prenatal O 1 0.7463439702987671
diagnosis O 1 0.9950398802757263
of O 0 2.275012775498908e-05
TSD B-Disease 1 0.998160183429718
in O 0 0.00016767509805504233
fetuses O 0 0.03840658813714981
having O 0 6.40301441308111e-05
the O 0 1.599383722350467e-05
incomplete O 0 0.0021524757612496614
hex B-Disease 0 0.006208234000951052
A I-Disease 0 0.04000726714730263
deficiency I-Disease 1 0.9999486207962036
of O 0 1.016483793137013e-06
the O 0 3.143175126751885e-05
type O 0 0.00482893968001008
described O 0 0.00019657923257909715
in O 0 3.4382007925159996e-06
the O 0 7.559803179901792e-06
four O 0 2.1348107111407444e-05
healthy O 0 0.005488090682774782
individuals O 0 0.00012465241889003664

The O 0 0.002457238966599107
tumor B-Disease 1 0.9976484179496765
suppressor O 0 0.01790129952132702
gene O 0 0.0008206402417272329
Smad4 O 0 0.04652370139956474
/ O 0 0.004761870484799147
Dpc4 O 0 0.001562626101076603
is O 0 5.028157829656266e-06
required O 0 4.846931915380992e-06
for O 0 4.211708983348217e-06
gastrulation O 0 0.006762838456779718
and O 0 3.133134896415868e-06
later O 0 3.732847108040005e-05
for O 0 5.546399734157603e-06
anterior O 0 0.35398244857788086
development O 0 4.151492703385884e-06
of O 0 1.114627252718492e-06
the O 0 8.379810606129467e-05
mouse O 0 0.0040475353598594666
embryo O 0 0.002487167250365019
. O 0 0.0001399976317770779

Mutations O 0 0.0004960402147844434
in O 0 2.1204208678682335e-05
the O 0 0.00010230649058939889
SMAD4 O 1 0.9899600744247437
/ O 0 0.2855618894100189
DPC4 O 1 0.985278844833374
tumor B-Disease 1 0.9991738200187683
suppressor O 0 0.0015726132551208138
gene O 0 2.2753491066396236e-05
, O 0 6.62656816530216e-07
a O 0 2.9710304261243436e-06
key O 0 4.165151040069759e-06
signal O 0 2.6225206966046244e-05
transducer O 0 0.00012256854097358882
in O 0 3.7443624023580924e-06
most O 0 2.6643416276783682e-05
TGFbeta O 0 0.021121395751833916
- O 0 0.001427841722033918
related O 0 0.00014983039000071585
pathways O 0 0.0005263719358481467
, O 0 1.8055530972560518e-06
are O 0 1.6389049051213078e-07
involved O 0 2.4942030449892627e-06
in O 0 2.174174369429238e-06
50 O 0 6.740615845046705e-06
% O 0 1.26306895253947e-05
of O 0 7.184292917372659e-05
pancreatic B-Disease 1 0.9999964237213135
cancers I-Disease 1 0.9999673366546631
. O 0 0.001737911719828844

Homozygous O 0 0.009801380336284637
Smad4 O 0 0.0555788017809391
mutant O 0 0.0298775564879179
mice O 1 0.8853919506072998
die O 1 0.7984190583229065
before O 0 6.043414759915322e-05
day O 0 6.631849828409031e-05
7 O 0 9.506825153948739e-05
. O 0 4.070179784321226e-05

5 O 0 5.403586328611709e-05
of O 0 9.208177289110608e-06
embryogenesis O 0 0.03985579311847687
. O 0 0.00023150822380557656

Mutant O 0 0.0016346852062270045
embryos O 0 0.0002411189634585753
have O 0 7.548478151875315e-06
reduced O 0 0.00013553797907661647
size O 0 3.6726294638356194e-05
, O 0 7.370876573986607e-06
fail O 0 0.00012596053420566022
to O 0 1.6017107782317908e-06
gastrulate O 0 0.0007589611341245472
or O 0 8.638827239337843e-06
express O 0 2.1593774363282137e-05
a O 0 2.9652797820745036e-05
mesodermal O 0 0.007923640310764313
marker O 0 0.0011340755736455321
, O 0 6.301952453213744e-06
and O 0 3.771538331420743e-06
show O 0 9.039323776960373e-05
abnormal O 0 0.026406632736325264
visceral O 0 0.025182833895087242
endoderm O 1 0.7210911512374878
development O 0 0.0004268012708052993
. O 0 0.0003897254937328398

Growth B-Disease 1 0.9905703067779541
retardation I-Disease 1 0.9995378255844116
of O 0 8.64503272168804e-06
the O 0 0.00034875184064731
Smad4 O 1 0.9932809472084045
- O 1 0.7849020957946777
deficient O 1 0.9931087493896484
embryos O 0 5.5918666475918144e-05
results O 0 1.7499220120953396e-05
from O 0 1.3865455912309699e-05
reduced O 0 0.0021008444018661976
cell O 0 0.006644209381192923
proliferation O 0 0.0015369252068921924
rather O 0 2.3950174181663897e-06
than O 0 1.4545437352353474e-06
increased O 0 5.845558916917071e-05
apoptosis O 0 0.004693164024502039
. O 0 0.00010236308298772201

Aggregation O 0 0.0002703809295780957
of O 0 1.1122424439236056e-05
mutant O 0 0.0021092030219733715
Smad4 O 0 0.02989186905324459
ES O 0 0.003729006974026561
cells O 0 0.00015109148807823658
with O 0 4.167836777924094e-06
wild O 0 0.00023099647660274059
- O 0 0.0009679915965534747
type O 0 0.0003990509721916169
tetraploid O 0 0.0013473557773977518
morulae O 0 0.01335291750729084
rescues O 0 0.005451681092381477
the O 0 0.00036678180913440883
gastrulation B-Disease 1 0.9955145716667175
defect I-Disease 1 0.9980481863021851
. O 0 0.0007135752821341157

These O 0 7.59018666940392e-06
results O 0 5.21533984283451e-05
indicate O 0 7.938437192933634e-05
that O 0 6.890370059409179e-06
Smad4 O 0 0.0014759639743715525
is O 0 3.362766847203602e-06
initially O 0 7.805126188031863e-06
required O 0 8.004127494132263e-07
for O 0 1.4802797920765443e-07
the O 0 8.588846185375587e-07
differentiation O 0 6.315158771030838e-06
of O 0 3.700534705330938e-07
the O 0 2.3673879695707e-05
visceral O 0 0.007486868184059858
endoderm O 0 0.0329480804502964
and O 0 4.539684141491307e-06
that O 0 2.229557139798999e-06
the O 0 3.9991318772081286e-05
gastrulation B-Disease 1 0.8564332723617554
defect I-Disease 1 0.9713413715362549
in O 0 1.6444470020360313e-05
the O 0 5.24867900821846e-05
epiblast O 1 0.6602988243103027
is O 0 8.183114914572798e-06
secondary O 0 0.00011359656491549686
and O 0 7.319476026168559e-06
non O 0 0.0001817974989535287
- O 0 0.0008748777909204364
cell O 0 0.00040350601193495095
autonomous O 0 1.128169424191583e-05
. O 0 6.570756522705778e-05

Rescued O 0 0.1761026531457901
embryos O 0 0.006138904020190239
show O 0 0.004449998028576374
severe O 1 0.9996823072433472
anterior O 1 0.9989627599716187
truncations O 0 0.0264847744256258
, O 0 2.875007521652151e-05
indicating O 0 0.00019753637025132775
a O 0 9.727437827677932e-06
second O 0 3.913939963240409e-06
important O 0 1.3974022294860333e-06
role O 0 9.879227945930324e-06
for O 0 7.93836352386279e-06
Smad4 O 0 0.010784505866467953
in O 0 0.00011683140473905951
anterior O 1 0.9951867461204529
patterning O 0 0.1740589439868927
during O 0 0.006901190150529146
embryogenesis O 0 0.2902478575706482
. O 0 0.0005128642078489065

Prevalence O 0 0.018631931394338608
of O 0 7.928012564661913e-06
p16 O 0 0.002370331669226289
and O 0 2.9980223189340904e-05
CDK4 O 0 0.12489402294158936
germline O 0 0.009290074929594994
mutations O 0 0.0002556022664066404
in O 0 5.664315904141404e-05
48 O 0 0.14270369708538055
melanoma B-Disease 1 0.9999945163726807
- O 1 0.9874927997589111
prone O 1 0.8507096767425537
families O 0 7.617138180648908e-05
in O 0 5.50791883142665e-05
France O 0 0.00034517073072493076
. O 0 8.869254816090688e-05

The O 0 0.0004316942358855158
French O 0 0.021129541099071503
Familial B-Disease 1 0.9994485974311829
Melanoma I-Disease 1 0.9999812841415405
Study O 0 0.002234372077509761
Group O 0 0.0006457508425228298
. O 0 0.00026380663621239364

Germline O 0 0.01289336010813713
mutations O 0 0.00014727719826623797
in O 0 4.537749646260636e-06
the O 0 1.1714500033122022e-05
p16 O 0 0.0009728761506266892
and O 0 1.5384213838842697e-05
CDK4 O 0 0.01105966791510582
genes O 0 3.442219895077869e-05
have O 0 2.7350199616194004e-06
been O 0 1.7655736883170903e-05
reported O 0 3.698483487823978e-05
in O 0 1.2748939752782462e-06
a O 0 8.193758731067646e-06
subset O 0 6.136811862234026e-05
of O 0 4.9620994104770944e-05
melanoma B-Disease 1 0.9999939203262329
pedigrees O 0 0.009913618676364422
, O 0 1.1152982551720925e-05
but O 0 3.6383473798196064e-06
their O 0 3.1750107609695988e-06
prevalence O 0 0.09134433418512344
is O 0 7.142050435504643e-06
not O 0 2.152205979655264e-06
well O 0 6.127661436039489e-06
known O 0 0.00012001579307252541
. O 0 5.2546787628671154e-05

We O 0 1.1308958164590877e-05
searched O 0 0.0001176607547677122
for O 0 1.978847649297677e-06
such O 0 3.726881004695315e-06
germline O 0 0.0023256142158061266
mutations O 0 8.08940822025761e-05
in O 0 2.508584839233663e-05
48 O 0 0.0012453165836632252
French O 0 0.41225698590278625
melanoma B-Disease 1 0.9999932050704956
- O 1 0.8582240343093872
prone O 0 0.0656219944357872
families O 0 7.2831289799069054e-06
selected O 0 1.672735947977344e-06
according O 0 1.6590129234828055e-06
to O 0 4.493615506362403e-07
two O 0 1.0911209074038197e-06
major O 0 4.396712392917834e-05
criteria O 0 1.366484684695024e-05
families O 0 2.548835709603736e-06
with O 0 2.8189308522996726e-06
at O 0 3.858268973999657e-05
least O 0 3.7564798276434885e-06
three O 0 3.1802928788238205e-06
affected O 0 5.3431886044563726e-05
members O 0 3.5812984151561977e-06
( O 0 5.920184321439592e-06
n O 0 4.136710413149558e-05
= O 0 3.803376239375211e-05
20 O 0 2.9358232040976873e-06
) O 0 1.5504828070334042e-06
or O 0 1.7795823623600882e-06
families O 0 1.515464646217879e-06
with O 0 9.918279602061375e-07
two O 0 5.57246312382631e-06
affected O 0 9.243927343050018e-05
members O 0 1.7617941239223e-06
, O 0 8.633718380224309e-07
one O 0 2.132727132675427e-07
of O 0 1.1967978252869216e-07
them O 0 7.786417768329557e-07
affected O 0 2.0394511011545546e-05
before O 0 3.381186161277583e-06
the O 0 5.568535925704055e-07
age O 0 5.451435754366685e-06
of O 0 1.799881630404343e-07
50 O 0 5.253701601759531e-06
( O 0 1.925009428305202e-06
n O 0 1.7961889170692302e-05
= O 0 2.1834519429830834e-05
28 O 0 5.961218903394183e-06
) O 0 3.7036699040982057e-07
, O 0 1.394618180938778e-07
and O 0 1.4060175601571245e-07
one O 0 5.954213975201128e-07
additional O 0 6.781048796256073e-06
minor O 0 0.020315954461693764
criterion O 0 0.017797237262129784
. O 0 0.00026854968746192753

Sixteen O 0 0.00014518998796120286
different O 0 7.91334514360642e-06
p16 O 0 0.005698202643543482
germline O 0 0.006805791053920984
mutations O 0 0.00014393229503184557
were O 0 4.9435661821917165e-06
found O 0 2.4144017515936866e-05
in O 0 4.3711384023481514e-06
21 O 0 2.7518677597981878e-05
families O 0 3.5733219192479737e-06
, O 0 1.226071276505536e-06
while O 0 1.3061694517091382e-06
one O 0 5.014754151488887e-06
germline O 0 0.002783761592581868
mutation O 0 0.00018304531113244593
, O 0 1.3508276424545329e-05
Arg24His O 0 0.0029304090421646833
, O 0 1.4230666238290723e-05
was O 0 0.0002499802503734827
detected O 0 0.0003278179792687297
in O 0 5.44261001778068e-06
the O 0 2.526605749153532e-05
CDK4 O 0 0.07885772734880447
gene O 0 0.0006471301894634962
. O 0 8.288124809041619e-05

The O 0 3.2399520932813175e-06
frequency O 0 1.682055653873249e-06
of O 0 1.0821652267622994e-06
p16 O 0 0.0005028209998272359
gene O 0 2.7753421818488277e-05
mutation O 0 1.0273746738675982e-05
in O 0 3.04415664231783e-07
our O 0 1.6335930297373125e-07
sample O 0 5.015874080527283e-07
( O 0 7.171611855483206e-07
44 O 0 3.3497365166113013e-06
% O 0 1.5708493492638809e-06
) O 0 6.466394779636175e-07
is O 0 3.0054505373300344e-07
among O 0 1.280537844650098e-07
the O 0 1.4229292446543695e-06
highest O 0 6.96811912348494e-05
rates O 0 7.699587877141312e-05
yet O 0 1.5449048078153282e-05
reported O 0 4.337467908044346e-05
and O 0 7.132311452551221e-07
the O 0 5.250275989965303e-06
CDK4 O 0 0.005815260112285614
mutation O 0 2.4030245185713284e-05
is O 0 9.423919209439191e-07
the O 0 1.1723021771103959e-06
second O 0 7.259191534103593e-06
mutation O 0 6.541652692249045e-05
detected O 0 0.00015945863560773432
in O 0 1.2744040986945038e-06
this O 0 2.432195060464437e-06
gene O 0 7.950868166517466e-05
worldwide O 0 6.288589793257415e-05
. O 0 5.211154348216951e-05

In O 0 3.947626828448847e-05
summary O 0 9.088867955142632e-05
, O 0 5.519015303434571e-06
our O 0 1.0461442343512317e-06
results O 0 1.0669499715731945e-05
show O 0 6.367130026774248e-06
frequent O 0 1.9076560420216992e-05
involvement O 0 1.2790657820005435e-05
of O 0 3.0693666985825985e-07
the O 0 2.4750459488132037e-05
p16 O 0 0.002137711737304926
gene O 0 0.00024025152379181236
in O 0 0.00012379845429677516
familial B-Disease 1 0.999757707118988
melanoma I-Disease 1 0.9999929666519165
and O 0 1.9577235434553586e-05
confirm O 0 4.864884613198228e-05
the O 0 1.8495499034543172e-06
role O 0 1.962609985639574e-06
of O 0 4.881165978076751e-07
the O 0 2.1528017896343954e-05
CDK4 O 0 0.029767708852887154
gene O 0 0.0001357709406875074
as O 0 4.398893361212686e-05
a O 0 0.004908283241093159
melanoma B-Disease 1 0.9999890327453613
- O 0 0.03014877624809742
predisposing O 0 0.004840289242565632
gene O 0 0.000543723814189434
. O 0 4.108122084289789e-05
. O 0 0.00011404471297282726

Progression O 0 0.005623043514788151
of O 0 1.0342480891267769e-05
somatic O 0 0.002397742122411728
CTG O 0 0.05577578395605087
repeat O 0 0.000560204847715795
length O 0 5.7783083320828155e-05
heterogeneity O 0 0.00012671637523453683
in O 0 7.679482223466039e-06
the O 0 7.111793820513412e-05
blood O 1 0.9986439347267151
cells O 0 0.01328493282198906
of O 0 0.0005328491097316146
myotonic B-Disease 1 0.9999958276748657
dystrophy I-Disease 1 0.9999991655349731
patients O 1 0.9998973608016968
. O 0 0.0036697881296277046

The O 0 3.7636873457813635e-05
genetic O 0 0.00015815244114492089
basis O 0 1.1964265468122903e-05
of O 0 0.00034160586073994637
myotonic B-Disease 1 0.9999959468841553
dystrophy I-Disease 1 0.9999995231628418
( O 1 0.7577831745147705
DM B-Disease 1 0.9999713897705078
) O 0 1.4061120054975618e-05
is O 0 1.7394447695551207e-06
the O 0 8.419430628237023e-07
expansion O 0 4.797322162630735e-06
of O 0 4.1798276129156875e-07
an O 0 4.54470791737549e-05
unstable O 1 0.8407865166664124
CTG O 0 0.06755407899618149
repeat O 0 0.0004134975606575608
in O 0 1.7552033568790648e-06
the O 0 3.72663225789438e-06
34 O 0 1.1369624189683236e-05
UTR O 0 0.0002411389723420143
of O 0 7.191885060819914e-07
the O 0 3.918868605978787e-05
DM B-Disease 1 0.99777752161026
protein O 0 0.0001063331073964946
kinase O 0 7.802109757903963e-05
gene O 0 2.8087391910958104e-05
on O 0 1.0658050086931325e-05
chromosome O 0 0.00025323120644316077
19 O 0 0.0001742275635479018
. O 0 4.832905324292369e-05

One O 0 2.2325252757582348e-06
of O 0 3.8882441799614753e-07
the O 0 5.49655578652164e-06
principal O 0 1.2111239811929408e-05
features O 0 4.8133615564438514e-06
of O 0 1.176211526399129e-06
the O 0 0.0002126962208421901
DM B-Disease 1 0.9999066591262817
mutation O 0 0.00010894209117395803
is O 0 2.99757834909542e-06
an O 0 6.934914836165262e-06
extraordinarily O 0 0.0004880003398284316
high O 0 6.74327093292959e-05
level O 0 1.768601759977173e-05
of O 0 2.1093992472742684e-06
somatic O 0 0.002825765870511532
mosaicism O 1 0.710226833820343
, O 0 8.357946171599906e-06
due O 0 8.808819984551519e-05
to O 0 8.784713259046839e-07
an O 0 4.984210590919247e-06
extremely O 0 0.00013957711053080857
high O 0 3.080899114138447e-05
degree O 0 6.0080878938606475e-06
of O 0 9.82207097877108e-07
somatic O 0 0.0007874865550547838
instability O 0 0.00012110504030715674
both O 0 4.2809003275579016e-07
within O 0 6.563472538800852e-07
and O 0 9.662261390985805e-07
between O 0 3.5242492231191136e-06
different O 0 5.281724043015856e-06
tissues O 1 0.7732341885566711
. O 0 0.0002943444123957306

This O 0 0.00014840057701803744
instability O 0 0.002354231895878911
appears O 0 0.00022946097305975854
to O 0 1.1284698757663136e-06
be O 0 1.5738497722850298e-06
biased O 0 1.6964766473392956e-05
towards O 0 1.233182388205023e-06
further O 0 1.1828720971607254e-06
expansion O 0 8.325228009198327e-06
and O 0 3.1818868251320964e-07
continuous O 0 8.399321814067662e-06
throughout O 0 1.5201790120045189e-06
the O 0 9.400043268215086e-07
life O 0 1.5330140286096139e-06
of O 0 1.8282848657236173e-07
an O 0 4.921964773529908e-06
individual O 0 1.3191108791943407e-06
, O 0 2.6917830382444663e-06
features O 0 9.11427559913136e-06
that O 0 1.9927674657083116e-06
could O 0 3.058073161810171e-06
be O 0 9.868800816548173e-07
associated O 0 5.340548796084477e-06
with O 0 1.5540044842055067e-06
the O 0 1.0178720913245343e-05
progressive O 0 0.0028808561619371176
nature O 0 8.379251084988937e-05
of O 0 1.085193707694998e-05
the O 0 0.17477723956108093
disease O 1 0.9999942779541016
. O 0 0.0008445593994110823

Although O 0 9.148657409241423e-05
increasing O 0 4.390662434161641e-05
measured O 0 5.588246858678758e-05
allele O 0 5.907329614274204e-05
size O 0 5.488079841597937e-05
between O 0 0.00011339840420987457
patients O 1 0.9970478415489197
clearly O 0 5.4046740842750296e-05
correlates O 0 5.3135998314246535e-05
with O 0 3.914462467946578e-06
an O 0 2.4566052161389962e-05
increased O 0 0.00021006926544941962
severity O 0 0.281311571598053
of O 0 2.0410798242664896e-05
symptoms O 1 0.9999455213546753
and O 0 7.305932740564458e-06
an O 0 3.126193041680381e-05
earlier O 0 0.00019963602244388312
age O 0 0.00018270478176418692
of O 0 6.539551122841658e-06
onset O 1 0.9998891353607178
, O 0 6.780260264349636e-06
this O 0 5.200723762754933e-07
correlation O 0 3.8955145100771915e-06
is O 0 1.3168257737561362e-06
not O 0 3.2264171068163705e-07
precise O 0 2.1490227481990587e-06
and O 0 1.1009947229467798e-06
measured O 0 1.9480281480355188e-05
allele O 0 4.2417002987349406e-05
length O 0 3.2389569241786376e-05
cannot O 0 8.329730917466804e-06
be O 0 3.1643293141314643e-07
used O 0 5.268224185783765e-07
as O 0 4.030968341339758e-07
an O 0 4.5287987404663e-07
accurate O 0 3.768640453927219e-06
predictor O 0 5.506453453563154e-05
of O 0 5.133813374413876e-07
age O 0 0.00031721044797450304
of O 0 2.5038380044861697e-05
onset O 1 0.9998306035995483
. O 0 0.000873165437951684

In O 0 1.268662072106963e-05
order O 0 2.6161662844970124e-06
to O 0 9.84042799245799e-07
further O 0 2.507621047698194e-06
characterize O 0 9.707522258395329e-05
the O 0 7.4608205977710895e-06
dynamics O 0 0.00028414197731763124
of O 0 4.5292701543075964e-05
DM B-Disease 1 0.9998757839202881
CTG O 1 0.9701396226882935
repeat O 0 0.018716489896178246
somatic O 0 0.00407730508595705
instability O 0 0.0019211436156183481
, O 0 7.690899110457394e-06
we O 0 1.1772585821745452e-06
have O 0 7.402996970995446e-07
studied O 0 7.835470569261815e-06
repeat O 0 4.7983612603275105e-05
length O 0 9.02119336387841e-06
changes O 0 1.7480571159467218e-06
over O 0 1.4074948921916075e-06
time O 0 6.841112735855859e-06
in O 0 7.489234849344939e-05
111 O 1 0.9792431592941284
myotonic B-Disease 1 0.9999920129776001
dystrophy I-Disease 1 0.9999997615814209
patients O 1 0.9998359680175781
with O 0 0.0001226024323841557
varying O 0 0.0023037963546812534
clinical O 1 0.9973652958869934
severity O 1 0.9974939823150635
and O 0 8.979468839243054e-05
CTG O 0 0.12290175259113312
repeat O 0 0.000364228937542066
size O 0 4.052548320032656e-06
over O 0 4.224393990170938e-07
time O 0 1.8544622548688494e-07
intervals O 0 1.6450258044642396e-06
of O 0 5.57302996639919e-07
1 O 0 4.4853335566585883e-05
- O 0 0.00019328870985191315
7 O 0 2.2861284378450364e-05
years O 0 3.102350456174463e-05
. O 0 2.3586422685184516e-05

We O 0 8.388074093090836e-06
have O 0 1.5748257737868698e-06
found O 0 8.218707989726681e-06
a O 0 2.9330808501981664e-06
direct O 0 1.1248123428231338e-06
progression O 0 0.0003794668591581285
of O 0 2.8679141905740835e-07
the O 0 5.0993089644180145e-06
size O 0 1.6027490346459672e-05
heterogeneity O 0 4.7261317376978695e-05
over O 0 3.193781594745815e-06
time O 0 2.8280185233597877e-06
related O 0 1.6459625840070657e-05
to O 0 2.2052074655221077e-06
initial O 0 0.00023790120030753314
CTG O 0 0.02038445882499218
repeat O 0 0.0003174040757585317
size O 0 6.727246272930643e-06
and O 0 4.277402751995396e-07
the O 0 1.1290037491562543e-06
time O 0 2.0623206182790454e-06
interval O 0 2.015695281443186e-05
and O 0 1.1371121217962354e-06
always O 0 3.8124603634059895e-06
biased O 0 1.4469383131654467e-05
towards O 0 5.018777756049531e-06
further O 0 9.634707566874567e-06
expansion O 0 0.00016294368833769113
. O 0 4.8297675675712526e-05

Attempts O 0 1.4759320038137957e-05
to O 0 1.4433317119255662e-06
mathematically O 0 2.7751382731366903e-05
model O 0 9.808370123209897e-06
the O 0 9.954695997294039e-06
dynamics O 0 0.00022341121803037822
have O 0 7.946619916765485e-06
proved O 0 0.00022004650963936
only O 0 6.180458058224758e-06
partially O 0 0.0011363433441147208
successful O 0 4.445093873073347e-05
suggesting O 0 0.00012085632624803111
that O 0 8.943856073528877e-07
individual O 0 1.402117163706862e-06
specific O 0 9.050975677382667e-06
genetic O 0 0.0005566778127104044
and O 0 4.082137093064375e-05
/ O 0 0.01033107191324234
or O 0 4.5793549361405894e-05
environmental O 0 0.0001572179899085313
factors O 0 6.062478405510774e-06
also O 0 1.583053403919621e-06
play O 0 5.798241318188957e-07
a O 0 4.188852471997961e-06
role O 0 1.5848170733079314e-05
in O 0 1.6100320863188244e-05
somatic O 0 0.004456317983567715
mosaicism O 1 0.9717469215393066
. O 0 5.611326560028829e-05
. O 0 0.00012419787526596338

Aspartylglucosaminuria B-Disease 1 0.9745249152183533
among O 0 9.261274681193754e-05
Palestinian O 0 0.0009746387950144708
Arabs O 0 0.0004519794601947069
. O 0 0.0002798826026264578

Aspartylglucosaminuria B-Disease 1 0.9941737055778503
( O 0 0.005379092879593372
AGU B-Disease 1 0.9993740916252136
) O 0 3.334456778247841e-05
is O 0 2.388215762039181e-05
a O 0 0.0002371506707277149
rare O 1 0.7847316861152649
disorder B-Disease 1 0.9999209642410278
of I-Disease 0 5.2954354032408446e-05
glycoprotein I-Disease 1 0.9990785121917725
metabolism I-Disease 1 0.9991911053657532
caused O 1 0.9491395950317383
by O 0 5.888555824640207e-05
the O 0 0.0006259907386265695
deficiency B-Disease 1 0.9999814033508301
of I-Disease 0 3.147453071505879e-06
the I-Disease 0 0.00012820375559385866
lysosomal I-Disease 1 0.9985830783843994
enzyme I-Disease 0 0.04443710297346115
aspartylglucosaminidase I-Disease 0 0.1469329297542572
( O 0 0.00011875761992996559
AGA O 1 0.5327916741371155
) O 0 4.03570375056006e-05
. O 0 4.0735030779615045e-05

AGU B-Disease 1 0.9991061091423035
is O 0 0.0012529435334727168
inherited O 1 0.9933542013168335
as O 0 0.00011386107507860288
an O 0 0.0005452734767459333
autosomal O 1 0.9994569420814514
recessive O 1 0.9993616938591003
trait O 0 0.0829477608203888
and O 0 1.2522184078989085e-05
occurs O 0 7.263194856932387e-05
with O 0 1.5690302461734973e-06
a O 0 1.9578466890379786e-05
high O 0 4.952332892571576e-05
frequency O 0 2.1973853563395096e-06
in O 0 1.7103033087551012e-06
Finland O 0 4.7626858759031165e-06
because O 0 3.959321020374773e-06
of O 0 4.1902245584424236e-07
a O 0 0.00010648988245520741
founder O 0 0.0007726472103968263
effect O 0 0.00023014657199382782
. O 0 0.00012481298472266644

While O 0 0.0001815895811887458
very O 0 0.00018699976499192417
few O 0 0.0005770950228907168
patients O 1 0.9982713460922241
with O 0 0.0005196933052502573
AGU B-Disease 1 0.999769389629364
have O 0 3.178860424668528e-05
been O 0 6.510499224532396e-05
reported O 0 0.00018515880219638348
from O 0 8.109907867037691e-06
non O 0 4.4827076635556296e-05
- O 0 0.0001121901223086752
Finnish O 0 9.823252185015008e-05
origin O 0 4.413613169163e-06
, O 0 2.5925666705006734e-05
we O 0 0.00010903801012318581
diagnosed O 1 0.9999872446060181
the O 0 0.002485026838257909
disorder O 1 0.9999837875366211
in O 0 0.00031527181272394955
8 O 0 0.02417941205203533
patients O 1 0.99856036901474
originating O 0 7.965477561810985e-05
from O 0 1.8601353076519445e-05
3 O 0 6.786913581890985e-05
unrelated O 0 0.0008439143421128392
families O 0 1.0702417057473212e-05
, O 0 1.0526041478442494e-06
all O 0 1.3996481129652238e-07
Palestinian O 0 1.818876808101777e-05
Arabs O 0 3.8304201552818995e-06
from O 0 1.82124711045617e-06
the O 0 1.9870835785695817e-06
region O 0 4.578903372021159e-06
of O 0 2.2240633370529395e-06
Jerusalem O 0 0.0007653516950085759
. O 0 0.00020085778669454157

The O 0 0.0009762484696693718
clinical O 1 0.9351658821105957
diagnosis O 1 0.9993196725845337
of O 0 0.00022122666996438056
AGU B-Disease 1 0.9999432563781738
is O 0 9.537670848658308e-05
often O 0 4.2886993469437584e-05
difficult O 0 5.7933215430239215e-05
, O 0 2.6136374344787328e-06
in O 0 9.100778584070213e-07
particular O 0 1.6807343854452483e-06
early O 0 1.357509427180048e-05
in O 0 1.4962056411604863e-06
the O 0 3.3796809475461487e-06
course O 0 3.8399233744712546e-05
of O 0 2.887602477130713e-06
the O 0 0.0025702225975692272
disease O 1 0.9999935626983643
, O 0 4.7509547584922984e-06
and O 0 4.838415748054103e-07
most O 0 6.021608669470879e-07
of O 0 7.195575904006546e-07
the O 0 0.0008369515417143703
patients O 1 0.9998883008956909
are O 0 0.00011777423787862062
diagnosed O 1 0.9999960660934448
after O 0 0.0008553430088795722
the O 0 1.1489873941172846e-05
age O 0 6.489659426733851e-05
of O 0 1.281536356145807e-06
5 O 0 0.00011037915828637779
years O 0 0.0002680988982319832
. O 0 6.624100933549926e-05

However O 0 0.0006189466803334653
, O 0 7.569874287582934e-05
since O 0 0.00019656780932564288
these O 0 3.642479350673966e-05
patients O 1 0.9909840822219849
excrete O 0 0.005903111305087805
early O 0 3.4556131140561774e-05
large O 0 8.617327694082633e-06
amounts O 0 1.3559477338276338e-05
of O 0 2.2290173546934966e-06
aspartylglucosamine O 0 0.010823083110153675
in O 0 1.0849867067008745e-05
urine O 0 0.0011837971396744251
, O 0 6.529642632813193e-06
biochemical O 0 0.00019534082093741745
screening O 0 0.0001010372070595622
is O 0 2.4497799131495412e-06
easy O 0 1.1927399100386538e-05
by O 0 7.546620963694295e-06
urine O 0 0.002053772797808051
chromatography O 0 0.012287086807191372
. O 0 3.175366873620078e-05
. O 0 9.739158122101799e-05

Detection O 0 0.0002739190822467208
of O 0 2.291596729264711e-06
heterozygous O 0 0.00019193411571905017
carriers O 0 0.00014259126328397542
of O 0 4.874727437709225e-06
the O 0 0.0016786098713055253
ataxia B-Disease 1 0.9999866485595703
- I-Disease 1 0.9988664388656616
telangiectasia I-Disease 1 0.9992239475250244
( O 0 9.499856969341636e-05
ATM O 0 0.0016521549550816417
) O 0 9.812074495130219e-06
gene O 0 3.9935792301548645e-05
by O 0 1.2589139259944204e-05
G2 O 1 0.8270097374916077
phase O 0 0.0008716692100279033
chromosomal O 0 0.010411438532173634
radiosensitivity O 0 0.010692505165934563
of O 0 4.2196155845886096e-05
peripheral O 1 0.9996387958526611
blood O 1 0.9997237324714661
lymphocytes O 1 0.9950240254402161
. O 0 0.00043255146010778844

In O 0 0.0051991599611938
ataxia B-Disease 1 0.999962568283081
- I-Disease 1 0.9989640712738037
telangiectasia I-Disease 1 0.9995896220207214
( O 0 0.0009519758750684559
A B-Disease 1 0.9993720650672913
- I-Disease 1 0.9995600581169128
T I-Disease 1 0.9999275207519531
) O 0 0.00011063111014664173
patients O 1 0.9061878323554993
, O 0 4.32544038631022e-06
mutations O 0 1.3462506103678606e-05
in O 0 6.482547405539663e-07
a O 0 4.470478870644001e-06
single O 0 9.660727300797589e-06
gene O 0 3.4520391636760905e-05
, O 0 5.190771389607107e-06
ATM O 0 0.00040429161163046956
, O 0 3.7583395169349387e-06
result O 0 2.227896220574621e-05
in O 0 1.5762918337713927e-05
an O 0 0.004682095721364021
autosomal B-Disease 1 0.9999967813491821
recessive I-Disease 1 0.9999969005584717
syndrome I-Disease 1 1.0
that O 0 8.92087773536332e-05
embraces O 0 0.00023493729531764984
a O 0 3.0504730602842756e-05
variety O 0 1.2747135770041496e-05
of O 0 3.20005301546189e-06
clinical O 0 0.3662250339984894
features O 0 0.00023772046552039683
and O 0 5.164058893569745e-05
manifests O 0 0.09369844943284988
extreme O 0 0.0034400648437440395
radiosensitivity O 0 0.011567522771656513
and O 0 6.3498655435978435e-06
a O 0 4.4637166865868494e-05
strong O 0 5.7972345530288294e-05
pre O 0 0.006035767961293459
- O 0 0.0024629977997392416
disposition O 0 0.0011540150735527277
to O 0 6.975127325858921e-05
malignancy B-Disease 1 0.9989534616470337
. O 0 0.00022309769701678306

Heterozygotes O 0 0.0029443236999213696
for O 0 4.092029485036619e-06
the O 0 2.023352681135293e-05
ATM O 0 0.00183423375710845
gene O 0 6.006356852594763e-05
have O 0 8.829665603116155e-07
no O 0 6.187121925904648e-06
clinical O 0 0.00017846841365098953
expression O 0 8.466634426440578e-06
of O 0 5.124112249177415e-06
A B-Disease 1 0.999403715133667
- I-Disease 1 0.9992431402206421
T I-Disease 1 0.9998257756233215
but O 0 4.864624861511402e-05
may O 0 0.00033357279608026147
be O 0 0.00020446459529921412
cancer B-Disease 1 0.999929666519165
prone O 0 0.020138097926974297
with O 0 7.687381184950937e-06
a O 0 4.3748135794885457e-05
moderate O 0 0.0005392524180933833
increase O 0 2.626302193675656e-05
in O 0 5.094409516459564e-06
in O 0 2.7394671633373946e-05
vitro O 0 0.0008025252027437091
radiosensitivity O 0 0.016674723476171494
. O 0 0.000113223897642456

We O 0 1.4956271115806885e-05
performed O 0 9.429233614355326e-05
a O 0 7.725756586296484e-05
blind O 0 0.0028160279616713524
chromosomal O 0 0.0003435845428612083
analysis O 0 1.097112544812262e-05
on O 0 5.840076119056903e-05
G2 O 1 0.993933379650116
- O 0 0.0003795605443883687
phase O 0 0.00014589053171221167
lymphocytes O 0 0.003041759831830859
from O 0 8.151756446750369e-06
7 O 0 5.3078420023666695e-05
unrelated O 0 0.0018697244813665748
A B-Disease 1 0.998450756072998
- I-Disease 1 0.9992423057556152
T I-Disease 1 0.9999101161956787
patients O 1 0.996619701385498
, O 0 1.3826435861119535e-05
13 O 0 5.611262531601824e-05
obligate O 0 0.0006715058698318899
A B-Disease 1 0.9935275912284851
- I-Disease 1 0.9958059787750244
T I-Disease 1 0.999470055103302
heterozygotes O 0 0.004853046499192715
( O 0 7.426023785228608e-06
parents O 0 6.2221038206189405e-06
of O 0 1.067810785571055e-06
the O 0 0.00029413378797471523
patients O 1 0.9988716244697571
) O 0 1.000344127533026e-05
, O 0 3.0873179639456794e-06
and O 0 1.027660800900776e-06
14 O 0 7.88273428042885e-06
normal O 0 2.913068419729825e-05
controls O 0 1.270889970328426e-05
following O 0 3.386409662198275e-05
X O 0 0.0009240719955414534
- O 0 0.0001770784438122064
irradiation O 0 8.417934441240504e-05
with O 0 5.366495315684006e-06
1 O 0 6.380845297826454e-05
Gy O 0 0.0013839330058544874
in O 0 5.685870405613969e-07
order O 0 4.804299464922224e-07
to O 0 3.047560994673404e-07
evaluate O 0 4.833296770812012e-06
this O 0 7.107555006768962e-07
cytogenetic O 0 0.0002528379554860294
method O 0 1.8981058929057326e-06
as O 0 2.884126388380537e-06
a O 0 6.6558118305692915e-06
tool O 0 1.4040002497495152e-05
for O 0 1.1722406725311885e-06
detection O 0 5.961368151474744e-05
of O 0 3.5518357890396146e-06
ATM O 0 0.03920120373368263
carriers O 0 0.0019774343818426132
. O 0 0.00012621375208254904

Both O 0 0.00018697534687817097
A B-Disease 1 0.9958912134170532
- I-Disease 1 0.9974368810653687
T I-Disease 1 0.9996256828308105
homozygotes O 0 0.057857953011989594
and O 0 3.826777538051829e-05
heterozygotes O 0 0.00730914156883955
showed O 0 0.0008848852594383061
significantly O 0 0.0005528666079044342
increased O 0 4.3631145672407e-05
levels O 0 0.00021887077309656888
of O 0 1.9175162378815003e-05
radiation O 1 0.9972512125968933
- O 0 0.21216747164726257
induced O 1 0.9739624261856079
chromatid O 1 0.9642230868339539
damage O 0 0.1467340886592865
relative O 0 2.7580368623603135e-05
to O 0 5.241498115537979e-07
that O 0 4.3709653141377203e-07
of O 0 9.254520705326286e-07
normal O 0 0.00029973432538099587
controls O 0 0.00024016496900003403
. O 0 0.00014036228822078556

These O 0 3.0154121759551344e-06
results O 0 1.7368309272569604e-05
show O 0 4.318549144954886e-06
that O 0 7.888486379670212e-07
the O 0 1.5204475857899524e-05
G2 O 1 0.9813504219055176
- O 0 0.0004187888989690691
phase O 0 0.0001705834874883294
chromosomal O 0 0.001233959454111755
radiosensitivity O 0 0.0014333267463371158
assay O 0 4.4851196435047314e-05
can O 0 6.159541499073384e-07
be O 0 2.4171595214284025e-07
used O 0 3.6208220421940496e-07
for O 0 1.3582307190063148e-07
the O 0 7.85636814271129e-07
detection O 0 3.3141488529508933e-05
of O 0 2.2028700641385512e-06
A B-Disease 1 0.9992214441299438
- I-Disease 1 0.9968986511230469
T I-Disease 1 0.9994407296180725
heterozygotes O 0 0.013258611783385277
. O 0 0.0001715967373456806

In O 0 3.8557387597393245e-05
combination O 0 0.0002726457023527473
with O 0 1.1104873919975944e-05
molecular O 0 0.00029663112945854664
genetic O 0 0.00016810270608402789
analyses O 0 2.5468394596828148e-05
, O 0 2.8055960683559533e-06
this O 0 9.446018793823896e-07
test O 0 1.1835597433673684e-05
may O 0 5.902493739995407e-06
be O 0 7.172651805831265e-08
of O 0 1.0557227980712014e-08
value O 0 1.860093021832654e-07
in O 0 8.698115152583341e-07
studies O 0 3.5893131098418962e-06
of O 0 1.7756900660970132e-06
familial B-Disease 1 0.9949206709861755
and I-Disease 0 0.00011515782534843311
sporadic I-Disease 1 0.7913022041320801
cancers I-Disease 1 0.9994781613349915
aimed O 0 4.534547042567283e-05
at O 0 2.3121365302358754e-05
determination O 0 3.0163555493345484e-06
of O 0 1.0464271582577567e-07
the O 0 3.736938651854871e-06
potential O 0 9.245961337001063e-06
involvement O 0 2.1010569980717264e-05
of O 0 2.321321971976431e-06
ATM O 0 0.012961848638951778
mutations O 0 0.0007247905596159399
in O 0 0.0003010063956025988
tumor B-Disease 1 0.9999432563781738
risk O 0 0.1802045702934265
or O 0 5.351678919396363e-05
development O 0 4.639540202333592e-05
. O 0 4.0459544834448025e-05
. O 0 0.00010049325646832585

Ataxia B-Disease 1 0.9999444484710693
- I-Disease 1 0.998516857624054
telangiectasia I-Disease 1 0.9987826943397522
: O 0 4.5066510210745037e-05
identification O 0 8.22018955659587e-06
and O 0 1.719260012578161e-06
detection O 0 5.276259980746545e-05
of O 0 1.3843780379829695e-06
founder O 0 0.0007057901821099222
- O 0 0.0002744334633462131
effect O 0 1.0282274160999805e-05
mutations O 0 1.4020481103216298e-05
in O 0 1.0569900723567116e-06
the O 0 5.736289494961966e-06
ATM O 0 0.0008252087282016873
gene O 0 2.7936968763242476e-05
in O 0 2.4216365090978798e-06
ethnic O 0 5.6334420150960796e-06
populations O 0 9.709613368613645e-05
. O 0 0.00013865873916074634

To O 0 2.2465276288130553e-06
facilitate O 0 3.5336927339812974e-06
the O 0 2.789101699818275e-06
evaluation O 0 3.157448736601509e-05
of O 0 1.9348117348272353e-06
ATM O 0 0.006707468070089817
heterozygotes O 0 0.0011475399369373918
for O 0 6.347559065034147e-06
susceptibility O 0 0.0013050615089014173
to O 0 7.260465736180777e-06
other O 0 3.834726521745324e-05
diseases O 1 0.9999803304672241
, O 0 2.0416189727257006e-05
such O 0 3.153803845634684e-05
as O 1 0.5846174359321594
breast B-Disease 1 0.9999969005584717
cancer I-Disease 1 0.9999924898147583
, O 0 1.9282491848571226e-05
we O 0 1.0086429256261908e-06
have O 0 4.3646423364407383e-07
attempted O 0 3.960982667194912e-06
to O 0 2.7612307462732133e-07
define O 0 1.968467358892667e-06
the O 0 1.79205926542636e-06
most O 0 4.949613867211156e-06
common O 0 2.929454785771668e-05
mutations O 0 2.7915475584450178e-05
and O 0 5.227017254583188e-07
their O 0 4.0097199871524936e-07
frequencies O 0 7.5526545515458565e-06
in O 0 0.00014049993478693068
ataxia B-Disease 1 0.9999721050262451
- I-Disease 1 0.9986239671707153
telangiectasia I-Disease 1 0.9996476173400879
( O 0 0.0004741220036521554
A B-Disease 1 0.9981764554977417
- I-Disease 1 0.9964380264282227
T I-Disease 1 0.9994871616363525
) O 0 1.508149489382049e-05
homozygotes O 0 0.0006579809705726802
from O 0 5.75849389861105e-06
10 O 0 7.3855690061463974e-06
ethnic O 0 4.155327133048559e-06
populations O 0 6.929381925147027e-05
. O 0 8.2200720498804e-05

Both O 0 1.0820954230439384e-05
genomic O 0 0.00014245384954847395
mutations O 0 5.420049274107441e-05
and O 0 1.6276477481369511e-06
their O 0 1.5666947774661821e-06
effects O 0 0.0001820609759306535
on O 0 1.1418662325013429e-05
cDNA O 0 0.00011323362559778616
were O 0 1.9014043573406525e-05
characterized O 0 0.024588681757450104
. O 0 0.00023875423357822

Protein O 0 0.0005131434299983084
- O 0 0.00033642383641563356
truncation O 0 0.00013206691073719412
testing O 0 1.0043225302069914e-05
of O 0 1.3200101989241375e-07
the O 0 2.706201939872699e-06
entire O 0 4.0137685573427007e-05
ATM O 0 0.0005198184517212212
cDNA O 0 8.169044303940609e-05
detected O 0 0.0003488512884359807
92 O 0 9.57064185058698e-05
( O 0 4.661138518713415e-06
66 O 0 5.422324102255516e-05
% O 0 3.070197180932155e-06
) O 0 3.7364541185525013e-06
truncating O 0 0.00036477966932579875
mutations O 0 2.7735244657378644e-05
in O 0 2.030916675721528e-06
140 O 0 2.2811413145973347e-05
mutant O 0 0.0002744140801951289
alleles O 0 0.00011705980432452634
screened O 0 0.0014572247164323926
. O 0 7.639266550540924e-05

The O 0 8.075858931988478e-05
haplotyping O 0 0.004852666519582272
of O 0 2.093390685331542e-05
patients O 1 0.9981212019920349
with O 0 1.8577489754534326e-05
identical O 0 0.0006576476735062897
mutations O 0 0.0006353073986247182
indicates O 0 9.766816947376356e-05
that O 0 6.21572439740703e-07
almost O 0 7.802853474458971e-07
all O 0 2.9507338794587668e-08
of O 0 5.5301995871559484e-08
these O 0 1.9702842735114245e-07
represent O 0 1.231111923516437e-06
common O 0 2.9095368518028408e-05
ancestry O 0 3.21422703564167e-05
and O 0 5.2918126129952725e-06
that O 0 2.9062007342872676e-06
very O 0 1.3559490071202163e-05
few O 0 4.2594307160470635e-05
spontaneously O 0 0.004307059571146965
recurring O 0 0.10459544509649277
ATM O 0 0.09549712389707565
mutations O 0 0.0008390720468014479
exist O 0 5.106411117594689e-05
. O 0 0.00010171971371164545

Assays O 0 0.00028610022854991257
requiring O 0 0.00010716199176385999
minimal O 0 0.00010086701513500884
amounts O 0 1.0043417205451988e-05
of O 0 5.691431397281121e-07
genomic O 0 6.484858749900013e-05
DNA O 0 6.119046884123236e-05
were O 0 1.85119290563307e-06
designed O 0 5.819996658829041e-06
to O 0 2.659098754520528e-07
allow O 0 1.1041618108720286e-06
rapid O 0 0.00010931702854577452
screening O 0 4.795515997102484e-05
for O 0 7.624703926012444e-07
common O 0 1.8771143004414625e-05
ethnic O 0 1.2942290595674422e-05
mutations O 0 0.0010754496324807405
. O 0 0.0001103344329749234

These O 0 1.1583324521780014e-05
rapid O 0 0.0008103596046566963
assays O 0 0.00015446187171619385
detected O 0 0.0009219482308253646
mutations O 0 3.0888328183209524e-05
in O 0 2.5524284410494147e-06
76 O 0 7.581701356684789e-05
% O 0 1.898768573482812e-06
of O 0 1.3932664160165587e-06
Costa O 0 0.0003374856314621866
Rican O 0 0.0009530521929264069
patients O 1 0.9873563051223755
( O 0 1.1826570698758587e-05
3 O 0 1.3566759662353434e-05
) O 0 1.4085287602938479e-06
, O 0 6.130620704425382e-07
50 O 0 5.68743814710615e-07
% O 0 5.327783014763554e-07
of O 0 8.944837190938415e-07
Norwegian O 0 0.003104753326624632
patients O 1 0.9956755042076111
( O 0 1.9221886759623885e-05
1 O 0 2.1593650672002696e-05
) O 0 1.7046220364136389e-06
, O 0 5.605011210718658e-07
25 O 0 1.7330087302980246e-06
% O 0 1.1642490562735475e-06
of O 0 1.4230649867386092e-06
Polish O 1 0.5769997239112854
patients O 1 0.9990035891532898
( O 0 3.2073316106107086e-05
4 O 0 2.6934343622997403e-05
) O 0 2.538237822591327e-06
, O 0 4.847616423830914e-07
and O 0 2.814703066178481e-07
14 O 0 2.995857812493341e-06
% O 0 1.5604468899255153e-06
of O 0 1.5772246797496337e-06
Italian O 0 0.06621949374675751
patients O 1 0.9986467957496643
( O 0 4.625077053788118e-05
1 O 0 4.718480340670794e-05
) O 0 4.447550509212306e-06
, O 0 1.1256912557655596e-06
as O 0 1.3382008319240413e-06
well O 0 8.082275257947913e-07
as O 0 4.639253347704653e-06
in O 0 1.718476960377302e-05
patients O 1 0.6994339823722839
of O 0 6.0118650253571104e-06
Amish O 0 0.0066804829984903336
/ O 0 0.0032316194847226143
Mennonite O 0 0.0005728394025936723
and O 0 1.813960807339754e-05
Irish O 0 0.00044575645006261766
English O 0 0.00016044512449298054
backgrounds O 0 0.0001366029609926045
. O 0 0.00018722974346019328

Additional O 0 6.843265146017075e-05
mutations O 0 0.00016375628183595836
were O 0 4.816722594114253e-06
observed O 0 2.319245322723873e-05
in O 0 8.133415576594416e-06
Japanese O 0 0.00022148924472276121
, O 0 9.621631761547178e-06
Utah O 0 0.0001132997203967534
Mormon O 0 2.9919239750597626e-05
, O 0 4.112591796001652e-06
and O 0 4.240419912093785e-06
African O 0 0.00012132418487453833
American O 0 0.00040426754276268184
patients O 1 0.9985101819038391
. O 0 0.0003841800207737833

These O 0 4.509625341597712e-06
assays O 0 2.5161511075566523e-05
should O 0 1.1255807521592942e-06
facilitate O 0 3.2910331810853677e-06
screening O 0 5.2711304306285456e-05
for O 0 4.853083282796433e-06
A B-Disease 1 0.9195526242256165
- I-Disease 1 0.9280108213424683
T I-Disease 1 0.9991446733474731
heterozygotes O 0 0.0006549421232193708
in O 0 2.395835281276959e-06
the O 0 7.79805031925207e-06
populations O 0 2.1993095288053155e-05
studied O 0 5.815778422402218e-05
. O 0 3.668170393211767e-05
. O 0 7.652229396626353e-05

The O 0 0.0007394844433292747
von B-Disease 1 0.9660816788673401
Hippel I-Disease 1 0.9931544065475464
- I-Disease 1 0.9957230091094971
Lindau I-Disease 1 0.9986652135848999
tumor I-Disease 1 0.9994575381278992
suppressor O 0 0.002102780621498823
gene O 0 2.530340861994773e-05
is O 0 9.692644198366906e-07
required O 0 1.9876522401318653e-06
for O 0 1.804506382541149e-06
cell O 0 0.0006229556747712195
cycle O 0 0.00013787162606604397
exit O 0 0.00032660915167070925
upon O 0 8.967138273874298e-05
serum O 1 0.5060160160064697
withdrawal O 0 0.000978417112492025
. O 0 0.0001419119507772848

The O 0 3.4841035812860355e-05
inactivation O 0 0.001828701002523303
of O 0 1.597570530975645e-06
the O 0 0.0001331696257693693
von B-Disease 1 0.988332211971283
Hippel I-Disease 1 0.9951379895210266
- I-Disease 1 0.9793844223022461
Lindau I-Disease 1 0.9966720342636108
( I-Disease 0 0.001707463408820331
VHL I-Disease 1 0.9985114932060242
) I-Disease 0 0.0016423919005319476
tumor I-Disease 1 0.9993032217025757
suppressor O 0 0.12546196579933167
gene O 0 0.0010741277365013957
predisposes O 0 0.033408503979444504
affected O 0 0.00010645454312907532
individuals O 0 2.23844790525618e-06
to O 0 5.56135682927561e-06
the O 0 0.0001759487931849435
human O 1 0.9795485734939575
VHL B-Disease 1 0.9999961853027344
cancer I-Disease 1 0.9999998807907104
syndrome I-Disease 1 0.9999995231628418
and O 0 0.00011384478420950472
is O 0 6.503015174530447e-05
associated O 0 0.00023519906972069293
with O 0 0.0003152496356051415
sporadic B-Disease 1 0.9987990856170654
renal I-Disease 1 0.9999996423721313
cell I-Disease 1 0.999866247177124
carcinomas I-Disease 1 0.9999916553497314
( O 0 0.15066933631896973
RCC B-Disease 1 0.999936580657959
) O 0 0.00035018339985981584
and O 0 0.0001590718311490491
brain B-Disease 1 0.9991029500961304
hemangioblastomas I-Disease 1 0.7864640355110168
. O 0 0.00029456254560500383

VHL O 1 0.9838200807571411
- O 0 0.006297130603343248
negative O 0 0.0002653216361068189
786 O 0 0.034475065767765045
- O 0 0.00474798446521163
0 O 0 0.00028958049369975924
RCC B-Disease 1 0.9982263445854187
cells O 0 0.0006404078449122608
are O 0 2.716472636166145e-06
tumorigenic O 0 0.002459009177982807
in O 0 4.786761201103218e-05
nude O 0 0.01216764748096466
mice O 0 0.0024485059548169374
which O 0 2.0687382402684307e-06
is O 0 4.718471700471127e-06
suppressed O 0 0.0001252389483852312
by O 0 1.8758242958938354e-06
the O 0 5.858298209204804e-06
reintroduction O 0 0.0004819613241124898
of O 0 1.5651443391107023e-05
VHL B-Disease 1 0.998296320438385
. O 0 0.0002893696364481002

Remarkably O 0 0.010085471905767918
, O 0 1.1402438758523203e-05
this O 0 3.375895857971045e-06
occurs O 0 3.8220870919758454e-05
without O 0 1.1526551134011243e-05
affecting O 0 2.4007935280678794e-05
the O 0 7.463553174602566e-06
growth O 0 5.6471213611075655e-05
rate O 0 3.808653855230659e-05
and O 0 2.5086712867050664e-06
cell O 0 0.0003431661461945623
cycle O 0 9.145658259512857e-05
profile O 0 1.5740595699753612e-05
of O 0 4.2955534240718407e-07
these O 0 4.117912794754375e-06
cells O 0 0.0005232028779573739
in O 0 8.753922884352505e-06
culture O 0 6.490111991297454e-05
. O 0 9.257583587896079e-05

The O 0 0.0001952348684426397
786 O 0 0.01163941528648138
- O 0 0.000785969605203718
0 O 0 3.8488098653033376e-05
cell O 0 0.00046956067671999335
line O 0 5.9128025895915926e-05
, O 0 4.108891062060138e-06
like O 0 2.5423405531910248e-05
many O 0 5.634824265143834e-05
cancer B-Disease 1 0.99996018409729
cells O 0 0.003113802056759596
, O 0 8.37693914945703e-06
fails O 0 8.276238804683089e-05
to O 0 4.6653894969495013e-07
exit O 0 4.0488179365638644e-05
the O 0 3.5890700473828474e-06
cell O 0 0.00043705309508368373
cycle O 0 0.00013694413064513355
upon O 0 8.766971586737782e-05
serum O 1 0.6114806532859802
withdrawal O 0 0.0008720637997612357
. O 0 0.00016801086894702166

Here O 0 9.166201198240742e-05
, O 0 8.266257282230072e-06
it O 0 1.7006469761327025e-06
is O 0 1.6577762380620698e-06
shown O 0 2.725282229221193e-06
that O 0 3.3850668046397914e-07
reintroduction O 0 2.0041752577526495e-05
of O 0 2.2731141768872476e-07
the O 0 1.548471482237801e-05
wild O 0 0.00024915317771956325
- O 0 0.0027246647514402866
type O 0 0.002043472370132804
VHL B-Disease 1 0.9465860724449158
gene O 0 9.987086377805099e-05
restores O 0 0.00029126449953764677
the O 0 5.548198259930359e-06
ability O 0 1.4186437510943506e-05
of O 0 1.7026890418492258e-05
VHL O 1 0.9989712238311768
- O 1 0.9079814553260803
negative O 0 0.01714305952191353
RCC B-Disease 1 0.9999698400497437
cancer I-Disease 1 0.9999279975891113
cells O 0 0.0005610266816802323
to O 0 1.9260339740867494e-06
exit O 0 0.0001058077541529201
the O 0 6.542539722431684e-06
cell O 0 0.0004379071469884366
cycle O 0 8.167867781594396e-05
and O 0 4.206791345495731e-06
enter O 0 0.00015455734683200717
G0 O 0 0.30355778336524963
/ O 0 0.0008583581075072289
quiescence O 0 0.0014254357665777206
in O 0 2.438715637254063e-05
low O 0 0.011201963759958744
serum O 1 0.869104266166687
. O 0 0.00017431977903470397

Both O 0 0.0004914489109069109
VHL O 1 0.9929757118225098
- O 0 0.004119451157748699
positive O 0 6.254202162381262e-05
and O 0 5.941753988736309e-05
VHL O 1 0.9952341914176941
- O 0 0.015521788038313389
negative O 0 0.0005735247978009284
RCC B-Disease 1 0.9989805817604065
cells O 0 0.0006572056445293128
exit O 0 0.0001910095743369311
the O 0 7.66351877246052e-06
cell O 0 0.0007266477914527059
cycle O 0 0.00012185487867100164
by O 0 7.171938705141656e-06
contact O 0 0.00022498065663967282
inhibition O 0 0.0010372842662036419
. O 0 0.000100963436125312

The O 0 0.00014470085443463176
cyclin O 0 0.016017967835068703
- O 0 0.0005615527043119073
dependent O 0 9.81903649517335e-05
kinase O 0 0.0006320691318251193
inhibitor O 0 0.0025452803820371628
, O 0 1.1507857379911002e-05
p27 O 0 0.004167953971773386
, O 0 8.451693247479852e-06
accumulates O 0 0.0005915084038861096
upon O 0 4.445204103831202e-05
serum O 0 0.020151780918240547
withdrawal O 0 0.00010985099652316421
, O 0 1.021309230964107e-06
only O 0 1.7788023853881896e-07
in O 0 3.2932703675214725e-07
the O 0 1.8317873582418542e-06
presence O 0 6.3290258367487695e-06
of O 0 2.788824758681585e-06
VHL B-Disease 1 0.9980869293212891
, O 0 4.1794514800130855e-06
as O 0 2.271751782245701e-06
a O 0 3.2533739613427315e-06
result O 0 4.036109658045461e-06
of O 0 1.2088433720691683e-07
the O 0 4.869216809311183e-06
stabilization O 0 0.00010456212476128712
of O 0 4.671253179822088e-07
the O 0 2.1106483472976834e-05
protein O 0 0.000360499310772866
. O 0 5.5563748901477084e-05

We O 0 8.674011041875929e-06
propose O 0 1.4802454643358942e-05
that O 0 6.773498739676143e-07
the O 0 4.417394393385621e-06
loss O 0 0.00013181567192077637
of O 0 3.0604917355958605e-06
wild O 0 0.000433647190220654
- O 0 0.001671380246989429
type O 0 0.0013743252493441105
VHL B-Disease 1 0.9632106423377991
gene O 0 3.2170573831535876e-05
results O 0 6.8226613620936405e-06
in O 0 1.011160520647536e-06
a O 0 5.492825039254967e-06
specific O 0 9.301706995756831e-06
cellular O 0 0.0048840707167983055
defect O 1 0.9929800629615784
in O 0 9.200204658554867e-05
serum O 1 0.9919554591178894
- O 0 0.0014629281358793378
dependent O 0 6.399650010280311e-05
growth O 0 0.00010058077896246687
control O 0 3.721658140420914e-05
, O 0 3.649850896181306e-06
which O 0 6.184443464007927e-06
may O 0 0.0001857575698522851
initiate O 0 0.0011851973831653595
tumor B-Disease 1 0.9995067119598389
formation O 0 0.012308383360505104
. O 0 0.0002493910724297166

This O 0 2.424852573312819e-05
is O 0 3.553005080902949e-05
corrected O 0 0.0007358269649557769
by O 0 9.366397080157185e-07
the O 0 1.978321279239026e-06
reintroduction O 0 9.408612095285207e-05
of O 0 1.3361017181523493e-06
wild O 0 0.0006581548950634897
- O 0 0.00899952370673418
type O 0 0.02453685738146305
VHL B-Disease 1 0.998245358467102
, O 0 9.35914576984942e-05
implicating O 1 0.8260077238082886
VHL B-Disease 1 0.9965904951095581
as O 0 1.481625258747954e-05
the O 0 1.9515849999152124e-05
first O 0 0.0002579149149823934
tumor B-Disease 1 0.9993311166763306
suppressor O 0 0.0005860513774678111
involved O 0 6.704483894282021e-06
in O 0 1.0315678764527547e-06
the O 0 1.6186110087801353e-06
regulation O 0 1.599511961103417e-05
of O 0 1.3169250223654672e-06
cell O 0 0.0019020168110728264
cycle O 0 0.00026009391876868904
exit O 0 0.0005488291499204934
, O 0 1.9992583020211896e-06
which O 0 4.2257394738953735e-07
is O 0 9.37255322241981e-07
consistent O 0 3.4584713830554392e-06
with O 0 9.776456408872036e-07
its O 0 4.555743998935213e-06
gatekeeper O 0 0.0014141350984573364
function O 0 1.8771501345327124e-05
in O 0 1.9584163965191692e-05
the O 0 0.001112702302634716
kidney O 1 0.9999910593032837
. O 0 0.00020037156355101615
. O 0 0.00019548374984879047

Piebaldism B-Disease 1 0.9944721460342407
with O 0 0.006068346090614796
deafness B-Disease 1 0.9999922513961792
: O 0 3.10864343191497e-05
molecular O 0 6.815820233896375e-05
evidence O 0 5.016701470594853e-05
for O 0 7.878060387156438e-06
an O 0 0.0005789549904875457
expanded O 1 0.7836551070213318
syndrome O 1 0.9999940395355225
. O 0 0.0009269820875488222

In O 0 2.7453805159893818e-05
a O 0 5.2780866099055856e-05
South O 0 7.510153227485716e-05
African O 0 3.85276107408572e-05
girl O 0 0.0005725561059080064
of O 0 7.989417099452112e-06
Xhosa O 1 0.9772521257400513
stock O 0 0.024691494181752205
with O 0 0.001567626022733748
severe O 1 0.999948263168335
piebaldism B-Disease 1 0.9975640773773193
and O 0 0.0017898812657222152
profound O 1 0.9970760345458984
congenital O 1 0.9999998807907104
sensorineural B-Disease 1 0.9999983310699463
deafness I-Disease 1 0.9999995231628418
we O 0 7.161009853007272e-05
identified O 0 0.00012639633496291935
a O 0 1.8327575162402354e-05
novel O 0 3.743877459783107e-05
missense O 0 0.00010574330372037366
substitution O 0 9.10540529730497e-06
at O 0 1.2194768714834936e-05
a O 0 5.002616035199026e-06
highly O 0 2.409711669315584e-05
conserved O 0 1.0474256669112947e-05
residue O 0 0.00010359091538703069
in O 0 8.766451742303616e-07
the O 0 1.4871865232635173e-06
intracellular O 0 7.019380427664146e-05
kinase O 0 1.3263478649605531e-05
domain O 0 7.559843311355507e-07
of O 0 2.537020407089585e-07
the O 0 2.1567429939750582e-05
KIT O 0 0.14317774772644043
proto O 0 0.05615212395787239
- O 0 0.0039612785913050175
oncogene O 0 0.004679592326283455
, O 0 2.1117073629284278e-05
R796G O 0 0.0013526671100407839
. O 0 8.833450556267053e-05

Though O 0 0.001985858427360654
auditory B-Disease 0 0.4223147928714752
anomalies I-Disease 0 0.15079641342163086
have O 0 7.559601272077998e-06
been O 0 1.9062519641011022e-05
observed O 0 2.1998001102474518e-05
in O 0 1.2234723726578522e-05
mice O 0 0.0016050608828663826
with O 0 8.911079021345358e-06
dominant O 0 0.002088152104988694
white O 0 0.17337168753147125
spotting O 1 0.7202871441841125
( O 0 0.00019583709945436567
W O 1 0.9923744797706604
) O 0 1.6544956451980397e-05
due O 0 0.000137077528052032
to O 0 1.4232118701329455e-05
KIT O 1 0.9846243858337402
mutations O 0 0.0018571738619357347
, O 0 0.00017952232155948877
deafness B-Disease 1 0.9999812841415405
is O 0 2.445931386318989e-05
not O 0 4.694440576713532e-06
typical O 0 0.00011131566134281456
in O 0 1.933692692546174e-05
human O 0 0.00043268880108371377
piebaldism B-Disease 0 0.1289021521806717
. O 0 0.00025035429280251265

Thus O 0 9.437301923753694e-05
, O 0 8.507687198289204e-06
the O 0 1.7418402421753854e-05
occurrence O 0 0.0008623524918220937
of O 0 0.0001357954170089215
sensorineural B-Disease 1 0.9999873638153076
deafness I-Disease 1 0.9999988079071045
in O 0 0.00016009638784453273
this O 0 4.878989784629084e-05
patient O 1 0.9856377243995667
extends O 0 8.083101420197636e-05
considerably O 0 9.391330240759999e-05
the O 0 1.3815753163726185e-06
phenotypic O 0 1.6048228644649498e-05
range O 0 3.1168601708486676e-06
of O 0 1.719017404866463e-06
piebaldism B-Disease 0 0.006045960355550051
due O 0 0.00039488720358349383
to O 0 6.896464128658408e-06
KIT O 0 0.030005866661667824
gene O 0 0.00010291559010511264
mutation O 0 8.563166920794174e-05
in O 0 5.207734375289874e-06
humans O 0 6.55116600682959e-05
and O 0 7.395175089186523e-06
tightens O 0 0.003636689856648445
the O 0 1.3792931895295624e-05
clinical O 0 0.001485168468207121
similarity O 0 4.0888102375902236e-05
between O 0 2.075822885672096e-05
piebaldism B-Disease 0 0.0069948239251971245
and O 0 1.7672851981842541e-06
the O 0 1.717726149763621e-06
various O 0 9.628374755266123e-07
forms O 0 0.00019255622464697808
of O 0 0.003857068484649062
Waardenburg B-Disease 1 0.9999984502792358
syndrome I-Disease 1 0.9999998807907104
. O 0 0.001086830161511898
. O 0 0.0005025101127102971

Cycloheximide O 0 0.0040688044391572475
facilitates O 0 5.708706157747656e-05
the O 0 2.614505092424224e-06
identification O 0 3.952749011659762e-06
of O 0 8.202227945730556e-07
aberrant O 0 0.001191323739476502
transcripts O 0 0.00013660361582878977
resulting O 0 5.506579327629879e-05
from O 0 2.9654706850124057e-06
a O 0 1.97294975805562e-05
novel O 0 7.873374124756083e-05
splice O 0 0.0010822457261383533
- O 0 0.0003327127196826041
site O 0 5.214017437538132e-05
mutation O 0 2.4195258447434753e-05
in O 0 3.6849125990556786e-06
COL17A1 O 0 0.009968819096684456
in O 0 1.200170208903728e-05
a O 0 0.00042174875852651894
patient O 1 0.9937472343444824
with O 0 0.0003782248531933874
generalized O 1 0.9962097406387329
atrophic B-Disease 1 0.9999462366104126
benign I-Disease 1 0.9999586343765259
epidermolysis I-Disease 1 0.9998445510864258
bullosa I-Disease 1 0.9989786148071289
. O 0 0.004329372197389603

Patients O 1 0.9978679418563843
with O 0 0.002243698574602604
generalized O 1 0.9969720840454102
atrophic B-Disease 1 0.999966025352478
benign I-Disease 1 0.999981164932251
epidermolysis I-Disease 1 0.9998693466186523
bullosa I-Disease 1 0.9995326995849609
often O 0 0.0006838743574917316
show O 0 0.00014343892689794302
decreased O 0 0.0008201597956940532
expression O 0 1.8412578356219456e-05
of O 0 1.0942660992441233e-05
type O 1 0.9815826416015625
XVII O 1 0.999578058719635
collagen O 1 0.9912338852882385
, O 0 7.229504717543023e-06
a O 0 1.547984174976591e-05
transmembrane O 0 0.00039592827670276165
hemidesmosomal O 0 0.0006063183536753058
protein O 0 1.8450580682838336e-05
encoded O 0 7.024614660622319e-06
by O 0 2.2088248442742042e-05
COL17A1 O 0 0.4085440933704376
. O 0 0.00013291552022565156

This O 0 1.8399692635284737e-05
report O 0 3.774340802920051e-05
documents O 0 1.0930718417512253e-05
a O 0 1.796454489522148e-05
novel O 0 6.03853513894137e-05
splice O 0 0.0005686986842192709
- O 0 0.0003094176354352385
site O 0 3.514031050144695e-05
mutation O 0 2.8643780751735903e-05
in O 0 5.272112048260169e-06
COL17A1 O 0 0.014037871733307838
in O 0 1.1620866644079797e-05
a O 0 0.0002355999022256583
patient O 1 0.9940837025642395
with O 0 0.00038104300620034337
generalized O 1 0.9973457455635071
atrophic B-Disease 1 0.9999340772628784
benign I-Disease 1 0.9999585151672363
epidermolysis I-Disease 1 0.9997656941413879
bullosa I-Disease 1 0.999320387840271
, O 0 7.260895654326305e-05
and O 0 3.670998012239579e-06
applies O 0 9.011132533487398e-06
a O 0 6.418058092094725e-06
new O 0 1.9372896531422157e-06
methodology O 0 3.709392785822274e-06
to O 0 4.129138631014939e-07
define O 0 6.421842044801451e-06
and O 0 1.936395619850373e-06
characterize O 0 9.027281339513138e-05
the O 0 6.016930001351284e-06
resulting O 0 0.00014324375661090016
mRNA O 0 9.768353629624471e-05
splice O 0 0.0013639201642945409
variants O 0 0.0003353894571773708
. O 0 8.186996274162084e-05

Mutational O 0 0.0028146381955593824
analysis O 0 6.8162485149514396e-06
of O 0 5.426336429081857e-06
COL17A1 O 0 0.3859676420688629
identified O 0 0.00024222914362326264
a O 0 0.00017703288176562637
maternally O 0 0.015193001367151737
inherited O 1 0.9883133172988892
G O 0 0.05858367308974266
- O 0 0.0009427312761545181
to O 0 1.0985846529365517e-05
- O 0 0.0009810223709791899
T O 0 0.009915280155837536
transversion O 0 0.0001045857643475756
at O 0 6.9837951741646975e-06
the O 0 2.970690502479556e-06
- O 0 1.1918814379896503e-05
1 O 0 6.401337486749981e-07
position O 0 1.5459116298188746e-07
of O 0 1.5801950326022052e-07
exon O 0 0.0006406346801668406
32 O 0 6.626576941926032e-05
. O 0 5.6293996749445796e-05

This O 0 1.2501778655860107e-05
acceptor O 0 0.0013864249922335148
splice O 0 0.0013115304755046964
- O 0 0.000328642810927704
site O 0 2.615113407955505e-05
mutation O 0 8.918866114981938e-06
led O 0 2.32563820645737e-06
to O 0 1.3519914432436053e-07
the O 0 9.428611633666151e-07
formation O 0 4.974398325430229e-05
of O 0 1.1687968708429253e-06
aberrant O 0 0.0011427836725488305
transcripts O 0 9.246519766747952e-05
present O 0 1.6186717402888462e-05
at O 0 8.571139915147796e-05
extremely O 0 0.0009023752063512802
low O 0 0.0017842521192505956
levels O 0 0.0019667288288474083
. O 0 9.198932093568146e-05

Based O 0 1.2374361176625825e-05
on O 0 1.0768247193482239e-05
our O 0 2.372624521740363e-06
recent O 0 1.1717538654920645e-05
finding O 0 1.774437077983748e-05
that O 0 1.6490610505570658e-05
cycloheximide O 0 0.013780391775071621
stabilized O 0 0.05596255883574486
mutant O 0 0.0008121491991914809
COL17A1 O 0 0.00986118707805872
transcripts O 0 0.00020311938715167344
in O 0 1.2834913832193706e-05
keratinocytes O 0 0.0016651609912514687
homozygous O 0 0.00011361487850081176
for O 0 2.8560789360199124e-06
a O 0 6.577884050784633e-05
frameshift O 0 0.014815067872405052
mutation O 0 8.41151486383751e-05
, O 0 2.1597004433715483e-06
the O 0 2.9243497010611463e-06
effects O 0 4.224173244438134e-05
of O 0 5.992529850118444e-07
the O 0 2.4077911803033203e-05
splice O 0 0.0015885032480582595
- O 0 0.0002365069231018424
site O 0 2.915419463533908e-05
mutation O 0 5.283164682623465e-06
on O 0 9.887162377708592e-07
splicing O 0 7.205985184555175e-06
of O 0 1.0677048294382985e-06
COL17A1 O 0 0.018005438148975372
transcripts O 0 0.00011125061428174376
were O 0 2.52158770308597e-06
determined O 0 4.743810222862521e-06
using O 0 2.002475412155036e-06
reverse O 0 0.00018943165196105838
transcriptase O 0 0.0005677976296283305
polymerase O 0 0.0001919132482726127
chain O 0 0.00013010586553718895
reaction O 0 1.1776104656746611e-05
of O 0 1.407705383371649e-07
total O 0 2.277452495036414e-06
RNA O 0 9.462417801842093e-05
from O 0 1.2363697351247538e-05
keratinocytes O 0 0.0008593646925874054
incubated O 0 0.00013205532741267234
for O 0 6.091316208767239e-06
2 O 0 0.00013061327626928687
. O 0 5.6693625083426014e-05

5 O 0 0.0001349876110907644
h O 0 0.00024202758504543453
in O 0 4.266535597707843e-06
the O 0 3.6600847579393303e-06
presence O 0 1.0526932783250231e-05
or O 0 6.545054475282086e-06
absence O 0 4.316168269724585e-05
of O 0 1.127075961449009e-06
10 O 0 5.1474940846674144e-05
microg O 0 0.004414948169142008
cycloheximide O 0 0.00258382479660213
per O 0 5.3467098041437566e-05
ml O 0 0.012125319801270962
. O 0 0.0001762029860401526

Using O 0 1.800407699192874e-05
this O 0 2.7138730729348026e-06
approach O 0 1.8020500647253357e-05
, O 0 6.467816092481371e-06
an O 0 5.3199128160486e-05
abnormally O 1 0.6814281940460205
spliced O 0 0.0014176745899021626
transcript O 0 0.009503637440502644
was O 0 0.0002988121996168047
identified O 0 1.1325179912091698e-05
that O 0 1.6554459136841615e-07
contains O 0 7.17722969056922e-07
an O 0 7.198342473202501e-07
extra O 0 1.010610048979288e-06
264 O 0 2.068803041765932e-05
bases O 0 5.521661705643055e-07
upstream O 0 1.5599585822201334e-05
from O 0 2.302444499946432e-06
exon O 0 0.00014401729276869446
32 O 0 1.2655201317102183e-05
, O 0 1.9582350887503708e-06
resulting O 0 3.8805192161817104e-05
in O 0 5.962498107692227e-06
a O 0 9.330229659099132e-05
premature O 0 0.032000187784433365
termination O 0 0.0013007931411266327
codon O 0 8.338392217410728e-05
27 O 0 0.0001032052023219876
bp O 0 0.00028181419475004077
downstream O 0 7.824724161764607e-05
from O 0 5.63829007660388e-06
the O 0 2.386016603850294e-05
cryptic O 0 0.0035920352675020695
splice O 0 0.0019528452539816499
site O 0 0.000604034576099366
. O 0 0.00011604961764533073

Three O 0 1.1050550710933749e-05
other O 0 2.8460024168452946e-06
splice O 0 0.0005231829127296805
variants O 0 4.903880471829325e-05
, O 0 1.7180635722979787e-06
including O 0 3.7901330074419093e-07
one O 0 3.4981172802872607e-07
derived O 0 2.4074336124613183e-06
from O 0 2.1263388134684647e-06
the O 0 1.072525947165559e-06
skipping O 0 6.473853864008561e-05
of O 0 6.707494435431727e-07
exon O 0 0.000490108912345022
32 O 0 2.740946365520358e-05
, O 0 3.5823436519422103e-06
were O 0 5.394521394919138e-06
also O 0 2.5810728402575478e-05
identified O 0 0.0003456810081843287
. O 0 7.63266216381453e-05

These O 0 8.692543815413956e-06
results O 0 7.875274604884908e-05
indicate O 0 6.0921880503883585e-05
the O 0 8.589750905230176e-06
usefulness O 0 0.0001005974700092338
of O 0 2.6400671231385786e-06
cycloheximide O 0 0.10837016999721527
treatment O 0 0.19318611919879913
in O 0 6.369929451466305e-06
evaluating O 0 1.9309192794025876e-05
the O 0 8.757713658269495e-06
abnormal O 0 0.0008128362824209034
processing O 0 6.4503469729970675e-06
of O 0 2.581340936558263e-07
mRNA O 0 1.840032564359717e-05
due O 0 5.3473781008506194e-05
to O 0 2.198689116994501e-06
splice O 0 0.00047149695456027985
- O 0 0.0002816184132825583
site O 0 8.944950968725607e-05
mutations O 0 7.481053762603551e-05
, O 0 4.010862085124245e-06
because O 0 2.1075949916848913e-05
( O 0 1.3622221558762249e-05
i O 0 1.5977404473233037e-05
) O 0 1.66348854691023e-06
aberrant O 0 6.383308937074617e-05
splicing O 0 8.822141353448387e-06
often O 0 2.958420282084262e-06
generates O 0 6.776213467674097e-06
a O 0 3.0237832106649876e-05
premature O 0 0.026653334498405457
termination O 0 0.0020491417963057756
codon O 0 7.483994704671204e-05
, O 0 7.476875907741487e-06
( O 0 9.58712917054072e-06
ii O 0 0.002981670433655381
) O 0 5.354992026695982e-06
transcripts O 0 7.45712241041474e-05
with O 0 1.0927456060016993e-05
premature O 1 0.5738635659217834
termination O 0 0.0038006321992725134
codons O 0 0.00012961390893906355
can O 0 2.4379776277783094e-06
occur O 0 1.487265126343118e-05
at O 0 6.428716733353212e-05
low O 0 0.0009585469379089773
or O 0 9.937971481122077e-05
undetectable O 1 0.8911768794059753
levels O 0 0.0004239706031512469
due O 0 9.867545304587111e-05
to O 0 1.7716033653414343e-06
nonsense O 0 0.00015998314484022558
- O 0 3.566822488210164e-05
mediated O 0 5.956447057542391e-05
mRNA O 0 1.1926125807804056e-05
decay O 0 0.0002442174300085753
, O 0 4.759888724947814e-06
and O 0 3.2199300221691374e-06
( O 0 1.4729875147168059e-05
iii O 0 0.0009416442480869591
) O 0 1.999653022721759e-06
the O 0 9.88034685178718e-07
levels O 0 1.1305270163575187e-05
of O 0 7.474157115439084e-08
these O 0 2.300060231164025e-07
transcripts O 0 6.3312218117062e-05
can O 0 1.06627817331173e-06
be O 0 2.223384854005417e-06
increased O 0 1.1359805284882896e-05
by O 0 1.4310565347841475e-05
cycloheximide O 0 0.013741078786551952
. O 0 0.00017395979375578463

A O 0 0.0005413115723058581
deletion O 0 0.0010919487103819847
mutation O 0 0.00014917520456947386
in O 0 8.729894943826366e-06
COL17A1 O 0 0.013102957047522068
in O 0 8.575982974434737e-06
five O 0 1.964572220458649e-05
Austrian O 0 0.006227375008165836
families O 0 5.788566340925172e-05
with O 0 0.0002856434730347246
generalized O 1 0.9949506521224976
atrophic B-Disease 1 0.9999197721481323
benign I-Disease 1 0.9999198913574219
epidermolysis I-Disease 1 0.9994418025016785
bullosa I-Disease 1 0.9923198819160461
represents O 0 7.772695971652865e-05
propagation O 0 1.7384085367666557e-05
of O 0 1.1581449825825985e-06
an O 0 4.676368189393543e-05
ancestral O 0 0.0021286101546138525
allele O 0 0.0005844393162988126
. O 0 0.00016094387683551759

Patients O 1 0.9974422454833984
with O 0 0.001574895577505231
generalized O 1 0.9971344470977783
atrophic B-Disease 1 0.9999462366104126
benign I-Disease 1 0.9999598264694214
epidermolysis I-Disease 1 0.9998905658721924
bullosa I-Disease 1 0.9991205334663391
, O 0 9.980736649595201e-05
a O 0 6.607709656236693e-05
usually O 0 4.6177963668014854e-05
nonlethal O 0 0.0004636427911464125
form O 0 5.484683424583636e-05
of O 0 4.9386650061933324e-05
junctional B-Disease 1 0.998383641242981
epidermolysis I-Disease 1 0.9995526671409607
bullosa I-Disease 1 0.997410237789154
, O 0 8.338535553775728e-05
have O 0 2.4592540285084397e-05
generalized O 0 0.008071874268352985
blistering B-Disease 1 0.995477020740509
, O 0 0.003653113264590502
nail B-Disease 1 0.9999159574508667
dystrophy I-Disease 1 0.9999902248382568
, O 0 0.03929392620921135
patchy B-Disease 1 0.9998931884765625
alopecia I-Disease 1 0.9999951124191284
, O 0 0.0016829209635034204
and O 0 0.0014167871559038758
dental B-Disease 1 0.9999176263809204
abnormalities I-Disease 1 0.9998515844345093
. O 0 0.001822527265176177

Skin B-Disease 1 0.99981290102005
fragility I-Disease 1 0.9926993250846863
in O 0 7.795647979946807e-05
most O 0 3.1145609682425857e-05
cases O 0 0.00028189027216285467
is O 0 7.1947511059988756e-06
due O 0 9.039668657351285e-05
to O 0 1.4121252434051712e-06
mutations O 0 8.963359505287372e-06
in O 0 4.550063579245034e-07
the O 0 1.8369727285971749e-06
gene O 0 4.782245014212094e-05
encoding O 0 8.738092583371326e-05
type O 0 0.4672276973724365
XVII O 1 0.9993630051612854
collagen O 1 0.9987388253211975
( O 0 0.000301271938951686
COL17A1 O 1 0.7757886648178101
) O 0 5.064829019829631e-05
. O 0 5.916784721193835e-05

Recently O 0 0.0028337605763226748
, O 0 1.6056816093623638e-05
we O 0 3.2197915516007924e-06
reported O 0 7.341954187722877e-05
five O 0 8.544308002456091e-06
Austrian O 0 0.002091925358399749
families O 0 4.0579405322205275e-05
with O 0 0.00039302860386669636
generalized O 1 0.996217668056488
atrophic B-Disease 1 0.9999550580978394
benign I-Disease 1 0.9999642372131348
epidermolysis I-Disease 1 0.9997658133506775
bullosa I-Disease 1 0.9986500144004822
who O 0 0.0001328890211880207
share O 0 1.1718834684870671e-05
the O 0 1.3548658898798749e-05
same O 0 6.598565960302949e-05
COL17A1 O 1 0.8883664608001709
mutation O 0 0.0010526108089834452
. O 0 6.540067988680676e-05

Affected O 0 0.000642745231743902
individuals O 0 9.702950592327397e-06
in O 0 6.314417987596244e-06
three O 0 6.374116310325917e-06
families O 0 9.338869858765975e-06
are O 0 1.253870209438901e-06
homozygous O 0 9.894192044157535e-05
for O 0 3.8122095702419756e-06
4003delTC O 0 0.0014995649689808488
, O 0 3.2449891023134114e-06
whereas O 0 1.0284059499099385e-05
those O 0 6.814480002503842e-07
in O 0 1.8253247162647313e-06
two O 0 1.8447357206241577e-06
others O 0 2.0076857254025526e-05
are O 0 3.994584858446615e-06
compound O 0 0.007903394289314747
heterozygotes O 0 0.06393235921859741
. O 0 0.00040239220834337175

To O 0 3.5544890124583617e-06
determine O 0 5.552676611841889e-06
if O 0 2.1184350771363825e-06
the O 0 2.8592512535396963e-06
occurrence O 0 5.685486030415632e-05
of O 0 2.170898824260803e-06
4003delTC O 0 0.0029339944012463093
in O 0 9.328456144430675e-06
these O 0 2.5973201900342247e-06
unrelated O 0 0.0007683138246648014
families O 0 1.0311555342923384e-05
signifies O 0 6.297856452874839e-05
propagation O 0 3.539315002853982e-06
of O 0 3.342230172620475e-07
an O 0 1.34816882564337e-05
ancestral O 0 0.00024679178022779524
allele O 0 5.014443740947172e-05
or O 0 1.3477188076649327e-05
a O 0 6.957907316973433e-05
mutational O 0 0.007844293490052223
hot O 0 0.0019215754000470042
spot O 0 0.00020406533440109342
, O 0 7.290821940841852e-06
haplotypes O 0 0.00014323800860438496
were O 0 3.0815936042927206e-06
determined O 0 1.1880083548021503e-05
for O 0 1.2693679991571116e-06
polymorphisms O 0 6.418339762603864e-05
both O 0 9.335238360108633e-07
within O 0 6.166639650473371e-06
and O 0 3.392893631826155e-05
flanking O 0 0.18917042016983032
COL17A1 O 1 0.9794194102287292
. O 0 0.0005263583152554929

Five O 0 0.0001534947514301166
intragenic O 0 0.007171399891376495
polymorphisms O 0 0.0002735367161221802
were O 0 3.112834974672296e-06
chosen O 0 1.1448804571045912e-06
based O 0 1.765262140906998e-06
on O 0 4.707343123300234e-06
their O 0 6.63486071061925e-06
informativeness O 0 0.00981832854449749
. O 0 0.00012047649943269789

One O 0 3.5721907352126436e-06
of O 0 6.729040933350916e-07
these O 0 1.5495087382078054e-06
, O 0 6.400417987606488e-06
not O 0 3.6875949263048824e-06
previously O 0 7.716494292253628e-05
reported O 0 0.0002471822081133723
, O 0 8.42349800223019e-06
was O 0 0.00014251649554353207
2988 O 0 0.0004494887252803892
A O 0 5.289338150760159e-05
or O 0 6.282133199420059e-06
C O 0 7.856530282879248e-05
that O 0 2.7906745003747346e-07
introduces O 0 5.842893187946174e-06
a O 0 3.453494855421013e-06
new O 0 1.7549356243762304e-06
restriction O 0 1.3359742297325283e-05
site O 0 2.2534868548973463e-05
for O 0 3.374041853021481e-06
Eco0109 O 0 0.002490588231012225
I O 0 0.0010231506312265992
. O 0 3.700014713103883e-05

All O 0 1.8898044800153002e-06
the O 0 1.4932242265786044e-05
4003delTC O 0 0.0008311098790727556
alleles O 0 4.1031733417185023e-05
showed O 0 3.639268106780946e-05
the O 0 2.285158643644536e-06
same O 0 4.139533757552272e-06
haplotype O 0 0.0001200260958285071
for O 0 6.96685219736537e-07
these O 0 4.5899813017058477e-07
five O 0 9.735827006807085e-06
polymorphic O 0 0.003233192954212427
markers O 0 0.008145497180521488
. O 0 0.00017195574764627963

Fourteen O 0 0.0006055217236280441
microsatellite O 0 0.005860602483153343
polymorphisms O 0 0.0003723542904481292
were O 0 3.1457634577236604e-06
selected O 0 1.4399660130948178e-06
based O 0 6.251124773370975e-07
on O 0 9.809274388317135e-07
their O 0 6.838881176918221e-07
high O 0 0.00014349872071761638
heterozygosity O 0 0.00044035178143531084
and O 0 5.007810841561877e-07
their O 0 3.5334667813913256e-07
location O 0 9.513918485026807e-06
within O 0 4.474769866646966e-06
10q23 O 0 0.0018465369939804077
- O 0 0.0010762930614873767
q25 O 0 0.0014354201266542077
near O 0 0.0007293907110579312
COL17A1 O 0 0.0865262895822525
. O 0 0.00023494422202929854

Three O 0 3.440247382968664e-05
families O 0 2.8411044695531018e-05
shared O 0 6.0658167058136314e-05
microsatellite O 0 0.006311097647994757
polymorphisms O 0 0.0012977046426385641
covering O 0 0.00031778012635186315
at O 0 0.0002652416587807238
most O 0 1.9805469491984695e-05
19 O 0 0.00020698553998954594
cM O 0 0.009081385098397732
, O 0 7.223088687169366e-06
whereas O 0 2.356447839702014e-05
the O 0 4.32390652349568e-06
others O 0 6.154859420348657e-06
shared O 0 4.248629011271987e-06
smaller O 0 9.601521014701575e-06
regions O 0 7.261199243657757e-06
consistent O 0 4.6868284698575735e-05
with O 0 7.308204203582136e-06
cross O 0 0.00035530084278434515
- O 0 0.00012695789337158203
over O 0 7.605647169839358e-07
events O 0 6.224937010301801e-07
during O 0 9.764989044924732e-06
passage O 0 3.681614316519699e-06
of O 0 1.0738343547700424e-07
this O 0 9.68778294918593e-07
mutation O 0 2.2640329916612245e-05
through O 0 2.2281903966359096e-06
several O 0 5.788992439192953e-06
generations O 0 0.00015752139734104276
. O 0 0.00011728403478628024

These O 0 9.58211239776574e-06
results O 0 4.912084841635078e-05
indicate O 0 7.329152867896482e-05
that O 0 5.857136329723289e-06
4003delTC O 0 0.0005873836926184595
occurs O 0 1.3965488506073598e-05
on O 0 2.3830605186958564e-06
a O 0 9.738603694131598e-06
single O 0 9.608373147784732e-06
ancestral O 0 0.00021034908422734588
allele O 0 7.542809908045456e-05
. O 0 1.894739762065001e-05
. O 0 7.510347495554015e-05

The O 0 0.0002529763733036816
haptoglobin O 0 0.02028406411409378
- O 0 0.0006724818958900869
gene O 0 7.141901733120903e-05
deletion O 0 0.00032098210067488253
responsible O 0 7.316764094866812e-05
for O 0 2.057768688246142e-05
anhaptoglobinemia B-Disease 0 0.026207590475678444
. O 0 0.00019462319323793054

We O 0 1.0185955034103245e-05
have O 0 2.2830629404779756e-06
found O 0 6.471308097388828e-06
an O 0 3.6831700072070817e-06
allelic O 0 0.00019050031551159918
deletion O 0 0.0001132001489168033
of O 0 1.9185033579560695e-06
the O 0 5.236780270934105e-05
haptoglobin O 0 0.02046053484082222
( O 0 4.072944284416735e-05
Hp O 0 0.00025247447774745524
) O 0 4.202392119623255e-06
gene O 0 5.426874849945307e-06
from O 0 8.885112379175553e-07
an O 0 2.2443132365879137e-06
individual O 0 1.576803470015875e-06
with O 0 2.596223021100741e-05
anhaptoglobinemia B-Disease 0 0.38337549567222595
. O 0 0.00014862192620057613

The O 0 0.00012792217603418976
Hp O 0 0.0013483017683029175
gene O 0 0.00011690529208863154
cluster O 0 8.075220102909952e-05
consists O 0 1.969584673133795e-06
of O 0 4.03934961923369e-07
coding O 0 7.058754999889061e-05
regions O 0 6.907469582984049e-07
of O 0 2.0447114934540878e-07
the O 0 8.132399671012536e-06
alpha O 0 7.609399472130463e-05
chain O 0 0.00016912685532588512
and O 0 3.409434611967299e-06
beta O 0 0.00021558011940214783
chain O 0 4.3666190322255716e-05
of O 0 3.604725122841046e-07
the O 0 3.0481642170343548e-05
haptoglobin O 0 0.005413196515291929
gene O 0 0.00013116456102579832
( O 0 1.2225485988892615e-05
Hp O 0 0.00013062199286650866
) O 0 6.643507504122681e-07
and O 0 9.528500299893494e-08
of O 0 7.545748559323329e-08
the O 0 2.1945079424767755e-06
alpha O 0 6.843670416856185e-05
chain O 0 0.00011360155622242019
and O 0 1.29484101307753e-06
beta O 0 0.0001138585721491836
chain O 0 4.2607305658748373e-05
of O 0 8.522348480255459e-07
the O 0 5.5612355936318636e-05
haptoglobin O 0 0.04585784673690796
- O 0 0.0009412935469299555
related O 0 9.417013643542305e-05
gene O 0 0.00010999397636624053
( O 0 2.7000334739568643e-05
Hpr O 0 0.0050298236310482025
) O 0 4.380770405987278e-06
, O 0 1.7118812820626772e-06
in O 0 1.8303135220776312e-06
tandem O 0 0.00012449739733710885
from O 0 2.7404898901295383e-06
the O 0 1.3215008038969245e-05
5 O 0 9.400926501257345e-05
side O 0 0.00047674053348600864
. O 0 0.00013867660891264677

Southern O 0 0.000367076339898631
blot O 0 0.0031131270807236433
and O 0 1.403411260980647e-05
PCR O 0 0.0004630560288205743
analyses O 0 4.102915045223199e-05
have O 0 4.963794253853848e-06
indicated O 0 5.153894380782731e-05
that O 0 3.5147201060681255e-07
the O 0 4.6383456719922833e-07
individual O 0 3.664789005597413e-07
with O 0 6.205973022588296e-06
anhaptoglobinemia B-Disease 0 0.0023200346622616053
was O 0 0.00010156889038626105
homozygous O 0 3.209846909157932e-05
for O 0 7.142705840124108e-07
the O 0 3.951256076106802e-06
gene O 0 4.735167749458924e-05
deletion O 0 7.991772872628644e-05
and O 0 7.107311148502049e-07
that O 0 2.9726382422268216e-07
the O 0 1.8274479316460202e-06
gene O 0 2.0120363842579536e-05
deletion O 0 0.00012612182763405144
was O 0 3.561153062037192e-05
included O 0 3.6061112496099668e-06
at O 0 6.978063083806774e-06
least O 0 6.186893415360828e-07
from O 0 2.1222851955826627e-06
the O 0 4.866756626142887e-06
promoter O 0 0.0005533814546652138
region O 0 6.209223101905081e-06
of O 0 1.3683188626600895e-06
Hp O 0 0.0006801540148444474
to O 0 7.181150976975914e-06
Hpr O 0 0.004015362821519375
alpha O 0 8.400997467106208e-05
but O 0 3.7063482523080893e-06
not O 0 1.351559944851033e-06
to O 0 2.4337125523743453e-06
Hpr O 0 0.004483731463551521
beta O 0 0.0013618278317153454
( O 0 4.383248960948549e-05
Hpdel O 0 0.003518196986988187
) O 0 3.5612480132840574e-05
. O 0 6.028517600498162e-05

In O 0 2.55182330874959e-05
addition O 0 1.757778227329254e-05
, O 0 4.372514013084583e-06
we O 0 6.034186981196399e-07
found O 0 4.435537903191289e-06
seven O 0 1.0323443575543934e-06
individuals O 0 8.453608302261273e-07
with O 0 5.863149453944061e-06
hypohaptoglobinemia B-Disease 0 0.0033659387845546007
in O 0 3.698692808029591e-06
three O 0 4.670434464060236e-06
families O 0 8.677106052346062e-06
, O 0 1.693167291705322e-06
and O 0 8.02670797384053e-07
the O 0 3.165058387821773e-06
genotypes O 0 5.8646102843340486e-05
of O 0 2.7540144742488337e-07
six O 0 2.849620159395272e-06
of O 0 2.900989954923716e-07
the O 0 9.502284228801727e-06
seven O 0 8.533476830052678e-06
individuals O 0 2.882831267925212e-06
were O 0 5.3731323532701936e-06
found O 0 1.8587235899758525e-05
to O 0 1.470426695959759e-06
be O 0 2.2930282284505665e-05
Hp2 O 0 0.012570741586387157
/ O 0 0.0031967058312147856
Hpdel O 0 0.00662679597735405
. O 0 0.00011009155423380435

The O 0 0.00010016233864007518
phenotypes O 0 0.0011544636217877269
and O 0 1.944048926816322e-05
genotypes O 0 0.0003716826031450182
in O 0 2.0836434941884363e-06
one O 0 3.9584347177878954e-07
of O 0 1.1130069310638646e-07
these O 0 2.814093704728293e-07
three O 0 1.7105660390370758e-06
families O 0 7.273813935171347e-06
showed O 0 8.274604624602944e-05
the O 0 7.604633992741583e-06
father O 0 0.00010942257358692586
to O 0 2.582613888080232e-06
be O 0 8.109907867037691e-06
hypohaptoglobinemic B-Disease 0 0.0014552789507433772
( O 0 2.6240442821290344e-05
Hp2 O 0 0.001699121785350144
) O 0 1.1490345059428364e-05
and O 0 1.0439951438456774e-05
Hp2 O 0 0.02330946922302246
/ O 0 0.0014361849753186107
Hpdel O 0 0.0014542234130203724
, O 0 2.8977599413337884e-06
the O 0 5.5774080465198494e-06
mother O 0 0.0001278852141695097
to O 0 1.0521264357521432e-06
be O 0 4.208095560898073e-06
Hp2 O 0 0.0006897945422679186
- O 0 8.979537233244628e-05
1 O 0 1.0168591870751698e-05
and O 0 5.994912498863414e-06
Hp1 O 0 0.004696298856288195
/ O 0 0.0004542763053905219
Hp2 O 0 0.0004805330536328256
, O 0 1.1016605867553153e-06
one O 0 1.4671796577658824e-07
of O 0 5.9345545366795704e-08
the O 0 2.0744953417306533e-06
two O 0 1.955719426405267e-06
children O 0 1.7120026313932613e-05
to O 0 1.8001269381784368e-06
be O 0 9.992561899707653e-06
hypohaptoglobinemic B-Disease 0 0.001985010225325823
( O 0 3.0963943572714925e-05
Hp2 O 0 0.0013542564120143652
) O 0 6.9843081291764975e-06
and O 0 9.848692570813e-06
Hp2 O 0 0.01054102461785078
/ O 0 0.0015608564717695117
Hpdel O 0 0.0014944906579330564
, O 0 2.225756588813965e-06
and O 0 3.9328998013843375e-07
the O 0 1.4141252222543699e-06
other O 0 1.737672278068203e-06
child O 0 9.065980702871457e-05
to O 0 1.8058872228721157e-06
be O 0 1.04582277344889e-05
Hp1 O 0 0.001964099705219269
and O 0 2.0650917576858774e-05
Hp1 O 0 0.025409210473299026
/ O 0 0.0030900239944458008
Hpdel O 0 0.0025092640426009893
, O 0 5.811267328681424e-06
showing O 0 2.469557148288004e-05
an O 0 9.551867151458282e-06
anomalous O 0 0.0003116154111921787
inheritance O 0 8.299885666929185e-05
of O 0 3.297709326943732e-06
Hp O 0 0.003335569053888321
phenotypes O 0 0.0007026561070233583
in O 0 1.221370530402055e-05
the O 0 2.4001068595680408e-05
child O 0 0.0017614663811400533
with O 0 6.698560900986195e-05
Hp1 O 0 0.294264554977417
. O 0 0.00025410481612198055

The O 0 0.0006207700353115797
Hp2 O 0 0.23619365692138672
/ O 0 0.016525372862815857
Hpdel O 0 0.005088194273412228
individuals O 0 1.0127169844054151e-05
had O 0 3.679328438010998e-05
an O 0 5.397052973421523e-06
extremely O 0 0.00010715575626818463
low O 0 8.32118748803623e-05
level O 0 1.2758214325003792e-05
of O 0 7.276945552803227e-07
Hp O 0 0.000527817930560559
( O 0 1.2101576430723071e-05
mean O 0 3.836811811197549e-05
+ O 0 0.00020098499953746796
/ O 0 0.0001025150777422823
- O 0 3.305361678940244e-05
SD O 0 0.0001305008481722325
= O 0 1.0555138942436315e-05
0 O 0 1.03081265478977e-06
. O 0 1.4007873687660322e-06
049 O 0 0.0007756933337077498
+ O 0 0.0001348322257399559
/ O 0 8.615619299234822e-05
- O 0 3.172155993524939e-05
0 O 0 2.2448205072578276e-06
. O 0 2.7251705887465505e-06
043 O 0 0.001450091484002769
mg O 0 0.0029322905465960503
/ O 0 0.00034440107992850244
ml O 0 0.00041129073360934854
; O 0 4.241131591697922e-06
n O 0 3.5609151382232085e-05
= O 0 4.344219632912427e-05
6 O 0 1.0477514479134697e-05
) O 0 9.941821872416767e-07
, O 0 6.051106424820318e-07
compared O 0 2.4302105430251686e-06
with O 0 3.737725933206093e-07
the O 0 1.5567337641186896e-06
level O 0 1.3659530850418378e-05
( O 0 1.4390764135896461e-06
1 O 0 9.99778535515361e-07
. O 0 4.0490843389306974e-07
64 O 0 1.3328487511898857e-05
+ O 0 8.362774678971618e-05
/ O 0 3.8468722777906805e-05
- O 0 9.739393135532737e-06
1 O 0 1.914668473546044e-06
. O 0 1.5454031654371647e-06
07 O 0 0.0002903357381001115
mg O 0 0.0012031340738758445
/ O 0 0.00013487052638083696
ml O 0 0.00014137697871774435
) O 0 9.76004230324179e-07
obtained O 0 2.99708085549355e-06
from O 0 4.923344931739848e-06
52 O 0 7.967543933773413e-05
healthy O 0 0.0006376869278028607
volunteers O 0 7.11218744982034e-05
having O 0 0.00013183540431782603
phenotype O 0 0.002472825348377228
Hp2 O 0 0.003591209417209029
, O 0 5.9139706536370795e-06
whereas O 0 2.4048034902079962e-05
the O 0 2.0539122488116845e-05
serum O 0 0.024616925045847893
Hp O 0 0.0001249300257768482
level O 0 6.320340162346838e-06
of O 0 1.3575315449543268e-07
an O 0 1.56846476784267e-06
individual O 0 8.536680979887024e-07
with O 0 1.1954866749874782e-05
Hp1 O 0 0.19981539249420166
/ O 0 0.003915031906217337
Hpdel O 0 0.00325491139665246
was O 0 0.00039764310349710286
0 O 0 5.106732351123355e-05
. O 0 2.873573794204276e-05

50 O 0 0.00039365942939184606
mg O 0 0.08167631179094315
/ O 0 0.004136570263653994
ml O 0 0.0017633336829021573
, O 0 3.375277628947515e-06
which O 0 1.0626055200191331e-06
was O 0 1.0360931810282636e-05
approximately O 0 3.986214096585172e-07
half O 0 4.736879759548174e-07
the O 0 5.206823061598698e-07
level O 0 4.433110916579608e-06
of O 0 4.0474512275068264e-07
Hp O 0 0.0002975590468849987
in O 0 3.8598072933382355e-06
control O 0 5.986914038658142e-05
sera O 0 0.0014541458804160357
from O 0 5.666676315740915e-06
the O 0 2.063432111754082e-05
Hp1 O 0 0.003801674349233508
phenotype O 0 0.000518516986630857
( O 0 8.086492016445845e-06
1 O 0 9.639082236390095e-06
. O 0 1.5074703014761326e-06
26 O 0 2.9959499443066306e-05
+ O 0 0.00010857371671590954
/ O 0 4.164385245530866e-05
- O 0 1.2279633665457368e-05
0 O 0 1.1814121307907044e-06
. O 0 5.566210461438459e-07
33 O 0 1.7250808014068753e-05
mg O 0 0.0007265616441145539
/ O 0 0.00013923733786214143
ml O 0 0.0001810881803976372
; O 0 1.910413175210124e-06
n O 0 1.4885919881635346e-05
= O 0 2.514366315153893e-05
9 O 0 5.4160377658263315e-06
) O 0 5.317276077221322e-07
, O 0 4.86779185848718e-07
showing O 0 9.877438060357235e-06
a O 0 1.8946097043226473e-05
gene O 0 0.00028815498808398843
- O 0 0.0010705020977184176
dosage O 0 0.0028859092853963375
effect O 0 0.00017669543740339577
. O 0 9.348175080958754e-05

The O 0 3.063989424845204e-05
other O 0 6.468198080256116e-06
allele O 0 0.00017825700342655182
( O 0 3.684697367134504e-05
Hp2 O 0 0.0013798847794532776
) O 0 2.5538406589475926e-06
of O 0 6.337187983262993e-07
individuals O 0 7.570855359517736e-06
with O 0 4.458152034203522e-05
Hp2 O 1 0.9280246496200562
/ O 0 0.019199803471565247
Hpdel O 0 0.0081136180087924
was O 0 0.00029069470474496484
found O 0 1.1792097211582586e-05
to O 0 4.961448212270625e-07
have O 0 6.661118732154137e-07
, O 0 3.8381614331228775e-07
in O 0 1.371983699982593e-07
all O 0 1.441662789147813e-07
exons O 0 2.7643513021757826e-05
, O 0 2.8204178761370713e-06
no O 0 5.69476014788961e-06
mutation O 0 1.1533654287632089e-05
, O 0 1.2038416343784775e-06
by O 0 1.1978955853919615e-06
DNA O 0 9.993393905460835e-05
sequencing O 0 6.894324178574607e-05
. O 0 5.887483712285757e-05

On O 0 1.3741308976022992e-05
the O 0 1.4967123433962115e-06
basis O 0 2.3582136066124804e-07
of O 0 2.5537451620039064e-07
the O 0 2.506248620193219e-06
present O 0 1.1784350135712884e-05
study O 0 1.2488980246416759e-05
, O 0 1.0294569392499398e-06
the O 0 1.0078256309498101e-06
mechanism O 0 1.4397778613783885e-05
of O 0 1.150231923929823e-06
anhaptoglobinemia B-Disease 0 0.0017282087355852127
and O 0 1.0121813147634384e-06
the O 0 1.63083927873231e-06
mechanism O 0 1.9070082998950966e-05
of O 0 1.037254037328239e-06
anomalous O 0 0.0013607102446258068
inheritance O 0 0.0002316870668437332
of O 0 9.310395398642868e-06
Hp O 0 0.01163033489137888
phenotypes O 0 0.0028393797110766172
were O 0 2.6267758585163392e-05
well O 0 1.9798861103481613e-05
explained O 0 0.0004140556848142296
. O 0 0.0001064806419890374

However O 0 0.00011289110261714086
, O 0 3.4736569887172664e-06
the O 0 4.80458356832969e-06
mechanism O 0 3.652299346867949e-05
of O 0 6.339506853692001e-06
hypohaptoglobinemia B-Disease 0 0.274864137172699
remains O 0 0.007763918489217758
unknown O 0 0.0031933377031236887

ATM O 0 0.011929278261959553
mutations O 0 0.0005425941199064255
and O 0 2.8192693207529373e-05
phenotypes O 0 0.009203446097671986
in O 0 0.002042679348960519
ataxia B-Disease 1 0.9999901056289673
- I-Disease 1 0.9996494054794312
telangiectasia I-Disease 1 0.9996147155761719
families O 0 4.6258181100711226e-05
in O 0 1.0661324267857708e-05
the O 0 2.3097583834896795e-05
British O 0 0.00025452280533500016
Isles O 0 9.205119567923248e-05
: O 0 1.6660653727740282e-06
expression O 0 6.244260930543533e-07
of O 0 1.7523991857615329e-07
mutant O 0 9.638323535909876e-05
ATM O 0 0.00023856967163737863
and O 0 1.7907266283145873e-06
the O 0 1.3371672139328439e-05
risk O 0 0.006849344354122877
of O 0 0.00010826779180206358
leukemia B-Disease 1 0.9999997615814209
, O 1 0.9914576411247253
lymphoma B-Disease 1 1.0
, O 0 0.008705530315637589
and O 0 0.11572715640068054
breast B-Disease 1 0.9999984502792358
cancer I-Disease 1 0.9999905824661255
. O 0 0.001165534369647503

We O 0 8.851123311615083e-06
report O 0 9.013840099214576e-06
the O 0 1.5397333754663123e-06
spectrum O 0 9.258879799745046e-06
of O 0 5.181643700780114e-07
59 O 0 0.0002098128607030958
ATM O 0 0.0012099537998437881
mutations O 0 5.5963959312066436e-05
observed O 0 5.0327249482506886e-05
in O 0 0.0001278302224818617
ataxia B-Disease 1 0.999984622001648
- I-Disease 1 0.9989570379257202
telangiectasia I-Disease 1 0.999674916267395
( O 0 0.0003611938445828855
A B-Disease 1 0.9995381832122803
- I-Disease 1 0.9993834495544434
T I-Disease 1 0.9999152421951294
) O 0 0.00011038484080927446
patients O 1 0.7575196027755737
in O 0 7.027831088635139e-06
the O 0 2.3360198611044325e-05
British O 0 0.0006499499431811273
Isles O 0 0.0009135328000411391
. O 0 0.00017519461107440293

Of O 0 1.0036561434390023e-05
51 O 0 0.0005584419122897089
ATM O 0 0.00664623873308301
mutations O 0 0.0004496352339629084
identified O 0 6.979206227697432e-05
in O 0 3.0762523692828836e-06
families O 0 4.061850177095039e-06
native O 0 5.3587214097206015e-06
to O 0 8.016334049898433e-07
the O 0 6.585501068911981e-06
British O 0 0.00011388833081582561
Isles O 0 0.0001042853036778979
, O 0 6.4560827013337985e-06
11 O 0 2.7490350476000458e-05
were O 0 7.291106612683507e-06
founder O 0 0.00018783628183882684
mutations O 0 6.077941361581907e-05
, O 0 1.448173975404643e-06
and O 0 4.91748380682111e-07
2 O 0 1.871360836958047e-06
of O 0 1.713661959001911e-07
these O 0 1.8229744682685123e-06
11 O 0 4.2741514334920794e-05
conferred O 0 0.0007125128176994622
a O 0 0.00016697072715032846
milder O 0 0.053193338215351105
clinical O 0 0.028905458748340607
phenotype O 0 0.0016242762794718146
with O 0 2.4856688014551764e-06
respect O 0 2.8299743917159503e-06
to O 0 5.081167728349101e-06
both O 0 4.762048411066644e-05
cerebellar B-Disease 1 0.9997901320457458
degeneration I-Disease 1 0.9999817609786987
and O 0 0.00019191727915313095
cellular O 0 0.011759530752897263
features O 0 0.0006779849645681679
. O 0 0.0001721219450701028

We O 0 1.313577467954019e-05
report O 0 2.5516384994261898e-05
, O 0 1.9733372482733103e-06
in O 0 9.948499837264535e-07
two O 0 5.358231192076346e-06
A B-Disease 1 0.9924501180648804
- I-Disease 1 0.87094646692276
T I-Disease 1 0.99907386302948
families O 0 4.340064151620027e-06
, O 0 1.1464121598692145e-06
an O 0 6.624080924666487e-06
ATM O 0 0.0006369404727593064
mutation O 0 8.696129953023046e-05
( O 0 9.126921213464811e-06
7271T O 0 0.0005952657666057348
- O 0 0.0004490013816393912
- O 0 0.0002683305647224188
> O 0 0.00015815094229765236
G O 0 0.00031089165713638067
) O 0 1.8588742705105687e-06
that O 0 1.2359845413811854e-06
may O 0 8.980780876299832e-06
be O 0 4.0126232647708093e-07
associated O 0 1.998785592149943e-06
with O 0 5.153233360033482e-07
an O 0 1.0402743100712541e-05
increased O 0 0.00017174880485981703
risk O 0 0.007528644986450672
of O 0 0.00010006153752328828
breast B-Disease 1 0.9999977350234985
cancer I-Disease 1 0.9999880790710449
in O 0 2.7583497285377234e-05
both O 0 1.6981812223093584e-05
homozygotes O 0 0.4379253089427948
and O 0 3.6892964999424294e-05
heterozygotes O 0 0.008509468287229538
( O 0 3.430275683058426e-05
relative O 0 0.0001609593746252358
risk O 0 0.0050982264801859856
12 O 0 3.06493639072869e-05
. O 0 3.2490920602867845e-06
7 O 0 2.013787343457807e-05
; O 0 7.816551260475535e-06
P O 0 0.0017956164665520191
= O 0 0.00021425349405035377
. O 0 1.3646043953485787e-05
0025 O 0 0.008010296151041985
) O 0 3.1416743695444893e-06
, O 0 1.0606595424178522e-06
although O 0 1.7227429225386004e-06
there O 0 8.061459766395274e-07
is O 0 2.2970032205194e-06
a O 0 2.219069210696034e-05
less O 0 0.00019301062275189906
severe O 1 0.9998108744621277
A B-Disease 1 0.9995926022529602
- I-Disease 1 0.9990839958190918
T I-Disease 1 0.999763548374176
phenotype O 0 0.00030291330767795444
in O 0 6.180931677590706e-07
terms O 0 5.454949132399634e-07
of O 0 1.5430025257501256e-07
the O 0 8.162164704117458e-06
degree O 0 9.136382868746296e-05
of O 0 7.182648550951853e-05
cerebellar B-Disease 1 0.999915599822998
degeneration I-Disease 1 0.999985933303833
. O 0 0.007678130641579628

This O 0 2.6316525691072457e-05
mutation O 0 0.00014578511763829738
( O 0 2.4832213966874406e-05
7271T O 0 0.0014838587958365679
- O 0 0.0012938071740791202
- O 0 0.0003690324374474585
> O 0 0.00015522551257163286
G O 0 0.00015300071390811354
) O 0 6.148279680928681e-07
also O 0 2.634166662573989e-07
allows O 0 4.426349775599192e-08
expression O 0 1.4838443007647584e-07
of O 0 4.3112549974466674e-08
full O 0 7.166305294958875e-06
- O 0 3.3680262276902795e-05
length O 0 5.076009529147996e-06
ATM O 0 5.1826180424541235e-05
protein O 0 5.381224127631867e-06
at O 0 4.742661076306831e-06
a O 0 4.419691322254948e-06
level O 0 1.4474792806140613e-05
comparable O 0 1.5673518646508455e-05
with O 0 1.3372108469411614e-06
that O 0 3.2542800454393728e-06
in O 0 1.8481061488273554e-05
unaffected O 0 0.01627441495656967
individuals O 0 4.9228845455218107e-05
. O 0 0.0001724342000670731

In O 0 2.728282561292872e-05
addition O 0 1.1917029951291624e-05
, O 0 3.2425330118712736e-06
we O 0 3.5895519090445305e-07
have O 0 4.3519779069356446e-07
studied O 0 8.64990670379484e-06
18 O 0 6.187223334563896e-05
A B-Disease 1 0.9981796741485596
- I-Disease 1 0.9991275668144226
T I-Disease 1 0.9999517202377319
patients O 1 0.9936709403991699
, O 0 6.164458227431169e-06
in O 0 3.1473900889977813e-06
15 O 0 2.016329744947143e-05
families O 0 8.305267328978516e-06
, O 0 1.6043117284425534e-05
who O 0 0.000458079477539286
developed O 1 0.980423092842102
leukemia B-Disease 1 0.9999991655349731
, O 1 0.9234055280685425
lymphoma B-Disease 1 0.9999998807907104
, O 0 0.002139037474989891
preleukemic O 1 0.9973064661026001
T O 1 0.9996200799942017
- O 1 0.6693404316902161
cell O 0 0.0997392013669014
proliferation O 1 0.6470646262168884
, O 0 0.00010356287384638563
or O 0 0.07330524921417236
Hodgkin B-Disease 1 0.9999995231628418
lymphoma I-Disease 1 1.0
, O 0 0.00013946295075584203
mostly O 0 5.7523258874425665e-05
in O 0 0.00011934624490095302
childhood O 1 0.9941316246986389
. O 0 0.0005203072214499116

A O 0 0.00014473136980086565
wide O 0 2.3523482013843022e-05
variety O 0 4.20725291405688e-06
of O 0 1.8265837979924981e-06
ATM O 0 0.009665221907198429
mutation O 0 0.0001087574491975829
types O 0 1.5423216609633528e-05
, O 0 3.4134232009819243e-06
including O 0 3.771078127101646e-06
missense O 0 0.000400822696974501
mutations O 0 4.790506500285119e-05
and O 0 2.4262692477350356e-06
in O 0 2.1009527699789032e-05
- O 0 0.0006897426210343838
frame O 0 0.00034615787444636226
deletions O 0 5.9026002418249846e-05
, O 0 2.9807931696268497e-06
were O 0 4.600604825100163e-06
seen O 0 4.806674041901715e-05
in O 0 5.593857167696115e-06
these O 0 1.3994125765748322e-05
patients O 1 0.9991915822029114
. O 0 0.000292296550469473

We O 0 7.29119028619607e-06
also O 0 3.679634573927615e-06
show O 0 1.2732355116895633e-06
that O 0 1.7790193851396907e-07
25 O 0 5.949548267381033e-07
% O 0 1.362662800374892e-07
of O 0 1.0307246611773735e-07
all O 0 4.516378339758376e-06
A B-Disease 1 0.9984902143478394
- I-Disease 1 0.9982241988182068
T I-Disease 1 0.9998536109924316
patients O 1 0.8461447358131409
carried O 0 2.590895746834576e-05
in O 0 1.117809097195277e-05
- O 0 0.00029622073634527624
frame O 0 0.00017773614672478288
deletions O 0 9.340333053842187e-05
or O 0 2.2104284653323703e-05
missense O 0 0.0004852674901485443
mutations O 0 4.7547422582283616e-05
, O 0 1.2622986105270684e-06
many O 0 1.9088602698502655e-07
of O 0 2.3411497807046544e-07
which O 0 2.488538711986621e-06
were O 0 3.890947482432239e-06
also O 0 3.491225697871414e-06
associated O 0 5.401594989962177e-06
with O 0 6.204062970027735e-07
expression O 0 3.634539780250634e-06
of O 0 1.463130502088461e-06
mutant O 0 0.0005982432630844414
ATM O 0 0.002627951791509986
protein O 0 0.0004996889038011432
. O 0 9.363644494442269e-05

The O 0 0.00032291762181557715
DMPK O 0 0.0720657929778099
gene O 0 0.0007687268662266433
of O 0 0.00020267155196052045
severely O 1 0.999893069267273
affected O 1 0.997368574142456
myotonic B-Disease 1 0.9999966621398926
dystrophy I-Disease 1 0.9999997615814209
patients O 1 0.999919056892395
is O 0 0.0009222829830832779
hypermethylated O 0 0.17158903181552887
proximal O 0 0.018553776666522026
to O 0 7.309821739909239e-06
the O 0 1.7063743143808097e-05
largely O 0 0.0002446238650009036
expanded O 0 0.0004776288697030395
CTG O 0 0.15055544674396515
repeat O 0 0.0077902390621602535
. O 0 0.00022018817253410816

Using O 0 5.579769640462473e-05
methylation O 0 0.000482689356431365
- O 0 0.000634398078545928
sensitive O 0 7.944623939692974e-05
restriction O 0 5.055978908785619e-05
enzymes O 0 4.633720527635887e-05
, O 0 2.615856828924734e-06
we O 0 7.021548071861616e-07
characterized O 0 9.681305527919903e-05
the O 0 1.3174726518627722e-06
methylation O 0 1.1279295904387254e-05
pattern O 0 3.871729859383777e-05
on O 0 3.432120593060972e-06
the O 0 4.294834070606157e-06
5 O 0 5.061378033133224e-06
side O 0 6.266055606829468e-06
of O 0 2.9482930585800204e-07
the O 0 2.5199165975209326e-05
CTG O 0 0.011220253072679043
repeat O 0 0.00026285109925083816
in O 0 2.592054443084635e-06
the O 0 1.0505670616112184e-05
DMPK O 0 0.0024075701367110014
gene O 0 1.0657633538357913e-05
of O 0 3.759332969366369e-07
normal O 0 8.134383097058162e-05
individuals O 0 4.022660505142994e-06
and O 0 6.327396476990543e-06
of O 0 3.201110303052701e-05
patients O 1 0.999825656414032
affected O 0 0.20070317387580872
with O 0 0.4782431721687317
myotonic B-Disease 1 0.9999982118606567
dystrophy I-Disease 1 0.9999986886978149
, O 0 0.0002887776354327798
showing O 0 0.0003686871787067503
expansions O 0 0.00010308776109013706
of O 0 1.7536758605274372e-06
the O 0 3.9531001675641164e-05
repetitive O 0 0.05179506912827492
sequence O 0 0.0001870934065664187
. O 0 0.00017091839981731027

The O 0 4.2699964978965e-05
gene O 0 0.00010001401824411005
segment O 0 7.153816113714129e-05
analyzed O 0 7.6130227171233855e-06
corresponds O 0 1.952540060301544e-06
to O 0 4.4828078671343974e-07
the O 0 4.76941295346478e-06
genomic O 0 0.00015854927187319845
SacI O 0 0.006912022363394499
- O 0 0.00040585146052762866
HindIII O 0 0.0006906816270202398
fragment O 0 9.062550088856369e-05
carrying O 0 2.4327879145857878e-05
exons O 0 0.00011504434223752469
11 O 0 0.00011645580525510013
- O 0 0.00041502961539663374
15 O 0 2.909442628151737e-05
. O 0 2.4248964109574445e-05

There O 0 1.7436152120353654e-05
is O 0 7.477945473510772e-06
constitutive O 0 0.00014824217942077667
methylation O 0 3.459167055552825e-05
in O 0 9.698297617433127e-06
intron O 0 0.004065285436809063
12 O 0 3.069826925639063e-05
at O 0 1.984286427614279e-05
restriction O 0 1.1776913197536487e-05
sites O 0 1.6337487522832816e-06
of O 0 1.253420577995712e-06
SacII O 0 0.0024515115655958652
and O 0 1.3662006494996604e-05
HhaI O 0 0.0027185508515685797
, O 0 9.917675015458371e-06
localized O 0 0.00036686903331428766
1 O 0 2.435871101624798e-05
, O 0 4.1120661080640275e-06
159 O 0 7.687175093451515e-05
- O 0 5.824203253723681e-05
1 O 0 3.478636472209473e-06
, O 0 8.286559705084073e-07
232 O 0 2.1638628822984174e-05
bp O 0 3.585640661185607e-05
upstream O 0 4.919444563711295e-06
of O 0 2.8837226295763685e-07
the O 0 2.1266136172926053e-05
CTG O 0 0.022586505860090256
repeat O 0 0.0006963915657252073
, O 0 4.715151590062305e-06
whereas O 0 2.4493536329828203e-05
most O 0 5.5580380831088405e-06
, O 0 2.5249109967262484e-06
if O 0 1.2941089835294406e-06
not O 0 1.355297598593097e-07
all O 0 2.658494757667995e-08
, O 0 1.2129555670981063e-07
of O 0 3.339183507478083e-08
the O 0 6.316926146610058e-07
other O 0 4.909368271910353e-07
sites O 0 2.1855207705812063e-06
of O 0 1.670104325057764e-06
SacII O 0 0.02017594315111637
, O 0 3.343700882396661e-05
HhaI O 0 0.003301195101812482
, O 0 9.78783100435976e-06
and O 0 5.083416908746585e-06
HpaII O 0 0.0008929435280151665
in O 0 3.289323103672359e-06
this O 0 1.4957719258745783e-06
region O 0 8.799639545031823e-06
are O 0 5.910200115977204e-07
unmethylated O 0 0.0006395052187144756
, O 0 4.178383278485853e-06
in O 0 3.7516360862355214e-06
normal O 0 4.238489782437682e-05
individuals O 0 1.8755238215817371e-06
and O 0 8.090549954431481e-07
most O 0 1.1718282166839344e-06
of O 0 2.516302856747643e-06
the O 0 0.001101898611523211
patients O 1 0.9994348883628845
. O 0 0.0003047640493605286

In O 0 9.588711691321805e-06
a O 0 1.0620933608151972e-05
number O 0 8.041112096179859e-07
of O 0 2.2248948425840354e-06
young O 0 0.0008374705212190747
and O 0 0.000316651159664616
severely O 1 0.9997976422309875
affected O 1 0.6710363030433655
patients O 1 0.9995198249816895
, O 0 1.771218012436293e-05
however O 0 1.0969409231620375e-05
, O 0 9.589630280970596e-07
complete O 0 2.727315177253331e-06
methylation O 0 1.9002251292477013e-06
of O 0 8.967739262288887e-08
these O 0 3.6909338518853474e-07
restriction O 0 1.487524696131004e-05
sites O 0 3.225942009521532e-06
was O 0 3.8739341107429937e-05
found O 0 1.0637315426720306e-05
in O 0 1.227126517733268e-06
the O 0 1.2666443581110798e-05
mutated O 0 0.0013835877180099487
allele O 0 0.00025782472221180797
. O 0 5.564742241404019e-05

In O 0 1.6002990378183313e-05
most O 0 1.0651053798937937e-06
of O 0 9.55879613684374e-07
these O 0 1.6706679161870852e-05
patients O 1 0.9988988637924194
, O 0 1.21255479825777e-05
the O 0 2.524057708797045e-05
onset O 1 0.9992225170135498
of O 0 3.2522755645914e-05
the O 1 0.966253399848938
disease O 1 0.9999994039535522
was O 1 0.9998692274093628
congenital O 1 0.9999996423721313
. O 0 0.00746810482814908

Preliminary O 0 0.00019535796309355646
in O 0 7.382885087281466e-05
vivo O 0 0.0012657094048336148
footprinting O 0 0.008917036466300488
data O 0 3.3060032365028746e-06
gave O 0 8.860827620083e-06
evidence O 0 6.893584213685244e-06
for O 0 7.320819008782564e-07
protein O 0 6.746139115421101e-05
- O 0 7.714551611570641e-05
DNA O 0 1.7961889170692302e-05
contact O 0 6.646962901868392e-06
in O 0 1.2583118405018467e-06
normal O 0 1.9899638573406264e-05
genes O 0 6.176498118293239e-06
at O 0 1.6157628124346957e-05
an O 0 1.3359869626583531e-05
Sp1 O 0 0.007191717159003019
consensus O 0 4.379592155601131e-06
binding O 0 1.2840569979744032e-05
site O 0 2.288030373165384e-05
upstream O 0 1.5078576325322501e-05
of O 0 3.3944868960134045e-07
the O 0 2.1820447727805004e-05
CTG O 0 0.016529899090528488
repeat O 0 0.00020436597696971148
and O 0 5.500932047652896e-07
for O 0 2.9042843152637943e-07
a O 0 4.269628789188573e-06
significant O 0 4.732261004392058e-06
reduction O 0 7.528664355049841e-06
of O 0 4.3892573131643076e-08
this O 0 3.4436800433468306e-07
interaction O 0 1.002488147605618e-06
in O 0 4.62193338535144e-06
cells O 0 0.00016073943697847426
with O 0 5.85670068176114e-06
a O 0 0.00013901777856517583
hypermethylated O 0 0.020878365263342857
DMPK O 0 0.10435287654399872
gene O 0 0.0002203790791099891
. O 0 1.842900201154407e-05
. O 0 5.0560945965116844e-05

The O 0 0.0014716050354763865
hemochromatosis B-Disease 1 0.9998979568481445
gene O 0 0.0007646643207408488
product O 0 8.840781083563343e-05
complexes O 0 0.00022032068227417767
with O 0 3.926408226107014e-06
the O 0 4.009855183539912e-05
transferrin O 0 0.05463866889476776
receptor O 0 0.0003278010699432343
and O 0 2.917369329225039e-06
lowers O 0 0.000845442758873105
its O 0 5.83837561407563e-07
affinity O 0 1.1984545380983036e-05
for O 0 1.0787813380375155e-06
ligand O 0 0.0001444051886210218
binding O 0 9.656871407059953e-05
. O 0 8.386397530557588e-05

We O 0 7.351390377152711e-05
recently O 0 0.0005664382479153574
reported O 0 9.585850057192147e-05
the O 0 2.0461973235796904e-06
positional O 0 1.3738754205405712e-05
cloning O 0 9.742858310346492e-06
of O 0 1.3154999578546267e-07
a O 0 1.689920827629976e-05
candidate O 0 2.9753697162959725e-05
gene O 0 0.0003022717428393662
for O 0 0.0002346167020732537
hereditary B-Disease 1 0.9999897480010986
hemochromatosis I-Disease 1 0.9999997615814209
called O 1 0.9945487380027771
HFE O 1 0.99935382604599
. O 0 0.0015574449207633734

The O 0 3.8154958019731566e-05
gene O 0 8.310846897074953e-05
product O 0 1.0591882528387941e-05
, O 0 1.1189001725142589e-06
a O 0 1.954783328983467e-06
member O 0 1.4220313460100442e-06
of O 0 3.3048610248442856e-07
the O 0 2.140314427379053e-05
major O 0 0.0015653542941436172
histocompatibility O 1 0.9971344470977783
complex O 0 0.0015373696805909276
class O 0 0.0027681118808686733
I O 0 0.004124003928154707
- O 0 0.0002636713907122612
like O 0 4.262265065335669e-06
family O 0 1.3797891369904391e-05
, O 0 1.441903691556945e-06
was O 0 5.0262115109944716e-05
found O 0 3.6422215998754837e-06
to O 0 2.0129805022861547e-07
have O 0 2.7948772185482085e-07
a O 0 7.698825356783345e-06
mutation O 0 4.4201540731592104e-05
, O 0 8.36008257465437e-06
Cys O 0 0.027777204290032387
- O 0 0.0008354985620826483
282 O 0 0.0013761963928118348
- O 0 0.0026416503824293613
- O 0 0.0011598411947488785
> O 0 0.0008515412337146699
Tyr O 0 0.004855490755289793
( O 0 1.1540431842149701e-05
C282Y O 0 0.0001864398509496823
) O 0 2.622188503664802e-06
, O 0 7.039731144686812e-07
in O 0 6.132977432571352e-07
85 O 0 1.2365348993625958e-05
% O 0 1.9721051103260834e-06
of O 0 3.6594738048734143e-06
patient O 1 0.9756129384040833
chromosomes O 0 0.0005010116146877408
. O 0 0.00014176819240674376

This O 0 1.8619348338688724e-05
mutation O 0 0.00013811216922476888
eliminates O 0 0.00017437050701119006
the O 0 2.6586371859593783e-06
ability O 0 4.635397544916486e-06
of O 0 2.0299464722484117e-06
HFE O 0 0.4443620443344116
to O 0 3.436306087678531e-06
associate O 0 6.147782551124692e-05
with O 0 2.5885125069180503e-05
beta2 O 0 0.0565611869096756
- O 0 0.006016972940415144
microglobulin O 0 0.006712228059768677
( O 0 4.0455066482536495e-05
beta2m O 0 0.001794002833776176
) O 0 9.896200026560109e-06
and O 0 6.1780651776643936e-06
prevents O 0 0.00181938789319247
cell O 0 0.01837208867073059
- O 0 0.00129803828895092
surface O 0 0.00045388739090412855
expression O 0 0.00011551680654520169
. O 0 8.071594493230805e-05

A O 0 0.00016736188263166696
second O 0 4.9986316298600286e-05
mutation O 0 0.00010161520913243294
that O 0 1.9687713574967347e-06
has O 0 4.91985247208504e-06
no O 0 3.0233020424930146e-06
effect O 0 1.5133231499930844e-05
on O 0 2.613123979244847e-05
beta2m O 0 0.007185102440416813
association O 0 0.0012306759599596262
, O 0 2.648354711709544e-05
H63D O 0 0.013305808417499065
, O 0 1.4499591088679153e-05
was O 0 9.943848999682814e-05
found O 0 6.353287972160615e-06
in O 0 8.131150934787001e-07
eight O 0 8.923784093894938e-07
out O 0 2.530517519971909e-07
of O 0 4.33119311082919e-07
nine O 0 6.661652150796726e-05
patients O 1 0.7683382630348206
heterozygous O 0 6.903540634084493e-05
for O 0 1.6192007024073973e-06
the O 0 2.1873285731999204e-05
C282Y O 0 0.002860467415302992
mutant O 0 0.001013847766444087
. O 0 7.1729977207724e-05

In O 0 2.7431482521933503e-05
this O 0 1.1232773431402165e-05
report O 0 6.470268272096291e-05
, O 0 1.4028474879523856e-06
we O 0 2.6329058755436563e-07
demonstrate O 0 3.883355475409189e-06
in O 0 4.5258598220243584e-06
cultured O 0 0.0006905124755576253
293 O 0 0.0027357840444892645
cells O 0 0.004356783349066973
overexpressing O 0 0.015720698982477188
wild O 0 0.0003124453651253134
- O 0 0.0015366466250270605
type O 0 0.00026485201669856906
or O 0 1.764699845807627e-05
mutant O 0 0.00014496035873889923
HFE O 0 0.021600855514407158
proteins O 0 2.386631194895017e-06
that O 0 3.5532619335754134e-07
both O 0 3.8174303540472465e-07
the O 0 5.8655546126828995e-06
wild O 0 0.0001242354337591678
- O 0 0.000654460396617651
type O 0 0.00021223393559921533
and O 0 7.96830136096105e-06
H63D O 0 0.08464295417070389
HFE O 0 0.2627667188644409
proteins O 0 1.7964834114536643e-05
form O 0 5.01325775985606e-05
stable O 0 0.0031588957644999027
complexes O 0 0.0003156766761094332
with O 0 6.136386673460947e-06
the O 0 6.608459807466716e-05
transferrin O 1 0.8995252251625061
receptor O 0 0.010605224408209324
( O 0 0.00017674984701443464
TfR O 1 0.8003606796264648
) O 0 7.022915815468878e-05
. O 0 0.00010782270692288876

The O 0 7.560360245406628e-05
C282Y O 0 0.0022055599838495255
mutation O 0 0.0002147470077034086
nearly O 0 5.907234299229458e-05
completely O 0 0.00023237886489368975
prevents O 0 0.00014375783212017268
the O 0 5.988221801089821e-06
association O 0 3.549506436684169e-05
of O 0 3.502002527966397e-07
the O 0 2.1563439076999202e-05
mutant O 0 0.0006305224960669875
HFE O 0 0.4316052496433258
protein O 0 6.999487959546968e-05
with O 0 1.0891210877161939e-05
the O 0 0.0001878882321761921
TfR O 1 0.9913186430931091
. O 0 0.00023905193665996194

Studies O 0 6.315332575468346e-05
on O 0 0.00011342306243022904
cell O 0 0.007675431203097105
- O 0 0.001054174150340259
associated O 0 0.00011694108252413571
transferrin O 0 0.0038430551066994667
at O 0 3.091850521741435e-05
37 O 0 1.4569312043022364e-05
degrees O 0 6.19887532593566e-06
C O 0 0.00016117561608552933
suggest O 0 5.694640549336327e-06
that O 0 6.785886625948478e-07
the O 0 5.2822479119640775e-06
overexpressed O 0 0.004520495887845755
wild O 0 0.00012994059943594038
- O 0 0.0010808128863573074
type O 0 0.0010787113569676876
HFE O 0 0.13736170530319214
protein O 0 5.713706195820123e-05
decreases O 0 7.299175194930285e-05
the O 0 1.0647905810401426e-06
affinity O 0 6.985839718254283e-06
of O 0 6.29294106602174e-07
the O 0 7.532689051004127e-05
TfR O 1 0.9448431134223938
for O 0 2.75723486993229e-05
transferrin O 1 0.7700732350349426
. O 0 0.00025031130644492805

The O 0 0.00046963972272351384
overexpressed O 0 0.1553015559911728
H63D O 0 0.08491653949022293
protein O 0 0.00012959339073859155
does O 0 5.1279107537993696e-06
not O 0 3.3453133596594853e-07
have O 0 3.24918659089235e-07
this O 0 3.520134157497523e-07
effect O 0 3.4215711366414325e-06
, O 0 4.993108859707718e-07
providing O 0 8.38678204218013e-07
the O 0 2.638735168147832e-07
first O 0 2.8945456165274663e-07
direct O 0 3.7095307447998493e-07
evidence O 0 2.4194966954382835e-06
for O 0 2.616862389004382e-07
a O 0 5.421175046649296e-06
functional O 0 2.6494610210647807e-05
consequence O 0 2.9923521651653573e-05
of O 0 7.423124657179869e-07
the O 0 0.00013870527618564665
H63D O 1 0.9787738919258118
mutation O 0 0.001548845088109374
. O 0 0.00011824257671833038

Addition O 0 3.646257391665131e-05
of O 0 1.6705038433428854e-05
soluble O 1 0.9473499059677124
wild O 0 0.002159654628485441
- O 0 0.05200779438018799
type O 0 0.11701756715774536
HFE O 1 0.9961146116256714
/ O 0 0.01602284610271454
beta2m O 0 0.004640423227101564
heterodimers O 0 0.010698364116251469
to O 0 1.883386357803829e-05
cultured O 0 0.002070920541882515
cells O 0 0.0007836706354282796
also O 0 8.178457392205019e-06
decreased O 0 0.0002711781417019665
the O 0 6.051295713405125e-06
apparent O 0 7.130557060008869e-05
affinity O 0 7.31149475541315e-06
of O 0 5.686516146852227e-07
the O 0 1.6444595530629158e-05
TfR O 0 0.03964012861251831
for O 0 6.807035788369831e-07
its O 0 1.4344301462188014e-06
ligand O 0 6.18045887676999e-05
under O 0 3.5195789678255096e-05
steady O 0 0.0009514122502878308
- O 0 0.00011751901911338791
state O 0 5.672872703144094e-06
conditions O 0 0.00013280923303682357
, O 0 1.819363660615636e-06
both O 0 1.1612117987169768e-06
in O 0 1.4109613402979448e-05
293 O 0 0.0015788789605721831
cells O 0 0.0006405995809473097
and O 0 8.340365639014635e-06
in O 0 8.708528184797615e-05
HeLa O 1 0.9469572901725769
cells O 0 0.0034892719704657793
. O 0 0.00012076935672666878

Furthermore O 0 0.00022269919281825423
, O 0 7.566554359073052e-06
at O 0 1.4106814887782093e-05
4 O 0 7.176221515692305e-06
degrees O 0 9.36604556045495e-06
C O 0 0.00017807117546908557
, O 0 1.9128763142362004e-06
the O 0 3.276283905506716e-06
added O 0 2.8763513910234906e-05
soluble O 0 0.0016673648497089744
complex O 0 9.728910663397983e-05
of O 0 1.869225707196165e-05
HFE O 1 0.9981058835983276
/ O 0 0.008448934182524681
beta2m O 0 0.0025992633309215307
inhibited O 0 0.0002652998664416373
binding O 0 7.703099072386976e-06
of O 0 1.638903199818742e-06
transferrin O 0 0.015288978815078735
to O 0 1.2097631952201482e-05
HeLa O 0 0.047463152557611465
cell O 0 0.0022635769564658403
TfR O 0 0.047723691910505295
in O 0 5.707058335246984e-06
a O 0 4.9256879719905555e-05
concentration O 0 0.005250132642686367
- O 0 0.0006478447467088699
dependent O 0 3.961395123042166e-05
manner O 0 8.835825428832322e-05
. O 0 0.00012008380144834518

Scatchard O 0 0.0011567852925509214
plots O 0 1.385370433126809e-05
of O 0 3.887928983203892e-07
these O 0 1.3322121503733797e-06
data O 0 9.200364729622379e-06
indicate O 0 1.882079232018441e-05
that O 0 9.146859838438104e-07
the O 0 5.3590897550748195e-06
added O 0 4.200889452476986e-05
heterodimer O 0 0.0053370860405266285
substantially O 0 0.0011376483598724008
reduced O 0 6.294343620538712e-05
the O 0 1.4125644156592898e-06
affinity O 0 1.5131528925849125e-05
of O 0 4.244247520546196e-06
TfR O 1 0.9713225960731506
for O 0 4.923438609694131e-05
transferrin O 1 0.862678587436676
. O 0 0.00015039520803838968

These O 0 1.758842813615047e-06
results O 0 9.662606316851452e-06
establish O 0 5.9941689869447146e-06
a O 0 1.4807395928073674e-05
molecular O 0 0.00015369511675089598
link O 0 0.00016006859368644655
between O 0 2.7787718863692135e-05
HFE O 1 0.9322332739830017
and O 0 2.2922981770534534e-06
a O 0 1.077591150533408e-05
key O 0 1.0803692020999733e-05
protein O 0 3.321260737720877e-05
involved O 0 2.3929120288812555e-05
in O 0 2.6932801119983196e-05
iron O 1 0.9988057613372803
transport O 0 0.0008517705136910081
, O 0 1.550013985252008e-05
the O 0 4.459384945221245e-05
TfR O 1 0.869091808795929
, O 0 6.6440161390346475e-06
and O 0 1.5666349781895406e-06
raise O 0 8.457305739284493e-06
the O 0 1.851860247370496e-06
possibility O 0 1.442918619432021e-05
that O 0 2.0893101009278325e-06
alterations O 0 0.0001340892049483955
in O 0 2.0735301404783968e-06
this O 0 3.146177732560318e-06
regulatory O 0 0.0001216563323396258
mechanism O 0 6.158855103421956e-05
may O 0 7.711566468060482e-06
play O 0 2.6209659154119436e-07
a O 0 2.0176039470243268e-06
role O 0 2.440299113004585e-06
in O 0 1.584370352247788e-06
the O 0 2.6519663151702844e-05
pathogenesis O 1 0.9949541687965393
of O 0 0.0005026652943342924
hereditary B-Disease 1 0.9999984502792358
hemochromatosis I-Disease 1 0.9999998807907104
. O 0 0.004056666512042284
. O 0 0.0007766318740323186

Genomic O 0 0.00016938957560341805
organization O 0 1.550541855976917e-05
of O 0 1.634138243389316e-06
the O 0 0.00013897151802666485
UBE3A O 1 0.9815946817398071
/ O 0 0.01423114538192749
E6 O 0 0.21442949771881104
- O 0 0.0025925941299647093
AP O 0 0.00029071024619042873
gene O 0 6.142971687950194e-05
and O 0 6.465213118644897e-06
related O 0 0.00033492199145257473
pseudogenes O 0 0.007457526866346598
. O 0 0.00019452895503491163

The O 0 9.341687109554186e-05
UBE3A O 0 0.00892145000398159
gene O 0 2.7291256628814153e-05
encodes O 0 9.287462489737663e-06
the O 0 1.868993967946153e-05
E6 O 0 0.021367430686950684
- O 0 0.0003818926925305277
AP O 0 9.210641292156652e-05
ubiquitin O 0 0.00024836717057041824
- O 0 8.692184201208875e-05
protein O 0 9.796703125175554e-06
ligase O 0 7.520709914388135e-05
and O 0 1.2770283319696318e-06
has O 0 6.6753655119100586e-06
recently O 0 7.727334013907239e-05
been O 0 3.2293742151523475e-06
shown O 0 4.76430341223022e-06
to O 0 8.712502221897012e-07
be O 0 1.8455823010299355e-05
mutated O 0 0.019744733348488808
in O 0 0.01884855329990387
Angelman B-Disease 1 0.9999995231628418
syndrome I-Disease 1 1.0
patients O 1 0.9999480247497559
who O 0 0.011341950856149197
lack O 0 0.022753950208425522
15q11 O 0 0.10446951538324356
- O 0 0.011534139513969421
q13 O 0 0.001913246582262218
deletions O 0 0.000294750789180398
or O 0 6.268198194447905e-05
chromosome O 0 0.0007738106651231647
15 O 0 0.0002741771750152111
paternal O 0 0.030270332470536232
uniparental B-Disease 1 0.9881266355514526
disomy I-Disease 1 0.7842760682106018
. O 0 0.0007561495876871049

Previous O 0 0.0005653139669448137
UBE3A O 0 0.015072202309966087
cDNA O 0 0.00011123820877401158
analysis O 0 4.5208730625745375e-06
has O 0 7.111349987098947e-06
shown O 0 1.1394589819246903e-05
a O 0 9.246719855582342e-06
coding O 0 6.03035805397667e-05
region O 0 1.193859361592331e-06
of O 0 3.4463087672520487e-07
approximately O 0 2.610090268717613e-05
2 O 0 0.00020344946824479848
. O 0 8.838816575007513e-05

6 O 0 0.0005613386165350676
kb O 0 0.000840416643768549
and O 0 6.437428965000436e-06
a O 0 6.479641160694882e-05
3 O 0 0.00011000949598383158
- O 0 0.0005453666090033948
untranslated O 0 0.0007086748955771327
region O 0 1.0325903531338554e-05
( O 0 8.71444080985384e-06
UTR O 0 0.0005763636436313391
) O 0 8.749113362682692e-07
of O 0 5.448112005979056e-07
< O 0 0.0006195008754730225
50 O 0 1.5374474969576113e-05
bp O 0 0.0002789028512779623
, O 0 1.3800820397591451e-06
whereas O 0 5.545511157833971e-06
Northern O 0 1.685429310782638e-06
analysis O 0 1.0684708513508667e-06
has O 0 3.185978584951954e-06
indicated O 0 1.2227118531882297e-05
mRNA O 0 1.988033318411908e-06
sizes O 0 5.032356398260163e-07
of O 0 3.0446560117525223e-07
5 O 0 3.812574868788943e-05
- O 0 0.00018523562175687402
8 O 0 3.259323420934379e-05
kb O 0 0.0008362265070900321
. O 0 5.304583100951277e-05

We O 0 1.564186459290795e-05
have O 0 1.6282253909594147e-06
analyzed O 0 1.2469437933759764e-05
additional O 0 2.240835783595685e-06
cDNA O 0 4.350243034423329e-05
clones O 0 9.625245002098382e-05
and O 0 4.170073282239173e-07
provide O 0 1.1320905741740717e-06
evidence O 0 2.915044433393632e-06
for O 0 3.29992587921879e-07
an O 0 2.607155010991846e-06
additional O 0 3.525620741129387e-06
0 O 0 2.919776670751162e-05
. O 0 2.3914019038784318e-05

5 O 0 7.702041330048814e-05
kb O 0 0.00030699200578965247
of O 0 1.9835335933748866e-06
5 O 0 0.00011138001718791202
- O 0 0.0003231960581615567
UTR O 0 0.0004863267531618476
and O 0 2.058754034806043e-06
> O 0 6.600101914955303e-05
2 O 0 3.6198316593072377e-06
kb O 0 6.467448838520795e-05
of O 0 1.7843611885837163e-06
3 O 0 0.0001586852449690923
- O 0 0.002083769766613841
UTR O 0 0.010187597014009953
. O 0 6.057342761778273e-05

We O 0 7.2572743192722555e-06
have O 0 1.2197339174235822e-06
established O 0 1.7875189541882719e-06
the O 0 1.9431554392213e-06
genomic O 0 2.289920848852489e-05
organization O 0 4.775612069352064e-06
of O 0 7.195129683168489e-07
UBE3A O 0 0.005620542913675308
and O 0 5.489690124704794e-07
the O 0 7.11872075953579e-07
sequence O 0 2.08747997021419e-06
of O 0 3.105984887952218e-06
intron O 1 0.9668101072311401
- O 0 0.002968101529404521
exon O 0 0.001646301127038896
borders O 0 9.110075188800693e-05
. O 0 5.5115600844146684e-05

We O 0 7.066063517413568e-06
have O 0 1.2382780596453813e-06
also O 0 1.7208708413818385e-06
mapped O 0 5.988410066493088e-06
two O 0 9.079582810045395e-07
highly O 0 8.511632040608674e-05
homologous O 0 0.000322472769767046
processed O 0 0.00022265463485382497
pseudogenes O 0 0.0014996191021054983
, O 0 6.549042882397771e-05
UBE3AP1 O 0 0.02034599706530571
and O 0 2.633131225593388e-05
UBE3AP2 O 0 0.008788724429905415
, O 0 2.4138662411132827e-06
to O 0 3.0452804367087083e-07
chromosomes O 0 4.790043931279797e-06
2 O 0 6.0567804212041665e-06
and O 0 1.415318024555745e-06
21 O 0 1.530531153548509e-05
, O 0 2.0940199192409636e-06
respectively O 0 9.340740689367522e-06
, O 0 1.4771928817935986e-06
and O 0 5.580098445534531e-07
determined O 0 5.9125727602804545e-06
their O 0 1.3974370176583761e-06
genomic O 0 0.00012933586549479514
organization O 0 9.44809871725738e-05
. O 0 0.00010873960854951292

These O 0 4.777452431881102e-06
results O 0 1.4417508282349445e-05
will O 0 4.6965089950390393e-07
form O 0 1.1501650760692428e-06
the O 0 2.869140018901817e-07
basis O 0 1.0226528246448652e-07
for O 0 2.3230616363889567e-07
studies O 0 8.525079806531721e-07
of O 0 3.070201159971475e-07
mutation O 0 5.232516923570074e-05
and O 0 3.25409405377286e-06
imprinting O 0 0.0006431729416362941
of O 0 3.6178109439788386e-05
UBE3A O 1 0.9705219268798828
. O 0 0.00043626161641441286

Mutation O 0 0.00043381648720242083
spectrum O 0 0.0001256032264791429
and O 0 1.0713445590226911e-05
genotype O 0 0.003010575193911791
- O 0 0.002678138669580221
phenotype O 0 0.0016712123760953546
analyses O 0 0.00017767786630429327
in O 0 0.0005892079789191484
Cowden B-Disease 1 0.9998761415481567
disease I-Disease 1 0.9999932050704956
and O 0 0.0007429919787682593
Bannayan B-Disease 1 0.9996458292007446
- I-Disease 1 0.9998599290847778
Zonana I-Disease 1 0.999925971031189
syndrome I-Disease 1 0.9999983310699463
, O 0 0.00022154075850266963
two O 0 0.000412752473494038
hamartoma B-Disease 1 0.999664306640625
syndromes I-Disease 1 0.999747097492218
with O 0 0.0034031381364911795
germline O 1 0.9913213849067688
PTEN O 1 0.9955022931098938
mutation O 0 0.006440689321607351
. O 0 0.00015252918819896877

The O 0 0.006913692224770784
tumour B-Disease 1 0.9999262094497681
suppressor O 0 0.23908329010009766
gene O 0 0.0011302178027108312
PTEN O 0 0.25925159454345703
, O 0 5.554810741159599e-06
which O 0 1.2101900210836902e-06
maps O 0 1.3146463970770128e-05
to O 0 6.36034428680432e-06
10q23 O 0 0.0017583727603778243
. O 0 0.00010650024341885

3 O 0 2.15917552850442e-05
and O 0 7.546467486463371e-07
encodes O 0 2.809028273986769e-06
a O 0 5.546251486521214e-06
403 O 0 1.9963848899351433e-05
amino O 0 1.0394768651167396e-05
acid O 0 0.00048254671855829656
dual O 0 2.548773591115605e-05
specificity O 0 2.887220398406498e-05
phosphatase O 0 0.007390046492218971
( O 0 1.2731510651065037e-05
protein O 0 7.258493133122101e-05
tyrosine O 0 0.00033375347265973687
phosphatase O 0 0.014612730592489243
; O 0 2.550991121097468e-05
PTPase O 0 0.0015115997521206737
) O 0 3.6782380448130425e-06
, O 0 1.993809064515517e-06
was O 0 3.315141293569468e-05
shown O 0 9.836583558353595e-06
recently O 0 1.0679965271265246e-05
to O 0 8.657482908347447e-08
play O 0 2.3621031175480312e-07
a O 0 3.914798526238883e-06
broad O 0 4.073021773365326e-05
role O 0 2.7758795113186352e-05
in O 0 3.695035775308497e-05
human O 0 0.0030440858099609613
malignancy B-Disease 1 0.9995068311691284
. O 0 0.0005944756558164954

Somatic O 0 0.014487926848232746
PTEN O 0 0.44517701864242554
deletions O 0 0.0003180340863764286
and O 0 4.662414994527353e-06
mutations O 0 3.985190414823592e-05
were O 0 2.144363406841876e-06
observed O 0 1.5765173884574324e-05
in O 0 2.4058586859609932e-05
sporadic B-Disease 1 0.8089892268180847
breast I-Disease 1 0.9999790191650391
, I-Disease 0 0.003540076781064272
brain I-Disease 1 0.9999277591705322
, I-Disease 0 0.03268242999911308
prostate I-Disease 1 0.9999985694885254
and I-Disease 1 0.886344313621521
kidney I-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999986886978149
cell O 1 0.6751931309700012
lines O 0 0.00013413488341029733
and O 0 4.695900770457229e-06
in O 0 6.168374966364354e-06
several O 0 1.6594289263593964e-05
primary O 0 0.01968625746667385
tumours B-Disease 1 0.9999346733093262
such O 0 7.161938992794603e-05
as O 0 0.0885448306798935
endometrial B-Disease 1 0.999970555305481
carcinomas I-Disease 1 0.9999983310699463
, O 1 0.9994656443595886
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 0.999444305896759
thyroid B-Disease 1 1.0
tumours I-Disease 1 0.9999969005584717
. O 0 0.007229183800518513

In O 0 7.814671698724851e-05
addition O 0 6.450246291933581e-05
, O 0 9.743450209498405e-05
PTEN O 1 0.7682598829269409
was O 0 0.00025410769740119576
identified O 0 2.2629968952969648e-05
as O 0 3.352954763613525e-06
the O 0 5.449907803267706e-06
susceptibility O 0 0.0006091862451285124
gene O 0 7.141819514799863e-05
for O 0 1.056968449120177e-05
two O 0 0.0006707010325044394
hamartoma B-Disease 1 0.9999114274978638
syndromes I-Disease 1 0.9999895095825195
Cowden B-Disease 1 0.9999827146530151
disease I-Disease 1 0.9999973773956299
( O 0 0.0019264431903138757
CD B-Disease 0 0.04586585611104965
; O 0 0.00020051069441251457
MIM O 1 0.9561447501182556
158350 O 0 0.00577355595305562
) O 0 2.110527566401288e-05
and O 0 1.839674405346159e-05
Bannayan B-Disease 0 0.039301954209804535
- I-Disease 0 0.008003872819244862
Zonana I-Disease 0 0.12411881983280182
( I-Disease 0 8.010281453607604e-05
BZS I-Disease 0 0.026346836239099503
) I-Disease 0 2.4904165911721066e-05
or I-Disease 0 9.519688319414854e-05
Ruvalcaba I-Disease 0 0.3746945261955261
- I-Disease 0 0.02170822024345398
Riley I-Disease 0 0.020864879712462425
- I-Disease 1 0.980628252029419
Smith I-Disease 1 0.9707094430923462
syndrome I-Disease 1 0.9999949932098389
( O 0 0.0017608720809221268
MIM O 1 0.9901903867721558
153480 O 0 0.07339019328355789
) O 0 9.033428796101362e-05
. O 0 0.00016309773491229862

Constitutive O 0 0.0011877481592819095
DNA O 0 0.0002829967124853283
from O 0 1.8666889445739798e-05
37 O 0 6.234540342120454e-05
CD B-Disease 0 0.00019646681903395802
families O 0 8.113923286146019e-06
and O 0 3.027583716175286e-06
seven O 0 5.893359411857091e-05
BZS B-Disease 0 0.0662013366818428
families O 0 2.908618625951931e-05
was O 0 0.0003409785858821124
screened O 0 0.0004201910924166441
for O 0 1.3925351595389657e-05
germline O 0 0.05326949059963226
PTEN O 1 0.9654274582862854
mutations O 0 0.00201913109049201
. O 0 0.00018045610340777785

PTEN O 1 0.8163036108016968
mutations O 0 0.0005817256169393659
were O 0 1.2695840268861502e-05
identified O 0 2.2737091057933867e-05
in O 0 1.5252093135131872e-06
30 O 0 2.8083857159799663e-06
of O 0 4.7648663326071983e-07
37 O 0 2.8300011763349175e-05
( O 0 6.910553111083573e-06
81 O 0 7.287663902388886e-05
% O 0 4.128671662328998e-06
) O 0 4.3442505557322875e-06
CD B-Disease 0 6.0005233535775915e-05
families O 0 3.3288552003796212e-06
, O 0 1.5877192254265537e-06
including O 0 2.0814547951886198e-06
missense O 0 0.0003311412292532623
and O 0 5.498820428329054e-06
nonsense O 0 0.0002937638491857797
point O 0 3.979569373768754e-05
mutations O 0 7.221755367936566e-05
, O 0 5.0534681577119045e-06
deletions O 0 3.687457137857564e-05
, O 0 1.8064436062559253e-06
insertions O 0 2.411840614513494e-05
, O 0 4.084722604602575e-06
a O 0 3.710049350047484e-05
deletion O 0 0.0020180155988782644
/ O 0 0.0006364693399518728
insertion O 0 0.00012480633449740708
and O 0 4.774956323672086e-06
splice O 0 0.001108786091208458
site O 0 0.00044518467620946467
mutations O 0 0.0006078078877180815
. O 0 7.230506889754906e-05

These O 0 1.0790100532176439e-05
mutations O 0 0.00014908192679286003
were O 0 5.4070578698883764e-06
scattered O 0 9.228378985426389e-06
over O 0 1.315949475610978e-06
the O 0 2.6755824364954606e-06
entire O 0 1.3324242900125682e-05
length O 0 1.8756254576146603e-05
of O 0 2.103148290188983e-06
PTEN O 1 0.5916863083839417
, O 0 1.6795454484963557e-06
with O 0 4.927036343360669e-07
the O 0 9.974625072572962e-07
exception O 0 2.9517018447222654e-06
of O 0 8.84613768903364e-08
the O 0 2.391169573456864e-06
first O 0 5.53453264728887e-06
, O 0 1.5059715678944485e-06
fourth O 0 8.870601050148252e-06
and O 0 2.181162699343986e-06
last O 0 6.285310519160703e-05
exons O 0 0.00040932235424406826
. O 0 8.754047303227708e-05

A O 0 0.0005444809212349355
hot O 0 0.0010837404988706112
spot O 0 0.00012434138625394553
for O 0 7.375475888693472e-06
PTEN O 0 0.03718286380171776
mutation O 0 5.895753565710038e-05
in O 0 3.7229733607091475e-06
CD B-Disease 0 0.0002090498455800116
was O 0 0.0001482339866925031
identified O 0 3.12630036205519e-05
in O 0 2.574275413280702e-06
exon O 0 0.00015748641453683376
5 O 0 4.69712767880992e-06
that O 0 3.213608863461559e-07
contains O 0 1.4907193417457165e-06
the O 0 5.024975052947411e-06
PTPase O 0 0.0008198367431759834
core O 0 3.5522800317266956e-05
motif O 0 0.00011320781777612865
, O 0 1.2713862815871835e-06
with O 0 6.924175295353052e-07
13 O 0 5.137646894581849e-06
of O 0 3.615787420585548e-07
30 O 0 1.2447672816051636e-05
( O 0 2.533698307161103e-06
43 O 0 5.096085715194931e-06
% O 0 1.828460767683282e-06
) O 0 1.6851851114552119e-06
CD B-Disease 0 8.047138544498011e-05
mutations O 0 1.651320962992031e-05
identified O 0 1.3540417057811283e-05
in O 0 2.475047722327872e-06
this O 0 5.9677263379853684e-06
exon O 0 0.003758318955078721
. O 0 0.00014944429858587682

Seven O 0 1.7614715034142137e-05
of O 0 2.1147127426957013e-06
30 O 0 4.170402098679915e-05
( O 0 7.875325536588207e-06
23 O 0 2.024954665102996e-05
% O 0 3.25221390085062e-06
) O 0 1.0090249134009355e-06
were O 0 3.749876213987591e-07
within O 0 1.2426251316810522e-07
the O 0 1.307069169342867e-06
core O 0 1.8115233615390025e-05
motif O 0 9.753378253662959e-05
, O 0 1.3239441614132375e-06
the O 0 1.5079260720085585e-06
majority O 0 1.7411109638487687e-06
( O 0 1.1985846413153922e-06
five O 0 3.555350076567265e-07
of O 0 1.444871173816864e-07
seven O 0 3.4512759157223627e-06
) O 0 9.380162850902707e-07
of O 0 1.1289805712522138e-07
which O 0 4.326121143094497e-06
were O 0 1.1802098924817983e-05
missense O 0 0.0003969678655266762
mutations O 0 6.076249337638728e-05
, O 0 3.950668542529456e-06
possibly O 0 3.5165019653504714e-05
pointing O 0 2.1719219148508273e-05
to O 0 1.477473290378839e-07
the O 0 7.169847435761767e-07
functional O 0 6.150071385491174e-06
significance O 0 1.0403787200630177e-06
of O 0 6.766803153368528e-07
this O 0 1.28172641780111e-05
region O 0 0.00013071057037450373
. O 0 0.00011989842460025102

Germline O 0 0.13348300755023956
PTEN O 0 0.44174742698669434
mutations O 0 0.0003996363375335932
were O 0 9.993295861931983e-06
identified O 0 1.576345857756678e-05
in O 0 7.023396051408781e-07
four O 0 3.9665292206336744e-07
of O 0 4.203508296996006e-07
seven O 0 1.6454525393783115e-05
( O 0 2.3127364329411648e-05
57 O 0 0.00011322196223773062
% O 0 1.974039332708344e-05
) O 0 3.826186730293557e-05
BZS B-Disease 0 0.0151287242770195
families O 0 2.694575050554704e-05
studied O 0 0.0003027285565622151
. O 0 0.00015234967577271163

Interestingly O 0 0.0018650202546268702
, O 0 7.299929166038055e-06
none O 0 3.2634923172736308e-06
of O 0 2.047505915925285e-07
these O 0 1.457932285120478e-06
mutations O 0 6.472168752225116e-05
was O 0 4.967410859535448e-05
observed O 0 1.1574710697459523e-05
in O 0 3.2954267226159573e-06
the O 0 1.909295860968996e-05
PTPase O 0 0.005349838640540838
core O 0 0.0003586208913475275
motif O 0 0.0025947997346520424
. O 0 0.00011609256034716964

It O 0 1.0268124242429622e-05
is O 0 2.8713127449009335e-06
also O 0 1.0593313390927506e-06
worthy O 0 2.2905564946995582e-06
of O 0 1.3321812275535194e-07
note O 0 1.1813427590823267e-05
that O 0 7.340183856285876e-07
a O 0 5.45614784641657e-06
single O 0 7.951319275889546e-06
nonsense O 0 6.845589086879045e-05
point O 0 1.6163254258572124e-05
mutation O 0 3.989578181062825e-05
, O 0 4.1930575207516085e-06
R233X O 0 0.00025886931689456105
, O 0 2.9719913072767667e-06
was O 0 4.547612479655072e-05
observed O 0 6.87913598085288e-06
in O 0 1.4916635109329945e-06
the O 0 6.212047992448788e-06
germline O 0 0.0008939062827266753
DNA O 0 3.715217826538719e-05
from O 0 2.8608903903659666e-06
two O 0 2.120573526553926e-06
unrelated O 0 0.0007186410948634148
CD B-Disease 0 0.0005211882526054978
families O 0 9.116431101574562e-06
and O 0 6.28530915491865e-06
one O 0 3.485319757601246e-05
BZS B-Disease 1 0.6886232495307922
family O 0 0.0006547826924361289
. O 0 0.00026097672525793314

Genotype O 0 0.022772502154111862
- O 0 0.006988910958170891
phenotype O 0 0.0010908839758485556
studies O 0 7.77522200223757e-06
were O 0 2.7121627681481186e-06
not O 0 6.236434728634777e-07
performed O 0 2.8462793579819845e-06
on O 0 8.749530593377131e-07
this O 0 4.489237994675932e-07
small O 0 2.2031599655747414e-06
group O 0 2.5697377168398816e-06
of O 0 3.4561239772301633e-06
BZS B-Disease 1 0.8013597130775452
families O 0 0.0001783163461368531
. O 0 0.0002130910288542509

However O 0 0.00013233265781309456
, O 0 3.378832479938865e-05
genotype O 0 0.0011294586583971977
- O 0 0.0006394906085915864
phenotype O 0 0.0002544245508033782
analysis O 0 7.179192380135646e-06
inthe O 0 0.0009214186575263739
group O 0 6.371709332597675e-06
of O 0 7.495127647416666e-07
CD B-Disease 0 0.00121096963994205
families O 0 1.0789709449454676e-05
revealed O 0 0.00016998921637423337
two O 0 7.306423412956065e-07
possible O 0 3.2668615403963486e-06
associations O 0 2.2472668206319213e-06
worthy O 0 7.936879228509497e-06
of O 0 2.3860616238380317e-07
follow O 0 9.797226084629074e-06
- O 0 5.95229139435105e-05
up O 0 1.2089199117326643e-06
in O 0 1.0628426707626204e-06
independent O 0 1.4015316764925956e-06
analyses O 0 4.2959771235473454e-05
. O 0 7.299808203242719e-05

The O 0 2.788982237689197e-05
first O 0 1.9418070223764516e-05
was O 0 0.00025135689065791667
an O 0 1.5304580301744863e-05
association O 0 0.00022955486201681197
noted O 0 1.9588345821830444e-05
in O 0 9.33406340664078e-07
the O 0 1.8920876527772634e-06
group O 0 1.7237091469723964e-06
of O 0 5.967949050500465e-07
CD B-Disease 0 0.0015802656998857856
families O 0 9.456201951252297e-05
with O 0 0.1165054589509964
breast B-Disease 1 0.9999988079071045
disease I-Disease 1 0.999996542930603
. O 0 0.00221873726695776

A O 0 0.00019425388018134981
correlation O 0 6.0935879446333274e-05
was O 0 0.00010994972399203107
observed O 0 8.557249202567618e-06
between O 0 2.1342439140425995e-06
the O 0 1.529162545921281e-05
presence O 0 9.691336163086817e-05
/ O 0 0.00021951257076580077
absence O 0 2.3689328372711316e-05
of O 0 1.19579544843873e-06
a O 0 0.00022956317116040736
PTEN O 1 0.5781739354133606
mutation O 0 8.506893209414557e-05
and O 0 1.442665734430193e-06
the O 0 8.997343684313819e-06
type O 0 0.0011156905675306916
of O 0 4.626400186680257e-05
breast O 1 0.9999476671218872
involvement O 0 0.008882342837750912
( O 0 0.0003515506978146732
unaffected O 1 0.7995880246162415
versus O 0 0.18772560358047485
benign O 1 0.9997523427009583
versus O 1 0.9973402619361877
malignant O 1 0.999996542930603
) O 0 0.0006704191328026354
. O 0 0.00019644697022158653

Specifically O 0 0.0001223954459419474
and O 0 5.411432539403904e-06
more O 0 1.223572780872928e-06
directly O 0 1.3314004718267825e-05
, O 0 4.254532541381195e-06
an O 0 9.436408618057612e-06
association O 0 0.0005253549315966666
was O 0 0.0001384080242132768
also O 0 3.191741598129738e-06
observed O 0 2.6732564037956763e-06
between O 0 9.572544286129414e-07
the O 0 1.910741048050113e-06
presence O 0 2.8028255201206775e-06
of O 0 1.035409809446719e-06
a O 0 0.0008604978211224079
PTEN O 1 0.9952493906021118
mutation O 0 0.018421214073896408
and O 0 0.014411171898245811
malignant B-Disease 1 0.9999994039535522
breast I-Disease 1 0.9999995231628418
disease I-Disease 1 0.9999982118606567
. O 0 0.004164143931120634

Secondly O 0 0.003672774415463209
, O 0 3.4628345019882545e-05
there O 0 8.56859242048813e-06
appeared O 0 8.868798613548279e-05
to O 0 7.688778396186535e-07
be O 0 2.024218474616646e-06
an O 0 6.221083367563551e-06
interdependent O 0 0.0009203701629303396
association O 0 0.00029998389072716236
between O 0 1.5226954019453842e-05
mutations O 0 0.00010813820699695498
upstream O 0 8.333774167113006e-05
and O 0 1.3204009974288056e-06
within O 0 1.267820493922045e-06
the O 0 1.5577092199237086e-05
PTPase O 0 0.002425100887194276
core O 0 9.95356313069351e-05
motif O 0 0.0002153453096980229
, O 0 1.7131322920249659e-06
the O 0 2.9500188247766346e-06
core O 0 3.0471062927972525e-05
motif O 0 6.611162825720385e-05
containing O 0 4.846071988140466e-06
the O 0 1.5439653680004994e-06
majority O 0 1.597893515281612e-06
of O 0 1.9019148567167576e-06
missense O 0 0.0009276075870729983
mutations O 0 0.00011071268090745434
, O 0 2.170689640479395e-06
and O 0 5.427783094091865e-07
the O 0 2.257327878396609e-06
involvement O 0 2.089455483655911e-05
of O 0 4.0281054225488333e-07
all O 0 3.833401933661662e-06
major O 0 0.001490436727181077
organ O 1 0.9994258880615234
systems O 0 0.053005702793598175
( O 0 0.00021017747349105775
central O 0 0.001995428465306759
nervous O 1 0.9973690509796143
system O 0 0.08429080992937088
, O 0 0.008086398243904114
thyroid O 1 0.9999969005584717
, O 0 0.051184602081775665
breast O 1 0.9999810457229614
, O 0 0.05663629621267319
skin O 1 0.9999803304672241
and O 0 0.3412986695766449
gastrointestinal O 1 0.9999980926513672
tract O 1 0.9999699592590332
) O 0 0.002311628544703126
. O 0 0.0008617467246949673

However O 0 0.00011337720934534445
, O 0 3.1105735160963377e-06
these O 0 3.005682742696081e-07
observations O 0 2.187028258049395e-06
would O 0 1.541672872917843e-06
need O 0 1.5665467572034686e-06
to O 0 2.2498112173252593e-07
be O 0 8.478759241370426e-07
confirmed O 0 8.672819603816606e-06
by O 0 4.427692488206958e-07
studying O 0 1.9846802388201468e-06
a O 0 2.738420789683005e-06
larger O 0 1.2382686236378504e-06
number O 0 1.412913093190582e-07
of O 0 4.5326487452257425e-07
CD B-Disease 0 0.0012468131026253104
families O 0 3.127328818663955e-05
. O 0 8.444457489531487e-05

Molecular O 0 0.056603845208883286
defects O 1 0.9993724226951599
leading O 0 0.0002355251053813845
to O 0 6.150576155050658e-06
human O 0 5.9973423049086705e-05
complement B-Disease 0 0.0001627793681109324
component I-Disease 0 0.24405448138713837
C6 I-Disease 1 0.999984622001648
deficiency I-Disease 1 0.9999977350234985
in O 0 1.1840631486847997e-05
an O 0 2.4706079784664325e-05
African O 0 7.144163100747392e-05
- O 0 0.00036300596548244357
American O 0 1.5654430171707645e-05
family O 0 5.937811511103064e-05
. O 0 6.877481064293534e-05

Complement B-Disease 0 0.0023895965423434973
component I-Disease 1 0.7730451822280884
C6 I-Disease 1 0.9999721050262451
deficiency I-Disease 1 0.9999990463256836
( O 0 0.0008373771561309695
C6D B-Disease 1 0.9527827501296997
) O 0 0.0001186319932457991
was O 0 0.17748403549194336
diagnosed O 1 0.9999771118164062
in O 0 9.656415386416484e-06
a O 0 2.514594052627217e-05
16 O 0 5.08457342220936e-05
- O 0 0.00019811202946584672
year O 0 2.08524343179306e-05
- O 0 6.378557736752555e-05
old O 0 7.928322156658396e-05
African O 0 2.8199307053000666e-05
- O 0 0.00013186306750867516
American O 0 1.3299867532623466e-05
male O 0 0.00021483711316250265
with O 0 0.0008246710640378296
meningococcal B-Disease 1 0.9999929666519165
meningitis I-Disease 1 0.9999868869781494
. O 0 0.001348890014924109

The O 0 0.0018160102190449834
patients O 1 0.9978883862495422
father O 0 0.0010781422024592757
and O 0 9.754936399986036e-06
two O 0 1.293338391405996e-05
brothers O 0 0.0010045368690043688
also O 0 7.331361121032387e-05
had O 0 0.0006790318293496966
C6D B-Disease 0 0.14309149980545044
, O 0 4.149078449700028e-06
but O 0 1.3051994756096974e-06
gave O 0 5.987987606204115e-06
no O 0 2.868750698326039e-06
history O 0 7.269257821462816e-06
of O 0 2.2662625269731507e-05
meningitis B-Disease 1 0.9999675750732422
or O 0 0.0004262397706042975
other O 0 0.0001338264555670321
neisserial B-Disease 1 0.9985896944999695
infection I-Disease 1 0.9999182224273682
. O 0 0.0006403688457794487

By O 0 1.2963810149813071e-05
using O 0 1.0377882063039578e-05
exon O 0 0.0010499185882508755
- O 0 0.00012205581879243255
specific O 0 3.4339147987338947e-06
polymerase O 0 0.00032576979720033705
chain O 0 0.0005775362951681018
reaction O 0 0.00015599663311149925
( O 0 8.461742254439741e-06
PCR O 0 0.00012556900037452579
) O 0 5.6667463468329515e-06
/ O 0 4.5181055611465126e-05
single O 0 7.415846539515769e-06
- O 0 4.125092891626991e-05
strand O 0 2.7704900276148692e-05
conformation O 0 1.543567850603722e-05
polymorphism O 0 4.0663535401108675e-06
as O 0 7.905219945314457e-07
a O 0 4.937954145134427e-06
screening O 0 1.0536372428759933e-05
step O 0 7.745625225652475e-07
and O 0 3.456646879840264e-08
nucleotide O 0 4.472149726097996e-07
sequencing O 0 1.9667285755531339e-07
of O 0 5.276459802416866e-08
target O 0 2.900607796618715e-06
exons O 0 1.8892598745878786e-05
, O 0 1.3736740811509662e-06
we O 0 1.629242945000442e-07
determined O 0 2.338671265533776e-06
that O 0 2.391084592545667e-07
the O 0 2.3499860617448576e-06
proband O 0 0.0005204773624427617
was O 0 4.14892565459013e-05
a O 0 1.4673793884867337e-05
compound O 0 0.00019688198517542332
heterozygote O 0 0.0002432265755487606
for O 0 2.9593825274787378e-06
two O 0 2.2014244677848183e-05
C6 O 1 0.9958444237709045
gene O 0 0.0004919349448755383
mutations O 0 0.0003612400032579899
. O 0 6.303955160547048e-05

The O 0 1.908533158712089e-05
first O 0 1.2080684427928645e-05
, O 0 6.756551101716468e-06
1195delC O 0 0.00022776189143769443
located O 0 1.9743914890568703e-05
in O 0 3.770524244828266e-06
exon O 0 0.00021981311147101223
7 O 0 1.749277907947544e-05
, O 0 8.711380701242888e-07
is O 0 6.241480150492862e-07
a O 0 4.700632416643202e-06
novel O 0 1.8156499208998866e-05
mutation O 0 2.2846899810247123e-05
, O 0 8.135261850839015e-07
while O 0 8.402521416428499e-07
the O 0 2.8217225462867646e-06
second O 0 8.619374057161622e-06
, O 0 4.3275445023027714e-06
1936delG O 0 0.0003144781512673944
in O 0 9.36380365601508e-06
exon O 0 0.0005222815671004355
12 O 0 3.268565342295915e-05
, O 0 5.255771611700766e-06
has O 0 7.506840574933449e-06
been O 0 1.3337973541638348e-05
described O 0 6.323468551272526e-05
before O 0 2.01324000954628e-05
to O 0 5.379802587412996e-06
cause O 0 0.002251757076010108
C6D B-Disease 0 0.010829930193722248
in O 0 7.532715244451538e-06
an O 0 2.6278583391103894e-05
unrelated O 0 0.0011337321484461427
African O 0 0.00016558787319809198
- O 0 0.0006072300602681935
American O 0 1.4245872080209665e-05
individual O 0 9.703016075945925e-06
. O 0 7.15439673513174e-05

Both O 0 1.9610026356531307e-05
mutations O 0 0.00028370230575092137
result O 0 0.00018110456585418433
in O 0 5.885283098905347e-05
premature O 1 0.9165080785751343
termination O 0 0.013301058672368526
codons O 0 0.0005844226107001305
and O 0 3.9586004277225584e-05
C6 O 1 0.9561273455619812
null O 0 0.0005608094506897032
alleles O 0 0.0003066246281377971
. O 0 0.00012886966578662395

Allele O 0 0.0007990732556208968
- O 0 0.000249031581915915
specific O 0 8.200528100132942e-06
PCR O 0 0.00039832087350077927
indicated O 0 0.00010710068454500288
that O 0 8.328486273967428e-07
the O 0 6.391494480340043e-06
probands O 0 0.0007899796473793685
two O 0 7.269389243447222e-06
brothers O 0 0.0006317640654742718
also O 0 0.00013381025928538293
inherited O 0 0.17418226599693298
the O 0 3.5635206586448476e-05
1195delC O 0 0.0028760251589119434
mutation O 0 6.120331090642139e-05
from O 0 3.987855961895548e-06
their O 0 2.0100580968573922e-06
heterozygous O 0 9.744389535626397e-05
mother O 0 0.00016589887673035264
and O 0 1.7576422806087066e-06
the O 0 7.6713567978004e-06
1936delG O 0 0.000615182681940496
mutation O 0 2.64025256910827e-05
from O 0 2.5453887246840168e-06
their O 0 2.6113627882295987e-06
homozygous O 0 0.0005351869040168822
father O 0 0.0009472963283769786
. O 0 4.792955951415934e-05
. O 0 0.00012674367462750524

PAX6 O 1 0.9400481581687927
mutations O 0 0.003613462671637535
reviewed O 0 0.0014520965050905943
. O 0 0.00030496835825033486

Mutations O 0 0.0010824131313711405
in O 0 7.816900324542075e-05
PAX6 O 1 0.6081250309944153
are O 0 2.6583786620903993e-06
responsible O 0 2.1995861970935948e-05
for O 0 7.207614544313401e-06
human O 0 0.0002748084079939872
aniridia B-Disease 1 0.9823848605155945
and O 0 1.0786490747705102e-05
have O 0 3.771912361116847e-06
also O 0 8.001304195204284e-06
been O 0 2.0663424947997555e-05
found O 0 7.474188168998808e-05
in O 0 6.0172264056745917e-05
patients O 1 0.9991196990013123
with O 0 0.0006383932195603848
Peters B-Disease 1 0.9996516704559326
anomaly I-Disease 1 0.9996517896652222
, O 0 0.0008234617998823524
with O 1 0.9732666015625
congenital B-Disease 1 1.0
cataracts I-Disease 1 0.9999995231628418
, O 0 0.0005655643180944026
with O 0 0.0026311057154089212
autosomal B-Disease 1 0.9998302459716797
dominant I-Disease 1 0.9980948567390442
keratitis I-Disease 1 0.9998520612716675
, O 0 0.00013604568084701896
and O 0 3.0277971745817922e-05
with O 0 0.0005483294953592122
isolated B-Disease 1 0.9975965619087219
foveal I-Disease 1 0.9997879862785339
hypoplasia I-Disease 1 0.9999607801437378
. O 0 0.0035192202776670456

No O 0 0.00012683338718488812
locus O 0 0.000109528424218297
other O 0 1.2620265579244005e-06
than O 0 5.270433121040696e-06
chromosome O 0 0.0007004637736827135
11p13 O 0 0.0015808555763214827
has O 0 4.7893096052575856e-05
been O 0 9.813645738177001e-05
implicated O 0 0.007596592418849468
in O 0 4.5052500354358926e-05
aniridia B-Disease 1 0.99566251039505
, O 0 2.293472243763972e-05
and O 0 8.25005645310739e-06
PAX6 O 0 0.22442269325256348
is O 0 9.804665751289576e-06
clearly O 0 2.2003749108989723e-05
the O 0 4.134132723265793e-06
major O 0 4.4075346522731707e-05
, O 0 3.927932539227186e-06
if O 0 2.156572008971125e-06
not O 0 6.830863412687904e-07
only O 0 6.40656480754842e-07
, O 0 3.713208343469887e-06
gene O 0 7.692132203374058e-05
responsible O 0 0.0001605297438800335
. O 0 0.00011680890747811645

Twenty O 0 0.0003289820160716772
- O 0 0.0002093468647217378
eight O 0 5.214229076955235e-06
percent O 0 8.087255082500633e-06
of O 0 9.602955515219946e-07
identified O 0 0.0002929141919594258
PAX6 O 0 0.4549386203289032
mutations O 0 0.00012693963071797043
are O 0 3.1041281545185484e-06
C O 0 0.010657306760549545
- O 0 0.007145903538912535
T O 0 0.01921708695590496
changes O 0 9.066984603123274e-06
at O 0 4.344223998486996e-05
CpG O 0 0.0006592120626010001
dinucleotides O 0 0.0007771286182105541
, O 0 4.0257232285512146e-06
20 O 0 3.3923943192348816e-06
% O 0 1.2167132581453188e-06
are O 0 2.682383524188481e-07
splicing O 0 3.4160944778705016e-05
errors O 0 0.00010147111606784165
, O 0 1.3647635341840214e-06
and O 0 2.1498333069303044e-07
more O 0 1.5219488602724596e-07
than O 0 2.6035223754661274e-07
30 O 0 3.1887932436802657e-06
% O 0 1.5291680028894916e-06
are O 0 2.5503817369099124e-07
deletion O 0 0.00017261631728615612
or O 0 1.4644128896179609e-05
insertion O 0 0.00032988213934004307
events O 0 4.6113142161630094e-05
. O 0 0.00012277229689061642

There O 0 2.1884634406887926e-05
is O 0 1.3369836779020261e-05
a O 0 6.652409501839429e-05
noticeably O 0 0.005840805359184742
elevated O 1 0.6502171158790588
level O 0 2.369994945183862e-05
of O 0 6.185400707181543e-07
mutation O 0 3.7651236198144034e-05
in O 0 1.014502345242363e-06
the O 0 3.9919268601806834e-06
paired O 0 0.00010037746687885374
domain O 0 6.7261812546348665e-06
compared O 0 1.6549942301935516e-05
with O 0 1.0711091817938723e-06
the O 0 1.8460592627889127e-06
rest O 0 4.197237558400957e-06
of O 0 4.0482544250153296e-07
the O 0 3.093855775659904e-05
gene O 0 0.000471640145406127
. O 0 9.169899567496032e-05

Increased O 0 0.0001425636583007872
mutation O 0 8.269343379652128e-05
in O 0 2.178431032007211e-06
the O 0 4.693330538430018e-06
homeodomain O 0 0.0011129628401249647
is O 0 3.788979938690318e-06
accounted O 0 9.043797035701573e-06
for O 0 4.4410137434169883e-07
by O 0 2.714201627895818e-06
the O 0 1.763925865816418e-05
hypermutable O 0 0.003293885849416256
CpG O 0 0.001343190437182784
dinucleotide O 0 0.0006690481677651405
in O 0 7.581982572446577e-06
codon O 0 6.897236744407564e-05
240 O 0 6.144125654827803e-05
. O 0 4.21991317125503e-05

Very O 0 6.375322118401527e-05
nearly O 0 3.106139411102049e-05
all O 0 3.3238111427635886e-06
mutations O 0 0.00011272587289568037
appear O 0 7.690841448493302e-05
to O 0 5.752972356276587e-06
cause O 0 0.0026866267435252666
loss O 0 0.00010177112562814727
of O 0 2.1652013515449653e-07
function O 0 2.0834208953601774e-06
of O 0 3.706263100866636e-07
the O 0 8.437454198428895e-06
mutant O 0 0.00010051022400148213
allele O 0 1.1701670700858813e-05
, O 0 6.730774089191982e-07
and O 0 1.7013999809023517e-07
more O 0 6.104442462628867e-08
than O 0 3.2314397913069115e-07
80 O 0 2.873822040783125e-06
% O 0 1.1736948408724857e-06
of O 0 5.210667382016254e-07
exonic O 0 0.002062703249976039
substitutions O 0 3.310964166303165e-05
result O 0 3.69812041753903e-05
in O 0 1.7427359125576913e-05
nonsense O 0 0.0006916838465258479
codons O 0 0.00042190737440250814
. O 0 9.087533544516191e-05

In O 0 1.5635479940101504e-05
a O 0 3.293537156423554e-05
gene O 0 3.307903534732759e-05
with O 0 2.07826928999566e-06
such O 0 2.0740326363011263e-06
extraordinarily O 0 0.0012160212500020862
high O 0 7.020893099252135e-05
sequence O 0 5.190078354644356e-06
conservation O 0 1.2429619346221443e-05
throughout O 0 6.724999366269913e-07
evolution O 0 4.37464132119203e-06
, O 0 3.183139142493019e-06
there O 0 2.4937462512752973e-06
are O 0 1.972975951503031e-06
presumed O 0 0.0009557647281326354
undiscovered O 0 0.00472823204472661
missense O 0 0.0009397481335327029
mutations O 0 0.00011301475024083629
, O 0 2.3054897155816434e-06
these O 0 2.2716838543601625e-07
are O 0 3.9913837213134684e-07
hypothesized O 0 5.8189849369227886e-05
to O 0 3.039147031813627e-07
exist O 0 9.052028531186807e-07
in O 0 1.5238949799822876e-06
as O 0 1.9110684661427513e-05
- O 0 0.00034924421925097704
yet O 0 2.1778558220830746e-05
unidentified O 0 0.0012977817095816135
phenotypes O 0 0.0014934585196897388
. O 0 3.3799246011767536e-05
. O 0 0.00016096887702587992

Genetic O 0 0.001763724023476243
heterogeneity O 0 0.0006680767983198166
and O 0 1.3791865967505146e-05
penetrance O 0 0.0019911485724151134
analysis O 0 1.5225759852910414e-06
of O 0 1.0339612117604702e-06
the O 0 3.377167013240978e-05
BRCA1 O 0 0.012892898172140121
and O 0 1.2697523743554484e-05
BRCA2 O 0 0.007602166384458542
genes O 0 0.0001851168053690344
in O 0 0.0031694131903350353
breast B-Disease 1 0.9999966621398926
cancer I-Disease 1 0.9999924898147583
families O 0 0.0009367530583404005
. O 0 0.00034470672835595906

The O 1 0.7166885733604431
Breast B-Disease 1 0.9999947547912598
Cancer I-Disease 1 0.999991774559021
Linkage O 0 0.20335662364959717
Consortium O 0 0.0060743424110114574
. O 0 0.0003685859264805913

The O 0 1.3010775546717923e-05
contribution O 0 1.1291585906292312e-05
of O 0 5.017749117541825e-06
BRCA1 O 0 0.03648821637034416
and O 0 4.807393634109758e-05
BRCA2 O 0 0.11392122507095337
to O 0 0.0005024968995712698
inherited B-Disease 1 0.9999949932098389
breast I-Disease 1 0.9999992847442627
cancer I-Disease 1 0.9999996423721313
was O 1 0.552241325378418
assessed O 0 0.0019347453489899635
by O 0 1.4887111319694668e-05
linkage O 0 0.0003539695171639323
and O 0 2.4811970433802344e-06
mutation O 0 2.9540409741457552e-05
analysis O 0 3.660768925328739e-06
in O 0 5.276286628941307e-06
237 O 0 0.00017005177505780011
families O 0 2.913351636379957e-06
, O 0 3.3074653060793935e-07
each O 0 3.604868581419396e-08
with O 0 6.201791507010057e-07
at O 0 1.2901527043140959e-05
least O 0 2.497521109035006e-06
four O 0 4.512413397605997e-06
cases O 0 0.0001678846892900765
of O 0 0.00025929766707122326
breast B-Disease 1 0.9999983310699463
cancer I-Disease 1 0.9999918937683105
, O 0 1.0314998689864296e-05
collected O 0 1.9236043954151683e-05
by O 0 4.576564970193431e-05
the O 0 0.20062190294265747
Breast B-Disease 1 0.9999990463256836
Cancer I-Disease 1 0.9999970197677612
Linkage O 0 0.3576880097389221
Consortium O 0 0.003455700119957328
. O 0 0.0002593594545032829

Families O 0 9.20219681574963e-05
were O 0 5.0473317969590425e-06
included O 0 6.6182778937218245e-06
without O 0 4.365822405816289e-06
regard O 0 2.7684659471560735e-06
to O 0 5.937678793088708e-07
the O 0 4.992622052668594e-06
occurrence O 0 0.0004409882239997387
of O 0 8.332296420121565e-05
ovarian B-Disease 1 0.9999973773956299
or I-Disease 0 0.0018673829035833478
other I-Disease 0 0.00035352533450350165
cancers I-Disease 1 0.999822199344635
. O 0 0.0005419024382717907

Overall O 0 0.015131011605262756
, O 0 0.003574407659471035
disease O 1 0.9999817609786987
was O 0 0.010246148332953453
linked O 0 0.0030756359919905663
to O 0 3.825301973847672e-06
BRCA1 O 0 0.0011259580496698618
in O 0 1.2454740954126464e-06
an O 0 3.953842224291293e-06
estimated O 0 1.2108734154026024e-05
52 O 0 1.3031774869887158e-05
% O 0 1.0231019587081391e-06
of O 0 1.9366474646176357e-07
families O 0 6.744576694472926e-06
, O 0 2.601725327622262e-06
to O 0 2.1056728201074293e-06
BRCA2 O 0 0.0006407470209524035
in O 0 2.160709755116841e-06
32 O 0 6.686687356705079e-06
% O 0 9.7982137958752e-07
of O 0 3.787249909237289e-07
families O 0 7.043820460239658e-06
, O 0 1.6739710417823517e-06
and O 0 5.225905397310271e-07
to O 0 3.570845024114533e-07
neither O 0 2.034241333603859e-05
gene O 0 1.1175308827660047e-05
in O 0 2.2213459942577174e-06
16 O 0 8.540055205230601e-06
% O 0 3.2134878438228043e-06
( O 0 2.026029960688902e-06
95 O 0 3.5606469737103907e-06
% O 0 1.5460634585906519e-06
confidence O 0 1.3710037819691934e-05
interval O 0 4.815174906980246e-05
[ O 0 0.0001698730484349653
CI O 0 0.40364065766334534
] O 0 5.404962575994432e-05
6 O 0 1.370703012071317e-05
% O 0 3.6839464883087203e-06
- O 0 4.6214438043534756e-05
28 O 0 9.597621101420373e-06
% O 0 3.059201844735071e-06
) O 0 2.8177751119073946e-06
, O 0 2.65502399088291e-06
suggesting O 0 6.249623402254656e-05
other O 0 8.007701580936555e-06
predisposition O 0 0.05176908150315285
genes O 0 0.00018607312813401222
. O 0 0.00011582463775994256

The O 0 2.8754024242516607e-05
majority O 0 1.7645888874540105e-05
( O 0 1.6035806766012684e-05
81 O 0 0.00014740152982994914
% O 0 4.430337867233902e-06
) O 0 2.0421207409526687e-06
of O 0 2.0040306480950676e-06
the O 0 0.014262132346630096
breast B-Disease 1 0.9999978542327881
- I-Disease 1 0.9999803304672241
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999992847442627
families O 0 0.0001990439632209018
were O 0 2.8288357498240657e-05
due O 0 0.0009336188668385148
to O 0 9.286532986152451e-06
BRCA1 O 0 0.005243455991148949
, O 0 2.517053871997632e-06
with O 0 1.3081241831969237e-06
most O 0 3.2774557894299505e-06
others O 0 1.057972895068815e-05
( O 0 6.521887826238526e-06
14 O 0 9.767298251972534e-06
% O 0 4.779781193064991e-06
) O 0 6.105238753661979e-06
due O 0 0.00020577028044499457
to O 0 2.0049705199198797e-05
BRCA2 O 0 0.01629413105547428
. O 0 6.701167876599357e-05

Conversely O 0 0.0008832848398014903
, O 0 6.327444680209737e-06
the O 0 1.4373785006682738e-06
majority O 0 2.3241616418090416e-06
of O 0 5.617511646960338e-07
families O 0 9.478843821852934e-06
with O 0 1.2595685802807566e-05
male B-Disease 0 0.0005350527935661376
and I-Disease 0 0.00012679191422648728
female I-Disease 1 0.9887278079986572
breast I-Disease 1 0.9999951124191284
cancer I-Disease 1 0.9999909400939941
were O 0 3.080896203755401e-05
due O 0 0.0022079620976001024
to O 0 1.561721001053229e-05
BRCA2 O 0 0.011657987721264362
( O 0 2.0569641492329538e-05
76 O 0 0.0004958398058079183
% O 0 1.9728988263523206e-05
) O 0 2.7454407245386392e-05
. O 0 3.93093578168191e-05

The O 0 5.666595825459808e-05
largest O 0 0.00014617724809795618
proportion O 0 5.018299998482689e-05
( O 0 1.075837280950509e-05
67 O 0 6.912908429512754e-05
% O 0 3.0734431675227825e-06
) O 0 8.47776504997455e-07
of O 0 1.6810264469313552e-07
families O 0 4.775201887241565e-06
due O 0 9.751499601406977e-05
to O 0 6.858155074951355e-07
other O 0 7.603268841194222e-07
genes O 0 1.2699982107733376e-05
was O 0 7.798212755005807e-05
found O 0 1.123536640079692e-05
in O 0 1.1749772284019855e-06
families O 0 1.116627458941366e-06
with O 0 9.525326163384307e-07
four O 0 3.112555759798852e-06
or O 0 8.596331099397503e-06
five O 0 7.231966264953371e-06
cases O 0 7.781995373079553e-05
of O 0 1.6966643670457415e-05
female O 1 0.9967446327209473
breast B-Disease 1 0.9999967813491821
cancer I-Disease 1 0.999985933303833
only O 0 7.294561510207132e-05
. O 0 0.00017493253108114004

These O 0 1.2927637726534158e-05
estimates O 0 0.0001286924525629729
were O 0 1.1887948858202435e-05
not O 0 1.2548985978355631e-05
substantially O 0 0.0008692207629792392
affected O 0 2.411205969110597e-05
either O 0 2.4494995614077197e-06
by O 0 1.1594999023145647e-06
changing O 0 1.0634697900968604e-05
the O 0 7.083734544721665e-06
assumed O 0 0.00025947176618501544
penetrance O 0 0.0044199014082551
model O 0 2.363544081163127e-05
for O 0 5.161406079423614e-06
BRCA1 O 0 0.005711396224796772
or O 0 7.72550811234396e-06
by O 0 2.531116479076445e-06
including O 0 4.227600584272295e-06
or O 0 2.656332253536675e-05
excluding O 0 0.000158555296366103
BRCA1 O 0 0.03708341717720032
mutation O 0 0.00028278742684051394
data O 0 6.274076440604404e-05
. O 0 8.114905358524993e-05

Among O 0 1.9922939827665687e-05
those O 0 1.1211026503588073e-05
families O 0 8.593465463491157e-05
with O 0 0.00746007077395916
disease O 1 0.999995231628418
due O 0 0.0268593467772007
to O 0 4.430619810591452e-05
BRCA1 O 0 0.023313425481319427
that O 0 3.93799973608111e-06
were O 0 4.323931079852628e-06
tested O 0 4.592255936586298e-05
by O 0 2.888870085371309e-07
one O 0 1.7958043940780044e-07
of O 0 8.045778798759784e-08
the O 0 2.3217889975057915e-06
standard O 0 7.958902278915048e-05
screening O 0 4.3611587898340076e-05
methods O 0 2.911082674472709e-06
, O 0 2.74527951660275e-06
mutations O 0 3.397375257918611e-05
were O 0 3.1028171179059427e-06
detected O 0 0.00013812507677357644
in O 0 4.4227340367797296e-07
the O 0 1.1599346407820121e-06
coding O 0 1.715878170216456e-05
sequence O 0 1.4987905387897626e-06
or O 0 3.2023488074628403e-06
splice O 0 3.381865462870337e-05
sites O 0 8.069643513408664e-07
in O 0 3.519764675274928e-07
an O 0 1.9909894035663456e-06
estimated O 0 1.1674150300677866e-05
63 O 0 4.581075700116344e-05
% O 0 3.5712507724383613e-06
( O 0 2.6118186724488623e-06
95 O 0 1.3675457921635825e-05
% O 0 1.4061898582440335e-05
CI O 0 0.19162261486053467
51 O 0 4.646934394259006e-05
% O 0 1.2059193068125751e-05
- O 0 0.00014339530025608838
77 O 0 5.578375930781476e-05
% O 0 8.55678354128031e-06
) O 0 1.069888639904093e-05
. O 0 2.7282956580165774e-05

The O 0 5.920486728427932e-05
estimated O 0 7.9278826888185e-05
sensitivity O 0 6.483708421001211e-05
was O 0 3.5591088817454875e-05
identical O 0 5.9156968745810445e-06
for O 0 2.842392916591052e-07
direct O 0 1.1302502116450341e-06
sequencing O 0 7.733484380878508e-06
and O 0 9.21313358048792e-07
other O 0 8.118583423311065e-07
techniques O 0 4.018809340777807e-05
. O 0 7.323989848373458e-05

The O 0 9.340742690255865e-05
penetrance O 0 0.009429232217371464
of O 0 1.3731785657000728e-05
BRCA2 O 0 0.016748392954468727
was O 0 0.0001588512968737632
estimated O 0 9.123562449531164e-06
by O 0 1.3601845694211079e-06
maximizing O 0 1.4018875845067669e-05
the O 0 8.47987030283548e-06
LOD O 0 0.004878743086010218
score O 0 4.851538051298121e-06
in O 0 1.6536121620447375e-05
BRCA2 O 0 0.012601402588188648
- O 0 0.00045316325849853456
mutation O 0 4.344571789260954e-05
families O 0 2.59854641626589e-06
, O 0 1.0316545058230986e-06
over O 0 1.10772145944793e-06
all O 0 3.1199627414935094e-07
possible O 0 1.735241494316142e-05
penetrance O 0 0.013267586939036846
functions O 0 4.092114613740705e-05
. O 0 0.00020264681370463222

The O 0 2.7367539587430656e-05
estimated O 0 0.0001524875988252461
cumulative O 0 0.00412293104454875
risk O 0 0.03562408685684204
of O 0 0.00017798850603867322
breast B-Disease 1 0.999990701675415
cancer I-Disease 1 0.9999700784683228
reached O 0 0.00015074280963744968
28 O 0 5.949533078819513e-05
% O 0 4.2589413169480395e-06
( O 0 2.2120336780062644e-06
95 O 0 7.59766089686309e-06
% O 0 7.308357453439385e-06
CI O 0 0.08100421726703644
9 O 0 1.391860769217601e-05
% O 0 2.4356024823646294e-06
- O 0 2.0685545678134076e-05
44 O 0 2.967332420666935e-06
% O 0 5.280940627017117e-07
) O 0 2.7738704488911026e-07
by O 0 2.8330293844192056e-07
age O 0 1.9399190932745114e-05
50 O 0 2.7609987682808423e-06
years O 0 6.5464469116705e-06
and O 0 9.907710136758396e-07
84 O 0 5.890314423595555e-05
% O 0 3.5611972180049634e-06
( O 0 2.7044941361964447e-06
95 O 0 1.1511567208799534e-05
% O 0 8.430940397374798e-06
CI O 0 0.05696748569607735
43 O 0 2.5677200028439984e-05
% O 0 3.278074700574507e-06
- O 0 3.2208550692303106e-05
95 O 0 2.424020976832253e-06
% O 0 7.55522364670469e-07
) O 0 5.960725388831634e-07
by O 0 1.2812968179787276e-06
age O 0 9.346695151180029e-05
70 O 0 5.184170004213229e-05
years O 0 0.00012691821029875427
. O 0 8.09766715974547e-05

The O 0 0.0012206778628751636
corresponding O 1 0.9855514764785767
ovarian B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999995231628418
risks O 1 0.9796937108039856
were O 0 7.937967166071758e-05
0 O 0 0.00014601009024772793
. O 0 8.518891263520345e-05

4 O 0 7.805883069522679e-05
% O 0 8.929248906497378e-06
( O 0 8.070373951341026e-06
95 O 0 1.4020106391399167e-05
% O 0 9.260937986255158e-06
CI O 0 0.04113052412867546
0 O 0 5.0058806664310396e-06
% O 0 2.552888645368512e-06
- O 0 1.4758137695025653e-05
1 O 0 1.8175617242377484e-06
% O 0 5.759931696047715e-07
) O 0 5.60975990993029e-07
by O 0 5.042733732807392e-07
age O 0 2.5538345653330907e-05
50 O 0 2.9861764687666437e-06
years O 0 4.666400400310522e-06
and O 0 6.963185796848848e-07
27 O 0 1.0797388313221745e-05
% O 0 1.6715064248273848e-06
( O 0 1.3979007462694426e-06
95 O 0 4.608790277416119e-06
% O 0 4.965906100551365e-06
CI O 0 0.022196218371391296
0 O 0 2.959492348963977e-06
% O 0 2.2157539660838665e-06
- O 0 1.6793735994724557e-05
47 O 0 6.1343794186541345e-06
% O 0 7.26592588762287e-07
) O 0 5.127350277689402e-07
by O 0 1.4317089380710968e-06
age O 0 5.754575249738991e-05
70 O 0 5.9781508753076196e-05
years O 0 0.00011988070036750287
. O 0 7.803769403835759e-05

The O 0 0.00021418262622319162
lifetime O 0 0.03292171657085419
risk O 0 0.21864891052246094
of O 0 0.00046256498899310827
breast B-Disease 1 0.9999984502792358
cancer I-Disease 1 0.9999927282333374
appears O 0 0.0012053725076839328
similar O 0 1.4984253539296333e-05
to O 0 2.4443165784759913e-06
the O 0 3.9789323636796325e-05
risk O 0 0.005798072088509798
in O 0 7.465903763659298e-05
BRCA1 O 1 0.6945092082023621
carriers O 0 0.0009968113154172897
, O 0 4.674274805438472e-06
but O 0 1.5553166576864896e-06
there O 0 1.3821974107486312e-06
was O 0 8.08544245956e-06
some O 0 1.5242351025790413e-07
suggestion O 0 1.014507233776385e-05
of O 0 3.5857780744663614e-07
a O 0 0.00018846202874556184
lower O 1 0.5131540894508362
risk O 0 0.018890541046857834
in O 0 6.0741636843886226e-05
BRCA2 O 0 0.03778179734945297
carriers O 0 0.0008480367250740528
< O 0 0.00045971039799042046
50 O 0 5.66864355278085e-06
years O 0 6.803312317060772e-06
of O 0 1.130046484831837e-06
age O 0 0.0008724577492102981
. O 0 0.00010947318514809012

Eye B-Disease 1 0.9915299415588379
movement I-Disease 0 0.0020585672464221716
abnormalities I-Disease 1 0.9979569911956787
correlate O 0 0.00031801831210032105
with O 0 2.0691622921731323e-05
genotype O 0 0.0051942793652415276
in O 0 0.00014032334729563445
autosomal O 1 0.9994891881942749
dominant O 1 0.9950581789016724
cerebellar B-Disease 1 0.999958872795105
ataxia I-Disease 1 0.9999750852584839
type I-Disease 1 0.9998311996459961
I I-Disease 1 0.9965919256210327
. O 0 0.0005312257562763989

We O 0 5.979245179332793e-05
compared O 0 0.0007259906269609928
horizontal O 0 0.010424907319247723
eye O 1 0.9174554347991943
movements O 0 0.00015802838606759906
( O 0 6.99298907420598e-05
visually O 0 0.0020562137942761183
guided O 0 0.0008951140916906297
saccades O 0 0.05447383597493172
, O 0 3.4304586733924225e-05
antisaccades O 0 0.001704784226603806
, O 0 4.316436388762668e-06
and O 0 1.44234104482166e-06
smooth O 0 0.00012687017442658544
pursuit O 0 0.00013632694026455283
) O 0 6.860503162897658e-06
in O 0 2.318301994819194e-06
control O 0 1.4054899111215491e-05
subjects O 0 2.0577803297783248e-05
( O 0 7.537673809565604e-06
n O 0 0.000101478275610134
= O 0 0.00012143959611421451
14 O 0 2.367792149016168e-05
) O 0 3.474813183856895e-06
and O 0 4.225431439408567e-06
patients O 0 0.12797287106513977
with O 0 1.2352445537544554e-06
three O 0 1.6496917396580102e-06
forms O 0 2.550558201619424e-05
of O 0 2.063316060230136e-05
autosomal O 1 0.9995260238647461
dominant O 1 0.987011194229126
cerebellar B-Disease 1 0.9997233748435974
ataxias I-Disease 1 0.9980529546737671
type I-Disease 1 0.9986209869384766
I I-Disease 1 0.9729776978492737
spinocerebellar B-Disease 1 0.9985048770904541
ataxias I-Disease 0 0.016548270359635353
1 I-Disease 0 6.118242163211107e-05
and I-Disease 0 3.392387952771969e-06
2 I-Disease 0 2.9864679163438268e-05
( O 0 1.0810505045810714e-05
SCA1 B-Disease 0 0.0013114861212670803
, O 0 3.1632298487238586e-06
n O 0 2.549580494815018e-05
= O 0 4.303082823753357e-05
11 O 0 7.512684533139691e-06
; O 0 2.97303699881013e-06
SCA2 B-Disease 0 0.00048087144386954606
, O 0 1.9833330497931456e-06
n O 0 1.9303779481560923e-05
= O 0 2.7769016014644876e-05
10 O 0 2.835382701960043e-06
) O 0 2.0563068119372474e-06
and O 0 4.511410679697292e-06
SCA3 B-Disease 1 0.9931723475456238
/ O 0 0.0034797892440110445
Machado B-Disease 0 0.007284514605998993
- I-Disease 0 0.013199001550674438
Joseph I-Disease 0 0.023365747183561325
disease I-Disease 1 0.9999480247497559
( O 0 0.0003012222587130964
MJD B-Disease 1 0.9981122016906738
) O 0 3.17347512464039e-05
( O 0 1.4887849829392508e-05
n O 0 9.498959843767807e-05
= O 0 0.00010698085679905489
16 O 0 1.875657653727103e-05
) O 0 7.0392206907854415e-06
. O 0 1.0842212759598624e-05

In O 0 0.00017446212586946785
SCA1 B-Disease 0 0.02471579983830452
, O 0 2.065972330456134e-05
saccade O 0 0.0002785037213470787
amplitude O 0 3.633525193436071e-05
was O 0 0.00018612829444464296
significantly O 0 0.00024600850883871317
increased O 0 1.6125150068546645e-05
, O 0 3.449748874118086e-06
resulting O 0 0.00015187553071882576
in O 0 4.0124177758116275e-05
hypermetria B-Disease 0 0.028606589883565903
. O 0 0.00017766056407708675

The O 0 2.4102035240503028e-05
smooth O 0 0.0003975675499532372
pursuit O 0 0.00033439556136727333
gain O 0 0.00031729365582577884
was O 0 0.006659669801592827
decreased O 0 0.03381151333451271
. O 0 9.326378494733945e-05

In O 0 0.00018810063193086535
SCA2 B-Disease 0 0.024893229827284813
, O 0 2.2586440536542796e-05
saccade O 0 0.0004799127927981317
velocity O 0 0.00013947718252893537
was O 0 0.0028648420702666044
markedly O 0 0.09324676543474197
decreased O 0 0.01615268364548683
. O 0 0.00010936009493889287

The O 0 1.5123910998227075e-05
percentage O 0 2.3012695237412117e-05
of O 0 2.026853280767682e-06
errors O 0 0.0008750440320000052
in O 0 3.970120087615214e-05
antisaccades O 0 0.03791659325361252
was O 0 0.0015374250942841172
greatly O 0 0.00032751623075455427
increased O 0 1.2109057934139855e-05
and O 0 3.836093583231559e-06
was O 0 0.0002539168344810605
significantly O 0 0.0001756942947395146
correlated O 0 8.965625602286309e-05
with O 0 1.9644525309558958e-05
age O 0 0.01597362570464611
at O 1 0.9375690817832947
disease O 1 0.9999970197677612
onset O 1 0.9999202489852905
. O 0 0.001796581782400608

In O 0 1.747110582073219e-05
addition O 0 1.743091706885025e-05
, O 0 1.857603706412192e-06
a O 0 4.476101821637712e-06
correlation O 0 7.031973837001715e-06
between O 0 3.652078930826974e-06
smooth O 0 0.0001100623921956867
pursuit O 0 6.407820910681039e-05
gain O 0 1.3583654435933568e-05
and O 0 4.4943098487237876e-07
the O 0 6.998984645179007e-07
number O 0 2.792679083540861e-07
of O 0 2.4548314740968635e-06
trinucleotide O 1 0.9965577721595764
repeats O 0 0.008278410881757736
was O 0 0.002233352744951844
found O 0 0.00026108475867658854
. O 0 7.701086724409834e-05

In O 0 0.0004911752766929567
SCA3 B-Disease 1 0.9966874718666077
, O 0 0.00026063009863719344
gaze B-Disease 0 0.034896526485681534
- I-Disease 0 0.017259495332837105
evoked I-Disease 0 0.010824466124176979
nystagmus I-Disease 1 0.6809509992599487
was O 0 0.0012340659741312265
often O 0 4.091958180652e-05
present O 0 2.4263790692202747e-05
as O 0 3.2067811844171956e-05
was O 0 0.0002620960876811296
saccade O 0 0.0011043455451726913
hypometria O 0 0.0006359608378261328
and O 0 2.2142098714539316e-06
smooth O 0 0.00022121613437775522
pursuit O 0 0.00026649312349036336
gain O 0 0.0002105001622112468
was O 0 0.007301810197532177
markedly O 0 0.1710669994354248
decreased O 0 0.024858077988028526
. O 0 0.00014700026076752692

Three O 0 2.5652627300587483e-05
major O 0 9.132899140240625e-05
criteria O 0 2.7227386453887448e-05
, O 0 3.21947231896047e-06
saccade O 0 0.0001734293473418802
amplitude O 0 1.3439377653412521e-05
, O 0 4.661410002881894e-06
saccade O 0 8.053771307459101e-05
velocity O 0 1.2130695722589735e-05
, O 0 1.592979060660582e-06
and O 0 5.051113589615852e-07
presence O 0 6.111868515290553e-06
of O 0 2.476504505466437e-06
gaze B-Disease 0 0.03159596025943756
- I-Disease 0 0.0056799957528710365
evoked I-Disease 0 0.005549916997551918
nystagmus I-Disease 0 0.020737268030643463
, O 0 4.157403964200057e-06
permitted O 0 3.221066208425327e-06
the O 0 4.134471510042204e-06
correct O 0 6.574546569027007e-05
assignment O 0 9.037657946464606e-06
of O 0 1.7039330657553364e-07
90 O 0 3.7633717511198483e-06
% O 0 4.842298153562297e-07
of O 0 2.1104726499743265e-07
the O 0 1.2596802662301343e-05
SCA1 B-Disease 0 0.009022478945553303
, O 0 1.4545327076120884e-06
90 O 0 8.685499324201373e-07
% O 0 3.1305793868341425e-07
of O 0 1.2456268905225443e-07
the O 0 1.3277336620376445e-05
SCA2 B-Disease 0 0.014808096922934055
, O 0 3.750191353901755e-06
and O 0 1.91917297343025e-06
93 O 0 5.522861101781018e-05
% O 0 1.2372864830467734e-06
of O 0 7.809650242052157e-07
the O 0 0.0001117823994718492
patients O 1 0.996311366558075
with O 0 3.2995481888065115e-05
SCA3 B-Disease 1 0.9976966977119446
to O 0 2.089308281938429e-06
their O 0 3.4124336707463954e-06
genetically O 0 0.0010709530906751752
confirmed O 0 0.0031118455808609724
patient O 1 0.8876466751098633
group O 0 3.451018710620701e-05
and O 0 5.62290551897604e-06
, O 0 7.667978024983313e-06
therefore O 0 2.206306999141816e-05
, O 0 1.1051667570427526e-05
may O 0 0.00011050153261749074
help O 0 1.6367743228329346e-05
orient O 0 0.0008004240808077157
diagnoses O 0 0.02393479458987713
of O 0 1.8485592590877786e-05
SCA1 B-Disease 1 0.9890642762184143
, O 0 8.649197116028517e-05
SCA2 B-Disease 0 0.2566499710083008
, O 0 1.52985976455966e-05
and O 0 9.46906948229298e-06
SCA3 B-Disease 1 0.9893847107887268
at O 0 8.858951332513243e-05
early O 0 9.206804679706693e-05
clinical O 0 0.0006434470415115356
stages O 0 0.00013026711530983448
of O 0 7.909949999884702e-06
the O 0 0.02167379856109619
diseases O 1 0.999995231628418
. O 0 0.00020778639009222388
. O 0 0.0001516757911304012

Genetic O 0 0.0001968711003428325
basis O 0 2.2099652596807573e-06
and O 0 7.2653692768653855e-06
molecular O 0 0.00044788693776354194
mechanism O 0 0.005393597297370434
for O 0 0.008341377601027489
idiopathic B-Disease 1 0.9999996423721313
ventricular I-Disease 1 0.9999903440475464
fibrillation I-Disease 1 0.9999978542327881
. O 0 0.020139390602707863

Ventricular B-Disease 1 0.9994813799858093
fibrillation I-Disease 1 0.9998735189437866
causes O 0 0.20423537492752075
more O 0 3.1874192245595623e-06
than O 0 4.358691512607038e-06
300 O 0 1.3168410077923909e-05
, O 0 5.847135071235243e-06
000 O 0 8.000189700396731e-05
sudden O 0 0.010173517279326916
deaths O 0 0.00031618779757991433
each O 0 7.105711574695306e-07
year O 0 1.940644324349705e-05
in O 0 4.34823778050486e-06
the O 0 2.9123852073098533e-05
USA O 0 0.00047078265924938023
alone O 0 0.00028900569304823875
. O 0 6.238096102606505e-05

In O 0 1.0444751751492731e-05
approximately O 0 1.2009807505819481e-05
5 O 0 2.6881738449446857e-05
- O 0 3.952817132812925e-05
12 O 0 1.5669158983655507e-06
% O 0 2.592101395748614e-07
of O 0 9.759951069554518e-08
these O 0 1.7829663647717098e-06
cases O 0 0.00011465511488495395
, O 0 4.785359124070965e-06
there O 0 3.254335979363532e-06
are O 0 1.1242975688219303e-06
no O 0 7.310501678148285e-05
demonstrable O 1 0.8284950852394104
cardiac O 1 0.9997952580451965
or O 0 0.001396849867887795
non O 0 0.15366101264953613
- O 1 0.9989204406738281
cardiac O 1 0.9998478889465332
causes O 0 0.003138893051072955
to O 0 1.2032907079628785e-06
account O 0 1.0370345080445986e-06
for O 0 8.117592642520322e-07
the O 0 4.395051746541867e-06
episode O 0 0.0001014090157696046
, O 0 1.4197900100043626e-06
which O 0 5.229804287409934e-07
is O 0 2.936299551947741e-06
therefore O 0 2.488441350578796e-05
classified O 0 0.13930416107177734
as O 0 0.034899257123470306
idiopathic B-Disease 1 0.9999995231628418
ventricular I-Disease 1 0.9999856948852539
fibrillation I-Disease 1 0.9999972581863403
( O 1 0.6526452898979187
IVF B-Disease 1 0.9995748400688171
) O 0 0.00044208887265995145
. O 0 0.00036126491613686085

A O 0 0.00018133492267224938
distinct O 0 3.285894854343496e-05
group O 0 5.076075467513874e-05
of O 0 5.318786861607805e-05
IVF B-Disease 1 0.9999239444732666
patients O 1 0.9997182488441467
has O 0 0.00010281160211889073
been O 0 2.2501366402138956e-05
found O 0 5.639107257593423e-06
to O 0 1.6017230564102647e-07
present O 0 2.0975876395823434e-06
with O 0 2.509578052922734e-06
a O 0 5.983557639410719e-05
characteristic O 0 0.0009866725886240602
electrocardiographic O 0 0.1529189646244049
pattern O 0 0.007264658808708191
. O 0 0.0002643374027684331

Because O 0 2.852174839063082e-05
of O 0 4.701841760379466e-07
the O 0 3.773927346628625e-06
small O 0 4.612351858668262e-06
size O 0 2.299844027220388e-06
of O 0 1.7173856292629353e-07
most O 0 2.822578380801133e-06
pedigrees O 0 0.0001031383071676828
and O 0 1.5911024320303113e-06
the O 0 1.2108411283406895e-05
high O 0 0.0034523194190114737
incidence O 1 0.7491692304611206
of O 0 8.212597094825469e-06
sudden B-Disease 1 0.9971293807029724
death I-Disease 0 0.08281638473272324
, O 0 1.543491453048773e-05
however O 0 1.128415715356823e-05
, O 0 3.6277388062444516e-06
molecular O 0 4.521976370597258e-05
genetic O 0 7.165203714976087e-05
studies O 0 6.6393859015079215e-06
of O 0 5.448790034279227e-06
IVF B-Disease 1 0.996915340423584
have O 0 1.2330328900134191e-05
not O 0 4.1631096792116296e-06
yet O 0 1.9870511096087284e-05
been O 0 2.3697668439126574e-05
done O 0 5.1964154408778995e-05
. O 0 4.586950672091916e-05

Because O 0 0.02143155038356781
IVF B-Disease 1 0.9975870847702026
causes O 1 0.9980559349060059
cardiac O 1 0.9998747110366821
rhythm O 1 0.9796976447105408
disturbance O 1 0.9936124682426453
, O 0 5.565761239267886e-05
we O 0 7.582748821732821e-06
investigated O 0 0.0003711542522069067
whether O 0 2.075058910122607e-05
malfunction O 0 0.01194156426936388
of O 0 5.76286595332931e-07
ion O 0 0.0003524990752339363
channels O 0 7.34245841158554e-05
could O 0 4.558858199743554e-05
cause O 0 0.00398783665150404
the O 0 0.00010704637679737061
disorder O 1 0.9998681545257568
by O 0 9.832119758357294e-06
studying O 0 4.239269401296042e-05
mutations O 0 6.725104321958497e-05
in O 0 6.896911600051681e-06
the O 0 6.819897680543363e-05
cardiac O 1 0.9990735054016113
sodium O 0 0.002774202497676015
channel O 0 0.000263828260358423
gene O 0 0.0005201995954848826
SCN5A O 0 0.04987403750419617
. O 0 0.00015536899445578456

We O 0 1.1269016795267817e-05
have O 0 1.980376964638708e-06
now O 0 5.1682968660315964e-06
identified O 0 1.6865671568666585e-05
a O 0 1.610311483091209e-05
missense O 0 0.0002004552516154945
mutation O 0 4.3757441744674e-05
, O 0 2.868296633096179e-06
a O 0 2.5464436475886032e-05
splice O 0 0.0019565457478165627
- O 0 0.0015176768647506833
donor O 0 0.00036916547105647624
mutation O 0 4.858499960391782e-05
, O 0 1.1647842939055408e-06
and O 0 8.113753438010463e-07
a O 0 3.0144175980240107e-05
frameshift O 0 0.004087792243808508
mutation O 0 5.1522336434572935e-05
in O 0 1.3589994978246978e-06
the O 0 3.103172275586985e-06
coding O 0 5.93636796111241e-05
region O 0 2.399621735094115e-06
of O 0 1.0528622169658775e-06
SCN5A O 0 0.0543527714908123
in O 0 2.2082118448452093e-05
three O 0 7.345140329562128e-05
IVF B-Disease 1 0.9955703616142273
families O 0 0.0001279984280699864
. O 0 0.0001392628182657063

We O 0 4.606628408510005e-06
show O 0 2.758261871349532e-06
that O 0 2.505772727090516e-07
sodium O 0 1.57343820319511e-05
channels O 0 9.201752959597798e-07
with O 0 6.526901756842562e-07
the O 0 1.362890179734677e-05
missense O 0 0.0011339420452713966
mutation O 0 0.0006091173854656518
recover O 0 0.008655905723571777
from O 0 4.136386633035727e-05
inactivation O 0 0.014700256288051605
more O 0 1.4049575156604988e-06
rapidly O 0 0.00013210647739470005
than O 0 6.49802188945614e-07
normal O 0 1.7321894119959325e-05
and O 0 1.042168150888756e-06
that O 0 1.0097901395056397e-06
the O 0 9.538857739244122e-06
frameshift O 0 0.005410476122051477
mutation O 0 0.00013595735072158277
causes O 0 0.0003277935611549765
the O 0 4.036109658045461e-06
sodium O 0 0.00013673692592419684
channel O 0 7.485115474992199e-06
to O 0 3.6758535770786693e-07
be O 0 2.4246405700978357e-06
non O 0 2.6909079679171555e-05
- O 0 0.0001595988724147901
functional O 0 9.95445589069277e-05
. O 0 5.6848410167731345e-05

Our O 0 1.569766209286172e-05
results O 0 6.502617907244712e-05
indicate O 0 7.361415191553533e-05
that O 0 2.8062383989890805e-06
mutations O 0 8.644522313261405e-05
in O 0 2.645635868248064e-05
cardiac O 1 0.995762825012207
ion O 0 0.0011044576531276107
- O 0 0.00024377705994993448
channel O 0 1.2345294635451864e-05
genes O 0 9.95080540633353e-07
contribute O 0 1.134216063292115e-06
to O 0 2.526035416394734e-07
the O 0 5.658910595229827e-06
risk O 0 0.00030887944740243256
of O 0 2.892668362619588e-06
developing O 0 0.0011200928129255772
IVF B-Disease 1 0.9975689053535461
. O 0 4.9731272156350315e-05
. O 0 7.064318197080866e-05

Molecular O 0 0.0009696198394522071
heterogeneity O 0 0.0015488002682104707
in O 0 0.00013241406122688204
mucopolysaccharidosis B-Disease 0 0.1214633584022522
IVA I-Disease 1 0.9800000190734863
in O 0 1.748497561493423e-05
Australia O 0 7.114796062523965e-06
and O 0 2.1025625756010413e-06
Northern O 0 9.32773582462687e-06
Ireland O 0 1.4035289495950565e-05
: O 0 2.906156396420556e-06
nine O 0 4.996947154722875e-06
novel O 0 4.703779995907098e-05
mutations O 0 5.773692828370258e-05
including O 0 5.366576715459814e-06
T312S O 0 0.0010487890103831887
, O 0 2.3451884771930054e-06
a O 0 9.226513611793052e-06
common O 0 1.612984124221839e-05
allele O 0 5.511623385245912e-05
that O 0 3.834045401163166e-06
confers O 0 0.0025634297635406256
a O 0 0.0014087355230003595
mild O 1 0.9989811778068542
phenotype O 1 0.678193986415863
. O 0 0.0005150926299393177

Mucopolysaccharidosis B-Disease 1 0.9275032877922058
IVA I-Disease 1 0.9962367415428162
( O 0 0.002182616852223873
MPS B-Disease 1 0.9927021265029907
IVA I-Disease 1 0.999203622341156
) O 0 5.050908657722175e-05
is O 0 1.767364483384881e-05
an O 0 0.00015342701226472855
autosomal B-Disease 1 0.9995750784873962
recessive I-Disease 1 0.999944806098938
lysosomal I-Disease 1 0.9999942779541016
storage I-Disease 1 0.9999721050262451
disorder I-Disease 1 0.9999992847442627
caused O 1 0.9991596937179565
by O 0 0.00013466055679600686
a O 0 0.004264302086085081
genetic B-Disease 1 0.9981220364570618
defect I-Disease 1 0.9996850490570068
in O 0 6.792048225179315e-05
N O 0 0.005699761211872101
- O 0 0.0015980203170329332
acetylgalactosamine O 0 0.003496885532513261
- O 0 0.0005124615272507071
6 O 0 0.00013061401841696352
- O 0 0.0017360582714900374
sulfate O 0 0.4094177782535553
sulfatase O 1 0.9354983568191528
( O 0 0.00012171597336418927
GALNS O 0 0.19540037214756012
) O 0 5.311852146405727e-05
. O 0 6.872576341265813e-05

Previous O 0 0.00011865223495988175
studies O 0 3.3046744647435844e-05
of O 0 1.2881511793239042e-05
patients O 1 0.9963380098342896
from O 0 4.4441949285101146e-05
a O 0 0.00017386760737281293
British O 0 0.000789809855632484
- O 0 0.0008743763901293278
Irish O 0 6.890235090395436e-05
population O 0 1.9837530089716893e-06
showed O 0 2.1487940102815628e-05
that O 0 4.5735782805422787e-07
the O 0 2.8318238491920056e-06
I113F O 0 0.00027597101870924234
mutation O 0 2.9568933314294554e-05
is O 0 1.0288778184985858e-06
the O 0 1.199619532599172e-06
most O 0 1.82612564003648e-06
common O 0 3.228961577406153e-05
single O 0 6.493292312370613e-05
mutation O 0 0.0006573077407665551
among O 0 0.00010144877160200849
MPS B-Disease 1 0.9988929629325867
IVA I-Disease 1 0.9999833106994629
patients O 1 0.9996181726455688
and O 0 4.5470053009921685e-05
produces O 0 0.0015097986906766891
a O 0 0.018550442531704903
severe O 1 0.999923825263977
clinical O 1 0.9958323836326599
phenotype O 1 0.9794405698776245
. O 0 0.0006084045744501054

We O 0 9.460350156587083e-06
studied O 0 3.909219958586618e-05
mutations O 0 3.379879126441665e-05
in O 0 2.5486097001703456e-06
the O 0 1.0080129868583754e-05
GALNS O 0 0.008956207893788815
gene O 0 3.5889592254534364e-05
from O 0 9.454794053453952e-06
23 O 0 9.564748324919492e-05
additional O 0 8.21304420242086e-05
MPS B-Disease 1 0.9928408861160278
IVA I-Disease 1 0.9999117851257324
patients O 1 0.9989117383956909
( O 0 2.342239167774096e-05
15 O 0 8.822747076919768e-06
from O 0 4.476417416299228e-06
Australia O 0 1.99910209630616e-06
, O 0 7.308387921511894e-07
8 O 0 2.7142611997987842e-06
from O 0 1.2915431852889014e-06
Northern O 0 2.4615337679279037e-06
Ireland O 0 5.84769259148743e-06
) O 0 1.740898483149067e-06
, O 0 6.294363288361637e-07
with O 0 8.739472718843899e-07
various O 0 1.0507514161872678e-05
clinical O 1 0.9146233797073364
phenotypes O 1 0.8141116499900818
( O 0 0.004639880731701851
severe O 1 0.9999393224716187
, O 0 0.00010480330092832446
16 O 0 0.00025320996064692736
cases O 0 0.0002228022349299863
; O 0 1.1415058907005005e-05
intermediate O 0 0.0011109631741419435
, O 0 1.4422115782508627e-05
4 O 0 6.255240441532806e-05
cases O 0 0.0004278302367310971
; O 0 0.00011012137838406488
mild O 1 0.9991067051887512
, O 0 3.4982698707608506e-05
3 O 0 0.00014418517821468413
cases O 0 0.0006298251682892442
) O 0 3.503274274407886e-05
. O 0 5.892651461181231e-05

We O 0 1.6756364857428707e-05
found O 0 2.4356988433282822e-05
two O 0 1.7008643453664263e-06
common O 0 4.3926054786425084e-05
mutations O 0 4.0356728277402e-05
that O 0 5.725871119466319e-07
together O 0 5.382744916460069e-07
accounted O 0 3.85483372156159e-06
for O 0 4.945835030412127e-07
32 O 0 2.4348453280254034e-06
% O 0 2.885230117044557e-07
of O 0 1.3300193302256957e-07
the O 0 6.9921784415782895e-06
44 O 0 4.8148445785045624e-05
unrelated O 0 0.00043302567792125046
alleles O 0 7.02977558830753e-05
in O 0 2.1077557903481647e-05
these O 0 4.9347858293913305e-05
patients O 1 0.9984853863716125
. O 0 0.00046273626503534615

One O 0 1.0726633263402618e-05
is O 0 4.723144229501486e-06
the O 0 6.988292170717614e-06
T312S O 0 0.0004723667516373098
mutation O 0 6.592755380552262e-05
, O 0 1.548610498502967e-06
a O 0 8.453224836557638e-06
novel O 0 3.957614899263717e-05
mutation O 0 8.886660361895338e-05
found O 0 3.185430250596255e-05
exclusively O 0 5.4236741561908275e-05
in O 0 0.0002166873891837895
milder O 1 0.9928217530250549
patients O 1 0.9992105960845947
. O 0 0.0006785650621168315

The O 0 1.6089512428152375e-05
other O 0 1.687058329480351e-06
is O 0 3.7351287573983427e-06
the O 0 9.014502211357467e-06
previously O 0 0.00017414287140127271
described O 0 0.00046377917169593275
I113F O 0 0.0009453307138755918
that O 0 9.104250239033718e-06
produces O 0 0.00023914720804896206
a O 0 0.0023591509088873863
severe O 1 0.9997785687446594
phenotype O 1 0.9139127731323242
. O 0 0.0007386645884253085

The O 0 7.686720346100628e-05
I113F O 0 0.0013112255837768316
and O 0 1.2521813005150761e-05
T312S O 0 0.0006230046274140477
mutations O 0 4.250280107953586e-05
accounted O 0 1.402942871209234e-05
for O 0 1.6462749954371247e-06
8 O 0 1.2190351299068425e-05
( O 0 3.3189489840879105e-06
18 O 0 5.344528290152084e-06
% O 0 1.6350346641047508e-06
) O 0 8.794210089035914e-07
and O 0 6.337296554193017e-07
6 O 0 6.657716767222155e-06
( O 0 1.2181448028059094e-06
14 O 0 2.004405359912198e-06
% O 0 6.719800467180903e-07
) O 0 5.023576363782922e-07
of O 0 2.5311621243417903e-07
44 O 0 4.270264980732463e-05
unrelated O 0 0.00040967133827507496
alleles O 0 9.058859723154455e-05
, O 0 2.5986804757849313e-05
respectively O 0 0.0002601338492240757
. O 0 0.00021051200747024268

The O 0 8.432492177234963e-05
relatively O 0 0.0005131722427904606
high O 0 0.001250487519428134
residual O 0 0.0034055549185723066
GALNS O 0 0.019459696486592293
activity O 0 4.263656592229381e-05
seen O 0 3.262090831412934e-05
when O 0 5.4811762311146595e-06
the O 0 1.199769485538127e-06
T312S O 0 9.723159746499732e-05
mutant O 0 2.5627929062466137e-05
cDNA O 0 1.9107843399979174e-05
is O 0 5.176357262826059e-06
overexpressed O 0 0.0006234165630303323
in O 0 2.307212071173126e-06
mutant O 0 0.00013387369108386338
cells O 0 5.569052882492542e-05
provides O 0 2.5726458261488006e-06
an O 0 1.6419818393842434e-06
explanation O 0 4.391603852127446e-06
for O 0 1.930828602780821e-06
the O 0 4.844394788960926e-05
mild O 1 0.9993292093276978
phenotype O 0 0.222556009888649
in O 0 0.0001305028417846188
patients O 1 0.998521625995636
with O 0 1.576502290845383e-05
this O 0 3.8945778214838356e-05
mutation O 0 0.0011602190788835287
. O 0 0.00010023867798736319

The O 0 6.510950242955005e-06
distribution O 0 1.2430652986950008e-06
and O 0 4.1416953422412917e-07
relative O 0 1.4980788591856253e-06
frequencies O 0 3.0954467433730315e-07
of O 0 1.850820865456626e-07
the O 0 1.0902807844104245e-05
I113F O 0 0.000618172634858638
and O 0 7.155610546760727e-06
T312S O 0 0.0007623781566508114
mutations O 0 5.2012939704582095e-05
in O 0 4.062919742864324e-06
Australia O 0 4.822173650609329e-06
corresponded O 0 1.917106783366762e-05
to O 0 6.755989261364448e-07
those O 0 1.0959746532535064e-06
observed O 0 8.876897481968626e-06
in O 0 3.3804319627961377e-06
Northern O 0 9.09392474568449e-06
Ireland O 0 7.828083653294016e-06
and O 0 8.614201760792639e-07
are O 0 6.780796013572399e-08
unique O 0 2.3667683990424848e-07
to O 0 1.0797410965324161e-07
these O 0 9.992907479272617e-08
two O 0 1.0497670928089065e-06
populations O 0 1.6577174392296e-05
, O 0 3.5698135434358846e-06
suggesting O 0 4.5650445827050135e-05
that O 0 8.540964699932374e-07
both O 0 3.2156610814126907e-06
mutations O 0 6.634948658756912e-05
were O 0 5.538714958674973e-06
probably O 0 1.8473008822184056e-05
introduced O 0 3.994234248239081e-06
to O 0 3.025745627383003e-07
Australia O 0 1.1744035646188422e-06
by O 0 1.166921265394194e-06
Irish O 0 3.081620889133774e-05
migrants O 0 6.3639122345193755e-06
during O 0 3.271855166531168e-05
the O 0 1.0568897778284736e-05
19th O 0 0.0002477054949849844
century O 0 0.00018538122822064906
. O 0 0.00012948011863045394

Haplotype O 0 0.0014541633427143097
analysis O 0 1.2235458598297555e-05
using O 0 1.3364967344386969e-05
6 O 0 0.000149662620970048
RFLPs O 0 0.0010022454662248492
provides O 0 4.642621661332669e-06
additional O 0 1.1943114941459498e-06
data O 0 1.2814141427952563e-06
that O 0 5.277566970107728e-07
the O 0 4.616607384377858e-06
I113F O 0 0.00044943770626559854
mutation O 0 4.004260335932486e-05
originated O 0 1.166558013210306e-05
from O 0 3.4137096918129828e-06
a O 0 2.1803580239065923e-05
common O 0 0.00014322462084237486
ancestor O 0 0.000563920708373189
. O 0 0.00021782190015073866

The O 0 2.1192665371927433e-05
other O 0 3.436397719269735e-06
9 O 0 6.924111221451312e-05
novel O 0 0.00011203809845028445
mutations O 0 9.953791595762596e-05
identified O 0 6.151682464405894e-05
in O 0 4.540047939372016e-06
these O 0 3.5353375551494537e-06
23 O 0 0.002173452638089657
patients O 1 0.9824507832527161
were O 0 1.2267684041944449e-06
each O 0 1.8267616042066948e-07
limited O 0 2.019328803726239e-06
to O 0 3.687358969273191e-07
a O 0 1.4003925571159925e-05
single O 0 3.190178904333152e-05
family O 0 0.00013821256288792938
. O 0 6.685860716970637e-05

These O 0 1.785699168976862e-06
data O 0 4.478890332393348e-06
provide O 0 1.2820070196539746e-06
further O 0 1.996689888983383e-06
evidence O 0 8.411553608311806e-06
for O 0 2.0385250536492094e-06
extensive O 0 0.0002570096112322062
allelic O 0 0.002456066897138953
heterogeneity O 0 0.001460945000872016
in O 0 0.00016240357945207506
MPS B-Disease 1 0.9820929765701294
IVA I-Disease 1 0.9993684887886047
in O 0 0.0002210552484029904
British O 0 0.026787735521793365
- O 1 0.5152453184127808
Irish O 0 0.005597425624728203
patients O 1 0.9489399194717407
and O 0 1.8398304746369831e-06
provide O 0 3.0988899197836872e-06
evidence O 0 7.857980563130695e-06
for O 0 4.794289338860835e-07
their O 0 7.579124599033094e-07
transmission O 0 9.814553777687252e-05
to O 0 1.057098984347249e-06
Australia O 0 3.794396661760402e-06
by O 0 4.9473674152977765e-06
British O 0 0.00022920800256542861
- O 0 0.0005979151464998722
Irish O 0 9.797319944482297e-05
migrants O 0 1.4746264241694007e-05
. O 0 1.405130751663819e-05
. O 0 5.579450589721091e-05

Identification O 0 1.7518723325338215e-05
of O 0 2.381283820795943e-06
constitutional O 0 0.0003521291073411703
WT1 O 1 0.9893139600753784
mutations O 0 0.0006174810114316642
, O 0 2.307823160663247e-05
in O 0 7.248594920383766e-05
patients O 1 0.9989411234855652
with O 0 0.0004985796404071152
isolated O 1 0.9969204664230347
diffuse B-Disease 1 0.9997568726539612
mesangial I-Disease 1 0.9999936819076538
sclerosis I-Disease 1 0.9999997615814209
, O 0 0.00012138645251980051
and O 0 4.411790996527998e-06
analysis O 0 3.713264732141397e-06
of O 0 6.0354923334671184e-06
genotype O 0 0.029784636572003365
/ O 0 0.01592954620718956
phenotype O 0 0.00035748930531553924
correlations O 0 1.2205077837279532e-05
by O 0 8.542455134374904e-07
use O 0 5.117013870403753e-07
of O 0 5.173076829123602e-07
a O 0 6.437471165554598e-05
computerized O 0 0.003851194167509675
mutation O 0 0.0002776087785605341
database O 0 0.00015174743020907044
. O 0 7.47375306673348e-05

Constitutional O 0 8.74934921739623e-05
mutations O 0 3.5481360100675374e-05
of O 0 6.518553732348664e-07
the O 0 3.448294955887832e-05
WT1 O 0 0.05535437911748886
gene O 0 2.538832268328406e-05
, O 0 9.561886145093013e-07
encoding O 0 4.002203240816016e-06
a O 0 0.00011023452680092305
zinc O 1 0.9907141923904419
- O 0 0.0015826801536604762
finger O 0 0.0009510203381069005
transcription O 0 0.00013664894504472613
factor O 0 3.85522362194024e-05
involved O 0 6.990843394305557e-05
in O 0 0.0005122876609675586
renal O 1 0.999994158744812
and O 0 0.00024472700897604227
gonadal O 1 0.9905611872673035
development O 0 0.00010707761975936592
, O 0 8.068726856436115e-06
are O 0 1.0068283700093161e-06
found O 0 3.264511906309053e-05
in O 0 1.0004690921050496e-05
most O 0 0.00010824715718626976
patients O 1 0.9990341663360596
with O 0 0.0013512031873688102
Denys B-Disease 1 0.9988320469856262
- I-Disease 1 0.9997727274894714
Drash I-Disease 1 0.9996360540390015
syndrome I-Disease 1 0.9999994039535522
( O 0 0.09678304940462112
DDS B-Disease 1 0.9999567270278931
) O 0 0.0001855746959336102
, O 0 5.448546653497033e-05
or O 0 0.0020348362158983946
diffuse B-Disease 1 0.998769223690033
mesangial I-Disease 1 0.9999812841415405
sclerosis I-Disease 1 0.9999997615814209
( O 0 0.16125603020191193
DMS B-Disease 1 0.999491810798645
) O 0 0.0001097088388632983
associated O 0 0.00022404904302675277
with O 0 0.00011090542102465406
pseudohermaphroditism B-Disease 1 0.9990208148956299
and O 0 0.00016139507351908833
/ O 1 0.6821678876876831
or O 0 0.005432505160570145
Wilms B-Disease 1 0.9999537467956543
tumor I-Disease 1 0.9999617338180542
( O 0 0.001217700308188796
WT B-Disease 1 0.9979586601257324
) O 0 0.00016045889060478657
. O 0 0.00014076867955736816

Most O 0 0.00013147058780305088
mutations O 0 0.002199021866545081
in O 0 0.0017178136622533202
DDS B-Disease 1 0.9999843835830688
patients O 1 0.9993687272071838
lie O 0 0.0005590090295299888
in O 0 1.8712409655563533e-05
exon O 0 0.0012798699317499995
8 O 0 4.701269426732324e-05
or O 0 9.31634713197127e-06
exon O 0 0.00023830051941331476
9 O 0 2.6246476409141906e-05
, O 0 1.7230419189218082e-06
encoding O 0 1.0866600860026665e-05
zinc O 0 0.19862376153469086
finger O 0 0.004327764734625816
2 O 0 0.00010872695565922186
or O 0 8.821867231745273e-05
zinc O 1 0.8728759288787842
finger O 0 0.0026140694972127676
3 O 0 2.0540808691293932e-05
, O 0 1.6153973092514207e-06
respectively O 0 5.102017894387245e-06
, O 0 4.601947125593142e-07
with O 0 8.844953640618769e-07
a O 0 1.7486410797573626e-05
hot O 0 0.0003426948678679764
spot O 0 8.031039760680869e-05
( O 0 6.643686447205255e-06
R394W O 0 0.0002270741097163409
) O 0 1.5814388234502985e-06
in O 0 3.6102678677707445e-06
exon O 0 0.0010984308319166303
9 O 0 0.00024606575607322156
. O 0 7.002065103733912e-05

We O 0 4.6446898522845e-06
analyzed O 0 1.991102908505127e-05
a O 0 2.5373592507094145e-06
series O 0 3.941989689337788e-06
of O 0 1.7821299707065918e-06
24 O 0 0.001001905184239149
patients O 1 0.9980254173278809
, O 0 1.1990421626251191e-05
10 O 0 1.5808756870683283e-05
with O 0 2.903571839851793e-05
isolated B-Disease 1 0.7054551243782043
DMS I-Disease 1 0.9994682669639587
( O 0 0.0003823717124760151
IDMS B-Disease 1 0.9931407570838928
) O 0 1.5237847946991678e-05
, O 0 3.824699888355099e-06
10 O 0 7.682690920773894e-06
with O 0 3.5882134397979826e-05
DDS B-Disease 1 0.9999231100082397
, O 0 6.891007615195122e-06
and O 0 2.2621702555625234e-06
4 O 0 3.482160173007287e-05
with O 0 8.926059672376141e-05
urogenital B-Disease 1 0.9998108744621277
abnormalities I-Disease 1 0.9998562335968018
and O 0 0.0004291865334380418
/ O 1 0.8695353865623474
or O 0 0.001611838350072503
WT B-Disease 1 0.9985411167144775
. O 0 0.00028366909828037024

We O 0 6.218080670805648e-05
report O 0 0.0002648737281560898
WT1 O 0 0.028900614008307457
heterozygous O 0 0.0002779445785563439
mutations O 0 0.00013539704377762973
in O 0 2.3626045731361955e-05
16 O 0 0.0009376522502861917
patients O 1 0.9977625608444214
, O 0 4.867758889304241e-06
4 O 0 9.010084795590956e-06
of O 0 1.0860816246349714e-06
whom O 0 0.0001877546455943957
presented O 0 0.00043366686441004276
with O 0 0.000692588509991765
IDMS B-Disease 1 0.9984856247901917
. O 0 0.0006404173327609897

One O 0 1.8814189388649538e-05
male O 0 0.0001109166259993799
and O 0 4.8803744903125335e-06
two O 0 2.156066329916939e-05
female O 0 0.06720622628927231
IDMS B-Disease 1 0.9997377991676331
patients O 1 0.9991505146026611
with O 0 0.0010631592012941837
WT1 O 1 0.9984696507453918
mutations O 0 0.18511676788330078
underwent O 1 0.9995582699775696
normal O 0 0.018819564953446388
puberty O 1 0.9901974201202393
. O 0 0.0003555668517947197

Two O 0 5.218404476181604e-05
mutations O 0 0.0010331893572583795
associated O 0 0.00035240096622146666
with O 0 0.00012188751134090126
IDMS B-Disease 1 0.9975651502609253
are O 0 6.509756644845766e-07
different O 0 1.7640205385305308e-07
from O 0 9.341826626041438e-06
those O 0 1.4271846339397598e-05
described O 0 0.027985811233520508
in O 0 0.003305553225800395
DDS B-Disease 1 0.9999908208847046
patients O 1 0.9997072815895081
. O 0 0.0006389788468368351

No O 0 0.0008866239804774523
WT1 O 0 0.4245925545692444
mutations O 0 0.00025118724443018436
were O 0 8.53010806167731e-06
detected O 0 0.0003338101087138057
in O 0 1.5705571740909363e-06
the O 0 5.954877906333422e-06
six O 0 3.3680775231914595e-05
other O 0 8.967788744485006e-05
IDMS B-Disease 1 0.9997928738594055
patients O 1 0.9992891550064087
, O 0 4.390009416965768e-05
suggesting O 0 0.0005755717284046113
genetic O 0 0.00020766793750226498
heterogeneity O 0 0.0002897147205658257
of O 0 1.3704076081921812e-05
this O 0 0.005334540270268917
disease O 1 0.9999910593032837
. O 0 0.0007930353749543428

We O 0 2.4888448024285026e-05
analyzed O 0 0.0004769951046910137
genotype O 0 0.0018836376257240772
/ O 0 0.0014919646782800555
phenotype O 0 0.0003749206953216344
correlations O 0 3.28226487908978e-05
, O 0 6.882980869704625e-07
on O 0 6.100054861235549e-07
the O 0 1.1007367817228442e-07
basis O 0 4.232619943422833e-08
of O 0 3.426007211260185e-08
the O 0 9.978678008337738e-07
constitution O 0 4.4400735532690305e-07
of O 0 3.854322869756288e-07
a O 0 0.00011761385394493118
WT1 O 0 0.04786461964249611
mutation O 0 2.889514871640131e-05
database O 0 7.395774900942342e-06
of O 0 2.1766493318864377e-06
84 O 0 0.01663045771420002
germ O 1 0.9987311959266663
- O 0 0.0013158746296539903
line O 0 8.63249515532516e-05
mutations O 0 2.3497250367654487e-05
, O 0 5.516929491022893e-07
to O 0 2.0446628923309618e-07
compare O 0 3.043105152755743e-06
the O 0 4.3507577629497973e-07
distribution O 0 1.2877502513219952e-06
and O 0 1.7278665609410382e-06
type O 0 6.787360325688496e-05
of O 0 1.1970184914389392e-06
mutations O 0 0.00016667756426613778
, O 0 2.5154724880849244e-06
according O 0 2.5342008029838325e-06
to O 0 1.2135078577557579e-06
the O 0 1.0714549716794863e-05
different O 0 1.4041824215382803e-05
symptoms O 1 0.9998880624771118
. O 0 0.0007520182989537716

This O 0 2.130610664607957e-05
demonstrated O 0 0.00013674005458597094
( O 0 1.072183749784017e-05
1 O 0 1.0266636309097521e-05
) O 0 1.7302870674029691e-06
the O 0 2.7892106118088122e-06
association O 0 5.1304792577866465e-05
between O 0 3.1606064112565946e-06
mutations O 0 4.209391408949159e-05
in O 0 2.1241319245746126e-06
exons O 0 4.442059434950352e-05
8 O 0 2.0746314476127736e-05
and O 0 3.2219600143434945e-06
9 O 0 5.0194103096146137e-05
and O 0 9.781158951227553e-06
DMS B-Disease 1 0.9891563653945923
; O 0 8.583706403442193e-06
( O 0 8.247020559792873e-06
2 O 0 2.2566546249436215e-05
) O 0 7.285073934326647e-06
among O 0 1.85505959962029e-05
patients O 1 0.989562451839447
with O 0 5.3507552365772426e-05
DMS B-Disease 1 0.9986336827278137
, O 0 2.434585439914372e-06
a O 0 2.488818836354767e-06
higher O 0 2.4068046968750423e-06
frequency O 0 4.572496266064263e-07
of O 0 3.1252275789483974e-07
exon O 0 0.00040179520146921277
8 O 0 3.680813097162172e-05
mutations O 0 3.271886453148909e-05
among O 0 2.4359835606446723e-06
46 O 0 5.6570923334220424e-05
, O 0 3.746884613065049e-05
XY O 1 0.8991070985794067
patients O 1 0.8400534391403198
with O 0 1.0863461284316145e-05
female O 0 0.0004314856487326324
phenotype O 0 0.0014236577553674579
than O 0 2.0738227703986922e-06
among O 0 5.223451807978563e-06
46 O 0 0.00021901415311731398
, O 0 7.575355266453698e-05
XY O 1 0.9852564930915833
patients O 1 0.9610899090766907
with O 0 8.902499757823534e-06
sexual O 0 0.00012093712575733662
ambiguity O 0 0.00010885985102504492
or O 0 8.464379061479121e-05
male O 0 0.0019844602793455124
phenotype O 0 0.010718920268118382
; O 0 1.1197028470633086e-05
and O 0 5.5027448979672045e-06
( O 0 8.464874554192647e-06
3 O 0 5.0971061682503205e-06
) O 0 1.246724309567071e-06
statistically O 0 3.4810057059075916e-06
significant O 0 2.433118424960412e-06
evidence O 0 7.247238499985542e-06
that O 0 1.2795641168850125e-06
mutations O 0 7.946134246594738e-06
in O 0 1.0043120255431859e-06
exons O 0 4.600215106620453e-05
8 O 0 1.6756892364355735e-05
and O 0 1.6341632544936147e-06
9 O 0 2.1477941118064336e-05
preferentially O 0 2.9438971978379413e-05
affect O 0 2.9153668492654106e-06
amino O 0 5.649371814797632e-06
acids O 0 1.1740380614355672e-05
with O 0 6.021201670591836e-07
different O 0 1.360683796747253e-07
functions O 0 3.899182502209442e-06
. O 0 1.6579879229539074e-05
. O 0 5.859220618731342e-05

The O 0 0.0002511235943529755
185delAG O 0 0.020543742924928665
BRCA1 O 0 0.010732488706707954
mutation O 0 0.00013806292554363608
originated O 0 3.272017420385964e-05
before O 0 6.850109002698446e-06
the O 0 1.593769297869585e-06
dispersion O 0 6.87454485159833e-06
of O 0 2.2962861123687617e-07
Jews O 0 5.271659574646037e-06
in O 0 1.8122879055226804e-06
the O 0 3.2956249924609438e-06
diaspora O 0 4.295407507015625e-06
and O 0 1.4701000736749847e-06
is O 0 2.56076464211219e-06
not O 0 6.307210469458369e-07
limited O 0 6.314701295195846e-06
to O 0 4.680011443269905e-06
Ashkenazim O 0 0.0029204227030277252
. O 0 7.123128307284787e-05

The O 0 5.025679638492875e-05
185delAG O 0 0.0017449677689000964
mutation O 0 0.00017551012570038438
in O 0 1.66659719980089e-05
BRCA1 O 0 0.01548284012824297
is O 0 1.649539262871258e-05
detected O 0 0.0007223915308713913
in O 0 5.5277860155911185e-06
Ashkenazi O 0 0.0004964459803886712
Jews O 0 9.28838380787056e-06
both O 0 4.8041893023764715e-06
in O 0 0.00043587564141489565
familial B-Disease 1 0.9999021291732788
breast I-Disease 1 0.9999963045120239
and I-Disease 1 0.9987533092498779
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
and O 0 1.8145870853913948e-05
in O 0 9.801534361031372e-06
the O 0 2.2942511350265704e-05
general O 0 9.210246207658201e-05
population O 0 1.8893284504883923e-05
. O 0 6.844127346994355e-05

All O 0 1.7965228835237212e-05
tested O 0 0.002925280947238207
Ashkenazi O 0 0.0019122542580589652
mutation O 0 0.00013586028944700956
carriers O 0 4.5550947106676176e-05
share O 0 1.311675760007347e-06
the O 0 1.1295443300696206e-06
same O 0 4.257552518538432e-06
allelic O 0 0.0003259329532738775
pattern O 0 0.00014660843589808792
at O 0 7.106533303158358e-05
the O 0 7.567731518065557e-05
BRCA1 O 0 0.014596556313335896
locus O 0 0.0008724752115085721
. O 0 0.00013182951079215854

Our O 0 1.528506436443422e-05
previous O 0 5.044766658102162e-05
study O 0 4.816084401682019e-05
showed O 0 0.00012178795441286638
that O 0 2.2504386834043544e-06
this O 0 3.1457245768251596e-06
Ashkenazi O 0 0.0010977291967719793
mutation O 0 7.813509000698105e-05
also O 0 5.547563432628522e-06
occurs O 0 2.525454510760028e-05
in O 0 2.814487970681512e-06
Iraqi O 0 2.2977083062869497e-05
Jews O 0 5.257761586108245e-06
with O 0 2.1617340735247126e-06
a O 0 2.9941020329715684e-05
similar O 0 9.081070311367512e-05
allelic O 0 0.01160664577037096
pattern O 0 0.0076775019988417625
. O 0 0.00024885000311769545

We O 0 5.505221906787483e-06
extended O 0 7.259911399160046e-06
our O 0 3.453688179888559e-07
analysis O 0 4.5235717038849543e-07
to O 0 4.698023019500397e-07
other O 0 1.2929074273415608e-06
non O 0 9.403283183928579e-05
- O 0 0.0001989802112802863
Ashkenazi O 0 9.065409540198743e-05
subsets O 0 6.583052254427457e-06
354 O 0 1.6628635421511717e-05
of O 0 3.48816314499345e-07
Moroccan O 0 6.177253817440942e-05
origin O 0 3.0998712645669e-06
, O 0 4.943623025610577e-06
200 O 0 8.90802766662091e-06
Yemenites O 0 0.0008661220781505108
and O 0 3.257192474848125e-06
150 O 0 1.7584770830580965e-05
Iranian O 0 3.613018270698376e-05
Jews O 0 3.506178472889587e-05
. O 0 6.14402670180425e-05

Heteroduplex O 0 0.0035505027044564486
analysis O 0 1.2293600775592495e-05
complemented O 0 4.749603976961225e-05
by O 0 2.0322474938438972e-06
direct O 0 1.2267462352610892e-06
DNA O 0 3.0723283998668194e-05
sequencing O 0 7.039650427032029e-06
of O 0 2.7212022359890398e-06
abnormally O 1 0.9870898127555847
migrating O 0 0.00013731967192143202
bands O 0 5.998388951411471e-05
were O 0 1.3591999959317036e-05
employed O 0 0.00021290115546435118
. O 0 0.00011566627654246986

Four O 0 3.5784782994596753e-06
of O 0 1.1125098353659268e-06
Moroccan O 0 9.306886204285547e-05
origin O 0 3.0224946385715157e-06
( O 0 6.764003956050146e-06
1 O 0 6.468506398960017e-06
. O 0 1.3790755701847957e-06
1 O 0 4.066222118126461e-06
% O 0 1.8117245872417698e-06
) O 0 1.264988327420724e-06
and O 0 3.341656338307075e-07
none O 0 2.738478315222892e-06
of O 0 2.730797916683514e-07
the O 0 1.880608033388853e-05
Yemenites O 0 0.003119564848020673
or O 0 1.4591963918064721e-05
Iranians O 0 1.2868815247202292e-05
was O 0 2.9276114219101146e-05
a O 0 8.777965376793873e-06
carrier O 0 3.897877104463987e-05
of O 0 3.586667389754439e-07
the O 0 3.6981589801143855e-05
185delAG O 0 0.005730365868657827
mutation O 0 0.0008359577041119337
. O 0 8.821715164231136e-05

BRCA1 O 0 0.03503716364502907
allelic O 0 0.0015340647660195827
patterns O 0 4.7914476454025134e-05
were O 0 2.8768658921762835e-06
determined O 0 4.227378667565063e-06
for O 0 2.1990466336774261e-07
four O 0 3.4469758247723803e-07
of O 0 1.22356070164642e-07
these O 0 2.6271419528711704e-07
individuals O 0 6.025061338732485e-07
and O 0 4.585417912039702e-07
for O 0 5.327168537405669e-07
12 O 0 6.506077625090256e-06
additional O 0 3.148825271637179e-06
non O 0 4.7933765017660335e-05
- O 0 0.0007496877806261182
Ashkenazi O 0 0.0008494706125929952
185delAG O 0 0.0015649786219000816
mutation O 0 0.00038115016650408506
carriers O 0 0.0011233006371185184
who O 0 0.0007854978903196752
had O 1 0.9298218488693237
breast B-Disease 1 0.9999940395355225
/ I-Disease 1 0.9999256134033203
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
. O 0 0.0019140323856845498

Six O 0 0.0002879468083847314
non O 0 0.001135599915869534
- O 0 0.006226241122931242
Ashkenazi O 0 0.0004375846474431455
individuals O 0 1.5906048247416038e-06
shared O 0 4.454916052054614e-06
the O 0 1.687110670900438e-05
common O 0 0.0002594376273918897
Ashkenazi O 0 0.01107797771692276
haplotype O 0 0.002892875811085105
, O 0 6.050049250916345e-06
four O 0 3.284479817011743e-06
had O 0 6.416308315237984e-05
a O 0 2.211035643995274e-05
closely O 0 1.4685316273244098e-05
related O 0 6.181943899719045e-05
pattern O 0 0.00043106425437144935
, O 0 3.4830381991923787e-06
and O 0 1.7037524457919062e-06
the O 0 7.664658369321842e-06
rest O 0 3.383084913366474e-05
( O 0 6.7855839915864635e-06
n O 0 5.470099858939648e-05
= O 0 7.611720502609387e-05
6 O 0 1.1001236998708919e-05
) O 0 9.933482942869887e-07
displayed O 0 9.360652256873436e-06
a O 0 1.2977094229427166e-05
distinct O 0 7.01723838574253e-05
BRCA1 O 0 0.016721904277801514
allelic O 0 0.004285968840122223
pattern O 0 0.005516824312508106
. O 0 0.0005318352486938238

We O 0 8.462242476525716e-06
conclude O 0 5.059939212515019e-05
that O 0 1.006315869744867e-06
the O 0 6.698105607938487e-06
185delAG O 0 0.0023556810338050127
BRCA1 O 0 0.0037444031331688166
mutation O 0 6.477331044152379e-05
occurs O 0 2.2749714844394475e-05
in O 0 2.4610340005892795e-06
some O 0 2.5826655019045575e-06
non O 0 0.00018634281877893955
- O 0 0.0020354583393782377
Ashkenazi O 0 0.0007281724829226732
populations O 0 7.05948286849889e-06
at O 0 2.21964673983166e-05
rates O 0 4.17321061831899e-05
comparable O 0 1.8132654076907784e-05
with O 0 8.349529139195511e-07
that O 0 1.3600704278360354e-06
of O 0 4.901433385384735e-06
Ashkenazim O 0 0.035815294831991196
. O 0 0.0001460546482121572

The O 0 1.4940903383831028e-05
majority O 0 4.887500381300924e-06
of O 0 2.666473392309854e-06
Jewish O 0 0.00021451187785714865
185delAG O 0 0.020071271806955338
mutation O 0 0.0012773167109116912
carriers O 0 0.00026301026809960604
have O 0 2.3920772491692333e-06
a O 0 9.824892913457006e-06
common O 0 3.461236337898299e-05
allelic O 0 0.0007927936385385692
pattern O 0 0.00029195789829827845
, O 0 6.358670816553058e-06
supporting O 0 1.4020386515767314e-05
the O 0 1.1773746336984914e-05
founder O 0 0.00033934833481907845
effect O 0 2.901828156609554e-05
notion O 0 2.289562689838931e-05
, O 0 1.8611501673149178e-06
but O 0 1.275780618925637e-06
dating O 0 7.665923476452008e-06
the O 0 1.3760735555479187e-06
mutations O 0 6.207363639987307e-06
origin O 0 3.0007251439201355e-07
to O 0 2.8777884608643944e-07
an O 0 2.136923967555049e-06
earlier O 0 1.7718548406264745e-05
date O 0 6.2372419051826e-06
than O 0 1.2308079249123693e-06
currently O 0 1.5859692211961374e-05
estimated O 0 7.157500658649951e-05
. O 0 8.029385207919404e-05

However O 0 5.211392999626696e-05
, O 0 3.0869969123159535e-06
the O 0 8.903127763915109e-07
different O 0 2.513554022698372e-07
allelic O 0 0.000405819941079244
pattern O 0 0.00022106367396190763
at O 0 9.91544293356128e-05
the O 0 3.412883961573243e-05
BRCA1 O 0 0.0026818884070962667
locus O 0 4.8762361984699965e-05
even O 0 4.3584254854067694e-06
in O 0 1.010617779684253e-06
some O 0 4.3255212744952587e-07
Jewish O 0 2.687625601538457e-05
mutation O 0 0.00040807947516441345
carriers O 0 0.00035861507058143616
, O 0 6.629939889535308e-06
might O 0 1.3243949069874361e-05
suggest O 0 3.2315858788933838e-06
that O 0 2.793134399325936e-07
the O 0 4.982784957974218e-06
mutation O 0 9.456328552914783e-05
arose O 0 4.583513873512857e-05
independently O 0 1.5200721463770606e-05
. O 0 1.616709414520301e-05
. O 0 4.741000884678215e-05

Crystal O 0 0.013269691728055477
structure O 0 0.0001940926449606195
of O 0 8.885366696631536e-06
the O 0 0.002261510118842125
hemochromatosis B-Disease 1 0.9999842643737793
protein O 0 0.005873768590390682
HFE O 1 0.9606855511665344
and O 0 3.041071295228903e-06
characterization O 0 1.122176672652131e-05
of O 0 1.2772814272921096e-07
its O 0 1.0504361398488982e-06
interaction O 0 4.899662144453032e-06
with O 0 1.8583868950372562e-05
transferrin O 1 0.6116090416908264
receptor O 0 0.005655787885189056
. O 0 9.252430027117953e-05

HFE O 1 0.8803695440292358
is O 0 4.976690615876578e-05
an O 0 7.641263073310256e-05
MHC O 0 0.3822276294231415
- O 0 0.00048022856935858727
related O 0 1.567578874528408e-05
protein O 0 1.3261543244880158e-05
that O 0 6.114575512583542e-07
is O 0 2.5327947241748916e-06
mutated O 0 8.06217867648229e-05
in O 0 2.868772753572557e-06
the O 0 0.0001512481685495004
iron B-Disease 1 0.9999443292617798
- I-Disease 1 0.9998562335968018
overload I-Disease 1 0.9999656677246094
disease I-Disease 1 0.9999983310699463
hereditary B-Disease 1 0.9999960660934448
hemochromatosis I-Disease 1 0.9999996423721313
. O 0 0.03392939269542694

HFE O 0 0.2833360433578491
binds O 0 0.0004949229187332094
to O 0 2.0407760530360974e-05
transferrin O 0 0.040293700993061066
receptor O 0 0.0019370081136003137
( O 0 3.3912539947777987e-05
TfR O 0 0.026598982512950897
) O 0 1.7978005644181394e-06
and O 0 4.976318450644612e-07
reduces O 0 4.4080814404878765e-05
its O 0 6.029291625964106e-07
affinity O 0 1.38595059979707e-05
for O 0 5.678296474798117e-06
iron O 1 0.9983648657798767
- O 0 0.0015045710606500506
loaded O 0 0.00018939371511805803
transferrin O 0 0.0358913354575634
, O 0 2.9000075301155448e-05
implicating O 0 0.23088768124580383
HFE O 1 0.9942611455917358
in O 0 0.0003400015411898494
iron O 1 0.9994710087776184
metabolism O 1 0.981217622756958
. O 0 0.00033275652094744146

The O 0 0.00013220765686128289
2 O 0 0.0002492686326149851
. O 0 7.456837920472026e-05

6 O 0 0.0005053233471699059
A O 0 0.00046643256791867316
crystal O 0 0.007271219976246357
structure O 0 0.00012065217015333474
of O 0 5.361154308047844e-06
HFE O 1 0.9971058964729309
reveals O 0 0.0003357758978381753
the O 0 4.857102794630919e-06
locations O 0 8.250890459748916e-06
of O 0 2.7179677999811247e-05
hemochromatosis B-Disease 1 0.9999935626983643
mutations O 0 0.0021426130551844835
and O 0 1.3681225027539767e-05
a O 0 0.0007335749105550349
patch O 1 0.9978412389755249
of O 0 8.321394489030354e-06
histidines O 0 0.029277516528964043
that O 0 6.582964488188736e-06
could O 0 4.923541837342782e-06
be O 0 9.989513500840985e-07
involved O 0 4.713322141469689e-06
in O 0 1.1737513887055684e-05
pH O 0 0.17011421918869019
- O 0 0.000728350190911442
dependent O 0 5.2236275223549455e-05
interactions O 0 2.790397593344096e-05
. O 0 8.904635615181178e-05

We O 0 1.9255277948104776e-05
also O 0 1.525880361441523e-05
demonstrate O 0 3.3120570151368156e-05
that O 0 2.4879525881260633e-05
soluble O 1 0.9435163736343384
TfR O 1 0.9836180806159973
and O 0 7.769819785607979e-05
HFE O 1 0.9548020362854004
bind O 0 0.00014841642405372113
tightly O 0 5.1190483645768836e-05
at O 0 1.3889513866160996e-05
the O 0 1.4677872286483762e-06
basic O 0 8.599594366387464e-06
pH O 0 0.00036579251172952354
of O 0 5.540017014027399e-07
the O 0 2.3107146262191236e-05
cell O 0 0.004555361345410347
surface O 0 0.00044001988135278225
, O 0 3.741032287507551e-06
but O 0 1.2763526910930523e-06
not O 0 2.5767019451450324e-07
at O 0 4.974713192495983e-06
the O 0 3.884911166096572e-06
acidic O 0 0.0025102156214416027
pH O 0 0.0012223718222230673
of O 0 5.340451934898738e-06
intracellular O 0 0.019868317991495132
vesicles O 0 0.09613407403230667
. O 0 0.0002706806408241391

TfR O 1 0.9672579169273376
HFE O 1 0.9703217148780823
stoichiometry O 0 0.0023753163404762745
( O 0 8.211414387915283e-05
2 O 0 7.933698361739516e-05
1 O 0 5.047047307016328e-05
) O 0 7.075241683196509e-06
differs O 0 6.931431562406942e-05
from O 0 5.525178858079016e-05
TfR O 1 0.6101921200752258
transferrin O 0 0.017567994073033333
stoichiometry O 0 0.0003192333970218897
( O 0 1.363152750855079e-05
2 O 0 1.519043325970415e-05
2 O 0 1.0934044439636637e-05
) O 0 9.665948255133117e-07
, O 0 4.490903791065648e-07
implying O 0 7.305765393539332e-06
a O 0 5.895136041544902e-07
different O 0 2.0310153558966704e-08
mode O 0 1.9020380932488479e-06
of O 0 2.5819957727435394e-07
binding O 0 3.270616434747353e-05
for O 0 1.649962541705463e-05
HFE O 1 0.9920417666435242
and O 0 3.2420506613561884e-05
transferrin O 0 0.08759869635105133
to O 0 1.668909862928558e-05
TfR O 1 0.7845274209976196
, O 0 3.519305209920276e-06
consistent O 0 1.0572991413937416e-05
with O 0 1.12705345145514e-06
our O 0 2.1039486455265433e-06
demonstration O 0 7.474993617506698e-05
that O 0 1.1766540410462767e-05
HFE O 1 0.8981000185012817
, O 0 2.7540785595192574e-05
transferrin O 0 0.025649163872003555
, O 0 1.4220518096408341e-05
and O 0 1.0409828973934054e-05
TfR O 0 0.1585666984319687
form O 0 2.7072323064203374e-05
a O 0 9.80632976279594e-05
ternary O 0 0.012745734304189682
complex O 0 0.005549275316298008
. O 0 0.0005619862931780517

Identification O 0 6.579826276720269e-06
of O 0 5.836794230162923e-07
three O 0 5.030350166634889e-06
novel O 0 7.0919246354606e-05
mutations O 0 3.336066220072098e-05
and O 0 7.078265298332553e-07
a O 0 4.103706032765331e-06
high O 0 2.327578840777278e-05
frequency O 0 6.533434202538047e-07
of O 0 3.057132289541187e-07
the O 0 1.6277801478281617e-05
Arg778Leu O 0 0.00543321343138814
mutation O 0 0.00024438140098936856
in O 0 7.428562821587548e-05
Korean O 1 0.974675714969635
patients O 1 0.9993358254432678
with O 0 0.002477237954735756
Wilson B-Disease 1 0.999342143535614
disease I-Disease 1 0.9999910593032837
. O 0 0.0012775309151038527

Four O 0 0.00014674075646325946
mutations O 0 0.0015581940533593297
- O 0 0.006461661774665117
- O 0 0.0006316030048765242
R778L O 0 0.00041391083505004644
, O 0 7.56835879656137e-06
A874V O 0 0.0003055749402847141
, O 0 6.02724958298495e-06
L1083F O 0 0.00027055860846303403
, O 0 4.592744971887441e-06
and O 0 3.7914487620582804e-06
2304delC O 0 0.0011028297012671828
- O 0 0.00024635379668325186
- O 0 3.03856886603171e-05
in O 0 1.0425956133985892e-06
the O 0 5.6995741033460945e-06
copper O 0 0.00679742218926549
- O 0 0.00010780255979625508
transporting O 0 5.092803621664643e-05
enzyme O 0 0.000150482272147201
, O 0 6.71851375955157e-06
P O 0 0.001492828712798655
- O 0 0.00030702477670274675
type O 0 0.000337158446200192
ATPase O 0 0.0008917641825973988
( O 0 1.900604911497794e-05
ATP7B O 0 0.004024637397378683
) O 0 3.4933339065901237e-06
, O 0 1.8727997712630895e-06
were O 0 3.066691533604171e-06
identified O 0 5.434764170786366e-05
in O 0 4.028582407045178e-05
Korean O 1 0.9953184723854065
Patients O 1 0.9996854066848755
with O 0 0.00581288943067193
Wilson B-Disease 1 0.9988407492637634
disease I-Disease 1 0.9999880790710449
. O 0 0.0016808713553473353

Arg778Leu O 0 0.015508350916206837
, O 0 1.5332934708567336e-05
the O 0 9.534564924251754e-06
most O 0 7.83837094786577e-06
frequently O 0 0.0001181361876660958
reported O 0 0.00010585973359411582
mutation O 0 9.69659595284611e-06
of O 0 2.2769847873860272e-07
this O 0 3.101811216765782e-06
enzyme O 0 0.00029103856650181115
, O 0 4.910266397928353e-06
was O 0 5.1516246458049864e-05
found O 0 4.669957888836507e-06
in O 0 6.89847695412027e-07
six O 0 9.84920802693523e-07
of O 0 8.576208756494452e-07
eight O 0 0.00018269188876729459
unrelated O 1 0.6772141456604004
patients O 1 0.9981326460838318
studied O 0 4.787359284819104e-05
, O 0 2.3711950234428514e-06
an O 0 1.4986419500928605e-06
allele O 0 3.2640771223668708e-06
frequency O 0 6.121564979366667e-07
of O 0 5.287300268719264e-07
37 O 0 0.00017745485820341855
. O 0 7.547839777544141e-05

5 O 0 0.0001061323273461312
% O 0 1.5057810742291622e-05
, O 0 4.025369889859576e-06
which O 0 1.706204443507886e-06
is O 0 3.660859647425241e-06
considerably O 0 4.554104452836327e-05
higher O 0 6.25149277766468e-06
than O 0 5.36671166173619e-07
those O 0 5.472983843901602e-07
in O 0 2.6124912437808234e-06
other O 0 3.1708470942248823e-06
Asian O 0 0.00021517455752473325
populations O 0 8.540202543372288e-05
. O 0 8.550592610845342e-05

The O 0 1.6502001017215662e-05
novel O 0 3.101297625107691e-05
single O 0 9.823758773563895e-06
nucleotide O 0 4.869883196079172e-05
deletion O 0 0.0004160642856732011
, O 0 9.131815204455052e-06
2304delC O 0 0.0005119935376569629
, O 0 5.645628789352486e-06
was O 0 0.00010999858204741031
found O 0 1.9549213902791962e-05
in O 0 5.969975063635502e-06
one O 0 5.741457789554261e-05
patient O 1 0.9888743162155151
. O 0 0.00017959269462153316

Since O 0 0.0001636351371416822
a O 0 2.9184237064328045e-05
mutation O 0 2.8498421670519747e-05
at O 0 1.4504335013043601e-05
cDNA O 0 5.2757164667127654e-05
nucleotide O 0 0.00011251441173953936
2302 O 0 0.015547966584563255
( O 0 1.4352757716551423e-05
2302insC O 0 0.0005592179368250072
) O 0 8.209965017158538e-06
had O 0 4.4776916183764115e-05
been O 0 1.4357221516547725e-05
previously O 0 7.090104918461293e-05
described O 0 0.00011912827176274732
, O 0 2.2037272628949722e-06
this O 0 4.5552084770861256e-07
region O 0 1.078647642316355e-06
of O 0 3.5201540526941244e-07
the O 0 3.7749243347207084e-05
ATP7B O 1 0.9140811562538147
gene O 0 0.0005756430327892303
may O 0 0.0001559236116008833
be O 0 1.2171508387837093e-05
susceptible O 0 0.009337672963738441
to O 0 1.0676451893232297e-05
gene O 0 0.0015034982934594154
rearrangements O 0 0.14377081394195557
causing O 1 0.9986414313316345
Wilson B-Disease 1 0.9989318251609802
disease I-Disease 1 0.9999895095825195
. O 0 0.0010529987048357725

Disruption O 0 0.000777663488406688
of O 0 1.063192371475452e-06
splicing O 0 0.00010697556717786938
regulated O 0 7.381596515187994e-05
by O 0 7.482039563910803e-06
a O 0 6.525627395603806e-05
CUG O 0 0.029223831370472908
- O 0 0.0002500770497135818
binding O 0 3.5494620533427224e-05
protein O 0 0.00022021417680662125
in O 0 0.0005302327917888761
myotonic B-Disease 1 0.9999841451644897
dystrophy I-Disease 1 0.9999957084655762
. O 0 0.0035405599046498537

Myotonic B-Disease 1 0.9999479055404663
dystrophy I-Disease 1 0.9999960660934448
( O 1 0.8800088763237
DM B-Disease 1 0.9999823570251465
) O 0 0.0003198719350621104
is O 0 8.183156023733318e-05
caused O 0 0.004465784411877394
by O 0 7.820121936674695e-06
a O 0 6.633721204707399e-05
CTG O 0 0.004075708333402872
expansion O 0 2.5882853151415475e-05
in O 0 2.235072997791576e-06
the O 0 5.937571131653385e-06
3 O 0 3.960526373703033e-05
untranslated O 0 0.0006751783657819033
region O 0 1.0348686373617966e-05
of O 0 3.454239049460739e-06
the O 0 0.0007689254125580192
DM B-Disease 1 0.999701201915741
gene O 0 0.002152351662516594
. O 0 0.00019226087897550315

One O 0 1.9277729734312743e-05
model O 0 6.512510299216956e-05
of O 0 8.724021608941257e-05
DM B-Disease 1 0.9999473094940186
pathogenesis O 1 0.9980408549308777
suggests O 0 0.00027700752252712846
that O 0 5.284091457724571e-06
RNAs O 0 0.00041224516462534666
from O 0 1.4857774885967956e-06
the O 0 1.2309780004216009e-06
expanded O 0 5.048973434895743e-06
allele O 0 3.6162155083729886e-06
create O 0 3.021555983195867e-07
a O 0 4.405244908411987e-06
gain O 0 1.3116584341332782e-05
- O 0 2.408808722975664e-05
of O 0 3.8392852275137557e-07
- O 0 7.271489448612556e-05
function O 0 4.5155857151257806e-06
mutation O 0 1.0105347428179812e-05
by O 0 6.172479061206104e-07
the O 0 1.6245182905549882e-06
inappropriate O 0 3.0452907594735734e-05
binding O 0 8.21124331196188e-07
of O 0 1.5303395173305034e-07
proteins O 0 7.089857263054e-06
to O 0 1.44108162203338e-06
the O 0 4.297095802030526e-05
CUG O 0 0.06965471804141998
repeats O 0 0.004785183351486921
. O 0 0.00018168642418459058

Data O 0 0.0001120502784033306
presented O 0 6.729947926942259e-05
here O 0 1.4002470379637089e-05
indicate O 0 1.9407129002502188e-05
that O 0 6.928132165739953e-07
the O 0 2.213122570537962e-06
conserved O 0 4.4753098336514086e-05
heterogeneous O 0 0.0024299924261868
nuclear O 0 0.004302728921175003
ribonucleoprotein O 1 0.578651487827301
, O 0 3.087972800130956e-05
CUG O 0 0.006193360313773155
- O 0 9.401491115568206e-05
binding O 0 9.469503311265726e-06
protein O 0 5.173932004254311e-05
( O 0 1.4225998711481225e-05
CUG O 0 0.02239018864929676
- O 0 0.000888659677002579
BP O 0 0.0012100597377866507
) O 0 3.608485030781594e-06
, O 0 1.789746647773427e-06
may O 0 1.1773690857808106e-05
mediate O 0 5.6703742302488536e-05
the O 0 9.324986422143411e-06
trans O 0 0.0006295059574767947
- O 0 9.399787086294964e-05
dominant O 0 8.22416586743202e-06
effect O 0 1.3187838021622156e-06
of O 0 1.770048356775078e-07
the O 0 1.1634382644842844e-05
RNA O 0 0.0007672160281799734
. O 0 4.4206091843079776e-05

CUG O 1 0.9410945177078247
- O 0 0.05577191710472107
BP O 0 0.013178533874452114
was O 0 0.00021170642867218703
found O 0 1.13725300252554e-05
to O 0 4.963890205544885e-07
bind O 0 2.01071106857853e-05
to O 0 9.429007832295611e-07
the O 0 3.2474970794282854e-05
human O 0 0.002050034236162901
cardiac O 1 0.9998378753662109
troponin O 1 0.9987850785255432
T O 1 0.9951422214508057
( O 0 4.372811599751003e-05
cTNT O 0 0.001162742031738162
) O 0 7.432825896103168e-06
pre O 0 0.00024019702686928213
- O 0 9.993575076805428e-05
messenger O 0 2.2450825781561434e-05
RNA O 0 1.0679395018087234e-05
and O 0 2.8897846959807794e-07
regulate O 0 8.591913683630992e-06
its O 0 9.197243002745381e-07
alternative O 0 1.336434252152685e-05
splicing O 0 0.00017068811575882137
. O 0 8.768525731284171e-05

Splicing O 0 0.00012479061842896044
of O 0 9.209354175254703e-06
cTNT O 0 0.020571956411004066
was O 0 0.004544368013739586
disrupted O 0 0.07472269237041473
in O 0 0.00116471026558429
DM B-Disease 1 0.9999455213546753
striated O 1 0.998406708240509
muscle O 1 0.99299156665802
and O 0 1.1257759979343973e-05
in O 0 2.096895332215354e-05
normal O 0 0.0007667610188946128
cells O 0 0.0006997782038524747
expressing O 0 0.00011974577500950545
transcripts O 0 0.00016693203360773623
that O 0 1.0378465958638117e-05
contain O 0 0.00022038078168407083
CUG O 0 0.19840563833713531
repeats O 0 0.0073366109281778336
. O 0 0.00018756887584459037

Altered O 0 0.0008508704486303031
expression O 0 1.7250578821403906e-05
of O 0 1.344871407127357e-06
genes O 0 4.5726035750703886e-05
regulated O 0 0.00030072039226070046
posttranscriptionally O 0 0.0025538280606269836
by O 0 3.723414920386858e-05
CUG O 1 0.9803358316421509
- O 0 0.009729458950459957
BP O 0 0.004228489939123392
therefore O 0 3.35542754328344e-05
may O 0 5.156460247235373e-05
contribute O 0 2.3551088816020638e-05
to O 0 4.134162372793071e-05
DM B-Disease 1 0.999845027923584
pathogenesis O 1 0.997794508934021
. O 0 9.045307524502277e-05
. O 0 0.00012927655188832432

Identification O 0 1.7546195522299968e-05
of O 0 1.0578814908512868e-06
a O 0 4.735470429295674e-05
novel O 0 0.00019313619122840464
nonsense O 0 0.0003864830359816551
mutation O 0 5.2041810704395175e-05
and O 0 1.6511336298208334e-06
a O 0 1.5276844351319596e-05
missense O 0 8.933767094276845e-05
substitution O 0 6.921964541106718e-06
in O 0 2.731232825681218e-06
the O 0 1.5640907804481685e-05
vasopressin O 0 0.003710285061970353
- O 0 0.0008222331525757909
neurophysin O 0 0.0019851764664053917
II O 0 0.029521223157644272
gene O 0 2.5991465008701198e-05
in O 0 1.309338585997466e-06
two O 0 2.049661816272419e-06
Spanish O 0 8.769186388235539e-05
kindreds O 0 0.0035053351894021034
with O 0 0.000255238963291049
familial B-Disease 1 0.9997958540916443
neurohypophyseal I-Disease 1 0.9999219179153442
diabetes I-Disease 1 0.9999996423721313
insipidus I-Disease 1 0.9998522996902466
. O 0 0.005765973124653101

Familial B-Disease 1 0.9992671608924866
neurohypophyseal I-Disease 1 0.9998003840446472
diabetes I-Disease 1 0.9999995231628418
insipidus I-Disease 1 0.9998968839645386
( O 0 0.01802212744951248
FNDI B-Disease 1 0.9997029900550842
) O 0 8.686217915965244e-05
is O 0 2.7220143238082528e-05
an O 0 0.00019673185306601226
autosomal B-Disease 1 0.9995951056480408
dominant I-Disease 1 0.9995337724685669
disease I-Disease 1 0.9999995231628418
caused O 1 0.99982088804245
by O 1 0.7617222666740417
deficiency O 1 0.9999983310699463
in O 0 0.00013621573452837765
the O 0 0.00022077134053688496
antidiuretic O 1 0.7858638763427734
hormone O 0 0.23250821232795715
arginine O 0 0.0028395766858011484
vasopressin O 0 0.004718855023384094
( O 0 5.744158261222765e-05
AVP O 0 0.007815729826688766
) O 0 1.5104765225260053e-06
encoded O 0 1.5532355064351577e-06
by O 0 2.904338771259063e-06
the O 0 3.7287449231371284e-05
AVP O 1 0.8946648836135864
- O 0 0.0026361006312072277
neurophysin O 0 0.007093727122992277
II O 1 0.8809545040130615
( O 0 0.00013422929623629898
AVP O 1 0.6728672385215759
- O 0 0.001104106311686337
NPII O 0 0.0039028336759656668
) O 0 4.170500687905587e-06
gene O 0 1.7671738532953896e-05
on O 0 1.5573572454741225e-05
chromosome O 0 0.0005962912691757083
20p13 O 0 0.002080557867884636
. O 0 0.0001023884688038379

In O 0 2.1984791601425968e-05
this O 0 4.273164449841715e-06
study O 0 2.2808389985584654e-05
, O 0 3.236672228013049e-06
we O 0 3.4317827157792635e-07
analyzed O 0 5.054027042206144e-06
two O 0 5.641267648570647e-07
families O 0 4.542338956525782e-06
with O 0 1.2142570085416082e-05
FNDI B-Disease 1 0.6100525259971619
using O 0 2.907697762566386e-06
direct O 0 3.0611981856054626e-06
automated O 0 0.00011888224980793893
fluorescent O 0 0.0002471035113558173
, O 0 2.340040964554646e-06
solid O 0 5.772393706138246e-05
phase O 0 6.242654490051791e-05
, O 0 4.4977541620028205e-06
single O 0 1.1296712727926206e-05
- O 0 7.902379729785025e-05
stranded O 0 3.309367093606852e-05
DNA O 0 6.8566182562790345e-06
sequencing O 0 6.48038394501782e-07
of O 0 3.630856610925548e-07
PCR O 0 0.0007174370111897588
- O 0 0.0008053940837271512
amplified O 0 0.0008976113749668002
AVP O 0 0.11957238614559174
- O 0 0.002290384378284216
NPII O 0 0.010815173387527466
DNA O 0 0.0008854428306221962
. O 0 0.00010492518777027726

In O 0 9.101420801016502e-06
one O 0 9.086443242267706e-07
of O 0 4.4750126448889205e-07
the O 0 1.9005070498678833e-05
families O 0 3.070207458222285e-05
, O 0 1.3634049537358806e-05
affected O 0 4.53690008725971e-05
individuals O 0 2.657458708199556e-06
presented O 0 2.9495766284526326e-05
a O 0 2.6786030502989888e-05
novel O 0 9.542064071865752e-05
nonsense O 0 0.0003163334622513503
mutation O 0 4.099872239748947e-05
in O 0 2.067062041533063e-06
exon O 0 0.00013433865387924016
3 O 0 3.154827709295205e-06
of O 0 1.3091158734823694e-07
the O 0 3.7670736219297396e-06
gene O 0 2.5170342269120738e-05
, O 0 5.661419208990992e-07
consisting O 0 1.9865626654791413e-06
in O 0 2.5633883069531294e-06
a O 0 3.288227162556723e-05
G O 0 0.000792773615103215
to O 0 4.690556579589611e-06
T O 0 0.00651027774438262
transition O 0 1.6118752682814375e-05
at O 0 2.8945836675120518e-05
nucleotide O 0 7.929456478450447e-05
2101 O 0 0.005162482615560293
, O 0 1.962875785466167e-06
which O 0 6.701720849378034e-07
produces O 0 6.79054301144788e-06
a O 0 5.073120519227814e-06
stop O 0 2.020206011366099e-05
signal O 0 2.7258171030553058e-05
in O 0 5.435690127342241e-06
codon O 0 6.305392162175849e-05
82 O 0 0.00035750039387494326
( O 0 4.1776191210374236e-05
Glu O 0 0.019708074629306793
) O 0 4.96329766974668e-06
of O 0 5.496839094121242e-06
NPII O 0 0.4865472912788391
. O 0 0.00022201082902029157

The O 0 0.0003114769933745265
premature O 0 0.16964316368103027
termination O 0 0.0038255227264016867
eliminates O 0 0.00021857941464986652
part O 0 2.9083328172418987e-06
of O 0 2.816094024638005e-07
the O 0 2.197971843997948e-05
C O 0 0.005915267858654261
- O 0 0.0004137734358664602
terminal O 0 0.0005764710367657244
domain O 0 2.0810857677133754e-06
of O 0 6.330175210678135e-07
NPII O 0 0.007604267448186874
, O 0 1.434094997421198e-06
including O 0 5.707259447262913e-07
a O 0 7.01748967912863e-06
cysteine O 0 5.024141864851117e-05
residue O 0 0.0001193905045511201
in O 0 2.289346639372525e-06
position O 0 1.580759635544382e-05
85 O 0 5.958145629847422e-05
, O 0 1.417203520759358e-06
which O 0 5.998545020702295e-07
could O 0 1.3784167549601989e-06
be O 0 5.161678586773633e-07
involved O 0 1.2089844858564902e-06
in O 0 5.553505957323068e-07
the O 0 2.0952663817297434e-06
correct O 0 8.134476229315624e-05
folding O 0 0.0009451109799556434
of O 0 2.2043916487746174e-06
the O 0 0.00022511478164233267
prohormone O 1 0.9710171222686768
. O 0 0.00029068085132166743

In O 0 1.6140134903253056e-05
the O 0 8.801855983620044e-06
second O 0 2.0711799152195454e-05
family O 0 4.131395689910278e-05
, O 0 2.5643957997090183e-06
a O 0 9.203664376400411e-06
G279A O 0 9.964085620595142e-05
substitution O 0 6.357361144182505e-06
at O 0 6.971039965719683e-06
position O 0 5.439309461507946e-06
- O 0 1.1728809113265015e-05
1 O 0 3.4135624105147144e-07
of O 0 4.217887905610951e-08
the O 0 1.7497617363915197e-06
signal O 0 4.3546344386413693e-05
peptide O 0 0.00017809664132073522
was O 0 3.553479473339394e-05
observed O 0 8.167435225914232e-06
in O 0 2.0292477529437747e-06
all O 0 1.1821300631709164e-06
affected O 0 0.00012816538219340146
individuals O 0 2.3365057131741196e-05
. O 0 0.00010927887342404574

This O 0 5.130034332978539e-05
missense O 0 0.0016775802941992879
mutation O 0 0.0002530550118535757
, O 0 1.3327609849511646e-05
which O 0 2.275014776387252e-05
replaces O 0 0.02742902562022209
Ala O 1 0.6273797750473022
with O 0 7.984444528119639e-05
Thr O 1 0.9904851317405701
, O 0 1.2397607861203142e-05
is O 0 1.6885047443793155e-05
frequent O 0 0.00020113031496293843
among O 0 0.00018003417062573135
FNDI B-Disease 1 0.9999099969863892
patients O 1 0.9995971322059631
and O 0 1.1681121577566955e-05
is O 0 1.1265964531048667e-05
thought O 0 8.155878276738804e-06
to O 0 4.747018635953282e-07
reduce O 0 9.486078852205537e-06
the O 0 5.415369059846853e-07
efficiency O 0 3.816716343862936e-06
of O 0 9.736280617289594e-07
cleavage O 0 0.0041535091586411
by O 0 2.161110023735091e-05
signal O 0 0.00027961962041445076
peptidases O 0 0.0020300159230828285
. O 0 3.0665942176710814e-05
. O 0 6.51561567792669e-05

Genetic O 0 0.000949614099226892
heterogeneity O 0 0.0008165575563907623
of O 0 6.743348058080301e-05
Saethre B-Disease 1 0.9985089898109436
- I-Disease 1 0.9994014501571655
Chotzen I-Disease 1 0.999453604221344
syndrome I-Disease 1 0.9999988079071045
, O 0 7.025273225735873e-05
due O 0 0.0007470896816812456
to O 0 7.341580840147799e-06
TWIST O 0 0.0020772023126482964
and O 0 3.657715205918066e-05
FGFR O 1 0.7757788300514221
mutations O 0 0.0015825319569557905
. O 0 0.000226520947762765

Thirty O 0 0.0010971204610541463
- O 0 0.0020050329621881247
two O 0 1.862782119133044e-05
unrelated O 0 0.03171428292989731
patients O 1 0.9935466647148132
with O 0 1.0298664165020455e-05
features O 0 4.568450458464213e-05
of O 0 3.7581285141641274e-05
Saethre B-Disease 1 0.999100923538208
- I-Disease 1 0.9995602965354919
Chotzen I-Disease 1 0.9994837045669556
syndrome I-Disease 1 0.9999985694885254
, O 0 6.444958853535354e-05
a O 0 0.000212053710129112
common O 0 0.004262696951627731
autosomal B-Disease 1 0.9996832609176636
dominant I-Disease 1 0.9960278272628784
condition I-Disease 1 0.9998304843902588
of O 0 0.0008527316385880113
craniosynostosis B-Disease 1 0.9999865293502808
and O 0 0.021120596677064896
limb B-Disease 1 0.9999420642852783
anomalies I-Disease 1 0.9980431795120239
, O 0 2.2575693947146647e-05
were O 0 1.0321020454284735e-05
screened O 0 0.00015248454292304814
for O 0 2.26247630052967e-06
mutations O 0 4.2503816075623035e-05
in O 0 7.531206847488647e-06
TWIST O 0 0.0017604035092517734
, O 0 3.5255310649517924e-05
FGFR2 O 0 0.057401567697525024
, O 0 2.8262846171855927e-05
and O 0 2.0615516405086964e-05
FGFR3 O 0 0.3301851451396942
. O 0 0.00011400492076063529

Nine O 0 9.358503302792087e-05
novel O 0 0.00012030396464979276
and O 0 1.3094236237520818e-05
three O 0 3.0407607482629828e-05
recurrent O 1 0.9913300275802612
TWIST O 0 0.009336388669908047
mutations O 0 0.0002547898911871016
were O 0 1.3515080354409292e-05
found O 0 7.091254519764334e-05
in O 0 1.125471135310363e-05
12 O 0 4.879697007709183e-05
families O 0 2.885673166019842e-05
. O 0 6.483362085418776e-05

Seven O 0 7.552633906016126e-05
families O 0 2.020764623011928e-05
were O 0 8.379240171052516e-06
found O 0 1.5694606190663762e-05
to O 0 7.757126923024771e-07
have O 0 1.4441524172070785e-06
the O 0 1.2356036677374505e-05
FGFR3 O 0 0.020258408039808273
P250R O 0 0.0014291531406342983
mutation O 0 0.00012166723900008947
, O 0 2.0606612451956607e-06
and O 0 4.0994478922584676e-07
one O 0 5.860543978997157e-07
individual O 0 9.834433285504929e-07
was O 0 9.915669943438843e-05
found O 0 1.2111714568163734e-05
to O 0 5.139505674378597e-07
have O 0 9.944477596945944e-07
an O 0 1.008699655358214e-05
FGFR2 O 0 0.01631155051290989
VV269 O 0 0.0031207366846501827
- O 0 0.0006718195509165525
270 O 0 0.00015465597971342504
deletion O 0 0.0017783239018172026
. O 0 0.0001058411507983692

To O 0 5.570061603066279e-06
date O 0 2.3540738766314462e-05
, O 0 1.4480414165518596e-06
our O 0 6.26294536232308e-07
detection O 0 3.662654853542335e-05
rate O 0 1.613228778296616e-05
for O 0 1.6952061514530214e-06
TWIST O 0 0.00042884284630417824
or O 0 3.6930839996784925e-05
FGFR O 0 0.011190518736839294
mutations O 0 4.818298839381896e-05
is O 0 3.875437869282905e-06
68 O 0 3.8485311961267143e-05
% O 0 3.892064796673367e-06
in O 0 5.8025948419526685e-06
our O 0 3.7835816328879446e-05
Saethre B-Disease 1 0.9631171822547913
- I-Disease 1 0.9975524544715881
Chotzen I-Disease 1 0.9992969036102295
syndrome I-Disease 1 0.9999997615814209
patients O 1 0.9998095631599426
, O 0 3.840183126158081e-05
including O 0 1.160105693998048e-05
our O 0 2.51270776061574e-05
five O 0 0.0003012684755958617
patients O 1 0.9994183778762817
elsewhere O 0 0.00021357962395995855
reported O 0 0.0004536077321972698
with O 0 3.090453537879512e-05
TWIST O 0 0.019398566335439682
mutations O 0 0.0016867819940671325
. O 0 0.0001548981381347403

More O 0 1.8227361806566478e-06
than O 0 7.33260662855173e-07
35 O 0 6.438227501348592e-06
different O 0 5.087691192784405e-07
TWIST O 0 0.0008261363254860044
mutations O 0 6.129664689069614e-05
are O 0 4.097102817013365e-07
now O 0 6.94029995429446e-06
known O 0 1.369276378682116e-05
in O 0 2.0105660496483324e-06
the O 0 8.077211532508954e-06
literature O 0 3.599327465053648e-05
. O 0 0.00013328777276910841

The O 0 3.283595651737414e-05
most O 0 1.0802682481880765e-05
common O 0 4.0276223444379866e-05
phenotypic O 0 0.0001147868242696859
features O 0 2.9948014343972318e-05
, O 0 3.6109636312176008e-06
present O 0 2.9902003007009625e-06
in O 0 7.143339075810218e-07
more O 0 8.574166798780425e-08
than O 0 1.0802951777577618e-07
a O 0 1.4840157973594614e-06
third O 0 1.0027138159784954e-06
of O 0 4.876517891716503e-07
our O 0 1.7716774891596287e-05
patients O 1 0.8762568831443787
with O 0 2.294167825311888e-05
TWIST O 0 0.00532631017267704
mutations O 0 0.00032297614961862564
, O 0 6.1352166085271165e-06
are O 0 3.5471309729473433e-06
coronal B-Disease 0 0.010473966598510742
synostosis I-Disease 0 0.015835657715797424
, O 0 5.182870154385455e-05
brachycephaly B-Disease 0 0.007527219131588936
, O 0 6.48035784251988e-05
low B-Disease 0 0.3290744423866272
frontal I-Disease 1 0.9997910857200623
hairline I-Disease 1 0.9999895095825195
, O 0 0.003758865175768733
facial B-Disease 1 0.9996399879455566
asymmetry I-Disease 1 0.9746023416519165
, O 0 0.0023438301868736744
ptosis B-Disease 1 0.999795138835907
, O 0 0.00033531300141476095
hypertelorism B-Disease 1 0.9940423369407654
, O 0 7.270692003658041e-05
broad B-Disease 0 0.0015831347554922104
great I-Disease 0 0.0014764827210456133
toes I-Disease 1 0.983472466468811
, O 0 3.7388108466984704e-05
and O 0 3.241005470044911e-05
clinodactyly B-Disease 0 0.09729866683483124
. O 0 0.00015851238276809454

Significant O 0 0.0003041849413421005
intra O 0 0.0066201635636389256
- O 0 0.000924014369957149
and O 0 7.6041042120778e-06
interfamilial O 0 0.0005808895220980048
phenotypic O 0 0.00014627653581555933
variability O 0 0.00015739513037260622
is O 0 3.92249694414204e-06
present O 0 4.291157893021591e-06
for O 0 2.2951878690946614e-06
either O 0 4.138027725275606e-05
TWIST O 0 0.003450328018516302
mutations O 0 0.0005992984515614808
or O 0 0.00015987656661309302
FGFR O 1 0.8813807964324951
mutations O 0 0.0022839675657451153
. O 0 0.00023613963276147842

The O 0 2.4394321371801198e-05
overlap O 0 4.704085222329013e-05
in O 0 2.2019094103598036e-05
clinical O 0 0.0012148699024692178
features O 0 1.5016296856629197e-05
and O 0 2.0315653728175675e-06
the O 0 2.474731672919006e-06
presence O 0 8.892029654816724e-06
, O 0 1.0492967703612521e-06
in O 0 2.649853740877006e-07
the O 0 7.127545131879742e-07
same O 0 8.570468708057888e-07
genes O 0 1.952513912328868e-06
, O 0 2.73153261787229e-07
of O 0 1.1793797227710456e-07
mutations O 0 8.192117093130946e-06
for O 0 2.790299049593159e-07
more O 0 2.526539049085841e-07
than O 0 1.0944559107883833e-06
one O 0 1.5907877241261303e-05
craniosynostotic B-Disease 0 0.3625347912311554
condition I-Disease 1 0.9977694749832153
- O 0 0.00033104087924584746
such O 0 1.8617234900375479e-06
as O 0 3.5570737964008003e-05
Saethre B-Disease 0 0.01350608840584755
- I-Disease 0 0.001723665394820273
Chotzen I-Disease 0 0.0029419998172670603
, I-Disease 0 1.2844892808061559e-05
Crouzon I-Disease 0 0.00416663009673357
, I-Disease 0 3.268197178840637e-05
and I-Disease 0 0.0001195053118863143
Pfeiffer I-Disease 1 0.9989323019981384
syndromes I-Disease 1 0.9997324347496033
- O 0 0.004085156600922346
support O 0 6.730736913596047e-06
the O 0 4.779639766638866e-06
hypothesis O 0 6.440338620450348e-05
that O 0 2.904277835114044e-06
TWIST O 0 0.0003389306366443634
and O 0 5.0550102059787605e-06
FGFRs O 0 0.0004047229595016688
are O 0 1.2156004913776997e-07
components O 0 6.68245945689705e-07
of O 0 9.666928946217013e-08
the O 0 1.248189960278978e-06
same O 0 2.390980398558895e-06
molecular O 0 7.030446431599557e-05
pathway O 0 0.00011399491631891578
involved O 0 3.0900071124051465e-06
in O 0 8.882621500561072e-07
the O 0 2.00405747818877e-06
modulation O 0 4.6812670916551724e-05
of O 0 1.283929668716155e-05
craniofacial O 1 0.9996974468231201
and O 0 0.00016462047642562538
limb O 1 0.9987398982048035
development O 0 0.00011473889026092365
in O 0 4.0827246266417205e-05
humans O 0 0.0005953270592726767
. O 0 3.976811422035098e-05
. O 0 9.632702131057158e-05

Mutation O 0 0.00024990757810883224
analysis O 0 1.3791707715427037e-05
of O 0 3.041839590878226e-05
UBE3A O 1 0.9981861710548401
in O 1 0.9888116121292114
Angelman B-Disease 1 0.9999996423721313
syndrome I-Disease 1 1.0
patients O 1 0.9999662637710571
. O 0 0.0063104829750955105

Angelman B-Disease 1 0.9999982118606567
syndrome I-Disease 1 0.9999998807907104
( O 0 0.0076919482089579105
AS B-Disease 1 0.9941100478172302
) O 0 8.668791997479275e-05
is O 0 5.812263043480925e-05
caused O 0 0.006876211613416672
by O 0 3.1123396183829755e-05
chromosome O 0 0.0011632683454081416
15q11 O 0 0.004786420147866011
- O 0 0.0004896477912552655
q13 O 0 0.0002745156525634229
deletions O 0 1.4199377801560331e-05
of O 0 8.863936500347336e-07
maternal O 0 0.0013179790694266558
origin O 0 1.3602853869087994e-05
, O 0 1.3678863069799263e-05
by O 0 4.5579192374134436e-05
paternal O 0 0.07142528146505356
uniparental B-Disease 1 0.9962026476860046
disomy I-Disease 1 0.9597495198249817
( O 0 0.0007927548140287399
UPD B-Disease 1 0.9970515966415405
) O 0 2.8832526368205436e-05
15 O 0 2.2563899619854055e-05
, O 0 6.332708835543599e-06
by O 0 3.1208517611958086e-05
imprinting O 0 0.15545684099197388
defects O 1 0.9996139407157898
, O 0 6.311732704489259e-06
and O 0 1.2155371678090887e-06
by O 0 8.093018550425768e-06
mutations O 0 5.462541594170034e-05
in O 0 5.912612323299982e-06
the O 0 7.264587475219741e-05
UBE3A O 1 0.7685320377349854
gene O 0 0.0008375595207326114
. O 0 7.114100299077109e-05

UBE3A O 0 0.019120225682854652
encodes O 0 8.919440006138757e-05
a O 0 5.6324708566535264e-05
ubiquitin O 0 0.0008464680868200958
- O 0 0.00019836645515169948
protein O 0 2.401274468866177e-05
ligase O 0 0.0001714771642582491
and O 0 4.451786026038462e-06
shows O 0 0.0001170963078038767
brain O 1 0.9927614331245422
- O 0 0.0006949029047973454
specific O 0 2.0311517801019363e-05
imprinting O 0 0.004727881867438555
. O 0 0.00028283329447731376

Here O 0 6.976603617658839e-05
we O 0 3.2881844163057394e-06
describe O 0 9.050580410985276e-05
UBE3A O 0 0.033911459147930145
coding O 0 0.0014007262652739882
- O 0 0.0005544120213016868
region O 0 3.0760194931644946e-05
mutations O 0 0.00011900497338501737
detected O 0 0.00035774585558101535
by O 0 7.747554263914935e-06
SSCP O 0 0.005517195910215378
analysis O 0 7.958329661050811e-06
in O 0 1.0098718121298589e-05
13 O 0 0.00012811699707526714
AS B-Disease 0 0.004401590209454298
individuals O 0 9.885598046821542e-06
or O 0 7.755451952107251e-05
families O 0 7.378212467301637e-05
. O 0 0.00014389703574124724

Two O 0 1.0352704521210399e-05
identical O 0 0.00014746242959517986
de O 0 0.00013721143477596343
novo O 0 0.0002033249766100198
5 O 0 5.6512693845434114e-05
- O 0 0.00018631367129273713
bp O 0 0.00018150753749068826
duplications O 0 4.6953369746915996e-05
in O 0 5.141229848959483e-06
exon O 0 0.0004443202051334083
16 O 0 5.8400426496518776e-05
were O 0 1.3362099707592279e-05
found O 0 0.00013059470802545547
. O 0 5.875576243852265e-05

Among O 0 9.30926762521267e-06
the O 0 3.27839939018304e-06
other O 0 8.128188824230165e-07
11 O 0 2.1735257178079337e-05
unique O 0 3.084374839090742e-06
mutations O 0 6.7307693825569e-05
, O 0 3.179203986292123e-06
8 O 0 7.38185099180555e-06
were O 0 1.8733445585894515e-06
small O 0 3.984115664934507e-06
deletions O 0 3.790392293012701e-05
or O 0 7.218186055979459e-06
insertions O 0 0.00010140804806724191
predicted O 0 0.0001794047566363588
to O 0 6.043636858521495e-06
cause O 0 0.0032511914614588022
frameshifts O 0 0.004350237548351288
, O 0 6.696330274280626e-06
1 O 0 1.1339003322063945e-05
was O 0 2.282708192069549e-05
a O 0 4.005269602203043e-06
mutation O 0 4.079435711901169e-06
to O 0 6.134813901326197e-08
a O 0 1.5206182979454752e-06
stop O 0 3.4461581890354864e-06
codon O 0 2.6974157663062215e-06
, O 0 4.350168580913305e-07
1 O 0 2.037422973444336e-06
was O 0 1.0708501577028073e-05
a O 0 7.469463071174687e-06
missense O 0 0.00010820833995239809
mutation O 0 3.2780139008536935e-05
, O 0 2.264017439301824e-06
and O 0 1.943811412274954e-06
1 O 0 1.6419759049313143e-05
was O 0 0.0001506320113549009
predicted O 0 8.194933616323397e-05
to O 0 1.097589574783342e-06
cause O 0 0.00019986533152405173
insertion O 0 3.618079790612683e-05
of O 0 6.02683144279581e-07
an O 0 1.927697485371027e-05
isoleucine O 0 0.0019323952728882432
in O 0 3.428103354963241e-06
the O 0 6.750291049684165e-06
hect O 0 0.0003880986769217998
domain O 0 4.616501882992452e-06
of O 0 5.557140525525028e-07
the O 0 2.1320312953321263e-05
UBE3A O 0 0.01569230481982231
protein O 0 2.6732088372227736e-05
, O 0 7.537448141192726e-07
which O 0 1.2262545112662337e-07
functions O 0 4.231554555644834e-07
in O 0 2.578004796305322e-06
E2 O 0 0.0026010044384747744
binding O 0 1.3432509149424732e-05
and O 0 3.3429230370529694e-06
ubiquitin O 0 0.0004326254711486399
transfer O 0 5.0674763770075515e-05
. O 0 8.472284389426932e-05

Eight O 0 1.339638311037561e-05
of O 0 1.7612666169952718e-06
the O 0 4.561445894069038e-05
cases O 0 0.0006607537507079542
were O 0 2.8788674171664752e-05
familial O 1 0.984211266040802
, O 0 1.3669226973433979e-05
and O 0 3.0373296340258094e-06
five O 0 8.92112893779995e-06
were O 0 2.5579973225831054e-05
sporadic O 0 0.002575930207967758
. O 0 0.00021430765627883375

In O 0 5.535579475690611e-05
two O 0 6.342056440189481e-05
familial O 1 0.9981439113616943
cases O 0 0.0017795718740671873
and O 0 1.3742632290814072e-05
one O 0 1.802973019948695e-05
sporadic O 0 0.002627059817314148
case O 0 0.0011617816053330898
, O 0 4.150057793594897e-05
mosaicism O 0 0.03958146646618843
for O 0 3.2292264222633094e-05
UBE3A O 1 0.7629035115242004
mutations O 0 0.0006702604005113244
was O 0 0.0005898102535866201
detected O 0 0.0004110769077669829
in O 0 1.7122993085649796e-06
the O 0 3.1482966278417734e-06
mother O 0 8.864553092280403e-05
of O 0 5.869107440048538e-07
three O 0 1.2594591680681333e-05
AS B-Disease 0 0.06006330996751785
sons O 0 0.0006439893040806055
, O 0 3.556588353603729e-06
in O 0 2.1736830149166053e-06
the O 0 7.385583103314275e-06
maternal O 0 0.0009583799401298165
grandfather O 0 0.00014753892901353538
of O 0 3.6069840803065745e-07
two O 0 4.3716386244341265e-06
AS B-Disease 0 0.0015985164791345596
first O 0 9.758992746355943e-06
cousins O 0 0.00010082469088956714
, O 0 1.9497711036819965e-06
and O 0 6.508794285764452e-07
in O 0 1.1126137451356044e-06
the O 0 3.664160203697975e-06
mother O 0 0.00011671950778691098
of O 0 8.646391052025137e-07
an O 0 9.627576946513727e-05
AS B-Disease 1 0.7822117805480957
daughter O 0 0.27278923988342285
. O 0 0.00016418092127423733

The O 0 7.385301614704076e-06
frequencies O 0 1.4692702734464547e-06
with O 0 2.021540694840951e-06
which O 0 1.2960073263457161e-06
we O 0 1.9668802906380733e-06
detected O 0 0.00016896887973416597
mutations O 0 1.0550378647167236e-05
were O 0 1.6166702607733896e-06
5 O 0 5.72647832086659e-06
( O 0 1.6131803022290114e-06
14 O 0 3.227849902032176e-06
% O 0 9.067580890587124e-07
) O 0 2.208417839710819e-07
of O 0 6.870560298466444e-08
35 O 0 8.454474482277874e-06
in O 0 4.7328744585684035e-06
sporadic O 0 0.0003089624806307256
cases O 0 9.313873306382447e-05
and O 0 3.557673835530295e-06
8 O 0 1.8535427443566732e-05
( O 0 3.5351354199519847e-06
80 O 0 3.996909526904346e-06
% O 0 6.877574492136773e-07
) O 0 1.8455031636221975e-07
of O 0 1.4998315123193606e-07
10 O 0 9.686023076938e-06
in O 0 2.0126140952925198e-05
familial O 1 0.9982695579528809
cases O 0 0.006985125597566366
. O 0 6.51234295219183e-05
. O 0 0.00013850571122020483

The O 0 0.0016891621053218842
hemochromatosis B-Disease 1 0.9998539686203003
845 O 0 0.3875647783279419
G O 0 0.13827678561210632
- O 0 0.003779939142987132
- O 0 0.00017765379743650556
> O 0 5.4670490499120206e-05
A O 0 7.833468771423213e-06
and O 0 7.89474768225773e-07
187 O 0 1.7984102669288404e-05
C O 0 0.000309472787193954
- O 0 0.00015315733617171645
- O 0 6.738630327163264e-05
> O 0 7.840057514840737e-05
G O 0 0.000322177802445367
mutations O 0 4.036850805277936e-05
: O 0 7.500807441829238e-06
prevalence O 0 0.0031531716231256723
in O 0 1.099589735531481e-05
non O 0 0.0004035871534142643
- O 0 0.0051052263006567955
Caucasian O 0 0.002008314011618495
populations O 0 0.00011819714563898742
. O 0 7.111671584425494e-05

Hemochromatosis B-Disease 1 0.9996201992034912
, O 0 0.0006446648621931672
the O 0 0.006712890695780516
inherited B-Disease 1 0.9999905824661255
disorder I-Disease 1 0.9999978542327881
of I-Disease 0 0.0002447892911732197
iron I-Disease 1 0.9999773502349854
metabolism I-Disease 1 0.9979608058929443
, O 0 4.7760688175912946e-05
leads O 0 0.0006743238773196936
, O 0 5.691377373295836e-05
if O 0 0.000295305741019547
untreated O 1 0.999452531337738
, O 0 1.522114598628832e-05
to O 0 1.2308241821301635e-05
progressive O 1 0.6597029566764832
iron B-Disease 1 0.9998242259025574
overload I-Disease 1 0.9995550513267517
and O 0 0.0006368715548887849
premature B-Disease 1 0.9984941482543945
death I-Disease 1 0.6549103856086731
. O 0 0.0003580360789783299

The O 0 0.004456741735339165
hemochromatosis B-Disease 1 0.9999693632125854
gene O 0 0.005619396921247244
, O 0 0.00020662428869400173
HFE O 1 0.9962170720100403
, O 0 6.300974200712517e-05
recently O 0 0.0014361412031576037
has O 0 3.1385985494125634e-05
been O 0 2.0870780645054765e-05
identified O 0 3.249977817176841e-05
, O 0 1.5242859490172123e-06
and O 0 5.076365141576389e-07
characterization O 0 1.3640578799822833e-05
of O 0 2.540717503052292e-07
this O 0 4.373339834273793e-06
gene O 0 7.023986836429685e-05
has O 0 9.722985851112753e-06
shown O 0 7.0798309934616555e-06
that O 0 2.958528568797192e-07
it O 0 2.25533639763853e-07
contains O 0 5.692229478881927e-07
two O 0 4.998844929104962e-07
mutations O 0 1.3735923857893795e-05
that O 0 4.6161622435647587e-07
result O 0 4.828219971386716e-06
in O 0 1.1527544074851903e-06
amino O 0 1.3395693713391665e-05
acid O 0 0.0005297873867675662
substitutions O 0 1.928637175296899e-05
- O 0 2.38215179706458e-05
cDNA O 0 1.3955689610156696e-05
nucleotides O 0 3.2981635740725324e-05
845 O 0 0.0011130054481327534
G O 0 0.0018396981758996844
- O 0 0.0005771530559286475
- O 0 0.00014779562479816377
> O 0 4.483238444663584e-05
A O 0 1.830041583161801e-05
( O 0 4.023619567306014e-06
C282Y O 0 7.168731099227443e-05
) O 0 8.114093930089439e-07
and O 0 7.827276817806705e-07
187 O 0 2.9827109756297432e-05
C O 0 0.0003111594123765826
- O 0 0.00022554599854629487
- O 0 0.0001264471939066425
> O 0 0.0001649184850975871
G O 0 0.00039138045394793153
( O 0 2.0023146134917624e-05
H63D O 0 0.004706030711531639
) O 0 2.1932670279056765e-05
. O 0 5.0637761887628585e-05

Although O 0 0.025652490556240082
hemochromatosis B-Disease 1 0.9999864101409912
is O 0 0.00011859816731885076
common O 0 0.0001423489156877622
in O 0 3.482133615761995e-05
Caucasians O 0 0.0049196104519069195
, O 0 1.2377548046060838e-05
affecting O 0 0.00016057214816100895
> O 0 0.001200593775138259
= O 0 0.00020693168335128576
1 O 0 2.5207840735674836e-05
/ O 0 4.369626549305394e-05
300 O 0 7.842010631975427e-07
individuals O 0 1.3331612080946798e-07
of O 0 9.951917689932088e-08
northern O 0 4.496690507949097e-06
European O 0 5.02193734064349e-06
origin O 0 3.465781446720939e-06
, O 0 3.682067244881182e-06
it O 0 1.7686727460386464e-06
has O 0 1.4568482811228023e-06
not O 0 4.449594257494027e-07
been O 0 2.0723994111904176e-06
recognized O 0 3.0046362553548533e-06
in O 0 1.5441037248820066e-06
other O 0 4.279020686226431e-06
populations O 0 0.00012124104978283867
. O 0 0.00011093471403000876

The O 0 1.675406383583322e-05
present O 0 1.764839544193819e-05
study O 0 1.3523306733986828e-05
used O 0 9.859800229605753e-06
PCR O 0 0.00019301468273624778
and O 0 2.4881921945052454e-06
restriction O 0 8.55426987982355e-05
- O 0 0.0001203517967951484
enzyme O 0 7.031666609691456e-05
digestion O 0 6.454664253396913e-05
to O 0 1.079108997714684e-07
analyze O 0 7.416345511046529e-07
the O 0 1.2372683499961568e-07
frequency O 0 1.6046739403918764e-07
of O 0 5.964102456346154e-08
the O 0 7.2556481427454855e-06
845 O 0 0.001561510725878179
G O 0 0.0019542137160897255
- O 0 0.00036746810656040907
- O 0 4.1763920307857916e-05
> O 0 2.0495723219937645e-05
A O 0 4.314917987358058e-06
and O 0 8.446565402664419e-07
187 O 0 3.781424311455339e-05
C O 0 0.000296518875984475
- O 0 0.00015134150453377515
- O 0 5.508323374669999e-05
> O 0 5.992013757349923e-05
G O 0 0.00018502752936910838
mutations O 0 2.8695645596599206e-05
in O 0 5.338842584023951e-06
HLA O 0 0.06320586800575256
- O 0 4.693707523983903e-05
typed O 0 1.6008592865546234e-05
samples O 0 5.069841336080572e-06
from O 0 9.881253390631173e-06
non O 0 0.00013927039981354028
- O 0 0.001293118461035192
Caucasian O 0 0.0006636811885982752
populations O 0 1.2182424143247772e-05
, O 0 2.965623707495979e-06
comprising O 0 1.1161504517076537e-05
Australian O 0 0.00021140305034350604
Aboriginal O 0 0.00015784738934598863
, O 0 1.481177423556801e-05
Chinese O 0 2.333552583877463e-05
, O 0 6.479941475845408e-06
and O 0 7.487707080144901e-06
Pacific O 0 0.0005637145950458944
Islanders O 0 0.0008396591292694211
. O 0 0.00015788062592037022

Results O 0 0.0002118986885761842
showed O 0 9.150088590104133e-05
that O 0 9.532441254123114e-07
the O 0 7.85346310294699e-06
845 O 0 0.002332086209207773
G O 0 0.004624601453542709
- O 0 0.0007666349993087351
- O 0 0.00013924544327892363
> O 0 5.389131183619611e-05
A O 0 1.9669681933009997e-05
mutation O 0 1.957581662281882e-05
was O 0 1.7042844774550758e-05
present O 0 2.0365353066154057e-06
in O 0 1.4213885606295662e-06
these O 0 3.3034493185368774e-07
populations O 0 2.684696937649278e-06
( O 0 8.113397029774205e-07
allele O 0 1.6330336620740127e-06
frequency O 0 1.0030103112512734e-06
0 O 0 1.942040171343251e-06
. O 0 6.400556458174833e-07
32 O 0 2.7876496915268945e-06
% O 0 1.5759104599055718e-06
) O 0 1.6950963299677824e-06
, O 0 5.831320208926627e-07
and O 0 4.622607150395197e-07
, O 0 1.470426695959759e-06
furthermore O 0 1.800986319722142e-05
, O 0 1.3836877315043239e-06
it O 0 1.5301453686333844e-06
was O 0 6.194318848429248e-05
always O 0 5.254909410723485e-06
seen O 0 1.2726692148135044e-05
in O 0 1.2840737326769158e-06
conjunction O 0 6.785237201256678e-05
with O 0 5.081074050394818e-05
HLA O 1 0.9974644184112549
haplotypes O 0 0.0024314005859196186
common O 0 9.849909838521853e-05
in O 0 4.8075955419335514e-05
Caucasians O 0 0.006771697662770748
, O 0 2.3350019546342082e-05
suggesting O 0 0.00026564585277810693
that O 0 9.12318046175642e-06
845 O 0 0.008182487450540066
G O 0 0.03238047659397125
- O 0 0.0055007110349833965
- O 0 0.0005708067328669131
> O 0 0.00023502734256908298
A O 0 0.0001231818023370579
may O 0 2.9003120289416984e-05
have O 0 9.289403806178598e-07
been O 0 2.1936102712061256e-06
introduced O 0 8.634336268187326e-07
into O 0 4.5858772068640974e-07
these O 0 3.6868948427581927e-07
populations O 0 8.237665497290436e-06
by O 0 1.7150749044958502e-05
Caucasian O 0 0.011524717323482037
admixture O 0 0.02340635657310486
. O 0 0.000426950806286186

187 O 0 0.0009655221947468817
C O 0 0.0029571237973868847
- O 0 0.0010405376087874174
- O 0 0.00022674545471090823
> O 0 0.00010400047176517546
G O 0 0.00015375447401311249
was O 0 1.2928094292874448e-05
present O 0 1.299316522818117e-06
at O 0 2.7142664293933194e-06
an O 0 5.178373498893052e-07
allele O 0 2.199523805757053e-06
frequency O 0 6.799990046602034e-07
of O 0 3.587207686450711e-07
2 O 0 9.942208998836577e-05
. O 0 5.102793511468917e-05

68 O 0 0.00038430929998867214
% O 0 8.25522693048697e-06
in O 0 1.853552930697333e-06
the O 0 2.097503738696105e-06
two O 0 1.6827231092975126e-06
populations O 0 2.4953567844931968e-05
analyzed O 0 7.127232674974948e-05
( O 0 8.50294964038767e-06
Australian O 0 5.7155266404151917e-05
Aboriginal O 0 4.778561196872033e-05
and O 0 6.643205324508017e-06
Chinese O 0 5.507545574801043e-05
) O 0 4.955639087711461e-05
. O 0 5.3113708418095484e-05

In O 0 1.925338619912509e-05
the O 0 1.061297552951146e-05
Australian O 0 9.121584298554808e-05
Aboriginal O 0 3.0051896828808822e-05
samples O 0 1.8977632862515748e-05
, O 0 4.165492555330275e-06
187 O 0 6.384307198459283e-05
C O 0 0.0004664188309106976
- O 0 0.0003591350687202066
- O 0 0.00012488881475292146
> O 0 0.0001032233121804893
G O 0 0.0001875342131825164
was O 0 3.4103268262697384e-05
found O 0 3.6187100249662763e-06
to O 0 2.641895378019399e-07
be O 0 1.0960018244077219e-06
associated O 0 1.3560887055064086e-05
with O 0 3.464313704171218e-05
HLA O 1 0.9986520409584045
haplotypes O 0 0.002250057877972722
common O 0 0.0003331936022732407
in O 0 9.400576527696103e-05
Caucasians O 0 0.030518077313899994
, O 0 1.7339843907393515e-05
suggesting O 0 0.00012033664825139567
that O 0 1.7781488850232563e-06
it O 0 2.05457422453037e-06
was O 0 4.422861093189567e-05
introduced O 0 1.0607450349198189e-05
by O 0 7.260105121531524e-06
recent O 0 0.00014241419557947665
admixture O 0 0.005027328617870808
. O 0 0.00022138490749057382

In O 0 1.0426341759739444e-05
the O 0 3.434550080783083e-06
Chinese O 0 4.898125553154387e-06
samples O 0 9.668285201769322e-06
analyzed O 0 2.178208887926303e-05
, O 0 3.642152478278149e-06
187 O 0 5.459547173813917e-05
C O 0 0.0006897610728628933
- O 0 0.0004416263836901635
- O 0 0.00013264495646581054
> O 0 0.00011485843424452469
G O 0 0.00022589979926124215
was O 0 3.465946429059841e-05
present O 0 5.118007265991764e-06
in O 0 5.023245194024639e-06
association O 0 6.19311977061443e-05
with O 0 1.1547140275069978e-06
a O 0 1.0460321391292382e-05
wide O 0 6.181684057082748e-06
variety O 0 6.5840126808325294e-06
of O 0 4.713847829407314e-06
HLA O 1 0.999329686164856
haplotypes O 0 0.001960891531780362
, O 0 7.329409527301323e-06
showing O 0 3.3556636481080204e-05
this O 0 1.4538309187628329e-06
mutation O 0 2.6916624847217463e-05
to O 0 7.775613539706683e-07
be O 0 2.955284344352549e-06
widespread O 0 2.3661650629946962e-05
and O 0 1.768433207871567e-06
likely O 0 9.18562727747485e-06
to O 0 4.991375703866652e-07
predate O 0 0.0001011122003546916
the O 0 1.5818339988982189e-06
more O 0 7.027576884865994e-07
genetically O 0 6.115418364061043e-05
restricted O 0 4.9797519750427455e-05
845 O 0 0.004378296434879303
G O 0 0.01847955398261547
- O 0 0.004220222122967243
- O 0 0.0002963032457046211
> O 0 0.00010695689707063138
A O 0 9.630377462599427e-05
mutation O 0 0.00022159061336424202
. O 0 3.548254244378768e-05

Genotype O 0 0.014403019100427628
- O 0 0.008510023355484009
phenotype O 0 0.0020142318680882454
correlations O 0 0.0005769943818449974
in O 0 0.0007540304795838892
attenuated B-Disease 1 0.9988025426864624
adenomatous I-Disease 1 0.9999687671661377
polyposis I-Disease 1 0.9999758005142212
coli I-Disease 1 0.9999450445175171
. O 0 0.0033661071211099625

Germ O 1 0.9920136332511902
- O 0 0.001633628737181425
line O 0 4.1016319300979376e-05
mutations O 0 1.1538142643985339e-05
of O 0 1.171218286799558e-06
the O 0 0.0002863810514099896
tumor B-Disease 1 0.9997166991233826
suppressor O 0 0.0382162369787693
APC O 0 0.014097493141889572
are O 0 1.020711351884529e-05
implicated O 0 0.07801079005002975
in O 0 0.0007885645609349012
attenuated B-Disease 1 0.9992436170578003
adenomatous I-Disease 1 0.9999915361404419
polyposis I-Disease 1 0.9999904632568359
coli I-Disease 1 0.9999799728393555
( O 0 0.037044886499643326
AAPC B-Disease 1 0.9998138546943665
) O 0 4.5939465053379536e-05
, O 0 6.426112122426275e-06
a O 0 5.943266296526417e-05
variant O 0 0.08750632405281067
of O 0 0.00012784435239154845
familial B-Disease 1 0.9999920129776001
adenomatous I-Disease 1 0.999992847442627
polyposis I-Disease 1 0.9999970197677612
( O 1 0.5382086038589478
FAP B-Disease 1 0.9991624355316162
) O 0 0.00036480388371273875
. O 0 0.000159777031512931

AAPC B-Disease 1 0.9955520033836365
is O 0 2.1757838112534955e-05
recognized O 0 1.0279489288222976e-05
by O 0 3.2203690807364183e-06
the O 0 6.039153959136456e-06
occurrence O 0 0.00012874524691142142
of O 0 5.224642336543184e-06
< O 0 0.017756540328264236
100 O 0 0.00017136601672973484
colonic B-Disease 1 0.9925351142883301
adenomas I-Disease 1 0.9689101576805115
and O 0 7.676011591684073e-06
a O 0 7.940374780446291e-05
later O 0 0.000784427160397172
onset O 1 0.9998304843902588
of O 0 0.15030354261398315
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
( O 0 0.0003076515276916325
age O 0 0.0040377420373260975
> O 0 0.0024902026634663343
40 O 0 2.700151890167035e-05
years O 0 5.85737252549734e-05
) O 0 1.3742317605647258e-05
. O 0 2.6884430553764105e-05

The O 0 1.0697263860492967e-05
aim O 0 4.454419013200095e-06
of O 0 1.7737306734488811e-07
this O 0 2.21512209463981e-06
study O 0 1.0345835107727908e-05
was O 0 4.840931069338694e-05
to O 0 1.8780472146318061e-06
assess O 0 0.00011362267832737416
genotype O 0 0.0013727727346122265
- O 0 0.00172355305403471
phenotype O 0 0.0010604150593280792
correlations O 0 0.00028970971470698714
in O 0 0.00029432057635858655
AAPC B-Disease 1 0.9979839324951172
families O 0 0.0005485534784384072
. O 0 0.00023823531228117645

By O 0 5.396948108682409e-05
protein O 0 0.00031261282856576145
- O 0 0.000463423173641786
truncation O 0 0.00029933653422631323
test O 0 2.707712337723933e-05
( O 0 4.071654529980151e-06
PTT O 0 5.944264557911083e-05
) O 0 1.032900740938203e-06
assay O 0 1.013723885989748e-05
, O 0 5.025809741709963e-07
the O 0 5.839361278958677e-07
entire O 0 1.1175201507285237e-05
coding O 0 3.6289442505221814e-05
region O 0 7.622006705787499e-07
of O 0 3.73694916788736e-07
the O 0 2.5881841793307103e-05
APC B-Disease 0 0.014902344904839993
gene O 0 0.00011806130351033062
was O 0 0.00023439357755705714
screened O 0 0.00020165089517831802
in O 0 8.088280992524233e-06
affected O 0 8.521329436916858e-05
individuals O 0 1.2596273336384911e-05
from O 0 8.351809083251283e-05
11 O 0 0.0038551653269678354
AAPC B-Disease 1 0.9985588192939758
kindreds O 0 0.011081485077738762
, O 0 8.748281288717408e-06
and O 0 1.6542605862923665e-06
their O 0 9.612998610464274e-07
phenotypic O 0 0.00017493921041022986
differences O 0 0.0001775349082890898
were O 0 8.391725714318454e-05
examined O 0 0.015753943473100662
. O 0 0.00021294987527653575

Five O 0 0.00016191376198548824
novel O 0 0.0019335016841068864
germ O 1 0.9952131509780884
- O 0 0.005335977301001549
line O 0 0.0003632263105828315
APC B-Disease 0 0.00787761528044939
mutations O 0 9.808462345972657e-05
were O 0 7.23870107322e-06
identified O 0 5.264880746835843e-05
in O 0 4.781016286869999e-06
seven O 0 4.054806777276099e-05
kindreds O 0 0.009767056442797184
. O 0 0.0002616998099256307

Mutations O 0 0.0006770050968043506
were O 0 9.927999599312898e-06
located O 0 8.998767953016795e-06
in O 0 7.843963203413296e-07
three O 0 2.5926675562004675e-07
different O 0 5.758048615689404e-08
regions O 0 3.979411360433005e-07
of O 0 3.1790872867532016e-07
the O 0 2.8948901672265492e-05
APC B-Disease 0 0.006811917293816805
gene O 0 3.880548683810048e-05
( O 0 4.5413989937515e-06
1 O 0 5.43207306691329e-06
) O 0 9.843779480434023e-07
at O 0 2.3987981876416598e-06
the O 0 1.128084591073275e-06
5 O 0 3.4577590213302756e-06
end O 0 7.034952432150021e-06
spanning O 0 1.6690435586497188e-05
exons O 0 2.72188972303411e-05
4 O 0 1.4468003428191878e-05
and O 0 1.8588636976346606e-06
5 O 0 4.486966190597741e-06
, O 0 9.332888453172927e-07
( O 0 9.458855174671044e-07
2 O 0 1.1759378821807331e-06
) O 0 2.0296606351166702e-07
within O 0 2.644476637669868e-07
exon O 0 9.731853060657158e-05
9 O 0 1.575555324961897e-05
, O 0 9.915405598803773e-07
and O 0 4.7309072215284687e-07
( O 0 1.9103385966445785e-06
3 O 0 3.327052354507032e-06
) O 0 5.221511969466519e-07
at O 0 1.9946116935898317e-06
the O 0 1.214015014738834e-06
3 O 0 1.0299616405973211e-05
distal O 0 0.0006145755760371685
end O 0 1.0606822797853965e-05
of O 0 5.856303459950141e-07
the O 0 1.9500836060615256e-05
gene O 0 0.0002647394430823624
. O 0 5.342302029021084e-05

Variability O 0 0.00033701382926665246
in O 0 4.12899089496932e-06
the O 0 8.415164302277844e-06
number O 0 1.0631837540131528e-05
of O 0 0.0006168839754536748
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999867677688599
was O 0 0.051701948046684265
most O 0 2.0413035599631257e-05
apparent O 0 0.0016289822524413466
in O 0 3.9403062146448065e-06
individuals O 0 2.5856870706775226e-06
with O 0 7.327801540668588e-06
mutations O 0 7.116027700249106e-05
in O 0 5.949939350102795e-06
region O 0 1.460777912143385e-05
1 O 0 2.7718429919332266e-05
, O 0 5.775168574473355e-06
and O 0 1.7753036445355974e-05
upper O 1 0.9990972280502319
- O 1 0.9993059635162354
gastrointestinal O 1 0.9999313354492188
manifestations O 0 0.05307745933532715
were O 0 6.403239967767149e-05
more O 0 3.901916352333501e-05
severe O 1 0.9998878240585327
in O 0 4.018269100924954e-05
them O 0 1.273158432013588e-05
. O 0 0.0001737595594022423

In O 0 3.538138116709888e-05
individuals O 0 7.310225555556826e-06
with O 0 7.914522939245217e-06
mutations O 0 0.0001594680652488023
in O 0 7.203772838693112e-06
either O 0 1.399638222210342e-05
region O 0 9.539621714793611e-06
2 O 0 1.6842623153934255e-05
or O 0 5.479738774738507e-06
region O 0 3.589429525163723e-06
3 O 0 3.2225011636910494e-06
, O 0 5.409892196439614e-07
the O 0 7.893242468526296e-07
average O 0 5.823861101816874e-06
number O 0 4.849123911299102e-07
of O 0 2.833250164258061e-06
adenomas B-Disease 1 0.9938680529594421
tended O 0 0.00015601269842591137
to O 0 1.4398947314475663e-06
be O 0 2.9962977805553237e-06
lower O 0 0.00013423826021607965
than O 0 6.528725862153806e-07
those O 0 8.147840730998723e-07
in O 0 1.8157028307541623e-06
individuals O 0 9.254759447685501e-07
with O 0 3.276602456026012e-06
mutations O 0 7.387758523691446e-05
in O 0 5.44768863619538e-06
region O 0 1.3635870345751755e-05
1 O 0 3.477215432212688e-05
, O 0 4.3284694584144745e-06
although O 0 1.8133967387257144e-05
age O 0 0.0004186003061477095
at O 0 0.001676361309364438
diagnosis O 1 0.9996035695075989
was O 0 0.001041015493683517
similar O 0 8.175114635378122e-05
. O 0 0.0001820780016714707

In O 0 9.311236499343067e-05
all O 0 3.71552596334368e-05
AAPC B-Disease 1 0.9956985712051392
kindreds O 0 0.004452727735042572
, O 0 8.520905794284772e-06
a O 0 3.107007432845421e-05
predominance O 0 0.0002967773762065917
of O 0 9.123536983679514e-06
right O 0 0.1227017268538475
- O 1 0.999131977558136
sided O 1 0.9998376369476318
colorectal B-Disease 1 0.9999998807907104
adenomas I-Disease 1 0.9999808073043823
and O 0 0.04040369391441345
rectal B-Disease 1 0.9999861717224121
polyp I-Disease 1 0.9998558759689331
sparing O 0 0.07328305393457413
was O 0 0.0032497921492904425
observed O 0 0.0003866871993523091
. O 0 0.00011089822510257363

No O 0 0.004931983537971973
desmoid B-Disease 1 0.9961447715759277
tumors I-Disease 1 0.9999773502349854
were O 0 5.458500891108997e-05
found O 0 5.467273513204418e-05
in O 0 5.507312380359508e-06
these O 0 5.331103693606565e-06
kindreds O 0 0.007151634432375431
. O 0 0.00012796156806871295

Our O 0 1.020522540784441e-05
data O 0 1.747263922879938e-05
suggest O 0 2.4036433387664147e-05
that O 0 3.3951259865716565e-06
, O 0 6.8154558903188445e-06
in O 0 3.897371425409801e-05
AAPC B-Disease 1 0.9972116351127625
families O 0 1.546518979012035e-05
, O 0 1.4705473176945816e-06
the O 0 6.02518184678047e-07
location O 0 3.026238573511364e-06
of O 0 5.774369356004172e-07
the O 0 6.141565245343372e-05
APC B-Disease 1 0.7858555316925049
mutation O 0 0.0015932542737573385
may O 0 0.0003743392589967698
partially O 0 0.002119929762557149
predict O 0 6.275584746617824e-05
specific O 0 5.33823686055257e-06
phenotypic O 0 0.00027398328529670835
expression O 0 0.0002679174649529159
. O 0 0.00018969208758790046

This O 0 4.3106815610371996e-06
should O 0 3.6430658383324044e-06
help O 0 1.1334310556776472e-06
in O 0 4.651790561638336e-07
the O 0 1.4838147990303696e-06
design O 0 7.628240837220801e-06
of O 0 1.6173549965969869e-06
tailored O 0 0.002106935018673539
clinical O 1 0.5407575964927673
- O 0 0.02433161437511444
management O 0 0.00021201407071202993
protocols O 0 8.62081433297135e-05
in O 0 1.8388411717751296e-06
this O 0 1.6525103774256422e-06
subset O 0 4.455899397726171e-05
of O 0 4.658861507778056e-05
FAP B-Disease 1 0.9998766183853149
patients O 1 0.9997206330299377
. O 0 9.096602298086509e-05
. O 0 0.0001883727527456358

Wilms B-Disease 1 0.9992208480834961
' I-Disease 0 0.323703408241272
tumor I-Disease 1 0.997892439365387
1 O 0 6.0465852584457025e-05
and O 0 9.523768312647007e-06
Dax O 0 0.019052522256970406
- O 0 0.00011134899978060275
1 O 0 6.7221280914964154e-06
modulate O 0 9.349637548439205e-05
the O 0 1.1345644452376291e-05
orphan O 0 0.02393347956240177
nuclear O 0 0.0006196141475811601
receptor O 0 0.001984904520213604
SF O 0 0.09370209276676178
- O 0 6.740481330780312e-05
1 O 0 2.5700096557557117e-06
in O 0 9.095676318793267e-07
sex O 0 1.6327925550285727e-05
- O 0 3.242841921746731e-05
specific O 0 1.2367155477477354e-06
gene O 0 5.1833598263328895e-05
expression O 0 4.39895193267148e-05
. O 0 9.12128816707991e-05

Products O 0 0.00016102922381833196
of O 0 2.1620273400912993e-05
steroidogenic O 1 0.6884047985076904
factor O 0 0.00017631945956964046
1 O 0 9.786171722225845e-05
( O 0 7.053392619127408e-05
SF O 0 0.3064826428890228
- O 0 0.0001703988091321662
1 O 0 1.5694637113483623e-05
) O 0 6.700649009871995e-06
and O 0 4.57117821497377e-05
Wilms B-Disease 1 0.9996308088302612
tumor I-Disease 1 0.9996390342712402
1 O 0 0.0002202144096372649
( O 0 7.128497236408293e-05
WT1 O 0 0.05510096624493599
) O 0 3.0301284823508468e-06
genes O 0 1.6011885008992977e-06
are O 0 6.583388767467113e-08
essential O 0 2.0635739019780885e-06
for O 0 1.6477326880703913e-06
mammalian O 0 0.0006496142596006393
gonadogenesis O 0 0.0016603319672867656
prior O 0 2.5568609999027103e-05
to O 0 2.0710835997306276e-06
sexual O 0 0.00012031785445287824
differentiation O 0 0.0006439663702622056
. O 0 0.00014860407100059092

In O 0 4.7545974666718394e-05
males O 0 0.00012052453530486673
, O 0 7.88894685683772e-05
SF O 1 0.9288510680198669
- O 0 0.00017449956794735044
1 O 0 6.448993644880829e-06
participates O 0 2.5763736630324274e-05
in O 0 1.1113052096334286e-06
sexual O 0 1.0733429007814266e-05
development O 0 2.7992996365355793e-06
by O 0 1.50566711454303e-06
regulating O 0 4.5779488573316485e-05
expression O 0 2.897629883591435e-06
of O 0 7.081681587806088e-07
the O 0 9.074613626580685e-05
polypeptide O 0 0.3016613721847534
hormone O 1 0.9017723202705383
Mullerian O 1 0.8112531304359436
inhibiting O 0 0.012553157284855843
substance O 0 0.3372730612754822
( O 0 0.0004290593496989459
MIS O 1 0.9659779071807861
) O 0 4.2593004764057696e-05
. O 0 4.49207509518601e-05

Here O 0 7.772992830723524e-05
, O 0 5.6975472944031935e-06
we O 0 1.3948884998171707e-06
show O 0 9.854696145339403e-06
that O 0 8.76708872965537e-06
WT1 O 0 0.10963939130306244
- O 0 0.001089041936211288
KTS O 0 0.012772882357239723
isoforms O 0 3.6316821933723986e-05
associate O 0 7.865810039220378e-05
and O 0 8.202561730286106e-06
synergize O 0 0.003524072701111436
with O 0 0.00011713481944752857
SF O 1 0.9932291507720947
- O 0 0.00043849824578501284
1 O 0 8.615757906227373e-06
to O 0 4.779593609782751e-07
promote O 0 1.8773615011014044e-05
MIS O 0 0.03754262253642082
expression O 0 6.0797039623139426e-05
. O 0 4.5510307245422155e-05

In O 0 0.00010072245640913025
contrast O 0 0.00042299024062231183
, O 0 0.0001275586982956156
WT1 O 0 0.37381619215011597
missense O 0 0.002266170224174857
mutations O 0 0.00018927799828816205
, O 0 8.86961970536504e-06
associated O 0 3.315097274025902e-05
with O 0 2.2391297534340993e-05
male B-Disease 0 0.003920596092939377
pseudohermaphroditism I-Disease 1 0.9987034797668457
in O 0 0.001201749313622713
Denys B-Disease 1 0.9990346431732178
- I-Disease 1 0.9995630383491516
Drash I-Disease 1 0.9995129108428955
syndrome I-Disease 1 0.9999983310699463
, O 0 8.612909005023539e-05
fail O 0 0.0006776851369068027
to O 0 4.5730380406894255e-06
synergize O 0 0.0039221495389938354
with O 0 0.00010376027785241604
SF O 1 0.9965353012084961
- O 0 0.003239077515900135
1 O 0 8.800424984656274e-05
. O 0 2.6342160708736628e-05

Additionally O 0 0.00020348730322439224
, O 0 9.353977475257125e-06
the O 0 2.1472247681231238e-05
X O 0 0.004670297726988792
- O 0 0.002488719765096903
linked O 0 0.0005690008983947337
, O 0 4.531505055638263e-06
candidate O 0 2.9858189009246416e-05
dosage O 0 0.00447126803919673
- O 0 0.00034113283618353307
sensitive O 0 9.884159226203337e-05
sex O 0 7.874605944380164e-05
- O 0 0.0003627594851423055
reversal O 0 0.00047519730287604034
gene O 0 7.117303175618872e-05
, O 0 2.0584557205438614e-05
Dax O 0 0.013410615734755993
- O 0 0.0001611926854820922
1 O 0 1.0869295692828018e-05
, O 0 1.975110990315443e-06
antagonizes O 0 0.0005579284625127912
synergy O 0 9.025215695146471e-05
between O 0 3.2351355912396684e-05
SF O 1 0.98643559217453
- O 0 0.0005217113648541272
1 O 0 1.1101781637989916e-05
and O 0 6.070010840630857e-06
WT1 O 0 0.01619831845164299
, O 0 2.697384843486361e-06
most O 0 5.599497399089159e-07
likely O 0 1.945042640727479e-06
through O 0 2.0008327794585057e-07
a O 0 9.042278747983801e-07
direct O 0 2.4506113049937994e-07
interaction O 0 1.944961013577995e-06
with O 0 3.75972012989223e-05
SF O 1 0.9983546137809753
- O 0 0.0025580611545592546
1 O 0 6.991349073359743e-05
. O 0 3.6504708987195045e-05

We O 0 2.165973091905471e-05
propose O 0 8.198778959922493e-05
that O 0 1.3347668755159248e-05
WT1 O 0 0.025615788996219635
and O 0 2.9111715775798075e-05
Dax O 0 0.23133395612239838
- O 0 0.0005336384056136012
1 O 0 1.4849055332888383e-05
functionally O 0 9.63163620326668e-05
oppose O 0 3.367664248798974e-06
each O 0 1.2576708741107723e-07
other O 0 4.44644257413529e-07
in O 0 4.07908191846218e-06
testis O 0 0.0018400343833491206
development O 0 1.1106547390227206e-05
by O 0 2.146262522728648e-05
modulating O 0 0.020449917763471603
SF O 1 0.9942622184753418
- O 0 0.0014390326105058193
1 O 0 7.172081677708775e-05
- O 0 0.00023953926574904472
mediated O 0 0.0010047360556200147
transactivation O 0 0.005820064339786768
. O 0 5.112998769618571e-05
. O 0 0.00010623327398207039

A O 0 0.0006398072000592947
mouse O 0 0.00102972739841789
model O 0 9.604488150216639e-05
for O 0 0.00032179313711822033
Prader B-Disease 1 0.9999752044677734
- I-Disease 1 0.9999176263809204
Willi I-Disease 1 0.9999873638153076
syndrome I-Disease 1 0.999997615814209
imprinting O 1 0.9693772792816162
- O 1 0.8630874156951904
centre O 0 0.003348279045894742
mutations O 0 0.001884489436633885
. O 0 0.0001866468955995515

Imprinting O 0 0.0010992682073265314
in O 0 1.4482800906989723e-05
the O 0 5.466772927320562e-05
15q11 O 0 0.0034550302661955357
- O 0 0.0006611858843825758
q13 O 0 0.00030832012998871505
region O 0 4.5645551836059894e-06
involves O 0 1.7632766684982926e-05
an O 0 1.8444228771841154e-05
imprinting O 0 0.0013189518358558416
centre O 0 0.00034155542380176485
( O 0 3.5934597690356895e-05
IC O 0 0.0025161230005323887
) O 0 3.469611328910105e-06
, O 0 5.360769250728481e-07
mapping O 0 3.5290015603095526e-06
in O 0 6.4727555582067e-07
part O 0 1.4293871117843082e-06
to O 0 2.4859645009200904e-07
the O 0 3.4406020859023556e-06
promoter O 0 0.0002199256996391341
and O 0 1.290749082727416e-06
first O 0 4.068231191922678e-06
exon O 0 0.0002939249388873577
of O 0 7.562730843346799e-06
SNRPN O 1 0.9297528862953186
. O 0 0.00024042521545197815

Deletion O 0 0.0006026463815942407
of O 0 2.9412708499876317e-06
this O 0 2.310099807800725e-05
IC O 0 0.021337658166885376
abolishes O 0 0.003521347651258111
local O 0 1.731707016006112e-05
paternally O 0 0.0009788648458197713
derived O 0 2.4304086764459498e-05
gene O 0 3.5443281376501545e-05
expression O 0 1.2165171938249841e-05
and O 0 8.134128620440606e-06
results O 0 0.00022338399139698595
in O 0 0.0009595237206667662
Prader B-Disease 1 0.9999890327453613
- I-Disease 1 0.9999598264694214
Willi I-Disease 1 0.9999966621398926
syndrome I-Disease 1 0.9999998807907104
( O 1 0.963645339012146
PWS B-Disease 1 0.9999712705612183
) O 0 0.0007891888963058591
. O 0 0.0004190817999187857

We O 0 1.3554356883105356e-05
have O 0 1.5672117115173023e-06
created O 0 4.869161330134375e-06
two O 0 2.0574250356730772e-06
deletion O 0 0.0007088565034791827
mutations O 0 0.0001902766671264544
in O 0 3.650018334155902e-05
mice O 0 0.007446870673447847
to O 0 9.274044714402407e-06
understand O 0 0.0003131521225441247
PWS B-Disease 1 0.9994353652000427
and O 0 3.124010845567682e-06
the O 0 2.907974931076751e-06
mechanism O 0 2.3602939108968712e-05
of O 0 1.8031131503448705e-06
this O 0 4.8255820729536936e-05
IC O 0 0.1815413534641266
. O 0 0.00017994818335864693

Mice O 0 0.4828096032142639
harbouring O 0 0.3486281633377075
an O 0 0.00012437719851732254
intragenic O 0 0.01785288378596306
deletion O 0 0.001935645006597042
in O 0 3.575199662009254e-05
Snrpn O 0 0.01070313435047865
are O 0 7.79061701905448e-06
phenotypically O 0 0.005993517115712166
normal O 0 0.00016357992717530578
, O 0 6.897358616697602e-06
suggesting O 0 3.7471741961780936e-05
that O 0 1.155874201685947e-06
mutations O 0 1.6064919691416435e-05
of O 0 1.1179669172634021e-06
SNRPN O 0 0.10902876406908035
are O 0 1.0621251931297593e-06
not O 0 1.6661018662489369e-06
sufficient O 0 2.096573189191986e-05
to O 0 1.2923569556733128e-05
induce O 0 0.021585028618574142
PWS B-Disease 1 0.9993569254875183
. O 0 0.0005803483654744923

Mice O 0 0.0028630157466977835
with O 0 5.546315151150338e-06
a O 0 2.5846322387224063e-05
larger O 0 2.2224130589165725e-05
deletion O 0 0.0003101181355305016
involving O 0 2.623296131787356e-05
both O 0 9.398750080436002e-06
Snrpn O 0 0.006421311758458614
and O 0 8.930748663260601e-06
the O 0 9.944076737156138e-05
putative O 0 0.4745771288871765
PWS O 1 0.9998470544815063
- O 0 0.05720595642924309
IC O 0 0.009416693821549416
lack O 0 5.8760411775438115e-05
expression O 0 4.501676357904216e-06
of O 0 5.8750771358973e-07
the O 0 3.775687582674436e-05
imprinted O 0 0.005897419061511755
genes O 0 0.0001541698002256453
Zfp127 O 0 0.004725845064967871
( O 0 3.2039293728303164e-05
mouse O 0 0.0003782064304687083
homologue O 0 0.0002689278335310519
of O 0 8.976586286735255e-06
ZNF127 O 1 0.7119255661964417
) O 0 4.0180617361329496e-05
, O 0 2.8607011699932627e-05
Ndn O 0 0.011802498251199722
and O 0 1.6261605196632445e-05
Ipw O 0 0.0034674182534217834
, O 0 6.556205335073173e-06
and O 0 4.4567600525624584e-06
manifest O 0 0.00036086514592170715
several O 0 2.6023482860182412e-05
phenotypes O 0 0.006214833352714777
common O 0 0.0014780174242332578
to O 0 0.001178857171908021
PWS B-Disease 1 0.999976634979248
infants O 1 0.9990260601043701
. O 0 0.0008481328259222209

These O 0 2.67465884462581e-06
data O 0 7.5378752626420464e-06
demonstrate O 0 5.712443908123532e-06
that O 0 2.538036483201722e-07
both O 0 1.442244439431306e-07
the O 0 4.891580829280429e-07
position O 0 1.3697915619559353e-06
of O 0 3.357375533141749e-07
the O 0 1.0419582395115867e-05
IC O 0 0.0014872242463752627
and O 0 5.599609380624315e-07
its O 0 7.553169893981249e-07
role O 0 3.2524435482628178e-06
in O 0 7.498830996155448e-07
the O 0 7.578192935397965e-07
coordinate O 0 1.868614504019206e-06
expression O 0 1.212843812936626e-06
of O 0 1.965015172800122e-07
genes O 0 5.800514372822363e-06
is O 0 1.7103064919865574e-06
conserved O 0 4.837419510295149e-06
between O 0 8.725201951165218e-06
mouse O 0 0.0004671247734222561
and O 0 3.169580395478988e-06
human O 0 2.2390529920812696e-05
, O 0 3.575210484996205e-06
and O 0 1.1843688980661682e-06
indicate O 0 1.85810677066911e-05
that O 0 1.3823541848978493e-06
the O 0 5.3579806262860075e-06
mouse O 0 9.853243682300672e-05
is O 0 1.4031204500497552e-06
a O 0 3.6760711736860685e-06
suitable O 0 3.201293293386698e-05
model O 0 2.2204343622433953e-05
system O 0 4.515245746006258e-05
in O 0 1.3284098940857803e-06
which O 0 4.868841187999351e-07
to O 0 2.2079356654103321e-07
investigate O 0 4.417403033585288e-06
the O 0 1.2826196780224564e-06
molecular O 0 1.856000926636625e-05
mechanisms O 0 1.1049391105188988e-05
of O 0 5.482146434587776e-07
imprinting O 0 0.00027021756977774203
in O 0 2.7646851776808035e-06
this O 0 8.780726261647942e-07
region O 0 1.629732196306577e-06
of O 0 3.610222734096169e-07
the O 0 1.8433360310154967e-05
genome O 0 0.00015351743786595762
. O 0 1.652351056691259e-05
. O 0 5.404452167567797e-05

Mutations O 0 5.739263360737823e-05
of O 0 5.713772566195985e-07
the O 0 2.278641113662161e-05
ATM O 0 0.004573367536067963
gene O 0 0.00033835627255029976
detected O 0 0.0010595255298539996
in O 0 4.770684608956799e-05
Japanese O 1 0.9853874444961548
ataxia B-Disease 1 0.9999953508377075
- I-Disease 1 0.9999231100082397
telangiectasia I-Disease 1 0.99996018409729
patients O 1 0.9995879530906677
: O 0 3.834331801044755e-05
possible O 0 1.5674011592636816e-05
preponderance O 0 0.00033549146610312164
of O 0 4.3885754053007986e-07
the O 0 9.230051546182949e-06
two O 0 8.964915650722105e-06
founder O 0 0.0005154223763383925
mutations O 0 0.0002867364964913577
4612del165 O 0 0.0010692281648516655
and O 0 2.1291216398822144e-05
7883del5 O 0 0.004321908578276634
. O 0 0.00018227726104669273

The O 0 8.181401062756777e-05
ATM O 0 0.003720842534676194
( O 0 7.41061958251521e-05
A O 1 0.9731475710868835
- O 1 0.9054231643676758
T O 1 0.9992503523826599
, O 0 7.4096124080824666e-06
mutated O 0 0.00013423852215055376
) O 0 2.6311338388040895e-06
gene O 0 1.9625575077952817e-05
on O 0 1.3989455510454718e-05
human O 0 0.00014241269673220813
chromosome O 0 0.002533944323658943
11q22 O 0 0.005819426849484444
. O 0 0.0001723342720651999

3 O 0 0.00042328552808612585
has O 0 0.00010039661719929427
recently O 0 0.00025284517323598266
been O 0 1.1330139386700466e-05
identified O 0 1.0467587344464846e-05
as O 0 9.583148994352086e-07
the O 0 1.5682733192079468e-06
gene O 0 1.5145026736718137e-05
responsible O 0 8.242695912485942e-06
for O 0 3.070806087634992e-06
the O 0 5.883392077521421e-05
human O 0 0.10575786232948303
recessive B-Disease 1 0.9999573230743408
disease I-Disease 1 0.9999995231628418
ataxia B-Disease 1 0.9999988079071045
- I-Disease 1 0.9999151229858398
telangiectasia I-Disease 1 0.999920129776001
( O 0 0.002771468833088875
A B-Disease 1 0.9997696280479431
- I-Disease 1 0.9995688796043396
T I-Disease 1 0.9998433589935303
) O 0 4.845290823141113e-05
. O 0 5.2958846936235204e-05

In O 0 6.520719125546748e-06
order O 0 1.3452485063680797e-06
to O 0 3.604742175866704e-07
define O 0 2.071656354019069e-06
the O 0 4.156456725468161e-06
types O 0 5.776021862402558e-05
of O 0 7.329543586820364e-05
disease O 1 0.999996542930603
- O 1 0.8047400116920471
causing O 0 0.050397228449583054
ATM O 0 0.003080477472394705
mutations O 0 0.00010843992640729994
in O 0 8.371092917514034e-06
Japanese O 0 0.005750101990997791
A B-Disease 1 0.9993982315063477
- I-Disease 1 0.9996129870414734
T I-Disease 1 0.9999533891677856
patients O 1 0.9961808919906616
as O 0 8.363049346371554e-06
well O 0 2.1643229501933092e-06
as O 0 2.5286988147854572e-06
to O 0 4.6458848146357923e-07
look O 0 5.009066171623999e-06
for O 0 6.586108156625414e-07
possible O 0 1.4213467693480197e-05
mutational O 0 0.002312930068001151
hotspots O 0 0.00035838232724927366
, O 0 6.986253083596239e-06
reverse O 0 0.0003655525215435773
- O 0 9.092369145946577e-05
transcribed O 0 2.902074447774794e-05
RNA O 0 3.659840513137169e-05
derived O 0 5.134947969054338e-06
from O 0 7.949045539135113e-06
ten O 0 7.104880205588415e-05
patients O 1 0.8902252912521362
belonging O 0 5.4844742408022285e-05
to O 0 3.6821481899096398e-06
eight O 0 2.7370671887183562e-05
unrelated O 0 0.003595382208004594
Japanese O 0 0.025334397330880165
A B-Disease 1 0.999161958694458
- I-Disease 1 0.998235821723938
T I-Disease 1 0.9995599389076233
families O 0 1.428028645023005e-05
was O 0 5.81242966291029e-05
analyzed O 0 1.7704260244499892e-05
for O 0 9.370667726216197e-07
mutations O 0 2.0010204025311396e-05
by O 0 1.676508190939785e-06
the O 0 7.335170266742352e-06
restriction O 0 0.00012770060857292265
endonuclease O 0 0.0012421061983332038
fingerprinting O 0 9.947641956387088e-05
method O 0 9.598297765478492e-06
. O 0 6.0432590544223785e-05

As O 0 0.00016847034567035735
has O 0 6.303083500824869e-05
been O 0 5.8310837630415335e-05
reported O 0 0.0001257677940884605
by O 0 5.266378138912842e-06
others O 0 1.1001403436239343e-05
, O 0 2.9495631679310463e-06
mutations O 0 9.137826054939069e-06
that O 0 3.69221510254647e-07
lead O 0 6.207440947036957e-06
to O 0 1.2392350754453219e-06
exon O 0 0.000815747887827456
skipping O 0 0.0010931434808298945
or O 0 7.893025758676231e-05
premature O 0 0.0501251295208931
protein O 0 6.807025783928111e-05
truncation O 0 0.00038592302007600665
were O 0 4.911470568913501e-06
also O 0 4.322100267017959e-06
predominant O 0 2.2065278244554065e-05
in O 0 3.494856628094567e-06
our O 0 9.939842129824683e-06
mutants O 0 0.0007383331540040672
. O 0 0.00011179094144608825

Six O 0 3.3974272810155526e-05
different O 0 1.8150033156416612e-06
mutations O 0 7.181375985965133e-05
were O 0 3.979672328568995e-06
identified O 0 9.131971637543757e-06
on O 0 1.6957350226221024e-06
12 O 0 9.324374445895955e-07
of O 0 9.9054645374963e-08
the O 0 7.528463356720749e-06
16 O 0 4.19067800976336e-05
alleles O 0 0.00010332169040339068
examined O 0 0.0038280710577964783
. O 0 0.00010108674905495718

Four O 0 2.101690370182041e-05
were O 0 1.1309044566587545e-05
deletions O 0 3.683882096083835e-05
involving O 0 1.4647090210928582e-05
a O 0 3.700254819705151e-05
loss O 0 0.0001365494099445641
of O 0 2.531048721721163e-07
a O 0 1.178971342596924e-05
single O 0 1.2652933037315961e-05
exon O 0 0.00035323415067978203
exon O 0 0.0003028168866876513
7 O 0 1.640089976717718e-05
, O 0 1.7215257912539528e-06
exon O 0 0.00010412888514110819
16 O 0 8.403904757869896e-06
, O 0 1.5200167808870901e-06
exon O 0 0.00010817573638632894
33 O 0 1.3388056686380878e-05
or O 0 5.167784365767147e-06
exon O 0 0.00042556540574878454
35 O 0 5.7422625104663894e-05
. O 0 4.340620944276452e-05

The O 0 3.8747210055589676e-05
others O 0 1.5134560271690134e-05
were O 0 3.717470690389746e-06
minute O 0 4.742765213450184e-06
deletions O 0 3.2978743547573686e-05
, O 0 3.6786873351957183e-06
4649delA O 0 0.0002509268233552575
in O 0 5.1720935516641475e-06
exon O 0 0.0003822709550149739
33 O 0 2.874236997740809e-05
and O 0 3.798375473706983e-06
7883del5 O 0 0.0003619663475546986
in O 0 9.714385669212788e-06
exon O 0 0.0010793240508064628
55 O 0 0.00017050380120053887
. O 0 5.7766334066400304e-05

The O 0 0.0001174698190880008
mutations O 0 0.000359214871423319
4612del165 O 0 0.0008226771024055779
and O 0 1.1768986951210536e-05
7883del5 O 0 0.0005304761580191553
were O 0 4.440439624886494e-06
found O 0 9.459077773499303e-06
in O 0 8.781237283983501e-07
more O 0 1.233194808492044e-07
than O 0 2.79009441328526e-07
two O 0 1.2418341839293134e-06
unrelated O 0 0.0004528946301434189
families O 0 1.1159143468830734e-05
; O 0 5.2765885811822955e-06
44 O 0 1.884971425170079e-05
% O 0 3.3969461128435796e-06
( O 0 1.936558192028315e-06
7 O 0 1.8408378537060344e-06
of O 0 1.0102026948288767e-07
16 O 0 3.7045986118755536e-06
) O 0 2.0473144957122713e-07
of O 0 3.733956432938612e-08
the O 0 2.764887994999299e-06
mutant O 0 4.4131626054877415e-05
alleles O 0 5.798639904242009e-06
had O 0 3.962244591093622e-06
one O 0 9.927764210715395e-08
of O 0 9.83044188274107e-08
the O 0 5.122133643453708e-06
two O 0 1.027010330290068e-05
mutations O 0 0.0004430579429026693
. O 0 0.00014395397738553584

The O 0 8.365327812498435e-05
4612del165 O 0 0.001555330236442387
mutations O 0 8.296578016597778e-05
in O 0 2.6404800337331835e-06
three O 0 5.609684876617393e-07
different O 0 3.095996135016321e-07
families O 0 2.96280791189929e-06
were O 0 1.1570532478799578e-06
all O 0 1.4707589457430004e-07
ascribed O 0 2.1478350390680134e-05
to O 0 3.537343786774727e-07
the O 0 3.3820765565906186e-06
same O 0 3.934941196348518e-05
T O 1 0.9420509934425354
- O 0 0.0002958877303171903
- O 0 4.878343315795064e-05
> O 0 1.7420512449461967e-05
A O 0 4.559668923320714e-06
substitution O 0 2.610969431771082e-06
at O 0 3.9228712012118194e-06
the O 0 3.0602116112277145e-06
splice O 0 0.00022776711557526141
donor O 0 0.0002454743080306798
site O 0 8.972817886387929e-05
in O 0 1.3781742381979711e-05
intron O 0 0.12258222699165344
33 O 0 0.0004015438025817275
. O 0 7.119835208868608e-05

Microsatellite O 0 0.009442486800253391
genotyping O 0 0.0007570857997052372
around O 0 5.407120170275448e-06
the O 0 1.0745308827608824e-05
ATM O 0 0.0008394269971176982
locus O 0 9.467615745961666e-05
also O 0 4.428724423632957e-06
indicated O 0 5.644978227792308e-05
that O 0 8.994391009764513e-07
a O 0 1.329086626356002e-05
common O 0 3.194203236489557e-05
haplotype O 0 0.0018326941644772887
was O 0 7.76474698795937e-05
shared O 0 2.431582970530144e-06
by O 0 1.6933157667153864e-06
the O 0 4.103052560822107e-06
mutant O 0 9.25954373087734e-05
alleles O 0 1.732947930577211e-05
in O 0 5.524713287741179e-06
both O 0 9.133844287134707e-06
mutations O 0 0.0006691868184134364
. O 0 0.00013208278687670827

This O 0 2.7548192520043813e-05
suggests O 0 5.725372466258705e-05
that O 0 7.178112468864128e-07
these O 0 2.1183389264933794e-07
two O 0 2.6971224542648997e-06
founder O 0 0.0004425948718562722
mutations O 0 0.00026394601445645094
may O 0 0.000126110520795919
be O 0 2.4964067506516585e-06
predominant O 0 2.3883003450464457e-05
among O 0 4.854120561503805e-06
Japanese O 0 0.0005005159182474017
ATM O 0 0.004266540519893169
mutant O 0 0.0005176601698622108
alleles O 0 0.00021062664745841175
. O 0 0.00013928792031947523

W474C O 0 0.0029179856646806
amino O 0 0.00017665987252257764
acid O 0 0.0021849919576197863
substitution O 0 5.8875506510958076e-05
affects O 0 7.103308598743752e-05
early O 0 3.0242422326409724e-06
processing O 0 9.555615179124288e-07
of O 0 5.044551443234013e-08
the O 0 1.6016223298720433e-06
alpha O 0 1.0414793905511033e-05
- O 0 2.8418446618161397e-06
subunit O 0 6.093414981478418e-07
of O 0 2.7755351084124413e-07
beta O 0 0.000415454909671098
- O 0 0.00016833850531838834
hexosaminidase O 0 0.00022918461763765663
A O 0 2.1001695131417364e-05
and O 0 1.2365031807348714e-06
is O 0 5.563149443332804e-06
associated O 0 4.267235999577679e-05
with O 0 0.00010272507643094286
subacute O 1 0.9996814727783203
G B-Disease 1 0.9913190007209778
( I-Disease 0 0.0004948986461386085
M2 I-Disease 1 0.9886636137962341
) I-Disease 0 0.00015200069174170494
gangliosidosis I-Disease 0 0.010792974382638931
. O 0 0.0001300635776715353

Mutations O 0 0.00029506543069146574
in O 0 5.23777816852089e-06
the O 0 2.2504329535877332e-05
HEXA O 0 0.03934798017144203
gene O 0 1.687703115749173e-05
, O 0 2.74535835842471e-07
encoding O 0 3.3681479294500605e-07
the O 0 6.980219495744677e-07
alpha O 0 1.1220718079130165e-05
- O 0 3.7119655189599143e-06
subunit O 0 9.030833894030366e-07
of O 0 3.215344008822285e-07
beta O 0 0.0005770279676653445
- O 0 0.0002598014834802598
hexosaminidase O 0 0.0005628166836686432
A O 0 4.561484820442274e-05
( O 0 6.085011136747198e-06
Hex O 0 0.00010882299829972908
A O 0 3.338383248774335e-05
) O 0 1.646573423386144e-06
, O 0 4.0022621305979555e-07
that O 0 1.98855914845808e-07
abolish O 0 3.448801362537779e-05
Hex O 0 6.937144644325599e-05
A O 0 5.182820314075798e-05
enzyme O 0 0.0007340885349549353
activity O 0 0.0004461660864762962
cause O 1 0.9971381425857544
Tay B-Disease 1 0.999984860420227
- I-Disease 1 0.9997385144233704
Sachs I-Disease 1 0.9999734163284302
disease I-Disease 1 0.9999887943267822
( O 0 0.0007787309004925191
TSD B-Disease 1 0.9973315000534058
) O 0 3.364180520293303e-05
, O 0 1.1850889677589294e-05
the O 0 7.976164488354698e-05
fatal O 1 0.9993382096290588
infantile B-Disease 1 0.9968740940093994
form I-Disease 0 6.489957013400272e-05
of I-Disease 0 1.1403200005588587e-05
G I-Disease 1 0.9227573275566101
( I-Disease 0 0.00010285387543262914
M2 I-Disease 1 0.880034327507019
) I-Disease 0 2.3586559109389782e-05
gangliosidosis I-Disease 0 0.0014111080672591925
, I-Disease 0 1.2394865734677296e-05
Type I-Disease 0 0.0008599249995313585
1 I-Disease 0 7.702982111368328e-05
. O 0 3.952120096073486e-05

Less O 0 0.01173819787800312
severe O 1 0.999850869178772
, O 0 0.0043377336114645
subacute O 1 0.9997852444648743
( O 0 0.018056441098451614
juvenile O 1 0.9998815059661865
- O 1 0.9985870122909546
onset O 1 0.9998773336410522
) O 0 0.00047585403081029654
and O 0 0.001995242200791836
chronic O 1 0.9999979734420776
( O 0 0.0008144368184730411
adult O 0 0.06438107788562775
- O 1 0.9879953265190125
onset O 1 0.9997617602348328
) O 0 2.9041035304544494e-05
variants O 0 5.0332579121459275e-05
are O 0 1.3794950746159884e-06
characterized O 0 0.0005615937989205122
by O 0 4.086218723386992e-06
a O 0 2.0208341084071435e-05
broad O 0 0.00011449231533333659
spectrum O 0 6.908683280926198e-05
of O 0 9.457715350436047e-06
clinical O 1 0.7428520917892456
manifestations O 0 0.011518997140228748
and O 0 3.6163189633953152e-06
are O 0 1.5369811308119097e-06
associated O 0 3.2083626138046384e-05
with O 0 5.176278136787005e-06
residual O 0 0.0011710128746926785
levels O 0 7.244310108944774e-05
of O 0 6.772704068680468e-07
Hex O 0 0.0004759960575029254
A O 0 0.00011601820006035268
enzyme O 0 0.0006849232595413923
activity O 0 7.842860941309482e-05
. O 0 3.867729174089618e-05

We O 0 3.1557869078824297e-05
identified O 0 9.593521826900542e-05
a O 0 0.00015156043809838593
1422 O 0 0.23813827335834503
G O 0 0.020175082609057426
- O 0 0.0022635499481111765
- O 0 0.00028127574478276074
> O 0 0.00012652535224333405
C O 0 6.685644621029496e-05
( O 0 1.960765303010703e-06
amino O 0 7.803339940437581e-06
acid O 0 0.0005250941612757742
W474C O 0 0.00011855518823722377
) O 0 5.337852826414746e-07
substitution O 0 1.251885464625957e-06
in O 0 2.6423512622386625e-07
the O 0 2.714823210681061e-07
first O 0 4.580116694796743e-07
position O 0 4.576178298520972e-07
of O 0 2.5056533559109084e-07
exon O 0 0.00030075106769800186
13 O 0 1.1467126569186803e-05
of O 0 1.3948432524557575e-06
HEXA O 0 0.008260680362582207
of O 0 1.1098309187218547e-06
a O 0 6.395452510332689e-05
non O 0 0.00017644171020947397
- O 0 0.0006067270296625793
Jewish O 0 6.266320997383446e-05
proband O 0 0.005984458141028881
who O 0 8.006401913007721e-05
manifested O 0 0.003726786468178034
a O 0 0.0007534896722063422
subacute O 1 0.9977753758430481
variant O 0 0.10614856332540512
of O 0 2.363251223869156e-05
G B-Disease 1 0.9924103021621704
( I-Disease 0 0.0004368665104266256
M2 I-Disease 1 0.993529736995697
) I-Disease 0 0.0001025653473334387
gangliosidosis I-Disease 0 0.010384446941316128
. O 0 8.779921336099505e-05

On O 0 2.7515110559761524e-05
the O 0 1.2254085049789865e-05
second O 0 7.961210212670267e-05
maternally O 0 0.008378243073821068
inherited O 0 0.3219807744026184
allele O 0 0.00012015331594739109
, O 0 3.7806134969287086e-06
we O 0 9.881496225716546e-07
identified O 0 3.111425758106634e-05
the O 0 2.3311371478484944e-05
common O 0 0.018488872796297073
infantile O 1 0.9999513626098633
disease O 1 0.9999970197677612
- O 1 0.9870469570159912
causing O 1 0.9099528789520264
4 O 0 0.0005728609976358712
- O 0 0.0017702635377645493
bp O 0 0.0005206126370467246
insertion O 0 0.00020907337602693588
, O 0 1.927567063830793e-05
+ O 0 0.0011662173783406615
TATC O 0 0.03391734138131142
1278 O 0 0.046804316341876984
, O 0 9.082225005840883e-06
in O 0 1.0786706297949422e-05
exon O 0 0.0015930556692183018
11 O 0 0.00028019497403874993
. O 0 9.481042070547119e-05

Pulse O 0 0.013352163136005402
- O 0 0.0008891178877092898
chase O 0 0.00035098628723062575
analysis O 0 5.244501153356396e-06
using O 0 3.1275791116058826e-05
proband O 0 0.0065886229276657104
fibroblasts O 0 0.0031578962225466967
revealed O 0 0.0005024918937124312
that O 0 1.1646800430753501e-06
the O 0 7.79422862251522e-06
W474C O 0 0.0002824975235853344
- O 0 2.9428671041387133e-05
containing O 0 5.7683432714839e-06
alpha O 0 2.118682641594205e-05
- O 0 2.0897266949759796e-05
subunit O 0 7.841600563551765e-06
precursor O 0 9.809117182157934e-05
was O 0 3.9431601180695e-05
normally O 0 9.874499482975807e-06
synthesized O 0 6.137607124401256e-05
, O 0 1.8438353208694025e-06
but O 0 1.6887421452338458e-06
not O 0 6.962083602957136e-07
phosphorylated O 0 6.0059672250645235e-05
or O 0 8.456998330075294e-06
secreted O 0 5.463552588480525e-05
, O 0 1.2129086144341272e-06
and O 0 5.138624032952066e-07
the O 0 5.4339175221684854e-06
mature O 0 0.0005409244331531227
lysosomal O 0 0.48143884539604187
alpha O 0 0.00022445039940066636
- O 0 0.00017059064703062177
subunit O 0 3.683566319523379e-05
was O 0 0.00018384067516308278
not O 0 1.753119249769952e-05
detected O 0 0.0013308553025126457
. O 0 7.777477730996907e-05

When O 0 4.621813786798157e-05
the O 0 8.811514817352872e-06
W474C O 0 0.000438658578786999
- O 0 3.259317236370407e-05
containing O 0 7.632854249095544e-06
alpha O 0 5.350643186829984e-05
- O 0 2.8652333639911376e-05
subunit O 0 1.0168057997361757e-05
was O 0 0.00016617229266557842
transiently O 0 0.0022675690706819296
co O 0 0.00035592226777225733
- O 0 4.393497874843888e-05
expressed O 0 3.045694711545366e-06
with O 0 3.721649193266785e-07
the O 0 2.6509710551181342e-06
beta O 0 0.00013240231783129275
- O 0 1.065622109308606e-05
subunit O 0 1.0439686093377532e-06
to O 0 1.5025973709725804e-07
produce O 0 1.211606786455377e-06
Hex O 0 5.750790296588093e-05
A O 0 4.1313011024612933e-05
( O 0 7.408693363686325e-06
alphabeta O 0 0.00042010514880530536
) O 0 4.5753936319670174e-06
in O 0 1.2589715879585128e-05
COS O 1 0.6493023037910461
- O 0 0.0003875161928590387
7 O 0 2.4883747755666263e-05
cells O 0 4.081109364051372e-05
, O 0 4.3556775608522e-07
the O 0 1.1361322549419128e-06
mature O 0 3.043824472115375e-05
alpha O 0 2.4169728931155987e-05
- O 0 2.1765039491583593e-05
subunit O 0 7.427171112794895e-06
was O 0 2.22688504436519e-05
present O 0 2.8716522137983702e-06
, O 0 1.6948619077084004e-06
but O 0 5.228961299508228e-07
its O 0 6.97550149197923e-07
level O 0 2.5905399525072426e-05
was O 0 2.966914871649351e-05
much O 0 3.7200702536210883e-06
lower O 0 6.679565558442846e-05
than O 0 2.747987934981211e-07
that O 0 2.5880703447000997e-07
from O 0 6.947769861653796e-07
normal O 0 1.063217223418178e-05
alpha O 0 3.43779829563573e-05
- O 0 2.4756031052675098e-05
subunit O 0 9.863176273938734e-06
transfections O 0 0.00029164605075493455
, O 0 1.228065343639173e-06
although O 0 3.4359554774709977e-06
higher O 0 9.554462849337142e-06
than O 0 8.136612450471148e-07
in O 0 2.171621645175037e-06
those O 0 2.6839647944143508e-06
cells O 0 0.00024761524400673807
transfected O 0 0.0006025918410159647
with O 0 1.146291879194905e-06
an O 0 5.37431060365634e-06
alpha O 0 6.001450674375519e-05
- O 0 5.07269796798937e-05
subunit O 0 1.7804137314669788e-05
associated O 0 5.4132880904944614e-05
with O 0 7.345903577515855e-05
infantile O 1 0.9994283318519592
TSD B-Disease 1 0.998187243938446
. O 0 0.0006626342656090856

Furthermore O 0 0.00025385196204297245
, O 0 7.235588327603182e-06
the O 0 2.9124489628884476e-06
precursor O 0 9.927705104928464e-05
level O 0 5.98116730543552e-06
of O 0 8.983420940467113e-08
the O 0 2.5183289835695177e-06
W474C O 0 0.000166203361004591
alpha O 0 3.15022116410546e-05
- O 0 2.297309401910752e-05
subunit O 0 6.880447926960187e-06
was O 0 2.089252302539535e-05
found O 0 5.403707291407045e-06
to O 0 6.365753506543115e-07
accumulate O 0 7.395604916382581e-05
in O 0 6.089029511713306e-07
comparison O 0 1.6958530295596574e-06
to O 0 2.0609627426892985e-07
the O 0 7.695689419051632e-07
normal O 0 1.5682817320339382e-05
alpha O 0 2.6819980121217668e-05
- O 0 3.206276232958771e-05
subunit O 0 2.0048903024871834e-05
precursor O 0 0.0005601403536275029
levels O 0 0.0003988680837210268
. O 0 7.72529310779646e-05

We O 0 1.2747925211442634e-05
conclude O 0 4.9852973461383954e-05
that O 0 1.3115518413542304e-06
the O 0 1.84554355655564e-05
1422 O 0 0.2327110469341278
G O 0 0.014637221582233906
- O 0 0.0018169509712606668
- O 0 0.0002463909040670842
> O 0 0.00010908940021181479
C O 0 7.257323886733502e-05
mutation O 0 5.90986701354268e-06
is O 0 4.6729729774597217e-07
the O 0 1.7687975741864648e-06
cause O 0 0.00012431625509634614
of O 0 1.7753056908986764e-06
Hex B-Disease 0 0.0034766823519021273
A I-Disease 0 0.035296715795993805
enzyme I-Disease 1 0.9997532963752747
deficiency I-Disease 1 0.9999985694885254
in O 0 3.360550545039587e-05
the O 0 0.00014082562120165676
proband O 0 0.048718005418777466
. O 0 0.000186393634066917

The O 0 6.366756133502349e-05
resulting O 0 0.0005468872841447592
W474C O 0 0.0009826977038756013
substitution O 0 4.222783900331706e-05
clearly O 0 3.883229146595113e-05
interferes O 0 0.00012180142948636785
with O 0 1.9176470686943503e-06
alpha O 0 5.269009852781892e-05
- O 0 2.208129626524169e-05
subunit O 0 3.3538406114530517e-06
processing O 0 5.738845175073948e-06
, O 0 1.0261067018291214e-06
but O 0 7.87126964496565e-07
because O 0 1.01749537861906e-06
the O 0 4.96675511385547e-07
base O 0 5.26616713614203e-06
substitution O 0 9.887389751384035e-06
falls O 0 0.0005773295997641981
at O 0 3.417690095375292e-06
the O 0 3.667551311536954e-07
first O 0 3.210977297385398e-07
position O 0 5.196989718569966e-07
of O 0 3.1872687600298377e-07
exon O 0 0.00037383963353931904
13 O 0 4.617505692294799e-05
, O 0 4.06449271395104e-06
aberrant O 0 0.00038001075154170394
splicing O 0 5.407277058111504e-05
may O 0 2.3353828510153107e-05
also O 0 2.8677222871920094e-06
contribute O 0 3.656574790511513e-06
to O 0 1.635758280826849e-06
Hex B-Disease 0 0.0011180414585396647
A I-Disease 0 0.025619888678193092
deficiency I-Disease 1 0.9999784231185913
in O 0 1.7215017578564584e-05
this O 0 3.1827614293433726e-05
proband O 0 0.014681241475045681
. O 0 4.63832329842262e-05
. O 0 0.00011107455065939575

Two O 0 3.580214979592711e-05
frequent O 0 0.0013049812987446785
missense O 0 0.011568999849259853
mutations O 0 0.007127357646822929
in O 0 0.004992961417883635
Pendred B-Disease 1 0.999955415725708
syndrome I-Disease 1 0.9999998807907104
. O 0 0.005200935993343592

Pendred B-Disease 1 0.9998592138290405
syndrome I-Disease 1 0.9999997615814209
is O 0 0.006855957675725222
an O 1 0.835398256778717
autosomal B-Disease 1 0.9999988079071045
recessive I-Disease 1 0.9999997615814209
disorder I-Disease 1 1.0
characterized O 1 0.9997844099998474
by O 0 0.028340531513094902
early O 1 0.998647153377533
childhood O 1 0.9999822378158569
deafness B-Disease 1 0.9999997615814209
and O 1 0.9868600964546204
goiter B-Disease 1 0.9999990463256836
. O 0 0.007409194018691778

A O 0 0.00024337389913853258
century O 0 5.721158959204331e-05
after O 0 9.584634244674817e-05
its O 0 2.3671866529184626e-06
recognition O 0 1.2449453606677707e-05
as O 0 9.877854608930647e-05
a O 0 0.11406146734952927
syndrome O 1 0.9999971389770508
by O 0 0.00010697291872929782
Vaughan O 0 0.04009493067860603
Pendred O 0 0.3690996468067169
, O 0 8.838858047965914e-05
the O 0 0.00124778610188514
disease O 1 0.9999628067016602
gene O 0 0.0032175560481846333
( O 0 0.00028618567739613354
PDS O 1 0.9909817576408386
) O 0 2.2522794097312726e-05
was O 0 0.00011500617256388068
mapped O 0 3.241104423068464e-05
to O 0 3.0714154490851797e-06
chromosome O 0 0.0004279532004147768
7q22 O 0 0.003535753581672907
- O 0 0.0014992564683780074
q31 O 0 0.0014604477910324931
. O 0 7.770508818794042e-05

1 O 0 0.0001584934798302129
and O 0 1.4141672181722242e-05
, O 0 1.7077336451620795e-05
recently O 0 0.00011354945308994502
, O 0 1.690808062448923e-06
found O 0 1.5714382470832788e-06
to O 0 1.0947027107022222e-07
encode O 0 8.345899118467059e-07
a O 0 3.4970889828400686e-05
putative O 0 0.004884672816842794
sulfate O 1 0.9935212731361389
transporter O 1 0.94438636302948
. O 0 0.00021022514556534588

We O 0 6.846308224339737e-06
performed O 0 3.0292932933662087e-05
mutation O 0 8.450741916021798e-06
analysis O 0 3.5420228527982545e-07
of O 0 3.746094421330781e-07
the O 0 4.139922384638339e-05
PDS B-Disease 1 0.9830922484397888
gene O 0 0.0003446328337304294
in O 0 8.05424788268283e-05
patients O 1 0.9970790147781372
from O 0 5.1107464969391e-05
14 O 0 0.00036241140333004296
Pendred B-Disease 0 0.006173629779368639
families O 0 6.570589448529063e-06
originating O 0 1.4651770470663905e-05
from O 0 3.8109881188574946e-06
seven O 0 3.4637462249520468e-06
countries O 0 2.0988593973925163e-07
and O 0 1.1014587926183594e-06
identified O 0 2.5742123398231342e-05
all O 0 1.0016510714194737e-06
mutations O 0 0.0002841311215888709
. O 0 5.972635335638188e-05

The O 0 2.208207661169581e-05
mutations O 0 3.4597971534822136e-05
include O 0 1.3904392517360975e-06
three O 0 1.3470073554344708e-06
single O 0 9.652881999500096e-06
base O 0 1.5007120055088308e-05
deletions O 0 2.3756181690259837e-05
, O 0 1.173072746496473e-06
one O 0 1.4992681371950312e-06
splice O 0 0.00019479253387544304
site O 0 7.329571235459298e-05
mutation O 0 4.251638529240154e-05
and O 0 2.3063080334395636e-06
10 O 0 2.6311179681215435e-05
missense O 0 0.0009117632871493697
mutations O 0 0.00035043939715251327
. O 0 5.1518407417461276e-05

One O 0 5.3005980589659885e-05
missense O 0 0.0022594924084842205
mutation O 0 0.0004632003547158092
( O 0 2.655402568052523e-05
L236P O 0 0.00043537397868931293
) O 0 6.1690575421380345e-06
was O 0 6.423685408663005e-05
found O 0 8.607742529420648e-06
in O 0 1.1589494306463166e-06
a O 0 1.059034821082605e-05
homozygous O 0 4.912211443297565e-05
state O 0 2.7461883291834965e-06
in O 0 1.8538482891017338e-06
two O 0 3.232032895539305e-06
consanguineous O 0 0.004090500995516777
families O 0 8.83953271113569e-06
and O 0 1.1500728760438506e-06
in O 0 1.169059942185413e-06
a O 0 7.559096502518514e-06
heterozygous O 0 1.4668841686216183e-05
state O 0 5.210931135479768e-07
in O 0 6.199113045113336e-07
five O 0 1.910258333737147e-06
additional O 0 7.773665856802836e-06
non O 0 0.0002218453591922298
- O 0 0.0024628122337162495
consanguineous O 0 0.006094430573284626
families O 0 6.914557161508128e-05
. O 0 0.00010823538468685001

Another O 0 0.00030072269146330655
missense O 0 0.0017422918463125825
mutation O 0 0.0004034811572637409
( O 0 2.5245728465961292e-05
T416P O 0 0.0005469000898301601
) O 0 5.528792826225981e-06
was O 0 3.668236604426056e-05
found O 0 7.46556088415673e-06
in O 0 1.1362557188476785e-06
a O 0 5.631368367176037e-06
homozygous O 0 3.597004251787439e-05
state O 0 2.265408511448186e-06
in O 0 1.3403924867816386e-06
one O 0 1.4373111980603426e-06
family O 0 1.07468868009164e-05
and O 0 5.240813720774895e-07
in O 0 8.977311836133595e-07
a O 0 6.220857812877512e-06
heterozygous O 0 1.6667467207298614e-05
state O 0 1.043051042870502e-06
in O 0 2.1003941128583392e-06
four O 0 8.43036195874447e-06
families O 0 3.421173823880963e-05
. O 0 8.473019988741726e-05

Pendred B-Disease 1 0.9766726493835449
patients O 1 0.9931301474571228
in O 0 3.807760731433518e-05
three O 0 4.7237888793461025e-05
non O 0 0.001345631550066173
- O 0 0.004707633052021265
consanguineous O 0 0.005844494327902794
families O 0 1.1097568858531304e-05
were O 0 3.213527634216007e-06
shown O 0 1.0880060472118203e-05
to O 0 7.109032367225154e-07
be O 0 4.544180228549521e-06
compound O 0 0.0003826824249699712
heterozygotes O 0 0.0008779666968621314
for O 0 1.0904408554779366e-05
L236P O 0 0.0013830290408805013
and O 0 2.726019920373801e-05
T416P O 0 0.0032390037085860968
. O 0 0.0002133268426405266

In O 0 1.7598058548173867e-05
total O 0 5.055882866145112e-06
, O 0 3.5318666959938128e-06
one O 0 8.32822422580648e-07
or O 0 1.3680590882358956e-06
both O 0 9.624797314700118e-08
of O 0 1.2367634383281256e-07
these O 0 7.474426979570126e-07
mutations O 0 3.0042583603062667e-05
were O 0 2.1286662104103016e-06
found O 0 9.221447726304177e-06
in O 0 9.154819053946994e-07
nine O 0 1.3671683518623468e-06
of O 0 4.3572686081461143e-07
the O 0 1.9693443391588517e-05
14 O 0 7.192230987129733e-05
families O 0 3.062908581341617e-05
analyzed O 0 0.00039991570520214736
. O 0 0.00010616683721309528

The O 0 9.550836693961173e-06
identification O 0 3.7502695704461075e-06
of O 0 3.6567453776115144e-07
two O 0 6.992592261667596e-06
frequent O 0 0.0009673443273641169
PDS B-Disease 1 0.989645779132843
mutations O 0 3.0290710128610954e-05
will O 0 4.1969511244133173e-07
facilitate O 0 2.222623606940033e-06
the O 0 1.130507644120371e-05
molecular O 0 0.003946149256080389
diagnosis O 1 0.9995492100715637
of O 0 0.0012922210153192282
Pendred B-Disease 1 0.9999629259109497
syndrome I-Disease 1 0.9999998807907104
. O 0 0.0064750961028039455

Insertional O 0 0.014639285393059254
mutation O 0 0.00023295474238693714
by O 0 1.1063372767239343e-05
transposable O 0 0.0007124677067622542
element O 0 3.737227962119505e-05
, O 0 1.0573556210147217e-05
L1 O 0 0.0033225100487470627
, O 0 3.931968876713654e-06
in O 0 3.8992798181425314e-06
the O 0 3.742020999197848e-05
DMD B-Disease 1 0.9989334940910339
gene O 0 9.508864604867995e-05
results O 0 5.946413511992432e-05
in O 0 7.798770093359053e-05
X B-Disease 1 0.9884018301963806
- I-Disease 1 0.997348427772522
linked I-Disease 1 0.9963512420654297
dilated I-Disease 1 0.9997305274009705
cardiomyopathy I-Disease 1 0.9999974966049194
. O 0 0.004816863220185041

X B-Disease 1 0.9890224933624268
- I-Disease 1 0.9971875548362732
linked I-Disease 1 0.9977433681488037
dilated I-Disease 1 0.9998430013656616
cardiomyopathy I-Disease 1 0.9999984502792358
( O 0 0.0029169393237680197
XLDCM B-Disease 1 0.9847831130027771
) O 0 3.883147655869834e-05
is O 0 1.0459334589540958e-05
a O 0 7.69711405155249e-05
clinical O 0 0.0033223184291273355
phenotype O 0 0.0007070052670314908
of O 0 4.327181613916764e-06
dystrophinopathy B-Disease 0 0.030566101893782616
which O 0 1.772877476469148e-05
is O 0 4.9486032366985455e-05
characterized O 0 0.010871442034840584
by O 0 0.0001387797819916159
preferential O 0 0.30154526233673096
myocardial B-Disease 1 0.9999849796295166
involvement I-Disease 0 0.0019989777356386185
without O 0 3.32132403855212e-05
any O 0 2.058789505099412e-05
overt O 0 0.0017985925078392029
clinical O 0 0.29057759046554565
signs O 0 0.26853621006011963
of O 0 0.0005538420518860221
skeletal B-Disease 1 0.9999977350234985
myopathy I-Disease 1 0.9999990463256836
. O 0 0.02402987889945507

To O 0 5.005704224458896e-06
date O 0 1.5317897123168223e-05
, O 0 2.035331363003934e-06
several O 0 3.1684469377069036e-06
mutations O 0 0.00014669403026346117
in O 0 2.5705716325319372e-05
the O 0 0.0026269846130162477
Duchenne B-Disease 1 0.9999567270278931
muscular I-Disease 1 0.9999783039093018
dystrophy I-Disease 1 0.99998939037323
gene O 1 0.520824670791626
, O 0 0.0033340901136398315
DMD O 1 0.9999685287475586
, O 0 4.5044296712148935e-05
have O 0 6.438485343096545e-06
been O 0 4.536930282483809e-05
identified O 0 0.0002229813690064475
in O 0 6.486367783509195e-05
patients O 1 0.9977148771286011
with O 0 3.149500480503775e-05
XLDCM B-Disease 1 0.9965973496437073
, O 0 8.75686964718625e-06
but O 0 3.2365364859288093e-06
a O 0 4.950878519593971e-06
pathogenic O 0 2.4318576834048145e-05
correlation O 0 1.061411467162543e-06
of O 0 2.1626732404911309e-07
these O 0 3.1885197131487075e-06
cardiospecific O 0 0.014290992170572281
mutations O 0 0.0005423953989520669
in O 0 7.534744509030133e-05
DMD O 1 0.9998273253440857
with O 0 2.6613681257003918e-05
the O 0 0.0001243797887582332
XLDCM B-Disease 1 0.9936017394065857
phenotype O 0 0.01835590973496437
has O 0 3.9183902117656544e-05
remained O 0 0.00022343125601764768
to O 0 2.5303709207946667e-06
be O 0 1.817531301639974e-05
elucidated O 0 0.008973980322480202
. O 0 0.00010458086762810126

We O 0 2.2721354980603792e-05
report O 0 1.863153556769248e-05
here O 0 1.3415179864750826e-06
the O 0 5.239334655016137e-07
identification O 0 5.167136123418459e-07
of O 0 6.81480543107682e-08
a O 0 8.208055078284815e-06
unique O 0 3.336756662974949e-06
de O 0 2.6904821424977854e-05
novo O 0 5.0053378799930215e-05
L1 O 0 0.0005233559641055763
insertion O 0 6.532065162900835e-05
in O 0 4.761151103593875e-06
the O 0 1.7965588995139115e-05
muscle O 0 0.035992901772260666
exon O 0 0.0013693051878362894
1 O 0 0.0001046704564942047
in O 0 7.066041871439666e-05
DMD O 1 0.9996676445007324
in O 0 1.718093699309975e-05
three O 0 4.837321466766298e-05
XLDCM B-Disease 1 0.9981598258018494
patients O 1 0.9967599511146545
from O 0 1.964450530067552e-05
two O 0 7.143514721974498e-06
unrelated O 0 0.009348071180284023
Japanese O 0 0.010039635002613068
families O 0 0.00017510693578515202
. O 0 0.0001827389351092279

The O 0 3.5306322388350964e-05
insertion O 0 0.0002350704016862437
was O 0 0.00024290122382808477
a O 0 3.9019982068566605e-05
5 O 0 3.484542321530171e-05
- O 0 6.047034912626259e-05
truncated O 0 0.00010606848809402436
form O 0 2.4858252345438814e-06
of O 0 6.524984428324387e-07
human O 0 6.140617188066244e-05
L1 O 0 0.001650227583013475
inversely O 0 6.089022281230427e-05
integrated O 0 2.2981026631896384e-05
in O 0 2.993921270899591e-06
the O 0 7.084383014444029e-06
5 O 0 6.138321623438969e-05
- O 0 0.00020446789858397096
untranslated O 0 0.000310980569338426
region O 0 6.511372703243978e-06
in O 0 2.5646452286309795e-06
the O 0 2.62331868725596e-05
muscle O 0 0.488286554813385
exon O 0 0.001363248797133565
1 O 0 4.5805780246155336e-05
, O 0 3.445704578552977e-06
which O 0 1.8078740140481386e-06
affected O 0 7.596479917992838e-06
the O 0 9.355470069749572e-07
transcription O 0 6.796233355998993e-05
or O 0 4.246523076290032e-06
the O 0 1.7100766172006843e-06
stability O 0 3.694427277878276e-06
of O 0 5.241968210611958e-07
the O 0 2.891308940888848e-05
muscle O 0 0.08098354935646057
form O 0 1.6213660273933783e-05
of O 0 6.7349169512453955e-06
dystrophin O 0 0.378757506608963
transcripts O 0 0.00024159115855582058
but O 0 2.138724539690884e-06
not O 0 1.5588628343721211e-07
that O 0 9.538137391018608e-08
of O 0 3.492393716442166e-07
the O 0 8.831108425511047e-05
brain O 1 0.9973906874656677
or O 0 0.00014288851525634527
Purkinje O 1 0.6693971157073975
cell O 0 0.0053464500233531
form O 0 6.782443233532831e-05
, O 0 1.9947654436691664e-05
probably O 0 8.92458701855503e-05
due O 0 3.79995399271138e-05
to O 0 2.2261038168380765e-07
its O 0 3.4806831195055565e-07
unique O 0 1.0526804317123606e-06
site O 0 1.2299910849833395e-05
of O 0 8.353511589120899e-07
integration O 0 0.00010402665793662891
. O 0 0.00012028617493342608

We O 0 1.9252449419582263e-05
speculate O 0 2.960634810733609e-05
that O 0 2.0737088846090046e-07
this O 0 1.466183761067441e-07
insertion O 0 5.844269708177308e-06
of O 0 1.799358244625182e-07
an O 0 8.86500311025884e-06
L1 O 0 0.0018387167947366834
sequence O 0 2.4054525056271814e-05
in O 0 6.928067887201905e-05
DMD O 1 0.9998277425765991
is O 0 8.957284080679528e-06
responsible O 0 6.58081717119785e-06
for O 0 2.914514425356174e-07
some O 0 4.078802362528222e-08
of O 0 6.40169730559137e-08
the O 0 1.8967451751450426e-06
population O 0 7.218848736556538e-07
of O 0 2.133708676410606e-06
Japanese O 0 0.15925002098083496
patients O 1 0.9987682700157166
with O 0 0.00016831987886689603
XLDCM B-Disease 1 0.9951684474945068
. O 0 9.521867468720302e-05
. O 0 0.00011465850548120216

Severe O 1 0.9995366334915161
early O 1 0.9099700450897217
- O 1 0.999572217464447
onset O 1 0.9999759197235107
obesity B-Disease 1 0.9999954700469971
, O 0 0.21374653279781342
adrenal B-Disease 1 0.9999794960021973
insufficiency I-Disease 1 0.9999918937683105
and O 0 0.00607925932854414
red O 1 0.9996082186698914
hair O 1 0.9996711015701294
pigmentation O 1 0.9986962676048279
caused O 1 0.983004093170166
by O 0 0.0005376273184083402
POMC O 1 0.9983534812927246
mutations O 0 0.0008319489425048232
in O 0 6.864978786325082e-05
humans O 0 0.0009435886167921126
. O 0 0.00019669810717459768

Sequential O 0 5.393846004153602e-05
cleavage O 0 0.00038141204277053475
of O 0 3.4925801628560293e-07
the O 0 5.575663180934498e-06
precursor O 0 0.00021660000493284315
protein O 0 4.7807585360715166e-05
pre O 0 0.0006108178640715778
- O 0 0.0004140556848142296
pro O 0 0.00038074597250670195
- O 0 0.0006664663669653237
opiomelanocortin O 0 0.0017106363084167242
( O 0 2.9693776014028117e-05
POMC O 0 0.021349899470806122
) O 0 4.800525402970379e-06
generates O 0 9.58562122832518e-06
the O 0 2.4038290575845167e-05
melanocortin O 0 0.048586491495370865
peptides O 0 0.0011535512749105692
adrenocorticotrophin O 0 0.011317114345729351
( O 0 0.00012470259389374405
ACTH O 0 0.12276320904493332
) O 0 1.7842994566308334e-05
, O 0 2.52955942414701e-05
melanocyte O 0 0.06820806115865707
- O 0 0.0015240373322740197
stimulating O 0 0.0012981321197003126
hormones O 0 0.002441969234496355
( O 0 6.061468229745515e-05
MSH O 1 0.6603794097900391
) O 0 2.808942554111127e-06
alpha O 0 1.3626640793518163e-05
, O 0 1.0054620815935778e-06
beta O 0 2.507714270905126e-05
and O 0 3.2938544336502673e-07
gamma O 0 1.539698314445559e-05
as O 0 1.030368366627954e-06
well O 0 4.420558070705738e-07
as O 0 4.986808335161186e-07
the O 0 1.526117216599232e-06
opioid O 0 0.0064585404470562935
- O 0 0.00013665141887031496
receptor O 0 9.964960190700367e-05
ligand O 0 0.00015484572213608772
beta O 0 0.0025356863625347614
- O 0 0.0025677543599158525
endorphin O 0 0.042917877435684204
. O 0 5.267773667583242e-05

While O 0 5.536967364605516e-05
a O 0 5.6724995374679565e-05
few O 0 3.057935100514442e-05
cases O 0 9.10014205146581e-05
of O 0 2.826371019182261e-05
isolated O 1 0.9981254935264587
ACTH B-Disease 1 0.9998944997787476
deficiency I-Disease 1 0.9999958276748657
have O 0 0.00011028321750927716
been O 0 0.0003877310664393008
reported O 0 0.0070527298375964165
( O 0 0.00026274987612850964
OMIM O 1 0.9931294322013855
201400 O 0 0.006872978992760181
) O 0 1.1253144293732475e-05
, O 0 8.862483809934929e-06
an O 0 0.00016476321616210043
inherited O 1 0.999377965927124
POMC O 1 0.9996767044067383
defect O 1 0.9991793036460876
has O 0 0.00014824628306087106
not O 0 9.36476862989366e-06
been O 0 3.430089054745622e-05
described O 0 0.0003041365125682205
so O 0 2.0901392417727038e-05
far O 0 3.432055746088736e-05
. O 0 6.209855928318575e-05

Recent O 0 0.0003057200228795409
studies O 0 4.740761505672708e-05
in O 0 1.5810835975571536e-05
animal O 0 0.00026385794626548886
models O 0 3.761391053558327e-05
elucidated O 0 0.0006683404208160937
a O 0 1.1778305633924901e-05
central O 0 1.3594139090855606e-05
role O 0 2.020230112975696e-06
of O 0 1.258199063158827e-06
alpha O 0 0.0007027806714177132
- O 0 0.002098213881254196
MSH O 0 0.19913052022457123
in O 0 1.2730994285448105e-06
the O 0 1.2325427860560012e-06
regulation O 0 1.3256295460450929e-05
of O 0 6.37467849173845e-07
food O 0 9.15894124773331e-05
intake O 0 0.00023220834555104375
by O 0 1.042790472638444e-06
activation O 0 1.7069471141439863e-05
of O 0 7.828247703400848e-07
the O 0 6.00195380684454e-05
brain O 1 0.9944908618927002
melanocortin O 0 0.43186154961586
- O 0 0.0006484949262812734
4 O 0 6.850892532384023e-05
- O 0 0.0002758986665867269
receptor O 0 0.000244540860876441
( O 0 1.893466105684638e-05
MC4 O 0 0.14076851308345795
- O 0 0.0004751458764076233
R O 0 0.0005182530730962753
; O 0 9.247424713976216e-06
refs O 0 0.00045531135401688516
3 O 0 3.5979581298306584e-05
- O 0 8.933255594456568e-05
5 O 0 3.597383283704403e-06
) O 0 4.894571929980884e-07
and O 0 1.300619061339603e-07
the O 0 9.134603828897525e-07
linkage O 0 5.702324415324256e-05
of O 0 2.0242125629010843e-06
human O 0 0.0019246396841481328
obesity B-Disease 1 0.9996583461761475
to O 0 4.355139026301913e-06
chromosome O 0 0.0001063683012034744
2 O 0 7.896383067418355e-06
in O 0 1.1178805152667337e-06
close O 0 3.91218600270804e-06
proximity O 0 4.332913249527337e-06
to O 0 7.044170615699841e-07
the O 0 1.713348501652945e-05
POMC O 0 0.12560255825519562
locus O 0 9.435844549443573e-05
, O 0 1.2655228829316911e-06
led O 0 2.476894451319822e-06
to O 0 2.8043794486620754e-07
the O 0 9.713538702271762e-07
proposal O 0 6.229881819308503e-06
of O 0 2.5003279802149336e-07
an O 0 1.3533330275095068e-05
association O 0 0.00019345281179994345
of O 0 1.1197349522262812e-05
POMC O 1 0.9981065988540649
with O 0 0.00022709685435984284
human O 0 0.06929802894592285
obesity B-Disease 1 0.9999184608459473
. O 0 0.0010861358605325222

The O 0 1.593266824784223e-05
dual O 0 4.251833161106333e-05
role O 0 1.2229206731717568e-05
of O 0 3.3419987630622927e-06
alpha O 0 0.001639602822251618
- O 0 0.013975757174193859
MSH O 1 0.9753965139389038
in O 0 1.3559335457102861e-05
regulating O 0 0.0007174804923124611
food O 0 0.00045595673145726323
intake O 0 0.002811508486047387
and O 0 2.061449413304217e-05
influencing O 0 0.0008411518065258861
hair O 1 0.9932131767272949
pigmentation O 0 0.40854591131210327
predicts O 0 0.0007114980253390968
that O 0 3.86858164347359e-06
the O 0 2.0919518647133373e-05
phenotype O 0 0.0013978952774778008
associated O 0 4.280441498849541e-05
with O 0 1.4135039236862212e-05
a O 0 0.002107011154294014
defect O 1 0.9984667301177979
in O 0 0.00010761891462607309
POMC O 1 0.988959789276123
function O 0 8.338646875927225e-05
would O 0 2.1850935809197836e-05
include O 0 0.0003940587630495429
obesity B-Disease 1 0.9999454021453857
, O 0 4.0058341255644336e-05
alteration O 0 0.00804444681853056
in O 0 0.0002700166660360992
pigmentation O 1 0.9983820915222168
and O 0 0.0053114090114831924
ACTH B-Disease 1 0.9998898506164551
deficiency I-Disease 1 0.9999948740005493
. O 0 0.0010129720903933048

The O 0 3.737723454833031e-05
observation O 0 0.00015489518409594893
of O 0 3.996151008323068e-06
these O 0 8.254217391368002e-05
symptoms O 1 0.999819815158844
in O 0 2.513846084184479e-05
two O 0 2.135751310561318e-05
probands O 0 0.07509392499923706
prompted O 0 0.00024658103939145803
us O 0 7.434272447426338e-06
to O 0 9.806396406020212e-08
search O 0 8.580724397688755e-07
for O 0 4.7644439860050625e-07
mutations O 0 1.0013205610448495e-05
within O 0 9.255941790797806e-07
their O 0 6.3442421378567815e-06
POMC O 1 0.9442528486251831
genes O 0 0.00017402270168531686
. O 0 9.247851266991347e-05

Patient O 1 0.9548013806343079
1 O 0 0.00015396910021081567
was O 0 9.494720870861784e-05
found O 0 8.783407793089282e-06
to O 0 2.5960795824175875e-07
be O 0 4.1156377506013087e-07
a O 0 2.4704258976271376e-06
compound O 0 8.894044731277972e-05
heterozygote O 0 7.037349860183895e-05
for O 0 5.1482277285686e-07
two O 0 9.361119168715959e-07
mutations O 0 2.4954473701654933e-05
in O 0 4.85700093122432e-06
exon O 0 0.0005740607739426196
3 O 0 5.662187686539255e-05
( O 0 1.5351735783042386e-05
G7013T O 0 0.0005946556339040399
, O 0 1.3419500646705274e-05
C7133delta O 0 0.0011093973880633712
) O 0 3.872741672239499e-06
which O 0 6.13648182934412e-07
interfere O 0 3.07135405819281e-06
with O 0 2.8665306217590114e-07
appropriate O 0 1.7958675471163588e-06
synthesis O 0 2.460009272908792e-05
of O 0 4.817949047719594e-06
ACTH O 0 0.40593114495277405
and O 0 2.49382464971859e-05
alpha O 0 0.0017295862780883908
- O 0 0.0262752752751112
MSH O 1 0.9794279932975769
. O 0 0.0001507817505626008

Patient O 1 0.5644932389259338
2 O 0 0.00011206854833289981
was O 0 0.00013393675908446312
homozygous O 0 2.386965752521064e-05
for O 0 5.218171281740069e-07
a O 0 8.373575838049874e-06
mutation O 0 2.562147710705176e-05
in O 0 4.612070370058063e-06
exon O 0 0.00044038411579094827
2 O 0 4.888061812380329e-05
( O 0 1.538075230200775e-05
C3804A O 0 0.00033572822576388717
) O 0 7.26814187146374e-06
which O 0 9.128697456617374e-06
abolishes O 0 0.014909227378666401
POMC O 1 0.634135365486145
translation O 0 0.0003250119916629046
. O 0 0.00015731231542304158

These O 0 5.519667865883093e-06
findings O 0 2.5888310119626112e-05
represent O 0 3.6807119840887026e-07
the O 0 8.763994401306263e-07
first O 0 7.401324069178372e-07
examples O 0 2.299885636602994e-06
of O 0 1.8839563153960626e-06
a O 0 0.0010960276704281569
genetic B-Disease 1 0.9969106316566467
defect I-Disease 1 0.9995290040969849
within O 0 1.4544975783792324e-05
the O 0 8.819048525765538e-05
POMC O 1 0.9807167649269104
gene O 0 5.1586244808277115e-05
and O 0 1.100486656469002e-06
define O 0 1.5911351511022076e-05
a O 0 9.78114185272716e-05
new O 0 0.0005727971438318491
monogenic B-Disease 1 0.999339759349823
endocrine I-Disease 1 0.9999634027481079
disorder I-Disease 1 0.9999901056289673
resulting O 0 0.03550058230757713
in O 0 0.0003253635368309915
early O 1 0.8924325704574585
- O 1 0.9997285008430481
onset O 1 0.9999885559082031
obesity B-Disease 1 0.9999955892562866
, O 0 0.13147975504398346
adrenal B-Disease 1 0.999985933303833
insufficiency I-Disease 1 0.9999960660934448
and O 0 0.021165763959288597
red O 1 0.9997307658195496
hair O 1 0.9997546076774597
pigmentation O 1 0.9967854022979736
. O 0 0.00010371209646109492
. O 0 0.0001826504449127242

A O 0 0.0006987142842262983
European O 0 0.00018698391795624048
multicenter O 0 0.020987436175346375
study O 0 0.00011740958143491298
of O 0 5.0923179514938965e-05
phenylalanine B-Disease 1 0.9995929598808289
hydroxylase I-Disease 1 0.9995081424713135
deficiency I-Disease 1 0.9999996423721313
: O 0 8.465613791486248e-05
classification O 0 0.0007380594615824521
of O 0 1.202158500746009e-06
105 O 0 0.0001914599706651643
mutations O 0 4.626986992661841e-05
and O 0 7.575013114546891e-07
a O 0 5.654459982906701e-06
general O 0 8.27234543976374e-06
system O 0 2.4083241441985592e-05
for O 0 1.7969846339838114e-06
genotype O 0 0.000386193540180102
- O 0 6.280343950493261e-05
based O 0 1.4278379012466758e-06
prediction O 0 7.643725984962657e-05
of O 0 1.2041759873682167e-05
metabolic O 1 0.9988008737564087
phenotype O 0 0.4285224974155426
. O 0 0.0002496287343092263

Phenylketonuria B-Disease 1 0.9975770115852356
( O 0 0.007208405528217554
PKU B-Disease 1 0.9995160102844238
) O 0 0.0002272033889312297
and O 0 0.0002525669406168163
mild B-Disease 1 0.9997525811195374
hyperphenylalaninemia I-Disease 1 0.9995217323303223
( O 0 0.02176165208220482
MHP B-Disease 1 0.9999667406082153
) O 0 0.00017398867930751294
are O 0 4.788240767084062e-05
allelic B-Disease 1 0.9927722811698914
disorders I-Disease 1 0.9999902248382568
caused O 1 0.9746196866035461
by O 0 2.272625351906754e-05
mutations O 0 5.6778360885800794e-05
in O 0 1.592122316651512e-06
the O 0 4.636573066818528e-06
gene O 0 3.095012652920559e-05
encoding O 0 2.4050581487244926e-05
phenylalanine O 0 0.011653279885649681
hydroxylase O 0 0.06391443312168121
( O 0 0.0016956167528405786
PAH O 1 0.9998883008956909
) O 0 0.00010469322296557948
. O 0 8.389436698053032e-05

Previous O 0 0.0002208096266258508
studies O 0 4.121035453863442e-05
have O 0 3.1852616757532815e-06
suggested O 0 1.4637482308899052e-05
that O 0 6.838476451775932e-07
the O 0 3.7064082789584063e-06
highly O 0 0.00011486029688967392
variable O 0 0.00034420794690959156
metabolic O 1 0.9962454438209534
phenotypes O 0 0.08405263721942902
of O 0 0.008636200800538063
PAH B-Disease 1 0.9999996423721313
deficiency I-Disease 1 0.9999984502792358
correlate O 0 0.12195858359336853
with O 0 0.024737277999520302
PAH O 1 0.9999874830245972
genotypes O 1 0.714369535446167
. O 0 0.0004547138814814389

We O 0 1.4089792784943711e-05
identified O 0 6.004386523272842e-05
both O 0 5.292110472510103e-06
causative O 0 0.004138646647334099
mutations O 0 0.00044055652688257396
in O 0 5.805106775369495e-05
686 O 1 0.9901303648948669
patients O 1 0.998149037361145
from O 0 3.833260780083947e-05
seven O 0 5.17840962857008e-05
European O 0 0.00012075184349669144
centers O 0 0.000249699893174693
. O 0 0.00016512448200955987

On O 0 5.571161636908073e-06
the O 0 7.193647775238787e-07
basis O 0 1.5101279871032602e-07
of O 0 8.320866839994778e-08
the O 0 2.286941935381037e-06
phenotypic O 0 3.868393105221912e-05
characteristics O 0 2.0104464056203142e-05
of O 0 1.529515429865569e-05
297 O 0 0.24279406666755676
functionally O 1 0.9916062355041504
hemizygous O 1 0.9931545257568359
patients O 1 0.9970898032188416
, O 0 4.4091284507885575e-06
105 O 0 7.275853477040073e-06
of O 0 2.752974523900775e-07
the O 0 7.862965503591113e-06
mutations O 0 3.854620808851905e-05
were O 0 8.025024271773873e-07
assigned O 0 2.6872303351410665e-06
to O 0 7.225709452995943e-08
one O 0 1.0309252473916786e-07
of O 0 6.197925017659145e-08
four O 0 1.4693544017063687e-06
arbitrary O 0 2.5350724172312766e-05
phenotype O 0 0.00406036339700222
categories O 0 0.00021357228979468346
. O 0 0.00014058424858376384

We O 0 9.151099220616743e-06
proposed O 0 3.14431163133122e-05
and O 0 3.4295096611458575e-06
tested O 0 9.024149039760232e-05
a O 0 2.060490487565403e-06
simple O 0 2.506284545233939e-06
model O 0 2.7888702334166737e-06
for O 0 4.0206634821515763e-07
correlation O 0 2.889905317715602e-06
between O 0 3.4434312965458957e-06
genotype O 0 0.0003172652213834226
and O 0 4.482496933633229e-06
phenotypic O 0 0.0003125192888546735
outcome O 0 0.00031089314143173397
. O 0 0.00016887160018086433

The O 0 2.854182821465656e-05
observed O 0 0.00010523109813220799
phenotype O 0 0.0005403819959610701
matched O 0 5.937001697020605e-05
the O 0 1.1585490028664935e-05
predicted O 0 0.0002995352551806718
phenotype O 0 0.0004129073058720678
in O 0 6.347389444272267e-06
79 O 0 9.872252121567726e-05
% O 0 2.098860250043799e-06
of O 0 4.953944880980998e-07
the O 0 1.5799787433934398e-05
cases O 0 0.00015240517677739263
, O 0 2.7956714347965317e-06
and O 0 6.013987672304211e-07
in O 0 9.672569376562024e-07
only O 0 4.429559226082347e-07
5 O 0 2.21467848859902e-06
of O 0 1.4832008901066729e-06
184 O 0 0.009984531439840794
patients O 1 0.9974349141120911
was O 0 9.912229143083096e-05
the O 0 4.728002750198357e-06
observed O 0 4.3722608097596094e-05
phenotype O 0 0.00017557975661475211
more O 0 2.47413169063293e-07
than O 0 3.191575785876921e-07
one O 0 1.2336305417193216e-06
category O 0 7.553778686997248e-06
away O 0 2.9925338367320364e-06
from O 0 2.5884403385134647e-06
that O 0 2.536793090257561e-06
expected O 0 3.777510210056789e-05
. O 0 6.15789758739993e-05

Among O 0 1.1976914720435161e-05
the O 0 5.678935394826112e-06
seven O 0 1.8473712771083228e-05
contributing O 0 0.00012098373554181308
centers O 0 2.162748933187686e-05
, O 0 1.742188942444045e-06
the O 0 2.6719283141574124e-06
proportion O 0 1.3246110029285774e-05
of O 0 7.930803803901654e-06
patients O 1 0.9989184141159058
for O 0 4.8254673856718e-06
whom O 0 4.155213537160307e-05
the O 0 1.201691156893503e-05
observed O 0 0.00013156075146980584
phenotype O 0 0.0024420993868261576
did O 0 8.794187124294695e-06
not O 0 4.1892894842021633e-07
match O 0 2.1700916477129795e-06
the O 0 3.948841822420945e-06
predicted O 0 0.00020291554392315447
phenotype O 0 0.0005773073062300682
was O 0 7.007636304479092e-05
4 O 0 1.4033817933523096e-05
% O 0 5.584273822023533e-06
- O 0 5.265221989247948e-05
23 O 0 1.4889155863784254e-05
% O 0 2.425473212497309e-06
( O 0 6.804908480262384e-06
P O 0 0.001458456157706678
< O 0 0.0005068303435109556
. O 0 1.256738141819369e-05
0001 O 0 0.014757566154003143
) O 0 3.59364207724866e-06
, O 0 2.2746112335880753e-06
suggesting O 0 2.360512371524237e-05
that O 0 3.164564645885548e-07
differences O 0 2.762242047538166e-06
in O 0 7.199296305770986e-07
methods O 0 1.6980216059891973e-06
used O 0 5.913260338274995e-06
for O 0 4.662049832404591e-06
mutation O 0 0.000171816602232866
detection O 0 0.000501707661896944
or O 0 8.2361490058247e-05
phenotype O 0 0.01301562413573265
classification O 0 0.021685922518372536
may O 0 5.2286060963524505e-05
account O 0 5.600699068963877e-07
for O 0 4.014322598777653e-07
a O 0 4.312169949116651e-06
considerable O 0 4.428074134921189e-06
proportion O 0 9.605422746972181e-06
of O 0 4.948197329213144e-06
genotype O 0 0.031157011166214943
- O 0 0.19000263512134552
phenotype O 0 0.013418384827673435
inconsistencies O 0 0.0024555413983762264
. O 0 0.0001468073605792597

Our O 0 8.923528184823226e-06
data O 0 1.0891542842728086e-05
indicate O 0 5.394102481659502e-05
that O 0 4.800342139787972e-06
the O 0 0.000183754600584507
PAH O 1 0.9999436140060425
- O 0 0.0005773293669335544
mutation O 0 2.542287256801501e-05
genotype O 0 1.6846928701852448e-05
is O 0 3.647028563591448e-07
the O 0 6.865418527013389e-07
main O 0 7.579553766845493e-06
determinant O 0 3.6747209378518164e-05
of O 0 5.50558979739435e-06
metabolic O 1 0.998940646648407
phenotype O 0 0.08165756613016129
in O 0 4.538656503427774e-05
most O 0 0.000668996071908623
patients O 1 0.9998918771743774
with O 1 0.9977631568908691
PAH B-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999992847442627
. O 0 0.002109583467245102

In O 0 1.283682377106743e-05
the O 0 4.895103757007746e-06
present O 0 9.565211257722694e-06
study O 0 8.053712917899247e-06
, O 0 1.8456032648828113e-06
the O 0 4.423869995662244e-06
classification O 0 0.0008872468606568873
of O 0 9.466974006500095e-06
105 O 0 0.12471561878919601
PAH O 1 0.9999724626541138
mutations O 0 0.0002563180751167238
may O 0 1.1326940693834331e-05
allow O 0 1.8994644790382154e-07
the O 0 4.044133277147921e-07
prediction O 0 9.916890121530741e-06
of O 0 1.0170815301080438e-07
the O 0 8.477039955323562e-06
biochemical O 0 0.0008855368942022324
phenotype O 0 0.0009208179544657469
in O 0 1.01111891126493e-05
> O 0 0.00046008877689018846
10 O 0 8.697851626493502e-06
, O 0 4.207870460959384e-06
000 O 0 2.8355636459309608e-05
genotypes O 0 0.00016298503032885492
, O 0 1.679732804404921e-06
which O 0 7.058796995806915e-07
may O 0 5.417644842964364e-06
be O 0 1.36803791406237e-07
useful O 0 3.1836566449783277e-07
for O 0 1.3159026934772555e-07
the O 0 2.86531667370582e-06
management O 0 7.536749762948602e-05
of O 0 3.338112492201617e-06
hyperphenylalaninemia B-Disease 1 0.9984000325202942
in O 0 0.0004051587893627584
newborns O 1 0.9954110980033875
. O 0 0.000405793049139902

Somatic O 0 0.0019294270314276218
instability O 0 0.0002608404029160738
of O 0 1.9229269128118176e-06
the O 0 0.00010935091268038377
CTG O 0 0.14344188570976257
repeat O 0 0.002876406768336892
in O 0 3.0113718821667135e-05
mice O 0 0.004665359854698181
transgenic O 0 0.0004112788010388613
for O 0 3.030824700545054e-05
the O 0 0.003373776562511921
myotonic B-Disease 1 0.9999951124191284
dystrophy I-Disease 1 0.9999982118606567
region O 0 0.000507915101479739
is O 0 5.386181510402821e-05
age O 0 0.0002916001249104738
dependent O 0 5.2556508308043703e-05
but O 0 3.0870205591781996e-06
not O 0 5.787154009340156e-07
correlated O 0 1.2282631359994411e-05
to O 0 1.4952884441754577e-07
the O 0 1.4883698895573616e-06
relative O 0 3.732982440851629e-05
intertissue O 0 0.0019493000581860542
transcription O 0 0.0013354960829019547
levels O 0 0.002974370727315545
and O 0 7.379267481155694e-05
proliferative O 1 0.996042013168335
capacities O 0 0.002501859562471509
. O 0 0.00023856943880673498

A O 0 0.0014302765484899282
( O 0 0.00010869139805436134
CTG O 0 0.010667994618415833
) O 0 1.6538770069018938e-05
nexpansion O 0 0.0005438696825876832
in O 0 3.9271603782253806e-06
the O 0 7.852946509956382e-06
3 O 0 0.00011702485790010542
- O 0 0.000473827647510916
untranslated O 0 0.0006846609176136553
region O 0 1.5039715435705148e-05
( O 0 8.25326787889935e-06
UTR O 0 0.0007487967377528548
) O 0 1.100064764614217e-06
of O 0 3.51175145851812e-07
the O 0 5.374555257731117e-05
DM O 1 0.9966530203819275
protein O 0 0.0002655012649483979
kinase O 0 0.0004756320849992335
gene O 0 0.00012948000221513212
( O 0 2.3295817300095223e-05
DMPK O 0 0.007340333890169859
) O 0 5.690428224625066e-06
is O 0 4.305722541175783e-06
responsible O 0 5.055029032519087e-05
for O 0 0.0001703812595224008
causing O 1 0.9986823201179504
myotonic B-Disease 1 0.999992847442627
dystrophy I-Disease 1 0.9999982118606567
( O 1 0.9743312001228333
DM B-Disease 1 0.9999849796295166
) O 0 0.0008351277210749686
. O 0 0.0003082569455727935

Major O 0 0.0034903003834187984
instability O 0 0.002854863880202174
, O 0 9.646586477174424e-06
with O 0 4.317931143305032e-06
very O 0 1.1004929547198117e-05
large O 0 2.0759180188179016e-05
expansions O 0 6.664124521194026e-05
between O 0 3.6366545828059316e-06
generations O 0 1.964568582479842e-05
and O 0 2.650556325534126e-06
high O 0 0.00016137660713866353
levels O 0 5.726617746404372e-05
of O 0 1.3019013067605556e-06
somatic O 0 0.003004667116329074
mosaicism O 1 0.865156352519989
, O 0 8.589456228946801e-06
is O 0 6.978162673476618e-06
observed O 0 7.715229003224522e-05
in O 0 0.00024142468464560807
patients O 1 0.998616099357605
. O 0 0.0002783900999929756

There O 0 1.0802848009916488e-05
is O 0 4.059735601913417e-06
a O 0 4.8435495045850985e-06
good O 0 3.0156077173160156e-06
correlation O 0 2.8728686629619915e-06
between O 0 2.759672042884631e-06
repeat O 0 0.00030598972807638347
size O 0 1.3962665434519295e-05
( O 0 3.271850118835573e-06
at O 0 1.2164289728389122e-05
least O 0 1.955846300916164e-06
in O 0 5.3814396778761875e-06
leucocytes O 0 0.0025062107015401125
) O 0 1.0688901966204867e-05
, O 0 1.2454750503820833e-05
clinical O 0 0.018508950248360634
severity O 0 0.3615320324897766
and O 0 7.896444003563374e-06
age O 0 0.0004462466458790004
of O 0 3.664939504233189e-05
onset O 1 0.9999181032180786
. O 0 0.001103508984670043

The O 0 0.0009203078807331622
trinucleotide O 1 0.9920459985733032
repeat O 0 0.011816143989562988
instability O 0 0.001453088945709169
mechanisms O 0 0.0002486870507709682
involved O 0 0.0001554042537463829
in O 0 0.0003280389937572181
DM B-Disease 1 0.9999433755874634
and O 0 2.023603519774042e-05
other O 0 1.654814332141541e-05
human O 0 0.03253592178225517
genetic B-Disease 1 0.9998992681503296
diseases I-Disease 1 0.9999985694885254
are O 0 2.7674846933223307e-05
unknown O 0 0.0027694599702954292
. O 0 0.00027101841988041997

We O 0 1.8609798644320108e-05
studied O 0 0.00012125434295739979
somatic O 0 0.0008504660218022764
instability O 0 0.00026961846742779016
by O 0 9.170982593786903e-06
measuring O 0 0.0002647515502758324
the O 0 8.059256651904434e-05
CTG O 0 0.06796368211507797
repeat O 0 0.0006118406890891492
length O 0 3.874192771036178e-05
at O 0 1.9240282199461944e-05
several O 0 2.0535162548185326e-06
ages O 0 4.657413228414953e-05
in O 0 2.034929821093101e-06
various O 0 2.2555439045390813e-06
tissues O 0 0.0011319471523165703
of O 0 8.605575203546323e-06
transgenic O 0 0.0032927116844803095
mice O 0 0.0023345407098531723
carrying O 0 3.927676152670756e-05
a O 0 7.30697502149269e-05
( O 0 4.2686158849392086e-05
CTG O 0 0.00998488999903202
) O 0 1.7493130144430324e-05
55expansion O 0 0.000938687298912555
surrounded O 0 0.00013278174446895719
by O 0 3.35944923790521e-06
45 O 0 9.580066034686752e-06
kb O 0 6.848292105132714e-05
of O 0 1.1027789241779828e-06
the O 0 4.821718903258443e-05
human O 0 0.001096268999390304
DM B-Disease 1 0.9997809529304504
region O 0 4.5428922021528706e-05
, O 0 2.6442698981554713e-06
using O 0 2.6564980544208083e-06
small O 0 3.2622276194160804e-05
- O 0 0.0009751795441843569
pool O 0 0.0006750234169885516
PCR O 0 0.0007571312598884106
. O 0 5.7956483942689374e-05

These O 0 8.438283839495853e-05
mice O 0 0.00878127571195364
have O 0 4.3915033529629e-06
been O 0 8.050050382735208e-06
shown O 0 7.73155170463724e-06
to O 0 3.344914887293271e-07
reproduce O 0 1.5604317013639957e-05
the O 0 3.085707476202515e-06
intergenerational O 0 0.00017468967416789383
and O 0 4.2297901927668136e-06
somatic O 0 0.0001839979668147862
instability O 0 8.592203812440857e-05
of O 0 6.208478566804843e-07
the O 0 2.5980511054513045e-05
55 O 0 0.00041870283894240856
CTG O 0 0.14288926124572754
repeat O 0 0.0012397079262882471
suggesting O 0 0.00012757658259943128
that O 0 6.860751682324917e-07
surrounding O 0 5.753778623329708e-06
sequences O 0 3.1881304494163487e-06
and O 0 9.607563242752803e-07
the O 0 8.478932613797951e-06
chromatin O 0 0.0005227696383371949
environment O 0 3.331729749334045e-05
are O 0 9.56267172114167e-07
involved O 0 2.9391141652013175e-05
in O 0 2.539064735174179e-05
instability O 0 0.002230067504569888
mechanisms O 0 0.001017739181406796
. O 0 0.0003013118985109031

As O 0 3.6493223888101056e-05
observed O 0 1.3608369044959545e-05
in O 0 1.37314896164753e-06
some O 0 1.9409165474826295e-07
of O 0 7.731941877864301e-07
the O 0 3.928907972294837e-05
tissues O 0 0.24201396107673645
of O 0 0.0005755926249548793
DM B-Disease 1 0.9999990463256836
patients O 1 0.9998816251754761
, O 0 1.846131453930866e-05
there O 0 4.418658591021085e-06
is O 0 6.143939572211821e-06
a O 0 1.1648526196950115e-05
tendency O 0 0.00010072149598272517
for O 0 2.388949496889836e-06
repeat O 0 0.0004381925973575562
length O 0 4.3615793401841074e-05
and O 0 5.736535968026146e-06
somatic O 0 0.0005414296756498516
mosaicism O 0 0.006974392104893923
to O 0 5.748758553636435e-07
increase O 0 1.2056592595399707e-06
with O 0 3.877746053149167e-07
the O 0 1.9747096757782856e-06
age O 0 1.3694004337594379e-05
of O 0 6.246982593438588e-07
the O 0 5.987850818200968e-05
mouse O 0 0.0023557855747640133
. O 0 0.00011129189078928903

Furthermore O 0 0.0006673792959190905
, O 0 1.1864073712786194e-05
we O 0 1.2232776498422027e-06
observed O 0 4.872789304499747e-06
no O 0 1.2206625115140923e-06
correlation O 0 8.678651397531212e-07
between O 0 4.7329015728792e-07
the O 0 4.589229320117738e-06
somatic O 0 0.00028244982240721583
mutation O 0 0.0001067664343281649
rate O 0 0.00013376421702560037
and O 0 3.586759339668788e-05
tissue O 1 0.9982112646102905
proliferation O 0 0.46714526414871216
capacity O 0 0.00034707653685472906
. O 0 0.00010164213745156303

The O 0 0.00010520902287680656
somatic O 0 0.001078455476090312
mutation O 0 0.00035806369851343334
rates O 0 0.00011320663179503754
in O 0 1.973519829334691e-06
different O 0 1.261497118321131e-06
tissues O 0 0.002476318972185254
were O 0 5.248033176030731e-06
also O 0 2.6743682610685937e-06
not O 0 4.946429044139222e-07
correlated O 0 8.225577403209172e-06
to O 0 1.6876910535756906e-07
the O 0 2.092520617225091e-06
relative O 0 4.0600069041829556e-05
inter O 0 0.0019633390475064516
- O 0 0.006320356857031584
tissue O 0 0.009046008810400963
difference O 0 5.490478542924393e-06
in O 0 1.6439154251202126e-06
transcriptional O 0 3.199846833012998e-05
levels O 0 1.2136734767409507e-05
of O 0 1.1670443456068824e-07
the O 0 2.940693320852006e-06
three O 0 2.589492169136065e-06
genes O 0 1.6852263797773048e-05
( O 0 1.3474823390424717e-05
DMAHP O 0 0.00744003988802433
, O 0 1.629421785764862e-05
DMPK O 0 0.003474566852673888
and O 0 9.254995347873773e-06
59 O 0 0.0001677114050835371
) O 0 5.3941203077556565e-06
surrounding O 0 1.9443345081526786e-05
the O 0 2.4248016416095197e-05
repeat O 0 0.0043166084215044975
. O 0 3.0497691113851033e-05
. O 0 8.398193313041702e-05

A O 0 0.0006150636472739279
novel O 0 0.0005602692253887653
missense O 0 0.005596974864602089
mutation O 0 0.0012963295448571444
in O 0 0.00017180647409986705
patients O 1 0.9982081651687622
from O 0 8.048520248848945e-05
a O 0 0.001133513986133039
retinoblastoma B-Disease 1 0.996174693107605
pedigree O 0 0.02381785959005356
showing O 0 0.0002813921601045877
only O 0 1.303110366279725e-05
mild O 1 0.5804266333580017
expression O 0 2.1162088160053827e-05
of O 0 5.460140528157353e-06
the O 0 0.002736086957156658
tumor B-Disease 1 0.9998708963394165
phenotype O 0 0.26067689061164856
. O 0 0.0003273938491474837

We O 0 5.60840817342978e-06
have O 0 8.100779496089672e-07
used O 0 1.129751240114274e-06
single O 0 5.535683612833964e-06
strand O 0 3.935083805117756e-05
conformation O 0 1.4914481653249823e-05
polymorphism O 0 2.8875556381535716e-06
analysis O 0 2.0920747090258374e-07
to O 0 9.209199447468563e-08
study O 0 1.3384776593738934e-06
the O 0 1.0064003390652942e-06
27 O 0 8.973692274594214e-06
exons O 0 5.645434612233657e-06
of O 0 5.400993927651143e-07
the O 0 7.801136234775186e-05
RB1 O 1 0.9930139183998108
gene O 0 6.159459735499695e-05
in O 0 2.610006049508229e-06
individuals O 0 1.1565821296244394e-06
from O 0 8.880369932739995e-06
a O 0 2.897674494306557e-05
family O 0 0.00015639131015632302
showing O 0 0.0005908719613216817
mild O 1 0.9653003811836243
expression O 0 9.097619113163091e-06
of O 0 3.0713276828464586e-06
the O 0 0.0007341924938373268
retinoblastoma B-Disease 1 0.9988372921943665
phenotype O 0 0.3979301154613495
. O 0 0.0004683903243858367

In O 0 3.239244324504398e-05
this O 0 1.8507536879042163e-05
family O 0 0.00021791957260575145
affected O 0 0.0003557321906555444
individuals O 0 5.425908966572024e-05
developed O 0 0.04981721565127373
unilateral B-Disease 1 0.9776319265365601
tumors I-Disease 1 0.9999966621398926
and O 0 1.6043914001784287e-05
, O 0 4.183857981843175e-06
as O 0 3.4285153560631443e-06
a O 0 8.048653398873284e-06
result O 0 7.172574441938195e-06
of O 0 6.546351301039977e-07
linkage O 0 0.00028835725970566273
analysis O 0 1.0962884516629856e-05
, O 0 2.479943577782251e-05
unaffected O 0 0.011483662761747837
mutation O 0 0.00021385715808719397
carriers O 0 0.00011561223800526932
were O 0 3.6353997074911604e-06
also O 0 4.8694305405661e-06
identified O 0 1.2503722246037796e-05
within O 0 1.9912190509785432e-06
the O 0 2.73612004093593e-05
pedigree O 0 0.013800099492073059
. O 0 0.00014759591431356966

A O 0 0.00021467209444381297
single O 0 3.3598778827581555e-05
band O 0 9.938293806044385e-05
shift O 0 1.7740867406246252e-05
using O 0 1.081897244148422e-05
SSCP O 0 0.011595459654927254
was O 0 0.0001712523226160556
identified O 0 2.1136253053555265e-05
in O 0 3.727727062141639e-06
exon O 0 0.00030566786881536245
21 O 0 1.5642355720046908e-05
which O 0 6.442948006224469e-07
resulted O 0 1.3241929082141723e-05
in O 0 9.200348927151936e-07
a O 0 1.6604801203357056e-05
missense O 0 0.00012957979924976826
mutation O 0 1.9870209143846296e-05
converting O 0 1.2577607776620425e-05
a O 0 0.00010983047832269222
cys O 0 0.3969807028770447
- O 0 0.0011308877728879452
- O 0 0.0001928057026816532
> O 0 0.0001055653701769188
arg O 0 4.648082540370524e-05
at O 0 1.9573706140363356e-06
nucleotide O 0 3.0506541861541336e-06
position O 0 1.982841240533162e-06
28 O 0 6.695282991131535e-06
in O 0 1.4067286429053638e-06
the O 0 1.1915870345546864e-05
exon O 0 0.0018279376672580838
. O 0 9.525173663860187e-05

The O 0 0.00013077854237053543
mutation O 0 0.0005636197165586054
destroyed O 0 0.0009273707401007414
an O 0 4.105548941879533e-05
NdeI O 0 0.00373840075917542
restriction O 0 0.000182023155502975
enzyme O 0 0.0007266342872753739
site O 0 0.00023517326917499304
. O 0 5.268185486784205e-05

Analysis O 0 5.981959930068115e-06
of O 0 6.242009931156645e-07
all O 0 9.640751841288875e-07
family O 0 4.1104183765128255e-05
members O 0 3.1800107080925955e-06
demonstrated O 0 2.597228558443021e-05
that O 0 8.661700690026919e-07
the O 0 8.45403155835811e-06
missense O 0 0.0004761635500472039
mutation O 0 0.0003062281757593155
co O 0 0.0019773354288190603
- O 0 0.0012591466074809432
segregated O 0 0.001241920399479568
with O 0 0.0003016976115759462
patients O 1 0.999891996383667
with O 0 0.37779220938682556
tumors B-Disease 1 0.9999986886978149
or O 0 0.0007019488839432597
who O 0 6.437845149775967e-05
, O 0 2.3895463527878746e-06
as O 0 2.142619678124902e-06
a O 0 4.137441919738194e-06
result O 0 5.038214112573769e-06
of O 0 3.0227434422158694e-07
linkage O 0 0.0003350363112986088
analysis O 0 7.829196874808986e-06
had O 0 6.264539842959493e-05
been O 0 2.0382962247822434e-05
predicted O 0 1.866482307377737e-05
to O 0 3.3268099741690094e-07
carry O 0 3.39173425345507e-06
the O 0 8.785694262769539e-06
predisposing O 0 0.002972367685288191
mutation O 0 0.0007791385287418962
. O 0 0.00011286892549833283

These O 0 9.848794206845923e-07
observations O 0 1.2987442232770263e-06
point O 0 3.6189067031955346e-06
to O 0 4.695138500210305e-07
another O 0 3.4512891033955384e-06
region O 0 1.859583562691114e-06
of O 0 4.177819050710241e-07
the O 0 7.68169411458075e-05
RB1 O 1 0.9937864542007446
gene O 0 8.762249490246177e-05
where O 0 6.2407284531218465e-06
mutations O 0 1.452457217965275e-05
only O 0 3.13537469764924e-07
modify O 0 5.657853307639016e-06
the O 0 3.854484589282947e-07
function O 0 6.854682510493149e-07
of O 0 2.201037716531573e-07
the O 0 7.827225090295542e-06
gene O 0 4.4622353016166016e-05
and O 0 1.5046853150124662e-06
raise O 0 8.249506208812818e-06
important O 0 7.298483524209587e-07
questions O 0 4.781581992574502e-06
for O 0 2.091361693601357e-06
genetic O 0 0.00042917567770928144
counseling O 0 0.00043291240581311285
in O 0 4.9491418394609354e-06
families O 0 5.896738457522588e-06
with O 0 3.917793492291821e-06
these O 0 7.737121450190898e-06
distinctive O 0 0.0018458184786140919
phenotypes O 0 0.020764293149113655
. O 0 6.610110722249374e-05
. O 0 0.0002193500113207847

Maternal B-Disease 0 0.4347853362560272
disomy I-Disease 1 0.9279761910438538
and O 0 0.00604637898504734
Prader B-Disease 1 0.9999926090240479
- I-Disease 1 0.999958872795105
Willi I-Disease 1 0.9999949932098389
syndrome I-Disease 1 0.9999984502792358
consistent O 0 0.001769570866599679
with O 0 8.11380596132949e-05
gamete O 0 0.015422076918184757
complementation O 0 0.0652167871594429
in O 0 6.439393928303616e-06
a O 0 2.0409375792951323e-05
case O 0 1.8340129827265628e-05
of O 0 1.7194404335896252e-06
familial O 1 0.9909239411354065
translocation O 0 0.011854522861540318
( O 0 3.753229248104617e-05
3 O 0 3.563939026207663e-05
; O 0 5.6398707783955615e-06
15 O 0 8.895727660274133e-06
) O 0 4.1490629882900976e-06
( O 0 3.962433765991591e-06
p25 O 0 0.0005665443604812026
; O 0 6.671394203294767e-06
q11 O 0 0.00021371386537794024
. O 0 4.867420557275182e-06
2 O 0 2.734007648541592e-05
) O 0 1.2741264981741551e-05
. O 0 3.448051575105637e-05

Maternal B-Disease 1 0.8925808668136597
uniparental I-Disease 1 0.9936071634292603
disomy I-Disease 1 0.9574210047721863
( I-Disease 0 0.001169881783425808
UPD I-Disease 1 0.995428204536438
) I-Disease 0 1.2736125427181832e-05
for I-Disease 0 2.5663653104857076e-06
chromosome I-Disease 0 7.061112410156056e-05
15 I-Disease 0 5.839544883201597e-06
is O 0 1.1647877045106725e-06
responsible O 0 3.831019057543017e-06
for O 0 4.686267800479982e-07
an O 0 2.854992317224969e-06
estimated O 0 9.474326361669227e-06
30 O 0 2.685014578673872e-06
% O 0 8.3604373912749e-07
of O 0 6.801818699386786e-07
cases O 0 0.00032542497501708567
of O 0 0.00030913070077076554
Prader B-Disease 1 0.9999971389770508
- I-Disease 1 0.9999847412109375
Willi I-Disease 1 0.9999985694885254
syndrome I-Disease 1 0.9999998807907104
( O 1 0.9810815453529358
PWS B-Disease 1 0.9999833106994629
) O 0 0.0009704336407594383
. O 0 0.0002393733011558652

We O 0 1.0204592399531975e-05
report O 0 1.115072791435523e-05
on O 0 2.8078286504751304e-06
an O 0 3.192213398506283e-06
unusual O 0 2.8382932214299217e-05
case O 0 3.8767837395425886e-05
of O 0 3.562773372323136e-06
maternal B-Disease 0 0.12961657345294952
disomy I-Disease 0 0.09277302771806717
15 I-Disease 0 0.0002672169648576528
in O 0 0.0001665446034166962
PWS B-Disease 1 0.9998698234558105
that O 0 4.137556516070617e-06
is O 0 3.975318122684257e-06
most O 0 8.622313885098265e-07
consistent O 0 1.0030285011453088e-05
with O 0 5.440036147774663e-06
adjacent O 0 0.00031941302586346865
- O 0 0.00027155381394550204
1 O 0 7.762065251881722e-06
segregation O 0 3.946949072997086e-05
of O 0 3.4716362051767646e-07
a O 0 6.457755080191419e-05
paternal O 0 0.004744740203022957
t O 0 0.047080185264348984
( O 0 1.1018077202606946e-05
3 O 0 1.591948421264533e-05
; O 0 3.040221599803772e-06
15 O 0 8.83903521753382e-06
) O 0 2.374480573053006e-06
( O 0 4.340300165495137e-06
p25 O 0 0.0006920419400557876
; O 0 5.397773747972678e-06
q11 O 0 0.0001780867896741256
. O 0 1.868707158791949e-06
2 O 0 5.686543772753794e-06
) O 0 6.483016932179453e-07
with O 0 4.099506440979894e-07
simultaneous O 0 1.1846053894259967e-05
maternal O 0 0.0026490488089621067
meiotic O 0 0.02839556336402893
nondisjunction O 0 0.007302228827029467
for O 0 1.8180582628701814e-05
chromosome O 0 0.0008234327542595565
15 O 0 0.00014605115575250238
. O 0 0.00010197066876571625

The O 0 0.00048052481724880636
patient O 1 0.9808805584907532
( O 0 0.00011287248344160616
J O 1 0.9389457702636719
. O 0 1.6541389413760044e-05
B O 0 0.0002532971266191453
. O 0 1.2990859659112175e-06
) O 0 4.10557476016038e-07
, O 0 2.750998362444079e-07
a O 0 2.999013759108493e-06
17 O 0 3.6476449167821556e-05
- O 0 0.00012143137428211048
year O 0 3.199492857675068e-05
- O 0 0.00025737646501511335
old O 0 0.0005003873957321048
white O 0 0.0011490745237097144
male O 0 0.00042394292540848255
with O 0 0.00047391417319886386
PWS B-Disease 1 0.9999287128448486
, O 0 8.249180973507464e-05
was O 0 0.000599564693402499
found O 0 1.948853059730027e-05
to O 0 4.924767722513934e-07
have O 0 1.2232484323249082e-06
47 O 0 7.084031949489145e-06
chromosomes O 0 3.3795874969655415e-06
with O 0 3.734316806003335e-06
a O 0 6.314791244221851e-05
supernumerary O 0 0.12900185585021973
, O 0 2.1081597878946923e-05
paternal O 0 0.0027271551080048084
der O 0 0.10432804375886917
( O 0 7.283170816663187e-06
15 O 0 5.243401119514601e-06
) O 0 4.223048506446503e-07
consisting O 0 7.975370976964768e-07
of O 0 4.77585331282171e-07
the O 0 2.3485039491788484e-05
short O 0 0.0007243568543344736
arm O 0 0.005284666083753109
and O 0 3.6593096410797443e-06
the O 0 1.65605524671264e-05
proximal O 1 0.7427352070808411
long O 0 0.008119307458400726
arm O 0 0.009683039039373398
of O 0 3.6888261547574075e-06
chromosome O 0 0.0006995064904913306
15 O 0 4.002336208941415e-05
, O 0 6.969883543206379e-06
and O 0 1.594428249518387e-05
distal O 1 0.6338860392570496
chromosome O 0 0.25173524022102356
arm O 1 0.9966457486152649
3p O 1 0.9925500154495239
. O 0 0.0003219085338059813

The O 0 0.00033153672120533884
t O 0 0.02862497977912426
( O 0 1.661357600823976e-05
3 O 0 1.863153556769248e-05
; O 0 3.263143526055501e-06
15 O 0 6.281510195549345e-06
) O 0 1.937016349984333e-06
was O 0 9.826345376495738e-06
present O 0 1.2319763982304721e-06
in O 0 6.973127142373414e-07
the O 0 1.3383207715378376e-06
balanced O 0 1.0589903467916884e-05
state O 0 3.11660755869525e-06
in O 0 6.002361260470934e-06
the O 0 0.00011541705316631123
patients O 1 0.9980189800262451
father O 0 0.0006019902066327631
and O 0 1.5596549928886816e-05
a O 0 0.0003139479085803032
sister O 0 0.004966723266988993
. O 0 0.00017653999384492636

Fluorescent O 0 0.001488796784542501
in O 0 2.1453661247505806e-05
situ O 0 0.0015832793433219194
hybridization O 0 2.8874186682514846e-05
analysis O 0 9.112780389841646e-06
demonstrated O 0 7.136876956792548e-05
that O 0 5.642033102049027e-06
the O 0 0.00013856661098543555
PWS B-Disease 1 0.9998044371604919
critical O 0 0.00048222418990917504
region O 0 5.1443290431052446e-05
resided O 0 0.0002735552261583507
on O 0 5.709437573386822e-06
the O 0 5.598180450760992e-06
derivative O 0 0.00015782646369189024
chromosome O 0 0.00012490633525885642
3 O 0 9.708032848720904e-06
and O 0 7.084843218763126e-07
that O 0 1.0691619536373764e-06
there O 0 1.4935239960323088e-06
was O 0 3.7014189729234204e-05
no O 0 2.0563227280945284e-06
deletion O 0 2.6767289455165155e-05
of O 0 9.837341394813848e-07
the O 0 0.00018289127910975367
PWS B-Disease 1 0.9998205304145813
region O 0 1.1401220035622828e-05
on O 0 2.677453494470683e-06
the O 0 1.6567187230975833e-06
normal O 0 1.474803593737306e-05
pair O 0 5.619046078209067e-06
of O 0 1.0153967195947189e-06
15s O 0 0.004131338559091091
present O 0 2.668476190592628e-05
in O 0 9.843787120189518e-05
J O 1 0.9944562315940857
. O 0 0.00016599445370957255

B O 0 0.06033948063850403
. O 0 0.000526268093381077

Methylation O 0 4.241716305841692e-05
analysis O 0 4.2754227251862176e-06
at O 0 2.011800643231254e-05
exon O 0 9.513572149444371e-05
alpha O 0 5.821651484438917e-06
of O 0 1.285050927890552e-07
the O 0 3.978617769462289e-06
small O 0 3.805633241427131e-05
nuclear O 0 0.001477137440815568
ribonucleoprotein O 0 0.48991161584854126
- O 0 0.0005480732070282102
associated O 0 0.00011492987687233835
polypeptide O 0 0.001758518978022039
N O 0 0.0007384397904388607
( O 0 1.88105277629802e-05
SNRPN O 0 0.004381679464131594
) O 0 4.46980629931204e-06
gene O 0 3.124932118225843e-05
showed O 0 3.458339051576331e-05
a O 0 8.75189380167285e-06
pattern O 0 4.6840716095175594e-05
characteristic O 0 9.74790509644663e-06
of O 0 2.959414757697232e-07
only O 0 1.9120263914373936e-06
the O 0 1.622015770408325e-05
maternal O 0 0.003570334520190954
chromosome O 0 0.00041147074080072343
15 O 0 6.0135327657917514e-05
in O 0 5.7777517213253304e-05
J O 1 0.99595707654953
. O 0 0.00012971367686986923

B O 0 0.07450289279222488
. O 0 0.00039074168307706714

Maternal B-Disease 0 0.3686024844646454
disomy I-Disease 0 0.191217303276062
was O 0 0.0024157084990292788
confirmed O 0 0.000240633002249524
by O 0 7.122263923520222e-06
polymerase O 0 0.0005833896575495601
chain O 0 0.00021232562721706927
reaction O 0 1.9309929484734312e-05
analysis O 0 7.748247980998713e-07
of O 0 7.720874464212102e-07
microsatellite O 0 0.0012079973239451647
repeats O 0 0.0003526335349306464
at O 0 1.7224934708792716e-05
the O 0 5.698090717487503e-06
gamma O 0 0.00028852117247879505
- O 0 0.00031451802351512015
aminobutyric O 0 0.0011839264770969748
acid O 0 0.0023092827759683132
receptor O 0 0.0005930557381361723
beta3 O 0 0.0011483283014968038
subunit O 0 7.89007535786368e-05
( O 0 4.033479854115285e-05
GABRB3 O 0 0.008978256955742836
) O 0 2.2239837562665343e-05
locus O 0 0.00029770462424494326
. O 0 5.7243520132033154e-05

A O 0 0.0009041838929988444
niece O 0 0.00923912599682808
( O 0 3.828872650046833e-05
B O 0 0.0009680442162789404
. O 0 4.658361376641551e-06
B O 0 0.00017580273561179638
. O 0 6.286252869358577e-07
) O 0 3.996853763510444e-07
with O 0 2.3442440522103425e-07
45 O 0 7.922208737909386e-07
chromosomes O 0 6.999631523285643e-07
and O 0 1.7398565432813484e-07
the O 0 6.974124744374421e-07
derivative O 0 2.86808171949815e-05
3 O 0 1.0046330316981766e-05
but O 0 3.0159499146975577e-06
without O 0 3.9194305827550124e-06
the O 0 1.4431622730626259e-05
der O 0 0.00929489079862833
( O 0 6.0258071243879385e-06
15 O 0 4.562157300824765e-06
) O 0 1.934525926117203e-06
demonstrated O 0 1.1756365893234033e-05
a O 0 1.4360987734107766e-05
phenotype O 0 0.00030585413333028555
consistent O 0 2.010193384194281e-05
with O 0 2.7775950002251193e-06
that O 0 3.7550116758211516e-06
reported O 0 6.772852066205814e-05
for O 0 1.6562779592277366e-06
haploinsufficiency O 0 0.0003778907412197441
of O 0 1.906831244014029e-06
distal O 1 0.7233525514602661
3 O 0 0.0014889365993440151
p O 0 0.023505687713623047
. O 0 0.00019912766583729535

Uniparental B-Disease 1 0.9976115226745605
disomy I-Disease 1 0.9894591569900513
associated O 0 0.0009681787923909724
with O 0 9.971194958779961e-05
unbalanced O 0 0.2487320601940155
segregation O 0 0.0013295764802023768
of O 0 5.838163815496955e-06
non O 0 0.0009363872231915593
- O 0 0.006365684792399406
Robertsonian O 0 0.005194759927690029
translocations O 0 0.0004459693736862391
has O 0 3.634835593402386e-05
been O 0 5.92131182202138e-05
reported O 0 0.0002704371581785381
previously O 0 9.911038796417415e-05
but O 0 8.207789505831897e-06
has O 0 3.4960901302838465e-06
not O 0 4.5896396727584943e-07
, O 0 2.3132103876832844e-07
to O 0 5.702689520603599e-08
our O 0 1.2005862970454473e-07
knowledge O 0 1.285745156565099e-06
, O 0 1.6120300188049441e-06
been O 0 2.6375503239250975e-06
observed O 0 5.747071554651484e-06
in O 0 3.0669195894006407e-06
a O 0 6.201690121088177e-05
case O 0 0.0002073319919873029
of O 0 8.048259769566357e-05
PWS B-Disease 1 0.9998778104782104
. O 0 0.000815033505205065

Furthermore O 0 0.0007552591268904507
, O 0 8.75362275110092e-06
our O 0 3.184836259606527e-06
findings O 0 3.769664908759296e-05
are O 0 4.2797898913704557e-07
best O 0 2.4044531983236084e-06
interpreted O 0 1.2857357432949357e-05
as O 0 3.582207000363269e-06
true O 0 3.128157914034091e-05
gamete O 0 0.002135571790859103
complementation O 0 0.03070848248898983
resulting O 0 0.0009283188846893609
in O 0 0.00015804813301656395
maternal B-Disease 1 0.9820607900619507
UPD I-Disease 1 0.9989649057388306
15 I-Disease 0 0.001156692742370069
and O 0 0.0007229817565530539
PWS B-Disease 1 0.9995250701904297

Schwartz B-Disease 1 0.9058352708816528
- I-Disease 1 0.9947255253791809
Jampel I-Disease 1 0.9980772733688354
syndrome I-Disease 1 0.9999967813491821
type I-Disease 1 0.5218348503112793
2 I-Disease 0 0.0010130265727639198
and O 0 0.00011736257147276774
Stuve B-Disease 1 0.9974976181983948
- I-Disease 1 0.999269425868988
Wiedemann I-Disease 1 0.9998106360435486
syndrome I-Disease 1 0.9999963045120239
: O 0 4.207272286294028e-05
a O 0 5.171046359464526e-05
case O 0 0.00010345114424126223
for O 0 5.634322860714747e-06
" O 0 2.8988048143219203e-05
lumping O 0 0.0009804248111322522
" O 0 6.277648935792968e-05
. O 0 4.055224417243153e-05

Recent O 0 0.00028884646599180996
studies O 0 2.1238978661131114e-05
demonstrated O 0 4.285481190891005e-05
the O 0 4.547943262878107e-06
existence O 0 1.1147633813379798e-05
of O 0 6.576486271114845e-07
a O 0 4.892077049589716e-05
genetically O 0 7.099868525983766e-05
distinct O 0 1.2333598533587065e-05
, O 0 4.764930508827092e-06
usually O 0 1.4187276974553242e-05
lethal O 0 0.00026653328677639365
form O 0 9.063310244528111e-06
of O 0 3.5500072499417e-06
the O 0 0.0009130280814133584
Schwartz B-Disease 1 0.959087610244751
- I-Disease 1 0.9973957538604736
Jampel I-Disease 1 0.9979559183120728
syndrome I-Disease 1 0.9999980926513672
( O 0 0.010326783172786236
SJS B-Disease 1 0.9993149042129517
) O 0 3.5421991924522445e-05
of O 0 4.5050437620375305e-05
myotonia B-Disease 1 0.9997103810310364
and O 0 0.0029307156801223755
skeletal B-Disease 1 0.9999752044677734
dysplasia I-Disease 1 0.9999924898147583
, O 0 0.00011814700701506808
which O 0 1.2508719919424038e-05
we O 0 1.0710830792959314e-05
called O 0 0.00189340696670115
SJS B-Disease 1 0.9968851208686829
type I-Disease 0 0.0015935031697154045
2 I-Disease 0 0.00016343944298569113
. O 0 5.5812812206568196e-05

This O 0 0.0008490874315612018
disorder O 1 0.9998486042022705
is O 0 3.249082146794535e-05
reminiscent O 0 0.0003398764238227159
of O 0 3.847561401926214e-06
another O 0 0.0006726101855747402
rare O 1 0.9598755836486816
condition O 1 0.9997442364692688
, O 0 5.3803603805135936e-05
the O 0 0.00045954063534736633
Stuve B-Disease 1 0.997281551361084
- I-Disease 1 0.9994581341743469
Wiedemann I-Disease 1 0.9998512268066406
syndrome I-Disease 1 0.9999985694885254
( O 0 0.0021091760136187077
SWS B-Disease 1 0.9980131387710571
) O 0 2.0126217350480147e-05
, O 0 2.648787585712853e-06
which O 0 8.845460115480819e-07
comprises O 0 1.088033059204463e-05
campomelia B-Disease 0 0.002543909475207329
at O 0 0.0001875234884209931
birth O 0 0.0061249262653291225
with O 0 0.0013519767671823502
skeletal B-Disease 1 0.9999773502349854
dysplasia I-Disease 1 0.9999972581863403
, O 0 0.002482946263626218
contractures B-Disease 1 0.9993637204170227
, O 0 3.594199370127171e-05
and O 0 1.3110830877849367e-05
early B-Disease 0 0.0005107953911647201
death I-Disease 0 0.02776394784450531
. O 0 0.00012847322796005756

To O 0 8.931191587180365e-06
test O 0 2.0026125639560632e-05
for O 0 2.399257937213406e-06
possible O 0 2.550908538978547e-05
nosologic O 0 0.003122778609395027
identity O 0 2.6363022698205896e-05
between O 0 2.8186539566377178e-05
these O 0 0.00019980095385108143
disorders O 1 0.9999879598617554
, O 0 1.601810618012678e-05
we O 0 1.3418864455161383e-06
reviewed O 0 1.38080013130093e-05
the O 0 9.582079201209126e-07
literature O 0 1.1462001339168637e-06
and O 0 5.214783413975965e-07
obtained O 0 3.269086619184236e-06
a O 0 4.380427526484709e-06
follow O 0 1.7370426803609007e-06
- O 0 7.359399660344934e-06
up O 0 1.2768259693984874e-07
of O 0 2.1619758427959823e-08
the O 0 3.361611220498162e-07
only O 0 3.305188727154018e-07
two O 0 2.823935346896178e-06
surviving O 1 0.7893057465553284
patients O 1 0.9987500905990601
, O 0 5.8370728766021784e-06
one O 0 4.1987473196059e-06
with O 0 6.910271622473374e-05
SJS B-Disease 1 0.9986675977706909
type I-Disease 0 0.000598931044805795
2 I-Disease 0 2.6048533982248046e-05
at O 0 3.3815333154052496e-05
age O 0 3.913065302185714e-05
10 O 0 2.2134454411570914e-06
years O 0 3.3744215670594713e-06
and O 0 6.620181807193148e-07
another O 0 7.498075774492463e-06
with O 0 1.2790498658432625e-05
SWS B-Disease 1 0.9852554798126221
at O 0 0.00011714074207702652
age O 0 0.0003690521407406777
7 O 0 8.132583752740175e-05
years O 0 0.00010186472354689613
. O 0 7.648143946425989e-05

Patients O 1 0.9985236525535583
reported O 0 0.004901064094156027
as O 0 0.00010331095108995214
having O 0 0.001164410263299942
either O 0 0.012267869897186756
neonatal O 1 0.9999743700027466
SJS B-Disease 1 0.9997934699058533
or O 0 0.0005474589415825903
SWS B-Disease 1 0.918813169002533
presented O 0 2.323435910511762e-05
a O 0 1.756590063450858e-05
combination O 0 5.091026469017379e-05
of O 0 2.8841868697782047e-06
a O 0 0.01105351559817791
severe O 1 0.9999322891235352
, O 0 0.001841675373725593
prenatal O 1 0.999595582485199
- O 1 0.9997456669807434
onset O 1 0.9999899864196777
neuromuscular B-Disease 1 0.9999990463256836
disorder I-Disease 1 0.9999983310699463
( O 0 0.12828518450260162
with O 1 0.987457811832428
congenital B-Disease 1 1.0
joint I-Disease 1 0.9998788833618164
contractures I-Disease 1 0.9999920129776001
, O 1 0.9980043768882751
respiratory O 1 0.9999994039535522
and O 0 0.0011588162742555141
feeding O 1 0.8325541019439697
difficulties O 0 0.11707129329442978
, O 0 7.739073771517724e-05
tendency O 0 0.0008843095856718719
to O 0 3.553649003151804e-05
hyperthermia B-Disease 1 0.9993419051170349
, O 0 1.4556882888427936e-05
and O 0 4.534924300969578e-06
frequent O 0 0.00026961564435623586
death O 0 0.00960894301533699
in O 0 4.47062193416059e-05
infancy O 0 0.27902674674987793
) O 0 7.456780167558463e-06
with O 0 2.816445203279727e-06
a O 0 4.671086207963526e-05
distinct O 0 0.00014928847667761147
campomelic B-Disease 1 0.9943600296974182
- I-Disease 1 0.997300922870636
metaphyseal I-Disease 1 0.9965280890464783
skeletal I-Disease 1 0.9998922348022461
dysplasia I-Disease 1 0.999968409538269
. O 0 0.0030827117152512074

The O 0 1.2322758266236633e-05
similarity O 0 1.672105645411648e-05
of O 0 1.8454202290740795e-06
the O 0 0.00010706720786402002
clinical O 0 0.04606730118393898
and O 0 4.61545423604548e-05
radiographic O 0 0.08158128708600998
findings O 0 0.0005575254908762872
is O 0 1.385585892421659e-05
so O 0 9.737628715811297e-06
extensive O 0 0.00016091272118501365
that O 0 7.952851774462033e-06
these O 0 2.643804509716574e-05
disorders O 1 0.9999637603759766
appear O 0 5.253395647741854e-05
to O 0 7.53865549540933e-07
be O 0 8.208213557736599e-07
a O 0 7.1786857915867586e-06
single O 0 1.3496171959559433e-05
entity O 0 8.204511686926708e-05
. O 0 0.00010234941873932257

The O 0 3.0515846447087824e-05
follow O 0 2.67730065388605e-05
- O 0 6.873153324704617e-05
up O 0 1.1746993777705939e-06
observation O 0 7.446803465427365e-06
of O 0 8.581938004681433e-08
an O 0 2.531891595936031e-06
identical O 0 1.54962526721647e-05
and O 0 1.5713872016931418e-06
unique O 0 4.429662112670485e-06
pattern O 0 0.00014475398347713053
of O 0 2.625884189910721e-05
progressive O 1 0.9997153878211975
bone B-Disease 1 0.9999991655349731
dysplasia I-Disease 1 0.9999922513961792
in O 0 0.00010532746819080785
the O 0 9.96946546365507e-05
two O 0 0.00026162524591200054
patients O 1 0.9997113347053528
( O 0 2.4163484340533614e-05
one O 0 1.1527781680342741e-05
with O 0 0.00011687140795402229
SJS B-Disease 1 0.9995390176773071
type I-Disease 0 0.0008294200524687767
2 I-Disease 0 3.156957609462552e-05
, O 0 1.9080516722169705e-06
one O 0 1.1692640100591234e-06
with O 0 2.4509328795829788e-05
SWS B-Disease 1 0.9940515160560608
) O 0 2.5003448172356002e-05
surviving O 0 0.0007836871081963181
beyond O 0 0.0001108278229366988
infancy O 0 0.01380100380629301
adds O 0 4.561358582577668e-05
to O 0 2.793880469198484e-07
the O 0 1.2123581427658792e-06
evidence O 0 6.022997240506811e-06
in O 0 9.794709967536619e-07
favor O 0 1.587941710567975e-06
of O 0 1.4069044027564814e-06
identity O 0 7.42132542654872e-05
. O 0 0.00012623901420738548

The O 0 0.00012432668881956488
hypothesis O 0 0.0005820919177494943
that O 0 0.00012570808758027852
SWS B-Disease 1 0.9901028871536255
and O 0 0.0003071363316848874
SJS B-Disease 1 0.9980384707450867
type I-Disease 0 0.0007126473356038332
2 I-Disease 0 2.391280941083096e-05
are O 0 3.923960605334287e-07
the O 0 5.9976459851895925e-06
same O 0 0.00013170887541491538
disorder O 1 0.9999080896377563
should O 0 5.671812232321827e-06
be O 0 1.3902615592087386e-06
testable O 0 1.094499839382479e-05
by O 0 1.6152092712218291e-06
molecular O 0 4.672681461670436e-05
methods O 0 1.5305777196772397e-05
. O 0 2.888751623686403e-05
. O 0 7.244496373459697e-05

A O 0 0.0012398379622027278
mouse O 0 0.001514578703790903
model O 0 0.00012055143452016637
of O 0 0.00014965176524128765
severe O 1 0.9999932050704956
von B-Disease 1 0.9999967813491821
Willebrand I-Disease 1 0.9999988079071045
disease I-Disease 1 1.0
: O 1 0.9941850304603577
defects O 1 0.9999606609344482
in O 0 0.007052702829241753
hemostasis O 1 0.9998761415481567
and O 0 0.03353644534945488
thrombosis B-Disease 1 0.9999908208847046
. O 0 0.004028115887194872

von B-Disease 1 0.9884870052337646
Willebrand I-Disease 1 0.9985802173614502
factor I-Disease 0 0.005169998854398727
( I-Disease 0 0.0017417529597878456
vWf I-Disease 1 0.9913924932479858
) I-Disease 0 0.36794883012771606
deficiency I-Disease 1 0.999998927116394
causes O 1 0.999913215637207
severe O 1 0.9999983310699463
von B-Disease 1 0.9999982118606567
Willebrand I-Disease 1 0.9999995231628418
disease I-Disease 1 1.0
in O 0 0.00485491007566452
humans O 0 0.012359913438558578
. O 0 0.00032444726093672216

We O 0 5.885490736545762e-06
generated O 0 2.8798140192520805e-06
a O 0 9.156380656349938e-06
mouse O 0 0.00010763317550299689
model O 0 7.343358902289765e-06
for O 0 2.0353138552309247e-06
this O 0 3.068083242396824e-05
disease O 1 0.99988853931427
by O 0 4.843438546231482e-06
using O 0 1.0855995242309291e-05
gene O 0 0.00011248920054640621
targeting O 0 4.713295493274927e-05
. O 0 7.258389086928219e-05

vWf B-Disease 1 0.9634419083595276
- I-Disease 1 0.9931350946426392
deficient I-Disease 1 0.999377965927124
mice O 0 0.07666691392660141
appeared O 0 0.0005660774186253548
normal O 0 0.00020159033010713756
at O 0 8.977336983662099e-05
birth O 0 0.0006931761745363474
; O 0 7.714538696745876e-06
they O 0 1.0321839454263682e-06
were O 0 3.851765086437808e-06
viable O 0 4.8053676437120885e-05
and O 0 8.694650205143262e-06
fertile O 0 0.0018565658247098327
. O 0 0.0001468877453589812

Neither O 0 0.008599523454904556
vWf O 0 0.1287219375371933
nor O 0 0.00595979206264019
vWf O 0 0.09882716834545135
propolypeptide O 0 0.18156252801418304
( O 0 0.0006490983651019633
von B-Disease 1 0.9902287721633911
Willebrand I-Disease 1 0.999366819858551
antigen O 1 0.9971325397491455
II O 1 0.997470498085022
) O 0 1.7840238797361962e-05
were O 0 8.649428309581708e-06
detectable O 0 0.000692306028213352
in O 0 5.4094925872050226e-06
plasma O 0 0.0006339683313854039
, O 0 1.3643961210618727e-05
platelets O 0 0.026306210085749626
, O 0 1.228237397299381e-05
or O 0 3.622955046012066e-05
endothelial O 0 0.03477902710437775
cells O 0 5.3020641644252464e-05
of O 0 5.117818773214822e-07
the O 0 2.2172498574946076e-05
homozygous O 0 0.00134192721452564
mutant O 0 0.004657706245779991
mice O 0 0.023092404007911682
. O 0 9.20535676414147e-05

The O 0 0.00020788902475032955
mutant O 0 0.02236052416265011
mice O 1 0.9450942873954773
exhibited O 0 0.3792290985584259
defects O 1 0.9997001886367798
in O 0 0.0002030853065662086
hemostasis O 1 0.9968992471694946
with O 0 6.830813072156161e-05
a O 0 0.001287945662625134
highly O 1 0.5265271067619324
prolonged O 1 0.9997543692588806
bleeding O 1 0.9999767541885376
time O 0 6.1017050029477105e-05
and O 0 3.8428392144851387e-05
spontaneous O 0 0.01986546628177166
bleeding O 1 0.9999061822891235
events O 0 6.852062597317854e-06
in O 0 2.8883762297482463e-06
approximately O 0 4.236895165377064e-06
10 O 0 7.338542673096526e-06
% O 0 7.3135729508067016e-06
of O 0 8.095211342151742e-06
neonates O 1 0.979300320148468
. O 0 0.00029949008603580296

As O 0 3.809968620771542e-05
in O 0 1.5439989510923624e-05
the O 0 5.686483928002417e-05
human O 0 0.008745579048991203
disease O 1 0.9999836683273315
, O 0 6.606813713005977e-06
the O 0 6.689474957966013e-06
factor O 0 6.364552245941013e-05
VIII O 0 0.04215473681688309
level O 0 4.8462334234500304e-05
in O 0 4.231008460919838e-06
these O 0 4.14705345974653e-06
mice O 0 0.003764408640563488
was O 0 0.00022265313600655645
reduced O 0 6.587990355910733e-05
strongly O 0 1.4453716175921727e-05
as O 0 1.2958539628016297e-06
a O 0 5.541747214010684e-06
result O 0 5.362478987080976e-06
of O 0 2.1247426218451437e-07
the O 0 6.697837761748815e-06
lack O 0 0.00010723067680373788
of O 0 2.2378544599632733e-06
protection O 0 0.0022544884122908115
provided O 0 0.0001134277117671445
by O 0 9.915915870806202e-05
vWf O 0 0.053848620504140854
. O 0 0.0003266654966864735

Defective O 1 0.9992358684539795
thrombosis B-Disease 1 0.9999593496322632
in O 0 0.0004317802668083459
mutant O 0 0.0166887566447258
mice O 0 0.0691738948225975
was O 0 0.0004140801611356437
also O 0 5.073701231594896e-06
evident O 0 4.4402982894098386e-05
in O 0 1.3068287216810859e-06
an O 0 4.0675872696738224e-06
in O 0 5.906587830395438e-06
vivo O 0 0.00011169514618813992
model O 0 3.445205220486969e-05
of O 0 0.0001058505367836915
vascular B-Disease 1 0.9999967813491821
injury I-Disease 1 0.9999157190322876
. O 0 0.0016883419593796134

In O 0 1.385526320518693e-05
this O 0 2.413806441836641e-06
model O 0 8.995164535008371e-06
, O 0 2.5451581677771173e-06
the O 0 7.776290658512153e-06
exteriorized O 0 0.0030376804061233997
mesentery O 0 0.012411019764840603
was O 0 0.0007190288160927594
superfused O 0 0.003256873693317175
with O 0 3.342543641338125e-05
ferric O 1 0.999211311340332
chloride O 1 0.8294700384140015
and O 0 1.091208469006233e-05
the O 0 2.2132167941890657e-05
accumulation O 0 0.0055145202204585075
of O 0 2.461961776134558e-05
fluorescently O 1 0.9892706871032715
labeled O 1 0.5407962799072266
platelets O 1 0.9481693506240845
was O 0 0.00037925093783997
observed O 0 3.533852213877253e-05
by O 0 1.2396674719639122e-05
intravital O 0 0.0049255057238042355
microscopy O 0 0.0008095583762042224
. O 0 0.0001393696293234825

We O 0 1.0859866051760036e-05
conclude O 0 9.028331987792626e-05
that O 0 2.5364688553963788e-06
these O 0 3.492261384963058e-06
mice O 0 0.0031354601960629225
very O 0 4.3522100895643234e-05
closely O 0 0.0005768791306763887
mimic O 1 0.9909489750862122
severe O 1 0.999953031539917
human O 1 0.9973607659339905
von B-Disease 1 0.9999909400939941
Willebrand I-Disease 1 0.9999980926513672
disease I-Disease 1 0.9999998807907104
and O 0 6.355703226290643e-05
will O 0 3.727406920006615e-06
be O 0 1.5548569081147434e-06
very O 0 1.0470974984855275e-06
useful O 0 8.26643201889965e-07
for O 0 4.4426573708733486e-07
investigating O 0 2.4001205019885674e-05
the O 0 1.8487211264073267e-06
role O 0 5.35096432940918e-06
of O 0 2.512370201657177e-06
vWf O 0 0.003172289114445448
in O 0 1.2572380910569336e-05
normal O 0 0.00035295591806061566
physiology O 0 0.008173099718987942
and O 0 3.939620000892319e-05
in O 0 0.0007368711521849036
disease O 1 0.9999911785125732
models O 0 0.00029838515911251307
. O 0 4.4596912630368024e-05
. O 0 7.483195076929405e-05

Oral O 0 0.11391792446374893
contraceptives O 0 0.02626274898648262
and O 0 1.934760803123936e-05
the O 0 0.00010578062210697681
risk O 0 0.21530908346176147
of O 0 0.0003734804049599916
hereditary B-Disease 1 0.9999960660934448
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
. O 0 0.005514558870345354

Hereditary B-Disease 1 0.9998940229415894
Ovarian I-Disease 1 0.9999991655349731
Cancer I-Disease 1 0.9999924898147583
Clinical O 1 0.9852230548858643
Study O 0 0.001103959046304226
Group O 0 0.0003823697043117136
. O 0 0.0003358694084454328

BACKGROUND O 0 0.0006208842969499528
Women O 0 4.488790364121087e-05
with O 0 1.1385377547412645e-05
mutations O 0 7.397097942885011e-05
in O 0 5.1912070375692565e-06
either O 0 1.3683938050235156e-05
the O 0 2.1829229808645323e-05
BRCA1 O 0 0.004847709089517593
or O 0 9.634652997192461e-06
the O 0 8.965061169874389e-06
BRCA2 O 0 0.0013080437202006578
gene O 0 1.8710446965997107e-05
have O 0 9.553027666697744e-07
a O 0 2.9706918212468736e-05
high O 0 0.0017809123964980245
lifetime O 0 0.04939930886030197
risk O 1 0.773052453994751
of O 0 0.009643598459661007
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
. O 0 0.00471124891191721

Oral O 1 0.9355724453926086
contraceptives O 1 0.9857193827629089
protect O 0 0.20470157265663147
against O 1 0.9979264736175537
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999988079071045
in O 0 7.832756818970665e-05
general O 0 0.000101040284789633
, O 0 1.0424432730360422e-05
but O 0 2.957991455332376e-06
it O 0 7.434048825416539e-07
is O 0 9.791572210815502e-07
not O 0 6.710578190904926e-07
known O 0 4.746977992908796e-06
whether O 0 1.949507122844807e-06
they O 0 7.265621775331965e-07
also O 0 3.5741534247790696e-06
protect O 0 3.598822877393104e-05
against O 0 2.5436840587644838e-05
hereditary B-Disease 1 0.9942604303359985
forms I-Disease 0 0.0033347478602081537
of I-Disease 1 0.9268734455108643
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
. O 0 0.005717014893889427

METHODS O 0 8.475671347696334e-05
We O 0 1.24154385048314e-05
enrolled O 0 0.00034598202910274267
207 O 0 0.000849260191898793
women O 0 9.038943971972913e-05
with O 0 0.0013896053424105048
hereditary B-Disease 1 0.9999822378158569
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999991655349731
and O 0 3.104827555944212e-05
161 O 0 8.221647294703871e-05
of O 0 1.0127645282409503e-06
their O 0 4.773385171574773e-06
sisters O 0 7.704774179728702e-05
as O 0 4.539260316960281e-06
controls O 0 8.140297723002732e-06
in O 0 2.912437821578351e-06
a O 0 2.855238926713355e-05
case O 0 0.00028982965159229934
- O 0 0.00040704660932533443
control O 0 4.6681114326929674e-05
study O 0 9.836861863732338e-05
. O 0 4.7439585614483804e-05

All O 0 4.021218046545982e-06
the O 0 8.371520380023867e-05
patients O 1 0.8659968972206116
carried O 0 1.4741511222382542e-05
a O 0 2.7605679861153476e-05
pathogenic O 0 0.00045534176751971245
mutation O 0 6.115803262218833e-05
in O 0 3.8662319639115594e-06
either O 0 4.9213449528906494e-05
BRCA1 O 0 0.006668795365840197
( O 0 1.4686870599689428e-05
179 O 0 0.00016679569671396166
women O 0 2.3042826796881855e-05
) O 0 9.31032445805613e-06
or O 0 3.742927947314456e-05
BRCA2 O 0 0.004269343335181475
( O 0 1.6465435692225583e-05
28 O 0 9.83122517936863e-05
women O 0 3.594418740249239e-05
) O 0 1.636827437323518e-05
. O 0 2.8496137019828893e-05

The O 0 7.918892515590414e-05
control O 0 0.0001609067403478548
women O 0 3.960220419685356e-05
were O 0 6.595318609470269e-06
enrolled O 0 6.094489071983844e-05
regardless O 0 2.759782773864572e-06
of O 0 3.5696669442586426e-07
whether O 0 1.0669397852325346e-05
or O 0 1.121804234571755e-05
not O 0 1.4323701407192857e-06
they O 0 9.82254846348951e-07
had O 0 1.7523469068692066e-05
either O 0 2.355715332669206e-05
mutation O 0 0.0002667386725079268
. O 0 5.091104321763851e-05

Lifetime O 0 0.0030385630670934916
histories O 0 0.00027773555484600365
of O 0 1.0169143934035674e-05
oral O 1 0.9854788780212402
- O 0 0.21170799434185028
contraceptive O 0 0.010613678954541683
use O 0 3.992741767433472e-06
were O 0 2.309080855411594e-06
obtained O 0 1.07964415292372e-05
by O 0 5.986777068756055e-06
interview O 0 0.00014377306797541678
or O 0 4.11489418183919e-06
by O 0 1.0963279919451452e-06
written O 0 2.312706328666536e-06
questionnaire O 0 7.616854418301955e-05
and O 0 5.1276465455885045e-06
were O 0 1.2549153325380757e-05
compared O 0 0.00018256981275044382
between O 0 0.00011591182556003332
patients O 1 0.9994238615036011
and O 0 9.489027434028685e-06
control O 0 0.00010380787716712803
women O 0 2.3405869796988554e-05
, O 0 4.294301561458269e-06
after O 0 4.8778361815493554e-05
adjustment O 0 7.134753104764968e-05
for O 0 7.479133614651801e-07
year O 0 5.8811028793570586e-06
of O 0 6.904176643729443e-07
birth O 0 0.002350021153688431
and O 0 2.0330951883806847e-05
parity O 0 0.005855809431523085
. O 0 0.00018584102508611977

RESULTS O 0 0.0006594549049623311
The O 0 4.7870445996522903e-05
adjusted O 0 0.0009594269213266671
odds O 0 0.004820059984922409
ratio O 0 0.0009726212592795491
for O 0 0.014602764509618282
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999990463256836
associated O 0 0.00039704065420664847
with O 0 3.774035576498136e-06
any O 0 2.4212808966694865e-06
past O 0 1.934005695147789e-06
use O 0 6.80409584674635e-07
of O 0 1.4218387605069438e-06
oral O 1 0.8304665088653564
contraceptives O 1 0.9015209078788757
was O 0 0.003931900952011347
0 O 0 6.910732918186113e-05
. O 0 4.280498615116812e-05

5 O 0 0.00012636632891371846
( O 0 7.133207873266656e-06
95 O 0 1.1117292160633951e-05
percent O 0 8.330192031280603e-06
confidence O 0 5.5245659495994914e-06
interval O 0 4.656655619328376e-06
, O 0 5.425242193268787e-07
0 O 0 9.005858032651304e-07
. O 0 1.7967636267712805e-07
3 O 0 5.628875214824802e-07
to O 0 1.348038836113119e-07
0 O 0 1.5631054566256353e-06
. O 0 1.2676161986746592e-06
8 O 0 1.2109242561564315e-05
) O 0 5.247932676866185e-06
. O 0 1.3304205822350923e-05

The O 0 0.0004291462537366897
risk O 0 0.03678203374147415
decreased O 0 0.0014217306161299348
with O 0 3.3676512884994736e-06
increasing O 0 9.169828445010353e-06
duration O 0 1.2315897038206458e-05
of O 0 2.4861188308022975e-07
use O 0 3.6896351502946345e-06
( O 0 9.290155503549613e-06
P O 0 0.00023933587362989783
for O 0 1.643250811866892e-06
trend O 0 4.1379567846888676e-05
, O 0 2.1333830773073714e-06
< O 0 7.370104140136391e-05
0 O 0 2.0181234958727146e-06
. O 0 1.609624291631917e-06
001 O 0 7.919276686152443e-05
) O 0 2.855436775917042e-07
; O 0 9.198350880978978e-08
use O 0 7.509537880423522e-08
for O 0 1.2067860666320485e-07
six O 0 1.3438074120131205e-06
or O 0 2.8202780413266737e-06
more O 0 4.3125751858497097e-07
years O 0 1.3366853636398446e-05
was O 0 8.946331217885017e-05
associated O 0 8.700273610884324e-06
with O 0 1.3318717719812412e-06
a O 0 1.6492749637109227e-05
60 O 0 1.7396159819327295e-05
percent O 0 4.214628643239848e-05
reduction O 0 0.0006324053392745554
in O 0 3.5817789466818795e-05
risk O 0 0.11349856108427048
. O 0 0.00012040369620081037

Oral O 0 0.3684791624546051
- O 0 0.041389260441064835
contraceptive O 0 0.020650742575526237
use O 0 6.156013841973618e-05
protected O 1 0.6019582152366638
against O 1 0.9924458861351013
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999979734420776
both O 0 5.206567038840149e-06
for O 0 4.876876118942164e-06
carriers O 0 5.785024768556468e-05
of O 0 5.338820301403757e-07
the O 0 4.237609027768485e-05
BRCA1 O 0 0.02600540593266487
mutation O 0 0.00014018946967553347
( O 0 7.770181582600344e-06
odds O 0 0.00015833457291591913
ratio O 0 8.763845471548848e-06
, O 0 1.306876015405578e-06
0 O 0 1.5002163991084672e-06
. O 0 3.510324972921808e-07
5 O 0 1.064029220287921e-06
; O 0 5.158617568667978e-07
95 O 0 1.7341824332106626e-06
percent O 0 3.3038948004104896e-06
confidence O 0 4.4161056393932085e-06
interval O 0 4.072322099091252e-06
, O 0 5.389864554672386e-07
0 O 0 5.611103119917971e-07
. O 0 1.448954236593636e-07
3 O 0 3.457864181655168e-07
to O 0 6.915498573789591e-08
0 O 0 8.239530302489584e-07
. O 0 3.2858855547601706e-07
9 O 0 2.228759967692895e-06
) O 0 1.4510658274957677e-07
and O 0 7.785707367702344e-08
for O 0 2.60021749909356e-07
carriers O 0 1.1685779099934734e-05
of O 0 2.555972287154873e-07
the O 0 2.3303016860154457e-05
BRCA2 O 0 0.004807732999324799
mutation O 0 7.707874465268105e-05
( O 0 6.90992055751849e-06
odds O 0 0.0002763780939858407
ratio O 0 1.510808306193212e-05
, O 0 1.4438907101066434e-06
0 O 0 2.026014499278972e-06
. O 0 7.960310313137597e-07
4 O 0 3.5267305520392256e-06
; O 0 6.078278715904162e-07
95 O 0 2.9103748602210544e-06
percent O 0 2.649856241987436e-06
confidence O 0 3.834246854239609e-06
interval O 0 6.228147412912222e-06
, O 0 8.472106856061146e-07
0 O 0 1.113717758016719e-06
. O 0 3.6550824233927415e-07
2 O 0 8.24366452434333e-07
to O 0 1.2975590379937785e-07
1 O 0 2.5195445232384373e-06
. O 0 1.1193698128408869e-06
1 O 0 6.891920747875702e-06
) O 0 4.586683189700125e-06
. O 0 1.2421478459145874e-05

CONCLUSIONS O 0 0.0020157075487077236
Oral O 0 0.11609486490488052
- O 0 0.015092156827449799
contraceptive O 0 0.005021225661039352
use O 0 1.3717203728447203e-05
may O 0 0.00013013552234042436
reduce O 0 0.0001859016192611307
the O 0 3.3968695788644254e-05
risk O 0 0.1816573590040207
of O 0 0.0015976082067936659
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999990463256836
in O 0 3.215661854483187e-05
women O 0 3.1521656637778506e-05
with O 0 1.9412107576499693e-05
pathogenic O 0 0.0015214107697829604
mutations O 0 4.5815126213710755e-05
in O 0 7.058526989567326e-06
the O 0 6.631052383454517e-05
BRCA1 O 0 0.1436329483985901
or O 0 0.0003063631011173129
BRCA2 O 0 0.046891700476408005
gene O 0 0.0027339658699929714

A O 0 0.0013991284649819136
Japanese O 0 0.0027331493329256773
family O 0 0.0002654294075910002
with O 0 0.00015784904826432467
adrenoleukodystrophy B-Disease 1 0.9998186230659485
with O 0 1.2584050637087785e-05
a O 0 3.916365312761627e-05
codon O 0 6.971244147280231e-05
291 O 0 0.00022905267542228103
deletion O 0 0.00032199721317738295
: O 0 6.254301297303755e-06
a O 0 5.651851824950427e-05
clinical O 0 0.002798842266201973
, O 0 1.425636492058402e-05
biochemical O 0 0.0025180885568261147
, O 0 3.797577664954588e-05
pathological O 1 0.9555562138557434
, O 0 1.4634188119089231e-05
and O 0 1.6441381376353092e-05
genetic O 0 0.002205534838140011
report O 0 0.0006193576264195144
. O 0 0.0001475289318477735

We O 0 3.681413363665342e-05
report O 0 7.600941171403974e-05
a O 0 4.893840377917513e-05
Japanese O 0 0.0007032040739431977
family O 0 0.0007181232213042676
with O 0 0.001931354170665145
adrenoleukodystrophy B-Disease 1 0.999991774559021
( O 0 0.02764071337878704
ALD B-Disease 1 0.9999842643737793
) O 0 1.449938372388715e-05
with O 0 1.1201408369743149e-06
a O 0 7.936220754345413e-06
three O 0 1.3030938816882554e-06
base O 0 1.0471600035089068e-05
pair O 0 2.5060669941012748e-05
deletion O 0 0.0005511069903150201
( O 0 1.8918433852377348e-05
delGAG O 0 0.0013683360302820802
291 O 0 0.00024961563758552074
) O 0 4.893442110187607e-06
in O 0 6.882784418849042e-06
the O 0 0.0002495580702088773
ALD B-Disease 1 0.9998518228530884
gene O 0 0.0029550634790211916
. O 0 0.0001382559275953099

A O 0 0.00015284717665053904
variety O 0 1.7112404748331755e-05
of O 0 2.679519866433111e-06
phenotypes O 0 0.0015704690013080835
were O 0 6.10291044722544e-06
observed O 0 1.3077251423965208e-05
within O 0 2.9144023301341804e-06
this O 0 1.1306811757094692e-05
family O 0 0.00026777980383485556
. O 0 0.00011783297668443993

While O 0 5.207591675571166e-05
the O 0 7.935227040434256e-05
proband O 0 0.02951142005622387
( O 0 0.00017545690934639424
patient O 1 0.58914715051651
1 O 0 0.00010095900506712496
) O 0 1.5744408301543444e-05
was O 0 0.000406867970013991
classified O 0 0.0004913913435302675
as O 0 6.566192041645991e-06
having O 0 1.8749280570773408e-05
a O 0 2.3799353584763594e-05
rare O 0 0.0003378995170351118
intermediate O 0 0.0006951089017093182
type O 0 0.00037183394306339324
of O 0 6.968766683712602e-06
adult O 0 0.060083914548158646
cerebral O 1 0.9997993111610413
and O 0 0.00036585115594789386
cerebello O 1 0.9977846741676331
- O 1 0.9973661303520203
brain O 1 0.9983439445495605
stem O 0 0.0030693060252815485
forms O 0 5.7839984947349876e-05
, O 0 1.0964483408315573e-05
his O 0 0.00012724004045594484
younger O 0 0.0010576717322692275
brother O 0 0.0021520485170185566
( O 0 0.0001520195510238409
patient O 1 0.7234367728233337
2 O 0 5.765769674326293e-05
) O 0 8.519085895386524e-06
and O 0 6.3654661062173545e-06
nephew O 0 0.00743640772998333
( O 0 0.00013006458175368607
patient O 1 0.5725460648536682
3 O 0 6.21729195700027e-05
) O 0 1.815310497477185e-05
had O 0 0.00013181417307350785
a O 0 0.000763728457968682
childhood O 1 0.9973421692848206
ALD B-Disease 1 0.9999784231185913
type O 1 0.9864699244499207
. O 0 0.0005802540690638125

Another O 0 0.000722300261259079
nephew O 0 0.031008180230855942
( O 0 0.0002501963172107935
patient O 1 0.5136505365371704
4 O 0 4.744832040159963e-05
) O 0 4.447364517545793e-06
of O 0 2.129854010490817e-06
patient O 1 0.9780824184417725
1 O 0 9.349584433948621e-05
was O 0 0.0006628888077102602
classified O 0 0.0010005530202761292
as O 0 3.6060700949747115e-06
having O 0 2.6099807655555196e-05
an O 0 2.3162947400123812e-05
adolescent O 0 0.03586160019040108
form O 0 0.0003204867534805089
. O 0 0.0001901513314805925

The O 0 6.478338036686182e-05
tau O 0 0.0011107265017926693
level O 0 9.439796122023836e-05
in O 0 9.490873708273284e-06
the O 0 6.635289901169017e-05
cerebrospinal O 1 0.8737428784370422
fluid O 0 0.08871468156576157
( O 0 0.0003012639353983104
CSF O 1 0.9696241021156311
) O 0 1.1249690032855142e-05
in O 0 1.261822853848571e-05
patient O 0 0.10098524391651154
1 O 0 2.5731864297995344e-05
was O 0 0.00011302735947538167
as O 0 4.7499170250375755e-06
high O 0 3.784368163906038e-05
as O 0 1.8693737047215109e-06
that O 0 1.0118840236827964e-06
of O 0 8.52532684803009e-06
patients O 1 0.9998098015785217
with O 1 0.9626297950744629
Alzheimers B-Disease 1 0.9999995231628418
disease I-Disease 1 0.9999984502792358
( O 0 0.002742000389844179
AD B-Disease 0 0.026103273034095764
) O 0 0.0001465816021664068
. O 0 0.00010986943379975855

His O 0 0.0012471622321754694
brain O 1 0.8570713996887207
magnetic O 0 0.00023573156795464456
resonance O 0 0.0004013344878330827
image O 0 0.0010762346209958196
( O 0 0.00016940444766078144
MRI O 1 0.5807134509086609
) O 0 5.640351082547568e-05
showed O 0 0.0030440310947597027
abnormalities B-Disease 1 0.9961557984352112
in I-Disease 0 9.556604709359817e-06
the I-Disease 0 3.738724990398623e-05
bilateral I-Disease 0 0.0018423472065478563
cerebellar I-Disease 1 0.9991242289543152
hemispheres I-Disease 0 0.011615648865699768
and O 0 0.000618882360868156
brain O 1 0.9998175501823425
stem O 0 0.2617890238761902
, O 0 8.845190677675419e-06
but O 0 2.8739946174027864e-06
not O 0 7.794292855578533e-07
in O 0 3.981730060331756e-06
the O 0 0.0001805943320505321
cerebral O 1 0.9998040795326233
white O 0 0.024057939648628235
matter O 0 2.2920621631783433e-05
, O 0 6.0080997172917705e-06
where O 0 5.335620244295569e-06
marked O 0 7.127803837647662e-05
reductions O 0 5.4390053264796734e-05
of O 0 1.1470235676824814e-06
the O 0 0.000417342409491539
cerebral O 1 0.9998948574066162
blood O 1 0.9953047037124634
flow O 0 0.00024390792532358319
and O 0 3.775824370677583e-05
oxygen O 0 0.028643617406487465
metabolism O 0 0.006196312606334686
were O 0 5.669979145750403e-06
clearly O 0 2.6767875169753097e-05
demonstrated O 0 2.9246257327031344e-05
by O 0 1.0591842510621063e-05
positron O 0 0.002007866045460105
emission O 0 0.0003610912535805255
tomography O 0 0.000684412952978164
( O 0 8.674596028868109e-05
PET O 0 0.022259196266531944
) O 0 4.417823220137507e-05
. O 0 7.501600339310244e-05

In O 0 0.0005646892241202295
patients O 1 0.9922283291816711
2 O 0 5.541631981031969e-05
and O 0 2.6847840217669727e-06
3 O 0 1.1571068171178922e-05
, O 0 2.3401526050292887e-06
the O 0 6.215953362698201e-06
autopsy O 0 0.013385963626205921
findings O 0 0.0006436171825043857
showed O 0 0.0022178019862622023
massive O 0 0.04535644128918648
demyelination B-Disease 1 0.9989399313926697
of I-Disease 0 1.4600566828448791e-05
the I-Disease 0 0.005363949574530125
cerebral I-Disease 1 0.9999505281448364
white I-Disease 0 0.019730987027287483
matter I-Disease 0 1.509330832050182e-05
with O 0 2.9851228191546397e-06
sparing O 0 5.543354927795008e-05
of O 0 1.3653258292833925e-06
the O 0 6.395050877472386e-05
U O 1 0.972987174987793
- O 0 0.007798292674124241
fibers O 0 0.00729158241301775
, O 0 1.76731384726736e-06
compatible O 0 2.7842249892273685e-06
with O 0 1.1512140645209001e-06
the O 0 4.809204710909398e-06
findings O 0 9.219103958457708e-05
of O 0 2.6670693841879256e-05
childhood O 1 0.9992876648902893
ALD B-Disease 1 0.9999862909317017
. O 0 0.0025494350120425224

Oleic O 0 0.18325722217559814
and O 0 0.00014074075443204492
erucic O 1 0.7315263152122498
acids O 0 0.0009259286453016102
( O 0 9.465269977226853e-05
Lorenzos O 0 0.006144929211586714
Oil O 0 0.00013034067524131387
) O 0 3.925816599803511e-06
were O 0 2.71286376118951e-06
administered O 0 8.884128328645602e-05
to O 0 6.64803428662708e-06
patients O 1 0.7406161427497864
1 O 0 1.872508437372744e-05
and O 0 1.7122861208918039e-06
4 O 0 1.4153073607303668e-05
, O 0 1.992147872442729e-06
but O 0 1.5377993349829921e-06
sufficient O 0 1.4336862477648538e-05
effectiveness O 0 0.00018613325664773583
was O 0 7.851481495890766e-05
not O 0 2.0417178347997833e-06
obtained O 0 4.819677269551903e-05
. O 0 5.4152191296452656e-05

The O 0 6.557528831763193e-05
findings O 0 9.102319745579734e-05
in O 0 5.791460807813564e-06
this O 0 4.611059011949692e-06
family O 0 5.6690707424422726e-05
suggest O 0 1.8456721591064706e-05
that O 0 1.6186974107768037e-06
delGAG291 O 0 0.00020153459627181292
is O 0 1.0606474916130537e-06
part O 0 1.0038274922408164e-06
of O 0 4.0013694047047466e-07
the O 0 4.7588528104824945e-05
cause O 0 0.002707874169573188
of O 0 1.6288515325868502e-05
Japanese O 1 0.9056192636489868
ALD B-Disease 1 0.9999535083770752
with O 0 3.163063229294494e-05
phenotypic O 0 0.0010889502009376884
variations O 0 0.0006964473286643624
. O 0 0.00036444165743887424

Moreover O 0 0.0005711594130843878
, O 0 8.35785067465622e-06
although O 0 3.958029992645606e-06
the O 0 8.912591624721244e-07
scale O 0 3.085042635575519e-06
of O 0 1.2555305772821157e-07
the O 0 3.0803212212049402e-06
study O 0 8.717208402231336e-06
is O 0 2.611410081954091e-06
limited O 0 2.895395255109179e-06
, O 0 6.899108484503813e-07
there O 0 3.676315998291102e-07
is O 0 8.495003385178279e-07
a O 0 5.189137937122723e-06
possibility O 0 2.5769975763978437e-05
that O 0 7.7579497883562e-06
PET O 0 0.0040526557713747025
can O 0 8.993792107503396e-06
detect O 0 0.0008445674902759492
an O 0 8.97632708074525e-05
insidious B-Disease 1 0.9939291477203369
lesion I-Disease 1 0.9997522234916687
which O 0 1.7458532965974882e-05
is O 0 3.8461679650936276e-05
undetectable O 0 0.07082972675561905
by O 0 1.0428629138914403e-05
computed O 0 0.00017356219177599996
tomogram O 0 0.011376346461474895
( O 0 0.00012198926560813561
CT O 1 0.9058898687362671
) O 0 1.3785316696157679e-05
or O 0 1.8065200492856093e-05
MRI O 0 0.00206174748018384
analysis O 0 2.3968887035152875e-06
, O 0 1.1129002359666629e-06
and O 0 2.588198526609631e-07
that O 0 2.4879594207050104e-07
the O 0 8.920508776100178e-07
higher O 0 7.876820745877922e-06
level O 0 4.426098257681588e-06
of O 0 3.132063568500598e-07
tau O 0 0.00022339061251841486
reflects O 0 4.321655069361441e-06
the O 0 8.580871622143604e-07
process O 0 3.321497842989629e-06
of O 0 1.0374804332968779e-05
neuronal B-Disease 1 0.9693732261657715
degeneration I-Disease 1 0.9999678134918213
in O 0 0.03788811340928078
ALD B-Disease 1 0.9999772310256958
. O 0 0.002044795546680689

Lorenzos O 0 0.017398010939359665
Oil O 0 0.00030391738982871175
should O 0 2.6258296657033497e-06
be O 0 4.835860067942122e-07
given O 0 4.20856224536692e-07
in O 0 6.670692869192862e-07
the O 0 2.1277367068250896e-06
early O 0 3.206230394425802e-05
stage O 0 0.00036052457289770246
. O 0 2.136447983502876e-05
. O 0 5.280493132886477e-05

Nonsense O 0 0.002733140252530575
mutation O 0 0.00015571308904327452
in O 0 6.367554760799976e-06
exon O 0 0.00021521394955925643
4 O 0 8.033669473661575e-06
of O 0 4.325269173932611e-07
human O 0 2.303346809640061e-05
complement O 0 4.718935088021681e-05
C9 O 0 0.4248541593551636
gene O 0 4.485410681809299e-05
is O 0 2.6956413421430625e-06
the O 0 4.122372956771869e-06
major O 0 0.0001320332958130166
cause O 0 0.0010809997329488397
of O 0 4.982784957974218e-06
Japanese O 0 0.030411290004849434
complement B-Disease 0 0.06851296126842499
C9 I-Disease 1 0.9998371601104736
deficiency I-Disease 1 0.9999955892562866
. O 0 0.0008008170407265425

Deficiency B-Disease 1 0.9998102784156799
of I-Disease 0 3.4469862839614507e-06
the I-Disease 0 2.482890158717055e-05
ninth I-Disease 0 0.0005864296690560877
component I-Disease 0 2.1992991605657153e-05
of I-Disease 0 4.193414611108892e-07
human I-Disease 0 6.049469448043965e-05
complement I-Disease 0 7.598363299621269e-05
( O 0 5.858550866832957e-05
C9 O 1 0.8052317500114441
) O 0 4.435707069205819e-06
is O 0 8.812949658931757e-07
the O 0 1.7121441260314896e-06
most O 0 6.8193567130947486e-06
common O 0 0.0006520588649436831
complement B-Disease 1 0.9872196912765503
deficiency I-Disease 1 0.9999992847442627
in O 0 7.918681512819603e-05
Japan O 0 0.0008158459677360952
but O 0 1.5513449397985823e-05
is O 0 1.014661120279925e-05
rare O 0 0.0001740459119901061
in O 0 2.8969252525712363e-06
other O 0 1.601090730218857e-06
countries O 0 3.4429422157700174e-06
. O 0 5.648166188620962e-05

We O 0 2.6145849005843047e-06
studied O 0 6.34332309346064e-06
the O 0 9.753667882250738e-07
molecular O 0 1.9181674360879697e-05
basis O 0 2.3577285901410505e-06
of O 0 2.6528308808337897e-05
C9 B-Disease 1 0.9997751116752625
deficiency I-Disease 1 0.9999884366989136
in O 0 1.8126913346350193e-05
four O 0 7.109936996130273e-05
Japanese O 1 0.9253113269805908
C9 B-Disease 1 0.999863862991333
- I-Disease 1 0.9996265172958374
deficient I-Disease 1 0.9999680519104004
patients O 1 0.9995515942573547
who O 0 0.00507735088467598
had O 1 0.7691545486450195
suffered O 1 0.9999591112136841
from O 1 0.5583033561706543
meningococcal B-Disease 1 0.9999938011169434
meningitis I-Disease 1 0.9999889135360718
. O 0 0.0018612672574818134

Direct O 0 7.190868927864358e-06
sequencing O 0 1.1991542123723775e-05
of O 0 2.4040587049967144e-06
amplified O 0 0.000673003843985498
C9 O 0 0.013356066308915615
cDNA O 0 3.602624201448634e-05
and O 0 1.891553665700485e-06
DNA O 0 0.00010974315227940679
revealed O 0 0.00024781888350844383
a O 0 1.636786873859819e-05
nonsense O 0 0.000167225967743434
substitution O 0 2.163037788704969e-05
( O 0 1.285698999708984e-05
CGA O 0 0.003553579328581691
- O 0 0.00064565718639642
- O 0 0.00017483049305155873
> O 0 9.444270835956559e-05
TGA O 0 0.0009030998917296529
) O 0 1.1726510820153635e-06
at O 0 3.154932983306935e-06
codon O 0 2.282943114551017e-06
95 O 0 1.71259966919024e-06
in O 0 4.069031547260238e-07
exon O 0 3.4049517125822604e-05
4 O 0 2.631899405969307e-06
in O 0 4.4143018840259174e-07
the O 0 6.15666158410022e-06
four O 0 6.185222446219996e-05
C9 B-Disease 1 0.9989546537399292
- I-Disease 1 0.9923948049545288
deficient I-Disease 1 0.9988046884536743
individuals O 0 5.6333199609071016e-05
. O 0 0.0001676330721238628

An O 0 5.311092172632925e-05
allele O 0 0.00012695825716946274
- O 0 0.00010598356311675161
specific O 0 2.509958676455426e-06
polymerase O 0 0.0005788002163171768
chain O 0 0.0008388166897930205
reaction O 0 0.00019488262478262186
system O 0 0.00010770031076390296
designed O 0 3.027750972250942e-05
to O 0 1.1557881407497916e-06
detect O 0 4.4835971493739635e-05
exclusively O 0 1.1706966915880912e-06
only O 0 1.388571888583101e-07
one O 0 9.363273534290784e-08
of O 0 8.085622482667532e-08
the O 0 2.8711922368529486e-06
normal O 0 3.3155396522488445e-05
and O 0 2.3883069388830336e-06
mutant O 0 7.404007919831201e-05
alleles O 0 2.4559070880059153e-05
indicated O 0 6.3333660364151e-05
that O 0 3.215892832031386e-07
all O 0 1.2335347321368317e-07
the O 0 3.97249823436141e-06
four O 0 2.4491808289894834e-05
patients O 1 0.8998484015464783
were O 0 7.337507213378558e-06
homozygous O 0 2.4865861632861197e-05
for O 0 5.89892636071454e-07
the O 0 3.877352810377488e-06
mutation O 0 3.364001167938113e-05
in O 0 2.475031124049565e-06
exon O 0 0.0002270780096296221
4 O 0 1.2361881999822799e-05
and O 0 3.330066533635545e-07
that O 0 2.897846229643619e-07
the O 0 8.552155463803501e-07
parents O 0 4.797545898327371e-06
of O 0 1.4536756225425052e-06
patient O 1 0.8775935769081116
2 O 0 8.687966328579932e-05
were O 0 2.207841316703707e-05
heterozygous O 0 0.0004311049124225974
. O 0 6.103835767135024e-05

The O 0 2.1875201127841137e-05
common O 0 3.423066664254293e-05
mutation O 0 3.817111792159267e-05
at O 0 1.4394868230738211e-05
codon O 0 1.021514708554605e-05
95 O 0 4.8372808123531286e-06
in O 0 1.9212129700463265e-06
exon O 0 0.00020849387510679662
4 O 0 2.31872563745128e-05
might O 0 5.4697929954272695e-06
be O 0 4.736974403840577e-07
responsible O 0 3.2035738968261285e-06
for O 0 1.962535179700353e-06
most O 0 3.2356758310925215e-05
Japanese O 1 0.7934187650680542
C9 B-Disease 1 0.9999055862426758
deficiency I-Disease 1 0.9999983310699463
. O 0 0.00021472139633260667
. O 0 0.00018829262990038842

BRCA1 O 0 0.004852123558521271
required O 0 2.2079591872170568e-05
for O 0 6.374335043801693e-06
transcription O 0 0.002766616875305772
- O 0 0.008460246957838535
coupled O 0 0.0020327323582023382
repair O 0 0.18935276567935944
of O 0 1.2936565326526761e-05
oxidative O 1 0.9931545257568359
DNA O 1 0.6029929518699646
damage O 1 0.9969454407691956
. O 0 0.0003725009155459702

The O 0 0.009885339066386223
breast B-Disease 1 0.9999098777770996
and I-Disease 1 0.722270131111145
ovarian I-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999953508377075
susceptibility O 1 0.6864311695098877
gene O 0 0.0008006968419067562
BRCA1 O 0 0.002694554626941681
encodes O 0 3.6143759643891826e-05
a O 0 0.00014502809790428728
zinc O 1 0.944953441619873
finger O 0 0.0011310698464512825
protein O 0 1.5493962564505637e-05
of O 0 1.1073411769757513e-06
unknown O 0 0.00020373640290927142
function O 0 0.000150619656778872
. O 0 0.00011286375956842676

Association O 0 0.0003167221148032695
of O 0 1.227608777298883e-06
the O 0 2.3176557078841142e-05
BRCA1 O 0 0.0010436279699206352
protein O 0 9.21213813853683e-06
with O 0 1.1529457424330758e-06
the O 0 9.026003681356087e-06
DNA O 0 0.0009033606620505452
repair O 1 0.7389522790908813
protein O 0 0.00042020814726129174
Rad51 O 0 0.007288673892617226
and O 0 1.2713402384179062e-06
changes O 0 1.1556878689589212e-06
in O 0 2.939993350992154e-07
the O 0 5.454230631585233e-07
phosphorylation O 0 1.1550433782758773e-06
and O 0 4.367107351299637e-07
cellular O 0 1.5229915334202815e-05
localization O 0 5.075946774013573e-06
of O 0 1.1911693320598715e-07
the O 0 2.8339177333691623e-06
protein O 0 5.4265612561721355e-05
after O 0 0.00013920202036388218
exposure O 0 0.001618791720829904
to O 0 3.0317269192892127e-06
DNA O 0 0.001097581465728581
- O 0 0.001695053419098258
damaging O 0 0.0008596981060691178
agents O 0 2.0074368876521476e-05
are O 0 1.604103232466514e-07
consistent O 0 5.71137070437544e-06
with O 0 1.1505380825838074e-06
a O 0 7.609581643919228e-06
role O 0 1.2005525604763534e-05
for O 0 6.899582331243437e-06
BRCA1 O 0 0.007018255535513163
in O 0 3.738297164090909e-05
DNA O 0 0.014160984195768833
repair O 1 0.9961791038513184
. O 0 0.00035836180904880166

Here O 0 9.062169556273147e-05
, O 0 5.2018372116435785e-06
it O 0 1.1963201131948153e-06
is O 0 2.2546062155015534e-06
shown O 0 7.900481250544544e-06
that O 0 1.7707064898786484e-06
mouse O 0 0.0005822275998070836
embryonic O 0 0.0036454549990594387
stem O 0 0.132205069065094
cells O 0 0.3649986982345581
deficient B-Disease 1 0.9992403984069824
in I-Disease 0 7.786019705235958e-05
BRCA1 I-Disease 0 0.033964063972234726
are O 0 5.750339369114954e-06
defective O 0 0.19638383388519287
in O 0 3.580099701139261e-06
the O 0 2.709874479478458e-06
ability O 0 3.1781705729372334e-06
to O 0 2.0153143509560323e-07
carry O 0 1.0974409860864398e-06
out O 0 2.5388962967554107e-06
transcription O 0 0.0004394657153170556
- O 0 0.0013055432355031371
coupled O 0 0.0009523904882371426
repair O 0 0.06672452390193939
of O 0 8.534079825039953e-06
oxidative O 1 0.9934611320495605
DNA O 0 0.4966980516910553
damage O 1 0.9969803690910339
, O 0 1.0511143045732751e-05
and O 0 2.0169497929600766e-06
are O 0 1.0542960353632225e-06
hypersensitive O 0 0.004848141688853502
to O 0 7.764107976981904e-06
ionizing O 0 0.03018975257873535
radiation O 0 0.0478597916662693
and O 0 1.2996463738090824e-05
hydrogen O 0 0.0016045093070715666
peroxide O 0 0.3701699376106262
. O 0 0.0002214981068391353

These O 0 7.672864740015939e-06
results O 0 4.257871114532463e-05
suggest O 0 3.836533869616687e-05
that O 0 9.720687558001373e-06
BRCA1 O 0 0.0038816288579255342
participates O 0 0.00015783232811372727
, O 0 2.9781392640870763e-06
directly O 0 4.88447676616488e-06
or O 0 1.2148408131906763e-05
indirectly O 0 6.837303226348013e-05
, O 0 3.485832621663576e-06
in O 0 5.161657099961303e-06
transcription O 0 0.0014124742010608315
- O 0 0.005752664990723133
coupled O 0 0.002021272899582982
repair O 0 0.1598634123802185
of O 0 1.0929238669632468e-05
oxidative O 1 0.9927800297737122
DNA O 0 0.4576440453529358
damage O 1 0.9965543746948242
. O 0 5.3699703130405396e-05
. O 0 9.494612459093332e-05

Truncation O 0 0.0061854589730501175
mutations O 0 0.00019517846521921456
in O 0 8.466335202683695e-06
the O 0 1.6065730960690416e-05
transactivation O 0 0.0020075326319783926
region O 0 1.4383313100552186e-05
of O 0 4.596829057845753e-06
PAX6 O 1 0.8905615210533142
result O 0 0.0001249103806912899
in O 0 2.4333703549928032e-05
dominant O 0 0.0014076600782573223
- O 0 0.0025423900224268436
negative O 0 0.00011093228386016563
mutants O 0 0.0012912236852571368
. O 0 8.766535756876692e-05

PAX6 O 0 0.06715574860572815
is O 0 9.817951649893075e-06
a O 0 1.1060419637942687e-05
transcription O 0 5.343647353583947e-05
factor O 0 3.2951220418908633e-06
with O 0 6.76437650781736e-07
two O 0 1.5015089047665242e-06
DNA O 0 0.00020034480257891119
- O 0 6.250386650208384e-05
binding O 0 8.297470230900217e-06
domains O 0 2.7585840143729e-05
( O 0 1.798238736228086e-05
paired O 0 0.00031507114181295037
box O 0 0.0004705541068688035
and O 0 7.966196790221147e-06
homeobox O 0 0.003153654048219323
) O 0 2.4092896637739614e-06
and O 0 5.588304929915466e-07
a O 0 1.0729723726399243e-05
proline O 0 0.0005539323901757598
- O 0 9.53202397795394e-05
serine O 0 7.84450676292181e-05
- O 0 0.00010447282693348825
threonine O 0 9.004593448480591e-05
( O 0 1.937158958753571e-05
PST O 0 0.007883875630795956
) O 0 1.5740955859655514e-05
- O 0 9.973211126634851e-05
rich O 0 1.644520671106875e-05
transactivation O 0 0.000845626404043287
domain O 0 0.00011387768608983606
. O 0 8.22492511360906e-05

PAX6 O 1 0.9630511403083801
regulates O 0 0.057929325848817825
eye O 1 0.7519411444664001
development O 0 6.127759115770459e-05
in O 0 1.7384714738000184e-05
animals O 0 6.277421925915405e-05
ranging O 0 5.493802382261492e-05
from O 0 4.2776464397320524e-05
jellyfish O 0 0.00022972475562710315
to O 0 1.0030332759924931e-06
Drosophila O 0 1.0498139090486802e-05
to O 0 2.2942992927710293e-06
humans O 0 0.00015124169294722378
. O 0 5.919922477914952e-05

Heterozygous O 0 0.0004968363791704178
mutations O 0 0.00010217779345111921
in O 0 4.386781711218646e-06
the O 0 1.1761389941966627e-05
human O 0 0.00015422404976561666
PAX6 O 0 0.28716087341308594
gene O 0 0.00015726358105894178
result O 0 3.986155934398994e-05
in O 0 3.2961215765681118e-06
various O 0 3.768029500861303e-06
phenotypes O 0 0.005050905980169773
, O 0 3.723081317730248e-05
including O 0 8.672793774167076e-05
aniridia B-Disease 1 0.9993324875831604
, O 0 0.0009096888825297356
Peters B-Disease 1 0.9992163181304932
anomaly I-Disease 1 0.9993246793746948
, O 0 0.00042564774048514664
autosomal B-Disease 1 0.9989726543426514
dominant I-Disease 1 0.9460052847862244
keratitis I-Disease 1 0.9996111989021301
, O 0 0.0006691281450912356
and O 0 0.0004109946603421122
familial B-Disease 1 0.999760091304779
foveal I-Disease 1 0.9996272325515747
dysplasia I-Disease 1 0.9999884366989136
. O 0 0.005699675530195236

It O 0 3.083640694967471e-05
is O 0 8.602243724453729e-06
believed O 0 2.063798274321016e-05
that O 0 5.422133426691289e-07
the O 0 1.8360934745942359e-06
mutated O 0 9.214762394549325e-05
allele O 0 5.6549511100456584e-06
of O 0 1.145661371992901e-06
PAX6 O 0 0.034898266196250916
produces O 0 4.237120083416812e-05
an O 0 1.7159321942017414e-05
inactive O 0 0.003226508619263768
protein O 0 0.00011239806917728856
and O 0 2.170319203287363e-05
aniridia B-Disease 1 0.9958630800247192
is O 0 8.779737254371867e-05
caused O 0 0.022032257169485092
due O 0 0.001061970484443009
to O 0 1.2584867363329977e-05
genetic O 0 0.0024529765360057354
haploinsufficiency O 0 0.15969255566596985
. O 0 0.0003152556309942156

However O 0 0.0001404363283654675
, O 0 8.849147889122833e-06
several O 0 7.714787898294162e-06
truncation O 0 0.00174884928856045
mutations O 0 0.00013753367238678038
have O 0 2.655576054166886e-06
been O 0 7.1729782575857826e-06
found O 0 3.8419957490987144e-06
to O 0 3.1278366918741085e-07
occur O 0 3.3261767384829e-06
in O 0 7.224661544569244e-07
the O 0 4.245000127411913e-06
C O 0 0.0012370067415758967
- O 0 0.00027527488418854773
terminal O 0 0.00043733022175729275
half O 0 1.5473394796572393e-06
of O 0 1.6067994010882103e-06
PAX6 O 1 0.9756657481193542
in O 0 0.00020567805040627718
patients O 1 0.9985424280166626
with O 0 0.00011029141751350835
Aniridia B-Disease 1 0.9978675842285156
resulting O 0 0.00042260895133949816
in O 0 7.895599992480129e-06
mutant O 0 8.42898734845221e-05
proteins O 0 2.402933432676946e-06
that O 0 4.713914734111313e-07
retain O 0 3.6260717024561018e-06
the O 0 2.9995285331096966e-06
DNA O 0 0.00012334657367318869
- O 0 5.210423478274606e-05
binding O 0 3.658220975921722e-06
domains O 0 8.735274604987353e-06
but O 0 2.0265015336917713e-06
have O 0 6.945676318537153e-07
lost O 0 9.94725814962294e-06
most O 0 3.673859509945032e-07
of O 0 2.7255086365585157e-07
the O 0 1.668079312366899e-05
transactivation O 0 0.004460411611944437
domain O 0 0.00023323146160691977
. O 0 0.00012024282477796078

It O 0 8.431551577814389e-06
is O 0 3.696848580148071e-06
not O 0 5.507629907697265e-07
clear O 0 4.250412530382164e-06
whether O 0 1.3609630968858255e-06
such O 0 1.2867214991274523e-06
mutants O 0 0.00023085114662535489
really O 0 3.655563705251552e-05
behave O 0 5.858126314706169e-05
as O 0 9.777270861377474e-06
loss O 0 0.0005136636318638921
- O 0 3.62265418516472e-05
of O 0 6.599091193493223e-07
- O 0 0.00013263444998301566
function O 0 6.465472324634902e-06
mutants O 0 7.69211765145883e-05
as O 0 9.345961188955698e-06
predicted O 0 0.00023704644991084933
by O 0 2.0896508431178518e-05
haploinsufficiency O 0 0.022453870624303818
. O 0 0.00020564395526889712

Contrary O 0 6.066256173653528e-05
to O 0 9.374725209454482e-07
this O 0 5.980791684123687e-07
theory O 0 2.123633521478041e-06
, O 0 1.1998597528872779e-06
our O 0 3.6124407643001177e-07
data O 0 4.2383503568999e-06
showed O 0 2.884118839574512e-05
that O 0 2.8346968861114874e-07
these O 0 2.2972938040766167e-07
mutants O 0 2.4725690309423953e-05
are O 0 2.5304862560915353e-07
dominant O 0 5.572112786467187e-05
- O 0 0.00012898929708171636
negative O 0 1.14606100396486e-05
in O 0 8.396342309424654e-06
transient O 0 0.002066247630864382
transfection O 0 0.0032798482570797205
assays O 0 0.0001092672100639902
when O 0 2.2085530872573145e-05
they O 0 1.4390215028470266e-06
are O 0 4.793462267116411e-07
coexpressed O 0 0.0003040622978005558
with O 0 7.862156053306535e-06
wild O 0 0.0005069312755949795
- O 0 0.005061219912022352
type O 0 0.006649875547736883
PAX6 O 1 0.9497030377388
. O 0 0.00019548840646166354

We O 0 1.5175923181232065e-05
found O 0 2.247104566777125e-05
that O 0 1.4552819038726739e-06
the O 0 7.677665962546598e-06
dominant O 0 0.0002961628488264978
- O 0 0.0005909469327889383
negative O 0 3.209357237210497e-05
effects O 0 0.00017649352957960218
result O 0 1.3886680790164974e-05
from O 0 3.751028089027386e-06
the O 0 4.274998900655191e-06
enhanced O 0 5.5215710744960234e-05
DNA O 0 1.935288673848845e-05
binding O 0 5.288346983434167e-06
ability O 0 2.426017090328969e-06
of O 0 3.769694103539223e-07
these O 0 4.5761180444969796e-06
mutants O 0 0.0011132132494822145
. O 0 0.00010195325739914551

Kinetic O 0 7.75451262597926e-05
studies O 0 8.006800271687098e-06
of O 0 6.216820906956855e-07
binding O 0 3.356495653861202e-05
and O 0 4.649032689485466e-06
dissociation O 0 0.001175470999442041
revealed O 0 0.0003987669770140201
that O 0 6.434897841245402e-07
various O 0 1.177177750832925e-06
truncation O 0 0.0007169685559347272
mutants O 0 0.00013970813597552478
have O 0 1.336187210654316e-06
3 O 0 1.9335138858878054e-05
- O 0 7.896045281086117e-05
5 O 0 7.47536432754714e-06
- O 0 1.4143156477075536e-05
fold O 0 6.5439312493253965e-06
higher O 0 1.9749375042010797e-06
affinity O 0 1.0892204045376275e-06
to O 0 4.761604799341512e-08
various O 0 3.4688494565671135e-07
DNA O 0 6.375425436999649e-05
- O 0 2.0116009181947447e-05
binding O 0 1.4190954971127212e-06
sites O 0 1.6043067034843261e-06
when O 0 4.129872650082689e-06
compared O 0 5.651726951327873e-06
with O 0 1.3168296391086187e-06
the O 0 1.1193463251402136e-05
wild O 0 0.000363120692782104
- O 0 0.004495513625442982
type O 0 0.0029941038228571415
PAX6 O 1 0.7569089531898499
. O 0 0.00016028500976972282

These O 0 4.069092483405257e-06
results O 0 1.692948535492178e-05
provide O 0 1.5715760355305974e-06
a O 0 4.288253421691479e-06
new O 0 1.2262607924640179e-06
insight O 0 2.897323156503262e-06
into O 0 5.329144983079459e-07
the O 0 1.2272528238099767e-06
role O 0 4.471673037187429e-06
of O 0 2.011882088481798e-06
mutant O 0 0.002127532847225666
PAX6 O 1 0.9609529376029968
in O 0 0.00024061005387920886
causing O 1 0.9940511584281921
aniridia B-Disease 1 0.9983226656913757
. O 0 0.00010960699000861496
. O 0 0.00019210802565794438

Reversal O 0 0.03227207809686661
of O 0 0.0011533404467627406
severe O 1 0.9999923706054688
hypertrophic B-Disease 1 0.9999988079071045
cardiomyopathy I-Disease 1 0.9999995231628418
and O 0 0.00048363671521656215
excellent O 0 0.0027028864715248346
neuropsychologic O 0 0.005662989802658558
outcome O 0 6.725853745592758e-05
in O 0 1.3338722965272609e-05
very B-Disease 0 5.903551573283039e-05
- I-Disease 0 0.000792640377767384
long I-Disease 0 0.0007593477494083345
- I-Disease 0 0.00040778121910989285
chain I-Disease 0 0.0004934605676680803
acyl I-Disease 0 0.003699159948155284
- I-Disease 0 0.0017396260518580675
coenzyme I-Disease 0 0.002371284645050764
A I-Disease 0 0.11217888444662094
dehydrogenase I-Disease 1 0.998580813407898
deficiency I-Disease 1 0.9999803304672241
. O 0 0.0005939248949289322

Very B-Disease 0 0.0003413820522837341
- I-Disease 0 0.0017355798045173287
long I-Disease 0 0.0005149224889464676
- I-Disease 0 0.0004137025971431285
chain I-Disease 0 0.0003606099635362625
acyl I-Disease 0 0.0016417930601164699
- I-Disease 0 0.00030838127713650465
coenzyme I-Disease 0 0.00027253213920630515
A I-Disease 0 0.0003779782564379275
dehydrogenase I-Disease 0 0.03241012617945671
( I-Disease 0 0.0001177284138975665
VLCAD I-Disease 1 0.9933807849884033
) I-Disease 0 0.0020982548594474792
deficiency I-Disease 1 0.9999890327453613
is O 0 6.350322655634955e-05
a O 0 0.0008539804839529097
disorder O 1 0.9998887777328491
of O 0 1.5661416910006665e-05
fatty O 1 0.9979459643363953
acid O 1 0.8530545234680176
beta O 0 0.004694337956607342
oxidation O 0 0.004358355421572924
that O 0 1.5677343981224112e-05
reportedly O 0 0.0008714852156117558
has O 0 1.4024947631696705e-05
high O 0 9.625998791307211e-05
rates O 0 5.819528814754449e-05
of O 0 4.793087100551929e-06
morbidity O 1 0.9957608580589294
and O 0 8.148139022523537e-05
mortality O 1 0.9780431985855103
. O 0 0.00020027703430969268

We O 0 2.665171450644266e-06
describe O 0 4.328989689383889e-06
the O 0 6.926183004907216e-07
outcome O 0 2.552328624005895e-06
of O 0 3.040263152342959e-07
a O 0 2.6640320356818847e-05
5 O 0 2.7323027097736485e-05
- O 0 0.00016013483400456607
year O 0 2.436284557916224e-05
- O 0 0.00020650276564992964
old O 0 0.0003587433020584285
girl O 0 0.0038248940836638212
with O 0 0.00047981031821109354
VLCAD B-Disease 1 0.9998741149902344
deficiency I-Disease 1 0.9999992847442627
who O 0 0.0004443362995516509
was O 0 0.0003064589109271765
first O 0 8.843099749356043e-06
seen O 0 2.7943415261688642e-05
at O 0 1.5126506696105935e-05
5 O 0 5.252819846646162e-06
months O 0 8.3358336269157e-06
of O 0 1.625866843824042e-06
age O 0 0.02739032730460167
with O 0 0.09263870120048523
severe O 1 0.9999978542327881
hypertrophic B-Disease 1 0.9999996423721313
cardiomyopathy I-Disease 1 1.0
, O 1 0.9992308616638184
hepatomegaly B-Disease 1 0.999995231628418
, O 1 0.9968495965003967
encephalopathy B-Disease 1 0.9999982118606567
, O 0 0.00045709603000432253
and O 0 0.00022186373826116323
hypotonia B-Disease 1 0.998688280582428
. O 0 0.0004073596210218966

Biochemical O 0 0.01252901740372181
studies O 0 0.0032800291664898396
indicated O 1 0.9934908747673035
VLCAD B-Disease 1 0.9999632835388184
deficiency I-Disease 1 0.9999997615814209
caused O 1 0.9945211410522461
by O 0 4.1655453969724476e-05
a O 0 0.0002208599471487105
stable O 0 0.009080792777240276
yet O 0 0.00030402897391468287
inactive O 0 0.01420024037361145
enzyme O 0 0.0033053650986403227
. O 0 7.26387370377779e-05

Molecular O 0 0.00030311441514641047
genetic O 0 5.549194247578271e-05
analysis O 0 2.37615245168854e-06
of O 0 1.7700530179354246e-06
her O 0 0.0010578068904578686
VLCAD O 1 0.6567356586456299
gene O 0 0.0006888616480864584
revealed O 0 0.0014055120991542935
a O 0 0.0001037041874951683
T1372C O 0 0.001632555853575468
( O 0 3.815521267824806e-05
F458L O 0 0.0005954859661869705
) O 0 1.1434736734372564e-05
missense O 0 0.0002329210110474378
mutation O 0 9.092620894080028e-05
and O 0 9.372559361509047e-06
a O 0 0.000557153660338372
1668 O 1 0.9876618385314941
ACAG O 1 0.9797250628471375
1669 O 1 0.6792561411857605
splice O 0 0.0036142629105597734
site O 0 0.0008750310516916215
mutation O 0 0.0008672402473166585
. O 0 0.00014042093243915588

After O 0 0.0025626993738114834
initial O 0 0.0018156740115955472
treatment O 1 0.9824138879776001
with O 0 5.879460513824597e-05
intravenous O 1 0.9980999827384949
glucose O 1 0.9282673597335815
and O 0 8.164924656739458e-05
carnitine O 1 0.966992974281311
, O 0 1.1637445822998416e-05
the O 0 2.8267053494346328e-05
patient O 1 0.5016030669212341
has O 0 2.4637703972985037e-05
thrived O 0 0.00033024497679434717
on O 0 6.031193606759189e-06
a O 0 4.98358131153509e-05
low O 0 0.002387021901085973
- O 0 0.0006973076378926635
fat O 0 0.0005593118257820606
diet O 0 0.0002544510061852634
supplemented O 0 7.84522489993833e-05
with O 0 8.65997662913287e-06
medium O 0 0.00015881496074143797
- O 0 0.0006769089959561825
chain O 0 0.000641347374767065
triglyceride O 0 0.0035807518288493156
oil O 0 0.00010344028851250187
and O 0 1.898490882012993e-05
carnitine O 0 0.10074661672115326
and O 0 5.928687642153818e-06
avoidance O 0 0.00167448865249753
of O 0 7.603589892823948e-06
fasting O 0 0.008121643215417862
. O 0 0.0002778926573228091

Her O 0 0.03816097974777222
ventricular O 1 0.9980498552322388
hypertrophy O 1 0.9975510239601135
resolved O 0 0.0039008730091154575
significantly O 0 0.0010790855158120394
over O 0 8.410117516177706e-06
1 O 0 5.9104233514517546e-05
year O 0 4.399468161864206e-05
, O 0 5.648273145197891e-06
and O 0 4.7271910261770245e-06
cognitively O 0 0.015459480695426464
, O 0 7.978384019224904e-06
she O 0 2.8256756195332855e-05
is O 0 1.3954206679045456e-06
in O 0 9.05945569229516e-07
the O 0 2.203134727096767e-06
superior O 0 0.0002188196376664564
range O 0 4.591540346154943e-06
for O 0 3.986722731497139e-06
age O 0 0.0005290675908327103
. O 0 0.00010619580280035734

Clinical O 0 0.006854623556137085
recognition O 0 0.00017588822811376303
of O 0 0.0003061493916902691
VLCAD B-Disease 1 0.9999954700469971
deficiency I-Disease 1 0.9999998807907104
is O 0 3.870688669849187e-05
important O 0 5.01451449963497e-06
because O 0 7.404187272186391e-06
it O 0 2.8396644324857334e-07
is O 0 1.7397370299931936e-07
one O 0 6.18718871692181e-08
of O 0 7.34217309172891e-08
the O 0 7.057349648675881e-06
few O 0 6.349777686409652e-05
directly O 0 0.00276584061793983
treatable O 1 0.9999904632568359
causes O 1 0.9937132000923157
of O 0 0.0011307821841910481
cardiomyopathy B-Disease 1 0.9999997615814209
in O 0 0.002606324153020978
children O 0 0.004026059526950121
. O 0 0.00015333210467360914
. O 0 0.00021139660384505987

Cloning O 0 0.0001713588135316968
of O 0 1.0204563523075194e-06
a O 0 2.3954487915034406e-05
novel O 0 3.538033342920244e-05
member O 0 5.847859938512556e-06
of O 0 5.705675221179263e-07
the O 0 1.360446276521543e-05
low O 0 0.0011827759444713593
- O 0 0.00042250624392181635
density O 0 5.2691204473376274e-05
lipoprotein O 1 0.9092442393302917
receptor O 0 0.003023617435246706
family O 0 0.0003339546383358538
. O 0 8.869390876498073e-05

A O 0 0.00012457376578822732
gene O 0 1.907761543407105e-05
encoding O 0 3.4188246900157537e-06
a O 0 2.3514756321674213e-05
novel O 0 7.496400939999148e-05
transmembrane O 0 0.0007727127522230148
protein O 0 0.00013166805729269981
was O 0 7.735141844023019e-05
identified O 0 1.392443482473027e-05
by O 0 4.447227013315569e-07
DNA O 0 5.791190233139787e-06
sequence O 0 4.240875171035441e-07
analysis O 0 3.4595427678141277e-07
within O 0 1.2427535693859681e-06
the O 0 6.840734567958862e-05
insulin B-Disease 1 0.9946744441986084
- I-Disease 1 0.9758872985839844
dependent I-Disease 1 0.9101794362068176
diabetes I-Disease 1 0.9999996423721313
mellitus I-Disease 1 0.9999939203262329
( O 0 0.003472341690212488
IDDM B-Disease 1 0.9903911352157593
) O 0 4.750418520416133e-05
locus O 0 0.0005976460524834692
IDDM4 O 0 0.025753600522875786
on O 0 8.015936327865347e-05
chromosome O 0 0.001216098782606423
11q13 O 0 0.004896076396107674
. O 0 0.00012961984612047672

Based O 0 8.654345947434194e-06
on O 0 6.1867090153100435e-06
its O 0 3.750556061277166e-06
chromosomal O 0 0.0004994833725504577
position O 0 7.298550826817518e-06
, O 0 1.3198759916122071e-06
this O 0 2.602718041089247e-07
gene O 0 4.638638529286254e-06
is O 0 6.823675562372955e-07
a O 0 2.127022298736847e-06
candidate O 0 4.76338527732878e-06
for O 0 2.1076054963486968e-06
conferring O 0 0.0037660347297787666
susceptibility O 1 0.6960530281066895
to O 0 0.001247292966581881
diabetes B-Disease 1 0.9999945163726807
. O 0 0.0009542787447571754

The O 0 3.506278881104663e-05
gene O 0 8.905951835913584e-05
, O 0 1.019021055981284e-05
termed O 0 0.0009602421196177602
low O 0 0.0008423203835263848
- O 0 0.00023461089585907757
density O 0 3.457363345660269e-05
lipoprotein O 0 0.11718947440385818
receptor O 0 0.0003695207415148616
related O 0 2.993762245750986e-05
protein O 0 5.480835534399375e-05
5 O 0 3.832255970337428e-05
( O 0 1.3642712474393193e-05
LRP5 O 0 0.001606898964382708
) O 0 9.80755316959403e-07
, O 0 2.991133669638657e-07
encodes O 0 9.840645134318038e-07
a O 0 1.1601747473832802e-06
protein O 0 4.13332054449711e-06
of O 0 4.3368183355596557e-07
1615 O 0 0.0012923057656735182
amino O 0 2.574070094851777e-05
acids O 0 2.4272167138406076e-05
that O 0 5.587153850683535e-07
contains O 0 1.2981001873413334e-06
conserved O 0 4.838166660192655e-06
modules O 0 5.0358407861494925e-06
which O 0 2.3897575829323614e-07
are O 0 8.59586322121686e-08
characteristic O 0 2.630295966810081e-06
of O 0 2.287700198166931e-07
the O 0 9.591564776201267e-06
low O 0 0.0009631095454096794
- O 0 0.00032862622174434364
density O 0 6.120232137618586e-05
lipoprotein O 1 0.988863468170166
( O 0 0.00011215481936233118
LDL O 1 0.9966657757759094
) O 0 3.61931488441769e-05
receptor O 0 0.0008617755374871194
family O 0 8.035024075070396e-05
. O 0 5.680949834641069e-05

These O 0 2.727989112827345e-06
modules O 0 2.1092719180160202e-05
include O 0 5.1912511480622925e-06
a O 0 1.5003727639850695e-05
putative O 0 0.00011631129018496722
signal O 0 2.2697642634739168e-05
peptide O 0 2.8383068638504483e-05
for O 0 3.147079041809775e-07
protein O 0 1.0019386536441743e-05
export O 0 5.5643386076553725e-06
, O 0 1.4112246162767406e-06
four O 0 7.369710601778934e-06
epidermal O 0 0.37955960631370544
growth O 0 0.0003376701788511127
factor O 0 9.572851558914408e-05
( O 0 3.7054665881441906e-05
EGF O 0 0.03996838629245758
) O 0 5.176712420507101e-06
repeats O 0 9.451352525502443e-05
with O 0 3.273704123785137e-06
associated O 0 4.068755151820369e-05
spacer O 0 0.0012390031479299068
domains O 0 5.274861177895218e-05
, O 0 1.0375783858762588e-05
three O 0 5.1381808589212596e-05
LDL O 1 0.999607503414154
- O 0 0.00212681433185935
receptor O 0 0.0004949514986947179
( O 0 1.1048442502215039e-05
LDLR O 0 0.001878965413197875
) O 0 2.537502041377593e-06
repeats O 0 5.5323547712760046e-05
, O 0 8.763943810663477e-07
a O 0 2.741415300988592e-06
single O 0 8.060483196459245e-06
transmembrane O 0 0.00021588765957858413
spanning O 0 4.180723044555634e-05
domain O 0 1.3414433851721697e-05
, O 0 3.136573013762245e-06
and O 0 8.225946999118605e-07
a O 0 1.655452069826424e-05
cytoplasmic O 0 0.00027105925255455077
domain O 0 8.862322283675894e-05
. O 0 7.001718040555716e-05

The O 0 9.842945473792497e-06
encoded O 0 5.701433565263869e-06
protein O 0 2.0338418835308403e-05
has O 0 2.563698899393785e-06
a O 0 3.5406078495725524e-06
unique O 0 2.5862148049782263e-06
organization O 0 4.986626208847156e-06
of O 0 3.0301314382086275e-06
EGF O 1 0.9351593852043152
and O 0 3.245849802624434e-05
LDLR O 0 0.44454216957092285
repeats O 0 0.0022984191309660673
; O 0 1.0525586731091607e-05
therefore O 0 1.538019387226086e-05
, O 0 1.0409203241579235e-05
LRP5 O 0 0.00595860555768013
likely O 0 1.3728040357818827e-05
represents O 0 2.3968477762537077e-06
a O 0 2.7788028091890737e-06
new O 0 1.0047939440482878e-06
category O 0 3.752820930458256e-06
of O 0 4.5624429390045407e-07
the O 0 5.7075085351243615e-05
LDLR O 1 0.9293719530105591
family O 0 0.000575864571146667
. O 0 0.00011330824781907722

Both O 0 4.1064929973799735e-05
human O 0 0.00011852864554384723
and O 0 4.499127680901438e-05
mouse O 0 0.010634138248860836
LRP5 O 1 0.731643557548523
cDNAs O 0 0.0074002668261528015
have O 0 1.1215988706680946e-05
been O 0 1.4913031009200495e-05
isolated O 0 7.89539044490084e-05
and O 0 4.250094320923381e-07
the O 0 9.250496759705129e-07
encoded O 0 2.6193470148427878e-06
mature O 0 2.6318961317883804e-05
proteins O 0 1.7813619024309446e-06
are O 0 1.8711683935634937e-07
95 O 0 4.4051312215742655e-06
% O 0 1.9401611552893883e-06
identical O 0 2.8108666811021976e-05
, O 0 5.781930212833686e-06
indicating O 0 6.489647785201669e-05
a O 0 1.014201552607119e-05
high O 0 4.657599492929876e-05
degree O 0 5.033061370340874e-06
of O 0 4.526531824922131e-07
evolutionary O 0 7.258278492372483e-05
conservation O 0 0.00022485500085167587
. O 0 2.4068545826594345e-05
. O 0 6.516299617942423e-05

The O 0 0.00021500003640539944
APC B-Disease 0 0.020161034539341927
variants O 0 0.0004868147079832852
I1307K O 0 0.0018342065159231424
and O 0 2.2647456717095338e-05
E1317Q O 0 0.0014518504031002522
are O 0 1.5276931662810966e-05
associated O 0 0.00604975875467062
with O 1 0.9930302500724792
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 0.00023500337556470186
but O 0 1.2293156032683328e-05
not O 0 1.3361042192627792e-06
always O 0 1.8946914224216016e-06
with O 0 1.8847595129045658e-06
a O 0 2.1268368072924204e-05
family O 0 0.00012179852637927979
history O 0 8.623132453067228e-05
. O 0 0.00014739928883500397

Classical O 0 0.07526159286499023
familial B-Disease 1 0.9999382495880127
adenomatous I-Disease 1 0.9999750852584839
polyposis I-Disease 1 0.999990701675415
( O 0 0.03593108803033829
FAP B-Disease 1 0.9984733462333679
) O 0 2.6845669708563946e-05
is O 0 1.1497316336317454e-05
a O 0 8.474491187371314e-05
high O 0 0.029760168865323067
- O 1 0.7468830347061157
penetrance O 1 0.9970332384109497
autosomal B-Disease 1 0.9996669292449951
dominant I-Disease 1 0.9993740916252136
disease I-Disease 1 0.9999982118606567
that O 0 9.98855393845588e-05
predisposes O 0 0.031212231144309044
to O 0 7.3730843723751605e-06
hundreds O 0 6.76416457281448e-05
or O 0 4.80450653412845e-05
thousands O 0 0.0002448067825753242
of O 0 0.001165775815024972
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999943971633911
and I-Disease 1 0.9039568305015564
carcinoma I-Disease 1 0.9999998807907104
and O 0 3.1463452614843845e-05
that O 0 8.124879968818277e-06
results O 0 4.0675564378034323e-05
from O 0 1.6138534192577936e-05
truncating O 0 0.002836815547198057
mutations O 0 9.613311704015359e-05
in O 0 7.724771421635523e-06
the O 0 5.4783686209702864e-05
APC B-Disease 0 0.052443306893110275
gene O 0 0.0009172710706479847
. O 0 0.00011673497647279873

A O 0 0.0017499001696705818
variant O 0 0.015317829325795174
of O 0 0.00010578314686426893
FAP B-Disease 1 0.9984656572341919
is O 0 0.005505912471562624
attenuated B-Disease 1 0.9984531402587891
adenomatous I-Disease 1 0.99997878074646
polyposis I-Disease 1 0.9999713897705078
coli I-Disease 1 0.9999170303344727
, O 0 3.415482206037268e-05
which O 0 5.726991730625741e-06
results O 0 4.375911157694645e-05
from O 0 5.723041977034882e-05
germ O 1 0.9975234866142273
- O 0 0.0003671517479233444
line O 0 2.045590736088343e-05
mutations O 0 5.404995590652106e-06
in O 0 3.217656683318637e-07
the O 0 9.859205647444469e-07
5 O 0 5.023618996347068e-06
and O 0 5.109187100060808e-07
3 O 0 2.4326127459062263e-06
regions O 0 3.3527649634379486e-07
of O 0 2.692124496661563e-07
the O 0 3.253944669268094e-05
APC B-Disease 0 0.037915460765361786
gene O 0 0.00044544320553541183
. O 0 6.157368625281379e-05

Attenuated B-Disease 1 0.9978995323181152
adenomatous I-Disease 1 0.9999792575836182
polyposis I-Disease 1 0.9999922513961792
coli I-Disease 1 0.9999938011169434
patients O 1 0.9998664855957031
have O 0 9.779380343388766e-05
" O 0 0.0003011723165400326
multiple O 0 0.013842359185218811
" O 1 0.9848565459251404
colorectal B-Disease 1 0.9999998807907104
adenomas I-Disease 1 0.9999737739562988
( O 0 0.0001278936251765117
typically O 0 5.979119669063948e-05
fewer O 0 1.6654468709020875e-05
than O 0 6.95930907568254e-07
100 O 0 3.3902986160683213e-06
) O 0 1.7021088751789648e-06
without O 0 2.554554384914809e-06
the O 0 1.0649230716808233e-05
florid O 0 0.008897694759070873
phenotype O 0 0.0004968152497895062
of O 0 3.201619165338343e-06
classical O 0 0.0028451746329665184
FAP B-Disease 1 0.9979525804519653
. O 0 0.0003980976762250066

Another O 0 0.00012221654469612986
group O 0 2.372129529248923e-05
of O 0 8.73269254952902e-06
patients O 1 0.999182403087616
with O 0 6.603791553061455e-05
multiple O 0 0.04627188667654991
adenomas B-Disease 1 0.9996066689491272
has O 0 5.113954466651194e-05
no O 0 1.0549725629971363e-05
mutations O 0 1.7930948160937987e-05
in O 0 1.26754480334057e-06
the O 0 8.391731171286665e-06
APC B-Disease 0 0.007621113210916519
gene O 0 3.755964644369669e-05
, O 0 1.4392604725799174e-06
and O 0 3.5805703646474285e-07
their O 0 1.6742728803365026e-06
phenotype O 0 0.0006548601086251438
probably O 0 3.972835111198947e-05
results O 0 5.9856697589566465e-06
from O 0 1.179825744657137e-06
variation O 0 8.950034498411696e-06
at O 0 1.9677900127135217e-05
a O 0 1.59722549142316e-05
locus O 0 7.5107192969881e-05
, O 0 3.842215392069193e-06
or O 0 1.0903265319939237e-05
loci O 0 4.937968333251774e-05
, O 0 2.835182613125653e-06
elsewhere O 0 4.21524509874871e-06
in O 0 1.3525875601771986e-06
the O 0 1.553669608256314e-05
genome O 0 0.00027466434403322637
. O 0 6.915572157595307e-05

Recently O 0 0.002559812506660819
, O 0 1.60888066602638e-05
however O 0 1.3609134839498438e-05
, O 0 2.9300613277882803e-06
a O 0 2.6718298613559455e-05
missense O 0 0.0003689670411404222
variant O 0 0.0010070422431454062
of O 0 7.693467523495201e-06
APC B-Disease 1 0.9298633933067322
( O 0 5.7588793424656615e-05
I1307K O 0 0.00074459781171754
) O 0 7.3524688559700735e-06
was O 0 7.206730515463278e-05
described O 0 3.539825411280617e-05
that O 0 9.712426844998845e-07
confers O 0 0.0001391493424307555
an O 0 1.2934837286593392e-05
increased O 0 0.00048464233987033367
risk O 1 0.6848466992378235
of O 0 0.003933379892259836
colorectal B-Disease 1 1.0
tumors I-Disease 1 0.9999997615814209
, O 0 0.00017373586888425052
including O 0 9.887702617561445e-05
multiple O 0 0.31560972332954407
adenomas B-Disease 1 0.9996627569198608
, O 0 8.158449782058597e-05
in O 0 0.00010584236588329077
Ashkenazim O 0 0.224641814827919
. O 0 0.00023530764156021178

We O 0 6.323583875200711e-06
have O 0 6.234168949958985e-07
studied O 0 2.9409568469418446e-06
a O 0 1.6997568081933423e-06
set O 0 1.0950280966426362e-06
of O 0 2.4320372631336795e-06
164 O 0 0.011383695527911186
patients O 1 0.9983128309249878
with O 0 0.0013706203317269683
multiple O 1 0.9993725419044495
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999923706054688
and I-Disease 0 0.009167919866740704
/ I-Disease 1 0.9992545247077942
or I-Disease 0 0.32277438044548035
carcinoma I-Disease 1 0.9999991655349731
and O 0 5.322409197106026e-05
analyzed O 0 0.0008737134048715234
codons O 0 0.0010674655204638839
1263 O 0 0.1820206642150879
- O 0 0.00444332230836153
1377 O 0 0.031738121062517166
( O 0 2.0021772797917947e-05
exon O 0 0.00046124804066494107
15G O 0 0.0003871048684231937
) O 0 5.658018835674739e-07
of O 0 8.176004229198952e-08
the O 0 1.1662021279335022e-05
APC B-Disease 0 0.0021486282348632812
gene O 0 4.667199027608149e-05
for O 0 7.593749614898115e-06
germ O 1 0.9951245188713074
- O 0 0.0013756256084889174
line O 0 0.00013222078268881887
variants O 0 0.0001817247102735564
. O 0 7.021763303782791e-05

Three O 0 0.00019916870223823935
patients O 1 0.9360727071762085
with O 0 9.27611381484894e-06
the O 0 3.176424070261419e-05
I1307K O 0 0.001625702134333551
allele O 0 5.283107384457253e-05
were O 0 9.203928129863925e-06
detected O 0 0.00025777972768992186
, O 0 2.483822356680321e-07
each O 0 1.34052115186023e-07
of O 0 1.9435408376011765e-06
Ashkenazi O 0 0.003811045316979289
descent O 0 0.0006686532287858427
. O 0 0.00015074237307999283

Four O 0 0.000788720091804862
patients O 1 0.9976032376289368
had O 0 0.0010325427865609527
a O 0 0.0010415342403575778
germ O 1 0.9968281388282776
- O 0 0.0026511484757065773
line O 0 0.00016003103519324213
E1317Q O 0 0.0011002833489328623
missense O 0 0.00045226968359202147
variant O 0 0.0007532060262747109
of O 0 6.604785539821023e-06
APC O 0 0.2429715245962143
that O 0 7.180014108598698e-06
was O 0 7.682338764425367e-05
not O 0 5.148679633748543e-07
present O 0 1.9848996544169495e-06
in O 0 1.110330686060479e-06
controls O 0 9.4215256467578e-06
; O 0 9.454246310269809e-07
one O 0 2.5851468876680883e-07
of O 0 1.462094019188953e-07
these O 0 4.676793707858451e-07
individuals O 0 2.978855263791047e-06
had O 0 2.3175716705736704e-05
an O 0 9.800478437682614e-06
unusually O 0 0.0010240297997370362
large O 0 1.1784620255639311e-05
number O 0 6.999204629209999e-07
of O 0 3.0224227884900756e-06
metaplastic B-Disease 0 0.27135932445526123
polyps I-Disease 1 0.7783467769622803
of I-Disease 0 4.6173249756975565e-06
the I-Disease 0 0.00020426350238267332
colorectum I-Disease 0 0.25805655121803284
. O 0 0.00027904435410164297

There O 0 2.929141919594258e-05
is O 0 7.709507372055668e-06
increasing O 0 1.1125182936666533e-05
evidence O 0 1.561702993058134e-05
that O 0 1.684188987383095e-06
there O 0 3.5842572287947405e-06
exist O 0 1.301961310673505e-05
germ O 1 0.9748260378837585
- O 0 0.00021251154248602688
line O 0 2.174968904000707e-05
variants O 0 4.2169094740529545e-06
of O 0 2.681514104097005e-07
the O 0 2.3717020667390898e-05
APC B-Disease 0 0.010241629555821419
gene O 0 4.24932804889977e-05
that O 0 1.4997571042840718e-06
predispose O 0 5.360510112950578e-05
to O 0 2.0395467004163947e-07
the O 0 1.6613450952718267e-06
development O 0 5.913271706958767e-06
of O 0 1.9775290638790466e-05
multiple O 1 0.9986972212791443
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999957084655762
and I-Disease 1 0.9934427738189697
carcinoma I-Disease 1 1.0
, O 0 0.00012524385238066316
but O 0 1.4303675925475545e-05
without O 0 8.227585567510687e-06
the O 0 1.8050546714221127e-05
florid O 0 0.023379378020763397
phenotype O 0 0.0008079477120190859
of O 0 3.442163915678975e-06
classical O 0 0.001041308045387268
FAP B-Disease 1 0.9963895678520203
, O 0 1.4504818864224944e-05
and O 0 2.3451973447663477e-06
possibly O 0 2.4861901692929678e-05
with O 0 5.398303983383812e-06
importance O 0 0.0002555699029471725
for O 0 0.3017970025539398
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
risk O 1 0.9395631551742554
in O 0 9.310803761763964e-06
the O 0 1.2337985936028417e-05
general O 0 4.36841874034144e-05
population O 0 4.674070169130573e-06
. O 0 1.687905751168728e-05
. O 0 8.805545076029375e-05

Genomic O 0 0.0002914506185334176
structure O 0 0.00014682779146824032
of O 0 8.160055585904047e-06
the O 0 0.0011531685013324022
human O 1 0.9899709820747375
congenital B-Disease 1 0.9999998807907104
chloride I-Disease 1 0.9999948740005493
diarrhea I-Disease 1 0.9999998807907104
( O 1 0.6963014006614685
CLD B-Disease 1 0.9995478987693787
) O 0 0.0003817358228843659
gene O 0 0.0017006528796628118
. O 0 0.00013524734822567552

Congenital B-Disease 1 0.9999991655349731
chloride I-Disease 1 0.9999827146530151
diarrhea I-Disease 1 0.9999997615814209
( O 1 0.8941420316696167
CLD B-Disease 1 0.999821126461029
) O 0 0.0001776500721462071
is O 0 8.067907037911937e-05
caused O 0 0.009262708015739918
by O 0 1.0465310879226308e-05
mutations O 0 4.8013411287683994e-05
in O 0 1.6558705056013423e-06
a O 0 8.58110433910042e-06
gene O 0 9.926560778694693e-06
which O 0 7.201741141216189e-07
encodes O 0 2.518864130252041e-05
an O 0 0.0002433822664897889
intestinal O 1 0.9999164342880249
anion O 1 0.9956651329994202
transporter O 1 0.990594744682312
. O 0 0.000369477755157277

We O 0 1.3931301509728655e-05
report O 0 1.34906658786349e-05
here O 0 1.3386271575654973e-06
the O 0 7.320239774344373e-07
complete O 0 9.255154509446584e-06
genomic O 0 1.5573854398098774e-05
organization O 0 3.0726107524969848e-06
of O 0 2.6143754894292215e-07
the O 0 2.9340093533392064e-05
human O 0 0.0006967423832975328
CLD B-Disease 1 0.9933424592018127
gene O 0 0.00015080621233209968
which O 0 6.264770945563214e-06
spans O 0 0.00033897615503519773
approximately O 0 1.6379704902647063e-05
39kb O 0 0.005023795645684004
, O 0 3.396796955712489e-06
and O 0 7.477486292373214e-07
comprises O 0 1.2004608834104147e-05
21 O 0 6.704402767354622e-05
exons O 0 0.00043379850103519857
. O 0 9.063854668056592e-05

All O 0 9.40319660003297e-06
exon O 0 0.0026205831672996283
/ O 0 0.0009318503434769809
intron O 0 0.001000144169665873
boundaries O 0 7.351210342676495e-07
conform O 0 2.4050030333455652e-05
to O 0 1.6690804613972432e-06
the O 0 3.627342084655538e-05
GT O 0 0.06166131794452667
/ O 0 0.018919367343187332
AG O 1 0.8502023220062256
rule O 0 8.982868166640401e-05
. O 0 0.00010915556777035818

An O 0 4.394972165755462e-06
analysis O 0 8.603307151133777e-07
of O 0 3.003312940563774e-07
the O 0 1.5934765542624518e-05
putative O 0 0.0005347065743990242
promoter O 0 0.0005365077522583306
region O 0 2.9284019547048956e-06
sequence O 0 3.034561814274639e-06
shows O 0 7.093562999216374e-06
a O 0 2.8838521757279523e-05
putative O 0 0.0018167641246691346
TATA O 1 0.7314829230308533
box O 0 0.0010419441387057304
and O 0 8.908970812626649e-06
predicts O 0 0.00012990491813980043
multiple O 0 2.6522291591390967e-05
transcription O 0 0.00028917001327499747
factor O 0 2.1281066437950358e-05
binding O 0 5.4674819693900645e-05
sites O 0 3.900435331161134e-05
. O 0 7.466573151759803e-05

The O 0 3.1428426154889166e-05
genomic O 0 0.0001350512175122276
structure O 0 0.00018874775560107082
was O 0 8.827302372083068e-05
determined O 0 7.993898179847747e-06
using O 0 1.5828132973183529e-06
DNA O 0 2.1697376723750494e-05
from O 0 1.0694658385546063e-06
several O 0 6.272114205785329e-07
sources O 0 3.0891233109286986e-06
including O 0 2.9343511869228678e-06
multiple O 0 0.00011206138879060745
large O 0 0.0003359387337695807
- O 0 0.0068220095708966255
insert O 0 0.0012921373127028346
libaries O 0 0.0006413396913558245
and O 0 8.934871402743738e-07
genomic O 0 4.317485945648514e-05
DNA O 0 0.00017981132259592414
from O 0 7.589440065203235e-05
Finnish O 1 0.9650841355323792
CLD B-Disease 1 0.9997901320457458
patients O 1 0.9993744492530823
and O 0 7.996209023986012e-05
controls O 0 0.0006910937954671681
. O 0 0.00027472825604490936

Exon O 0 0.0057834149338305
- O 0 0.0004933270392939448
specific O 0 6.42492977931397e-06
primers O 0 0.00016815046546980739
developed O 0 5.975187377771363e-05
in O 0 2.0288896394049516e-06
this O 0 5.886737426408217e-07
study O 0 2.1740354441135423e-06
will O 0 1.2683923955592036e-07
facilitate O 0 1.35177515403484e-06
mutation O 0 1.5459438145626336e-05
screening O 0 2.2102765797171742e-05
studies O 0 2.462165411998285e-06
of O 0 4.838669610762736e-06
patients O 1 0.9993798732757568
with O 0 0.00033596469438634813
the O 0 0.28464123606681824
disease O 1 0.9999954700469971
. O 0 0.0009337064693681896

Genomic O 0 4.884636655333452e-05
sequencing O 0 1.1097410606453195e-05
of O 0 2.108502258124645e-06
a O 0 0.00046998343896120787
BAC O 1 0.5012285709381104
clone O 0 0.08214857429265976
H O 1 0.9931010007858276
_ O 0 0.00017381308134645224
RG364P16 O 0 0.0006846216856501997
revealed O 0 8.533136133337393e-05
the O 0 1.4961071883590193e-06
presence O 0 2.1754124190920265e-06
of O 0 2.635704561271268e-07
another O 0 9.658074304752517e-06
, O 0 1.0814038660100778e-06
highly O 0 1.0057238796434831e-05
homologous O 0 3.8236219552345574e-05
gene O 0 1.6064077499322593e-05
3 O 0 2.955402806037455e-06
of O 0 4.987217039342795e-07
the O 0 3.9737522456562147e-05
CLD B-Disease 1 0.9941852688789368
gene O 0 4.2453506466699764e-05
, O 0 9.979810329241445e-07
with O 0 7.926606713226647e-07
a O 0 9.484449947194662e-06
similar O 0 7.241490493470337e-06
genomic O 0 6.521932664327323e-05
structure O 0 0.0005206212517805398
, O 0 3.301675678812899e-05
recently O 0 0.0007572810864076018
identified O 0 7.47952944948338e-05
as O 0 3.9436643419321626e-05
the O 0 0.0015668575651943684
Pendred B-Disease 1 0.9999138116836548
syndrome I-Disease 1 0.9999998807907104
gene O 0 0.020384162664413452
( O 0 0.0007538573117926717
PDS B-Disease 1 0.9985001087188721
) O 0 5.617869828711264e-05
. O 0 2.7335227059666067e-05
. O 0 5.44425674888771e-05

The O 0 0.00022855022689327598
APCI1307K O 0 0.23388715088367462
allele O 0 0.0010839371243491769
and O 0 0.00046482941252179444
cancer B-Disease 1 0.9999738931655884
risk O 0 0.019102858379483223
in O 0 5.5907694331835955e-06
a O 0 2.123873491655104e-05
community O 0 9.400730959896464e-06
- O 0 6.694410694763064e-05
based O 0 1.687301278252562e-06
study O 0 5.846588464919478e-06
of O 0 2.8698016194539377e-06
Ashkenazi O 0 0.007819147780537605
Jews O 0 0.00015447381883859634
. O 0 0.0001613827480468899

Mutations O 0 0.0011846927227452397
in O 0 5.8747864386532456e-05
APC O 0 0.057319317013025284
are O 0 1.080441325029824e-05
classically O 1 0.8820133209228516
associated O 0 0.0016959792701527476
with O 0 0.00780076440423727
familial B-Disease 1 0.9999902248382568
adenomatous I-Disease 1 0.9999936819076538
polyposis I-Disease 1 0.9999963045120239
( O 0 0.4003104567527771
FAP B-Disease 1 0.9993423819541931
) O 0 6.493645923910663e-05
, O 0 1.4833826753601898e-05
a O 0 0.00021083299361635
highly O 0 0.09410454332828522
penetrant O 1 0.9994516968727112
autosomal B-Disease 1 0.9999884366989136
dominant I-Disease 1 0.9998281002044678
disorder I-Disease 1 0.9999998807907104
characterized O 1 0.9997645020484924
by O 0 0.1759634166955948
multiple O 1 0.9997133612632751
intestinal O 1 0.9999996423721313
polyps B-Disease 1 0.9999032020568848
and O 0 9.642194345360622e-05
, O 0 4.0832965169101954e-05
without O 0 0.00012743310071527958
surgical O 1 0.9926042556762695
intervention O 0 0.00018361360707785934
, O 0 3.628790636867052e-06
the O 0 1.0180293429584708e-05
development O 0 6.924071203684434e-05
of O 0 0.002552414545789361
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
( O 0 0.00724972877651453
CRC B-Disease 1 0.9978951215744019
) O 0 0.00011102118878625333
. O 0 0.00011793967132689431

APC B-Disease 0 0.03202168270945549
is O 0 0.0001274159731110558
a O 0 0.0016584369586780667
tumour O 1 0.9999797344207764
- O 0 0.005694453604519367
suppressor O 0 0.0005115742678754032
gene O 0 1.6866863006725907e-05
, O 0 1.2718593325189431e-06
and O 0 3.8076022974564694e-06
somatic O 0 0.001180964638479054
loss O 0 0.026813754811882973
occurs O 0 0.003108065342530608
in O 0 0.0016356004634872079
tumours B-Disease 1 0.9999659061431885
. O 0 0.0006191599532030523

The O 0 0.00030195171711966395
germline O 0 0.0427434965968132
T O 1 0.9062888622283936
- O 0 0.000206887285457924
to O 0 2.0474114990065573e-06
- O 0 6.882217712700367e-05
A O 0 3.1200899684336036e-05
transversion O 0 0.00019843927293550223
responsible O 0 3.2254067718895385e-06
for O 0 4.0583856275588914e-07
the O 0 1.0928978554147761e-05
APC O 0 0.0026836437173187733
I1307K O 0 0.00021843606373295188
allele O 0 7.4841877903963905e-06
converts O 0 1.829310235734738e-06
the O 0 3.879971700371243e-06
wild O 0 6.563059287145734e-05
- O 0 7.108811405487359e-05
type O 0 1.946059819601942e-05
sequence O 0 1.2020175290672341e-06
to O 0 1.4345108638735837e-06
a O 0 0.00010480189666850492
homopolymer O 1 0.6070652008056641
tract O 1 0.9993070363998413
( O 0 0.00032576857483945787
A8 O 1 0.9980440139770508
) O 0 1.7201035007019527e-05
that O 0 3.5634939195006154e-06
is O 0 2.82194851024542e-05
genetically O 0 0.0010986269917339087
unstable O 1 0.9164419174194336
and O 0 2.9118989914422855e-05
prone O 0 0.0590188167989254
to O 0 1.6371302990592085e-05
somatic O 0 0.0025857400614768267
mutation O 0 0.0012631771387532353
. O 0 0.00012067473289789632

The O 0 6.289783777901903e-05
I1307K O 0 0.0021065440960228443
allele O 0 0.0002170268853660673
was O 0 0.00029096644720993936
found O 0 6.665827095275745e-05
in O 0 1.7128681065514684e-05
6 O 0 0.0002229252568213269
. O 0 6.808363104937598e-05

1 O 0 4.0388680645264685e-05
% O 0 6.527836831082823e-06
of O 0 4.938557594869053e-06
unselected O 0 0.20257768034934998
Ashkenazi O 0 0.006906889379024506
Jews O 0 3.534300412866287e-05
and O 0 6.079245395085309e-06
higher O 0 6.050311276339926e-05
proportions O 0 0.00019223924027755857
of O 0 4.051853011333151e-06
Ashkenazim O 0 0.008645541965961456
with O 0 2.7010944904759526e-05
family O 0 0.00022366487246472389
or O 0 2.8933087378391065e-05
personal O 0 3.984232898801565e-05
histories O 0 0.00021195810404606164
of O 0 2.536499232519418e-05
CRC B-Disease 1 0.9986328482627869
( O 0 0.0002620256273075938
ref O 0 0.349859356880188
. O 0 8.253456144302618e-06
2 O 0 2.3243623218149878e-05
) O 0 9.75242437561974e-06
. O 0 2.384974686719943e-05

To O 0 4.558382443065057e-06
evaluate O 0 1.9122095181955956e-05
the O 0 2.0390052668517455e-06
role O 0 5.472307748277672e-06
of O 0 3.832524726021802e-06
I1307K O 0 0.007378128357231617
in O 0 0.0004954374744556844
cancer B-Disease 1 0.9999563694000244
, O 0 1.156164853455266e-05
we O 0 4.330731826485135e-06
genotyped O 0 0.0011792110744863749
5 O 0 4.250049460097216e-05
, O 0 2.150735235773027e-05
081 O 0 0.019532160833477974
Ashkenazi O 0 0.0013196234358474612
volunteers O 0 3.4217449865536764e-05
in O 0 2.0135287286393577e-06
a O 0 1.4776333955524024e-05
community O 0 1.5908590285107493e-05
survey O 0 0.00012009638157906011
. O 0 6.329839379759505e-05

Risk O 0 0.021760117262601852
of O 0 9.841853170655668e-05
developing O 1 0.972211480140686
colorectal B-Disease 1 0.9999984502792358
, I-Disease 0 0.01593085564672947
breast I-Disease 1 0.9999483823776245
and I-Disease 0 4.1798219172051176e-05
other I-Disease 0 7.725771865807474e-05
cancers I-Disease 1 0.9999163150787354
were O 0 2.301805216120556e-05
compared O 0 0.00018426129827275872
between O 0 4.100857404409908e-05
genotyped O 0 0.28810223937034607
I1307K O 0 0.005371067672967911
carriers O 0 0.00044725718908011913
and O 0 5.554763447435107e-06
non O 0 9.071844397112727e-05
- O 0 0.00018047211051452905
carriers O 0 1.9348974092281424e-05
and O 0 2.673603205494146e-07
their O 0 1.899888530942917e-07
first O 0 8.0541503848508e-06
- O 0 0.0001404573704348877
degree O 0 3.14715871354565e-05
relatives O 0 0.00023878630599938333
. O 0 9.865099855232984e-05

Sperm O 0 0.0002017279912251979
DNA O 0 6.639797356911004e-05
analysis O 0 5.455487098515732e-06
in O 0 2.1940262740827166e-05
a O 0 0.0009883915772661567
Friedreich B-Disease 1 0.9952633380889893
ataxia I-Disease 1 0.9990668892860413
premutation O 1 0.9833478331565857
carrier O 0 0.034035757184028625
suggests O 0 0.00022972629813011736
both O 0 6.131987447588472e-06
meiotic O 0 0.00585883017629385
and O 0 1.0292753358953632e-05
mitotic O 0 0.001437405589967966
expansion O 0 5.927741221967153e-05
in O 0 7.046299742796691e-06
the O 0 3.503504558466375e-05
FRDA B-Disease 0 0.15095913410186768
gene O 0 0.0005014569032937288
. O 0 7.155536150094122e-05

Friedreich B-Disease 1 0.9948123693466187
ataxia I-Disease 1 0.9995301961898804
is O 0 0.0007088521379046142
usually O 0 0.0010117654455825686
caused O 0 0.01657109335064888
by O 0 3.835757070191903e-06
an O 0 5.4264914979285095e-06
expansion O 0 1.0538262358750217e-05
of O 0 5.066165158496005e-07
a O 0 0.00014042334805708379
GAA O 0 0.016312124207615852
trinucleotide O 1 0.6338061094284058
repeat O 0 0.0002543748414609581
in O 0 2.7088462957181036e-06
intron O 0 0.0021045503672212362
1 O 0 6.807205863879062e-06
of O 0 3.6638630263041705e-07
the O 0 3.283608384663239e-05
FRDA B-Disease 0 0.3750191032886505
gene O 0 0.000483536918181926
. O 0 7.077331247273833e-05

Occasionally O 0 0.000501413713209331
, O 0 1.1324639672238845e-05
a O 0 2.0772646166733466e-05
fully O 0 3.57707504008431e-05
expanded O 0 2.6289910238119774e-05
allele O 0 3.8548416341654956e-05
has O 0 1.1606623047555331e-05
been O 0 1.0283029951096978e-05
found O 0 1.2732919458358083e-05
to O 0 1.1103348924734746e-06
arise O 0 3.842978912871331e-05
from O 0 4.542832812148845e-06
a O 0 1.7771670172805898e-05
premutation O 0 0.00032501478563062847
of O 0 7.065989962029562e-07
100 O 0 1.3805381058773492e-05
or O 0 1.8503371393308043e-05
less O 0 3.978112727054395e-05
triplet O 0 0.025954943150281906
repeats O 0 0.00477807829156518
. O 0 0.0001406785158906132

We O 0 1.551531568111386e-05
have O 0 1.921121338455123e-06
examined O 0 4.0289822209160775e-05
the O 0 1.6817798496049363e-06
sperm O 0 2.1031979485997e-05
DNA O 0 1.319317289016908e-05
of O 0 1.0359095767853432e-06
a O 0 0.00020545185543596745
premutation O 0 0.035584140568971634
carrier O 0 0.008821362629532814
. O 0 0.00023788417456671596

This O 0 2.1287114577717148e-05
mans O 0 0.00035681293229572475
leucocyte O 0 0.001780147897079587
DNA O 0 0.00013330760702956468
showed O 0 4.501212970353663e-05
one O 0 9.916028602674487e-07
normal O 0 1.7990243577514775e-05
allele O 0 6.047349415894132e-06
and O 0 3.2823962214934e-07
one O 0 3.097499075011001e-07
allele O 0 1.2367155477477354e-06
of O 0 1.1451234627202211e-07
approximately O 0 6.886060873512179e-06
100 O 0 2.969499291793909e-05
repeats O 0 0.0014978294493630528
. O 0 0.00011132447252748534

His O 0 0.00013613027113024145
sperm O 0 0.00029494360205717385
showed O 0 8.005181007320061e-05
an O 0 2.7076582682639128e-06
expanded O 0 8.907204573915806e-06
allele O 0 7.991756319825072e-06
in O 0 1.9544552287698025e-06
a O 0 1.0645890142768621e-05
tight O 0 3.3560063457116485e-05
range O 0 2.7071055228589103e-06
centering O 0 4.579934284265619e-06
on O 0 1.2587836408783915e-06
a O 0 2.5763383746379986e-06
size O 0 1.319985472036933e-06
of O 0 3.6292539107307675e-07
approximately O 0 3.692901009344496e-05
320 O 0 0.000651287438813597
trinucleotide O 1 0.9420373439788818
repeats O 0 0.0056036291643977165
. O 0 0.00013276895333547145

His O 0 0.0015900825383141637
affected O 0 0.002957975724712014
son O 0 0.024190528318285942
has O 0 5.260374382487498e-05
repeat O 0 0.00021144257334526628
sizes O 0 5.7967713473772164e-06
of O 0 2.2736330720363185e-06
1040 O 0 0.3651745617389679
and O 0 3.2805470254970714e-05
540 O 0 0.0008871225290931761
. O 0 8.788281411398202e-05

These O 0 3.722540213857428e-06
data O 0 1.106290892494144e-05
suggest O 0 1.3313649105839431e-05
that O 0 1.2554866088976269e-06
expansion O 0 1.2797515410056803e-05
occurs O 0 8.828310456010513e-06
in O 0 5.992569640511647e-07
two O 0 6.488057806564029e-07
stages O 0 4.932640149490908e-05
, O 0 1.0722559409259702e-06
the O 0 8.522543453182152e-07
first O 0 1.6369536979254917e-06
during O 0 2.642572326294612e-05
meiosis O 0 5.786265683127567e-05
followed O 0 8.982117833511438e-06
by O 0 1.749309490151063e-06
a O 0 1.2516071365098469e-05
second O 0 3.103081326116808e-05
mitotic O 0 0.0036274923477321863
expansion O 0 0.0005815193871967494
. O 0 9.770169708644971e-05

We O 0 1.5685538528487086e-05
also O 0 7.005881798249902e-06
show O 0 3.146843710055691e-06
that O 0 3.1545130241283914e-07
in O 0 3.7105178307683673e-07
all O 0 2.0206104522912938e-07
informative O 0 2.2662386982119642e-05
carrier O 0 0.0003140718617942184
father O 0 0.00011216369603062049
to O 0 3.50157574757759e-06
affected O 0 0.00011384750541765243
child O 0 0.00022680623806081712
transmissions O 0 5.379986032494344e-05
, O 0 8.432070330854913e-07
with O 0 4.2295900470890047e-07
the O 0 2.3212021460494725e-06
notable O 0 9.670185136201326e-06
exception O 0 6.40987354927347e-06
of O 0 5.74190380575601e-07
the O 0 2.2250296751735732e-05
premutation O 0 0.011322703212499619
carrier O 0 0.0005726486560888588
, O 0 1.9604624412750127e-06
the O 0 2.308636112502427e-06
expansion O 0 2.809762372635305e-05
size O 0 2.836661587934941e-05
decreases O 0 0.00033811962930485606
. O 0 8.363400411326438e-06
. O 0 2.533204315113835e-05

The O 0 5.078777758171782e-05
R496H O 0 0.0009365646983496845
mutation O 0 4.8005029384512454e-05
of O 0 2.247517613795935e-06
arylsulfatase O 0 0.01700667291879654
A O 0 0.0009665465331636369
does O 0 4.770497980643995e-05
not O 0 5.667784716933966e-05
cause O 1 0.6729216575622559
metachromatic B-Disease 1 0.9982941746711731
leukodystrophy I-Disease 1 0.999847412109375
. O 0 0.001191722578369081

Deficiency B-Disease 1 0.9997491240501404
of I-Disease 0 2.4803151973173954e-05
arylsulfatase I-Disease 0 0.15585920214653015
A I-Disease 0 0.0037148091942071915
( O 0 0.0002551350917201489
ARSA O 1 0.9769972562789917
) O 0 3.261291203671135e-05
enzyme O 0 0.0014542206190526485
activity O 0 0.0006547290249727666
causes O 1 0.8980656862258911
metachromatic B-Disease 1 0.9989848732948303
leukodystrophy I-Disease 1 0.999937891960144
( O 0 0.01414872333407402
MLD B-Disease 1 0.999525785446167
) O 0 0.0005945439916104078
. O 0 0.00021440247655846179

A O 0 0.00010256612586090341
number O 0 1.3039652912993915e-06
of O 0 5.196457550482592e-06
ARSA O 1 0.963958203792572
gene O 0 0.00021830553305335343
mutations O 0 0.0001431532291462645
responsible O 0 8.749966218601912e-05
for O 0 6.729742017341778e-05
MLD B-Disease 1 0.9997745156288147
have O 0 3.030605148524046e-05
been O 0 0.000141242504469119
identified O 0 0.0005119742709212005
. O 0 6.296931678662077e-05

Recently O 0 0.001419411855749786
, O 0 7.213025128294248e-06
the O 0 8.406556844420265e-06
R496H O 0 0.0004903379012830555
mutation O 0 4.084948159288615e-05
of O 0 3.609201030485565e-06
ARSA O 1 0.9864311814308167
was O 0 0.00014271218969952315
proposed O 0 1.426150538463844e-05
to O 0 7.679809073124488e-07
be O 0 1.7371652347719646e-06
a O 0 1.3785264854959678e-05
cause O 0 0.0005587224150076509
of O 0 1.1937822819163557e-05
MLD B-Disease 1 0.9995600581169128
( O 0 0.00012295425403863192
Draghia O 0 0.00799098052084446
et O 0 0.0016994840698316693
al O 0 0.00019940546189900488
. O 0 4.140887995163212e-06
, O 0 6.348890565277543e-06
1997 O 0 0.00020288924861233681
) O 0 1.737274942570366e-05
. O 0 2.8791475415346213e-05

We O 0 2.9353668651310727e-05
have O 0 7.781899512337986e-06
investigated O 0 0.00019581877859309316
the O 0 1.0942369044641964e-05
R496H O 0 0.0010017204331234097
mutation O 0 4.714836904895492e-05
and O 0 1.0723867944761878e-06
found O 0 5.436167157313321e-06
this O 0 5.651369292536401e-07
mutation O 0 1.332535975961946e-05
at O 0 4.315510523156263e-06
a O 0 3.7475631415873067e-06
relatively O 0 7.44640601624269e-06
high O 0 8.658489605295472e-06
frequency O 0 6.318275609373813e-07
in O 0 3.7380900153038965e-07
an O 0 1.1571790992093156e-06
African O 0 2.1832979655300733e-06
American O 0 1.7423883491574088e-06
population O 0 5.372048121898843e-07
( O 0 9.430338536731142e-07
f O 0 1.1766988791350741e-05
= O 0 1.0498819392523728e-05
0 O 0 1.1149313650093973e-06
. O 0 6.891493740113219e-07
09 O 0 3.515874777804129e-05
, O 0 9.793234312382992e-07
n O 0 1.7473805201007053e-05
= O 0 3.928604564862326e-05
61 O 0 4.5036431401968e-05
subjects O 0 2.65633989329217e-05
) O 0 1.8888582417275757e-05
. O 0 4.9622794904280454e-05

The O 0 0.00039445413858629763
ARSA O 0 0.44266825914382935
enzyme O 0 0.0006037927814759314
activity O 0 2.05621327040717e-05
in O 0 4.26218366555986e-06
subjects O 0 9.837230209086556e-06
with O 0 3.0354156024259282e-06
and O 0 1.81582220193377e-06
without O 0 5.625517587759532e-06
the O 0 9.735548701428343e-06
R496H O 0 0.0013579183723777533
mutation O 0 0.0001350375678157434
was O 0 7.86999735282734e-05
determined O 0 1.4075999388296623e-05
and O 0 1.4972218878028798e-06
found O 0 9.050871994986665e-06
to O 0 4.7157718086054956e-07
be O 0 4.349195933173178e-06
normal O 0 0.00016091148427221924
. O 0 6.241488154046237e-05

It O 0 1.4118147191766184e-05
is O 0 1.0709257367125247e-05
therefore O 0 1.505906129750656e-05
concluded O 0 0.00013828335795551538
that O 0 7.46048328892357e-07
the O 0 2.896068963309517e-06
R496H O 0 0.000610665010754019
mutation O 0 4.458993862499483e-05
of O 0 4.6788063627900556e-06
ARSA O 1 0.9856569766998291
does O 0 1.1028295375581365e-05
not O 0 1.1583118748603738e-06
negatively O 0 6.281989044509828e-06
influence O 0 1.4423849279410206e-06
the O 0 1.5297601976271835e-06
activity O 0 7.040604032226838e-06
of O 0 5.035927642893512e-06
ARSA O 1 0.9860237836837769
and O 0 3.847572770609986e-06
is O 0 3.7993718251527753e-06
not O 0 2.161321845051134e-06
a O 0 5.7961900893133134e-05
cause O 0 0.0035654620733112097
of O 0 5.2309802413219586e-05
MLD B-Disease 1 0.9997085928916931

Down O 0 0.003042164957150817
- O 0 0.0002514515654183924
regulation O 0 2.7114569093100727e-05
of O 0 2.6315053673897637e-06
transmembrane O 0 0.010683390311896801
carbonic O 1 0.966060996055603
anhydrases O 1 0.6125744581222534
in O 0 0.008853921666741371
renal B-Disease 1 0.9999991655349731
cell I-Disease 1 0.9998888969421387
carcinoma I-Disease 1 0.9999997615814209
cell O 1 0.7686240673065186
lines O 0 0.00041645774035714567
by O 0 3.733459743671119e-05
wild O 0 0.0008398527279496193
- O 0 0.008423469960689545
type O 0 0.011252813041210175
von B-Disease 1 0.8806180357933044
Hippel I-Disease 1 0.9903278946876526
- I-Disease 1 0.8853194713592529
Lindau I-Disease 1 0.9861105680465698
transgenes O 0 0.048187967389822006
. O 0 0.0005979702691547573

To O 0 8.460209755867254e-06
discover O 0 4.601636828738265e-05
genes O 0 1.102074656955665e-05
involved O 0 2.119442433468066e-05
in O 0 5.5393073125742376e-05
von B-Disease 1 0.8945821523666382
Hippel I-Disease 1 0.9935938715934753
- I-Disease 1 0.9347807168960571
Lindau I-Disease 1 0.9945886135101318
( O 0 0.0007592009496875107
VHL B-Disease 1 0.995273768901825
) O 0 0.00011104573059128597
- O 0 0.001915161614306271
mediated O 0 0.004312893375754356
carcinogenesis O 1 0.8400118947029114
, O 0 1.4288364582171198e-05
we O 0 1.554401751491241e-05
used O 0 0.0010893340222537518
renal B-Disease 1 0.999996542930603
cell I-Disease 1 0.999911904335022
carcinoma I-Disease 1 0.9999998807907104
cell O 1 0.9612415432929993
lines O 0 0.0014558237744495273
stably O 0 0.014628208242356777
transfected O 0 0.011227233335375786
with O 0 4.131474270252511e-05
wild O 0 0.0013781484449282289
- O 0 0.030964970588684082
type O 0 0.0970267504453659
VHL O 1 0.9986923336982727
- O 0 0.010295105166733265
expressing O 0 0.0012456171680241823
transgenes O 0 0.01691223308444023
. O 0 0.0003302736149635166

Large O 0 0.00018999511667061597
- O 0 0.00015275944315362722
scale O 0 1.6690562915755436e-05
RNA O 0 4.5212993427412584e-05
differential O 0 1.4498664313578047e-05
display O 0 8.758883268455975e-06
technology O 0 1.0632781595631968e-05
applied O 0 2.746528707575635e-06
to O 0 4.568207430111215e-07
these O 0 7.051624493215058e-07
cell O 0 0.00037056670407764614
lines O 0 4.402926788316108e-05
identified O 0 2.7369966119294986e-05
several O 0 3.3534090562170604e-06
differentially O 0 0.000186759396456182
expressed O 0 1.0074824785988312e-05
genes O 0 7.993105100467801e-06
, O 0 1.1530139545357088e-06
including O 0 7.63114144319843e-07
an O 0 1.5421554053318687e-05
alpha O 0 0.0004961361992172897
carbonic O 0 0.4437137544155121
anhydrase O 0 0.45727214217185974
gene O 0 0.0004701138532254845
, O 0 5.223248808761127e-05
termed O 0 0.020343953743577003
CA12 O 1 0.9272371530532837
. O 0 0.000363973987987265

The O 0 1.0953436685667839e-05
deduced O 0 6.203605880727991e-05
protein O 0 2.597778438939713e-05
sequence O 0 1.0872085113078356e-05
was O 0 0.00015399407129734755
classified O 0 0.00014920224202796817
as O 0 3.1575277716910932e-06
a O 0 9.94869969872525e-06
one O 0 6.3735328694747295e-06
- O 0 0.00013471231795847416
pass O 0 2.3046957721817307e-05
transmembrane O 0 0.000788950186688453
CA O 0 0.0002636366698425263
possessing O 0 5.031237378716469e-05
an O 0 1.294167395826662e-05
apparently O 0 0.0001262445584870875
intact O 0 0.00014038142398931086
catalytic O 0 3.053313776035793e-05
domain O 0 4.953844381816452e-06
in O 0 2.3286563646252034e-06
the O 0 8.394788892474025e-06
extracellular O 0 0.0011642832541838288
CA O 0 0.00489600608125329
module O 0 0.0017614478711038828
. O 0 0.0001012358843581751

Reintroduced O 0 0.006465115584433079
wild O 0 0.002045087516307831
- O 0 0.01779106818139553
type O 0 0.009091422893106937
VHL B-Disease 1 0.9925891160964966
strongly O 0 0.00021302096138242632
inhibited O 0 0.0005735291633754969
the O 0 3.5655812098411843e-06
overexpression O 0 4.275537503417581e-05
of O 0 3.415802893869113e-07
the O 0 1.4995131095929537e-05
CA12 O 0 0.01182304322719574
gene O 0 3.456325066508725e-05
in O 0 4.034947323816596e-06
the O 0 6.302614201558754e-05
parental O 1 0.8862206339836121
renal B-Disease 1 0.9999991655349731
cell I-Disease 1 0.9999418258666992
carcinoma I-Disease 1 0.9999998807907104
cell O 1 0.9972967505455017
lines O 0 0.005399263929575682
. O 0 0.00039471182390116155

Similar O 0 0.00010214768553851172
results O 0 5.5714855989208445e-05
were O 0 7.691559403610881e-06
obtained O 0 2.4648184989928268e-05
with O 0 3.7680005334550515e-05
CA9 O 1 0.7447675466537476
, O 0 1.9364142644917592e-06
encoding O 0 3.045770199605613e-06
another O 0 2.1667850887752138e-05
transmembrane O 0 0.0018572267144918442
CA O 0 0.00023215895635075867
with O 0 1.3357628176891012e-06
an O 0 9.548022717353888e-06
intact O 0 0.0007681096321903169
catalytic O 0 0.0002357693447265774
domain O 0 0.00010485226812306792
. O 0 4.698042175732553e-05

Although O 0 4.878501204075292e-05
both O 0 1.90913647202251e-06
domains O 0 1.6176778444787487e-05
of O 0 1.1707413705153158e-06
the O 0 0.0001092259626602754
VHL B-Disease 1 0.9831477403640747
protein O 0 5.009057713323273e-05
contribute O 0 3.8987109292065725e-06
to O 0 4.845526859753591e-07
regulation O 0 1.0774801012303215e-05
of O 0 7.913623676358839e-07
CA12 O 0 0.01831497810781002
expression O 0 1.909121056087315e-05
, O 0 1.925646529343794e-06
the O 0 6.330498763418291e-06
elongin O 0 0.0009108047815971076
binding O 0 3.756483783945441e-05
domain O 0 6.347017915686592e-05
alone O 0 0.00011029205052182078
could O 0 1.3388656043389346e-05
effectively O 0 0.00015825501759536564
regulate O 0 0.0012167019303888083
CA9 O 1 0.9309945106506348
expression O 0 0.0003684686089400202
. O 0 0.00020648271311074495

We O 0 3.7799603887833655e-05
mapped O 0 0.0005443994887173176
CA12 O 0 0.0369916670024395
and O 0 6.285286508500576e-05
CA9 O 1 0.7404605746269226
loci O 0 0.0001949632860487327
to O 0 4.089036792720435e-06
chromosome O 0 0.0002280022163176909
bands O 0 9.528226655675098e-05
15q22 O 0 0.001237889053300023
and O 0 1.4342222129926085e-05
17q21 O 0 0.002960768761113286
. O 0 0.00017892027972266078

2 O 0 0.00020308974490035325
respectively O 0 0.00013462308561429381
, O 0 9.787495400814805e-06
regions O 0 1.0297367225575726e-05
prone O 0 0.004177920985966921
to O 0 1.6012954802135937e-06
amplification O 0 0.00018900907889474183
in O 0 6.481733635155251e-06
some O 0 1.1988958249276038e-05
human O 0 0.005181044805794954
cancers B-Disease 1 0.9997170567512512
. O 0 0.00026385317323729396

Additional O 0 1.766198329278268e-05
experiments O 0 2.96293364954181e-05
are O 0 2.883849106183334e-07
needed O 0 2.2324593373923562e-06
to O 0 7.741505214653444e-08
define O 0 1.1178507293152506e-06
the O 0 1.548173486298765e-06
role O 0 9.32375951379072e-06
of O 0 9.203436093230266e-06
CA O 0 0.3058938682079315
IX O 1 0.7550824880599976
and O 0 5.160307409823872e-05
CA O 0 0.0060432530008256435
XII O 0 0.04393157735466957
enzymes O 0 1.6365122064598836e-05
in O 0 6.632011491092271e-07
the O 0 1.1481747606012505e-06
regulation O 0 6.798707090638345e-06
of O 0 3.0124408567644423e-07
pH O 0 0.0015786775620654225
in O 0 1.5065877505548997e-06
the O 0 4.152799647272332e-06
extracellular O 0 0.00014301350165624171
microenvironment O 0 0.0005247305962257087
and O 0 5.228802137935418e-07
its O 0 1.4398012808669591e-06
potential O 0 1.6421510736108758e-05
impact O 0 9.604927618056536e-05
on O 0 0.0008675733115524054
cancer B-Disease 1 0.999957799911499
cell O 0 0.2142094224691391
growth O 0 0.0010976024204865098
. O 0 0.00011803450615843758

A O 0 5.000280725653283e-05
gene O 0 8.848330253385939e-06
encoding O 0 2.112606352966395e-06
a O 0 1.2036053703923244e-05
transmembrane O 0 0.00022191494645085186
protein O 0 4.2553216189844534e-05
is O 0 1.5630634152330458e-05
mutated O 0 0.0015426595928147435
in O 0 0.00014615508553106338
patients O 1 0.9997606873512268
with O 1 0.9961240887641907
diabetes B-Disease 1 1.0
mellitus I-Disease 1 0.9999995231628418
and O 1 0.9976963400840759
optic B-Disease 1 0.9999988079071045
atrophy I-Disease 1 0.9999874830245972
( O 1 0.9965963959693909
Wolfram B-Disease 1 0.9999877214431763
syndrome I-Disease 1 0.9999998807907104
) O 0 0.004039093852043152
. O 0 0.0006834137602709234

Wolfram B-Disease 1 0.9998918771743774
syndrome I-Disease 1 0.9999998807907104
( O 1 0.6497122645378113
WFS B-Disease 1 0.9997860789299011
; O 0 0.011868092231452465
OMIM O 1 0.99847811460495
222300 O 0 0.13133230805397034
) O 0 4.8674923164071515e-05
is O 0 3.135768565698527e-05
an O 0 0.0007368911174125969
autosomal B-Disease 1 0.9998952150344849
recessive I-Disease 1 0.9999808073043823
neurodegenerative I-Disease 1 0.9999990463256836
disorder I-Disease 1 0.9999980926513672
defined O 0 0.0067415786907076836
by O 0 0.0012140243779867887
young O 0 0.23346258699893951
- O 1 0.9948380589485168
onset O 1 0.9997949004173279
non O 0 0.3609201908111572
- O 1 0.9983966946601868
immune O 1 0.9995933175086975
insulin B-Disease 1 0.9991748929023743
- I-Disease 1 0.9977495074272156
dependent I-Disease 1 0.9857056140899658
diabetes I-Disease 1 0.9999997615814209
mellitus I-Disease 1 0.9999960660934448
and O 0 0.014286478981375694
progressive O 1 0.999757707118988
optic B-Disease 1 0.9999942779541016
atrophy I-Disease 1 0.9999064207077026
. O 0 0.0029997641686350107

Linkage O 0 0.0008706955122761428
to O 0 9.19948797672987e-06
markers O 0 0.0002081133279716596
on O 0 4.4324413465801626e-05
chromosome O 0 0.001665026298724115
4p O 1 0.978585958480835
was O 0 0.000413656875025481
confirmed O 0 7.58609821787104e-05
in O 0 2.8781007586076157e-06
five O 0 7.492421445931541e-06
families O 0 3.813684088527225e-05
. O 0 0.00010011630365625024

On O 0 9.677842172095552e-06
the O 0 1.0421323395348736e-06
basis O 0 8.426450790466333e-07
of O 0 5.880609478481347e-06
meiotic O 1 0.9552310705184937
recombinants O 1 0.9759975075721741
and O 0 0.0023289916571229696
disease O 1 0.9999889135360718
- O 0 0.11877896636724472
associated O 0 0.0004588072479236871
haplotypes O 0 0.0015408957842737436
, O 0 1.4505690160149243e-05
the O 0 4.8048270400613546e-05
WFS B-Disease 1 0.9931047558784485
gene O 0 0.000213107283343561
was O 0 9.782625420484692e-05
localized O 0 0.00029201750294305384
to O 0 3.0984467684902484e-06
a O 0 0.0001041108334902674
BAC O 0 0.02579076960682869
/ O 0 0.0009590403060428798
P1 O 0 0.003087422112002969
contig O 0 0.00015405839076265693
of O 0 2.9244287702567817e-07
less O 0 6.838940862508025e-06
than O 0 2.492122575858957e-06
250 O 0 3.4678407246246934e-05
kb O 0 0.0028664798010140657
. O 0 0.0001809079694794491

Mutations O 0 0.00021909605129621923
in O 0 3.7796255583089078e-06
a O 0 2.476845111232251e-05
novel O 0 5.6361783208558336e-05
gene O 0 0.00010224153083981946
( O 0 1.0667843525880016e-05
WFS1 O 0 0.0018834046786651015
) O 0 6.346375016619277e-07
encoding O 0 1.2527525541372597e-06
a O 0 8.097696991171688e-06
putative O 0 0.0002023888227995485
transmembrane O 0 0.000326067500282079
protein O 0 4.043169246870093e-05
were O 0 3.7524380331888096e-06
found O 0 1.3419973583950195e-05
in O 0 1.1771664958359906e-06
all O 0 7.569871627310931e-07
affected O 0 3.212253795936704e-05
individuals O 0 2.638073738125968e-06
in O 0 1.1681968317134306e-05
six O 0 0.0002420255186734721
WFS B-Disease 1 0.9981410503387451
families O 0 3.386732714716345e-05
, O 0 4.5577216951642185e-06
and O 0 8.192885161406593e-07
these O 0 5.031089926887944e-07
mutations O 0 3.644891330623068e-05
were O 0 6.09756989433663e-06
associated O 0 5.655475615640171e-05
with O 0 4.137451833230443e-05
the O 0 0.014003426767885685
disease O 1 0.9999885559082031
phenotype O 1 0.9753087162971497
. O 0 0.0005215395940467715

WFS1 O 0 0.100094273686409
appears O 0 0.00020557729294523597
to O 0 1.2623974043890485e-06
function O 0 5.587491614278406e-06
in O 0 4.68818598164944e-06
survival O 0 0.00042652530828490853
of O 0 2.900873141697957e-06
islet O 0 0.014508992433547974
beta O 0 0.024674290791153908
- O 0 0.006190414074808359
cells O 0 0.00031812387169338763
and O 0 5.815830263600219e-06
neurons O 0 0.0011544961016625166
. O 0 2.493078136467375e-05
. O 0 0.00010172475595027208

Stable O 0 0.0006324936402961612
interaction O 0 5.46138517165673e-06
between O 0 2.242901018689736e-06
the O 0 4.238899691699771e-06
products O 0 5.316871920513222e-06
of O 0 4.13573161495151e-07
the O 0 5.1495415391400456e-05
BRCA1 O 0 0.0315292626619339
and O 0 4.23640085500665e-05
BRCA2 O 0 0.3589463233947754
tumor B-Disease 1 0.9972917437553406
suppressor O 0 0.0008376408368349075
genes O 0 1.003488705464406e-05
in O 0 9.200022759614512e-06
mitotic O 0 0.0030812642071396112
and O 0 2.7097636120743118e-05
meiotic O 1 0.8499070405960083
cells O 0 0.024613626301288605
. O 0 0.00017617526464164257

BRCA1 O 0 0.031512659043073654
and O 0 3.4147396945627406e-05
BRCA2 O 0 0.0018615004373714328
account O 0 5.9849849094462115e-06
for O 0 2.782006049528718e-06
most O 0 8.259629794338252e-06
cases O 0 5.041255644755438e-05
of O 0 5.17438274982851e-06
familial O 1 0.9982319474220276
, O 0 0.000317018770147115
early O 0 0.19076363742351532
onset O 1 0.9999876022338867
breast B-Disease 1 0.999988317489624
and I-Disease 0 0.004339756444096565
/ I-Disease 1 0.9995006322860718
or I-Disease 1 0.9981021285057068
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999984502792358
and O 0 5.234018317423761e-06
encode O 0 4.669579084293218e-06
products O 0 9.055689588421956e-06
that O 0 5.103917715132411e-07
each O 0 2.556701304001763e-07
interact O 0 1.292213983106194e-05
with O 0 2.2910742700332776e-05
hRAD51 O 0 0.011602298356592655
. O 0 0.00023549211618956178

Results O 0 0.0002019044477492571
presented O 0 6.437691627070308e-05
here O 0 1.266280742129311e-05
show O 0 1.2148685527790803e-05
that O 0 3.4367976695648395e-06
BRCA1 O 0 0.002211309503763914
and O 0 9.259744729206432e-06
BRCA2 O 0 0.002658616751432419
coexist O 0 4.320484367781319e-05
in O 0 3.972680133301765e-06
a O 0 3.286653009126894e-05
biochemical O 0 0.0005171120283193886
complex O 0 0.00025250500766560435
and O 0 1.8882063159253448e-05
colocalize O 0 0.0035933121107518673
in O 0 2.3389424313791096e-05
subnuclear O 0 0.004790861625224352
foci O 0 0.0008560034330002964
in O 0 1.5829802578082308e-05
somatic O 0 0.0008310513221658766
cells O 0 0.0002912511699832976
and O 0 1.4901905842634733e-06
on O 0 2.3987661279534223e-06
the O 0 1.662639988353476e-06
axial O 0 3.964595452998765e-05
elements O 0 2.2601475393457804e-06
of O 0 3.032250333490083e-06
developing O 0 0.0008989249472506344
synaptonemal O 0 0.466971218585968
complexes O 0 0.02290252037346363
. O 0 0.00022253408678807318

Like O 0 0.0012456474360078573
BRCA1 O 0 0.03800247982144356
and O 0 7.391485996777192e-05
RAD51 O 1 0.9689378142356873
, O 0 7.500942592741922e-05
BRCA2 O 0 0.003196985460817814
relocates O 0 0.0007045583333820105
to O 0 1.0917998224613257e-05
PCNA O 0 0.07457298785448074
+ O 0 0.00027714119642041624
replication O 0 8.853038889355958e-05
sites O 0 4.982134214515099e-06
following O 0 1.8195813026977703e-05
exposure O 0 0.0008924127323552966
of O 0 1.4321215076051885e-06
S O 0 0.015820929780602455
phase O 0 0.0004577378567773849
cells O 0 0.00046513607958331704
to O 0 1.2039107787131798e-05
hydroxyurea O 0 0.03169521316885948
or O 0 0.00019072859140578657
UV O 1 0.8496402502059937
irradiation O 0 0.004078554455190897
. O 0 0.00011859296500915661

Thus O 0 0.00018378245295025408
, O 0 4.5960317947901785e-05
BRCA1 O 0 0.003535619005560875
and O 0 7.446760719176382e-06
BRCA2 O 0 0.0005201062303967774
participate O 0 1.3452460052576498e-06
, O 0 6.30442059446068e-07
together O 0 4.731349463327206e-07
, O 0 6.469343247772485e-07
in O 0 1.2625899898921489e-06
a O 0 2.514596599212382e-05
pathway O 0 0.0004024338268209249
( O 0 1.712786433927249e-05
s O 0 0.00025920619373209774
) O 0 1.9715464532055194e-06
associated O 0 3.7739348499599146e-06
with O 0 5.232138846622547e-07
the O 0 1.346208478025801e-06
activation O 0 2.8315611416473985e-05
of O 0 1.231696728609677e-06
double O 0 0.0013446958037093282
- O 0 0.0014560817508026958
strand O 0 0.00026585234445519745
break O 0 0.00022820445883553475
repair O 1 0.7179592251777649
and O 0 2.0116814994253218e-05
/ O 0 0.0004772302054334432
or O 0 1.6690881238901056e-05
homologous O 0 0.0002684227074496448
recombination O 0 0.0005052525666542351
. O 0 0.00014821378863416612

Dysfunction O 1 0.9858783483505249
of O 0 8.98926464287797e-06
this O 0 2.6112205887329765e-05
pathway O 0 0.0013551375595852733
may O 0 4.7473396989516914e-05
be O 0 1.0983350193782826e-06
a O 0 4.884974714514101e-06
general O 0 7.68519748817198e-06
phenomenon O 0 2.9658738640137017e-05
in O 0 7.183413117672899e-07
the O 0 1.153537368736579e-06
majority O 0 1.7375430161337135e-06
of O 0 1.0616472536639776e-06
cases O 0 0.00020755789591930807
of O 0 8.545367018086836e-05
hereditary B-Disease 1 0.9999645948410034
breast I-Disease 1 0.999992847442627
and I-Disease 0 0.016274239867925644
/ I-Disease 1 0.9997190833091736
or I-Disease 1 0.9992903470993042
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
. O 0 0.0004457411414477974
. O 0 0.0002791294828057289

A O 0 0.0005895764334127307
novel O 0 0.00021912068768870085
Arg362Ser O 0 0.002663904568180442
mutation O 0 6.389345071511343e-05
in O 0 3.1061272238730453e-06
the O 0 1.5375926523120143e-05
sterol O 0 0.004613323602825403
27 O 0 0.0003015107358805835
- O 0 0.0006328484741970897
hydroxylase O 0 0.0006057185237295926
gene O 0 8.944472938310355e-05
( O 0 1.9138167772325687e-05
CYP27 O 0 0.0044974153861403465
) O 0 4.197978341835551e-06
: O 0 1.0652597666194197e-06
its O 0 9.454508358430758e-07
effects O 0 6.31208749837242e-05
on O 0 5.70360907659051e-06
pre O 0 0.00017841464432422072
- O 0 2.386745109106414e-05
mRNA O 0 2.2667441044177394e-06
splicing O 0 6.451121862482978e-06
and O 0 1.0755270523077343e-06
enzyme O 0 0.00023981943377293646
activity O 0 6.829666381236166e-05
. O 0 4.398406599648297e-05

A O 0 0.00013565550034400076
novel O 0 9.191523713525385e-05
C O 0 0.0001464243105147034
to O 0 4.4682661837214255e-07
A O 0 1.6102654626592994e-05
mutation O 0 1.3959842362964991e-05
in O 0 1.0508398418096476e-06
the O 0 1.4016750355949625e-05
sterol O 0 0.00391773646697402
27 O 0 0.00023623961897101253
- O 0 0.0006355626974254847
hydroxylase O 0 0.001098279026336968
gene O 0 6.368826871039346e-05
( O 0 1.9518083718139678e-05
CYP27 O 0 0.00725048640742898
) O 0 7.85932206781581e-06
was O 0 8.750308188609779e-05
identified O 0 1.4643849681306165e-05
by O 0 2.2334324967232533e-06
sequencing O 0 2.3214777684188448e-05
amplified O 0 0.0003970132383983582
CYP27 O 0 0.007226001005619764
gene O 0 9.282936662202701e-05
products O 0 1.756992242007982e-05
from O 0 9.713515282783192e-06
a O 0 0.00023915951896924525
patient O 1 0.9779907464981079
with O 0 0.00025557479239068925
cerebrotendinous B-Disease 1 0.9984703660011292
xanthomatosis I-Disease 1 0.9988275170326233
( O 0 0.0010931517463177443
CTX B-Disease 1 0.9977161884307861
) O 0 0.00016023291391320527
. O 0 0.00010439753532409668

The O 0 4.031872595078312e-05
mutation O 0 0.00014741164341103286
changed O 0 4.148775406065397e-05
the O 0 5.3657990974897984e-06
adrenodoxin O 0 0.0008917386876419187
cofactor O 0 7.445923984050751e-05
binding O 0 1.533218710392248e-05
residue O 0 0.0004117614880669862
362Arg O 0 0.0006206372636370361
to O 0 7.146308234950993e-06
362Ser O 0 0.002693980699405074
( O 0 9.313811460742727e-05
CGT O 0 0.053264837712049484
362Arg O 0 0.003821396501734853
to O 0 5.865275670657866e-05
AGT O 1 0.9903539419174194
362Ser O 0 0.002745780162513256
) O 0 8.331398930749856e-06
, O 0 1.1473779295556596e-06
and O 0 1.2088690937162028e-06
was O 0 0.00010110139555763453
responsible O 0 9.805731679080054e-05
for O 0 8.259130117949098e-05
deficiency O 1 0.999963641166687
in O 0 1.4189550711307675e-05
the O 0 4.854476355831139e-05
sterol O 0 0.026140721514821053
27 O 0 0.0006022346788085997
- O 0 0.0004457505128812045
hydroxylase O 0 0.0003866737533826381
activity O 0 5.598426014330471e-06
, O 0 1.519587613074691e-06
as O 0 1.722716547192249e-06
confirmed O 0 1.044072905642679e-05
by O 0 2.1729772470280295e-07
expression O 0 5.589008651440963e-07
of O 0 1.5615945869740244e-07
mutant O 0 5.408690049080178e-05
cDNA O 0 2.8881731850560755e-05
into O 0 2.301157837791834e-05
COS O 0 0.43345996737480164
- O 0 0.0008631388191133738
1 O 0 9.748802403919399e-05
cells O 0 0.000691887573339045
. O 0 5.302782665239647e-05

Quantitative O 0 9.180346387438476e-05
analysis O 0 1.9557417545001954e-05
showed O 0 6.244857650017366e-05
that O 0 4.5219155708764447e-07
the O 0 9.169201007352967e-07
expression O 0 9.464575327911007e-07
of O 0 4.4186654690747673e-07
CYP27 O 0 0.0019118166528642178
gene O 0 1.4100722182774916e-05
mRNA O 0 5.9908088587690145e-06
in O 0 2.0262928046577144e-06
the O 0 9.581600352248643e-06
patient O 0 0.04323173686861992
represented O 0 2.2341280782711692e-05
52 O 0 0.00040189819992519915
. O 0 0.00013073875743430108

5 O 0 3.503718107822351e-05
% O 0 1.7009324437822215e-06
of O 0 1.697223694918648e-07
the O 0 1.1075576367147733e-05
normal O 0 0.0002702597703319043
level O 0 0.000298941828077659
. O 0 7.823373744031414e-05

As O 0 1.794979652913753e-05
the O 0 6.416540600184817e-06
mutation O 0 8.267466182587668e-05
occurred O 0 5.0111171731259674e-05
at O 0 8.571927537559532e-06
the O 0 1.3550678659157711e-06
penultimate O 0 0.00011877086944878101
nucleotide O 0 2.4747032512095757e-06
of O 0 3.950254949813825e-07
exon O 0 0.00031846557976678014
6 O 0 5.1871375035261735e-05
( O 0 5.478046205098508e-06
- O 0 1.7313703210675158e-05
2 O 0 8.142465048877057e-07
position O 0 4.295463043035852e-07
of O 0 1.7706631183500576e-07
exon O 0 0.00031031036633066833
6 O 0 6.033096360624768e-05
- O 0 0.0001536866184324026
intron O 0 0.0011388350976631045
6 O 0 2.19850644498365e-05
splice O 0 9.219262574333698e-05
site O 0 1.3291740287968423e-05
) O 0 3.2547967521168175e-07
of O 0 6.803325192095144e-08
the O 0 5.34639866600628e-06
gene O 0 4.174540299572982e-05
, O 0 2.808883664329187e-06
we O 0 7.46707428334048e-07
hypothesized O 0 5.7502093113726005e-05
that O 0 1.1562258350750199e-06
the O 0 1.1290057045698632e-05
mutation O 0 0.0003308301093056798
may O 0 0.00010515385656617582
partially O 0 0.0005067421589046717
affect O 0 2.6148043161811074e-06
the O 0 8.571335001761327e-07
normal O 0 1.436437014490366e-05
splicing O 0 1.371750477119349e-05
efficiency O 0 1.087709370040102e-05
in O 0 2.96366715701879e-06
exon O 0 0.00044643148430623114
6 O 0 5.285314909997396e-05
and O 0 2.90666366709047e-06
cause O 0 0.00019647074805106968
alternative O 0 8.321600944327656e-06
splicing O 0 4.567195719573647e-05
elsewhere O 0 6.065861725801369e-06
, O 0 1.3117720527588972e-06
which O 0 1.1937011095142225e-06
resulted O 0 9.229237184626982e-05
in O 0 1.3420805771602318e-05
decreased O 0 0.006053449586033821
transcript O 0 0.001968890195712447
in O 0 1.3178459084883798e-05
the O 0 0.00012469058856368065
patient O 1 0.9891886711120605
. O 0 0.0001277461415156722

Transfection O 0 0.004893920850008726
of O 0 1.1702943083946593e-05
constructed O 0 0.01177044678479433
minigenes O 0 0.03407849743962288
, O 0 1.3878314348403364e-05
with O 0 3.7075112686579814e-06
or O 0 7.234229087771382e-06
without O 0 4.058148533658823e-06
the O 0 3.484134595055366e-06
mutation O 0 3.0628503736807033e-05
, O 0 2.1328846742108e-06
into O 0 1.8485186956240796e-05
COS O 1 0.7827047109603882
- O 0 0.00038157100789248943
1 O 0 2.2631953470408916e-05
cells O 0 0.00012589847028721124
confirmed O 0 2.3817656256142072e-05
that O 0 3.977715437031293e-07
the O 0 2.7170531211595517e-06
mutant O 0 0.00016483299259562045
minigene O 0 0.0010496660834178329
was O 0 6.428360939025879e-05
responsible O 0 5.230226179264719e-06
for O 0 2.1468585487127712e-07
a O 0 4.23219444201095e-06
mRNA O 0 1.0802537872223184e-05
species O 0 2.147750592484954e-06
alternatively O 0 4.2323386878706515e-05
spliced O 0 7.872820424381644e-05
at O 0 2.318785118404776e-05
an O 0 1.9219174646423198e-05
activated O 0 0.002930322429165244
cryptic O 0 0.0006792110507376492
5 O 0 2.0190273062326014e-05
splice O 0 0.00026295389398001134
site O 0 7.602507685078308e-05
88 O 0 6.196250615175813e-05
bp O 0 0.00012479312135837972
upstream O 0 1.6163963664439507e-05
from O 0 1.034538286148745e-06
the O 0 7.801990591360664e-07
3 O 0 3.5744535580306547e-06
end O 0 5.484026132762665e-06
of O 0 1.106406898543355e-06
exon O 0 0.001478770631365478
6 O 0 0.0003418397973291576
. O 0 8.677384175825864e-05

Our O 0 4.3364643715904094e-06
data O 0 4.601653472491307e-06
suggest O 0 1.0032657883130014e-05
that O 0 3.784809052831406e-07
the O 0 1.317224018748675e-06
C O 0 3.761789048439823e-05
to O 0 3.5285466992718284e-07
A O 0 1.3353283975447994e-05
mutation O 0 6.88889849698171e-06
at O 0 2.117324129358167e-06
the O 0 7.069959906402801e-07
penultimate O 0 5.760472049587406e-05
nucleotide O 0 1.3443071793517447e-06
of O 0 1.3256696718144667e-07
exon O 0 0.00013763429888058454
6 O 0 4.523503775999416e-06
of O 0 1.8654134237294784e-07
the O 0 8.18413718661759e-06
CYP27 O 0 0.004438076168298721
gene O 0 2.03352374228416e-05
not O 0 1.3167730230634334e-06
only O 0 2.5621643544582184e-06
causes O 0 0.00244462164118886
the O 0 0.0003623093361966312
deficiency B-Disease 1 0.999987006187439
in I-Disease 0 1.555973540234845e-05
the I-Disease 0 4.2949326598318294e-05
sterol I-Disease 0 0.023321587592363358
27 I-Disease 0 0.00027994290576316416
- I-Disease 0 0.000392477260902524
hydroxylase I-Disease 0 0.0002853152109310031
activity I-Disease 0 7.589318101963727e-06
, O 0 1.9877622889907798e-06
but O 0 2.2835943127574865e-06
also O 0 6.603525889659068e-06
partially O 0 0.0002729544648900628
leads O 0 1.0818209375429433e-05
to O 0 4.396844985876669e-07
alternative O 0 4.221552899252856e-06
pre O 0 7.84040821599774e-05
- O 0 6.622406999667874e-06
mRNA O 0 4.435578659922612e-07
splicing O 0 7.459928497155488e-07
of O 0 1.1161553459260176e-07
the O 0 1.1844630535051692e-05
gene O 0 0.00025889280368573964
. O 0 0.00010112608288181946

To O 0 3.17659146276128e-06
our O 0 1.0170141422349843e-06
knowledge O 0 2.8392307740432443e-06
, O 0 1.2115167464799015e-06
this O 0 3.1890959917291184e-07
is O 0 1.3718845366383903e-06
the O 0 1.4205361367203295e-06
first O 0 4.604120476869866e-06
report O 0 1.6621786926407367e-05
regarding O 0 4.925007033307338e-06
effects O 0 0.00015673646703362465
on O 0 1.1102734788437374e-05
pre O 0 0.00014349188131745905
- O 0 7.4460931500652805e-06
mRNA O 0 4.792872232428635e-07
splicing O 0 6.702410928483005e-07
of O 0 5.245483336580037e-08
a O 0 5.578748186962912e-06
mutation O 0 1.4459010344580747e-05
at O 0 8.266469194495585e-06
the O 0 2.425945240247529e-06
- O 0 1.669740777288098e-05
2 O 0 9.683210464572767e-07
position O 0 4.0980799553835823e-07
of O 0 7.493470377539779e-08
a O 0 2.0241050151525997e-05
5 O 0 2.7452731956145726e-05
splice O 0 0.0004998663207516074
site O 0 0.0002806358097586781
. O 0 5.513032010640018e-05

ATM O 0 0.019858211278915405
germline O 0 0.012521798722445965
mutations O 0 0.0002657099103089422
in O 0 5.102745126350783e-05
classical O 0 0.01409714762121439
ataxia B-Disease 1 0.9999945163726807
- I-Disease 1 0.9999254941940308
telangiectasia I-Disease 1 0.9999657869338989
patients O 1 0.9995167255401611
in O 0 1.886071913759224e-05
the O 0 4.691496360464953e-05
Dutch O 0 0.000782240298576653
population O 0 2.77050585282268e-05
. O 0 8.200757292797789e-05

Germline O 0 0.007152737118303776
mutations O 0 6.783322896808386e-05
in O 0 4.118046490475535e-06
the O 0 1.4248847946873866e-05
ATM O 0 0.0009635013993829489
gene O 0 1.5882184015936218e-05
are O 0 3.1722760240882053e-07
responsible O 0 1.2190617781016044e-05
for O 0 6.4506912167416885e-06
the O 0 0.002242426387965679
autosomal B-Disease 1 0.9999955892562866
recessive I-Disease 1 0.9999996423721313
disorder I-Disease 1 1.0
ataxia B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999737739562988
telangiectasia I-Disease 1 0.9999727010726929
( O 0 0.012507268227636814
A B-Disease 1 0.9998478889465332
- I-Disease 1 0.9995278120040894
T I-Disease 1 0.9998805522918701
) O 0 4.386979344417341e-05
. O 0 4.307763447286561e-05

In O 0 2.6341507691540755e-05
our O 0 2.8462793579819845e-06
study O 0 1.3421266885416117e-05
, O 0 2.5490132884442573e-06
we O 0 3.3360711881869065e-07
have O 0 1.210026709941303e-07
determined O 0 1.8041520206679706e-06
the O 0 1.535639057692606e-06
ATM O 0 0.00030158806475810707
mutation O 0 3.2636497053317726e-05
spectrum O 0 1.4248114894144237e-05
in O 0 2.5845652089628857e-06
19 O 0 3.055344132008031e-05
classical O 0 0.00022303029254544526
A B-Disease 1 0.999291181564331
- I-Disease 1 0.9997226595878601
T I-Disease 1 0.9999722242355347
patients O 1 0.9973564147949219
, O 0 3.6481942515820265e-06
including O 0 7.786350693095301e-07
some O 0 1.040401457430562e-06
immigrant O 0 3.130404729745351e-05
populations O 0 1.1635936971288174e-05
, O 0 1.877893282653531e-06
as O 0 3.6371054648043355e-06
well O 0 7.925888780846435e-07
as O 0 1.5527215282418183e-06
12 O 0 1.902163376144017e-06
of O 0 3.264128451974102e-07
Dutch O 0 3.7188052374403924e-05
ethnic O 0 1.7527779618831119e-06
origin O 0 1.60197578225052e-05
. O 0 0.0001360762835247442

Both O 0 3.0390333449759055e-06
the O 0 4.8764850362204015e-06
protein O 0 4.1157571104122326e-05
truncation O 0 0.000443530356278643
test O 0 4.491621075430885e-05
( O 0 6.770354502805276e-06
PTT O 0 5.510803384822793e-05
) O 0 7.282388310159149e-07
and O 0 2.6963306254401687e-07
the O 0 1.3755775398749392e-06
restriction O 0 3.977649976150133e-05
endonuclease O 0 0.0013950938591733575
fingerprinting O 0 0.00041690818034112453
( O 0 1.8195569282397628e-05
REF O 0 0.006879367865622044
) O 0 5.660900797010981e-07
method O 0 8.756675811127934e-07
were O 0 9.371927376378153e-07
used O 0 1.7526792817079695e-06
and O 0 6.797033051952894e-07
compared O 0 1.2766844520228915e-05
for O 0 4.840391056859517e-07
their O 0 6.472064342233352e-07
detection O 0 0.00010265124728903174
efficiency O 0 1.7493146515334956e-05
, O 0 2.074983967759181e-06
identifying O 0 2.1060339349787682e-05
76 O 0 7.281384023372084e-05
% O 0 1.5034947864478454e-06
and O 0 2.3417258887548087e-07
60 O 0 1.3350050949156866e-06
% O 0 2.359572448540348e-07
of O 0 2.0275538759051415e-07
the O 0 1.1422812349337619e-05
mutations O 0 0.00013956378097645938
, O 0 6.8932031354052015e-06
respectively O 0 0.00011756094318116084
. O 0 9.030311048263684e-05

Most O 0 0.001093064434826374
patients O 1 0.9962747097015381
were O 0 2.0536834199447185e-05
found O 0 2.825362935254816e-05
to O 0 1.7180292388729868e-06
be O 0 7.109668331395369e-06
compound O 0 0.0012516583083197474
heterozygote O 0 0.006429180968552828
. O 0 0.0002309231203980744

Seventeen O 0 0.00042527439654804766
mutations O 0 9.277167555410415e-05
were O 0 1.8542494899520534e-06
distinct O 0 2.62753815150063e-06
, O 0 7.098173000485986e-07
of O 0 2.0626457342132198e-07
which O 0 1.6796865338619682e-06
10 O 0 5.064322976977564e-06
were O 0 2.4762944121903274e-06
not O 0 4.07683000958059e-06
reported O 0 0.00021491745428647846
previously O 0 0.0003504389023873955
. O 0 0.00011351827561156824

Mutations O 0 0.0005977542605251074
are O 0 2.8505280624813167e-06
small O 0 1.5231978068186436e-05
deletions O 0 0.00013801238674204797
or O 0 1.8855000234907493e-05
point O 0 6.469329673564062e-05
mutations O 0 0.00018027190526481718
frequently O 0 9.195170423481613e-05
affecting O 0 0.00016245158622041345
splice O 0 0.0012694539036601782
sites O 0 0.00011751139390980825
. O 0 0.00015267005073837936

Moreover O 0 0.00048087257891893387
, O 0 2.1895446479902603e-05
a O 0 6.0192982346052304e-05
16 O 0 0.00014856000780127943
. O 0 8.511827036272734e-05

7 O 0 0.0005234048585407436
- O 0 0.00036077055847272277
kb O 0 0.00019388861255720258
genomic O 0 1.8962758986162953e-05
deletion O 0 3.069072408834472e-05
of O 0 1.592581071463428e-07
the O 0 3.6692269986815518e-06
3 O 0 7.401899438264081e-06
end O 0 2.67904988504597e-06
of O 0 1.0389395299625903e-07
the O 0 2.6706545668275794e-06
gene O 0 2.519508052500896e-05
, O 0 1.0222827313555172e-06
most O 0 7.595608053634351e-07
likely O 0 5.242885890766047e-06
a O 0 3.496129920677049e-06
result O 0 2.839945636878838e-06
of O 0 1.5161454314238654e-07
recombination O 0 2.2334825189318508e-05
between O 0 1.4978274975874228e-06
two O 0 1.6993532199194306e-06
LINE O 0 0.00013506770483218133
elements O 0 7.046582140901592e-06
, O 0 1.3972203305456787e-05
was O 0 0.0009522942127659917
identified O 0 0.000264999020146206
. O 0 5.8747751609189436e-05

The O 0 3.999833279522136e-05
most O 0 1.1479743079689797e-05
frequently O 0 8.851527672959492e-05
found O 0 9.460053115617484e-05
mutation O 0 9.049872460309416e-05
, O 0 2.2597896531806327e-06
identified O 0 1.7232065147254616e-05
in O 0 1.6665961766193504e-06
three O 0 3.379684130777605e-06
unrelated O 0 0.0009204592206515372
Turkish O 0 0.0006823275471106172
A B-Disease 1 0.9987279772758484
- I-Disease 1 0.9968628883361816
T I-Disease 1 0.9995842576026917
individuals O 0 4.843706392421154e-06
, O 0 8.590675861341879e-06
was O 0 0.00016988099378068
previously O 0 3.299698801129125e-05
described O 0 3.4910211979877204e-05
to O 0 6.137553327789647e-07
be O 0 1.452431320103642e-06
a O 0 1.1170621291967109e-05
Turkish O 0 0.00012854210217483342
A B-Disease 1 0.9090436100959778
- I-Disease 1 0.878548264503479
T I-Disease 1 0.9991519451141357
founder O 0 0.0015665949322283268
mutation O 0 0.0008646897040307522
. O 0 7.578202348668128e-05

The O 0 1.3223328096501064e-05
presence O 0 1.0394571290817112e-05
of O 0 9.730506462801713e-07
a O 0 5.7810641010291874e-05
founder O 0 0.00040526787051931024
mutation O 0 0.00010739072604337707
among O 0 3.7709701246058103e-06
relatively O 0 2.521591704862658e-05
small O 0 2.618737198645249e-06
ethnic O 0 1.29454213038116e-06
population O 0 1.2017561630273121e-06
groups O 0 1.2358301546555595e-06
in O 0 3.5293817290948937e-06
Western O 0 2.4247416149592027e-05
Europe O 0 2.0686848074547015e-05
could O 0 2.8307142656558426e-06
indicate O 0 9.501750355411787e-06
a O 0 9.122866686084308e-06
high O 0 0.00011515222286107019
carrier O 0 6.183370715007186e-05
frequency O 0 2.54477481576032e-06
in O 0 1.028960241455934e-06
such O 0 1.4071889609112986e-06
communities O 0 1.5611760318279266e-05
. O 0 0.00010283445590175688

In O 0 0.0005480006220750511
patients O 1 0.717103123664856
of O 0 2.3991001398826484e-06
Dutch O 0 0.00014035319327376783
ethnic O 0 3.2557516078668414e-06
origin O 0 6.614562153117731e-06
, O 0 1.0565995580691379e-05
however O 0 2.0138142645009793e-05
, O 0 4.3618019844871014e-06
no O 0 7.417926553898724e-06
significant O 0 1.9880175386788324e-05
founder O 0 0.00016677312669344246
effect O 0 4.4059124775230885e-05
could O 0 1.2990504728804808e-05
be O 0 7.358235052379314e-06
identified O 0 0.00010812273831106722
. O 0 4.794244887307286e-05

The O 0 2.223159208369907e-05
observed O 0 6.811740604462102e-05
genetic O 0 0.00012323370901867747
heterogeneity O 0 4.70481209049467e-05
including O 0 1.2938312465848867e-06
the O 0 2.3583088477607816e-06
relative O 0 1.527551830804441e-05
high O 0 5.94764351262711e-05
percentage O 0 9.458617569180205e-06
of O 0 7.156853598644375e-07
splice O 0 0.0018865767633542418
- O 0 0.0011711400002241135
site O 0 7.363211625488475e-05
mutations O 0 5.942637289990671e-05
had O 0 1.7052794646588154e-05
no O 0 2.3029188014334068e-06
reflection O 0 7.158798325690441e-06
on O 0 8.072867785813287e-06
the O 0 4.809567690244876e-05
phenotype O 0 0.010898631066083908
. O 0 9.982953633880243e-05

All O 0 0.00012606628297362477
patients O 1 0.9936090707778931
manifested O 0 0.007253734394907951
classical O 0 0.0011860545491799712
A B-Disease 1 0.9989809393882751
- I-Disease 1 0.9979528188705444
T I-Disease 1 0.9989380240440369
and O 0 3.1414554086950375e-06
increased O 0 1.966129639185965e-05
cellular O 0 0.00014777264732401818
radioresistant O 0 0.0009194844751618803
DNA O 0 0.00012365335715003312
synthesis O 0 0.0002092336944770068
. O 0 7.087765698088333e-05

Determination O 0 1.6733147276681848e-05
of O 0 3.471718628134113e-07
the O 0 4.603782599588158e-06
genomic O 0 2.1724667021771893e-05
structure O 0 1.6763844541856088e-05
of O 0 8.025789952625928e-07
the O 0 2.5061935957637616e-05
COL4A4 O 0 0.06754143536090851
gene O 0 2.764588498394005e-05
and O 0 8.878606649886933e-07
of O 0 2.221964450654923e-06
novel O 0 0.0018589372048154473
mutations O 0 0.08931228518486023
causing O 1 0.9986687898635864
autosomal B-Disease 1 0.9999678134918213
recessive I-Disease 1 0.9999934434890747
Alport I-Disease 1 0.999998927116394
syndrome I-Disease 1 0.9999998807907104
. O 0 0.05026308074593544

Autosomal B-Disease 1 0.9996311664581299
recessive I-Disease 1 0.9999605417251587
Alport I-Disease 1 0.999997615814209
syndrome I-Disease 1 0.9999997615814209
is O 0 0.001357021275907755
a O 0 0.008788012899458408
progressive O 1 0.998673677444458
hematuric B-Disease 1 0.9993941783905029
glomerulonephritis I-Disease 1 0.9999781847000122
characterized O 1 0.9988574981689453
by O 0 0.012603307142853737
glomerular B-Disease 1 0.9999796152114868
basement I-Disease 1 0.9998136162757874
membrane I-Disease 1 0.9958421587944031
abnormalities I-Disease 1 0.9996317625045776
and O 0 1.702338340692222e-05
associated O 0 0.00010176743671763688
with O 0 6.929414666956291e-06
mutations O 0 7.808921509422362e-05
in O 0 4.28270323027391e-06
either O 0 8.602375601185486e-06
the O 0 1.5134977729758248e-05
COL4A3 O 0 0.033648934215307236
or O 0 1.2651556971832179e-05
the O 0 1.4566408935934305e-05
COL4A4 O 0 0.012332875281572342
gene O 0 3.430805736570619e-05
, O 0 3.944897741803288e-07
which O 0 1.1616965167604576e-07
encode O 0 5.477202762449451e-07
the O 0 5.6611024774611e-06
alpha3 O 0 0.0017892614705488086
and O 0 2.4442526409984566e-05
alpha4 O 0 0.07035183161497116
type O 1 0.7553368806838989
IV O 1 0.999578058719635
collagen O 1 0.999316930770874
chains O 0 0.01879819855093956
, O 0 5.0906481192214414e-05
respectively O 0 0.0001815419818740338
. O 0 8.055676880758256e-05

To O 0 5.124351901031332e-06
date O 0 1.9862061890307814e-05
, O 0 3.2947136787697673e-06
mutation O 0 1.735817568260245e-05
screening O 0 1.820546094677411e-05
in O 0 3.669356374302879e-07
the O 0 9.290308184972673e-07
two O 0 7.40496773232735e-07
genes O 0 2.037693775491789e-05
has O 0 2.337709338462446e-05
been O 0 6.72459791530855e-05
hampered O 0 0.011040455661714077
by O 0 3.4051129205181496e-06
the O 0 6.0308657339191996e-06
lack O 0 2.8020160243613645e-05
of O 0 6.490967052741325e-07
genomic O 0 0.0002357441553613171
structure O 0 0.0011436439817771316
information O 0 5.953199797659181e-05
. O 0 0.00010697332618292421

We O 0 1.8365228243055753e-05
report O 0 1.912935658765491e-05
here O 0 1.3026924534642603e-06
the O 0 7.624377076353994e-07
complete O 0 3.8455441426776815e-06
characterization O 0 2.6301346224499866e-05
of O 0 1.4722212426931947e-07
the O 0 2.5531660412525525e-06
48 O 0 7.779301995469723e-06
exons O 0 1.1211283890588675e-05
of O 0 2.8523533046609373e-07
the O 0 1.876709757198114e-05
COL4A4 O 0 0.008745991624891758
gene O 0 2.8354905225569382e-05
, O 0 9.211797191710502e-07
a O 0 4.548438027995871e-06
comprehensive O 0 2.873902667488437e-05
gene O 0 3.9135728002293035e-05
screen O 0 2.3446569684892893e-05
, O 0 7.816505558366771e-07
and O 0 2.885830099330633e-07
the O 0 1.1583041441554087e-06
subsequent O 0 2.230055906693451e-05
detection O 0 1.995174534386024e-05
of O 0 4.09400939815896e-07
10 O 0 1.2635712664632592e-05
novel O 0 5.274067370919511e-05
mutations O 0 7.6110809459351e-05
in O 0 2.198363836214412e-05
eight O 0 0.029975688084959984
patients O 1 0.9999872446060181
diagnosed O 1 0.9999995231628418
with O 1 0.9203613996505737
autosomal B-Disease 1 0.9999935626983643
recessive I-Disease 1 0.9999967813491821
Alport I-Disease 1 0.9999994039535522
syndrome I-Disease 1 0.9999998807907104
. O 0 0.12177512794733047

Furthermore O 0 0.00032118993112817407
, O 0 7.68345307733398e-06
we O 0 7.730305355835299e-07
identified O 0 6.490721716545522e-06
a O 0 4.135670678806491e-06
glycine O 0 7.545896369265392e-05
to O 0 5.155587814442697e-07
alanine O 0 8.163351594703272e-05
substitution O 0 6.628396477026399e-06
in O 0 1.7814229522628011e-06
the O 0 7.5699458648159634e-06
collagenous O 0 0.015772372484207153
domain O 0 2.1123962142155506e-05
that O 0 4.248767254466657e-06
is O 0 1.1178571185155306e-05
apparently O 0 0.00019512638391461223
silent O 0 0.0005755980964750051
in O 0 2.9158366032788763e-06
the O 0 8.850861377140973e-06
heterozygous O 0 0.00016466394299641252
carriers O 0 0.0002548673946876079
, O 0 4.289938715373864e-06
in O 0 5.792250703962054e-06
11 O 0 9.896117262542248e-05
. O 0 5.380293805501424e-05

5 O 0 2.072855750157032e-05
% O 0 1.8396935956843663e-06
of O 0 2.1877427514027659e-07
all O 0 5.210304721003922e-07
control O 0 1.9740375137189403e-05
individuals O 0 1.5427642665599706e-06
, O 0 1.3611086160381092e-06
and O 0 5.702558496523125e-07
in O 0 4.6033954959057155e-07
one O 0 6.264647822717961e-07
control O 0 5.020984644943383e-06
individual O 0 8.617431035418122e-07
homozygous O 0 2.4004913939279504e-05
for O 0 1.0458560382176074e-06
this O 0 1.8269356587552465e-06
glycine O 0 0.00043916856520809233
substitution O 0 0.00011284600623184815
. O 0 6.03187654633075e-05

There O 0 5.7942772400565445e-05
has O 0 3.003396159328986e-05
been O 0 9.381904419569764e-06
no O 0 2.172120730392635e-06
previous O 0 1.6148027270901366e-06
finding O 0 1.7131370668721502e-06
of O 0 1.581070847578303e-07
a O 0 9.9039416454616e-06
glycine O 0 0.00016273392247967422
substitution O 0 6.396244316420052e-06
that O 0 9.396153473062441e-07
is O 0 1.3886343595004291e-06
not O 0 5.373272529141104e-07
associated O 0 5.861249064764706e-06
with O 0 1.817435304474202e-06
any O 0 7.668285434192512e-06
obvious O 0 0.0003637403715401888
phenotype O 0 0.001958529930561781
in O 0 1.7242980902665295e-05
homozygous O 0 0.0008533749496564269
individuals O 0 4.120253288419917e-05
. O 0 0.0002871027681976557

Founder O 0 0.009833058342337608
BRCA1 O 0 0.014212734065949917
and O 0 4.230349077261053e-05
BRCA2 O 0 0.007351336069405079
mutations O 0 0.00020673741528298706
in O 0 3.792012284975499e-05
French O 0 0.0038871716242283583
Canadian O 1 0.6398541331291199
breast B-Disease 1 0.9999796152114868
and I-Disease 1 0.9891256093978882
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
families O 0 0.0022638512309640646
. O 0 0.0005713173886761069

We O 0 7.4548888733261265e-06
have O 0 1.7729521459841635e-06
identified O 0 9.834838238020893e-06
four O 0 1.3057036767349928e-06
mutations O 0 7.05052116245497e-06
in O 0 1.964213254268543e-07
each O 0 6.577390365691826e-08
of O 0 1.124477762459719e-06
the O 0 0.009052453562617302
breast B-Disease 1 0.9999949932098389
cancer I-Disease 1 0.9999923706054688
- O 0 0.02913094498217106
susceptibility O 0 0.0016713135410100222
genes O 0 2.4342825781786814e-05
, O 0 1.9535606043064035e-05
BRCA1 O 0 0.0036662924103438854
and O 0 1.1449533303675707e-05
BRCA2 O 0 0.0023806625977158546
, O 0 5.53743620912428e-06
in O 0 1.4751581147720572e-05
French O 0 0.0021232590079307556
Canadian O 1 0.918428897857666
breast B-Disease 1 0.9999911785125732
cancer I-Disease 1 0.9999949932098389
and O 1 0.658499002456665
breast B-Disease 1 0.9999990463256836
/ I-Disease 1 0.9999724626541138
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
families O 0 0.00043882225872948766
from O 0 0.000262838089838624
Quebec O 0 0.00634415028616786
. O 0 0.00034013105323538184

To O 0 2.7281890652375296e-05
identify O 0 0.0001420206535840407
founder O 0 0.002094225725159049
effects O 0 0.005390687845647335
, O 0 3.622989243012853e-05
we O 0 4.071347575518303e-06
examined O 0 0.0004763657634612173
independently O 0 3.9139795262599364e-05
ascertained O 0 0.0018743175314739347
French O 0 0.0010193537455052137
Canadian O 0 0.009561688639223576
cancer B-Disease 1 0.9998481273651123
families O 0 8.873426850186661e-06
for O 0 9.446072226637625e-07
the O 0 1.0241631116514327e-06
distribution O 0 8.750080837671703e-07
of O 0 2.6010781084551127e-07
these O 0 1.6963189182206406e-06
eight O 0 6.082406616769731e-05
mutations O 0 0.0007563928375020623
. O 0 8.030143362702802e-05

Mutations O 0 0.00036774500040337443
were O 0 1.2164963663963135e-05
found O 0 1.8832410205504857e-05
in O 0 3.031828100574785e-06
41 O 0 1.5259545762091875e-05
of O 0 8.518952085978526e-07
97 O 0 0.000651321024633944
families O 0 5.4401258239522576e-05
. O 0 0.0001294693793170154

Six O 0 1.5417732356581837e-05
of O 0 1.6263910538327764e-06
eight O 0 2.9283710318850353e-05
mutations O 0 6.113971903687343e-05
were O 0 3.405255711186328e-06
observed O 0 1.9774479369516484e-05
at O 0 6.060399755369872e-05
least O 0 1.791600698197726e-05
twice O 0 0.00028779503190889955
. O 0 6.731770554324612e-05

The O 0 0.000199880960281007
BRCA1 O 0 0.010192329064011574
C4446T O 0 0.0010995902121067047
mutation O 0 0.0001336437271675095
was O 0 2.7284855605103076e-05
the O 0 1.6440299077657983e-06
most O 0 1.2918019365315558e-06
common O 0 3.2899675716180354e-05
mutation O 0 0.0001254133094334975
found O 0 2.9341521440073848e-05
, O 0 2.0601896721927915e-06
followed O 0 1.158040868176613e-05
by O 0 4.715349405159941e-06
the O 0 5.8077308494830504e-05
BRCA2 O 0 0.027959411963820457
8765delAG O 0 0.006514794658869505
mutation O 0 0.0010616204235702753
. O 0 0.000123825971968472

Together O 0 2.1745541744166985e-05
, O 0 4.770814030052861e-06
these O 0 1.1701999937940855e-06
mutations O 0 2.237921580672264e-05
were O 0 4.2577557906042784e-06
found O 0 1.0901642781391274e-05
in O 0 2.406510702712694e-06
28 O 0 6.894385933264857e-06
of O 0 5.619826879410539e-07
41 O 0 4.780858944286592e-05
families O 0 5.2873988352075685e-06
identified O 0 2.027549999183975e-05
to O 0 8.291721655950823e-07
have O 0 2.6494190024095587e-06
a O 0 4.258228000253439e-05
mutation O 0 0.00024408382887486368
. O 0 5.098984911455773e-05

The O 0 4.017686296720058e-05
odds O 0 0.00024845858570188284
of O 0 4.6634369255116326e-07
detection O 0 2.1637804820784368e-05
of O 0 4.66100900098354e-08
any O 0 2.414707864772936e-07
of O 0 1.2545575600597658e-07
the O 0 4.257373802829534e-06
four O 0 1.4705736248288304e-05
BRCA1 O 0 0.013080471195280552
mutations O 0 0.00021669731358997524
was O 0 0.00041208017501048744
18 O 0 0.00011762731446651742
. O 0 5.582303128903732e-05

7x O 0 0.03409262001514435
greater O 0 1.059393343894044e-05
if O 0 4.376327069621766e-06
one O 0 8.736205927561969e-07
or O 0 4.669258487410843e-06
more O 0 1.7528398075228324e-06
cases O 0 0.0004779834416694939
of O 0 0.0023281520698219538
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
were O 0 4.660959166358225e-05
also O 0 9.962902367988136e-06
present O 0 1.1500990694912616e-05
in O 0 5.88726470596157e-06
the O 0 2.117355506925378e-05
family O 0 0.00027346835122443736
. O 0 0.00015504636394325644

The O 0 8.365949906874448e-05
odds O 0 0.000381182850105688
of O 0 7.20202251613955e-07
detection O 0 3.230961010558531e-05
of O 0 7.418397984793046e-08
any O 0 3.8191819839994423e-07
of O 0 1.282398045532318e-07
the O 0 6.5139315665874165e-06
four O 0 2.749748273345176e-05
BRCA2 O 0 0.007230630610138178
mutations O 0 0.0002047418092843145
was O 0 0.000607021152973175
5 O 0 0.00015590383554808795
. O 0 6.817380926804617e-05

3x O 0 0.0011287073139101267
greater O 0 6.800496521464083e-06
if O 0 3.8605799090873916e-06
there O 0 6.106795922278252e-07
were O 0 6.993559509282932e-07
at O 0 4.1357457121193875e-06
least O 0 5.117716455060872e-07
five O 0 1.920418071676977e-06
cases O 0 0.00011134953092550859
of O 0 0.00014790979912504554
breast B-Disease 1 0.9999959468841553
cancer I-Disease 1 0.9999821186065674
in O 0 5.0531347369542345e-05
the O 0 7.017118332441896e-05
family O 0 0.0008447879808954895
. O 0 0.0002376257471041754

Interestingly O 0 0.0007786831120029092
, O 0 6.330027645162772e-06
the O 0 2.575360895207268e-06
presence O 0 7.906766768428497e-06
of O 0 6.014749942551134e-06
a O 0 0.36445361375808716
breast B-Disease 1 0.999993085861206
cancer I-Disease 1 0.9999791383743286
case O 0 0.001738141756504774
< O 0 0.0025622767861932516
36 O 0 1.943665301951114e-05
years O 0 7.213066055555828e-06
of O 0 4.840834435526631e-07
age O 0 0.00018148038361687213
was O 0 7.315396942431107e-05
strongly O 0 5.743630936194677e-06
predictive O 0 1.2692855761997635e-06
of O 0 6.464939872330433e-08
the O 0 9.448216928831243e-07
presence O 0 8.99706719792448e-07
of O 0 4.569854539226981e-08
any O 0 1.7490530979102914e-07
of O 0 1.6252097623237205e-07
the O 0 6.770625986973755e-06
eight O 0 4.382672341307625e-05
mutations O 0 0.0007199386600404978
screened O 0 0.0024325805716216564
. O 0 6.93195906933397e-05

Carriers O 0 0.00019231971236877143
of O 0 4.1578465470593073e-07
the O 0 4.140224518778268e-06
same O 0 6.465139449574053e-06
mutation O 0 5.459515887196176e-05
, O 0 1.3309638688951964e-06
from O 0 1.8672001260711113e-06
different O 0 1.6364293742299196e-07
families O 0 4.56369343737606e-06
, O 0 2.8197860046930145e-06
shared O 0 6.565546755155083e-06
similar O 0 3.1886309443507344e-05
haplotypes O 0 0.0024319940712302923
, O 0 1.3634283277497161e-05
indicating O 0 0.0001147068542195484
that O 0 1.0270308621329605e-06
the O 0 4.600371994456509e-06
mutant O 0 6.39105201116763e-05
alleles O 0 1.1529277799127158e-05
were O 0 2.061561644950416e-06
likely O 0 3.793445102928672e-06
to O 0 1.269290095251563e-07
be O 0 2.7742089514504187e-07
identical O 0 1.6500505353178596e-06
by O 0 7.281569196493365e-07
descent O 0 1.4723415006301366e-05
for O 0 7.743874448351562e-07
a O 0 1.0001190275943372e-05
mutation O 0 4.7769710363354534e-05
in O 0 1.7960114746529143e-06
the O 0 8.655567398818675e-06
founder O 0 0.0003927733050659299
population O 0 2.3836515538278036e-05
. O 0 0.0001285032631130889

The O 0 9.839163794822525e-06
identification O 0 4.328857357904781e-06
of O 0 1.0043255542768748e-06
common O 0 0.0004793687257915735
BRCA1 O 0 0.05488022789359093
and O 0 1.6478379620821215e-05
BRCA2 O 0 0.0030725670512765646
mutations O 0 2.5902336346916854e-05
will O 0 2.6857856028073e-07
facilitate O 0 4.608860763255507e-06
carrier O 0 0.00027480762219056487
detection O 0 8.882916154107079e-05
in O 0 1.2935171071148943e-05
French O 0 0.0013644301798194647
Canadian O 0 0.46276232600212097
breast B-Disease 1 0.9999761581420898
cancer I-Disease 1 0.9999909400939941
and O 1 0.6528226733207703
breast B-Disease 1 0.9999988079071045
/ I-Disease 1 0.9999788999557495
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
families O 0 0.0027819431852549314
. O 0 0.0007206470472738147

Are O 0 5.818496720166877e-05
Dp71 O 0 0.010863359086215496
and O 0 0.00010738785204011947
Dp140 O 0 0.03911659121513367
brain O 1 0.9961310625076294
dystrophin O 0 0.03545505926012993
isoforms O 0 0.00012153248826507479
related O 0 0.0002548887860029936
to O 0 3.522399492794648e-05
cognitive B-Disease 0 0.3796301782131195
impairment I-Disease 1 0.99980229139328
in O 1 0.5615364909172058
Duchenne B-Disease 1 0.9999868869781494
muscular I-Disease 1 0.9999934434890747
dystrophy I-Disease 1 0.9999951124191284
? O 1 0.8729395866394043

Molecular O 0 0.0006950561655685306
study O 0 7.375369750661775e-05
and O 0 1.746304587868508e-05
neuropsychological O 0 0.001992500154301524
analysis O 0 4.341541625763057e-06
were O 0 3.9322276279563084e-06
performed O 0 2.5376219127792865e-05
concurrently O 0 2.624922854010947e-05
on O 0 6.314646452665329e-05
49 O 0 0.006756310351192951
patients O 1 0.9991905093193054
with O 0 0.05604664236307144
Duchenne B-Disease 1 0.9999755620956421
muscular I-Disease 1 0.9999901056289673
dystrophy I-Disease 1 0.9999966621398926
( O 1 0.9260236024856567
DMD B-Disease 1 0.9999744892120361
) O 0 4.7136189095908776e-05
in O 0 3.010774435097119e-06
order O 0 9.64667492553417e-07
to O 0 1.222698671199396e-07
find O 0 8.59122167184978e-07
a O 0 2.068544972644304e-06
molecular O 0 2.3346301532001235e-05
explanation O 0 1.2539547242340632e-05
for O 0 1.1461748954388895e-06
the O 0 2.286019480379764e-05
cognitive B-Disease 0 0.016462091356515884
impairment I-Disease 1 0.9980533123016357
observed O 0 0.0004727399500552565
in O 0 0.00018991163233295083
most O 0 0.009648622013628483
DMD B-Disease 1 0.9999898672103882
patients O 1 0.9997695088386536
. O 0 0.0009939299197867513

Complete O 0 3.886133708874695e-05
analysis O 0 1.5455593711521942e-06
of O 0 8.413811087848444e-07
the O 0 3.8059817597968504e-05
dystrophin O 0 0.03689466416835785
gene O 0 0.00015173570136539638
was O 0 9.167013922706246e-05
performed O 0 2.12103986996226e-05
to O 0 3.889037714088772e-07
define O 0 2.1193645807215944e-06
the O 0 1.6351094700439717e-06
localization O 0 2.936055534519255e-05
of O 0 6.53346546641842e-07
deletions O 0 8.540137787349522e-05
and O 0 2.2243900730245514e-06
duplications O 0 5.8451802033232525e-05
in O 0 1.5006613693913096e-06
relation O 0 5.667065579473274e-06
to O 0 8.206648658415361e-07
the O 0 8.357579645235091e-06
different O 0 2.2831480237073265e-05
DMD B-Disease 1 0.9998358488082886
promoters O 0 0.07033968716859818
. O 0 0.0002716770686674863

Qualitative O 0 8.521052222931758e-06
analysis O 0 1.2298796718823723e-06
of O 0 5.2003861128469e-07
the O 0 1.223908839165233e-05
Dp71 O 0 0.0037457107100635767
transcript O 0 0.000562343979254365
and O 0 7.89033720138832e-07
testing O 0 6.0158859014336485e-06
for O 0 1.1069562333432259e-07
the O 0 7.055034529912518e-07
specific O 0 3.933991195026465e-07
first O 0 2.3353684355242876e-06
exon O 0 6.59202560200356e-05
of O 0 6.839272259639984e-07
Dp140 O 0 0.0004535054904408753
were O 0 5.264374976832187e-06
also O 0 7.748159987386316e-06
carried O 0 1.177437570731854e-05
out O 0 1.6097617844934575e-05
. O 0 2.4248247427749448e-05

Neuropsychological O 0 0.013539725914597511
analysis O 0 7.785797060932964e-05
assessed O 0 0.0010779871372506022
verbal O 0 0.0005073664360679686
and O 0 6.660127837676555e-05
visuospatial O 0 0.06509142369031906
intelligence O 0 0.000388562330044806
, O 0 1.1097939932369627e-05
verbal O 0 0.00022146219271235168
memory O 0 0.007161147426813841
, O 0 7.298105174413649e-06
and O 0 5.363890522858128e-06
reading O 0 0.0002816638152580708
skills O 0 0.0002695971052162349
. O 0 0.00015911688387859613

Comparison O 0 5.973022052785382e-05
of O 0 1.9256851828686194e-06
molecular O 0 0.0003220831567887217
and O 0 2.3237793357111514e-05
psychometric O 0 0.005180722568184137
findings O 0 0.00029170248308219016
demonstrated O 0 9.802301065064967e-05
that O 0 4.6096429286990315e-06
deletions O 0 5.822015737066977e-05
and O 0 3.2570371786277974e-06
duplications O 0 9.265285189030692e-05
that O 0 1.785215658856032e-06
were O 0 4.358113983471412e-06
localized O 0 0.0004348121874500066
in O 0 2.634825023051235e-06
the O 0 6.928331004019128e-06
distal O 0 0.0020728479139506817
part O 0 5.598719781119144e-06
of O 0 5.255503197076905e-07
the O 0 1.4138840924715623e-05
gene O 0 0.00010181170364376158
seemed O 0 3.4900327591458336e-05
to O 0 4.1298278574686265e-07
be O 0 1.949343641172163e-06
preferentially O 0 5.8249032008461654e-05
associated O 0 7.200973777798936e-05
with O 0 8.207265636883676e-05
cognitive B-Disease 1 0.6857383251190186
impairment I-Disease 1 0.9996180534362793
. O 0 0.0008820396615192294

Two O 0 5.165689071873203e-05
altered O 0 0.001954606268554926
Dp71 O 0 0.0048941741697490215
transcripts O 0 0.00015163344505708665
and O 0 2.511500724722282e-06
two O 0 1.672924213380611e-06
deleted O 0 0.00016222467820625752
Dp140 O 0 0.00017373255104757845
DNA O 0 1.3757187844021246e-05
sequences O 0 2.4942244181147544e-06
were O 0 1.6409330783062615e-06
found O 0 1.3740588656219188e-05
in O 0 6.553749244631035e-06
four O 0 0.00015792687190696597
patients O 1 0.9997231364250183
with O 0 0.34276044368743896
severe O 1 0.9999977350234985
cerebral B-Disease 1 0.9999978542327881
dysfunction I-Disease 1 0.9999853372573853
. O 0 0.02194356732070446

These O 0 1.8370308680459857e-05
findings O 0 0.00014543745783157647
suggest O 0 1.4377868865267374e-05
that O 0 3.3389991926924267e-07
some O 0 1.0993436205808393e-07
sequences O 0 1.147713874161127e-06
located O 0 4.524750693235546e-06
in O 0 9.356647296954179e-07
the O 0 3.204020003977348e-06
distal O 0 0.0009677158086560667
part O 0 3.924315478798235e-06
of O 0 3.973540856350155e-07
the O 0 7.893612746556755e-06
gene O 0 2.8886965083074756e-05
and O 0 1.5724457398391678e-06
, O 0 1.8459501234247e-06
in O 0 1.4600501572203939e-06
particular O 0 4.615748821379384e-06
, O 0 7.587798336317064e-06
some O 0 1.0978849786624778e-05
DMD B-Disease 1 0.9988982677459717
isoforms O 0 5.414888437371701e-05
expressed O 0 4.954628457198851e-05
in O 0 2.6201107175438665e-05
the O 0 0.0005318773328326643
brain O 1 0.9996514320373535
may O 0 0.00032778139575384557
be O 0 2.343728283449309e-06
related O 0 1.2823510587622877e-05
to O 0 9.316987643614993e-07
the O 0 2.0840268916799687e-05
cognitive B-Disease 0 0.07958332449197769
impairment I-Disease 1 0.9997366070747375
associated O 0 0.009608925320208073
with O 0 0.0080970274284482
DMD B-Disease 1 0.9999892711639404
. O 0 0.00035932622267864645
. O 0 0.00022279309632722288

I1307K O 0 0.01375565305352211
APC O 0 0.011211850680410862
and O 0 2.020751344389282e-05
hMLH1 O 0 0.0018121583852916956
mutations O 0 5.323500226950273e-05
in O 0 2.8376011869113427e-06
a O 0 2.7529309591045603e-05
non O 0 8.013009937712923e-05
- O 0 0.0001503456151112914
Jewish O 0 7.518726761190919e-06
family O 0 4.8429948947159573e-05
with O 0 0.0001133787227445282
hereditary B-Disease 1 0.9997853636741638
non I-Disease 1 0.9985619187355042
- I-Disease 1 0.9999524354934692
polyposis I-Disease 1 0.9999961853027344
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
. O 0 0.007320529315620661

We O 0 7.274480140040396e-06
describe O 0 3.1654104532208294e-05
a O 0 5.2020182920387015e-05
French O 0 0.00046252619358710945
Canadian O 0 0.003050918225198984
hereditary B-Disease 1 0.9995230436325073
non I-Disease 1 0.9976880550384521
- I-Disease 1 0.9999605417251587
polyposis I-Disease 1 0.9999974966049194
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
( O 1 0.7078292965888977
HNPCC B-Disease 1 0.9999091625213623
) O 0 0.0001619457034394145
kindred O 0 0.012839042581617832
which O 0 3.878750703734113e-06
carries O 0 2.569451680756174e-05
a O 0 3.8245885662036017e-05
novel O 0 0.00017776107415556908
truncating O 0 0.00597677705809474
mutation O 0 0.0005343843949958682
in O 0 8.092779899016023e-05
hMLH1 O 0 0.01770525798201561
. O 0 0.00042860169196501374

Interestingly O 0 0.0013323138700798154
, O 0 9.969384336727671e-06
the O 0 2.1727506464230828e-05
I1307K O 0 0.0016465111402794719
APC O 0 0.0033017124515026808
polymorphism O 0 7.718892447883263e-05
, O 0 5.072801286587492e-06
associated O 0 1.2949401934747584e-05
with O 0 1.2589623565872898e-06
an O 0 1.650790545681957e-05
increased O 0 0.00031495248549617827
risk O 0 0.1638297736644745
of O 0 0.0015294207260012627
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
, O 0 5.664148193318397e-05
is O 0 1.1805959729827009e-05
also O 0 4.803969659405993e-06
present O 0 5.716013674827991e-06
in O 0 5.224044343776768e-06
this O 0 8.129452908178791e-06
family O 0 0.0003519272431731224
. O 0 0.00011326558160362765

The O 0 0.00010049546108348295
I1307K O 0 0.0006489951629191637
polymorphism O 0 6.750155444024131e-05
has O 0 1.1921259101654869e-05
previously O 0 1.7342143109999597e-05
only O 0 1.0272493682350614e-06
been O 0 1.0202801604464184e-05
identified O 0 2.132108602381777e-05
in O 0 1.2269532589925802e-06
individuals O 0 1.4715518545926898e-06
of O 0 3.2625709991407348e-06
self O 0 0.0017548032337799668
- O 0 0.05658408999443054
reported O 0 0.0025659401435405016
Ashkenazi O 0 0.0015366215957328677
Jewish O 0 4.602918488672003e-05
origins O 0 0.00020366374519653618
. O 0 0.00019597831123974174

In O 0 3.967856173403561e-05
addition O 0 1.8357348380959593e-05
, O 0 4.062679181515705e-06
in O 0 1.9185106339136837e-06
this O 0 2.3083741780283162e-06
family O 0 3.1117640901356936e-05
, O 0 2.6837035420612665e-06
there O 0 3.2187660963245435e-06
appears O 0 6.456412666011602e-05
to O 0 5.628612598229665e-07
be O 0 9.825471352087334e-07
no O 0 1.6130018138937885e-06
relationship O 0 3.0565802262572106e-06
between O 0 1.0622823083394906e-06
the O 0 5.3538992688118014e-06
I1307K O 0 0.00019330713257659227
polymorphism O 0 8.532728315913118e-06
and O 0 2.8793888873224205e-07
the O 0 1.7887125522975111e-06
presence O 0 1.349621106783161e-05
or O 0 1.3087831575830933e-05
absence O 0 0.0003389317716937512
of O 0 7.928737613838166e-05
cancer B-Disease 1 0.9999880790710449
. O 0 0.00010754136746982113
. O 0 0.00017181431758217514

Identification O 0 5.963447620160878e-06
of O 0 5.075261242382112e-07
a O 0 1.1137943147332408e-05
novel O 0 2.0004936231998727e-05
mutation O 0 1.0202529665548354e-05
of O 0 2.9625152819789946e-07
the O 0 1.61822736117756e-05
CPO O 0 0.00153830973431468
gene O 0 3.3320091461064294e-05
in O 0 3.2999807899614098e-06
a O 0 8.715357398614287e-05
Japanese O 0 0.00878570880740881
hereditary B-Disease 1 0.9987030029296875
coproporphyria I-Disease 1 0.9797520637512207
family O 0 0.0026550069451332092
. O 0 0.00042057898826897144

Hereditary B-Disease 1 0.9957900643348694
coproporphyria I-Disease 1 0.9806467294692993
( O 0 0.0018306707497686148
HCP B-Disease 1 0.9991704225540161
) O 0 3.712187026394531e-05
is O 0 9.865820175036788e-06
an O 0 8.230919775087386e-05
autosomal B-Disease 1 0.9997158646583557
dominant I-Disease 1 0.999566376209259
disease I-Disease 1 0.999998927116394
characterized O 1 0.9978627562522888
by O 0 0.0008677056175656617
a O 1 0.960475742816925
deficiency B-Disease 1 0.999996542930603
of I-Disease 0 3.203333471901715e-05
coproporphyrinogen I-Disease 1 0.9886770248413086
oxidase I-Disease 0 0.010522465221583843
( O 0 7.048383849905804e-05
CPO O 0 0.0024668057449162006
) O 0 1.0472629583091475e-05
caused O 0 0.00019816076382994652
by O 0 1.2284226613701321e-06
a O 0 1.5673907910240814e-05
mutation O 0 4.808063022210263e-05
in O 0 2.0919621874782024e-06
the O 0 3.452714008744806e-05
CPO O 0 0.004679129924625158
gene O 0 0.0003150696284137666
. O 0 6.296571518760175e-05

Only O 0 1.18453526738449e-05
11 O 0 2.2329395505948924e-05
mutations O 0 5.092169885756448e-06
of O 0 1.1609810002255472e-07
the O 0 8.041579349082895e-06
gene O 0 4.8883510316954926e-05
have O 0 2.846181587301544e-06
been O 0 3.25508663081564e-05
reported O 0 0.0008101456332951784
in O 0 0.00041647301986813545
HCP B-Disease 1 0.999842643737793
patients O 1 0.9993997812271118
. O 0 0.0008308897376991808

We O 0 8.45279009809019e-06
report O 0 4.065702887601219e-05
another O 0 1.450602212571539e-05
mutation O 0 3.8105572457425296e-05
in O 0 3.2821501463331515e-06
a O 0 5.734240767196752e-05
Japanese O 0 0.0011292133713141084
family O 0 0.0005057859816588461
. O 0 0.00014538379036821425

Polymerase O 0 0.004581201355904341
chain O 0 0.003007248044013977
reaction O 0 0.0005604040343314409
- O 0 0.00025836803251877427
single O 0 8.970047019829508e-06
strand O 0 5.936735760769807e-05
conformational O 0 2.3446169507224113e-05
polymorphism O 0 3.932816525775706e-06
and O 0 1.2367222268494515e-07
direct O 0 1.2662228243698337e-07
sequence O 0 6.156059271233971e-07
analyses O 0 4.282886948203668e-06
demonstrated O 0 1.2093018085579388e-05
a O 0 8.17186082713306e-06
C O 0 0.00011857396748382598
to O 0 1.5081244555403828e-06
T O 0 0.0006791396299377084
substitution O 0 1.5533643136222963e-06
in O 0 4.339883901138819e-07
exon O 0 3.664590258267708e-05
1 O 0 6.81952428749355e-07
of O 0 9.568822889605144e-08
the O 0 3.325656507513486e-06
CPO O 0 0.0002060564875137061
gene O 0 5.79928700972232e-06
at O 0 3.7662834984075744e-06
nucleotide O 0 6.046760972822085e-06
position O 0 6.76759145790129e-06
85 O 0 3.0173196137184277e-05
, O 0 1.4927707070455654e-06
which O 0 9.480972380515595e-07
lies O 0 8.559713933209423e-06
in O 0 1.797958361748897e-06
the O 0 7.254263891809387e-06
putative O 0 0.0004846593365073204
presequence O 0 0.0003068252117373049
for O 0 1.203869146593206e-06
targeting O 0 6.179137926665135e-06
to O 0 2.5362705855513923e-06
mitochondria O 0 0.0003362390852998942
. O 0 7.16833455953747e-05

This O 0 1.032328509609215e-05
mutation O 0 2.275674523843918e-05
changes O 0 9.829689133766806e-07
the O 0 6.714220717185526e-07
codon O 0 2.0521674741758034e-06
for O 0 1.4945042892122729e-07
glutamine O 0 1.792044895410072e-05
to O 0 2.40685920971373e-07
a O 0 4.057954811287345e-06
termination O 0 0.00014575482055079192
codon O 0 4.923274445900461e-06
at O 0 4.774136868945789e-06
amino O 0 1.6654454157105647e-05
acid O 0 0.0017178317066282034
position O 0 8.991971117211506e-05
29 O 0 0.0006244191317819059
. O 0 0.00010500656208023429

MaeI O 0 0.007915408350527287
restriction O 0 0.00010139895312022418
analysis O 0 8.813110980554484e-06
showed O 0 7.409445970552042e-05
two O 0 7.803292874086765e-07
other O 0 1.0948025419565965e-06
carriers O 0 0.00013783642498310655
in O 0 4.037665348732844e-06
the O 0 2.4190920157707296e-05
family O 0 0.0005144380265846848
. O 0 0.0001424956863047555

The O 0 0.00019121950026601553
C O 0 0.15601173043251038
- O 0 0.02817346341907978
T O 0 0.2629401683807373
mutation O 0 2.44846596615389e-05
is O 0 6.824117804171692e-07
located O 0 1.799289293558104e-06
within O 0 7.498109084735916e-07
a O 0 1.4398849998542573e-05
recently O 0 6.613988807657734e-05
proposed O 0 1.2978554877918214e-05
putative O 0 5.353113010642119e-05
alternative O 0 3.865391590807121e-06
translation O 0 4.508799975155853e-06
initiation O 0 6.656248297076672e-05
codon O 0 8.612876263214275e-05
( O 0 3.161256609018892e-05
TIC O 1 0.8225765228271484
- O 0 0.00010488067346159369
1 O 0 4.377629466034705e-06
) O 0 1.016701048683899e-06
, O 0 6.128031486696273e-07
supporting O 0 1.0095407560584135e-05
that O 0 1.0357523024140391e-05
TIC O 1 0.9355490207672119
- O 0 8.856408385327086e-05
1 O 0 5.330697149474872e-06
is O 0 1.0998014658980537e-06
the O 0 1.9793517367361346e-06
real O 0 3.4488144592614844e-05
TIC O 1 0.5640475153923035
rather O 0 5.415795385488309e-06
than O 0 1.6310386854456738e-05
TIC O 1 0.996807336807251
- O 0 0.0005520191043615341
2 O 0 2.266720730403904e-05
. O 0 5.745504040532978e-06
. O 0 2.1583149646176025e-05

Human B-Disease 0 0.00037962099304422736
complement I-Disease 0 0.00040609142160974443
factor I-Disease 0 0.007916424423456192
H I-Disease 1 0.9999408721923828
deficiency I-Disease 1 0.9999978542327881
associated O 1 0.983864963054657
with O 1 0.9986839890480042
hemolytic B-Disease 1 0.9999998807907104
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.37631070613861084

This O 0 1.0287963050359394e-05
study O 0 2.4334562112926506e-05
reports O 0 2.5757592084119096e-05
on O 0 7.758763786114287e-06
six O 0 3.0039374905754812e-05
cases O 0 0.00022803265892434865
of O 0 5.629281440633349e-05
deficiency B-Disease 1 0.9999966621398926
in I-Disease 0 1.0593842489470262e-05
the I-Disease 0 5.252980372461025e-06
human I-Disease 0 1.8722121239989065e-05
complement I-Disease 0 1.2889069694210775e-05
regulatory I-Disease 0 0.0003470550000201911
protein I-Disease 0 0.00019186931604053825
Factor I-Disease 0 0.00017658306751400232
H I-Disease 1 0.9336779713630676
( O 0 5.5383668950526044e-05
FH O 0 0.0349959060549736
) O 0 7.386347533611115e-07
in O 0 1.6198110586174153e-07
the O 0 3.663164136469277e-07
context O 0 1.4030348438609508e-06
of O 0 6.589761142095085e-06
an O 1 0.9004436731338501
acute B-Disease 1 0.9999996423721313
renal I-Disease 1 1.0
disease I-Disease 1 0.9999998807907104
. O 0 0.06286799162626266

Five O 0 7.974869731697254e-06
of O 0 1.8841144537873333e-06
the O 0 2.9639848435181193e-05
cases O 0 0.0001861831551650539
were O 0 5.82208940613782e-06
observed O 0 2.230808968306519e-05
in O 0 8.532963875040878e-06
children O 0 0.00017403166566509753
presenting O 0 0.005066289566457272
with O 1 0.9415884613990784
idiopathic O 1 0.9999997615814209
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9990565180778503
HUS B-Disease 1 0.9999903440475464
) O 0 0.004643128253519535
. O 0 0.000714931171387434

Two O 0 1.6984863577818032e-06
of O 0 1.3577313211499131e-06
the O 0 2.5112343791988678e-05
children O 0 0.00025223675766028464
exhibited O 0 0.0047577195800840855
a O 0 0.003297466319054365
homozygous O 1 0.9922013282775879
deficiency O 1 0.9999936819076538
characterized O 0 0.07828900218009949
by O 0 1.622454874450341e-05
the O 0 9.768444215296768e-06
absence O 0 5.310717097017914e-05
of O 0 4.6553097377000086e-07
the O 0 1.3167443285055924e-05
150 O 0 4.487909245654009e-05
- O 0 0.00012522187898866832
kD O 0 0.00014932008343748748
form O 0 6.782037189623225e-07
of O 0 4.7611374043299293e-07
Factor O 0 6.517989822896197e-05
H O 0 0.18541309237480164
and O 0 2.4416071937594097e-06
the O 0 3.567060502973618e-06
presence O 0 1.2353468264336698e-05
, O 0 1.2382095064822352e-06
upon O 0 6.475815098383464e-06
immunoblotting O 0 0.0003488536458462477
, O 0 6.16506042661058e-07
of O 0 1.355716392481554e-07
the O 0 1.0409709830128122e-05
42 O 0 0.00011673486733343452
- O 0 0.0002074765507131815
kD O 0 0.0007825900102034211
Factor O 0 2.6881789381150156e-05
H O 0 0.007578338496387005
- O 0 5.171036900719628e-05
like O 0 1.6394658359786263e-06
protein O 0 8.430812158621848e-06
1 O 0 7.952805390232243e-06
( O 0 7.942968295537867e-06
FHL O 0 0.01852746680378914
- O 0 5.108524419483729e-05
1 O 0 2.9208461000962416e-06
) O 0 7.277396321114793e-07
and O 0 5.192922571950476e-07
other O 0 3.5087491596641485e-06
FH O 1 0.8485086560249329
- O 0 0.0002821341622620821
related O 0 8.651300595374778e-05
protein O 0 0.00021363359701354057
( O 0 3.217664925614372e-05
FHR O 0 0.020394297316670418
) O 0 1.2712609532172792e-05
bands O 0 0.00010923513764282688
. O 0 8.706852531759068e-05

Southern O 0 0.0005501106497831643
blot O 0 0.0016731468494981527
and O 0 2.609433522593463e-06
PCR O 0 3.945014759665355e-05
analysis O 0 2.7887747933164064e-07
of O 0 9.465228600902265e-08
DNA O 0 2.0195511751808226e-05
of O 0 8.817228831503598e-07
one O 0 3.7701971450587735e-05
patient O 1 0.9718267321586609
with O 0 0.00031739377300255
homozygous O 1 0.9938212633132935
deficiency O 1 0.9999947547912598
ruled O 0 0.0008007250726222992
out O 0 2.0836434941884363e-06
the O 0 9.426400424672465e-07
presence O 0 1.0274403621224337e-06
of O 0 1.1902688612508427e-07
a O 0 6.596344064746518e-06
large O 0 5.244691237749066e-06
deletion O 0 5.667487857863307e-05
of O 0 9.372222393722041e-07
the O 0 6.7345958086662e-05
FH O 1 0.736623227596283
gene O 0 3.8408354157581925e-05
as O 0 6.323740763036767e-06
the O 0 2.1648082110914402e-05
underlying O 0 0.024502895772457123
defect O 1 0.9971765279769897
for O 0 6.543592462548986e-05
the O 0 0.03505004569888115
deficiency O 1 0.9999960660934448
. O 0 0.0005019580712541938

The O 0 1.3012488125241362e-05
other O 0 1.09859911390231e-06
four O 0 4.4599873945117e-06
children O 0 7.165709394030273e-05
presented O 0 0.00011022297258023173
with O 0 0.0001502200757386163
heterozygous O 1 0.9656639695167542
deficiency O 1 0.9999974966049194
and O 0 2.033178498095367e-05
exhibited O 0 0.0016847067745402455
a O 0 9.303868137067184e-05
normal O 0 0.0002472512423992157
immunoblotting O 0 0.0007922940421849489
pattern O 0 1.7521764675620943e-05
of O 0 1.263211117930041e-07
proteins O 0 3.350014367242693e-06
of O 0 1.0272424333379604e-06
the O 0 0.00018663692753762007
FH O 1 0.9963309168815613
family O 0 0.00030647643143311143
. O 0 0.00013193677295930684

Factor B-Disease 0 0.030466536059975624
H I-Disease 1 0.9998990297317505
deficiency I-Disease 1 0.9999874830245972
is O 0 1.6625463103991933e-05
the O 0 1.3214062164479401e-05
only O 0 2.7989366572001018e-05
complement B-Disease 1 0.9789574146270752
deficiency I-Disease 1 0.9999995231628418
associated O 0 0.021264970302581787
with O 0 0.0030259713530540466
HUS B-Disease 1 0.9999325275421143
. O 0 0.0012312456965446472

These O 0 2.753993157966761e-06
observations O 0 5.90901026953361e-06
suggest O 0 2.207399120379705e-05
a O 0 1.54749122884823e-05
role O 0 1.9588140276027843e-05
for O 0 1.5284829714801162e-05
FH O 1 0.9797852635383606
and O 0 2.2255666408455e-05
/ O 0 0.0019552349112927914
or O 0 5.90839481446892e-05
FH O 0 0.4338963031768799
receptors O 0 0.0001836206065490842
in O 0 4.788637397723505e-06
the O 0 3.7999398045940325e-05
pathogenesis O 1 0.9924915432929993
of O 0 0.00047708992497064173
idiopathic O 1 0.9999983310699463
HUS B-Disease 1 0.9999858140945435
. O 0 0.0012028407072648406
. O 0 0.0004745605692733079

Further O 0 2.0083578419871628e-05
evidence O 0 1.988643271033652e-05
for O 0 1.37033771352435e-06
a O 0 1.3095123904349748e-05
major O 0 7.927134720375761e-05
ancient O 0 0.0004196484514977783
mutation O 0 0.07238893955945969
underlying O 1 0.9987159967422485
myotonic B-Disease 1 0.9999963045120239
dystrophy I-Disease 1 0.9999969005584717
from O 0 0.0015915093244984746
linkage O 0 0.059810515493154526
disequilibrium O 0 0.054996881633996964
studies O 0 4.682119833887555e-05
in O 0 1.0392202057118993e-05
the O 0 3.077536530327052e-05
Japanese O 0 0.0009117003064602613
population O 0 3.139646287309006e-05
. O 0 7.531130540883169e-05

The O 0 0.04631859064102173
myotonic B-Disease 1 0.9999724626541138
dystrophy I-Disease 1 0.9999972581863403
( O 0 0.4880301058292389
DM B-Disease 1 0.9999715089797974
) O 0 0.00010429783287690952
mutation O 0 0.00016172735195141286
is O 0 8.561812137486413e-06
an O 0 4.483409065869637e-05
unstable O 1 0.8824334144592285
( O 0 5.837849312229082e-05
CTG O 0 0.009208569303154945
) O 0 1.5589710528729483e-05
n O 0 8.262234041467309e-05
repeat O 0 0.0001660631678532809
, O 0 6.909683065714489e-07
present O 0 2.7753337690228363e-06
at O 0 7.8432085501845e-06
a O 0 3.959978130296804e-06
copy O 0 6.0007582760590594e-06
number O 0 1.5715116319370281e-07
of O 0 2.378024532845302e-07
5 O 0 3.365682641742751e-05
- O 0 8.68734423420392e-05
37 O 0 7.207951057353057e-06
repeats O 0 5.4598076530965045e-05
on O 0 1.8946643649542239e-06
normal O 0 7.709890269325115e-06
chromosomes O 0 3.694141923915595e-06
but O 0 9.196611472361838e-07
amplified O 0 1.1416583220125176e-05
to O 0 2.9292633030308934e-07
50 O 0 4.616145361069357e-06
- O 0 4.714226088253781e-05
3000 O 0 3.817555989371613e-05
copies O 0 1.126347342506051e-05
on O 0 8.145250467350706e-05
DM B-Disease 1 0.9990164041519165
chromosomes O 0 0.0002538244007155299
. O 0 0.00013941602082923055

Previous O 0 0.00030550206429325044
findings O 0 0.00025487467064522207
in O 0 1.950643490999937e-05
Caucasian O 0 0.0011748430551961064
populations O 0 1.089005763788009e-05
of O 0 1.8817081581801176e-06
a O 0 0.007528943940997124
DM B-Disease 1 0.9999549388885498
founder O 0 0.003259369870647788
chromosome O 0 0.0002714259026106447
raise O 0 4.2953914089594036e-05
a O 0 9.770410542842e-06
question O 0 1.2752358315992751e-06
about O 0 3.5992047742183786e-07
the O 0 8.822056543067447e-07
molecular O 0 1.2539259842014872e-05
events O 0 1.234793444382376e-06
involved O 0 9.315112038166262e-06
in O 0 4.658592388295801e-06
the O 0 1.2893727216578554e-05
expansion O 0 0.0003871958761010319
mutation O 0 0.0007350703817792237
. O 0 0.00010169109737034887

To O 0 7.39657889425871e-06
investigate O 0 3.598994589992799e-05
whether O 0 4.255872227076907e-06
a O 0 1.3577011486631818e-05
founder O 0 8.087619789876044e-05
chromosome O 0 3.903084871126339e-05
for O 0 2.410760316706728e-06
the O 0 0.0001583919656695798
DM B-Disease 1 0.9999135732650757
mutation O 0 0.00021392444614320993
exists O 0 1.0744242899818346e-05
in O 0 1.7457681451560347e-06
the O 0 5.098069323139498e-06
Japanese O 0 0.00016745079483371228
population O 0 2.0632255655073095e-06
, O 0 1.4938075310055865e-06
we O 0 1.0058553243652568e-06
genotyped O 0 0.00022317279945127666
families O 0 2.6002965114457766e-06
using O 0 4.092669314559316e-06
polymorphic O 0 0.0005619067815132439
markers O 0 0.0006103779305703938
near O 0 0.00026918461662717164
the O 0 2.8376760383252986e-05
( O 0 5.010037057218142e-05
CTG O 0 0.00731144892051816
) O 0 1.9447386875981465e-05
n O 0 9.848087938735262e-05
repeat O 0 0.00024668354308232665
region O 0 1.3381649296206888e-05
and O 0 1.0337056664866395e-05
constructed O 0 0.0036222117487341166
haplotypes O 0 0.005355902016162872
. O 0 0.00028904457576572895

Six O 0 3.513327828841284e-05
different O 0 2.418506937829079e-06
haplotypes O 0 0.0009591874550096691
were O 0 3.689605728141032e-05
found O 0 0.00018876379181165248
and O 0 8.459795935777947e-05
DM B-Disease 1 0.999555766582489
alleles O 0 9.326395957032219e-05
were O 0 1.1292598173895385e-05
always O 0 2.6615280148689635e-05
haplotype O 0 0.0012589427642524242
A O 0 0.0004993188777007163
. O 0 7.388631638605148e-05

To O 0 2.619414317450719e-06
find O 0 1.5742912182759028e-06
an O 0 3.82740779514279e-07
origin O 0 2.539532886203233e-07
of O 0 2.9922435373919143e-07
the O 0 2.132222471118439e-05
( O 0 4.236736276652664e-05
CTG O 0 0.008152496069669724
) O 0 8.114333468256518e-06
n O 0 8.603797323303297e-05
repeat O 0 0.00030188410892151296
mutation O 0 2.3624286768608727e-05
and O 0 3.14722598204753e-07
to O 0 1.569800929246412e-07
investigate O 0 2.5602910227462417e-06
the O 0 4.5912858581687033e-07
mechanism O 0 3.399453817110043e-06
of O 0 1.5159358213168161e-07
the O 0 3.3697651815600693e-06
expansion O 0 3.3729760616552085e-05
mutation O 0 2.4815642973408103e-05
in O 0 1.6518627035111422e-06
the O 0 3.852415375149576e-06
Japanese O 0 0.00011223441106267273
population O 0 1.4073444845053018e-06
we O 0 3.923713904896431e-07
have O 0 4.593935898355994e-07
studied O 0 1.4915533938619774e-05
90 O 0 6.272682367125526e-05
Japanese O 0 0.006589347030967474
DM B-Disease 1 0.9993312358856201
families O 0 2.5469025786151178e-05
comprising O 0 2.1901712898397818e-05
190 O 0 0.0002502836287021637
affected O 0 0.0002531327190808952
and O 0 1.155275367636932e-05
130 O 0 0.00013664294965565205
unaffected O 0 0.006293426267802715
members O 0 3.624537930591032e-05
. O 0 0.00011252042895648628

The O 0 4.6935507270973176e-05
results O 0 5.560180579777807e-05
suggest O 0 2.821582711476367e-05
that O 0 1.0181544212173321e-06
a O 0 8.147613698383793e-06
few O 0 5.2713576224050485e-06
common O 0 2.679308454389684e-05
ancestral O 0 0.00040971391717903316
mutations O 0 0.00014088900934439152
in O 0 4.838748282054439e-06
both O 0 7.4154086178168654e-06
Caucasian O 0 0.005464209243655205
and O 0 2.0867077182629146e-05
Japanese O 0 0.0013591267634183168
populations O 0 2.906594454543665e-05
have O 0 1.4212855603545904e-06
originated O 0 3.7204288219072623e-06
by O 0 5.245208853921213e-07
expansion O 0 2.3138006781664444e-06
of O 0 1.31355676558087e-07
an O 0 3.3763722058210988e-06
ancestral O 0 0.0001312889507971704
n O 0 6.90808446961455e-05
= O 0 6.31683215033263e-05
5 O 0 3.827520686172647e-06
repeat O 0 1.5150401850405615e-05
to O 0 2.9930484402029833e-07
n O 0 1.4558020666299853e-05
= O 0 3.14411663566716e-05
19 O 0 2.465848228894174e-05
- O 0 4.967828135704622e-05
37 O 0 1.016195983538637e-05
copies O 0 1.995912862184923e-05
. O 0 2.988410778925754e-05

These O 0 4.150503173150355e-06
data O 0 1.2816053640563041e-05
support O 0 1.0029883924289607e-05
multistep O 0 0.00034797887201420963
models O 0 8.044540663831867e-06
of O 0 2.0709887849079678e-06
triplet O 0 0.017940843477845192
repeat O 0 0.0011220842134207487
expansion O 0 3.335429937578738e-05
that O 0 1.0052933703263989e-06
have O 0 7.691403993703716e-07
been O 0 2.5582455691619543e-06
proposed O 0 3.3338876619382063e-06
for O 0 2.152107526853797e-06
both O 0 4.839638131670654e-05
DM B-Disease 1 0.9999200105667114
and O 0 0.00018531846581026912
Friedreichs B-Disease 1 0.9949775338172913
ataxia I-Disease 1 0.9996306896209717
. O 0 0.00024111619859468192
. O 0 0.00023648595379199833

The O 0 9.914138900057878e-06
molecular O 0 5.6650667829671875e-05
basis O 0 9.805844456423074e-06
of O 0 0.00017806234245654196
C6 B-Disease 1 0.9999948740005493
deficiency I-Disease 1 0.9999991655349731
in O 0 1.619828435650561e-05
the O 0 1.8081023881677538e-05
western O 0 3.787378955166787e-05
Cape O 0 0.0003513361152727157
, O 0 1.0227117854810786e-05
South O 0 6.815079541411251e-05
Africa O 0 6.245655822567642e-05
. O 0 6.14250311627984e-05

Deficiency B-Disease 1 0.9997369647026062
of I-Disease 0 2.678436885616975e-06
the I-Disease 0 1.1397784874134231e-05
sixth I-Disease 0 8.591375808464363e-05
component I-Disease 0 2.1747531718574464e-05
of I-Disease 0 1.201696591124346e-06
human I-Disease 0 6.0712565755238757e-05
complement I-Disease 0 9.189086995320395e-05
( O 0 7.89560072007589e-05
C6 O 1 0.9893395304679871
) O 0 7.093021849868819e-06
has O 0 8.456467185169458e-06
been O 0 9.131518709182274e-06
reported O 0 1.9730550775420852e-05
in O 0 4.2371840436317143e-07
a O 0 1.1773988717322936e-06
number O 0 9.512375243048155e-08
of O 0 1.327488945435107e-07
families O 0 3.0501535093208076e-06
from O 0 4.833209004573291e-06
the O 0 8.003784387256019e-06
western O 0 2.670994399522897e-05
Cape O 0 0.00025345536414533854
, O 0 9.63263119047042e-06
South O 0 6.0362039221217856e-05
Africa O 0 6.24967142357491e-05
. O 0 4.5961194700794294e-05

Meningococcal B-Disease 1 0.9998373985290527
disease I-Disease 1 0.9999935626983643
is O 0 0.0007453950820490718
endemic O 0 0.02752416953444481
in O 0 9.256893463316374e-06
the O 0 1.5560342944809236e-05
Cape O 0 0.00015119451563805342
and O 0 5.497722099789826e-07
almost O 0 8.172143566298473e-07
all O 0 2.1310680153874273e-07
pedigrees O 0 8.673901174915954e-05
of O 0 5.6963576753332745e-06
total O 0 0.002931254915893078
C6 B-Disease 1 0.999993085861206
deficiency I-Disease 1 0.9999996423721313
( O 0 0.0005745908711105585
C6Q0 O 1 0.9735592603683472
) O 0 2.4060054784058593e-05
have O 0 4.277829248167109e-06
been O 0 2.7014859369955957e-05
ascertained O 0 0.0006813654908910394
because O 0 3.382875001989305e-05
of O 0 5.238083758740686e-05
recurrent O 1 0.9999511241912842
disease O 1 0.9999966621398926
. O 0 0.0018276540795341134

We O 0 9.576749107509386e-06
have O 0 2.3055599740473554e-06
sequenced O 0 2.015383870457299e-05
the O 0 1.4164548929329612e-06
expressed O 0 2.1694872884836514e-06
exons O 0 1.0464113074704073e-05
of O 0 4.207639392461715e-07
the O 0 4.153403278905898e-05
C6 O 1 0.9710964560508728
gene O 0 3.6682609788840637e-05
from O 0 2.932552206402761e-06
selected O 0 5.888241503271274e-06
cases O 0 3.532800838002004e-05
and O 0 1.5856279560466646e-06
have O 0 1.3635433333547553e-06
found O 0 1.0638694220688194e-05
three O 0 5.3136736823944375e-06
molecular O 0 0.004414742346853018
defects O 1 0.9996090531349182
leading O 0 0.00020535140356514603
to O 0 2.217708606622182e-05
total O 0 0.00035238434793427587
deficiency O 1 0.9999921321868896
879delG O 0 0.01821405626833439
, O 0 6.8320500759000424e-06
which O 0 2.057766550933593e-06
is O 0 4.50578227173537e-06
the O 0 8.182763849617913e-06
common O 0 0.0003506209177430719
defect O 1 0.9956028461456299
in O 0 9.339565622212831e-06
the O 0 2.1225047021289356e-05
Cape O 0 0.00048685973160900176
and O 0 2.162736745958682e-05
hitherto O 0 0.0012690331786870956
unreported O 0 0.0012657196493819356
, O 0 1.2306692951824516e-05
and O 0 9.27888322621584e-06
1195delC O 0 0.0014711846597492695
and O 0 1.5447751138708554e-05
1936delG O 0 0.0018235736060887575
, O 0 5.397372206061846e-06
which O 0 1.6316388382620062e-06
have O 0 1.3196745385357644e-06
been O 0 1.3759550711256452e-05
previously O 0 5.075369335827418e-05
reported O 0 0.00018349931633565575
in O 0 1.2073071047780104e-05
African O 0 0.00018643061048351228
- O 0 0.0025441162288188934
Americans O 0 8.819991489872336e-05
. O 0 6.168330583022907e-05

We O 0 1.3016236152907368e-05
also O 0 1.034067554428475e-05
show O 0 1.0217874660156667e-05
that O 0 1.5769825267852866e-06
the O 0 9.82207347988151e-06
879delG O 0 0.0015586843946948647
and O 0 3.8763697375543416e-05
1195delC O 1 0.9079968333244324
defects O 1 0.9995782971382141
are O 0 6.407758974091848e-06
associated O 0 0.00014473703049588948
with O 0 8.200514275813475e-05
characteristic O 0 0.3341135084629059
C6 O 1 0.999772846698761
/ O 1 0.5107945799827576
C7 O 1 0.9862183928489685
region O 0 3.8198864785954356e-05
DNA O 0 0.00027966941706836224
marker O 0 0.0005765462992712855
haplotypes O 0 0.0006994514260441065
, O 0 7.021118562988704e-06
although O 0 9.093004337046295e-06
small O 0 1.075489490176551e-05
variations O 0 2.805831900332123e-05
were O 0 1.3275412129587494e-05
observed O 0 0.00015126893413253129
. O 0 0.00010412511619506404

The O 0 0.0006943497573956847
1936delG O 0 0.3245440423488617
defect O 1 0.9955012202262878
was O 0 0.00023188506020233035
observed O 0 1.3288775335240643e-05
only O 0 1.4755808024347061e-06
once O 0 2.874911660910584e-05
in O 0 1.597418190613098e-06
the O 0 4.979488494427642e-06
Cape O 0 0.00016986137779895216
, O 0 3.893962002621265e-06
but O 0 1.3194808161642868e-06
its O 0 3.0409148621401982e-06
associated O 0 7.851646660128608e-05
haplotype O 0 0.0026431242004036903
could O 0 2.1950641894363798e-05
be O 0 6.523543106595753e-06
deduced O 0 0.00022974972671363503
. O 0 6.11242139711976e-05

The O 0 1.5760859241709113e-05
data O 0 6.8911522248527035e-06
from O 0 6.680817477899836e-06
the O 0 1.101706857298268e-05
haplotypes O 0 0.00031721711275167763
indicate O 0 2.038471393461805e-05
that O 0 2.2241663089062058e-07
these O 0 1.7145855224498519e-07
three O 0 3.7160352803766727e-06
molecular O 0 0.002012512180954218
defects O 1 0.9987088441848755
account O 0 9.032151865540072e-06
for O 0 5.2712571232405026e-06
the O 0 0.00010857422603294253
defects O 1 0.9995317459106445
in O 0 2.494084128557006e-06
all O 0 3.7212868164715474e-07
the O 0 8.511176929459907e-06
38 O 0 0.00018298652139492333
unrelated O 0 0.0028434921987354755
C6Q0 O 0 0.2209194004535675
individuals O 0 5.332232831278816e-06
we O 0 1.0379545756222797e-06
have O 0 6.950606348254951e-07
studied O 0 6.728426342306193e-06
from O 0 3.7947334021737333e-06
the O 0 1.8646855096449144e-05
Cape O 0 0.0014719596365466714
. O 0 0.00017146277241408825

We O 0 9.774659702088684e-06
have O 0 1.8048025367534137e-06
also O 0 2.338653303013416e-06
observed O 0 1.3231237062427681e-05
the O 0 1.6259680705843493e-05
879delG O 0 0.009005317464470863
defect O 0 0.3470306694507599
in O 0 1.259046075574588e-05
two O 0 3.2824620575411245e-05
Dutch O 0 0.49525776505470276
C6 B-Disease 1 0.9999747276306152
- I-Disease 1 0.9989174604415894
deficient I-Disease 1 0.9999016523361206
kindreds O 0 0.004737360868602991
, O 0 6.387771463778336e-06
but O 0 3.857069259538548e-06
the O 0 1.9045583030674607e-05
879delG O 0 0.007355693727731705
defect O 1 0.795015811920166
in O 0 4.912641543342033e-06
the O 0 1.3145097000233363e-05
Cape O 0 0.0004909547278657556
probably O 0 7.611713226651773e-05
did O 0 4.826696113013895e-06
not O 0 2.4151916022674413e-07
come O 0 3.002471089530445e-07
from O 0 1.0758614052974735e-06
The O 0 3.6932260627509095e-06
Netherlands O 0 2.38492702919757e-05
. O 0 1.0284029485774226e-05
. O 0 3.7240439269226044e-05

Complement B-Disease 0 0.13720357418060303
C7 I-Disease 1 0.9999808073043823
deficiency I-Disease 1 0.9999995231628418
: O 0 9.71306799328886e-05
seven O 0 3.667939381557517e-05
further O 0 7.031103450572118e-05
molecular O 0 0.011983665637671947
defects O 1 0.9996867179870605
and O 0 7.95682626630878e-06
their O 0 7.058460141706746e-06
associated O 0 0.0005466582369990647
marker O 0 0.009014373645186424
haplotypes O 0 0.00826862920075655
. O 0 0.0002143771416740492

Seven O 0 1.3715764907828998e-05
further O 0 5.062642685516039e-06
molecular O 0 6.244298128876835e-05
bases O 0 1.3698145266971551e-05
of O 0 0.00012361869448795915
C7 B-Disease 1 0.9999940395355225
deficiency I-Disease 1 0.9999998807907104
are O 0 3.9346341509371996e-05
described O 0 0.011355957947671413
. O 0 0.0005208890070207417

All O 0 7.641367005817301e-07
these O 0 1.1074214398831828e-06
new O 0 3.2080595701700076e-05
molecular O 0 0.0019776837434619665
defects O 1 0.9962848424911499
involve O 0 2.8292512070038356e-05
single O 0 3.061127063119784e-05
- O 0 6.436814874177799e-05
nucleotide O 0 7.317284143937286e-06
events O 0 1.9257806798123056e-06
, O 0 1.4119879097052035e-06
deletions O 0 9.879689059744123e-06
and O 0 5.03052376643609e-07
substitutions O 0 5.143313956068596e-06
, O 0 3.9142955188253836e-07
some O 0 8.784531502215032e-08
of O 0 1.7625828263589938e-07
which O 0 4.250663550919853e-06
alter O 0 0.00022067934332881123
splice O 0 0.00034538880572654307
sites O 0 1.119589705922408e-05
, O 0 5.6057456276903395e-06
and O 0 2.018150325966417e-06
others O 0 1.8869750419980846e-05
codons O 0 0.0004203607386443764
. O 0 0.0001017736503854394

They O 0 9.570404472469818e-06
are O 0 4.726636575469456e-07
distributed O 0 2.013730409089476e-06
along O 0 5.064410288468935e-06
the O 0 2.3335216610576026e-05
C7 O 1 0.9467678070068359
gene O 0 4.432784044183791e-05
, O 0 1.2830111018047319e-06
but O 0 5.617339979835378e-07
predominantly O 0 4.088792593393009e-07
towards O 0 1.780008346941031e-06
the O 0 6.284662049438339e-06
3 O 0 7.404820644296706e-05
end O 0 0.00019536430772859603
. O 0 6.71634916216135e-05

All O 0 2.8763281534338603e-06
were O 0 4.656327291741036e-06
found O 0 2.57198898907518e-05
in O 0 8.463913218292873e-06
compound O 0 0.001739921630360186
heterozygous O 0 0.00032059065415523946
individuals O 0 6.025678521837108e-05
. O 0 0.000254178186878562

The O 0 0.0016270950436592102
C6 O 1 0.9982272982597351
/ O 0 0.17935051023960114
C7 O 1 0.9712064266204834
marker O 0 0.0024739536456763744
haplotypes O 0 0.001934956293553114
associated O 0 0.00011324366641929373
with O 0 5.936430170550011e-05
most O 0 0.001114565646275878
C7 B-Disease 1 0.9998866319656372
defects I-Disease 1 0.999862790107727
are O 0 1.3782031601294875e-05
tabulated O 0 0.00470918882638216
. O 0 5.098566907690838e-05
. O 0 0.0001056928958860226

A O 0 0.0005660661263391376
genome O 0 0.00031410748488269746
- O 0 0.00010572434985078871
wide O 0 4.88336354464991e-06
search O 0 2.7236947062192485e-06
for O 0 6.742621735611465e-06
chromosomal O 0 0.003918938804417849
loci O 0 0.0009995736181735992
linked O 0 0.04127423092722893
to O 0 0.0001070271828211844
mental O 1 0.9996511936187744
health O 1 0.9863909482955933
wellness O 0 0.06581807881593704
in O 0 4.387598528410308e-05
relatives O 0 0.0003906897036358714
at O 0 0.00122512795496732
high O 0 0.2106749713420868
risk O 1 0.988064706325531
for O 0 0.0029910721350461245
bipolar B-Disease 1 0.9999990463256836
affective I-Disease 1 0.9999579191207886
disorder I-Disease 1 0.9999957084655762
among O 0 5.2909123041899875e-05
the O 0 8.94140248419717e-05
Old O 0 0.008316225372254848
Order O 0 3.868879866786301e-05
Amish O 0 0.001308670500293374
. O 0 9.87794846878387e-05

Bipolar B-Disease 1 0.9999946355819702
affective I-Disease 1 0.9999333620071411
disorder I-Disease 1 0.9999977350234985
( O 1 0.9408168196678162
BPAD B-Disease 1 0.9999542236328125
; O 1 0.9596812129020691
manic B-Disease 1 0.9999970197677612
- I-Disease 1 0.9999730587005615
depressive I-Disease 1 0.9999986886978149
illness I-Disease 1 0.9999884366989136
) O 0 0.00014708143135067075
is O 0 5.3655323426937684e-05
characterized O 0 0.007431569509208202
by O 0 1.600512769073248e-05
episodes O 0 0.00019241785048507154
of O 0 3.2985914003802463e-05
mania B-Disease 1 0.9998133778572083
and O 0 0.0001654565567150712
/ O 0 0.39485588669776917
or O 0 0.0004521227674558759
hypomania B-Disease 1 0.9966790676116943
interspersed O 0 0.001041896059177816
with O 0 1.6316935216309503e-05
periods O 0 0.0010585726704448462
of O 0 0.00011799523053923622
depression B-Disease 1 0.9999656677246094
. O 0 0.001421913388185203

Compelling O 0 0.00011409257422201335
evidence O 0 4.245658055879176e-05
supports O 0 1.928718302224297e-05
a O 0 7.844652827770915e-06
significant O 0 4.776819423568668e-06
genetic O 0 4.599723615683615e-05
component O 0 2.4733330064918846e-05
in O 0 2.664566636667587e-06
the O 0 1.3168598343327176e-05
susceptibility O 0 0.0014825048856437206
to O 0 1.2286286619200837e-05
develop O 0 0.0011865540873259306
BPAD B-Disease 1 0.9983365535736084
. O 0 0.000406079605454579

To O 0 9.552467417961452e-06
date O 0 4.761535456054844e-05
, O 0 7.277102213265607e-06
however O 0 1.4972396456869319e-05
, O 0 3.828502485703211e-06
linkage O 0 0.00014239083975553513
studies O 0 5.150878223503241e-06
have O 0 9.890754881780595e-07
attempted O 0 6.395451237040106e-06
only O 0 2.286182194666253e-07
to O 0 6.655315019088448e-07
identify O 0 2.2067213649279438e-05
chromosomal O 0 0.0009814916411414742
loci O 0 0.00013118155766278505
that O 0 1.6278576367767528e-05
cause O 0 0.0050761341117322445
or O 0 1.8399428881821223e-05
increase O 0 1.988846270251088e-05
the O 0 1.1487134543131106e-05
risk O 0 0.0008122845902107656
of O 0 4.200405328447232e-06
developing O 0 0.003865129081532359
BPAD B-Disease 1 0.9985799789428711
. O 0 0.00042592603131197393

To O 0 4.63826700070058e-06
determine O 0 1.5275227269739844e-05
whether O 0 6.006414878356736e-06
there O 0 5.178075298317708e-06
could O 0 9.024239261634648e-06
be O 0 5.220907041803002e-06
protective O 0 0.004299478139728308
alleles O 0 2.4793076590867713e-05
that O 0 3.82503912987886e-06
prevent O 0 0.0002989683416672051
or O 0 2.4657612812006846e-05
reduce O 0 0.0001525526022305712
the O 0 1.8224222003482282e-05
risk O 0 0.001095292973332107
of O 0 2.5871843263303163e-06
developing O 0 0.0019182201940566301
BPAD B-Disease 1 0.9993867874145508
, O 0 6.555461368407123e-06
similar O 0 2.837165311575518e-06
to O 0 6.912530352565227e-07
what O 0 1.2889088338852162e-06
is O 0 2.2510139388032258e-06
observed O 0 2.330428469576873e-05
in O 0 1.7626360204303637e-05
other O 0 9.067934297490865e-05
genetic B-Disease 1 0.9998369216918945
disorders I-Disease 1 0.9999991655349731
, O 0 0.00022972127771936357
we O 0 5.232281910139136e-05
used O 0 0.003261827863752842
mental O 1 0.9998583793640137
health O 1 0.9976208806037903
wellness O 1 0.8935337066650391
( O 0 4.978080323780887e-05
absence O 0 0.0003111689002253115
of O 0 1.2755307579936925e-05
any O 0 0.008483671583235264
psychiatric B-Disease 1 0.9999936819076538
disorder I-Disease 1 0.9999955892562866
) O 0 7.476462633349001e-05
as O 0 1.2907766176795121e-05
the O 0 1.764881562849041e-05
phenotype O 0 0.0005552261136472225
in O 0 4.104759227629984e-06
our O 0 2.9036023079243023e-06
genome O 0 0.00013999815564602613
- O 0 8.60936997924e-05
wide O 0 1.2017736480629537e-05
linkage O 0 0.0001625747827347368
scan O 0 9.644521196605638e-05
of O 0 2.6117288598470623e-07
several O 0 6.524252057715785e-06
large O 0 8.039990643737838e-05
multigeneration O 0 0.023855822160840034
Old O 0 0.0009197599720209837
Order O 0 1.452518245059764e-05
Amish O 0 0.00029865780379623175
pedigrees O 0 0.0006905427435413003
exhibiting O 0 0.0005508901085704565
an O 0 5.6828459491953254e-05
extremely O 0 0.00890463124960661
high O 0 0.013274667784571648
incidence O 1 0.9925641417503357
of O 0 5.7893063058145344e-05
BPAD B-Disease 1 0.9991293549537659
. O 0 0.0008022949332371354

We O 0 8.881555004336406e-06
have O 0 2.619067117848317e-06
found O 0 1.1365666978235822e-05
strong O 0 3.2540413030801574e-06
evidence O 0 6.1368668866634835e-06
for O 0 6.273957069424796e-07
a O 0 9.976860383176245e-06
locus O 0 5.362636875361204e-05
on O 0 2.1885341993765905e-05
chromosome O 0 0.0005970956990495324
4p O 0 0.2499215304851532
at O 0 5.506474190042354e-05
D4S2949 O 0 0.0002119922573911026
( O 0 3.084036734435358e-06
maximum O 0 9.852750736172311e-06
GENEHUNTER O 0 0.0034523552749305964
- O 0 6.056153142708354e-05
PLUS O 0 1.1015850759577006e-05
nonparametric O 0 2.957152719318401e-05
linkage O 0 2.5513172658975236e-05
score O 0 1.2039128023388912e-06
= O 0 2.2051772248232737e-05
4 O 0 3.7664235605916474e-06
. O 0 1.5662644727854058e-06
05 O 0 0.00017803873925004154
, O 0 1.956894720933633e-06
P O 0 0.0001607805024832487
= O 0 2.514479092496913e-05
5 O 0 3.0816993330518017e-06
. O 0 9.174868864647578e-07
22 O 0 3.878040843119379e-06
x O 0 1.22532310342649e-05
10 O 0 3.055312390642939e-06
( O 0 3.140913349852781e-06
- O 0 2.304594818269834e-05
4 O 0 5.146576768311206e-06
) O 0 1.216139025927987e-06
; O 0 1.9294370758871082e-06
SIBPAL O 0 0.0007419399335049093
Pempirical O 0 0.0001424082147423178
value O 0 1.811309971344599e-06
< O 0 0.00010347757779527456
3 O 0 4.412342150317272e-06
x O 0 1.430081101716496e-05
10 O 0 4.436832568899263e-06
( O 0 3.7866318507440155e-06
- O 0 2.5684745196485892e-05
5 O 0 1.6978241319520748e-06
) O 0 4.860272611040273e-07
) O 0 3.070511525038455e-07
and O 0 3.996316308985115e-07
suggestive O 0 8.958829857874662e-05
evidence O 0 7.780474334140308e-06
for O 0 7.392633278868743e-07
a O 0 1.3504412891052198e-05
locus O 0 0.00010078355262521654
on O 0 4.7305187763413414e-05
chromosome O 0 0.0032299263402819633
4q O 1 0.9069145917892456
at O 0 0.00011865417036460713
D4S397 O 0 0.000574474863242358
( O 0 7.966151315486059e-06
maximum O 0 2.371475966356229e-05
GENEHUNTER O 0 0.0071293022483587265
- O 0 0.0001150334719568491
PLUS O 0 1.67077305377461e-05
nonparametric O 0 2.420393684587907e-05
linkage O 0 1.4566840036422946e-05
score O 0 1.267552192985022e-06
= O 0 1.210788013850106e-05
3 O 0 1.4555080269929022e-06
. O 0 4.142082445923734e-07
29 O 0 8.489450920023955e-06
, O 0 1.1860574886668473e-06
P O 0 0.00011859160440508276
= O 0 1.945137591974344e-05
2 O 0 2.175242343582795e-06
. O 0 6.450172236327489e-07
57 O 0 1.0005941476265434e-05
x O 0 1.208238973049447e-05
10 O 0 4.925711891701212e-06
( O 0 4.296632141631562e-06
- O 0 3.0619270546594635e-05
3 O 0 4.615955731424037e-06
) O 0 1.5967937088134931e-06
; O 0 1.3399272802416817e-06
SIBPAL O 0 0.0007334903930313885
Pempirical O 0 0.00021631766867358238
value O 0 2.6032569167000474e-06
< O 0 9.626199607737362e-05
1 O 0 6.005155228194781e-06
x O 0 1.2730345588352066e-05
10 O 0 3.1451577342522796e-06
( O 0 3.354426098667318e-06
- O 0 2.5837598514044657e-05
3 O 0 2.47955063059635e-06
) O 0 4.0759488229014096e-07
) O 0 2.929369600224163e-07
that O 0 1.2851110398059973e-07
are O 0 4.607844630299951e-07
linked O 0 0.0006381624261848629
to O 0 4.034130324725993e-05
mental O 1 0.9992849230766296
health O 1 0.9964264035224915
wellness O 1 0.9810886383056641
. O 0 0.0006959065794944763

These O 0 1.4573273801943287e-05
findings O 0 7.159698725445196e-05
are O 0 6.852473006802029e-07
consistent O 0 1.2108642295061145e-05
with O 0 8.730442573323671e-07
the O 0 3.908985945599852e-06
hypothesis O 0 1.7944970750249922e-05
that O 0 5.340205575521395e-07
certain O 0 1.6768727846283582e-06
alleles O 0 3.550755718606524e-05
could O 0 1.8069094949169084e-05
prevent O 0 0.00021499408467207104
or O 0 1.710503056528978e-05
modify O 0 9.366735321236774e-05
the O 0 4.195924702798948e-05
clinical O 0 0.014326058328151703
manifestations O 0 0.002010054187849164
of O 0 3.418545384192839e-05
BPAD B-Disease 1 0.9998087286949158
and O 0 5.0215643568662927e-05
perhaps O 0 0.00023121900449041277
other O 0 3.573815411073156e-05
related O 0 0.09261438250541687
affective B-Disease 1 0.9997797608375549
disorders I-Disease 1 0.9999961853027344
. O 0 0.007968682795763016

Segregation O 0 0.1290171891450882
distortion O 0 0.37134116888046265
in O 0 0.029611609876155853
myotonic B-Disease 1 0.9999868869781494
dystrophy I-Disease 1 0.9999969005584717
. O 0 0.009369127452373505

Myotonic B-Disease 1 0.9999431371688843
dystrophy I-Disease 1 0.9999974966049194
( O 1 0.8462309837341309
DM B-Disease 1 0.9999785423278809
) O 0 9.274336480302736e-05
is O 0 2.8794631361961365e-05
an O 0 0.0002349977585254237
autosomal B-Disease 1 0.9996423721313477
dominant I-Disease 1 0.9987346529960632
disease I-Disease 1 0.9999966621398926
which O 0 1.684734525042586e-05
, O 0 4.058187187183648e-06
in O 0 2.3968589175638044e-06
the O 0 7.199500942078885e-06
typical O 0 0.0002846462884917855
pedigree O 0 0.0008816427434794605
, O 0 1.2797643194062402e-06
shows O 0 1.5456389519385993e-06
a O 0 3.889790150424233e-06
three O 0 3.2096133963932516e-06
generation O 0 8.473423804389313e-05
anticipation O 0 0.00045763381058350205
cascade O 0 0.007797886151820421
. O 0 8.919023821363226e-05

This O 0 3.24154352711048e-05
results O 0 0.0004959928919561207
in O 0 0.0008254597196355462
infertility B-Disease 1 0.9997263550758362
and O 0 0.4901392459869385
congenital B-Disease 1 0.9999998807907104
myotonic I-Disease 1 0.9999994039535522
dystrophy I-Disease 1 0.9999994039535522
( O 0 0.07963784784078598
CDM B-Disease 1 0.9965710639953613
) O 0 1.6435251382063143e-05
with O 0 3.748589278984582e-06
the O 0 9.436201253265608e-06
disappearance O 0 0.00020159033010713756
of O 0 1.3398760529526044e-05
DM B-Disease 1 0.9999399185180664
in O 0 2.7730802685255185e-05
that O 0 2.8345821192488074e-05
pedigree O 0 0.008603875525295734
. O 0 0.00012250473082531244

The O 0 1.7563204892212525e-05
concept O 0 7.865973202569876e-06
of O 0 2.9760437882941915e-06
segregation O 0 0.006057527847588062
distortion O 0 0.0012599797919392586
, O 0 3.9067613215593155e-06
where O 0 1.8943842405860778e-06
there O 0 9.131894671554619e-07
is O 0 7.860174946472398e-07
preferential O 0 7.710640602454077e-06
transmission O 0 8.602539310231805e-06
of O 0 7.785692446304893e-08
the O 0 1.1967673572144122e-06
larger O 0 6.380721060850192e-06
allele O 0 2.2574487957172096e-05
at O 0 5.420374873210676e-05
the O 0 8.305847586598247e-05
DM B-Disease 1 0.9996621608734131
locus O 0 0.00034786693868227303
, O 0 7.489128620363772e-06
has O 0 8.410943337366916e-06
been O 0 4.041563897771994e-06
put O 0 1.1560947541511268e-06
forward O 0 7.634359349140141e-07
to O 0 5.956225095360423e-07
explain O 0 4.962052116752602e-05
partially O 0 0.0012436996912583709
the O 0 1.7309444956481457e-05
maintenance O 0 0.006472715642303228
of O 0 1.9479315596981905e-05
DM B-Disease 1 0.9997983574867249
in O 0 1.5836627426324412e-05
the O 0 1.906912075355649e-05
population O 0 1.3120375115249772e-05
. O 0 6.24583481112495e-05

In O 0 1.793301635188982e-05
a O 0 2.9811413696734235e-05
survey O 0 5.6537384807597846e-05
of O 0 1.2234887435624842e-05
DM B-Disease 1 0.9996446371078491
in O 0 1.1152259503433015e-05
Northern O 0 1.1680876013997477e-05
Ireland O 0 2.0575724192894995e-05
, O 0 7.95779033069266e-06
59 O 0 0.00025777085102163255
pedigrees O 0 0.0006449447246268392
were O 0 4.136619463679381e-05
ascertained O 0 0.002616844605654478
. O 0 0.00010967013804474846

Sibships O 0 0.010109813883900642
where O 0 1.6655867511872202e-05
the O 0 4.282858299120562e-06
status O 0 4.359123977337731e-06
of O 0 2.2922121445390076e-07
all O 0 2.1215170420418872e-07
the O 0 3.7541954043263104e-06
members O 0 4.28230305260513e-06
had O 0 8.401446393691003e-05
been O 0 1.7657976059126668e-05
identified O 0 2.736761780397501e-05
were O 0 3.6536605421133572e-06
examined O 0 5.9645761211868376e-05
to O 0 2.6109120199180325e-07
determine O 0 1.1807194368884666e-06
the O 0 1.7374236449541058e-06
transmission O 0 6.480938463937491e-05
of O 0 9.985817541746655e-07
the O 0 0.0001293375826207921
DM B-Disease 1 0.9997524619102478
expansion O 0 0.00010521664808038622
from O 0 3.2264866604236886e-05
affected O 0 6.993582792347297e-05
parents O 0 8.50011292641284e-06
to O 0 7.132991868274985e-07
their O 0 4.016213097202126e-06
offspring O 0 0.00028532661963254213
. O 0 3.882518285536207e-05

Where O 0 1.9730023268493824e-05
the O 0 3.360204573255032e-05
transmitting O 0 0.005453682504594326
parent O 0 0.0007235603407025337
was O 0 0.0006339033716358244
male O 0 0.00023924917331896722
, O 0 1.5092818102857564e-05
58 O 0 0.000490567646920681
. O 0 9.3406270025298e-05

3 O 0 3.270875458838418e-05
% O 0 3.2604402804281563e-06
of O 0 7.343054448938346e-07
the O 0 1.4516346709569916e-05
offspring O 0 0.0003499765007290989
were O 0 1.342476207355503e-05
affected O 0 4.727975101559423e-05
, O 0 1.5926509604469175e-06
and O 0 6.797428682148166e-07
in O 0 1.2627898513528635e-06
the O 0 2.009807076319703e-06
case O 0 6.815085271227872e-06
of O 0 2.608445583973662e-07
a O 0 5.784340464742854e-05
female O 0 0.0002379309298703447
transmitting O 0 0.009552080184221268
parent O 0 0.0008572678198106587
, O 0 4.61100171378348e-05
68 O 0 0.0007436468149535358
. O 0 7.70499391364865e-05

7 O 0 0.000377310294425115
% O 0 5.662965486408211e-05
were O 0 4.385728607303463e-05
affected O 0 0.0005967736942693591
. O 0 0.00010591555474093184

Studies O 0 5.770269126514904e-05
on O 0 5.016816430725157e-05
meiotic O 0 0.011870044283568859
drive O 0 0.000406454288167879
in O 0 0.00012609176337718964
DM B-Disease 1 0.9996715784072876
have O 0 5.369264727050904e-06
shown O 0 1.6473368305014446e-05
increased O 0 6.784490324207582e-06
transmission O 0 1.887817597889807e-05
of O 0 9.075317564111174e-08
the O 0 1.474800001233234e-06
larger O 0 4.303969490138115e-06
allele O 0 1.3313141607795842e-05
at O 0 2.0934525309712626e-05
the O 0 3.568216925486922e-05
DM B-Disease 1 0.9986787438392639
locus O 0 0.00020125230366829783
in O 0 2.6954696295433678e-05
non O 0 0.0017907711444422603
- O 1 0.6053754091262817
DM O 1 0.9994379878044128
heterozygotes O 0 0.011549919843673706
for O 0 4.0367427573073655e-05
CTGn O 0 0.04718882963061333
. O 0 0.0002575615653768182

This O 0 9.65576236922061e-06
study O 0 1.692640216788277e-05
provides O 0 5.389194484450854e-06
further O 0 2.3019306354399305e-06
evidence O 0 1.614355278434232e-05
that O 0 3.1191464131552493e-06
the O 0 5.8992853155359626e-05
DM B-Disease 1 0.9994809031486511
expansion O 0 0.00013295495591592044
tends O 0 6.718366057612002e-05
to O 0 1.608476736691955e-06
be O 0 7.632294000359252e-06
transmitted O 0 0.0008400279912166297
preferentially O 0 0.00032640184508636594
. O 0 7.06228383933194e-05

Diagnosis O 1 0.9983185529708862
of O 0 0.0013227337040007114
hemochromatosis B-Disease 1 0.9999943971633911
. O 0 0.007875082083046436

If O 0 0.024533353745937347
untreated O 1 0.9998961687088013
, O 0 0.01611875370144844
hemochromatosis B-Disease 1 0.9999942779541016
can O 0 0.0059195030480623245
cause O 1 0.9991769194602966
serious O 1 0.9997640252113342
illness O 1 0.999988317489624
and O 0 4.94093110319227e-05
early B-Disease 0 0.0021434552036225796
death I-Disease 0 0.26911914348602295
, O 0 1.941175651154481e-05
but O 0 2.402036807325203e-05
the O 0 0.0005869754240848124
disease O 1 0.9999909400939941
is O 0 0.00010423429921502247
still O 0 0.00022628350416198373
substantially O 0 0.1069689616560936
under O 0 0.15826497972011566
- O 1 0.9997395873069763
diagnosed O 1 0.9999935626983643
. O 0 0.0004465232486836612

The O 0 3.9135054976213723e-05
cornerstone O 0 0.0006846895557828248
of O 0 6.204162218637066e-06
screening O 0 0.0003707949654199183
and O 0 5.628179678751621e-06
case O 0 5.681410038960166e-05
detection O 0 6.166272214613855e-05
is O 0 1.5710426168880076e-06
the O 0 7.684292882004229e-07
measurement O 0 1.4603281670133583e-05
of O 0 5.06403330291505e-06
serum O 0 0.43181610107421875
transferrin O 0 0.007540489546954632
saturation O 0 0.00015245228132698685
and O 0 3.5386096897127572e-06
the O 0 2.6959707611240447e-05
serum O 0 0.42448690533638
ferritin O 0 0.053415682166814804
level O 0 0.0006096957949921489
. O 0 0.0001285653852391988

Once O 0 0.0015525351045653224
the O 0 0.0002863161207642406
diagnosis O 1 0.9994275569915771
is O 0 0.0001719910214887932
suspected O 0 0.011358089745044708
, O 0 4.3865107727469876e-05
physicians O 0 0.0017444677650928497
must O 0 1.4943127098376863e-05
use O 0 3.891941742040217e-05
serum O 1 0.8556227087974548
ferritin O 1 0.8925163149833679
levels O 0 0.004884705878794193
and O 0 0.0002043215645244345
hepatic O 1 0.9997568726539612
iron O 1 0.9993201494216919
stores O 0 0.000720171956345439
on O 0 0.009372451342642307
liver O 1 0.999987006187439
biopsy O 1 0.9971254467964172
specimens O 0 0.000563297769986093
to O 0 1.38400637297309e-05
assess O 0 0.0012171221897006035
patients O 1 0.6947078108787537
for O 0 2.9528166578529635e-06
the O 0 7.779094630677719e-06
presence O 0 3.7928220990579575e-05
of O 0 2.1133573682163842e-05
iron B-Disease 1 0.9999033212661743
overload I-Disease 1 0.9994996786117554
. O 0 0.0007345536141656339

Liver O 1 0.9999710321426392
biopsy O 1 0.9970741271972656
is O 0 3.3724292734405026e-05
also O 0 4.126546173210954e-06
used O 0 1.1299096058792202e-06
to O 0 1.6102694644359872e-07
establish O 0 1.481590629737184e-06
the O 0 3.044196319024195e-06
presence O 0 1.3725526514463127e-05
or O 0 8.542849172954448e-06
absence O 0 0.00014614072279073298
of O 0 3.457026832620613e-05
cirrhosis B-Disease 1 0.9999959468841553
, O 0 3.788094181800261e-05
which O 0 9.376698471896816e-06
can O 0 3.484150147414766e-05
affect O 0 0.0003089103556703776
prognosis O 1 0.9997097849845886
and O 0 5.453672201838344e-05
management O 0 0.009026453830301762
. O 0 0.00022349689970724285

A O 0 0.0002561477886047214
DNA O 0 0.0002943315193988383
- O 0 6.603105430258438e-05
based O 0 1.2174410812804126e-06
test O 0 3.046577603527112e-06
for O 0 4.2352854734417633e-07
the O 0 7.886043022153899e-06
HFE O 0 0.31412389874458313
gene O 0 3.069785816478543e-05
is O 0 2.8345068585622357e-06
commercially O 0 1.1944291145482566e-05
available O 0 1.1243747621847433e-06
, O 0 2.8319030320744787e-07
but O 0 1.095703225928446e-07
its O 0 2.087646322479486e-07
place O 0 3.790819960158842e-07
in O 0 2.3613965822733007e-06
the O 0 6.060567466192879e-05
diagnosis O 1 0.9996071457862854
of O 0 0.0001709746429696679
hemochromatosis B-Disease 1 0.9999991655349731
is O 0 0.0007177458610385656
still O 0 0.0003753829514607787
being O 0 0.00028959900373592973
evaluated O 0 0.0011631426168605685
. O 0 9.667254198575392e-05

Currently O 0 3.336995359859429e-05
, O 0 1.8519309605835588e-06
the O 0 9.031833201333939e-07
most O 0 4.6543195253434533e-07
useful O 0 1.2798874422514928e-06
role O 0 1.0462938462296734e-06
for O 0 1.0828863850065318e-07
this O 0 5.945668704043783e-07
test O 0 4.564407390716951e-06
is O 0 9.67475557445141e-07
in O 0 5.543642487282341e-07
the O 0 1.9264989532530308e-06
detection O 0 0.00010807655053213239
of O 0 1.243521455762675e-05
hemochromatosis B-Disease 1 0.9999912977218628
in O 0 1.1432424798840657e-05
the O 0 8.63512195792282e-06
family O 0 2.1890937205171213e-05
members O 0 1.370435711578466e-06
of O 0 2.765842737062485e-06
patients O 1 0.998496413230896
with O 0 6.469987056334503e-06
a O 0 0.0002078462130157277
proven O 0 0.002702787285670638
case O 0 4.615234138327651e-05
of O 0 3.3278899991273647e-06
the O 0 0.00809919461607933
disease O 1 0.9999867677688599
. O 0 0.0005733859143219888

It O 0 1.0280284186592326e-05
is O 0 5.812081781186862e-06
crucial O 0 6.095273420214653e-05
to O 0 0.0002327673719264567
diagnose O 1 0.9999338388442993
hemochromatosis B-Disease 1 0.9999983310699463
before O 1 0.9987264275550842
hepatic B-Disease 1 0.9999970197677612
cirrhosis I-Disease 1 0.9999992847442627
develops O 1 0.9986990690231323
because O 0 0.08019396662712097
phlebotomy O 1 0.9991647005081177
therapy O 1 0.9989499449729919
can O 0 0.002430119551718235
avert O 1 0.9985681772232056
serious O 1 0.9999483823776245
chronic O 1 1.0
disease O 1 0.9999995231628418
and O 0 7.298910350073129e-05
can O 0 1.2033402526867576e-05
even O 0 6.928119546500966e-06
lead O 0 7.421818736474961e-06
to O 0 9.175866466648586e-07
normal O 0 0.00014479401579592377
life O 0 0.00014496006770059466
expectancy O 0 0.016710029914975166
. O 0 2.1550938981818035e-05
. O 0 7.926726539153606e-05

Prevalence O 0 0.01367104984819889
of O 0 4.456875103642233e-06
the O 0 5.155850521987304e-05
I1307K O 0 0.004647551104426384
APC B-Disease 0 0.03800959140062332
gene O 0 0.0003954848798457533
variant O 0 0.001569603686220944
in O 0 3.3453243304393254e-06
Israeli O 0 1.964519833563827e-05
Jews O 0 2.869320042009349e-06
of O 0 1.2291509676742862e-07
differing O 0 4.822090886591468e-06
ethnic O 0 2.961485961350263e-06
origin O 0 1.2664015230257064e-05
and O 0 0.00013057504838798195
risk O 1 0.9973880648612976
for O 1 0.7644643783569336
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
. O 0 0.0028677829541265965

BACKGROUND O 0 0.002681875368580222
& O 0 0.0020646024495363235
AIMS O 0 0.0001771149254636839
Israeli O 0 5.895269714528695e-05
Jews O 0 2.8633116926357616e-06
of O 0 1.0298123243046575e-06
European O 0 6.07217189099174e-05
birth O 0 0.003323510754853487
, O 0 2.511912134650629e-05
i O 0 6.16496690781787e-05
. O 0 3.5072639548161533e-06
e O 0 2.2495702069136314e-05
. O 0 1.0917037798208185e-06
, O 0 2.5522508622088935e-06
Ashkenazim O 0 0.0001781344908522442
, O 0 2.018042778217932e-06
have O 0 4.440413704287494e-06
the O 0 9.834630327532068e-05
highest O 1 0.998584508895874
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999991655349731
incidence O 1 0.9987106323242188
of O 0 2.2727788291376783e-06
any O 0 8.732168680580799e-06
Israeli O 0 0.00011285622167633846
ethnic O 0 1.1365895261405967e-05
group O 0 0.0001127051145886071
. O 0 0.00010572354949545115

The O 0 0.00013909878907725215
I1307K O 0 0.004408624954521656
APC B-Disease 0 0.018567172810435295
gene O 0 0.0006324854912236333
variant O 0 0.016666360199451447
was O 0 0.0005900315591134131
found O 0 8.412846364080906e-05
in O 0 2.3224478354677558e-05
6 O 0 0.0002786508703138679
. O 0 7.541321247117594e-05

1 O 0 3.6469631595537066e-05
% O 0 2.663748546183342e-06
of O 0 4.784058660334267e-07
American O 0 7.498297236452345e-06
Jews O 0 1.0510620995773934e-05
, O 0 2.5187755454680882e-06
28 O 0 8.053935744101182e-06
% O 0 1.1125639503006823e-06
of O 0 7.795348437866778e-07
their O 0 0.00042363288230262697
familial O 1 0.9999924898147583
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
cases O 1 0.8138680458068848
, O 0 4.539180372375995e-05
but O 0 5.409121513366699e-06
not O 0 1.925205879160785e-06
in O 0 6.965391548874322e-06
non O 0 0.00010971857409458607
- O 0 0.0009908023057505488
Jews O 0 3.7037778383819386e-05
. O 0 5.358997077564709e-05

We O 0 2.208803743997123e-05
assessed O 0 0.00020920619135722518
the O 0 3.156794991809875e-05
I1307K O 0 0.005566806998103857
prevalence O 0 0.020063357427716255
in O 0 4.109427663934184e-06
Israeli O 0 1.3088330888422206e-05
Jews O 0 1.7747164520187653e-06
of O 0 1.3928638509241864e-07
differing O 0 4.456007900444092e-06
ethnic O 0 2.7355990823707543e-06
origin O 0 1.172996053355746e-05
and O 0 0.00010716157703427598
risk O 1 0.9981216788291931
for O 1 0.7446391582489014
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
. O 0 0.003382109571248293

METHODS O 0 7.617152732564136e-05
DNA O 0 0.00018189995898865163
samples O 0 3.0016464734217152e-05
from O 0 1.9407721993047744e-05
500 O 0 4.728281783172861e-05
unrelated O 0 0.0001735363621264696
Jews O 0 3.978617769462289e-06
of O 0 7.389637630694779e-07
European O 0 3.09356655634474e-05
or O 0 2.715889786486514e-05
non O 0 0.00010997687058988959
- O 0 0.00011118029215140268
European O 0 2.096163825626718e-06
origin O 0 7.268199624377303e-07
, O 0 9.676804211267154e-07
with O 0 1.4961158285586862e-06
or O 0 7.536092198279221e-06
without O 0 4.742037162941415e-06
a O 0 1.5768842786201276e-05
personal O 0 3.0194698410923593e-05
and O 0 1.9423998310230672e-05
/ O 0 0.0014272218104451895
or O 0 1.3647007108374964e-05
family O 0 1.9888748283847235e-05
history O 0 8.957805221143644e-06
of O 0 1.567413164593745e-05
neoplasia B-Disease 1 0.999715268611908
, O 0 1.9482846255414188e-05
were O 0 8.184401849575806e-06
examined O 0 0.00023128249449655414
for O 0 1.1603340226429282e-06
the O 0 8.480987162329257e-06
I1307K O 0 0.000833959027659148
variant O 0 0.0007050964049994946
by O 0 3.109926865363377e-06
the O 0 5.026111011829926e-06
allele O 0 5.3734740504296497e-05
- O 0 5.0009672122541815e-05
specific O 0 4.0760060073807836e-06
oligonucleotide O 0 0.0006344449357129633
( O 0 5.9808193327626213e-05
ASO O 1 0.9886054396629333
) O 0 1.1075608199462295e-05
method O 0 1.3734404092247132e-05
. O 0 7.203446875791997e-05

RESULTS O 0 0.0005659776506945491
In O 0 1.9423219782765955e-05
persons O 0 2.5245344659197144e-05
at O 0 0.0004292935482226312
average O 0 0.00438138609752059
risk O 1 0.82301926612854
for O 0 0.03317106515169144
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
, O 0 0.00015647454711142927
I1307K O 0 0.005082385148853064
was O 0 0.0006807777681387961
found O 0 4.1950766899390146e-05
in O 0 1.0515604117244948e-05
5 O 0 8.600819273851812e-05
. O 0 5.8089164667762816e-05

0 O 0 1.68267943081446e-05
% O 0 1.6886745015654014e-06
of O 0 2.973420976104535e-07
120 O 0 1.2054329999955371e-05
European O 0 1.4151319192023948e-05
and O 0 4.328200702730101e-06
1 O 0 5.499767939909361e-05
. O 0 4.696627001976594e-05

6 O 0 0.00010010370169766247
% O 0 5.241471171757439e-06
of O 0 1.335571823801729e-06
188 O 0 0.00028669278253801167
non O 0 0.00014245955389924347
- O 0 0.00011948629980906844
European O 0 5.671303824783536e-06
Jews O 0 8.0576382970321e-06
( O 0 7.312066372833215e-06
P O 0 0.000619524740613997
= O 0 8.995040116133168e-05
0 O 0 6.22035940978094e-06
. O 0 2.5614046990085626e-06
08 O 0 0.00016365059127565473
) O 0 6.763165856682463e-06
. O 0 1.5508361684624106e-05

It O 0 6.735084025422111e-05
occurred O 0 0.0004536754568107426
in O 0 2.933933683380019e-05
15 O 0 0.00014364931848831475
. O 0 8.932855416787788e-05

4 O 0 4.305225593270734e-05
% O 0 2.3274662908079335e-06
of O 0 7.849523058212071e-07
52 O 0 0.0003011964145116508
Ashkenazi O 0 0.0017427264247089624
Israelis O 0 0.0001367683580610901
with O 0 0.00012781853729393333
familial O 1 0.9997345805168152
cancer B-Disease 1 0.9999810457229614
( O 0 0.00015856241225264966
P O 0 0.02795780450105667
= O 0 0.00042497008689679205
0 O 0 1.9286668248241767e-05
. O 0 6.089841008360963e-06
02 O 0 0.0012293168110772967
) O 0 1.0866122011066182e-06
and O 0 6.929004143785278e-07
was O 0 2.30899422604125e-05
not O 0 9.491348578194447e-07
detected O 0 8.925046131480485e-05
in O 0 2.012730192291201e-06
51 O 0 2.5064900910365395e-05
non O 0 3.320785617688671e-05
- O 0 9.542173211229965e-05
European O 0 4.211781288177008e-06
Jews O 0 1.8183773136115633e-05
at O 0 0.0006192927248775959
increased O 0 0.06898929923772812
cancer B-Disease 1 0.9999891519546509
risk O 1 0.9810274839401245
. O 0 0.0001900980423670262

Colorectal B-Disease 1 0.9999027252197266
neoplasia I-Disease 1 0.9988922476768494
occurred O 0 0.02113959938287735
personally O 0 0.0029307478107511997
or O 0 1.8241818906972185e-05
in O 0 2.0548957309074467e-06
the O 0 1.7637880773690995e-06
families O 0 1.4456874168899958e-06
of O 0 2.243743182361868e-07
13 O 0 1.0675749763322528e-05
of O 0 2.0307963950472185e-06
20 O 0 0.00011836316843982786
Ashkenazi O 0 0.004199497401714325
I1307K O 0 0.002370611298829317
carriers O 0 0.0002845163398887962
, O 0 4.220075425109826e-06
8 O 0 5.073556167189963e-06
of O 0 6.748288114977186e-07
whom O 0 8.70371368364431e-05
also O 0 1.8854425434255973e-05
had O 0 4.5373719331109896e-05
a O 0 1.1074394024035428e-05
personal O 0 2.039493847405538e-05
or O 0 3.2777388696558774e-05
family O 0 5.4309093684423715e-05
history O 0 2.6338897441746667e-05
of O 0 3.357670721015893e-05
noncolonic O 1 0.9978353381156921
neoplasia B-Disease 1 0.99953293800354
. O 0 0.000734903325792402

CONCLUSIONS O 0 0.0004749552463181317
The O 0 0.000144913763506338
I1307K O 0 0.01291564479470253
APC O 0 0.2495402991771698
variant O 0 0.020197037607431412
may O 0 3.601322532631457e-05
represent O 0 9.931095519277733e-07
a O 0 3.5967095755040646e-05
susceptibility O 0 0.002588762203231454
gene O 0 0.0003558405442163348
for O 0 0.0001185658184112981
colorectal B-Disease 1 0.9999982118606567
, I-Disease 0 2.483418029441964e-05
or I-Disease 0 1.910991886688862e-05
other I-Disease 0 8.800495379546192e-06
, I-Disease 0 0.00032684244797565043
cancers I-Disease 1 0.9997748732566833
in O 0 4.709821951109916e-05
Ashkenazi O 0 0.023345952853560448
Jews O 0 4.458041439647786e-05
, O 0 1.0918997759290505e-05
and O 0 1.0072270015371032e-05
partially O 0 0.004698330536484718
explains O 0 7.665953307878226e-05
the O 0 2.7467658583191223e-05
higher O 0 0.001309263869188726
incidence O 1 0.9992998838424683
of O 0 0.01293802261352539
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999991655349731
in O 0 0.00029162573628127575
European O 0 0.00040785782039165497
Israelis O 0 0.0008149356581270695
. O 0 0.00020478575606830418

Systematic O 0 9.85370425041765e-05
analysis O 0 3.0549745133612305e-06
of O 0 7.3936312219302636e-06
coproporphyrinogen O 0 0.1099860817193985
oxidase O 0 0.015909526497125626
gene O 0 0.00952273327857256
defects O 1 0.9994423985481262
in O 0 0.00011620222358033061
hereditary B-Disease 1 0.9994159936904907
coproporphyria I-Disease 1 0.6922249794006348
and O 0 4.133776019443758e-05
mutation O 0 0.0026466562412679195
update O 0 0.003714216174557805
. O 0 9.458439308218658e-05

Hereditary B-Disease 1 0.9961961507797241
coproporphyria I-Disease 1 0.9837046265602112
( O 0 0.0015052236849442124
HC B-Disease 1 0.9998595714569092
) O 0 0.00021387732704170048
is O 0 0.00017007401038426906
an O 0 0.007897967472672462
acute O 1 0.9999946355819702
hepatic B-Disease 1 0.999996542930603
porphyria I-Disease 1 0.99996018409729
with O 0 0.011675465852022171
autosomal O 1 0.9998557567596436
dominant O 1 0.979504406452179
inheritance O 1 0.9944400787353516
caused O 1 0.9989315867424011
by O 0 0.0016488156979903579
deficient B-Disease 1 0.9996445178985596
activity I-Disease 0 3.988185926573351e-05
of I-Disease 0 9.251923984265886e-06
coproporphyrinogen I-Disease 0 0.3340740501880646
III I-Disease 1 0.9951370358467102
oxidase I-Disease 0 0.005707663483917713
( O 0 0.00010188473970629275
CPO O 0 0.0018051121151074767
) O 0 2.039439459622372e-05
. O 0 4.5718756155110896e-05

Clinical O 0 0.03169625625014305
manifestations O 0 0.0022813091054558754
of O 0 2.109479100909084e-05
the O 0 0.29942965507507324
disease O 1 0.9999953508377075
are O 0 2.1779325834359042e-05
characterized O 1 0.9924463629722595
by O 0 0.004867536947131157
acute O 1 0.9999943971633911
attacks O 0 0.055156394839286804
of O 0 0.010342428460717201
neurological B-Disease 1 0.9999996423721313
dysfunction I-Disease 1 0.9999912977218628
often O 0 0.14506618678569794
precipitated O 1 0.9980886578559875
by O 0 0.00018369907047599554
drugs O 0 0.42143353819847107
, O 0 2.905665860453155e-05
fasting O 0 0.0014478189405053854
, O 0 5.737698302255012e-05
cyclical O 0 0.05919830501079559
hormonal O 1 0.8692167401313782
changes O 0 0.0002660970203578472
, O 0 0.0002718161849770695
or O 0 0.13500504195690155
infectious B-Disease 1 0.9999858140945435
diseases I-Disease 1 0.9999911785125732
. O 0 0.0018956131534650922

Skin O 1 0.9998656511306763
photosensitivity O 1 0.9988571405410767
may O 0 0.006956933531910181
also O 0 5.08912380610127e-05
be O 0 1.981724017241504e-05
present O 0 6.924698391230777e-05
. O 0 7.48579332139343e-05

The O 0 1.2076595339749474e-05
seven O 0 1.4300278962764423e-05
exons O 0 6.377681711455807e-05
, O 0 3.9996125451580156e-06
the O 0 8.040384273044765e-06
exon O 0 0.0013202492846176028
/ O 0 0.00033407373121008277
intron O 0 0.000746445672120899
boundaries O 0 5.6119648661479e-07
and O 0 3.8080420949881955e-07
part O 0 6.811964681219251e-07
of O 0 1.846100019520236e-07
3 O 0 1.0264795491821133e-05
noncoding O 0 7.169462332967669e-05
sequence O 0 5.80167068164883e-07
of O 0 2.0744565176755714e-07
the O 0 1.1304601684969384e-05
CPO O 0 0.0013475975720211864
gene O 0 2.3760396288707852e-05
were O 0 2.5303804704890354e-06
systematically O 0 2.202008181484416e-05
analyzed O 0 8.279504072561394e-06
by O 0 1.3818863635606249e-06
an O 0 8.281383088615257e-06
exon O 0 0.0006879423162899911
- O 0 0.00015730720770079643
by O 0 7.006703981460305e-06
- O 0 0.00010964901593979448
exon O 0 0.0002303195360582322
denaturing O 0 0.0023821520153433084
gradient O 0 0.0006873111124150455
gel O 0 0.014992648735642433
electrophoresis O 0 0.001999654807150364
( O 0 8.401334343943745e-05
DGGE O 0 0.008142711594700813
) O 0 3.5614486932900036e-06
strategy O 0 7.050104159134207e-06
followed O 0 2.142605353583349e-06
by O 0 3.718459709034505e-07
direct O 0 6.347658541017154e-07
sequencing O 0 5.8072891988558695e-06
in O 0 3.937740075343754e-06
seven O 0 1.959583823918365e-05
unrelated O 0 0.005311711225658655
heterozygous O 0 0.024332363158464432
HC B-Disease 1 0.9999262094497681
patients O 1 0.9995331764221191
from O 0 0.00025881058536469936
France O 0 0.0001814682618714869
, O 0 1.9281958884675987e-05
Holland O 0 0.00016339457943104208
, O 0 3.9984952309168875e-06
and O 0 1.6276136420856346e-06
Czech O 0 0.00012856526882387698
Republic O 0 3.418760024942458e-05
. O 0 9.305474668508396e-05

Seven O 0 8.764346421230584e-05
novel O 0 0.00011941351112909615
mutations O 0 6.295730418059975e-05
and O 0 1.4807699244556716e-06
two O 0 2.0518289147730684e-06
new O 0 2.4687094992259517e-05
polymorphisms O 0 0.0007607883308082819
were O 0 8.12461439636536e-05
detected O 0 0.01905297487974167
. O 0 0.00017024826956912875

Among O 0 1.1526627531566191e-05
these O 0 3.3980049920501187e-06
mutations O 0 4.773642649524845e-05
two O 0 1.5487065638808417e-06
are O 0 2.2208248537936015e-06
missense O 0 0.00045702760689891875
( O 0 2.5849969460978173e-05
G197W O 0 0.0008860513917170465
, O 0 1.2418469850672409e-05
W427R O 0 0.0004107725399080664
) O 0 3.5557063711166847e-06
, O 0 1.1410141951273545e-06
two O 0 3.6748227216776286e-07
are O 0 9.266443043998152e-07
nonsense O 0 0.00018761628598440439
( O 0 1.1235688361921348e-05
Q306X O 0 0.0002780649228952825
, O 0 8.755926501180511e-06
Q385X O 0 0.00028218523948453367
) O 0 3.40368433171534e-06
, O 0 1.1626646028162213e-06
two O 0 4.273725267012196e-07
are O 0 2.8163597676211793e-07
small O 0 1.104884358937852e-05
deletions O 0 0.00025612168246880174
( O 0 2.4791703253868036e-05
662de14bp O 0 0.0010135029442608356
; O 0 1.7967919120565057e-05
1168del3bp O 0 0.0008031000033952296
removing O 0 0.00015498044376727194
a O 0 2.265000694023911e-05
glycine O 0 0.00033041404094547033
at O 0 4.860428089159541e-05
position O 0 2.032136035268195e-05
390 O 0 8.64537141751498e-05
) O 0 2.5498982267890824e-06
, O 0 5.2605281553042e-07
and O 0 1.926427586340651e-07
one O 0 2.903918527863425e-07
is O 0 7.782846864756721e-07
a O 0 3.5274235870019766e-06
splicing O 0 2.4052484150161035e-05
mutation O 0 5.202836837270297e-05
( O 0 1.6318304915330373e-05
IVS1 O 0 0.008942408487200737
- O 0 0.00043738901149481535
15c O 0 0.0010262897703796625
- O 0 0.00038371735718101263
- O 0 0.00010640176333254203
> O 0 0.00012139200407546014
g O 0 4.8099795094458386e-05
) O 0 5.555370989895891e-07
which O 0 2.3823623962471174e-07
creates O 0 3.204591394023737e-06
a O 0 4.431977686181199e-06
new O 0 4.609590178006329e-06
acceptor O 0 0.0005730376578867435
splice O 0 0.0010708683403208852
site O 0 0.0004865785303991288
. O 0 7.198996900115162e-05

The O 0 0.0001293896493734792
pathological O 0 0.005982799455523491
significance O 0 4.021041604573838e-06
of O 0 4.954856649419526e-07
the O 0 7.840957550797611e-06
point O 0 5.250491085462272e-05
mutations O 0 0.00011328882101224735
G197W O 0 0.0004056903417222202
, O 0 9.568833775119856e-06
W427R O 0 0.0002937223471235484
, O 0 2.636099452502094e-06
and O 0 7.894680607023474e-07
the O 0 4.599227395374328e-06
in O 0 1.1536668353073765e-05
- O 0 0.0006631623255088925
frame O 0 0.0006781015545129776
deletion O 0 0.0017864537658169866
390delGly O 0 0.0023309672251343727
were O 0 1.1478812666609883e-05
assessed O 0 5.6481232604710385e-05
by O 0 6.726141350554826e-07
their O 0 2.1066780675482732e-07
respective O 0 1.0491645525689819e-06
expression O 0 4.330889169068541e-06
in O 0 2.1853227281098953e-06
a O 0 1.8067165001411922e-05
prokaryotic O 0 0.00011027743312297389
system O 0 6.567329546669498e-05
using O 0 9.624899576010648e-06
site O 0 0.00024334674526471645
- O 0 0.00032892340095713735
directed O 0 1.7027216017595492e-05
mutagenesis O 0 0.0011581480503082275
. O 0 9.387077443534508e-05

These O 0 1.1058183190471027e-05
mutations O 0 0.00015940253797452897
resulted O 0 0.00010980889783240855
in O 0 7.69667349231895e-06
the O 0 1.4056829968467355e-05
absence O 0 0.00028398865833878517
or O 0 1.7569955161889084e-05
a O 0 2.4617880626465194e-05
dramatic O 0 0.0001583228149684146
decrease O 0 0.0001870350824901834
of O 0 5.929659891990013e-06
CPO O 0 0.008628158830106258
activity O 0 0.00014607844059355557
. O 0 9.835961827775463e-05

The O 0 3.026356534974184e-05
two O 0 6.691133876302047e-06
polymorphisms O 0 0.0003599771298468113
were O 0 1.2696349585894495e-05
localized O 0 0.001054106862284243
in O 0 5.338893970474601e-06
noncoding O 0 0.00026828786940313876
part O 0 2.108011813106714e-06
of O 0 1.2664281712204684e-07
the O 0 3.368406169101945e-06
gene O 0 2.071160270133987e-05
1 O 0 5.65497248317115e-06
) O 0 1.3063826145298663e-06
a O 0 1.231594433193095e-05
C O 0 0.0005282852798700333
/ O 0 0.00013002959894947708
G O 0 0.00010682062566047534
polymorphism O 0 6.501692496385658e-06
in O 0 1.3059901675660512e-06
the O 0 9.937946742866188e-06
promotor O 0 0.007344748359173536
region O 0 3.392059079487808e-05
, O 0 1.0257807844027411e-05
142 O 0 9.796881204238161e-05
bp O 0 0.00023732914996799082
upstream O 0 4.0266004361910746e-05
from O 0 2.3084642180037918e-06
the O 0 9.944648127202527e-07
transcriptional O 0 4.8885838623391464e-05
initiation O 0 6.309735181275755e-05
site O 0 0.00012411312491167337
( O 0 1.677774343988858e-05
- O 0 0.0001673826336627826
142C O 0 0.0004060275969095528
/ O 0 0.00016094831516966224
G O 0 0.0002773619198706001
) O 0 2.102069402099005e-06
, O 0 6.478801992670924e-07
and O 0 5.245408942755603e-07
2 O 0 4.522020390140824e-06
) O 0 1.195859226754692e-06
a O 0 4.012391855212627e-06
6 O 0 2.0999592379666865e-05
bp O 0 0.00010076683975057676
deletion O 0 5.9874790167668834e-05
polymorphism O 0 9.301432328356896e-06
in O 0 1.1927520517929224e-06
the O 0 1.6636075770293246e-06
3 O 0 6.0602646954066586e-06
noncoding O 0 8.096848614513874e-05
part O 0 1.1878199757120456e-06
of O 0 3.1591852689416555e-07
the O 0 1.8307677237316966e-05
CPO O 0 0.0011382553493604064
gene O 0 6.097889126976952e-05
, O 0 7.186947186710313e-06
574 O 0 0.0007093154708854854
bp O 0 0.00021788652520626783
downstream O 0 1.0447271051816642e-05
of O 0 2.4152654987119604e-07
the O 0 2.609339162518154e-06
last O 0 1.734867510094773e-05
base O 0 8.41416408547957e-07
of O 0 3.701875073147676e-08
the O 0 2.4972209757834207e-06
normal O 0 5.6001863413257524e-05
termination O 0 0.000501002068631351
codon O 0 4.479194831219502e-05
( O 0 2.246206895506475e-05
+ O 0 0.0007102698436938226
574 O 0 0.0025104673113673925
delATTCTT O 0 0.0030658033210784197
) O 0 3.8567606679862365e-05
. O 0 5.48069947399199e-05

Five O 0 0.0004147043509874493
intragenic O 0 0.04694362357258797
dimorphisms O 0 0.01370108313858509
are O 0 4.158181582170073e-06
now O 0 1.9138295101583935e-05
well O 0 6.093477622926002e-06
characterized O 0 0.00048277119640260935
and O 0 1.4768802429898642e-06
the O 0 5.3441863201442175e-06
high O 0 6.648134149145335e-05
degree O 0 7.476105565729085e-06
of O 0 9.592063179297838e-07
allelic O 0 0.0016216718358919024
heterogeneity O 0 0.0009149910183623433
in O 0 9.885628242045641e-05
HC B-Disease 1 0.9998509883880615
is O 0 1.572368637425825e-05
demonstrated O 0 1.7722841221257113e-05
with O 0 6.441983373406401e-07
seven O 0 1.8077980712405406e-06
new O 0 1.2547900496429065e-06
different O 0 1.8474914043054014e-07
mutations O 0 8.969225746113807e-06
making O 0 7.348490385084006e-07
a O 0 2.4577245767432032e-06
total O 0 4.140893850035354e-07
of O 0 7.005495490375324e-07
nineteen O 0 0.0006908975192345679
CPO O 0 0.08696172386407852
gene B-Disease 0 0.010254818946123123
defects I-Disease 1 0.9995230436325073
reported O 0 0.004639330320060253
so O 0 3.343315256643109e-05
far O 0 3.274227128713392e-05
. O 0 1.8565906430012546e-05
. O 0 6.711131572956219e-05

Coincidence O 0 4.1490686271572486e-05
of O 0 4.6304344891723304e-07
two O 0 3.120104565823567e-06
novel O 0 0.00011147117038490251
arylsulfatase O 0 0.001771224313415587
A O 0 0.00010614194616209716
alleles O 0 2.209977355960291e-05
and O 0 5.355763278203085e-06
mutation O 0 0.00029006737167946994
459 O 0 0.0027461210265755653
+ O 0 0.0018749526934698224
1G O 0 0.008616887964308262
> O 0 0.00018723509856499732
A O 0 1.3221487279224675e-05
within O 0 1.226543759003107e-06
a O 0 2.244055394839961e-05
family O 0 0.00011260447354288772
with O 0 0.0001545510021969676
metachromatic B-Disease 1 0.9992638230323792
leukodystrophy I-Disease 1 0.9997712969779968
: O 0 2.0060799215571024e-05
molecular O 0 2.892064549087081e-05
basis O 0 9.827494977798779e-07
of O 0 2.0003492409159662e-06
phenotypic O 0 0.001860087621025741
heterogeneity O 0 0.006064907182008028
. O 0 0.0003696625353768468

In O 0 2.269359538331628e-05
a O 0 3.5927194403484464e-05
family O 0 2.5489727704552934e-05
with O 0 3.491944880806841e-06
three O 0 6.658008715021424e-06
siblings O 0 0.000636075681541115
, O 0 3.5990235573990503e-06
one O 0 3.006146926054498e-06
developed O 0 0.00010718713019741699
classical O 0 0.0005404057446867228
late O 1 0.7486139535903931
infantile O 1 0.9998251795768738
metachromatic B-Disease 1 0.9997032284736633
leukodystrophy I-Disease 1 0.9999746084213257
( O 0 0.017429746687412262
MLD B-Disease 1 0.9997195601463318
) O 0 0.00021733460016548634
, O 0 0.00011612357047852129
fatal O 1 0.9989467263221741
at O 0 0.0002560913853812963
age O 0 0.0005030878819525242
5 O 0 5.2653274906333536e-05
years O 0 5.149187927599996e-05
, O 0 6.866512194392271e-06
with O 0 3.740379906957969e-05
deficient O 1 0.9993340373039246
arylsulfatase O 0 0.02412896230816841
A O 0 0.0010194022906944156
( O 0 0.00010849154932657257
ARSA O 0 0.3908640146255493
) O 0 5.062468972028e-06
activity O 0 6.677530109300278e-06
and O 0 3.830705281870905e-06
increased O 0 7.800034654792398e-05
galactosylsulfatide O 0 0.005370705854147673
( O 0 0.00010553680476732552
GS O 1 0.9959920048713684
) O 0 5.857847281731665e-05
excretion O 0 0.002034795703366399
. O 0 9.888758359011263e-05

The O 0 1.671200334385503e-05
two O 0 3.323380042274948e-06
other O 0 5.154952305019833e-06
siblings O 0 0.0005924346041865647
, O 0 2.17131291719852e-05
apparently O 0 0.00045914045767858624
healthy O 0 0.0003989553661085665
at O 0 2.734038935159333e-05
12 O 0 1.6811187379062176e-05
( O 0 6.506940280814888e-06
1 O 0 1.3480941561283544e-05
/ O 0 5.577445335802622e-05
2 O 0 3.4173513085988816e-06
) O 0 6.66504604396323e-07
and O 0 4.956340831085981e-07
15 O 0 4.9498307816975284e-06
years O 0 9.933738510881085e-06
, O 0 1.9966385025327327e-06
respectively O 0 1.2387868991936557e-05
, O 0 2.1417349671537522e-06
and O 0 5.185944473851123e-07
their O 0 1.4481063317361986e-06
father O 0 0.0004257518157828599
, O 0 2.5605406335671432e-05
apparently O 0 0.0006626247777603567
healthy O 0 0.0009292016620747745
as O 0 1.1646793609543238e-05
well O 0 3.900577667081961e-06
, O 0 5.639413757307921e-06
presented O 0 0.00021994372946210206
ARSA O 1 0.7834287285804749
and O 0 1.6056403183029033e-05
GS O 0 0.48188722133636475
values O 0 4.42001407918724e-07
within O 0 6.360304496411118e-07
the O 0 3.4761224014800973e-06
range O 0 1.7757780369720422e-05
of O 0 3.282283796579577e-05
MLD B-Disease 1 0.9999299049377441
patients O 1 0.9991074204444885
. O 0 0.0005532600916922092

Mutation O 0 0.00045916647650301456
screening O 0 6.009817298036069e-05
and O 0 4.712368593118299e-07
sequence O 0 3.9520173231721856e-06
analysis O 0 4.944622560287826e-06
disclosed O 0 0.00046819369890727103
the O 0 3.1303334253607318e-06
involvement O 0 1.4312257917481475e-05
of O 0 2.5198204411935876e-07
three O 0 1.874558051895292e-06
different O 0 3.210035856682225e-06
ARSA O 1 0.9849226474761963
mutations O 0 7.69242542446591e-05
being O 0 4.090796210221015e-06
the O 0 6.140375035101897e-07
molecular O 0 8.702033483132254e-06
basis O 0 3.8916684275136504e-07
of O 0 1.8617517980601406e-06
intrafamilial O 0 0.006546963471919298
phenotypic O 0 0.0008005308918654919
heterogeneity O 0 0.003160730004310608
. O 0 0.0002810564765240997

The O 0 0.00034096965100616217
late O 1 0.5141860842704773
infantile O 1 0.9998291730880737
patient O 1 0.9996585845947266
inherited O 1 0.9976438879966736
from O 0 9.605000377632678e-05
his O 0 0.00017121966811828315
mother O 0 0.0010124231921508908
the O 0 8.70612529979553e-06
frequent O 0 0.00011605626059463248
0 O 0 4.067486952408217e-05
- O 0 0.0002899429528042674
type O 0 0.00022999828797765076
mutation O 0 0.00012374098878353834
459 O 0 0.001134601654484868
+ O 0 0.0007216532249003649
1G O 0 0.004184613469988108
> O 0 0.0001572776527609676
A O 0 2.483676144038327e-05
, O 0 2.2389601781469537e-06
and O 0 6.686130973321269e-07
from O 0 2.6300754143449012e-06
his O 0 1.5690431609982625e-05
father O 0 0.00017370043497066945
a O 0 2.1895071768085472e-05
novel O 0 3.274676782893948e-05
, O 0 4.255246949469438e-06
single O 0 1.5925817933748476e-05
basepair O 0 0.0011264656204730272
microdeletion O 0 0.0002421903336653486
of O 0 3.503949983496568e-07
guanine O 0 2.1131578250788152e-05
at O 0 8.486472324875649e-06
nucleotide O 0 6.458817097154679e-06
7 O 0 5.208325092098676e-06
in O 0 1.7306238078163005e-06
exon O 0 0.0002308414550498128
1 O 0 2.072302231681533e-05
( O 0 1.2845836863561999e-05
7delG O 0 0.0009149997495114803
) O 0 1.537761272629723e-05
. O 0 3.333350468892604e-05

The O 0 4.8038651584647596e-05
two O 0 7.035745511529967e-05
clinically O 1 0.9903239011764526
unaffected O 0 0.03144371509552002
siblings O 0 0.00044560604146681726
carried O 0 1.827941923693288e-05
the O 0 1.9365437765372917e-05
maternal O 0 0.008824829012155533
mutation O 0 0.001141094253398478
459 O 0 0.004302680026739836
+ O 0 0.0020433522295206785
1G O 0 0.011503691785037518
> O 0 0.00022306173923425376
A O 0 3.290629683760926e-05
and O 0 1.058982775248296e-06
, O 0 5.904335580453335e-07
on O 0 6.086782491365739e-07
their O 0 4.064610266141244e-07
paternal O 0 0.00011349836131557822
allele O 0 1.9696826711879112e-05
, O 0 1.139061510002648e-06
a O 0 3.002590801770566e-06
novel O 0 1.058467387338169e-05
cytosine O 0 7.296957392100012e-06
to O 0 4.178643848717911e-07
thymidine O 0 2.2761932996218093e-05
transition O 0 8.586327567172702e-06
at O 0 1.846046870923601e-05
nucleotide O 0 4.9512938858242705e-05
2435 O 0 0.0026786569505929947
in O 0 3.4125182537536602e-06
exon O 0 0.0003026867052540183
8 O 0 1.9885617803083733e-05
, O 0 1.2630139281100128e-06
resulting O 0 1.8121503671864048e-05
in O 0 6.880841283418704e-07
substitution O 0 4.558786713459995e-06
of O 0 9.971961389965145e-07
alanine O 0 0.0037050836253911257
464 O 0 0.0036012320779263973
by O 0 4.994704795535654e-05
valine O 0 0.011464337818324566
( O 0 8.931296179071069e-05
A464V O 0 0.0016203636769205332
) O 0 3.548088716343045e-05
. O 0 8.738625911064446e-05

The O 0 8.536847599316388e-05
fathers O 0 0.0001655152445891872
genotype O 0 0.0007426595548167825
thus O 0 7.643273420399055e-05
was O 0 0.004018387757241726
7delG O 0 0.030827563256025314
/ O 0 0.0041666836477816105
A464V O 0 0.0034953956492245197
. O 0 0.00011435877968324348

Mutation O 0 0.0018390128389000893
A464V O 0 0.002470612758770585
was O 0 0.00030264543602243066
not O 0 5.040213181928266e-06
found O 0 2.6390163839096203e-05
in O 0 1.0204835234617349e-05
18 O 0 0.00036600601742975414
unrelated O 1 0.9228777289390564
MLD B-Disease 1 0.9999719858169556
patients O 1 0.9994136095046997
and O 0 2.8519736588350497e-05
50 O 0 7.114073378033936e-05
controls O 0 0.00014007402933202684
. O 0 0.00010088182898471132

A464V O 0 0.008370528928935528
, O 0 5.516460441867821e-05
although O 0 9.117374429479241e-05
clearly O 0 0.00035178117104806006
modifying O 0 0.002656748751178384
ARSA O 1 0.9790094494819641
and O 0 0.0001938551722560078
GS O 1 0.9994103908538818
levels O 0 0.006845641415566206
, O 0 3.2328287488780916e-05
apparently O 0 0.0008773637237027287
bears O 0 0.0002024389832513407
little O 0 2.273795871587936e-05
significance O 0 5.860332294105319e-06
for O 0 6.928172297193669e-06
clinical O 0 0.015755733475089073
manifestation O 0 0.015241611748933792
of O 0 6.417874828912318e-05
MLD B-Disease 1 0.999861478805542
, O 0 5.8243589592166245e-05
mimicking O 0 0.0024366897996515036
the O 0 3.45226981153246e-05
frequent O 0 0.002815571380779147
ARSA O 1 0.9878984093666077
pseudodeficiency O 0 0.035146914422512054
allele O 0 0.0006817360990680754
. O 0 0.00012254352623131126

Our O 0 1.5026495930214878e-05
results O 0 2.1517917048186064e-05
demonstrate O 0 9.676642548583914e-06
that O 0 1.1347192412358709e-06
in O 0 3.03594242723193e-06
certain O 0 1.0794175977935083e-05
genetic O 0 0.003562893019989133
conditions O 1 0.9455152750015259
MLD B-Disease 1 0.9998595714569092
- O 0 0.438572496175766
like O 0 0.00017146571190096438
ARSA O 1 0.9868969321250916
and O 0 2.2935357264941558e-05
GS O 1 0.962068498134613
values O 0 1.1969865454375395e-06
need O 0 5.423372385848779e-06
not O 0 8.464999723400979e-07
be O 0 2.1343050775612937e-06
paralleled O 0 0.00017755641601979733
by O 0 9.856880933512002e-05
clinical O 1 0.9990440011024475
disease O 1 0.9999876022338867
, O 0 2.6843954401556402e-05
a O 0 5.991974103380926e-05
finding O 0 9.81355260591954e-05
with O 0 0.00014057538646738976
serious O 1 0.9876847267150879
diagnostic O 1 0.5642507076263428
and O 0 0.000177057518158108
prognostic O 1 0.9534361958503723
implications O 0 0.0037487726658582687
. O 0 0.00028078487957827747

Moreover O 0 0.0010518813505768776
, O 0 3.5284443583805114e-05
further O 0 0.0001064368843799457
ARSA O 1 0.864673912525177
alleles O 0 0.00024158471205737442
functionally O 0 0.0017587626352906227
similar O 0 3.01749514619587e-05
to O 0 8.148080269165803e-06
A464V O 0 0.00127109931781888
might O 0 2.0496056094998494e-05
exist O 0 1.2704444998234976e-06
which O 0 2.8613004587896285e-07
, O 0 1.7485527337157691e-07
together O 0 1.0186833065972678e-07
with O 0 1.6978013945845305e-06
0 O 0 5.364493699744344e-05
- O 0 0.0009344874997623265
type O 0 0.0006820669514127076
mutations O 0 0.0002162153978133574
, O 0 2.698694879654795e-05
may O 0 0.0006667213747277856
cause O 0 0.14443925023078918
pathological O 1 0.9949283599853516
ARSA O 1 0.9949376583099365
and O 0 0.00020916030916851014
GS O 1 0.9996415376663208
levels O 0 0.0031545564997941256
, O 0 8.511890882800799e-06
but O 0 4.340142368164379e-06
not O 0 8.93957621883601e-06
clinical O 0 0.008658381178975105
outbreak O 1 0.8379845023155212
of O 0 1.4650890079792589e-05
the O 0 0.12881091237068176
disease O 1 0.9999959468841553
. O 0 0.00026060527306981385
. O 0 0.00019992042507510632

Human O 1 0.5458200573921204
MLH1 O 1 0.9992144107818604
deficiency O 1 0.9999960660934448
predisposes O 1 0.9877267479896545
to O 0 0.000916545104701072
hematological B-Disease 1 0.9994391798973083
malignancy I-Disease 1 0.9999207258224487
and O 0 0.003471445757895708
neurofibromatosis B-Disease 1 0.9999908208847046
type I-Disease 1 0.9923872947692871
1 I-Disease 0 0.0022766320034861565
. O 0 0.00024281068181153387

Heterozygous O 0 0.011851093731820583
germ O 1 0.9896557331085205
- O 0 0.0022578483913093805
line O 0 7.114385516615584e-05
mutations O 0 1.5854973753448576e-05
in O 0 1.2878226698376238e-06
the O 0 1.1963568795181345e-05
DNA O 0 0.0012825283920392394
mismatch O 1 0.8861965537071228
repair O 1 0.8836956024169922
genes O 0 4.363130938145332e-05
lead O 0 7.953985914355144e-05
to O 0 8.74279357958585e-05
hereditary B-Disease 1 0.999812662601471
nonpolyposis I-Disease 1 0.9999251365661621
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
. O 0 0.004071881528943777

The O 0 0.00881054624915123
disease O 1 0.9999395608901978
susceptibility O 0 0.009177740663290024
of O 0 7.29630983187235e-06
individuals O 0 6.539631431223825e-05
who O 0 0.00021208201360423118
constitutionally O 0 0.0021856927778571844
lack O 0 0.00014280503091868013
both O 0 6.506791123683797e-06
wild O 0 0.00031497562304139137
- O 0 0.0008979243575595319
type O 0 0.00020967048476450145
alleles O 0 2.524341834941879e-05
is O 0 2.3276097635971382e-05
unknown O 0 0.00021874892991036177
. O 0 0.00011863221880048513

We O 0 1.6119798601721413e-05
have O 0 2.670351705091889e-06
identified O 0 1.1653081855911296e-05
three O 0 1.394686250932864e-06
offspring O 0 5.26307376276236e-05
in O 0 1.172945758298738e-05
a O 0 0.0036835558712482452
hereditary B-Disease 1 0.9998993873596191
nonpolyposis I-Disease 1 0.9999752044677734
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
family O 0 0.399073988199234
who O 0 0.00590371573343873
developed O 1 0.8261640071868896
hematological B-Disease 1 0.9997482895851135
malignancy I-Disease 1 0.9998849630355835
at O 0 0.00020926303113810718
a O 0 2.6040439479402266e-05
very O 0 9.144573596131522e-06
early O 0 4.3661861127475277e-05
age O 0 9.371407941216603e-05
, O 0 2.2523367988469545e-06
and O 0 5.190962042433966e-07
at O 0 5.6881385717133526e-06
least O 0 2.2147261802274443e-07
two O 0 5.400608671379814e-08
of O 0 1.376136253838922e-07
them O 0 1.241300196852535e-06
displayed O 0 0.00016434426652267575
signs O 0 0.0008978332625702024
of O 0 2.6979281756212004e-05
neurofibromatosis B-Disease 1 0.9999691247940063
type I-Disease 1 0.7387365698814392
1 I-Disease 0 0.0010329827200621367
( O 0 0.0002123494923580438
NF1 B-Disease 1 0.9679961204528809
) O 0 7.05851343809627e-05
. O 0 8.305839583044872e-05

DNA O 0 6.34505704510957e-05
sequence O 0 3.6084575185668655e-06
analysis O 0 2.5337658371427096e-06
and O 0 2.014383426285349e-06
allele O 0 2.397014213784132e-05
- O 0 2.097761353070382e-05
specific O 0 2.9840052206964174e-07
amplification O 0 2.7467396648717113e-05
in O 0 1.4925174127711216e-06
two O 0 3.272112280683359e-06
siblings O 0 0.00046134827425703406
revealed O 0 0.0004090136499144137
a O 0 7.6802731200587e-05
homozygous O 0 0.0010220989352092147
MLH1 O 0 0.3053002953529358
mutation O 0 0.00035926522105000913
( O 0 3.570395347196609e-05
C676T O 0 0.002670007525011897
- O 0 0.006617442239075899
- O 0 0.0013856838922947645
> O 0 0.000636714044958353
Arg226Stop O 0 0.002228850033134222
) O 0 1.951862395799253e-05
. O 0 5.332168802851811e-05

Thus O 0 6.71622110530734e-05
, O 0 1.0671758900571149e-05
a O 0 0.00010780400043586269
homozygous O 0 0.005099494010210037
germ O 1 0.9975851774215698
- O 0 0.006500644143670797
line O 0 0.0004108857538085431
MLH1 O 0 0.3050370216369629
mutation O 0 0.0006512451800517738
and O 0 4.161304605077021e-05
consequent O 1 0.9917171597480774
mismatch O 1 0.9994352459907532
repair O 1 0.9999552965164185
deficiency O 1 0.9999964237213135
results O 0 0.0002301678468938917
in O 0 2.6290937967132777e-05
a O 0 0.0004887293325737119
mutator O 1 0.9826434254646301
phenotype O 0 0.28835436701774597
characterized O 1 0.9866010546684265
by O 0 0.03962951526045799
leukemia B-Disease 1 0.9999994039535522
and O 0 0.006424890831112862
/ O 1 0.9994600415229797
or O 1 0.9807081818580627
lymphoma B-Disease 1 1.0
associated O 0 0.28348642587661743
with O 0 0.0539703369140625
neurofibromatosis B-Disease 1 0.9999938011169434
type I-Disease 1 0.958139955997467
1 I-Disease 0 0.0011355328606441617
. O 0 2.8561922590597533e-05
. O 0 5.062897253083065e-05

Missense O 0 0.0024621025659143925
mutations O 0 0.00013006209337618202
in O 0 3.422236659389455e-06
the O 0 2.6425407213537255e-06
most O 0 2.044278062385274e-06
ancient O 0 9.631280590838287e-06
residues O 0 4.3640884541673586e-05
of O 0 1.542069867355167e-06
the O 0 9.765840513864532e-05
PAX6 O 1 0.9071528315544128
paired O 0 0.0006361717823892832
domain O 0 9.147889795713127e-05
underlie O 0 0.0008384318789467216
a O 0 5.604236139333807e-05
spectrum O 0 0.00027478800620883703
of O 0 7.443986396538094e-05
human O 1 0.9973084926605225
congenital B-Disease 1 0.9999998807907104
eye I-Disease 1 0.9999672174453735
malformations I-Disease 1 0.9999707937240601
. O 0 0.0069561125710606575

Mutations O 0 9.763837442733347e-05
of O 0 9.825246252148645e-07
the O 0 3.048745566047728e-05
human O 0 0.0007784739136695862
PAX6 O 1 0.9852023720741272
gene O 0 0.005995695944875479
underlie O 1 0.9356237649917603
aniridia B-Disease 1 0.9995248317718506
( O 0 0.1700902283191681
congenital B-Disease 1 0.9999985694885254
absence I-Disease 0 0.003611252410337329
of I-Disease 0 6.8632912189059425e-06
the I-Disease 0 0.00034609585418365896
iris I-Disease 1 0.7757067680358887
) O 0 1.7885891793412156e-05
, O 0 4.022100256406702e-06
a O 0 5.687975499313325e-05
rare O 0 0.005679354537278414
dominant O 0 0.008457791060209274
malformation B-Disease 1 0.9998431205749512
of I-Disease 0 4.7420184273505583e-05
the I-Disease 0 0.010108014568686485
eye I-Disease 1 0.9984336495399475
. O 0 0.0004080445214640349

The O 0 1.3594528354587965e-05
spectrum O 0 6.66512205498293e-05
of O 0 1.025424717226997e-05
PAX6 O 1 0.9881733059883118
mutations O 0 0.0013339886208996177
in O 0 0.0002997549017891288
aniridia B-Disease 1 0.9996863603591919
patients O 1 0.9991546869277954
is O 0 3.581611963454634e-05
highly O 0 0.00014526350423693657
biased O 0 6.145314546301961e-05
, O 0 1.1342832522132085e-06
with O 0 1.2662050039580208e-06
92 O 0 4.903398803435266e-05
% O 0 5.035337267145223e-07
of O 0 1.1482915596161547e-07
all O 0 1.0202120392932557e-06
reported O 0 0.0003380599955562502
mutations O 0 4.6939847379690036e-05
leading O 0 3.4100015909643844e-05
to O 0 3.815006493823603e-06
premature O 0 0.010346051305532455
truncation O 0 0.00011795552563853562
of O 0 4.054339513004379e-07
the O 0 1.8387027012067847e-05
protein O 0 0.0001444744848413393
( O 0 1.655799314903561e-05
nonsense O 0 0.00011177878332091495
, O 0 1.334227363258833e-06
splicing O 0 1.150531170424074e-05
, O 0 1.7621403003431624e-06
insertions O 0 3.2059859222499654e-05
and O 0 2.117227268172428e-06
deletions O 0 4.32739507232327e-05
) O 0 1.994961621676339e-06
and O 0 5.907101012780913e-07
just O 0 1.8762501667879405e-06
2 O 0 1.2053235423081787e-06
% O 0 4.5406872573039436e-07
leading O 0 9.409873200638685e-07
to O 0 2.0403534861657135e-08
substitution O 0 1.441288901560256e-07
of O 0 1.8039571614281158e-08
one O 0 7.520703775298898e-07
amino O 0 2.3177926777862012e-05
acid O 0 0.0015372232301160693
by O 0 8.703992534719873e-06
another O 0 4.866415838478133e-05
( O 0 4.5888406020822003e-05
missense O 0 0.0008117069373838603
) O 0 1.9437189621385187e-05
. O 0 3.725556598510593e-05

The O 0 1.7647033018874936e-05
extraordinary O 0 2.119280725310091e-05
conservation O 0 8.054204045038205e-06
of O 0 3.0672308071189036e-07
the O 0 1.2016017535643186e-05
PAX6 O 0 0.007865997031331062
protein O 0 2.1450838175951503e-05
at O 0 6.944312190171331e-06
the O 0 1.220879084939952e-06
amino O 0 3.1797942938283086e-05
acid O 0 0.005380501039326191
level O 0 0.00010606038267724216
amongst O 0 6.881482840981334e-05
vertebrates O 0 0.0005607177736237645
predicts O 0 0.0009834583615884185
that O 0 1.5901143342489377e-05
pathological O 1 0.8555397391319275
missense O 0 0.003495872253552079
mutations O 0 0.00017692589608486742
should O 0 5.502408839674899e-06
in O 0 3.683450813696254e-06
fact O 0 1.1284673746558838e-05
be O 0 3.7373238228610717e-06
common O 0 2.2211163013707846e-05
even O 0 1.2205682651256211e-05
though O 0 1.129253359977156e-05
they O 0 7.935191206343006e-07
are O 0 7.927355341053044e-07
hardly O 0 7.991932943696156e-05
ever O 0 5.6340504670515656e-05
seen O 0 0.0002228995435871184
in O 0 0.0001778147998265922
aniridia B-Disease 1 0.9989480376243591
patients O 1 0.9989963173866272
. O 0 0.00044296859414316714

This O 0 2.8729984478559345e-05
indicates O 0 0.0001344091142527759
that O 0 1.4300223938334966e-06
there O 0 1.961109546755324e-06
is O 0 2.9367083698161878e-06
a O 0 3.069586819037795e-05
heavy O 0 0.0018807011656463146
ascertainment O 0 0.004593063145875931
bias O 0 5.9613288613036275e-05
in O 0 6.420211207114335e-07
the O 0 1.8173484477301827e-06
selection O 0 4.613847522705328e-06
of O 0 3.1891461276245536e-06
patients O 1 0.9948557615280151
for O 0 3.0857703677611426e-05
PAX6 O 1 0.715972900390625
mutation O 0 6.444694008678198e-05
analysis O 0 1.5912889921310125e-06
and O 0 8.774448474468954e-07
that O 0 1.2054305216224748e-06
the O 0 1.4840590665698983e-05
missing O 0 0.0020991924684494734
PAX6 O 1 0.9559046030044556
missense O 0 0.010570055805146694
mutations O 0 0.001137512968853116
frequently O 0 0.0006456926348619163
may O 0 0.0010796983260661364
underlie O 0 0.005781257059425116
phenotypes O 0 0.0017793414881452918
distinct O 0 0.0001214054282172583
from O 0 0.00039749074494466186
textbook O 1 0.8268697261810303
aniridia B-Disease 1 0.9967682361602783
. O 0 0.000628068286459893

Here O 0 4.5910208427812904e-05
we O 0 1.0692292562453076e-06
present O 0 5.755106485594297e-06
four O 0 5.349315870262217e-06
novel O 0 0.0003314608766231686
PAX6 O 1 0.722197949886322
missense O 0 0.0021291247103363276
mutations O 0 0.00011738730972865596
, O 0 4.0363097468798514e-06
two O 0 1.6101938626889023e-06
in O 0 1.776177487045061e-05
association O 0 0.0018794502830132842
with O 0 0.00018132748664356768
atypical O 1 0.9985747337341309
phenotypes O 1 0.8767951726913452
ectopia B-Disease 1 0.9831894636154175
pupillae I-Disease 1 0.954597532749176
( O 0 0.00028908008243888617
displaced B-Disease 0 0.001917187008075416
pupils I-Disease 0 0.0011630428489297628
) O 0 0.00022410249221138656
and O 0 0.001092755002900958
congenital B-Disease 1 0.9999986886978149
nystagmus I-Disease 1 0.9952487349510193
( O 0 0.00023149652406573296
searching B-Disease 0 0.0003390155907254666
gaze I-Disease 0 0.0013611658941954374
) O 0 7.539456419181079e-06
, O 0 1.187296675198013e-06
and O 0 3.890903599312878e-07
two O 0 5.104628257868171e-07
in O 0 8.643854016554542e-06
association O 0 0.00022443819034378976
with O 0 4.144870672462275e-06
more O 0 5.795693141408265e-06
recognizable O 0 0.010726384818553925
aniridia B-Disease 1 0.9972620010375977
phenotypes O 0 0.06507757306098938
. O 0 0.00039248657412827015

Strikingly O 0 0.001768447575159371
, O 0 3.5590448987932177e-06
all O 0 1.837016583294826e-07
four O 0 1.719135411804018e-06
mutations O 0 1.475854696764145e-05
are O 0 1.6865035945556883e-07
located O 0 3.6097860629524803e-06
within O 0 1.0148448836844182e-06
the O 0 1.8232827642350458e-05
PAX6 O 0 0.2731156647205353
paired O 0 0.0003391491190996021
domain O 0 1.3829073395754676e-05
and O 0 1.637637637941225e-06
affect O 0 4.841166628466453e-06
amino O 0 9.99419171421323e-06
acids O 0 3.18036436510738e-05
which O 0 8.570877980673686e-07
are O 0 1.5248240003984392e-07
highly O 0 7.931734216981567e-06
conserved O 0 4.83631220049574e-06
in O 0 5.507304194907192e-07
all O 0 3.0986868182480976e-07
known O 0 2.2251484551816247e-05
paired O 0 5.004497870686464e-05
domain O 0 2.7950158255407587e-05
proteins O 0 7.946601544972509e-05
. O 0 7.503666711272672e-05

Our O 0 9.26598204387119e-06
results O 0 1.2883329873147886e-05
support O 0 1.872328311947058e-06
the O 0 2.356732693442609e-06
hypothesis O 0 1.194379001390189e-05
that O 0 5.356200745154638e-07
the O 0 8.546260801267636e-07
under O 0 1.2613523722393438e-05
- O 0 1.081983918993501e-05
representation O 0 8.798633643891662e-08
of O 0 1.0052904144686181e-06
missense O 0 0.001129735610447824
mutations O 0 0.00040807208279147744
is O 0 2.4054044843069278e-05
caused O 0 0.014036267064511776
by O 0 3.979500979767181e-05
ascertainment O 0 0.11691004037857056
bias O 0 0.00040753852226771414
and O 0 2.781072453217348e-06
suggest O 0 1.0361336535424925e-05
that O 0 1.306047465732263e-06
a O 0 1.3987801139592193e-05
substantial O 0 8.723473001737148e-05
burden O 0 0.0011993146035820246
of O 0 2.554643106122967e-05
PAX6 B-Disease 1 0.999657392501831
- I-Disease 1 0.9992355108261108
related I-Disease 1 0.961268424987793
disease I-Disease 1 0.9999970197677612
remains O 0 0.00548595143482089
to O 0 8.218034054152668e-06
be O 0 2.5797418857109733e-05
uncovered O 0 0.0026581387501209974
. O 0 2.0493711417657323e-05
. O 0 7.115606422303244e-05

The O 0 5.5234409956028685e-05
chromosomal O 0 0.0003200180653948337
order O 0 1.3282401596370619e-06
of O 0 5.182720883567526e-07
genes O 0 2.420661439828109e-05
controlling O 0 0.00016009974933695048
the O 0 8.052311750361696e-05
major O 0 0.0019412662368267775
histocompatibility O 1 0.9975845813751221
complex O 0 0.0013504030648618937
, O 0 4.770220402861014e-05
properdin O 0 0.004094230011105537
factor O 0 0.00010781099263112992
B O 0 0.002170766703784466
, O 0 1.4625719813921023e-05
and O 0 2.7765574486693367e-05
deficiency B-Disease 1 0.9997705817222595
of I-Disease 0 3.606712652981514e-07
the I-Disease 0 4.84582278659218e-06
second I-Disease 0 8.413968316745013e-06
component I-Disease 0 1.3946296348876785e-05
of I-Disease 0 8.751825362196541e-07
complement I-Disease 0 9.746386058395728e-05
. O 0 9.969066741177812e-05

The O 0 1.1019527846656274e-05
relationship O 0 9.957183465303387e-06
of O 0 3.2834887520039047e-07
the O 0 3.998312422481831e-06
genes O 0 8.15498333395226e-06
coding O 0 7.788135553710163e-05
for O 0 6.054580353520578e-06
HLA O 0 0.04111788049340248
to O 0 6.371797098836396e-07
those O 0 8.220944209824665e-07
coding O 0 3.238855060772039e-05
for O 0 1.974997758225072e-06
properdin O 0 0.0019026289228349924
Factor O 0 5.963956209598109e-05
B O 0 0.0009110217215493321
allotypes O 0 0.0006104657659307122
and O 0 5.651139417750528e-06
for O 0 2.719694748520851e-05
deficiency B-Disease 1 0.9999221563339233
of I-Disease 0 2.421774354388617e-07
the I-Disease 0 2.7118626348965336e-06
second I-Disease 0 5.1899892241635825e-06
component I-Disease 0 7.952016858325806e-06
of I-Disease 0 3.1867125471762847e-07
complement I-Disease 0 2.667913940967992e-05
( O 0 2.86441900243517e-05
C2 O 1 0.893419623374939
) O 0 6.649987426499138e-06
was O 0 3.472066600807011e-05
studied O 0 1.0323481546947733e-05
in O 0 1.3667615803569788e-06
families O 0 9.447150659980252e-06
of O 0 2.3615053578396328e-05
patients O 1 0.9998407363891602
with O 0 0.07077730447053909
connective O 1 0.9999886751174927
tissue O 1 0.9999960660934448
disorders O 1 0.9999966621398926
. O 0 0.012026780284941196

Patients O 1 0.9970169067382812
were O 0 4.7181561967590824e-05
selected O 0 1.6327894627465867e-05
because O 0 1.3189825949666556e-05
they O 0 8.260183221864281e-07
were O 0 2.6958932721754536e-06
heterozygous O 0 7.64397336752154e-05
or O 0 3.315463618491776e-05
homozygous O 0 0.0016342937014997005
for O 0 0.0022005517967045307
C2 B-Disease 1 0.9999964237213135
deficiency I-Disease 1 0.9999994039535522
. O 0 0.0016911588609218597

12 O 0 7.563071267213672e-05
families O 0 7.657965397811495e-06
with O 0 5.941144991084002e-06
15 O 0 1.9029606846743263e-05
matings O 0 0.00043999552144668996
informative O 0 0.0001611371844774112
for O 0 0.0007681724964641035
C2 B-Disease 1 0.9999953508377075
deficiency I-Disease 1 0.9999996423721313
were O 0 0.00024157458392437547
found O 0 0.0007618128438480198
. O 0 9.411267092218623e-05

Of O 0 1.1948791325266939e-05
57 O 0 0.0003816841053776443
informative O 0 8.571401122026145e-05
meioses O 0 0.0016479728510603309
, O 0 3.4586694255267503e-06
two O 0 7.353173714363948e-07
crossovers O 0 1.386363055644324e-05
were O 0 3.829463366855634e-06
noted O 0 3.3575011912034824e-05
between O 0 1.673215774644632e-05
the O 0 0.0028894543647766113
C2 B-Disease 1 0.9999790191650391
deficiency I-Disease 1 0.9999972581863403
gene O 0 0.00015053754032123834
and O 0 4.103893843421247e-06
the O 0 4.9208945711143315e-05
HLA O 1 0.9972692131996155
- O 0 0.0008510269690304995
B O 0 0.00016827012586873025
gene O 0 4.941543920722324e-06
, O 0 1.606460813263766e-07
with O 0 1.786512200396828e-07
a O 0 2.6467421321285656e-06
recombinant O 0 1.763872023730073e-05
fraction O 0 3.05595654026547e-06
of O 0 1.0056423889182042e-06
0 O 0 6.346304144244641e-05
. O 0 4.99055786349345e-05

035 O 1 0.7062445878982544
. O 0 0.0011336057214066386

A O 0 0.00043232928146608174
lod O 0 0.0009675726178102195
score O 0 1.0035653303930303e-06
of O 0 2.8069456448065466e-07
13 O 0 1.8794318748405203e-05
was O 0 2.581415174063295e-05
calculated O 0 1.8150449250242673e-06
for O 0 2.31641456593934e-06
linkage O 0 0.0007406954537145793
between O 0 0.0009433315135538578
C2 B-Disease 1 0.9999915361404419
deficiency I-Disease 1 0.9999990463256836
and O 0 0.0001624066790100187
HLA O 1 0.9986534118652344
- O 0 0.0010591794271022081
B O 0 0.00019521309877745807
at O 0 5.162090019439347e-06
a O 0 8.386478498323413e-07
maximum O 0 6.316046778920281e-07
likelihood O 0 2.0041454718011664e-06
value O 0 2.3421073080953647e-08
of O 0 2.4278740795580234e-08
the O 0 6.475169698205718e-07
recombinant O 0 1.483526921219891e-05
fraction O 0 1.3285620070746518e-06
of O 0 6.206092848515254e-07
0 O 0 3.183198714395985e-05
. O 0 3.2034738978836685e-05

04 O 0 0.3988197147846222
. O 0 0.0006762570701539516

18 O 0 0.00020530128676909953
families O 0 1.379660261591198e-05
with O 0 6.5415479184594005e-06
21 O 0 2.6117286324733868e-05
informative O 0 9.304395462095272e-06
matings O 0 0.00012767844600602984
for O 0 1.0197384199273074e-06
both O 0 1.6732113863326958e-06
properdin O 0 0.0012875881511718035
Factor O 0 4.220983828417957e-05
B O 0 0.0007023109355941415
allotype O 0 0.000874036573804915
and O 0 2.108238186337985e-05
HLA O 1 0.9930236339569092
- O 0 0.0017404657555744052
B O 0 0.0006155073642730713
were O 0 6.907489478180651e-06
found O 0 8.963821164797992e-05
. O 0 4.144330523558892e-05

Of O 0 7.135330633900594e-06
72 O 0 0.0004336319398134947
informative O 0 7.852395356167108e-05
meioses O 0 0.0013920743949711323
, O 0 2.9865523174521513e-06
three O 0 2.8587223823706154e-06
recombinants O 0 0.0016258630203083158
were O 0 3.0923479243938345e-06
found O 0 9.793993740458973e-06
, O 0 5.379307026487368e-07
giving O 0 1.1873273706441978e-06
a O 0 2.7351661628927104e-06
recombinant O 0 1.8417878891341388e-05
fraction O 0 2.3317809336731443e-06
of O 0 8.035700034270121e-07
0 O 0 5.2355913794599473e-05
. O 0 4.1404160583624616e-05

042 O 0 0.07635664939880371
. O 0 0.0008924097055569291

A O 0 0.00018339349480811507
lod O 0 0.0005444145645014942
score O 0 6.925344564479019e-07
of O 0 3.881401369199011e-07
16 O 0 2.032767588389106e-05
between O 0 2.8487687814049423e-05
HLA O 1 0.9940452575683594
- O 0 0.0009794366778805852
B O 0 0.0002223095070803538
and O 0 1.3531242757380824e-06
Factor O 0 1.675432031333912e-05
B O 0 0.00031750756897963583
allotypes O 0 0.00042639460298232734
was O 0 1.0801343705679756e-05
calculated O 0 1.2969469480594853e-06
at O 0 2.9285697564773727e-06
a O 0 1.141193706644117e-06
maximum O 0 4.358041678642621e-07
likelihood O 0 1.68383246546e-06
value O 0 2.444443758520265e-08
of O 0 2.813215793651125e-08
the O 0 1.006033699013642e-06
recombinant O 0 3.506004941300489e-05
fraction O 0 3.056440391446813e-06
of O 0 1.0783071502373787e-06
0 O 0 5.377313573262654e-05
. O 0 3.955438296543434e-05

04 O 0 0.4889325201511383
. O 0 0.00038276048144325614

A O 0 0.0002758063783403486
crossover O 0 6.956368451938033e-05
was O 0 0.00016948588017839938
shown O 0 7.934821041999385e-06
to O 0 2.570110098076839e-07
have O 0 5.189987177800504e-07
occurred O 0 4.274762886780081e-06
between O 0 4.44241180730387e-07
genes O 0 1.5279960052794195e-06
for O 0 5.700209726455796e-07
Factor O 0 1.063798390532611e-05
B O 0 0.00018614072178024799
and O 0 7.1309909799310844e-06
HLA O 1 0.9455822110176086
- O 0 0.0007476772298105061
D O 0 0.00413555046543479
, O 0 1.4401417729459354e-06
in O 0 2.031133590207901e-06
which O 0 6.703870440105675e-06
HLA O 1 0.9632278680801392
- O 0 0.001290805172175169
D O 0 0.006576518062502146
segregared O 0 0.00042972390656359494
with O 0 1.8914646716439165e-05
HLA O 1 0.991644561290741
- O 0 0.0003061814932152629
A O 0 5.742602297686972e-05
and O 0 1.1208087016711943e-05
B O 0 0.00296206958591938
. O 0 6.540348840644583e-05

These O 0 4.518312834989047e-06
studies O 0 8.059221727307886e-06
suggest O 0 5.378725745686097e-06
that O 0 2.2826137069387187e-07
the O 0 4.668941357977019e-07
genes O 0 1.5233341628118069e-06
for O 0 1.399877987751097e-06
Factor O 0 6.605126691283658e-05
B O 0 0.010110229253768921
and O 0 0.00034066534135490656
C2 B-Disease 1 0.999992847442627
deficiency I-Disease 1 0.9999985694885254
are O 0 2.900441586461966e-06
located O 0 1.328318739979295e-05
outside O 0 2.8333663522062125e-06
those O 0 1.3666430049852352e-06
for O 0 6.2335429902304895e-06
HLA O 1 0.9745596647262573
, O 0 1.5108525985851884e-06
that O 0 2.6272522291037603e-07
the O 0 4.36502546108386e-07
order O 0 2.58296125821289e-07
of O 0 2.9424197123262275e-07
genese O 0 0.0010630580363795161
is O 0 1.7272770492127165e-05
HLA O 0 0.37949034571647644
- O 0 6.985478103160858e-05
A O 0 2.842768662958406e-05
, O 0 3.666330712803756e-06
- O 0 6.04531705903355e-05
B O 0 0.00013477553147822618
, O 0 3.7130453165445942e-06
- O 0 0.00014831939188297838
D O 0 0.0010258568217977881
, O 0 1.6485515743625e-06
Factor O 0 1.4132222531770822e-05
B O 0 0.0012621862115338445
allotype O 0 0.013507275842130184
, O 0 0.0009509107330814004
C2 B-Disease 1 0.9999784231185913
deficiency I-Disease 1 0.9999988079071045
, O 0 8.148126653395593e-06
that O 0 6.671023697890632e-07
the O 0 2.055781351373298e-06
genes O 0 1.5458392226719297e-05
coding O 0 0.0005643817712552845
for O 0 0.0003112626727670431
C2 B-Disease 1 0.9999922513961792
deficiency I-Disease 1 0.9999985694885254
and O 0 2.9805441954522394e-05
Factor O 0 9.049155778484419e-05
B O 0 0.0009155517909675837
allotypes O 0 0.00031090379343368113
are O 0 3.3420641898374015e-07
approximately O 0 1.4585024246116518e-06
3 O 0 2.8375001420499757e-05
- O 0 8.6683125118725e-05
- O 0 2.3635013349121436e-05
5 O 0 2.3241216240421636e-06
centimorgans O 0 6.53489405522123e-05
from O 0 1.7806926280172775e-06
the O 0 1.1047725820390042e-05
HLA O 0 0.116977758705616
- O 0 0.00011008735600626096
A O 0 3.421663132030517e-05
and O 0 1.2810140106012113e-05
HLA O 1 0.9793869853019714
- O 0 0.0007626477745361626
B O 0 0.0002595076512079686
loci O 0 3.431034565437585e-05
, O 0 1.0735594742072863e-06
and O 0 3.335097744638915e-07
that O 0 7.833183985894721e-07
the O 0 4.110670488444157e-06
apparent O 0 0.0005263350903987885
lack O 0 5.331797365215607e-05
of O 0 1.106544118556485e-06
recombinants O 0 0.0008222394390031695
between O 0 3.141901970593608e-06
the O 0 1.6918140318011865e-05
Factor O 0 6.213328015292063e-05
B O 0 0.0016676790546625853
gene O 0 0.00032920355442911386
and O 0 0.00032741817994974554
C2 B-Disease 1 0.9999868869781494
deficiency I-Disease 1 0.9999986886978149
gene O 0 0.0004923609085381031
suggests O 0 4.970628651790321e-05
that O 0 4.7451899831685296e-07
these O 0 1.256043162811693e-07
two O 0 6.008369268784008e-07
genes O 0 8.459403034066781e-06
lie O 0 1.694135607976932e-05
in O 0 1.2797593171853805e-06
close O 0 6.022601155564189e-06
proximity O 0 4.201434876449639e-06
to O 0 4.3463120391606935e-07
one O 0 1.7930371996044414e-06
another O 0 3.179797204211354e-05
. O 0 5.017802322981879e-05

Distribution O 0 1.6679297914379276e-05
of O 0 4.057126716361381e-06
emerin O 0 0.010649093426764011
and O 0 2.8818834834964946e-05
lamins O 0 0.04581739008426666
in O 0 2.506867895135656e-05
the O 0 0.0001328644430032
heart O 1 0.9983035326004028
and O 0 1.5249944226525258e-05
implications O 0 0.00020171802316326648
for O 0 5.831639646203257e-05
Emery B-Disease 1 0.9675819873809814
- I-Disease 1 0.9980810880661011
Dreifuss I-Disease 1 0.9993409514427185
muscular I-Disease 1 0.999969482421875
dystrophy I-Disease 1 0.999983549118042
. O 0 0.0037698489613831043

Emerin O 0 0.004954603500664234
is O 0 1.5151413208513986e-05
a O 0 1.8332628314965405e-05
nuclear O 0 0.00011691956751747057
membrane O 0 3.687277785502374e-05
protein O 0 1.3077651601633988e-05
which O 0 1.1254851415287703e-06
is O 0 9.23996776691638e-06
missing O 0 0.00017070812464226037
or O 0 7.670698687434196e-05
defective O 1 0.9935261011123657
in O 0 0.00025819294387474656
Emery B-Disease 1 0.9806004166603088
- I-Disease 1 0.9976060390472412
Dreifuss I-Disease 1 0.9990320205688477
muscular I-Disease 1 0.9999735355377197
dystrophy I-Disease 1 0.9999922513961792
( O 0 0.09916616976261139
EDMD B-Disease 1 0.9997289776802063
) O 0 0.0002510503400117159
. O 0 0.00013129670696798712

It O 0 1.2748667359119281e-05
is O 0 3.2183916118810885e-06
one O 0 8.800091677585442e-07
member O 0 2.168289711335092e-06
of O 0 2.4207699311773467e-07
a O 0 2.0977173335268162e-05
family O 0 5.246337241260335e-05
of O 0 1.012047960102791e-05
lamina O 1 0.9986949563026428
- O 0 0.0026926561258733273
associated O 0 4.558371438179165e-05
proteins O 0 6.214963377715321e-06
which O 0 2.9364168767642695e-06
includes O 0 1.5212119251373224e-05
LAP1 O 0 0.020774677395820618
, O 0 3.4920569305540994e-05
LAP2 O 0 0.010185533203184605
and O 0 2.8417223802534863e-05
lamin O 0 0.08819295465946198
B O 0 0.025330062955617905
receptor O 0 0.009114070795476437
( O 0 0.0003715490165632218
LBR O 1 0.9936279058456421
) O 0 7.18499140930362e-05
. O 0 8.149133645929396e-05

A O 0 0.0002377044002059847
panel O 0 0.00011129687482025474
of O 0 3.834886683762306e-06
16 O 0 0.00034365427563898265
monoclonal O 0 0.00290089612826705
antibodies O 0 0.0037443048786371946
( O 0 3.62043319910299e-05
mAbs O 0 0.0026210404466837645
) O 0 6.6774287006410304e-06
has O 0 3.897550868714461e-06
been O 0 2.25827739086526e-06
mapped O 0 4.744905254483456e-06
to O 0 1.5584436141580227e-07
six O 0 7.538756676694902e-07
specific O 0 4.869207828051003e-07
sites O 0 1.666208390815882e-06
throughout O 0 1.3235312508186325e-06
the O 0 5.321675871527987e-06
emerin O 0 0.0006095209973864257
molecule O 0 0.00010406783985672519
using O 0 1.2113007869629655e-05
phage O 0 0.0012989139650017023
- O 0 0.0001345939381280914
displayed O 0 4.8848185542738065e-05
peptide O 0 0.00016061501810327172
libraries O 0 5.0914222811115906e-06
and O 0 1.6268345461867284e-06
has O 0 6.241948540264275e-06
been O 0 4.460668151295977e-06
used O 0 1.9326541860209545e-06
to O 0 1.2904598634122522e-06
localize O 0 0.0005772281438112259
emerin O 0 0.002460992895066738
in O 0 1.9237988453824073e-05
human O 0 0.00019191122555639595
and O 0 0.000207920340471901
rabbit O 1 0.9952281713485718
heart O 1 0.999437153339386
. O 0 0.0006918166764080524

Several O 0 0.00016384075570385903
mAbs O 0 0.01009870134294033
against O 0 4.655148586607538e-05
different O 0 4.002974492323119e-06
emerin O 0 0.017672520130872726
epitopes O 0 0.0065290131606161594
did O 0 3.778342215809971e-05
not O 0 4.81062670587562e-06
recognize O 0 4.23870405938942e-05
intercalated O 0 0.005771040916442871
discs O 0 0.0010202700505033135
in O 0 1.682985748630017e-05
the O 0 0.00018913419626187533
heart O 1 0.9995632767677307
, O 0 1.9840177628793754e-05
though O 0 2.1902715161559172e-05
they O 0 1.8693845049710944e-06
recognized O 0 2.0038618458784185e-05
cardiomyocyte O 0 0.000925891101360321
nuclei O 0 0.00014105623995419592
strongly O 0 4.858430474996567e-05
, O 0 2.050733428404783e-06
both O 0 9.105909271056589e-07
at O 0 1.8824492144631222e-05
the O 0 9.958323062164709e-06
rim O 0 0.0007616919465363026
and O 0 4.2597580431902315e-06
in O 0 1.3537241102312692e-05
intranuclear O 0 0.0030569054652005434
spots O 0 7.147106225602329e-05
or O 0 2.169702565879561e-05
channels O 0 4.7163295676000416e-05
. O 0 6.537861190736294e-05

A O 0 0.005806150380522013
polyclonal O 0 0.08063225448131561
rabbit O 0 0.09372351318597794
antiserum O 0 0.030911337584257126
against O 0 0.00026646823971532285
emerin O 0 0.02628755383193493
did O 0 2.192695865232963e-05
recognize O 0 2.1280740838847123e-05
both O 0 3.3207948035851587e-06
nuclear O 0 0.00033691426506266
membrane O 0 0.00014990384806878865
and O 0 7.302254743990488e-06
intercalated O 0 0.008746860548853874
discs O 0 0.0004841846530325711
but O 0 5.084512849862222e-06
, O 0 1.4059547766009928e-06
after O 0 2.2610662199440412e-05
affinity O 0 1.811281435948331e-05
purification O 0 6.462467717938125e-05
against O 0 8.15207476989599e-06
a O 0 2.397828211542219e-05
pure O 0 7.538330100942403e-05
- O 0 0.0003002019366249442
emerin O 0 0.00042102328734472394
band O 0 3.557914897101e-05
on O 0 3.3845803955045994e-06
a O 0 1.017043450701749e-05
western O 0 1.3130738807376474e-05
blot O 0 0.001132778823375702
, O 0 2.9860625545552466e-06
it O 0 3.515840489853872e-06
stained O 0 0.01428158488124609
only O 0 6.215196322045813e-07
the O 0 7.784616173012182e-06
nuclear O 0 0.0005394675536081195
membrane O 0 0.0004905706737190485
. O 0 4.9829253839561716e-05

These O 0 8.120843631331809e-06
results O 0 3.267171996412799e-05
would O 0 2.9509417345252587e-06
not O 0 1.1070845857830136e-06
be O 0 1.7275864365728921e-06
expected O 0 1.2698407772404607e-05
if O 0 1.598882045072969e-05
immunostaining O 0 0.0011062740813940763
at O 0 0.00011245232599321753
intercalated O 0 0.01274178083986044
discs O 0 0.0007842978229746222
were O 0 9.699777365312912e-06
due O 0 6.618935731239617e-05
to O 0 5.59986062853568e-07
a O 0 2.518381961635896e-06
product O 0 9.78589696387644e-07
of O 0 1.3681135158094548e-07
the O 0 1.0961869520542677e-05
emerin O 0 0.0027902470901608467
gene O 0 4.096120028407313e-05
and O 0 2.9900920708314516e-06
, O 0 3.908479357050965e-06
therefore O 0 5.1014435484830756e-06
, O 0 1.7382789110342856e-06
cast O 0 2.8327665404503932e-06
some O 0 2.811489139276091e-07
doubt O 0 1.2783426427631639e-05
upon O 0 3.823259703494841e-06
the O 0 1.0700294296839274e-05
hypothesis O 0 0.0004191313637420535
that O 0 0.0003895146946888417
cardiac B-Disease 1 0.9999669790267944
defects I-Disease 1 0.9998972415924072
in O 0 0.0011699983151629567
EDMD B-Disease 1 0.9996715784072876
are O 0 3.285412094555795e-05
caused O 0 0.017741741612553596
by O 0 1.6179896192625165e-05
absence O 0 0.0002921620034612715
of O 0 1.2196978786960244e-05
emerin O 0 0.07238062471151352
from O 0 0.0002132300433004275
intercalated O 1 0.8849778175354004
discs O 0 0.03320771083235741
. O 0 0.00024248169211205095

Although O 0 0.0003944353375118226
emerin O 0 0.004902441520243883
was O 0 0.0001407807576470077
abundant O 0 1.3430408216663636e-05
in O 0 1.328906591879786e-06
the O 0 3.9603446566616185e-06
membranes O 0 0.00012753168994095176
of O 0 2.186323399655521e-06
cardiomyocyte O 0 0.004685821011662483
nuclei O 0 0.00040782903670333326
, O 0 7.0001251515350305e-06
it O 0 5.369515292841243e-06
was O 0 9.651061554905027e-05
absent O 0 0.0001677913824096322
from O 0 5.141171186551219e-06
many O 0 2.31708418141352e-06
non O 0 0.0001849678810685873
- O 0 0.0024377075023949146
myocyte O 0 0.042724478989839554
cells O 0 0.0002827755524776876
in O 0 1.1848855137941428e-05
the O 0 0.00015116699796635658
heart O 1 0.9994854927062988
. O 0 0.00021601695334538817

This O 0 4.2249603211530484e-06
distribution O 0 3.1880758797342423e-06
of O 0 2.3995439732971136e-06
emerin O 0 0.012834436260163784
was O 0 0.0001656041422393173
similar O 0 3.172214064761647e-06
to O 0 2.728327501699823e-07
that O 0 3.3054976711355266e-07
of O 0 3.864879261072929e-07
lamin O 0 0.004043176304548979
A O 0 3.6572932003764436e-05
, O 0 1.113431039811985e-06
a O 0 3.7219369914964773e-06
candidate O 0 2.4858868528099265e-06
gene O 0 5.641280040435959e-06
for O 0 5.216201088842354e-07
an O 0 1.4927558368071914e-05
autosomal O 1 0.7014095187187195
form O 0 0.0002786870172712952
of O 0 0.00014941593690309674
EDMD B-Disease 1 0.9998146891593933
. O 0 0.0013780751032754779

In O 0 6.830005440860987e-05
contrast O 0 0.0003628649574238807
, O 0 0.00022453279234468937
lamin O 1 0.9887143969535828
B1 O 1 0.999428927898407
was O 0 0.0011048237793147564
absent O 0 0.0012955137062817812
from O 0 3.844693492283113e-05
cardiomyocyte O 0 0.002759757684543729
nuclei O 0 0.00025480642216280103
, O 0 2.2968755729380064e-05
showing O 0 0.00013059320917818695
that O 0 2.4184553694794886e-05
lamin O 1 0.9574254751205444
B1 O 1 0.9989939332008362
is O 0 2.684993887669407e-06
not O 0 2.6413434284222603e-07
essential O 0 3.0314848231682845e-07
for O 0 1.0782634518591294e-07
localization O 0 1.2591997801791877e-05
of O 0 3.741235161669465e-07
emerin O 0 0.0007114181062206626
to O 0 1.592738954059314e-06
the O 0 2.6126106604351662e-05
nuclear O 0 0.004329960327595472
lamina O 1 0.9838135242462158
. O 0 0.0004358178994152695

Lamin O 1 0.9777722358703613
B1 O 1 0.9985128045082092
is O 0 5.187731221667491e-05
also O 0 2.5100349375861697e-05
almost O 0 2.6728061129688285e-05
completely O 0 0.0007297327392734587
absent O 0 0.002832957776263356
from O 0 0.00031481951009482145
skeletal O 1 0.9994557499885559
muscle O 1 0.9969266057014465
nuclei O 0 0.02152751386165619
. O 0 0.0007156403735280037

In O 0 0.0002834517217706889
EDMD B-Disease 1 0.9943150877952576
, O 0 9.812037205847446e-06
the O 0 3.028629180334974e-06
additional O 0 3.7243014503474114e-06
absence O 0 0.00013283557200338691
of O 0 2.6444275135872886e-05
lamin O 1 0.9953515529632568
B1 O 1 0.9997238516807556
from O 0 0.0011832909658551216
heart O 1 0.9995773434638977
and O 0 0.0005994826788082719
skeletal O 1 0.9997608065605164
muscle O 1 0.9983931183815002
nuclei O 0 0.0056945886462926865
which O 0 0.00010222553828498349
already O 0 0.0007581525715067983
lack O 0 0.0006488226354122162
emerin O 0 0.01562618277966976
may O 0 3.2638523407513276e-05
offer O 0 1.7342221099170274e-06
an O 0 1.5487581777051673e-06
alternative O 0 4.76649393021944e-06
explanation O 0 1.2428908121364657e-05
of O 0 9.385925068272627e-07
why O 0 5.06816286360845e-05
these O 0 2.7939440769841895e-06
tissues O 0 0.008490555919706821
are O 0 3.2922698665061034e-06
particularly O 0 0.00020809487614315003
affected O 0 0.00110540387686342
. O 0 4.7392513806698844e-05
. O 0 0.00010610430035740137

Genetic O 0 0.0002322530490346253
mapping O 0 2.1339823433663696e-05
of O 0 2.82720407085435e-06
the O 0 0.00018134043784812093
copper B-Disease 1 0.9965217113494873
toxicosis I-Disease 1 0.9905521869659424
locus O 0 0.000695847615133971
in O 0 4.015541708213277e-05
Bedlington O 0 0.031236372888088226
terriers O 0 0.001627485384233296
to O 0 5.943026280874619e-06
dog O 0 0.0029384379740804434
chromosome O 0 9.78124444372952e-05
10 O 0 4.712579993793042e-06
, O 0 1.4223866173779243e-06
in O 0 1.3531655440601753e-06
a O 0 1.855461232480593e-05
region O 0 1.3784133443550672e-05
syntenic O 0 0.0006946324137970805
to O 0 1.944875975823379e-06
human O 0 4.028682451462373e-05
chromosome O 0 0.0003751366166397929
region O 0 8.998283738037571e-05
2p13 O 0 0.00832337886095047
- O 0 0.0053733354434370995
p16 O 0 0.0030257657635957003
. O 0 0.0001207342284033075

Abnormal O 1 0.9964961409568787
hepatic B-Disease 1 0.9998130202293396
copper I-Disease 1 0.9981874823570251
accumulation I-Disease 1 0.865279495716095
is O 0 2.971932917716913e-05
recognized O 0 3.638302951003425e-05
as O 0 5.07474978803657e-05
an O 0 0.00424273731186986
inherited B-Disease 1 0.9999953508377075
disorder I-Disease 1 0.9999992847442627
in O 0 0.0015091800596565008
man O 1 0.8385743498802185
, O 0 9.188928379444405e-05
mouse O 0 0.004477489273995161
, O 0 8.612218516645953e-05
rat O 1 0.607462465763092
and O 0 5.2231345762265846e-05
dog O 0 0.03670491278171539
. O 0 0.0002005638525588438

The O 0 8.512281783623621e-05
major O 0 0.0007994559709914029
cause O 0 0.03261435031890869
of O 0 0.00015942395839374512
hepatic B-Disease 1 0.9999439716339111
copper I-Disease 1 0.9987987279891968
accumulation I-Disease 1 0.9171103835105896
in O 0 6.761719851056114e-05
man O 0 0.0016926844837144017
is O 0 2.0239122022758238e-05
a O 0 8.488127059536055e-05
dysfunctional O 0 0.456673800945282
ATP7B O 1 0.8274756669998169
gene O 0 0.0021860653068870306
, O 0 0.0002910152543336153
causing O 1 0.9963327646255493
Wilson B-Disease 1 0.998027503490448
disease I-Disease 1 0.9999915361404419
( O 0 0.003704206785187125
WD B-Disease 1 0.9994398951530457
) O 0 0.00018411799101158977
. O 0 0.00017055959324352443

Mutations O 0 0.00045272460556589067
in O 0 1.542674726806581e-05
the O 0 5.2593659347621724e-05
ATP7B O 0 0.029727594926953316
genes O 0 2.4490967916790396e-05
have O 0 3.1715003387944307e-06
also O 0 3.579072199499933e-06
been O 0 9.02007468539523e-06
demonstrated O 0 3.6312008887762204e-05
in O 0 1.2036788575642277e-05
mouse O 0 0.0011390602448955178
and O 0 4.6288980229292065e-05
rat O 1 0.58160799741745
. O 0 8.476996299577877e-05

The O 0 0.0001899733761092648
ATP7B O 0 0.15600258111953735
gene O 0 0.00021910482610110193
has O 0 2.403116195637267e-05
been O 0 1.6544576283195056e-05
excluded O 0 3.53092145815026e-05
in O 0 1.7045958884409629e-06
the O 0 6.824132469773758e-06
much O 0 4.519950380199589e-05
rarer O 0 0.15864987671375275
human O 0 0.00785192009061575
copper B-Disease 1 0.9997660517692566
overload I-Disease 1 0.999956488609314
disease O 1 0.9999940395355225
non B-Disease 0 0.022633936256170273
- I-Disease 0 0.2169952541589737
Indian I-Disease 0 0.0009542338084429502
childhood I-Disease 1 0.9990353584289551
cirrhosis I-Disease 1 0.9999889135360718
, O 0 0.00017909062444232404
indicating O 0 0.007543959654867649
genetic O 0 0.004433516878634691
heterogeneity O 0 0.006647652015089989
. O 0 0.000441658339696005

By O 0 4.8963382141664624e-05
investigating O 0 0.0007370428647845984
the O 0 6.918751751072705e-05
common O 0 0.0025336716789752245
autosomal O 1 0.9995895028114319
recessive O 1 0.9998063445091248
copper B-Disease 1 0.9999375343322754
toxicosis I-Disease 1 0.9998559951782227
( O 0 0.0073033482767641544
CT B-Disease 1 0.9981972575187683
) O 0 5.08010016346816e-05
in O 0 4.198695023660548e-05
Bedlington O 0 0.060939133167266846
terriers O 0 0.0027262254152446985
, O 0 5.24703227711143e-06
we O 0 7.26697976460855e-07
have O 0 3.653315445717453e-07
identified O 0 3.376755557837896e-06
a O 0 2.4390892576775514e-06
new O 0 3.712227453434025e-06
locus O 0 0.00011569504567887634
involved O 0 6.679679790977389e-05
in O 0 0.0012702618259936571
progressive O 1 0.9999046325683594
liver B-Disease 1 1.0
disease I-Disease 1 0.9999997615814209
. O 0 0.010649948380887508

We O 0 3.677066706586629e-05
examined O 0 0.0003300693060737103
whether O 0 2.0963174392818473e-05
the O 0 8.217572030844167e-05
WD B-Disease 1 0.9806153178215027
gene O 0 0.0004792812396772206
ATP7B O 0 0.036485444754362106
was O 0 0.000373959745047614
also O 0 1.9145780242979527e-05
causative O 0 0.0008737742900848389
for O 0 1.9698854885064065e-05
CT B-Disease 1 0.9423272013664246
by O 0 6.61268904877943e-06
investigating O 0 0.0001820033648982644
the O 0 4.1320890886709094e-05
chromosomal O 0 0.012497860006988049
co O 0 0.0026345413643866777
- O 0 0.0002206804056186229
localization O 0 7.797520811436698e-05
of O 0 3.2245916372630745e-06
ATP7B O 0 0.038960050791502
and O 0 8.384436114283744e-06
C04107 O 0 0.00031664755078963935
, O 0 9.88958504422044e-07
using O 0 1.2401607136780513e-06
fluorescence O 0 6.18255726294592e-05
in O 0 1.312643234996358e-05
situ O 0 0.0026582928840070963
hybridization O 0 7.036336319288239e-05
( O 0 3.048565486096777e-05
FISH O 0 0.00033695102320052683
) O 0 1.603574310138356e-05
. O 0 3.796759119722992e-05

C04107 O 0 0.0024287893902510405
is O 0 1.8522880054661073e-05
an O 0 1.3202688023739029e-05
anonymous O 0 0.00024390561156906188
microsatellite O 0 0.0032969273161143064
marker O 0 0.0008802810916677117
closely O 0 0.00017285630747210234
linked O 0 0.007839099504053593
to O 0 7.320002623600885e-05
CT B-Disease 1 0.9941756725311279
. O 0 0.00020340913033578545

However O 0 0.00040753348730504513
, O 0 0.00016219791723415256
BAC O 0 0.019048703834414482
clones O 0 0.0020870573353022337
containing O 0 0.00027655865414999425
ATP7B O 0 0.03662117198109627
and O 0 8.214257832150906e-06
C04107 O 0 0.00043255023774690926
mapped O 0 4.698472184827551e-05
to O 0 1.761973862812738e-06
the O 0 2.378206409048289e-05
canine O 0 0.03915363922715187
chromosome O 0 0.00033169452217407525
regions O 0 1.5976444046827964e-05
CFA22q11 O 0 0.0035280019510537386
and O 0 1.2415983292157762e-05
CFA10q26 O 0 0.004194506909698248
, O 0 5.697199412679765e-06
respectively O 0 1.1982258911302779e-05
, O 0 2.639427520989557e-06
demonstrating O 0 4.3944743083557114e-05
that O 0 1.668422919465229e-05
WD B-Disease 1 0.9527330994606018
cannot O 0 1.5533021723967977e-05
be O 0 2.139485332008917e-06
homologous O 0 0.00010955840116366744
to O 0 2.076149576168973e-05
CT B-Disease 1 0.9802808165550232
. O 0 7.055969763314351e-05

The O 0 0.00019687430176418275
copper O 1 0.6515862941741943
transport O 0 0.0023768115788698196
genes O 0 0.0003592415596358478
CTR1 O 0 0.027514370158314705
and O 0 3.320640098536387e-05
CTR2 O 0 0.018795454874634743
were O 0 1.2830531886720564e-05
also O 0 8.308563337777741e-06
excluded O 0 2.864058842533268e-05
as O 0 2.686571860976983e-06
candidate O 0 7.017436473688576e-06
genes O 0 5.514354597835336e-06
for O 0 8.721025551494677e-06
CT B-Disease 1 0.9870320558547974
since O 0 3.617776383180171e-05
they O 0 5.904645377086126e-07
both O 0 4.773726800522127e-07
mapped O 0 4.109407018404454e-05
to O 0 7.210928288259311e-06
canine O 0 0.05439858138561249
chromosome O 0 0.0018609750550240278
region O 0 0.00027268732083030045
CFA11q22 O 0 0.03984573855996132
. O 0 0.00034543490619398654

2 O 0 0.0009460460860282183
- O 0 0.003450024640187621
22 O 0 0.00016034951840993017
. O 0 5.550956120714545e-05

5 O 0 0.0011445278069004416
. O 0 0.00021555813145823777

A O 0 7.973077299539e-05
transcribed O 0 9.796983795240521e-05
sequence O 0 7.119473139027832e-06
identified O 0 3.013647256011609e-05
from O 0 4.1605062506278045e-06
the O 0 1.0022922651842237e-05
C04107 O 0 0.0014548313338309526
- O 0 0.0002868343726731837
containing O 0 7.531015580752864e-05
BAC O 0 0.0067724669352173805
was O 0 7.834654388716444e-05
found O 0 3.16088357976696e-06
to O 0 1.4359957845044846e-07
be O 0 3.44694939258261e-07
homologous O 0 5.102966952108545e-06
to O 0 1.679475332139191e-07
a O 0 5.24323104400537e-06
gene O 0 1.7675482013146393e-05
expressed O 0 6.154941729619168e-06
from O 0 1.09951743070269e-05
human O 0 0.0001650526828598231
chromosome O 0 0.0008871520403772593
2p13 O 0 0.0044295829720795155
- O 0 0.0011959552066400647
p16 O 0 0.00037157064070925117
, O 0 1.5670593711547554e-06
a O 0 4.155759143031901e-06
region O 0 3.9566034502058756e-06
devoid O 0 2.4003769794944674e-05
of O 0 2.4729922643018654e-07
any O 0 3.3052813250833424e-06
positional O 0 0.0001518868375569582
candidate O 0 6.918580766068771e-05
genes O 0 8.203603647416458e-05
. O 0 6.956507422728464e-05

Molecular O 0 6.531592225655913e-05
analysis O 0 1.7083781358451233e-06
of O 0 5.982457196296309e-07
the O 0 2.313618824700825e-05
APC B-Disease 0 0.0073171197436749935
gene O 0 5.227394649409689e-05
in O 0 5.49869491806021e-06
205 O 0 0.00014512008056044579
families O 0 9.14269003260415e-06
: O 0 6.723872502334416e-06
extended O 0 5.6811393733369187e-05
genotype O 0 0.0012370799668133259
- O 0 0.0007148245349526405
phenotype O 0 0.0002693317364901304
correlations O 0 0.0001447799295419827
in O 0 5.506122761289589e-05
FAP B-Disease 1 0.938871443271637
and O 0 2.8206088700244436e-06
evidence O 0 1.1262550287938211e-05
for O 0 5.436667720459809e-07
the O 0 1.2938559166286723e-06
role O 0 4.035182428197004e-06
of O 0 1.284022232539428e-06
APC B-Disease 0 0.0060151428915560246
amino O 0 0.000186002318514511
acid O 0 0.1559300273656845
changes O 0 0.001025574398227036
in O 1 0.5258294939994812
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
predisposition O 1 0.9993433356285095
. O 0 0.00106464431155473

BACKGROUND O 0 0.001575044123455882
/ O 0 0.0008187414496205747
AIMS O 0 5.5417167459381744e-05
The O 0 6.766017122572521e-06
development O 0 5.7324366935063154e-05
of O 0 0.0012092078104615211
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999986886978149
and O 0 6.472635050158715e-06
a O 0 1.6460347978863865e-05
variable O 0 1.3143379874236416e-05
range O 0 5.463370143843349e-06
of O 0 2.791536417134921e-06
extracolonic O 0 0.42999696731567383
manifestations O 0 0.1775338500738144
in O 0 0.004014885984361172
familial B-Disease 1 0.9999853372573853
adenomatous I-Disease 1 0.9999901056289673
polyposis I-Disease 1 0.9999969005584717
( O 0 0.1491215080022812
FAP B-Disease 1 0.9992306232452393
) O 0 2.4005761588341556e-05
is O 0 3.4790807603712892e-06
the O 0 1.7298713146374212e-06
result O 0 5.032461103837704e-06
of O 0 3.285383911588724e-07
the O 0 1.8009228369919583e-05
dominant O 0 0.0004872984136454761
inheritance O 0 0.00459957355633378
of O 0 0.0014640487497672439
adenomatous B-Disease 1 0.9999958276748657
polyposis I-Disease 1 0.9999922513961792
coli I-Disease 1 0.9999808073043823
( O 0 0.0025293563958257437
APC B-Disease 1 0.9583916068077087
) O 0 9.606704406905919e-05
gene O 0 0.0006218199850991368
mutations O 0 0.000397874420741573
. O 0 0.00013613274495583028

In O 0 1.417075236531673e-05
this O 0 2.505885504433536e-06
study O 0 7.176304279710166e-06
, O 0 7.056495405777241e-07
direct O 0 5.87931992868107e-07
mutation O 0 3.752344809981878e-06
analysis O 0 2.451347427268047e-07
of O 0 2.4341878201994405e-07
the O 0 2.730263258854393e-05
APC B-Disease 0 0.010335198603570461
gene O 0 7.058203482301906e-05
was O 0 4.0693412302061915e-05
performed O 0 8.906804396247026e-06
to O 0 6.302490760390356e-07
determine O 0 1.3592556570074521e-05
genotype O 0 0.0007032877183519304
- O 0 0.0003237749042455107
phenotype O 0 0.00023923230764921755
correlations O 0 2.7822510674013756e-05
for O 0 3.4204194889753126e-06
nine O 0 4.561415335047059e-05
extracolonic O 0 0.017095722258090973
manifestations O 0 0.0005030094180256128
and O 0 2.1509993075596867e-06
to O 0 7.222416229524242e-07
investigate O 0 2.1386334992712364e-05
the O 0 1.2363697351247538e-05
incidence O 0 0.03618748486042023
of O 0 2.7288738237984944e-06
APC B-Disease 0 0.08613822609186172
mutations O 0 0.00034166910336352885
in O 0 5.5618347687413916e-05
non O 0 0.07720450311899185
- O 1 0.9994006156921387
FAP O 1 0.9999241828918457
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999984502792358
. O 0 0.0019198163645341992

METHODS O 0 6.239381764316931e-05
The O 0 4.952219387632795e-05
APC B-Disease 0 0.008538867346942425
gene O 0 0.00012190565030323341
was O 0 8.523620635969564e-05
analysed O 0 5.477115701069124e-05
in O 0 7.320955774048343e-06
190 O 0 8.752953726798296e-05
unrelated O 0 0.002190204570069909
FAP B-Disease 1 0.944610059261322
and O 0 1.6665240764268674e-05
15 O 0 0.0002369425055803731
non O 0 0.01908147893846035
- O 1 0.9991357922554016
FAP O 1 0.9999141693115234
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
patients O 1 0.9992795586585999
using O 0 0.00015848001930862665
denaturing O 0 0.14055827260017395
gradient O 0 0.004532264079898596
gel O 0 0.021196313202381134
electrophoresis O 0 0.0006844364106655121
, O 0 3.8070468235673616e-06
the O 0 1.842411506913777e-06
protein O 0 2.5179610020131804e-05
truncation O 0 0.0001637406530790031
test O 0 1.1196815648872871e-05
, O 0 1.0582951972537558e-06
and O 0 3.3652901265668334e-07
direct O 0 1.4626953088736627e-06
sequencing O 0 4.6751014451729134e-05
. O 0 4.6142526116454974e-05

RESULTS O 0 0.0025303238071501255
Chain O 0 0.0019557077903300524
terminating O 0 0.0012292886385694146
signals O 0 4.4026077375747263e-05
were O 0 2.430233735140064e-06
only O 0 2.414041318843374e-06
identified O 0 0.00010695739911170676
in O 0 2.8780030334019102e-05
patients O 1 0.9708367586135864
belonging O 0 3.654594547697343e-05
to O 0 4.3913692024943884e-06
the O 0 6.285328709054738e-05
FAP B-Disease 1 0.983043372631073
group O 0 6.265185947995633e-05
( O 0 4.457820614334196e-05
105 O 0 0.001738451886922121
patients O 1 0.9975469708442688
) O 0 0.00010781591845443472
. O 0 9.138264431385323e-05

Amino O 0 0.0001782337494660169
acid O 0 0.003983350470662117
changes O 0 3.4743789001367986e-05
were O 0 6.80671246300335e-06
identified O 0 4.762048411066644e-05
in O 0 6.758149083907483e-06
four O 0 3.511552858981304e-05
patients O 1 0.9983183145523071
, O 0 3.43474334840721e-06
three O 0 1.320333012699848e-06
of O 0 9.44214548326272e-07
whom O 0 8.204715413739905e-05
belonged O 0 0.000139859679620713
to O 0 1.0608001730361138e-06
the O 0 1.4347174328577239e-05
non O 0 0.0003069097874686122
- O 0 0.00804905965924263
FAP O 1 0.7432445883750916
group O 0 0.00020693069382105023
of O 0 0.004626550246030092
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
patients O 1 0.9999004602432251
. O 0 0.00178825156763196

Genotype O 0 0.014242047443985939
- O 0 0.007079883478581905
phenotype O 0 0.0018137780716642737
correlations O 0 0.0001566674472996965
identified O 0 8.133483061101288e-05
significant O 0 1.5396632079500705e-05
differences O 0 1.0573536201263778e-05
in O 0 3.016695018231985e-06
the O 0 2.4759990537859267e-06
nature O 0 1.5758500012452714e-05
of O 0 1.0738502851381782e-06
certain O 0 4.172367334831506e-05
extracolonic O 0 0.3600721061229706
manifestations O 0 0.16031882166862488
in O 0 0.002323463326320052
FAP B-Disease 1 0.9997979998588562
patients O 1 0.9986061453819275
belonging O 0 9.09937807591632e-05
to O 0 2.6668928967410466e-06
three O 0 1.0501964425202459e-05
mutation O 0 0.00047874674783088267
subgroups O 0 0.0003163804649375379
. O 0 0.00024333443434443325

CONCLUSIONS O 0 0.0009290145244449377
Extended O 0 0.0006817838293500245
genotype O 0 0.003634088672697544
- O 0 0.0013388320803642273
phenotype O 0 0.00028735361411236227
correlations O 0 2.4581191610195674e-05
made O 0 3.091156486334512e-06
in O 0 1.8936111700895708e-06
this O 0 1.6591901612628135e-06
study O 0 1.8363460185355507e-05
may O 0 1.564117701491341e-05
have O 0 2.3818351735371834e-07
the O 0 8.16746080545272e-07
potential O 0 1.036606363413739e-06
to O 0 8.779841209616279e-08
determine O 0 8.171995773409435e-07
the O 0 6.74989109938906e-07
most O 0 8.317604169860715e-07
appropriate O 0 5.183485427551204e-06
surveillance O 0 0.00011834793258458376
and O 0 2.028317794611212e-05
prophylactic O 1 0.8361659049987793
treatment O 1 0.9974188804626465
regimens O 1 0.7103503346443176
for O 0 3.055032357224263e-05
those O 0 9.414068335900083e-05
patients O 1 0.9990243911743164
with O 0 3.668222780106589e-05
mutations O 0 0.0005881203687749803
associated O 0 0.00014219192962627858
with O 0 0.00010237869719276205
life O 0 0.010146471671760082
threatening O 1 0.9945914149284363
conditions O 1 0.8787574172019958
. O 0 0.0008023083209991455

This O 0 1.659398913034238e-05
study O 0 3.8175123336259276e-05
also O 0 8.950384653871879e-06
provided O 0 9.24099913390819e-06
evidence O 0 1.0103169188369066e-05
for O 0 1.6506501197000034e-06
the O 0 1.3953933375887573e-05
pathological O 0 0.011937391944229603
nature O 0 1.3824997949996032e-05
of O 0 1.0181873904002714e-06
amino O 0 0.00017057356308214366
acid O 0 0.015958858653903008
changes O 0 3.711995668709278e-05
in O 0 1.8343524061492644e-05
APC O 0 0.020174473524093628
associated O 0 4.963679748470895e-05
with O 0 9.855419193627313e-06
both O 0 4.284995884518139e-05
FAP B-Disease 1 0.9925283193588257
and O 0 5.5632248404435813e-05
non O 0 0.3538160026073456
- O 1 0.9996727705001831
FAP O 1 0.9999527931213379
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999523162841797
. O 0 0.0005109707126393914
. O 0 0.000450968713266775

Inherited B-Disease 1 0.9999346733093262
colorectal I-Disease 1 0.9999996423721313
polyposis I-Disease 1 0.9999879598617554
and O 0 0.455587774515152
cancer B-Disease 1 0.999994158744812
risk O 0 0.0418262779712677
of O 0 2.8672902772086672e-06
the O 0 0.00015416833048220724
APC O 0 0.20703765749931335
I1307K O 0 0.0024292021989822388
polymorphism O 0 0.00034943525679409504
. O 0 5.9608908486552536e-05

Germ O 1 0.9895407557487488
- O 0 0.0027922645676881075
line O 0 6.278738874243572e-05
and O 0 3.442282377363881e-06
somatic O 0 0.000224129602429457
truncating O 0 0.0007782988250255585
mutations O 0 1.9958119082730263e-05
of O 0 5.050602567280293e-07
the O 0 3.4950451663462445e-05
APC B-Disease 0 0.019775692373514175
gene O 0 4.045267269248143e-05
are O 0 6.445658300435753e-07
thought O 0 1.0841044968401548e-05
to O 0 7.578570148325525e-06
initiate O 0 0.012737167999148369
colorectal B-Disease 1 0.9999971389770508
tumor I-Disease 1 0.9999521970748901
formation O 1 0.9680142402648926
in O 0 0.025051631033420563
familial B-Disease 1 0.9999954700469971
adenomatous I-Disease 1 0.9999980926513672
polyposis I-Disease 1 0.9999998807907104
syndrome I-Disease 1 0.9999998807907104
and O 0 0.08799728751182556
sporadic O 1 0.9995720982551575
colorectal O 1 0.9999997615814209
carcinogenesis O 1 0.9997332692146301
, O 0 0.00027173300622962415
respectively O 0 0.0008554697269573808
. O 0 0.00017980994016397744

Recently O 0 0.002020384417846799
, O 0 2.1617839593091048e-05
an O 0 4.4043626985512674e-05
isoleucine O 0 0.022614482790231705
- O 0 0.003620847826823592
- O 0 0.00033465580781921744
> O 0 0.0001526875130366534
lysine O 0 0.00016262255667243153
polymorphism O 0 8.96175333764404e-06
at O 0 1.7437849237467162e-05
codon O 0 4.337823702371679e-05
1307 O 0 0.0011630478547886014
( O 0 4.685874955612235e-06
I1307K O 0 6.441296864068136e-05
) O 0 2.962467249290057e-07
of O 0 8.861368883117393e-08
the O 0 6.124681931396481e-06
APC B-Disease 0 0.0032897659111768007
gene O 0 4.0713865018915385e-05
has O 0 7.864353392506018e-06
been O 0 5.59272621103446e-06
identified O 0 8.129050002025906e-06
in O 0 1.2130057029935415e-06
6 O 0 1.6678470274200663e-05
% O 0 5.487479029397946e-06
- O 0 3.107220618403517e-05
7 O 0 1.8316826526643126e-06
% O 0 3.4376327562313236e-07
of O 0 1.3689319189325033e-07
the O 0 1.0642083907441702e-05
Ashkenazi O 0 0.0006846729083918035
Jewish O 0 3.8163692806847394e-05
population O 0 1.307792445004452e-05
. O 0 8.772607543505728e-05

To O 0 1.725076072034426e-05
assess O 0 0.00011581039143493399
the O 0 1.6669057004037313e-05
risk O 0 0.000348607572959736
of O 0 4.169007752352627e-07
this O 0 5.953753770882031e-06
common O 0 0.0002222872426500544
APC B-Disease 0 0.49096885323524475
allelic O 0 0.04515903443098068
variant O 1 0.9961056113243103
in O 0 0.020380476489663124
colorectal O 1 0.9999988079071045
carcinogenesis O 1 0.9993645548820496
, O 0 2.168167702620849e-05
we O 0 1.2815816035072203e-06
have O 0 4.922575271848473e-07
analyzed O 0 7.607332008774392e-06
a O 0 4.713469934358727e-06
large O 0 1.1969697879976593e-05
cohort O 0 0.00020353541185613722
of O 0 3.548802169461851e-06
unselected O 0 0.15675756335258484
Ashkenazi O 0 0.004174672998487949
Jewish O 0 7.263263978529721e-05
subjects O 0 0.0003016490372829139
with O 0 0.0015339319361373782
adenomatous B-Disease 1 0.9998584985733032
polyps I-Disease 1 0.999516487121582
and O 0 0.0002052104682661593
. O 0 0.0016025427030399442
or O 1 0.9986830353736877
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
, I-Disease 0 2.6007232008851133e-05
for O 0 5.373306066758232e-06
the O 0 6.245548865990713e-05
APC O 0 0.03093036822974682
I1307K O 0 0.0031197841744869947
polymorphism O 0 0.0006024086615070701
. O 0 0.00010837088484549895

The O 0 8.535707456758246e-05
APC O 0 0.006742613390088081
I1307K O 0 0.0008048717281781137
allele O 0 6.292663601925597e-05
was O 0 0.00014682248001918197
identified O 0 4.364783308119513e-05
in O 0 2.678176315384917e-06
48 O 0 1.6137119018821977e-05
( O 0 1.9714768768608337e-06
10 O 0 1.3652934285346419e-06
. O 0 4.7431362304450886e-07
1 O 0 1.8742451857178821e-06
% O 0 1.000184852273378e-06
) O 0 9.320818890046212e-07
of O 0 2.7235648758505704e-06
476 O 1 0.900636613368988
patients O 1 0.9988387227058411
. O 0 0.00027329090517014265

Compared O 0 0.00010412947449367493
with O 0 1.7385359569743741e-06
the O 0 1.585936502124241e-06
frequency O 0 1.3359627928366535e-06
in O 0 5.243647933639295e-07
two O 0 3.287019865183538e-07
separate O 0 4.856037321587792e-06
population O 0 1.287028339902463e-06
control O 0 6.356451649480732e-06
groups O 0 6.885029506520368e-07
, O 0 2.377807277298416e-06
the O 0 8.123904081003275e-06
APC O 0 0.00718258460983634
I1307K O 0 0.00041985715506598353
allele O 0 2.3931039322633296e-05
is O 0 2.3499974304286297e-06
associated O 0 6.583604772458784e-06
with O 0 7.558307970612077e-07
an O 0 4.619254013960017e-06
estimated O 0 2.4013341317186132e-05
relative O 0 4.421958510647528e-05
risk O 0 0.0007269926718436182
of O 0 2.5267825094488217e-06
1 O 0 0.00022659526439383626
. O 0 0.00010665511945262551

5 O 0 0.0006928129587322474
- O 0 0.0019286723108962178
1 O 0 6.239584035938606e-05
. O 0 3.345011646160856e-05

7 O 0 0.0012504749465733767
for O 0 0.0010710039641708136
colorectal B-Disease 1 0.999996542930603
neoplasia I-Disease 1 0.9995478987693787
( O 0 5.250316098681651e-05
both O 0 1.077646629710216e-05
P O 0 0.046204570680856705
= O 0 0.001618124428205192
. O 0 2.720317388593685e-05
01 O 0 0.015490401536226273
) O 0 2.0561934434226714e-05
. O 0 3.063288386329077e-05

Furthermore O 0 0.000552905083168298
, O 0 2.8449378078221343e-05
compared O 0 0.00012609802070073783
with O 0 2.9555345463450067e-05
noncarriers O 0 0.03582139313220978
, O 0 6.252621824387461e-05
APC O 0 0.023859625682234764
I1307K O 0 0.0029488347936421633
carriers O 0 0.0007113726460374892
had O 0 7.093020394677296e-05
increased O 0 1.5127430742722936e-05
numbers O 0 2.8426823064364726e-06
of O 0 7.091007319104392e-06
adenomas B-Disease 1 0.9991341233253479
and O 0 0.007844309322535992
colorectal B-Disease 1 0.9999991655349731
cancers I-Disease 1 0.9999262094497681
per O 0 0.0003051964449696243
patient O 1 0.9967843294143677
( O 0 8.070808689808473e-05
P O 0 0.017160922288894653
= O 0 0.00030025889282114804
. O 0 9.536837751511484e-06
03 O 0 0.0020088711753487587
) O 0 1.6820011978779803e-06
, O 0 4.340463419794105e-07
as O 0 8.035822247620672e-07
well O 0 3.714050933467661e-07
as O 0 1.8326261397305643e-06
a O 0 1.4339322660816833e-05
younger O 0 0.00015483598690479994
age O 0 0.0010168919106945395
at O 0 0.0056847501546144485
diagnosis O 1 0.9992252588272095
. O 0 0.0005640838062390685

We O 0 6.745000973751303e-06
conclude O 0 4.469705527299084e-05
that O 0 1.2220602911838796e-06
the O 0 1.2315426829445641e-05
APC O 0 0.00906996987760067
I1307K O 0 0.0013900818303227425
variant O 0 0.0038329437375068665
leads O 0 0.00013271630450617522
to O 0 1.9552699086489156e-05
increased O 0 0.0008932659402489662
adenoma B-Disease 1 0.9998927116394043
formation O 0 0.0016178509686142206
and O 0 4.71244538857718e-06
directly O 0 8.489937499689404e-06
contributes O 0 2.6902871468337253e-05
to O 0 3.6479434584180126e-07
3 O 0 4.644335149350809e-06
% O 0 2.6800566956808325e-06
- O 0 1.5673549569328316e-05
4 O 0 1.3954872883914504e-06
% O 0 3.2280391337735637e-07
of O 0 1.79668830924129e-07
all O 0 4.504029220697703e-06
Ashkenazi O 0 0.16246162354946136
Jewish O 0 0.44475290179252625
colorectal B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999984502792358
. O 0 0.0026799251791089773

The O 0 6.78541837260127e-05
estimated O 0 8.53479650686495e-05
relative O 0 0.00020037233480252326
risk O 0 0.01623663865029812
for O 0 2.254665014334023e-05
carriers O 0 0.0024807918816804886
may O 0 0.0001434080331819132
justify O 0 8.327362593263388e-05
specific O 0 5.355395387596218e-06
clinical O 0 0.0017176077235490084
screening O 0 0.0001055817847372964
for O 0 1.1643678590189666e-06
the O 0 7.144039500417421e-06
360 O 0 3.1400144507642835e-05
, O 0 4.763994184031617e-06
000 O 0 1.7956817828235216e-05
Americans O 0 4.510055987339001e-06
expected O 0 4.363341304269852e-06
to O 0 1.0277127557856147e-06
harbor O 0 0.0008146821055561304
this O 0 7.440581271112023e-07
allele O 0 1.3237888197181746e-05
, O 0 8.114209890663915e-07
and O 0 6.234168949958985e-07
genetic O 0 3.679577275761403e-05
testing O 0 1.558899566589389e-05
in O 0 8.861417200023425e-07
the O 0 6.597820174647495e-07
setting O 0 3.2210202789428877e-06
of O 0 1.922558340083924e-06
long O 0 0.0021766494028270245
- O 0 0.0008813550230115652
term O 0 0.00010304176976205781
- O 0 0.00011993113002972677
outcome O 0 1.0199941243627109e-05
studies O 0 1.1126944627903868e-05
may O 0 9.056320413947105e-05
impact O 0 0.00032204389572143555
significantly O 0 0.022600434720516205
on O 1 0.8236919641494751
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
prevention O 1 0.9977693557739258
in O 0 2.2789585273130797e-05
this O 0 1.008145682135364e-05
population O 0 1.3969058272778057e-05
. O 0 6.798307731514797e-05

Localization O 0 0.00028500528424046934
of O 0 3.4230984056193847e-06
human O 0 0.00018826444284059107
BRCA1 O 0 0.0026496637146919966
and O 0 1.6265802287307451e-06
its O 0 4.612404609360965e-06
loss O 0 0.0007695438107475638
in O 0 1.4105416084930766e-05
high O 0 0.0015260529471561313
- O 0 0.001649894518777728
grade O 0 0.005613053683191538
, O 0 1.3364202459342778e-05
non B-Disease 0 0.0017645268235355616
- I-Disease 1 0.9953919649124146
inherited I-Disease 1 0.9998224377632141
breast I-Disease 1 0.9999908208847046
carcinomas I-Disease 1 0.9999773502349854
. O 0 0.003369242185726762

Although O 0 3.4045100619550794e-05
the O 0 1.1990489838353824e-05
link O 0 0.000119405536679551
between O 0 1.720746877253987e-05
the O 0 0.00048512895591557026
BRCA1 O 1 0.9967834949493408
tumour B-Disease 1 0.9999858140945435
- O 0 0.035238321870565414
suppressor O 0 0.002699990989640355
gene O 0 0.00017704098718240857
and O 0 0.00010146501881536096
hereditary B-Disease 1 0.9999009370803833
breast I-Disease 1 0.9999967813491821
and I-Disease 1 0.9986935257911682
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
is O 0 8.295311272377148e-05
established O 0 1.7777467292035e-05
, O 0 2.9090181214996846e-06
the O 0 3.1563536140311044e-06
role O 0 1.1002747669408564e-05
, O 0 1.7681094277577358e-06
if O 0 6.298488983702555e-07
any O 0 2.446314795179205e-07
, O 0 4.1427028918405995e-07
of O 0 4.934701678394049e-07
BRCA1 O 0 0.010421298444271088
in O 0 3.434547397773713e-05
non B-Disease 0 0.004481839947402477
- I-Disease 1 0.989546000957489
familial I-Disease 1 0.9995291233062744
cancers I-Disease 1 0.9999637603759766
is O 0 0.00016217918891925365
unclear O 0 0.0005097329267300665
. O 0 0.00023226723715197295

BRCA1 O 0 0.07251301407814026
mutations O 0 0.00029808771796524525
are O 0 4.11214432460838e-06
rare O 0 0.0014227504143491387
in O 0 9.387551108375192e-05
sporadic B-Disease 1 0.937492847442627
cancers I-Disease 1 0.9999486207962036
, O 0 3.3494678064016625e-05
but O 0 1.4862032912787981e-05
loss O 0 0.0008174660615622997
of O 0 6.775948804715881e-06
BRCA1 O 0 0.19288969039916992
resulting O 0 0.00041176070226356387
from O 0 3.1106719688978046e-05
reduced O 0 0.0003936459543183446
expression O 0 2.0625939214369282e-05
or O 0 1.0887201824516524e-05
incorrect O 0 7.236521923914552e-05
subcellular O 0 7.066076068440452e-05
localization O 0 9.530242823529989e-05
is O 0 3.0597914246754954e-06
postulated O 0 2.2912272470421158e-05
to O 0 2.0150376656147273e-07
be O 0 3.470153160378686e-07
important O 0 3.966876818140008e-07
in O 0 4.0822105802362785e-06
non B-Disease 0 0.0013905036030337214
- I-Disease 1 0.9169127345085144
familial I-Disease 1 0.9997534155845642
breast I-Disease 1 0.9999934434890747
and I-Disease 1 0.9956560134887695
ovarian I-Disease 1 1.0
cancers I-Disease 1 0.999997615814209
. O 0 0.004718718584626913

Epigenetic O 0 0.013244383968412876
loss O 0 0.4639888107776642
, O 0 3.845819446723908e-05
however O 0 3.3860931580420583e-05
, O 0 6.054198820493184e-06
has O 0 6.025829861755483e-06
not O 0 1.2241855529282475e-06
received O 0 2.4984998162835836e-05
general O 0 1.3013655006943736e-05
acceptance O 0 0.0001240392739418894
due O 0 0.00015298173821065575
to O 0 1.353585048491368e-06
controversy O 0 1.4713493328599725e-05
regarding O 0 1.4381161008714116e-06
the O 0 3.326106934764539e-06
subcellular O 0 7.771628588670865e-05
localization O 0 5.067621168564074e-05
of O 0 3.0683297609357396e-06
BRCA1 O 0 0.0037060484755784273
proteins O 0 1.3988214050186798e-05
, O 0 2.2659096430288628e-06
reports O 0 2.765921863101539e-06
of O 0 2.6148242682211276e-07
which O 0 2.7770333872467745e-06
have O 0 1.3148907100912766e-06
ranged O 0 6.0162736190250143e-05
from O 0 4.1143171074509155e-06
exclusively O 0 1.116591283789603e-05
nuclear O 0 0.0001527227577753365
, O 0 1.214860390064132e-06
to O 0 7.641162937943591e-07
conditionally O 0 0.000611710362136364
nuclear O 0 0.00011131077917525545
, O 0 1.7628294699534308e-06
to O 0 8.720806476958387e-07
the O 0 3.739474050235003e-05
ER O 1 0.9865289926528931
/ O 0 0.0011505766306072474
golgi O 0 0.0040497854351997375
, O 0 1.1249926501477603e-06
to O 0 4.987906550013577e-07
cytoplasmic O 0 7.98339387984015e-05
invaginations O 0 0.00025659927632659674
into O 0 1.4529853160638595e-06
the O 0 1.0178564480156638e-05
nucleus O 0 0.0004261278372723609
. O 0 4.975380579708144e-05

In O 0 9.570660040481016e-06
an O 0 6.690189820801606e-06
attempt O 0 1.2103701010346413e-05
to O 0 1.3556132216763217e-06
resolve O 0 6.116363510955125e-05
this O 0 2.0024413061037194e-06
issue O 0 1.748737668094691e-05
, O 0 2.8999879759794567e-06
we O 0 8.357415595128259e-07
have O 0 2.7834391858050367e-06
comprehensively O 0 0.0005326000391505659
characterized O 0 0.004209441598504782
19 O 0 0.0006993251736275852
anti O 0 0.2433559000492096
- O 0 0.06622931361198425
BRCA1 O 0 0.04602818563580513
antibodies O 0 0.0029920421075075865
. O 0 8.221443567890674e-05

These O 0 1.3257586033432744e-05
reagents O 0 0.0008157592383213341
detect O 0 0.00043136224849149585
a O 0 3.5563680285122246e-05
220 O 0 7.394257409032434e-05
- O 0 0.00027142695034854114
kD O 0 0.0004331603122409433
protein O 0 1.8744165572570637e-05
localized O 0 0.00010801267490023747
in O 0 1.050474224939535e-06
discrete O 0 6.835895874246489e-06
nuclear O 0 0.00022936364985071123
foci O 0 0.00016983755631372333
in O 0 2.5912288492691005e-06
all O 0 3.265088935222593e-06
epithelial O 1 0.9947494864463806
cell O 0 0.023403111845254898
lines O 0 8.423731924267486e-05
, O 0 2.5080994419113267e-06
including O 0 8.385246133002511e-07
those O 0 3.274319169577211e-06
derived O 0 0.00016523819067515433
from O 0 0.0013465809170156717
breast B-Disease 1 0.9999516010284424
malignancies I-Disease 1 0.9980233907699585
. O 0 0.0007020633784122765

Immunohistochemical O 0 0.0452912412583828
staining O 0 0.003497598459944129
of O 0 4.158939918852411e-05
human O 0 0.017206914722919464
breast O 1 0.9998981952667236
specimens O 0 0.00532733416184783
also O 0 0.00010791755630634725
revealed O 0 0.014688609167933464
BRCA1 O 0 0.16394223272800446
nuclear O 0 0.0013393646804615855
foci O 0 0.0044625550508499146
in O 0 0.000788119446951896
benign O 1 0.9999356269836426
breast O 1 0.9999834299087524
, O 0 0.0038424269296228886
invasive B-Disease 1 0.9997245669364929
lobular I-Disease 1 0.9999864101409912
cancers I-Disease 1 0.9999688863754272
and O 0 0.0002254896389786154
low B-Disease 1 0.9920056462287903
- I-Disease 1 0.9969043135643005
grade I-Disease 1 0.9991952776908875
ductal I-Disease 1 0.9999089241027832
carcinomas I-Disease 1 0.99996018409729
. O 0 0.0013227893505245447

Conversely O 0 0.002407896565273404
, O 0 6.808402395108715e-05
BRCA1 O 0 0.002492982428520918
expression O 0 2.4066159312496893e-05
was O 0 0.0002471581392455846
reduced O 0 0.00030762251117266715
or O 0 3.074069172726013e-05
undetectable O 0 0.013845359906554222
in O 0 5.744105919802678e-07
the O 0 7.02835450283601e-07
majority O 0 8.226434147218242e-07
of O 0 1.2606576547113946e-06
high O 0 0.01530749723315239
- O 0 0.09620925784111023
grade O 1 0.9206944108009338
, O 0 0.000344159547239542
ductal B-Disease 1 0.9998142123222351
carcinomas I-Disease 1 0.999942421913147
, O 0 6.183878576848656e-05
suggesting O 0 0.0003974901919718832
that O 0 5.379202775657177e-06
absence O 0 9.891531226458028e-05
of O 0 4.9956033763010055e-06
BRCA1 O 1 0.5874127745628357
may O 0 5.193482866161503e-05
contribute O 0 2.5567455850250553e-06
to O 0 2.1480710188370722e-07
the O 0 3.6962071590096457e-06
pathogenesis O 0 0.002802059520035982
of O 0 2.663723250861949e-07
a O 0 1.5075183000590187e-05
significant O 0 2.287480492668692e-05
percentage O 0 2.74768808594672e-05
of O 0 9.404810953128617e-06
sporadic B-Disease 1 0.9969725608825684
breast I-Disease 1 0.9999957084655762
cancers I-Disease 1 0.9999600648880005
. O 0 0.0002204093470936641
. O 0 0.000239371249335818

